Uniprot.ID	Protein.IDs	Gene.names	Ratio.H.L.2.5M_R1	Ratio.H.L.2.5M_R2	iBAQ.H	Ratio.H.L.100k_R1	Ratio.H.L.100k_R2	Ratio.H.L.20k_R1	Ratio.H.L.20k_R2	Ratio.H.L.500k_R1	Ratio.H.L.500k_R2	iBAQ.L	sum.NA.L	Gene.names.1st	sum.NA.H	Protein.names	DNA.binding	Function..CC.	Pathway	Gene.ontology..biological.process.	Gene.ontology..cellular.component.	Gene.ontology..molecular.function.	Subcellular.location..CC.	Cross.reference..GeneID.	Cross.reference..CDD.	Cross.reference..InterPro.	Cross.reference..Pfam.	Cross.reference..SMART.	Mass	Compositional.bias	Region	Absorption	Active.site	Activity.regulation	Binding.site	EC.number	Metal.binding	pH.dependence	Annotation	Features	Miscellaneous..CC.	Keywords	Domain..FT.	Domain..CC.	Motif	Repeat	Zinc.finger	Cross.reference..PROSITE.	Gene.ID.1st	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	PFAM	SUPFAM	logFC	adj.P.Val	col	log.p	iBAQ	Category	RBP	domain	domain1	domain2	domain3	rank	Category2
P35700	P35700	Prdx1	3.3358	3.3059	23277500	11.6283126155564	19.2196809532962	NA	17.6264255371653	13.088491289609	14.4759698899826	5039435	1	Prdx1	0	Peroxiredoxin-1 (EC 1.11.1.24) (Macrophage 23 kDa stress protein) (Osteoblast-specific factor 3) (OSF-3) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1)		FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2) (By similarity). Reduces an intramolecular disulfide bond in GDPD5 that gates the ability to GDPD5 to drive postmitotic motor neuron differentiation (PubMed:19766572). {ECO:0000250|UniProtKB:Q06830, ECO:0000269|PubMed:19766572}.		cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	heme binding [GO:0020037]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q06830}.	18477;		IPR000866;IPR024706;IPR019479;IPR036249;IPR013766;	PF10417;PF00578;		22176			NA	ACT_SITE 52;  /note=Cysteine sulfenic acid (-SOH) intermediate;  /evidence=ECO:0000250|UniProtKB:Q06830			1.11.1.24			5 out of 5	Active site (1); Chain (1); Cross-link (3); Disulfide bond (2); Domain (1); Initiator methionine (1); Modified residue (9); Sequence conflict (1)	MISCELLANEOUS: The active site is a conserved redox-active cysteine residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to cysteine sulfenic acid (C(P)-SOH), which then reacts with another cysteine residue, the resolving cysteine (C(R)), to form a disulfide bridge. The disulfide is subsequently reduced by an appropriate electron donor to complete the catalytic cycle. In this typical 2-Cys peroxiredoxin, C(R) is provided by the other dimeric subunit to form an intersubunit disulfide. The disulfide is subsequently reduced by thioredoxin. {ECO:0000250|UniProtKB:Q06830}.	Acetylation;Antioxidant;Cytoplasm;Direct protein sequencing;Disulfide bond;Isopeptide bond;Oxidoreductase;Peroxidase;Phosphoprotein;Redox-active center;Reference proteome;Ubl conjugation	DOMAIN 6..165;  /note=Thioredoxin;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00691					PS51352;	18477	GO:0000302~response to reactive oxygen species,GO:0001895~retina homeostasis,GO:0006979~response to oxidative stress,GO:0008283~cell proliferation,GO:0019430~removal of superoxide radicals,GO:0032872~regulation of stress-activated MAPK cascade,GO:0034101~erythrocyte homeostasis,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042744~hydrogen peroxide catabolic process,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0031012~extracellular matrix,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004601~peroxidase activity,GO:0008379~thioredoxin peroxidase activity,GO:0016209~antioxidant activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0051920~peroxiredoxin activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000866:Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR019479:Peroxiredoxin, C-terminal,IPR024706:Peroxiredoxin, AhpC-type,	PF00578:AhpC/TSA family,PF10417:C-terminal domain of 1-Cys peroxiredoxin,	SSF52833:Thioredoxin-like,	3.28180589473083	4.64892243668487e-06	FDR<0.01	5.33264769959036	14158467.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	165	Cell adhesion
Q8VDD5	Q8VDD5	Myh9	8.2581	83.827	4588550	9.3711929528629	7.81860828772478	8.37170364169108	7.59128520458514	4.39000834101585	7.81616382679381	3191445	0	Myh9	0	Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)		FUNCTION: Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping (PubMed:19401332). Required for cortical actin clearance prior to oocyte exocytosis (PubMed:31118423). Promotes cell motility in conjunction with S100A4 (By similarity). During cell spreading, plays an important role in cytoskeleton reorganization, focal contact formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanically antagonized by MYH10 (By similarity). {ECO:0000250|UniProtKB:P35579, ECO:0000269|PubMed:19401332, ECO:0000269|PubMed:31118423}.		actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell morphogenesis involved in differentiation [GO:0000904]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]	actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]	actin binding [GO:0003779]; actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19401332}. Cytoplasm, cell cortex {ECO:0000269|PubMed:19401332, ECO:0000269|PubMed:31118423}. Cytoplasmic vesicle, secretory vesicle, Cortical granule {ECO:0000269|PubMed:31118423}. Note=Colocalizes with actin filaments at lamellipodia margins and at the leading edge of migrating cells (By similarity). In retinal pigment epithelial cells, predominantly localized to stress fiber-like structures with some localization to cytoplasmic puncta (By similarity). {ECO:0000250|UniProtKB:P35579}.	17886;		IPR000048;IPR036961;IPR001609;IPR027401;IPR004009;IPR008989;IPR002928;IPR027417;	PF00063;PF02736;PF01576;	SM00015;SM00242;	226372	COMPBIAS 1117..1149;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1770..1788;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..838;  /note=Mediates interaction with LIMCH1;  /evidence=ECO:0000250|UniProtKB:P35579; REGION 654..676;  /note=Actin-binding; REGION 1035..1057;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1117..1167;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1327..1352;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1768..1788;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1877..1908;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1939..1960;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Domain (3); Erroneous initiation (1); Initiator methionine (1); Modified residue (30); Nucleotide binding (1); Region (8); Sequence conflict (1)		ATP-binding;Acetylation;Actin-binding;Calmodulin-binding;Cell adhesion;Cell shape;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Direct protein sequencing;Methylation;Motor protein;Myosin;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 27..77;  /note=Myosin N-terminal SH3-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01190; DOMAIN 81..776;  /note=Myosin motor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00782; DOMAIN 779..808;  /note=IQ;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00116	DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles of a 28-residue repeat pattern composed of 4 heptapeptides, characteristic for alpha-helical coiled coils.				PS50096;PS51456;PS51844;	17886	GO:0000212~meiotic spindle organization,GO:0000904~cell morphogenesis involved in differentiation,GO:0000910~cytokinesis,GO:0001525~angiogenesis,GO:0001701~in utero embryonic development,GO:0001768~establishment of T cell polarity,GO:0006509~membrane protein ectodomain proteolysis,GO:0006911~phagocytosis, engulfment,GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007520~myoblast fusion,GO:0008360~regulation of cell shape,GO:0015031~protein transport,GO:0016337~single organismal cell-cell adhesion,GO:0030041~actin filament polymerization,GO:0030048~actin filament-based movement,GO:0030220~platelet formation,GO:0030224~monocyte differentiation,GO:0031032~actomyosin structure organization,GO:0031532~actin cytoskeleton reorganization,GO:0032796~uropod organization,GO:0043534~blood vessel endothelial cell migration,GO:0051295~establishment of meiotic spindle localization,GO:0051693~actin filament capping,GO:0061024~membrane organization,GO:0070527~platelet aggregation,GO:1903919~negative regulation of actin filament severing,GO:1903923~positive regulation of protein processing in phagocytic vesicle,	GO:0001725~stress fiber,GO:0001726~ruffle,GO:0001772~immunological synapse,GO:0001931~uropod,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005826~actomyosin contractile ring,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0008180~COP9 signalosome,GO:0008305~integrin complex,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030863~cortical cytoskeleton,GO:0031012~extracellular matrix,GO:0031252~cell leading edge,GO:0031594~neuromuscular junction,GO:0032154~cleavage furrow,GO:0042641~actomyosin,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0097513~myosin II filament,	GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0019904~protein domain specific binding,GO:0030898~actin-dependent ATPase activity,GO:0042803~protein homodimerization activity,GO:0043495~protein anchor,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR002928:Myosin tail,IPR004009:Myosin, N-terminal, SH3-like,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00063:Myosin head (motor domain),PF01576:Myosin tail,PF02736:Myosin N-terminal SH3-like domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.34010591389604	4.02192606016616e-06	FDR<0.01	5.3955659178161	3889997.5	Present in Nucleus	RBP	Others	Others	Others	Others	433	Cell adhesion
Q61553	Q61553	Fscn1	11.901	11.245	3864750	4.31853515287614	7.26321905868681	3.0539013589861	NA	7.29660707770886	3.64963503649635	1725540.5	1	Fscn1	0	Fascin (Singed-like protein)		FUNCTION: Actin-binding protein that contains 2 major actin binding sites (By similarity). Organizes filamentous actin into parallel bundles (PubMed:7738015). Plays a role in the organization of actin filament bundles and the formation of microspikes, membrane ruffles, and stress fibers (By similarity). Important for the formation of a diverse set of cell protrusions, such as filopodia, and for cell motility and migration (PubMed:21685497). Mediates reorganization of the actin cytoskeleton and axon growth cone collapse in response to NGF (By similarity). {ECO:0000250|UniProtKB:Q16658, ECO:0000269|PubMed:21685497, ECO:0000269|PubMed:7738015}.		actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell-cell junction assembly [GO:0007043]; cell migration [GO:0016477]; cell motility [GO:0048870]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534]	actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; drug binding [GO:0008144]; protein-macromolecule adaptor activity [GO:0030674]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q16658}. Cytoplasm, cell cortex {ECO:0000250|UniProtKB:Q16658}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q16658}. Cytoplasm, cytoskeleton, stress fiber {ECO:0000250|UniProtKB:Q16658}. Cell projection, growth cone {ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:24720729}. Cell projection, filopodium {ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:24720729}. Cell projection, invadopodium {ECO:0000269|PubMed:24720729}. Cell projection, microvillus {ECO:0000250|UniProtKB:Q16658}. Cell junction {ECO:0000250|UniProtKB:Q16658}. Note=Colocalized with RUFY3 and F-actin at filipodia of the axonal growth cone (PubMed:24720729). Colocalized with DBN1 and F-actin at the transitional domain of the axonal growth cone (PubMed:24720729). {ECO:0000250|UniProtKB:Q16658, ECO:0000269|PubMed:24720729}.	14086;	cd00257;	IPR008999;IPR010431;IPR022768;IPR024703;IPR030146;	PF06268;		54508			NA							5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (8); Sequence conflict (12)		Acetylation;Actin-binding;Cell junction;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: Composed of four fascin beta-trefoil domains. {ECO:0000250|UniProtKB:Q16658}.					14086	GO:0007015~actin filament organization,GO:0007043~cell-cell junction assembly,GO:0007163~establishment or maintenance of cell polarity,GO:0009653~anatomical structure morphogenesis,GO:0010592~positive regulation of lamellipodium assembly,GO:0016477~cell migration,GO:0030035~microspike assembly,GO:0030036~actin cytoskeleton organization,GO:0032534~regulation of microvillus assembly,GO:0032956~regulation of actin cytoskeleton organization,GO:0035089~establishment of apical/basal cell polarity,GO:0048870~cell motility,GO:0051017~actin filament bundle assembly,GO:0051491~positive regulation of filopodium assembly,GO:0071803~positive regulation of podosome assembly,GO:0090091~positive regulation of extracellular matrix disassembly,GO:0098609~cell-cell adhesion,	GO:0001725~stress fiber,GO:0001726~ruffle,GO:0002102~podosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0030426~growth cone,GO:0031253~cell projection membrane,GO:0031941~filamentous actin,GO:0042995~cell projection,GO:0043209~myelin sheath,GO:0044393~microspike,GO:0070062~extracellular exosome,GO:0071437~invadopodium,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008144~drug binding,GO:0030674~protein binding, bridging,GO:0044822~poly(A) RNA binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR008999:Actin cross-linking,IPR010431:Fascin,IPR022768:Fascin domain,IPR024703:Fascin, metazoans,	PF06268:Fascin domain,	SSF50405:Actin-crosslinking proteins,	2.62585788743924	4.48450041687231e-06	FDR<0.01	5.34828593127773	2795145.25	Unexpected	RBP	Others	Others	Others	Others	524	Cell adhesion
Q91VX2	Q91VX2	Ubap2	3.2847	7.0446	2237950	8.20950660865282	7.5007500750075	9.01144453455889	7.65052406089817	12.0949697021009	28.3881224095838	1732378.33333333	0	Ubap2	0	Ubiquitin-associated protein 2 (UBAP-2) (Protein lingerer homolog 1) (mLig-1)					cytoplasm [GO:0005737]; nucleus [GO:0005634]			68926;		IPR015940;IPR009060;IPR022166;	PF12478;	SM00165;	117966	COMPBIAS 105..171;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 186..202;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 389..404;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 421..455;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 602..639;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 648..679;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 892..914;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 999..1033;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1090..1132;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 95..202;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 221..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 331..351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 380..479;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 602..679;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 713..749;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 875..919;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 996..1033;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1040..1059;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1087..1132;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (9); Domain (1); Modified residue (4); Region (11); Sequence conflict (1)		Methylation;Phosphoprotein;Reference proteome	DOMAIN 48..92;  /note=UBA;  /evidence=ECO:0000255						68926	GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR009060:UBA-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR022166:Protein of unknown function DUF3697, ubiquitin-associated protein 2,	PF12478:Ubiquitin-associated protein 2 ,	SSF46934:UBA-like,	3.12593469193819	4.36522045613342e-07	FDR<0.01	6.35999381828955	1985164.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	620	Cell adhesion
P26231	P26231	Ctnna1	6.5664	4.742	1181405	5.07227998985544	6.63922453857389	NA	4.31890818001209	3.21667524446732	1.70227253383267	1422385	1	Ctnna1	0	Catenin alpha-1 (102 kDa cadherin-associated protein) (Alpha E-catenin) (CAP102)		FUNCTION: Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. Involved in the regulation of WWTR1/TAZ, YAP1 and TGFB1-dependent SMAD2 and SMAD3 nuclear accumulation (PubMed:21145499). May play a crucial role in cell differentiation. {ECO:0000269|PubMed:16325583, ECO:0000269|PubMed:21145499}.		actin filament organization [GO:0007015]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; gap junction assembly [GO:0016264]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein localization to nucleus [GO:1900181]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]	acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]	actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cell junction, adherens junction. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction. Note=Found at cell-cell boundaries and probably at cell-matrix boundaries.	12385;		IPR036723;IPR001033;IPR030047;IPR006077;IPR000633;	PF01044;		100106	COMPBIAS 864..884;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..228;  /note=Involved in homodimerization;  /evidence=ECO:0000250; REGION 97..148;  /note=Interaction with JUP and CTNNB1;  /evidence=ECO:0000250; REGION 325..394;  /note=Interaction with alpha-actinin;  /evidence=ECO:0000250; REGION 864..894;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (4); Chain (1); Compositional bias (1); Cross-link (2); Helix (25); Initiator methionine (1); Modified residue (11); Mutagenesis (5); Region (4); Turn (2)		3D-structure;Acetylation;Cell adhesion;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Membrane;Phosphoprotein;Reference proteome;Ubl conjugation						PS00663;	12385	GO:0001541~ovarian follicle development,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007406~negative regulation of neuroblast proliferation,GO:0007568~aging,GO:0008584~male gonad development,GO:0016264~gap junction assembly,GO:0031103~axon regeneration,GO:0034613~cellular protein localization,GO:0042127~regulation of cell proliferation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0043066~negative regulation of apoptotic process,GO:0043297~apical junction assembly,GO:0043627~response to estrogen,GO:0045880~positive regulation of smoothened signaling pathway,GO:0051291~protein heterooligomerization,GO:0071681~cellular response to indole-3-methanol,GO:0090136~epithelial cell-cell adhesion,GO:2000146~negative regulation of cell motility,GO:2001045~negative regulation of integrin-mediated signaling pathway,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0001669~acrosomal vesicle,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005915~zonula adherens,GO:0005925~focal adhesion,GO:0014704~intercalated disc,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016342~catenin complex,GO:0016600~flotillin complex,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0043231~intracellular membrane-bounded organelle,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0017166~vinculin binding,GO:0044822~poly(A) RNA binding,GO:0045295~gamma-catenin binding,GO:0045296~cadherin binding,GO:0046982~protein heterodimerization activity,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000633:Vinculin, conserved site,IPR001033:Alpha-catenin,IPR006077:Vinculin/alpha-catenin,	PF01044:Vinculin family,	SSF47220:alpha-catenin/vinculin-like,	2.08542091328114	1.77689640613136e-05	FDR<0.01	4.75033789102248	1301895	Unexpected	RBP	Others	Others	Others	Others	743	Cell adhesion
Q80X90	Q80X90;Q8VHX6-2;Q8VHX6	Flnb	3.0018	3.2713	1326345	4.57331016189518	3.54220537706776	7.73156022885418	3.78830927756942	2.72034820457019	4.28724544480171	700768.333333333	0	Flnb	0	Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin)		FUNCTION: Connects cell membrane constituents to the actin cytoskeleton. May promote orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton (By similarity). {ECO:0000250}.		actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519]	brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin binding [GO:0003779]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, stress fiber {ECO:0000250}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000250}.	286940;	cd00014;	IPR001589;IPR001715;IPR036872;IPR017868;IPR001298;IPR029874;IPR013783;IPR014756;	PF00307;PF00630;	SM00033;SM00557;	277825		REGION 1..239;  /note=Actin-binding; REGION 244..267;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 837..862;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1705..1728;  /note=Hinge 1;  /evidence=ECO:0000250; REGION 2472..2602;  /note=Self-association site, tail;  /evidence=ECO:0000250; REGION 2472..2506;  /note=Hinge 2;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Cross-link (1); Domain (2); Modified residue (24); Region (6); Repeat (24)		Acetylation;Actin-binding;Cytoplasm;Cytoskeleton;Isopeptide bond;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 16..122;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 139..242;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044	DOMAIN: Comprised of a NH2-terminal actin-binding domain, 24 internally homologous repeats and two hinge regions. Repeat 24 and the second hinge domain are important for dimer formation. The first hinge region prevents binding to ITGA and ITGB subunits (By similarity). {ECO:0000250}.		REPEAT 249..347;  /note=Filamin 1; REPEAT 349..446;  /note=Filamin 2; REPEAT 447..543;  /note=Filamin 3; REPEAT 544..636;  /note=Filamin 4; REPEAT 640..736;  /note=Filamin 5; REPEAT 737..839;  /note=Filamin 6; REPEAT 840..938;  /note=Filamin 7; REPEAT 939..1034;  /note=Filamin 8; REPEAT 1035..1127;  /note=Filamin 9; REPEAT 1128..1222;  /note=Filamin 10; REPEAT 1223..1322;  /note=Filamin 11; REPEAT 1323..1415;  /note=Filamin 12; REPEAT 1416..1511;  /note=Filamin 13; REPEAT 1512..1608;  /note=Filamin 14; REPEAT 1609..1704;  /note=Filamin 15; REPEAT 1729..1813;  /note=Filamin 16; REPEAT 1816..1908;  /note=Filamin 17; REPEAT 1919..1994;  /note=Filamin 18; REPEAT 1997..2089;  /note=Filamin 19; REPEAT 2091..2185;  /note=Filamin 20; REPEAT 2188..2280;  /note=Filamin 21; REPEAT 2282..2375;  /note=Filamin 22; REPEAT 2379..2471;  /note=Filamin 23; REPEAT 2507..2601;  /note=Filamin 24		PS00019;PS00020;PS50021;PS50194;	286940	GO:0003334~keratinocyte development,GO:0003382~epithelial cell morphogenesis,GO:0007519~skeletal muscle tissue development,GO:0030036~actin cytoskeleton organization,GO:0030154~cell differentiation,GO:0098609~cell-cell adhesion,	GO:0001725~stress fiber,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0030018~Z disc,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001298:Filamin/ABP280 repeat,IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,	PF00307:Calponin homology (CH) domain,PF00630:Filamin/ABP280 repeat,	SSF47576:Calponin-homology domain, CH-domain,SSF81296:E set domains,	1.96621682438852	1.5700085213767e-06	FDR<0.01	5.80409799040807	1013556.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	816	Cell adhesion
E9Q557	E9Q557	Dsp	NA	2.7459	16138	NA	1.89875821212927	3.7015102161682	17.1326754385965	NA	2.11555141847723	16002.15	2	Dsp	1	Desmoplakin (DP)		FUNCTION: Major high molecular weight protein of desmosomes. Involved in the organization of the desmosomal cadherin-plakoglobin complexes into discrete plasma membrane domains and in the anchoring of intermediate filaments to the desmosomes.		adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060]	basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; protein kinase C binding [GO:0005080]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]	SUBCELLULAR LOCATION: Cell junction, desmosome {ECO:0000250|UniProtKB:P15924}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P15924}. Cell membrane {ECO:0000269|PubMed:26403541}. Note=Innermost portion of the desmosomal plaque. Colocalizes with epidermal KRT5-KRT14 and simple KRT8-KRT18 keratins and VIM intermediate filaments network (By similarity). Localizes at the intercalated disk in cardiomyocytes (PubMed:26403541). {ECO:0000250|UniProtKB:P15924, ECO:0000269|PubMed:26403541}.	109620;		IPR028462;IPR041615;IPR041573;IPR043197;IPR035915;IPR001101;IPR001452;IPR018159;	PF00681;PF17902;PF18373;	SM00250;SM00150;	332912	COMPBIAS 2823..2883;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..1068;  /note=Globular 1; REGION 1..596;  /note=Interaction with plakophilin 1 and junction plakoglobin;  /evidence=ECO:0000250; REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1069..1957;  /note=Central fibrous rod domain; REGION 1958..2882;  /note=Globular 2; REGION 1972..2220;  /note=4.5 X 38 AA tandem repeats (Domain A); REGION 2256..2458;  /note=4.5 X 38 AA tandem repeats (Domain B); REGION 2621..2833;  /note=4.5 X 38 AA tandem repeats (Domain C); REGION 2822..2883;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2835..2858;  /note=6 X 4 AA tandem repeats of G-S-R-[SR]	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (1); Domain (1); Lipidation (1); Modified residue (24); Region (10); Repeat (24)		Cardiomyopathy;Cell junction;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Methylation;Phosphoprotein;Reference proteome;Repeat;SH3 domain	DOMAIN 470..527;  /note=SH3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00192	DOMAIN: Its association with epidermal and simple keratins is dependent on the tertiary structure induced by heterodimerization of these intermediate filaments proteins and most likely involves recognition sites located in the rod domain of these keratins. {ECO:0000250}.; DOMAIN: The N-terminal region is required for localization to the desmosomal plaque and interacts with the N-terminal region of plakophilin 1. {ECO:0000250}.; DOMAIN: The three tandem plakin repeat regions in the C-terminus mediate binding to intermediate filaments. {ECO:0000250}.		REPEAT 190..283;  /note=Spectrin 1; REPEAT 284..387;  /note=Spectrin 2; REPEAT 388..458;  /note=Spectrin 3a; REPEAT 528..557;  /note=Spectrin 3b; REPEAT 558..639;  /note=Spectrin 4; REPEAT 666..781;  /note=Spectrin 5; REPEAT 782..895;  /note=Spectrin 6; REPEAT 2021..2057;  /note=Plectin 1; REPEAT 2058..2095;  /note=Plectin 2; REPEAT 2096..2133;  /note=Plectin 3; REPEAT 2134..2171;  /note=Plectin 4; REPEAT 2175..2209;  /note=Plectin 5; REPEAT 2210..2245;  /note=Plectin 6; REPEAT 2263..2300;  /note=Plectin 7; REPEAT 2301..2338;  /note=Plectin 8; REPEAT 2339..2376;  /note=Plectin 9; REPEAT 2377..2414;  /note=Plectin 10; REPEAT 2418..2452;  /note=Plectin 11; REPEAT 2468..2505;  /note=Plectin 12; REPEAT 2519..2556;  /note=Plectin 13; REPEAT 2622..2659;  /note=Plectin 14; REPEAT 2660..2697;  /note=Plectin 15; REPEAT 2736..2773;  /note=Plectin 16; REPEAT 2774..2811;  /note=Plectin 17		PS50002;	109620	GO:0002934~desmosome organization,GO:0003223~ventricular compact myocardium morphogenesis,GO:0016337~single organismal cell-cell adhesion,GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,GO:0034332~adherens junction organization,GO:0042060~wound healing,GO:0043588~skin development,GO:0045104~intermediate filament cytoskeleton organization,GO:0045109~intermediate filament organization,GO:0071896~protein localization to adherens junction,GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication,GO:0086091~regulation of heart rate by cardiac conduction,GO:0098911~regulation of ventricular cardiac muscle cell action potential,	GO:0001533~cornified envelope,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005916~fascia adherens,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030057~desmosome,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005080~protein kinase C binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0044822~poly(A) RNA binding,GO:0050839~cell adhesion molecule binding,GO:0097110~scaffold protein binding,	IPR001101:Plectin repeat,IPR018159:Spectrin/alpha-actinin,	PF00681:Plectin repeat,	SSF75399:Plakin repeat,	1.89003232145611	0.00416263373562742	FDR<0.01	2.38063180040166	16070.075	Present in Nucleus	RBP	Others	Others	Others	Others	1455	Cell adhesion
Q9CPR4	Q9CPR4	Rpl17	32.863	28.347	66170500	19.6394202443144	30.5623471882641	14.3688483368058	18.7213329589067	49.438868838681	47.0743303676505	66071166.6666667	0	Rpl17	0	60S ribosomal protein L17		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P18621}.		cytoplasmic translation [GO:0002181]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]	A band [GO:0031672]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]			cd00336;	IPR001063;IPR018260;IPR005721;IPR036394;	PF00237;		21423	COMPBIAS 170..184;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 160..184;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Region (1)		3D-structure;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00464;	NA	GO:0006412~translation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,GO:0005844~polysome,GO:0015934~large ribosomal subunit,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR001063:Ribosomal protein L22/L17,IPR005721:Ribosomal protein L22/L17, eukaryotic/archaeal,IPR018260:Ribosomal protein L22/L17, conserved site,	PF00237:Ribosomal protein L22p/L17e,	SSF54843:Ribosomal protein L22,	4.79360082450283	6.69652395989103e-10	FDR<0.01	9.1741505729379	66120833.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	40	Cell cycle
Q8BK67	Q8BK67	Rcc2	4.3495	5.3457	95072000	25.4848492571166	18.31099392075	16.0305221141053	5.55401277422938	26.1882938326568	44.7647611799991	34427966.6666667	0	Rcc2	0	Protein RCC2		FUNCTION: Multifunctional protein that may effect its functions by regulating the activity of small GTPases, such as RAC1 and RALA. Required for normal progress through the cell cycle, both during interphase and during mitosis. Required for the presence of normal levels of MAD2L1, AURKB and BIRC5 on inner centromeres during mitosis, and for normal attachment of kinetochores to mitotic spindles. Required for normal organization of the microtubule cytoskeleton in interphase cells. Functions as guanine nucleotide exchange factor (GEF) for RALA. Interferes with the activation of RAC1 by guanine nucleotide exchange factors (By similarity). Prevents accumulation of active, GTP-bound RAC1, and suppresses RAC1-mediated reorganization of the actin cytoskeleton and formation of membrane protrusions (PubMed:25074804). Required for normal cellular responses to contacts with the extracellular matrix of adjacent cells, and for directional cell migration in response to a fibronectin gradient (in vitro) (By similarity). {ECO:0000250|UniProtKB:Q9P258, ECO:0000269|PubMed:25074804}.		activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]	chromosome, centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9P258}. Nucleus {ECO:0000250|UniProtKB:Q9P258}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9P258}. Chromosome, centromere {ECO:0000250|UniProtKB:Q9P258}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q9P258}. Chromosome {ECO:0000250|UniProtKB:Q9P258}. Midbody {ECO:0000250|UniProtKB:Q9P258}. Cell membrane {ECO:0000250|UniProtKB:Q9P258}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q9P258}; Cytoplasmic side {ECO:0000250|UniProtKB:Q9P258}. Note=Appears in the nucleus at G2, then concentrates at the inner centromere region of chromosomes during prophase. Redistributes to the midzone of the mitotic spindle during anaphase. Here, the protein covers the entire equatorial diameter from cortex to cortex. Colocalizes with cytoplasmic microtubules in interphase cells. Colocalizes with RAC1 at the cell membrane. {ECO:0000250|UniProtKB:Q9P258}.	108911;		IPR009091;IPR028641;IPR000408;	PF00415;		55983		REGION 1..78;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..323;  /note=Required for interaction with RAC1;  /evidence=ECO:0000250|UniProtKB:Q9P258	NA							5 out of 5	Chain (1); Modified residue (13); Region (2); Repeat (7)		Acetylation;Cell cycle;Cell division;Cell membrane;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Guanine-nucleotide releasing factor;Membrane;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 101..163;  /note=RCC1 1; REPEAT 166..217;  /note=RCC1 2; REPEAT 219..269;  /note=RCC1 3; REPEAT 271..345;  /note=RCC1 4; REPEAT 346..399;  /note=RCC1 5; REPEAT 401..445;  /note=RCC1 6; REPEAT 446..499;  /note=RCC1 7		PS00626;PS50012;	108911	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007229~integrin-mediated signaling pathway,GO:0010762~regulation of fibroblast migration,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0030334~regulation of cell migration,GO:0034260~negative regulation of GTPase activity,GO:0045184~establishment of protein localization,GO:0048041~focal adhesion assembly,GO:0051301~cell division,GO:0051895~negative regulation of focal adhesion assembly,GO:0051987~positive regulation of attachment of spindle microtubules to kinetochore,GO:0072356~chromosome passenger complex localization to kinetochore,GO:0090630~activation of GTPase activity,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1900027~regulation of ruffle assembly,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031901~early endosome membrane,GO:0034506~chromosome, centromeric core domain,GO:1990023~mitotic spindle midzone,	GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031267~small GTPase binding,GO:0044822~poly(A) RNA binding,GO:0048365~Rac GTPase binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,	PF00415:Regulator of chromosome condensation (RCC1) repeat,	SSF50985:RCC1/BLIP-II,	3.75960703852496	1.14707777744568e-06	FDR<0.01	5.94040713382473	64749983.3333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	42	Cell cycle
P97452	P97452	Bop1	1.149	1.6526	28532500	2.63657456232862	2.11394144382201	3.64843664489766	1.76289114147201	2.78256998163504	2.49775202317914	29251183.3333333	0	Bop1	0	Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein)		FUNCTION: Component of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S ribosome. {ECO:0000255|HAMAP-Rule:MF_03027, ECO:0000269|PubMed:10891491, ECO:0000269|PubMed:11390653, ECO:0000269|PubMed:12048210}.		cell population proliferation [GO:0008283]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex [GO:1990904]	ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm.	12181;		IPR028598;IPR012953;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF08145;PF00400;	SM01035;SM00320;	82546	COMPBIAS 34..48;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 71..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..93;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 251..413;  /note=Sufficient for nucleolar localization	NA							5 out of 5	Chain (1); Compositional bias (2); Erroneous initiation (1); Modified residue (3); Region (2); Repeat (7); Sequence conflict (3)		Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;WD repeat;rRNA processing				REPEAT 397..436;  /note=WD 1; REPEAT 438..478;  /note=WD 2; REPEAT 518..560;  /note=WD 3; REPEAT 563..601;  /note=WD 4; REPEAT 604..643;  /note=WD 5; REPEAT 647..686;  /note=WD 6; REPEAT 702..732;  /note=WD 7		PS00678;PS50082;PS50294;	12181	GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0008283~cell proliferation,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0030687~preribosome, large subunit precursor,GO:0070545~PeBoW complex,	GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR012953:BOP1, N-terminal domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,PF08145:BOP1NT (NUC169) domain,	SSF50978:WD40 repeat-like,	1.11074832498191	0.000389325414842672	FDR<0.01	3.40968724497009	28891841.6666667	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	83	Cell cycle
P62754	P62754	Rps6	12.243	32.789	20438000	31.9182891797	33.1762988521001	32.4580479729949	16.8219897049423	36.7714653428939	44.1657097429556	30829850	0	Rps6	0	40S ribosomal protein S6 (Phosphoprotein NP33)		FUNCTION: Component of the 40S small ribosomal subunit (By similarity). Plays an important role in controlling cell growth and proliferation through the selective translation of particular classes of mRNA (By similarity). {ECO:0000250|UniProtKB:P62753}.		activation-induced cell death of T cells [GO:0006924]; erythrocyte development [GO:0048821]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; glucose homeostasis [GO:0042593]; mammalian oogenesis stage [GO:0022605]; mitotic cell cycle [GO:0000278]; negative regulation of apoptotic process [GO:0043066]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; T cell differentiation in thymus [GO:0033077]; T cell proliferation involved in immune response [GO:0002309]; TOR signaling [GO:0031929]; translation [GO:0006412]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]	mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; structural constituent of ribosome [GO:0003735]		105244208;20104;		IPR014401;IPR001377;IPR018282;	PF01092;	SM01405;	28681	COMPBIAS 217..233;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 217..249;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Modified residue (9); Region (1)		Acetylation;Direct protein sequencing;Hydroxylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00578;	105244208	GO:0000082~G1/S transition of mitotic cell cycle,GO:0001890~placenta development,GO:0002309~T cell proliferation involved in immune response,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006924~activation-induced cell death of T cells,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0007369~gastrulation,GO:0022605~oogenesis stage,GO:0031929~TOR signaling,GO:0033077~T cell differentiation in thymus,GO:0042274~ribosomal small subunit biogenesis,GO:0042593~glucose homeostasis,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0048821~erythrocyte development,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR001377:Ribosomal protein S6e,IPR014401:Ribosomal protein S6, eukaryotic,IPR018282:Ribosomal protein S6e, conserved site,	PF01092:Ribosomal protein S6e,		4.80694600166281	5.96230278352958e-10	FDR<0.01	9.22458597297344	25633925	Present in Nucleus	RBP	Others	Others	Others	Others	88	Cell cycle
Q8BP67	Q8BP67	Rpl24	12.89	12.916	32078500	22.9242125532988	27.4002630425252	22.9526257803893	17.7654603919061	17.5021002520302	45.2837023955079	18352483.3333333	0	Rpl24	0	60S ribosomal protein L24				assembly of large subunit precursor of preribosome [GO:1902626]; cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		68193;	cd00472;	IPR038630;IPR000988;IPR023442;IPR011017;	PF01246;	SM00746;	17779	COMPBIAS 106..121;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 106..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (4); Erroneous initiation (1); Modified residue (7); Region (1); Sequence conflict (1)		3D-structure;Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01073;	68193	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,GO:0007093~mitotic cell cycle checkpoint,GO:0010458~exit from mitosis,GO:0021554~optic nerve development,GO:0031290~retinal ganglion cell axon guidance,GO:0060041~retina development in camera-type eye,GO:1902626~assembly of large subunit precursor of preribosome,	GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000988:Ribosomal protein L24e-related,IPR011017:TRASH domain,IPR023442:Ribosomal protein L24e, conserved site,	PF01246:Ribosomal protein L24e,		4.3720190684578	1.2927110122408e-09	FDR<0.01	8.88849855154391	25215491.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	90	Cell cycle
Q1HFZ0	Q1HFZ0;Q1HFZ0-2	Nsun2	27.732	32.159	22892000	6.8870523415978	8.85896527285613	26.5639527161642	5.69411228789432	5.35245945511963	15.8057785926535	8528906.66666667	0	Nsun2	0	RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)		FUNCTION: RNA cytosine C(5)-methyltransferase that methylates cytosine to 5-methylcytosine (m5C) in various RNAs, such as tRNAs, mRNAs and some long non-coding RNAs (lncRNAs) (PubMed:22144916, PubMed:23871666, PubMed:31199786). Involved in various processes, such as epidermal stem cell differentiation, testis differentiation and maternal to zygotic transition during early development: acts by increasing protein synthesis; cytosine C(5)-methylation promoting tRNA stability and preventing mRNA decay (PubMed:22144916, PubMed:22885326, PubMed:23401851, PubMed:31199786). Methylates cytosine to 5-methylcytosine (m5C) at positions 34 and 48 of intron-containing tRNA(Leu)(CAA) precursors, and at positions 48, 49 and 50 of tRNA(Gly)(GCC) precursors (PubMed:22885326, PubMed:23871666, PubMed:31199786). tRNA methylation is required generation of RNA fragments derived from tRNAs (tRFs) (PubMed:31199786). Also mediates C(5)-methylation of mitochondrial tRNAs (PubMed:31276587, PubMed:31287866). Catalyzes cytosine C(5)-methylation of mRNAs, leading to stabilize them and prevent mRNA decay: mRNA stabilization involves YBX1 that specifically recognizes and binds m5C-modified transcripts (By similarity). Cytosine C(5)-methylation of mRNAs also regulates mRNA export: methylated transcripts are specifically recognized by THOC4/ALYREF, which mediates mRNA nucleo-cytoplasmic shuttling (By similarity). Also mediates cytosine C(5)-methylation of non-coding RNAs, such as vault RNAs (vtRNAs), promoting their processing into regulatory small RNAs (PubMed:23871666). Cytosine C(5)-methylation of vtRNA VTRNA1.1 promotes its processing into small-vault RNA4 (svRNA4) and regulates epidermal differentiation (By similarity). May act downstream of Myc to regulate epidermal cell growth and proliferation (PubMed:16713953). Required for proper spindle assembly and chromosome segregation, independently of its methyltransferase activity (PubMed:19596847). {ECO:0000250|UniProtKB:Q08J23, ECO:0000269|PubMed:16713953, ECO:0000269|PubMed:19596847, ECO:0000269|PubMed:22144916, ECO:0000269|PubMed:22885326, ECO:0000269|PubMed:23401851, ECO:0000269|PubMed:23871666, ECO:0000269|PubMed:31199786, ECO:0000269|PubMed:31276587, ECO:0000269|PubMed:31287866}.		cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]	methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:16713953, ECO:0000269|PubMed:19596847}. Cytoplasm {ECO:0000250|UniProtKB:Q08J23}. Mitochondrion {ECO:0000250|UniProtKB:Q08J23}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19596847}. Secreted, extracellular exosome {ECO:0000269|PubMed:28341602}. Note=Concentrated in the nucleolus during interphase and translocates to the spindle during mitosis as an RNA-protein complex that includes 18S ribosomal RNA (PubMed:19596847). In testis, localizes to the chromatoid body (PubMed:23401851). {ECO:0000269|PubMed:19596847, ECO:0000269|PubMed:23401851}.	28114;		IPR001678;IPR023267;IPR023270;IPR029063;	PF01189;		85452	COMPBIAS 459..487;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 184..190;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; REGION 436..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 716..757;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 321;  /note=Nucleophile;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023	ACTIVITY REGULATION: Inhibited by magnesium ions. {ECO:0000250|UniProtKB:Q08J23}.	BINDING 215;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 242;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 268;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023	2.1.1.-; 2.1.1.203			5 out of 5	Active site (1); Alternative sequence (1); Binding site (3); Chain (1); Compositional bias (1); Cross-link (7); Erroneous initiation (2); Modified residue (9); Mutagenesis (1); Region (4); Sequence caution (1); Sequence conflict (7)		Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Differentiation;Isopeptide bond;Methyltransferase;Mitochondrion;Mitosis;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Secreted;Spermatogenesis;Transferase;Ubl conjugation;tRNA processing;tRNA-binding						PS51686;	28114	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007286~spermatid development,GO:0008033~tRNA processing,GO:0030488~tRNA methylation,GO:0032259~methylation,GO:0033313~meiotic cell cycle checkpoint,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0033391~chromatoid body,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016428~tRNA (cytosine-5-)-methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR023267:RNA (C5-cytosine) methyltransferase,IPR023270:tRNA (C5-cytosine) methyltransferase, NCL1,	PF01189:NOL1/NOP2/sun family,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	3.67188828498198	4.42870160952362e-07	FDR<0.01	6.3537235799778	15710453.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	146	Cell cycle
P62827	P62827;Q61820	Ran	18.417	19.882	19111000	10.1780134553338	23.508945153631	10.3612984779253	1.88189243102864	16.4506152530105	15.1071094056863	11620873.3333333	0	Ran	0	GTP-binding nuclear protein Ran (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)		FUNCTION: GTPase involved in nucleocytoplasmic transport, participating both to the import and the export from the nucleus of proteins and RNAs. Switches between a cytoplasmic GDP- and a nuclear GTP-bound state by nucleotide exchange and GTP hydrolysis. Nuclear import receptors such as importin beta bind their substrates only in the absence of GTP-bound RAN and release them upon direct interaction with GTP-bound RAN, while export receptors behave in the opposite way. Thereby, RAN controls cargo loading and release by transport receptors in the proper compartment and ensures the directionality of the transport. Interaction with RANBP1 induces a conformation change in the complex formed by XPO1 and RAN that triggers the release of the nuclear export signal of cargo proteins. RAN (GTP-bound form) triggers microtubule assembly at mitotic chromosomes and is required for normal mitotic spindle assembly and chromosome segregation. Required for normal progress through mitosis. The complex with BIRC5/survivin plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules. Acts as a negative regulator of the kinase activity of VRK1 and VRK2. Enhances AR-mediated transactivation. {ECO:0000250|UniProtKB:P62826}.		actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular protein localization [GO:0034613]; cellular response to mineralocorticoid stimulus [GO:0071389]; GTP metabolic process [GO:0046039]; hippocampus development [GO:0021766]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nucleolus [GO:1902570]; regulation of protein binding [GO:0043393]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; spermatid development [GO:0007286]	centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; manchette [GO:0002177]; melanosome [GO:0042470]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; RNA nuclear export complex [GO:0042565]; sperm flagellum [GO:0036126]	dynein intermediate chain binding [GO:0045505]; GDP binding [GO:0019003]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; importin-alpha family protein binding [GO:0061676]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18347012, ECO:0000269|PubMed:25946333}. Nucleus envelope {ECO:0000269|PubMed:25946333}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62826}. Cytoplasm {ECO:0000269|PubMed:18347012}. Melanosome {ECO:0000250|UniProtKB:P62826}. Note=Predominantly nuclear during interphase. Becomes dispersed throughout the cytoplasm during mitosis (By similarity). Identified by mass spectrometry in melanosome fractions from stage I to stage IV (By similarity). {ECO:0000250|UniProtKB:P62826}.	19384;		IPR027417;IPR002041;IPR005225;IPR001806;	PF00071;		24423		REGION 211..216;  /note=Interaction with RANBP1;  /evidence=ECO:0000250|UniProtKB:P62826	NA			BINDING 68;  /note=GTP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P62825				5 out of 5	Binding site (1); Chain (1); Cross-link (3); Initiator methionine (1); Modified residue (9); Mutagenesis (3); Nucleotide binding (4); Region (1); Sequence conflict (3); Site (1)		Acetylation;Cell cycle;Cell division;Cytoplasm;Direct protein sequencing;GTP-binding;Isopeptide bond;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation						PS51418;	19384	GO:0000054~ribosomal subunit export from nucleus,GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000060~protein import into nucleus, translocation,GO:0006606~protein import into nucleus,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007286~spermatid development,GO:0015031~protein transport,GO:0021766~hippocampus development,GO:0030036~actin cytoskeleton organization,GO:0032092~positive regulation of protein binding,GO:0034613~cellular protein localization,GO:0034629~cellular protein complex localization,GO:0043393~regulation of protein binding,GO:0051301~cell division,GO:0071389~cellular response to mineralocorticoid stimulus,GO:0071806~protein transmembrane transport,GO:1902570~protein localization to nucleolus,	GO:0000785~chromatin,GO:0001673~male germ cell nucleus,GO:0002177~manchette,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030496~midbody,GO:0031012~extracellular matrix,GO:0036126~sperm flagellum,GO:0042470~melanosome,GO:0042565~RNA nuclear export complex,GO:0043234~protein complex,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008320~protein transmembrane transporter activity,GO:0019003~GDP binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0045505~dynein intermediate chain binding,GO:0061676~importin-alpha family protein binding,GO:0070883~pre-miRNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001806:Small GTPase superfamily,IPR002041:Ran GTPase,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00071:Ras family,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.5826777003119	9.56009934538135e-07	FDR<0.01	6.01953759465625	15365936.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	151	Cell cycle
Q9EQ61	Q9EQ61	Pes1	23.526	37.556	17191000	15.5431555714441	7.95798185580137	16.3366660132	5.39170755378228	9.79623824451411	11.6800598019062	9093593.33333333	0	Pes1	0	Pescadillo homolog		FUNCTION: Component of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S ribosome. {ECO:0000255|HAMAP-Rule:MF_03028, ECO:0000269|PubMed:15225545, ECO:0000269|PubMed:17308336}.		cell population proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; nucleolus organization [GO:0007000]; protein localization to organelle [GO:0033365]; regulation of cell cycle [GO:0051726]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]	ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm. Chromosome. Note=Appears to localize to the periphery of metaphase chromosomes during mitosis and to the prenucleolar bodies that form in mitotic cells prior to the actual nucleoli.	64934;		IPR001357;IPR036420;IPR010613;	PF16589;PF06732;	SM00292;	67796	COMPBIAS 452..490;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 491..510;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 560..578;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..257;  /note=Sufficient for nucleolar localization;  /evidence=ECO:0000250; REGION 1..54;  /note=Required for 28S ribosomal RNA processing;  /evidence=ECO:0000250; REGION 312..414;  /note=Sufficient for interaction with MAP1B;  /evidence=ECO:0000269|PubMed:17308336; REGION 449..510;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 535..584;  /note=Required for 28S ribosomal RNA processing;  /evidence=ECO:0000250; REGION 560..584;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Domain (1); Modified residue (1); Region (6)		Acetylation;Chromosome;Isopeptide bond;Nucleus;Reference proteome;Ribosome biogenesis;Ubl conjugation;rRNA processing	DOMAIN 321..414;  /note=BRCT;  /evidence=ECO:0000255|HAMAP-Rule:MF_03028					PS50172;	64934	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0007000~nucleolus organization,GO:0008283~cell proliferation,GO:0033365~protein localization to organelle,GO:0042254~ribosome biogenesis,GO:0051726~regulation of cell cycle,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030687~preribosome, large subunit precursor,GO:0070545~PeBoW complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR001357:BRCT domain,IPR010613:Pescadillo,	PF06732:Pescadillo N-terminus,	SSF52113:BRCT domain,	3.75459416638738	7.8749027682834e-08	FDR<0.01	7.10375479975534	13142296.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	178	Cell cycle
P84089	P84089	Erh	23.02	31.332	10403750	215.470803706098	144.623617036662	333.555703802535	53.3304890405845	86.7377916558245	67.7874186550976	5907066.66666667	0	Erh	0	Enhancer of rudimentary homolog (Mer)		FUNCTION: May have a role in the cell cycle.		cell cycle [GO:0007049]; osteoblast differentiation [GO:0001649]	membrane [GO:0016020]; methylosome [GO:0034709]; midbody [GO:0030496]; nucleus [GO:0005634]	methyl-CpG binding [GO:0008327]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P84090}.	13877;		IPR035912;IPR000781;	PF01133;		12259			NA							4 out of 5	Beta strand (5); Chain (1); Cross-link (1); Helix (3); Initiator methionine (1); Modified residue (2); Turn (2)		3D-structure;Acetylation;Cell cycle;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation						PS01290;	13877	GO:0001649~osteoblast differentiation,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0007049~cell cycle,GO:0045747~positive regulation of Notch signaling pathway,	GO:0016020~membrane,GO:0030496~midbody,GO:0034709~methylosome,	GO:0008327~methyl-CpG binding,GO:0044822~poly(A) RNA binding,	IPR000781:Enhancer of rudimentary,	PF01133:Enhancer of rudimentary,	SSF143875:ERH-like,	6.38276197719742	8.26333606900289e-09	FDR<0.01	8.08284458417379	8155408.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	252	Cell cycle
P68372	P68372;Q9D6F9	Tubb4b;Tubb4a	13.522	15.935	10398650	NA	7.6645972254158	NA	NA	6.24648635142732	7.70416024653313	117033.333333333	3	Tubb4b	0	Tubulin beta-4B chain (Tubulin beta-2C chain)		FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.		microtubule-based process [GO:0007017]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]	double-stranded RNA binding [GO:0003725]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.	227613;		IPR013838;IPR002453;IPR008280;IPR000217;IPR018316;IPR037103;IPR036525;IPR023123;IPR017975;IPR003008;	PF00091;PF03953;	SM00864;SM00865;	49831	COMPBIAS 428..445;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 426..445;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Nucleotide binding (1); Region (1); Sequence conflict (2)		Acetylation;Cytoplasm;Cytoskeleton;Direct protein sequencing;GTP-binding;Isopeptide bond;Microtubule;Nucleotide-binding;Phosphoprotein;Reference proteome		DOMAIN: The highly acidic C-terminal region may bind cations such as calcium.				PS00227;PS00228;	227613	GO:0007017~microtubule-based process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0031012~extracellular matrix,GO:0043209~myelin sheath,GO:0045298~tubulin complex,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0003725~double-stranded RNA binding,GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002453:Beta tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR008280:Tubulin/FtsZ, C-terminal,IPR013838:Beta tubulin, autoregulation binding site,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	PF00091:Tubulin/FtsZ family, GTPase domain,PF03953:Tubulin C-terminal domain,	SSF52490:Tubulin nucleotide-binding domain-like,SSF55307:Tubulin C-terminal domain-like,	3.2556512709845	5.63994988034613e-06	FDR<0.01	5.24872475537585	5257841.66666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	359	Cell cycle
E9PVX6	E9PVX6;E9PVX6-2	Mki67	8.9271	13.873	5621800	10.2797109345285	9.49036727721363	6.43335048893464	7.82901432709622	8.68130914141853	9.07358678885764	2546481.66666667	0	Mki67	0	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog)		FUNCTION: Required to maintain individual mitotic chromosomes dispersed in the cytoplasm following nuclear envelope disassembly (PubMed:27362226). Associates with the surface of the mitotic chromosome, the perichromosomal layer, and covers a substantial fraction of the chromosome surface (PubMed:27362226). Prevents chromosomes from collapsing into a single chromatin mass by forming a steric and electrostatic charge barrier: the protein has a high net electrical charge and acts as a surfactant, dispersing chromosomes and enabling independent chromosome motility (PubMed:27362226). Binds DNA, with a preference for supercoiled DNA and AT-rich DNA (By similarity). Does not contribute to the internal structure of mitotic chromosomes (PubMed:26949251). May play a role in chromatin organization (PubMed:26949251). It is however unclear whether it plays a direct role in chromatin organization or whether it is an indirect consequence of its function in maintaining mitotic chromosomes dispersed. {ECO:0000250|UniProtKB:P46013, ECO:0000269|PubMed:26949251, ECO:0000269|PubMed:27362226, ECO:0000305}.		cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]	chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]	SUBCELLULAR LOCATION: Chromosome {ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}. Nucleus {ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}. Nucleus, nucleolus {ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}. Note=Associates with the surface of the mitotic chromosome, the perichromosomal layer, and covers a substantial fraction of the mitotic chromosome surface (PubMed:8834799, PubMed:12355204). Associates with satellite DNA in G1 phase (By similarity). Binds tightly to chromatin in interphase, chromatin-binding decreases in mitosis when it associates with the surface of the condensed chromosomes (By similarity). Predominantly localized in the G1 phase in the perinucleolar region, in the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix (By similarity). {ECO:0000250|UniProtKB:P46013, ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}.	17345;	cd00060;	IPR000253;IPR012568;IPR029334;IPR008984;	PF00498;PF08065;PF15276;	SM00240;SM01295;	350864	COMPBIAS 116..139;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 163..189;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 196..228;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 229..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 270..286;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 302..318;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 319..341;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 635..652;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 866..892;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1110..1132;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1163..1191;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1215..1250;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1252..1269;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1270..1303;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1335..1371;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1372..1389;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1763..1780;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1938..1960;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1993..2021;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2047..2083;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2084..2099;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2162..2200;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2201..2216;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2252..2269;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2282..2321;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2392..2441;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2553..2569;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2576..2593;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2620..2639;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2646..2661;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2676..2712;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2750..2780;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2781..2801;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2802..2828;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2881..2895;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2896..2921;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2956..2995;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3004..3030;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3045..3059;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3060..3094;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3120..3160;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 98..442;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 473..572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 614..652;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 793..815;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 835..901;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 956..989;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1109..1321;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1334..1410;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1526..1550;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1749..1797;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1925..2033;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2047..2112;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2124..2343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2378..2447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2538..2828;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2879..3160;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (41); Cross-link (13); Domain (2); Frameshift (2); Modified residue (98); Nucleotide binding (1); Region (16); Repeat (16); Sequence conflict (10)		ATP-binding;Acetylation;Alternative splicing;Cell cycle;Chromosome;DNA-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 27..76;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086; DOMAIN 462..509;  /note=PP1-binding;  /evidence=ECO:0000255			REPEAT 994..1101;  /note=K167R 1;  /evidence=ECO:0000255; REPEAT 1108..1216;  /note=K167R 2;  /evidence=ECO:0000255; REPEAT 1228..1336;  /note=K167R 3;  /evidence=ECO:0000255; REPEAT 1348..1450;  /note=K167R 4;  /evidence=ECO:0000255; REPEAT 1461..1569;  /note=K167R 5;  /evidence=ECO:0000255; REPEAT 1582..1684;  /note=K167R 6;  /evidence=ECO:0000255; REPEAT 1696..1806;  /note=K167R 7;  /evidence=ECO:0000255; REPEAT 1817..1925;  /note=K167R 8;  /evidence=ECO:0000255; REPEAT 1937..2046;  /note=K167R 9;  /evidence=ECO:0000255; REPEAT 2059..2163;  /note=K167R 10;  /evidence=ECO:0000255; REPEAT 2175..2284;  /note=K167R 11;  /evidence=ECO:0000255; REPEAT 2296..2405;  /note=K167R 12;  /evidence=ECO:0000255; REPEAT 2419..2526;  /note=K167R 13;  /evidence=ECO:0000255; REPEAT 2537..2639;  /note=K167R 14;  /evidence=ECO:0000255; REPEAT 2643..2748;  /note=K167R 15;  /evidence=ECO:0000255; REPEAT 2762..2870;  /note=K167R 16;  /evidence=ECO:0000255		PS50006;	17345	GO:0006259~DNA metabolic process,GO:0007049~cell cycle,GO:0007088~regulation of mitotic nuclear division,GO:0007126~meiotic nuclear division,GO:0008283~cell proliferation,GO:0014070~response to organic cyclic compound,GO:0030212~hyaluronan metabolic process,GO:0031100~organ regeneration,GO:0034605~cellular response to heat,GO:0051983~regulation of chromosome segregation,GO:0072574~hepatocyte proliferation,GO:1902275~regulation of chromatin organization,GO:1990705~cholangiocyte proliferation,	GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR012568:K167R,	PF00498:FHA domain,PF08065:K167R (NUC007) repeat,PF15276:Protein phosphatase 1 binding,	SSF49879:SMAD/FHA domain,	3.18932221813153	3.1835523882507e-09	FDR<0.01	8.49708799903055	4084140.83333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	418	Cell cycle
Q6NZJ6	Q6NZJ6;Q6NZJ6-2;Q80XI3-2;Q80XI3-4;Q80XI3;Q80XI3-3	Eif4g1	6.9615	7.9174	1415100	10.1642543503009	10.9348175525691	8.53096741170449	5.73361619173212	14.4527467445188	11.5692535517608	3554753.33333333	0	Eif4g1	0	Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1)		FUNCTION: Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome. As a member of the eIF4F complex, required for endoplasmic reticulum stress-induced ATF4 mRNA translation (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q04637}.		behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]	ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q04637}.	208643;		IPR016024;IPR037584;IPR003891;IPR016021;IPR003890;IPR003307;	PF02847;PF02854;PF02020;	SM00515;SM00544;SM00543;	176077	COMPBIAS 1..26;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 30..52;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 60..74;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 181..197;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 205..228;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 267..281;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..481;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 550..573;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 574..590;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1063..1091;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1103..1117;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1129..1143;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1144..1223;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..88;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 173..230;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 179..207;  /note=PABPC1-binding;  /evidence=ECO:0000250; REGION 243..326;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 366..501;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 507..526;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 541..606;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 611..622;  /note=EIF4E-binding;  /evidence=ECO:0000250; REGION 667..719;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 686..1089;  /note=eIF3/EIF4A-binding;  /evidence=ECO:0000250; REGION 734..760;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1029..1117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1129..1238;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1450..1600;  /note=EIF4A-binding;  /evidence=ECO:0000250; REGION 1585..1600;  /note=Necessary but not sufficient for MKNK1-binding;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (13); Domain (3); Modified residue (26); Region (15)		Acetylation;Alternative splicing;Cytoplasm;Initiation factor;Methylation;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Translation regulation	DOMAIN 765..993;  /note=MIF4G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00698; DOMAIN 1241..1363;  /note=MI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00698; DOMAIN 1429..1599;  /note=W2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00695					PS51366;PS51363;	208643	GO:0001662~behavioral fear response,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0045666~positive regulation of neuron differentiation,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016281~eukaryotic translation initiation factor 4F complex,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003307:W2 domain,IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	PF02020:eIF4-gamma/eIF5/eIF2-epsilon,PF02847:MA3 domain,PF02854:MIF4G domain,	SSF48371:ARM repeat,	3.19729562805977	7.85346273404391e-09	FDR<0.01	8.10493881271942	2484926.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	559	Cell cycle
Q68FD5	Q68FD5	Cltc	8.1062	7.8841	1791250	4.8174197899605	7.13877784123358	7.07063565014495	1.63299965707007	4.39985920450546	10.6606398516039	945365	0	Cltc	0	Clathrin heavy chain 1		FUNCTION: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Two different adapter protein complexes link the clathrin lattice either to the plasma membrane or to the trans-Golgi network. Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension. Plays a role in early autophagosome formation. {ECO:0000250|UniProtKB:P11442, ECO:0000250|UniProtKB:Q00610}.		amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572]	clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; photoreceptor ribbon synapse [GO:0098684]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315]	ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Membrane, coated pit {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Melanosome {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q00610}. Note=Cytoplasmic face of coated pits and vesicles. In complex with TACC3 and CKAP5 (forming the TACC3/ch-TOG/clathrin complex) localized to inter-microtubule bridges in mitotic spindles. {ECO:0000250, ECO:0000250|UniProtKB:Q00610}.	67300;		IPR016024;IPR000547;IPR015348;IPR016025;IPR022365;IPR016341;IPR011990;	PF00637;PF09268;PF01394;	SM00299;	191557		REGION 2..479;  /note=Globular terminal domain; REGION 24..67;  /note=WD40-like repeat 1; REGION 68..107;  /note=WD40-like repeat 2; REGION 108..149;  /note=WD40-like repeat 3; REGION 150..195;  /note=WD40-like repeat 4; REGION 196..257;  /note=WD40-like repeat 5; REGION 258..301;  /note=WD40-like repeat 6; REGION 302..330;  /note=WD40-like repeat 7; REGION 449..465;  /note=Binding site for the uncoating ATPase, involved in lattice disassembly;  /evidence=ECO:0000255; REGION 480..523;  /note=Flexible linker; REGION 524..1675;  /note=Heavy chain arm; REGION 524..634;  /note=Distal segment; REGION 639..1675;  /note=Proximal segment; REGION 1213..1522;  /note=Involved in binding clathrin light chain;  /evidence=ECO:0000250; REGION 1550..1675;  /note=Trimerization;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (28); Chain (1); Helix (19); Initiator methionine (1); Modified residue (18); Region (15); Repeat (7); Turn (7)		3D-structure;Acetylation;Autophagy;Cell cycle;Cell division;Coated pit;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Direct protein sequencing;Membrane;Mitosis;Phosphoprotein;Reference proteome;Repeat		DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40-like repeats, and projects inward from the polyhedral outer clathrin coat. It constitutes a major protein-protein interaction node (By similarity). {ECO:0000250}.		REPEAT 537..683;  /note=CHCR 1; REPEAT 686..828;  /note=CHCR 2; REPEAT 833..972;  /note=CHCR 3; REPEAT 979..1124;  /note=CHCR 4; REPEAT 1128..1269;  /note=CHCR 5; REPEAT 1274..1420;  /note=CHCR 6; REPEAT 1423..1566;  /note=CHCR 7		PS50236;	67300	GO:0001649~osteoblast differentiation,GO:0006886~intracellular protein transport,GO:0006898~receptor-mediated endocytosis,GO:0007030~Golgi organization,GO:0007067~mitotic nuclear division,GO:0016192~vesicle-mediated transport,GO:0031623~receptor internalization,GO:0033572~transferrin transport,GO:0042147~retrograde transport, endosome to Golgi,GO:0060236~regulation of mitotic spindle organization,GO:0090307~mitotic spindle assembly,GO:1900126~negative regulation of hyaluronan biosynthetic process,GO:1903077~negative regulation of protein localization to plasma membrane,	GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005819~spindle,GO:0005829~cytosol,GO:0005905~clathrin-coated pit,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0030130~clathrin coat of trans-Golgi network vesicle,GO:0030132~clathrin coat of coated pit,GO:0030136~clathrin-coated vesicle,GO:0030315~T-tubule,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0031523~Myb complex,GO:0042383~sarcolemma,GO:0042470~melanosome,GO:0043195~terminal bouton,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0071439~clathrin complex,GO:1903561~extracellular vesicle,GO:1990498~mitotic spindle microtubule,	GO:0003725~double-stranded RNA binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0019901~protein kinase binding,GO:0030506~ankyrin binding,GO:0031072~heat shock protein binding,GO:0032051~clathrin light chain binding,GO:0042277~peptide binding,GO:0044822~poly(A) RNA binding,	IPR000547:Clathrin, heavy chain/VPS, 7-fold repeat,IPR001473:Clathrin, heavy chain, propeller, N-terminal,IPR011990:Tetratricopeptide-like helical,IPR015348:Clathrin, heavy chain, linker, core motif,IPR016024:Armadillo-type fold,IPR016025:Clathrin, heavy chain, linker/propeller domain,IPR016341:Clathrin, heavy chain,IPR022365:Clathrin, heavy chain, propeller repeat,	PF00637:Region in Clathrin and VPS,PF01394:Clathrin propeller repeat,PF09268:Clathrin, heavy-chain linker,	SSF48371:ARM repeat,SSF50989:Clathrin heavy-chain terminal domain,	2.5228691861611	2.8861725250804e-06	FDR<0.01	5.53967771189431	1368307.5	Unexpected	RBP	Others	Others	Others	Others	725	Cell cycle
P62245	P62245	Rps15a	8.2374	12.556	471250	4.08129948575626	11.1155573340447	17.8993341447698	8.84486113568017	12.6761991684413	10.3944701418845	1655387.83333333	0	Rps15a	0	40S ribosomal protein S15a		FUNCTION: Structural component of the ribosome. Required for proper erythropoiesis. {ECO:0000250|UniProtKB:P62244}.		positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735]		267019;		IPR000630;IPR035987;	PF00410;		14840			NA							3 out of 5	Chain (1); Erroneous initiation (1); Modified residue (1); Sequence conflict (1)		Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00053;	267019	GO:0006412~translation,GO:0008284~positive regulation of cell proliferation,GO:0009615~response to virus,GO:0045787~positive regulation of cell cycle,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000630:Ribosomal protein S8,	PF00410:Ribosomal protein S8,	SSF56047:Ribosomal protein S8,	3.31806239817817	2.97718258437011e-08	FDR<0.01	7.52619453016588	1063318.91666667	Unexpected	RBP	Others	Others	Others	Others	798	Cell cycle
P63087	P63087;P63087-2	Ppp1cc	16.542	11.499	1207025	0.289502634473974	9.47508053818457	12.5483109973398	NA	5.05714574694043	10.9457092819615	743428.333333333	1	Ppp1cc	0	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)		FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Dephosphorylates RPS6KB1. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. {ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:21930935}.; FUNCTION: [Isoform 2]: Required for normal male fertility. {ECO:0000269|PubMed:23082183}.		cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]	chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine phosphatase activity [GO:0106306]; protein threonine phosphatase activity [GO:0106307]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P36873}. Nucleus {ECO:0000250|UniProtKB:P36873}. Cleavage furrow {ECO:0000250|UniProtKB:P36873}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P36873}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P36873}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P36873}. Nucleus speckle {ECO:0000250|UniProtKB:P36873}. Midbody {ECO:0000250|UniProtKB:P36873}. Mitochondrion {ECO:0000250|UniProtKB:P36873}. Cytoplasm, cytoskeleton, microtubule organizing center {ECO:0000250|UniProtKB:P36873}. Note=Colocalizes with SPZ1 in the nucleus (PubMed:15226296). Colocalizes with URI1 at mitochondrion. Rapidly exchanges between the nucleolar, nucleoplasmic and cytoplasmic compartments (By similarity). Highly mobile in cells and can be relocalized through interaction with targeting subunits (By similarity). In the presence of PPP1R8 relocalizes from the nucleolus to nuclear speckles (By similarity). Shows a dynamic targeting to specific sites throughout the cell cycle (By similarity). Highly concentrated in nucleoli of interphase cells and localizes at kinetochores early in mitosis (By similarity). Relocalization to chromosome-containing regions occurs at the transition from early to late anaphase (By similarity). Also accumulates at the cleavage furrow and midbody by telophase (By similarity). {ECO:0000250|UniProtKB:P36873, ECO:0000269|PubMed:15226296}.	19047;		IPR004843;IPR029052;IPR037981;IPR006186;IPR031675;	PF00149;PF16891;	SM00156;	36984		REGION 302..323;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 125;  /note=Proton donor;  /evidence=ECO:0000250	ACTIVITY REGULATION: Inactivated by binding to URI1. {ECO:0000250}.		3.1.3.16	METAL 64;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 66;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 92;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 92;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 124;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 173;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 248;  /note=Manganese 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Alternative sequence (1); Beta strand (15); Chain (1); Helix (11); Initiator methionine (1); Metal binding (7); Modified residue (3); Region (1); Sequence conflict (3); Turn (4)		3D-structure;Acetylation;Alternative splicing;Biological rhythms;Carbohydrate metabolism;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Glycogen metabolism;Hydrolase;Kinetochore;Manganese;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome						PS00125;	19047	GO:0005977~glycogen metabolic process,GO:0006470~protein dephosphorylation,GO:0007049~cell cycle,GO:0030182~neuron differentiation,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0046822~regulation of nucleocytoplasmic transport,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0000784~nuclear chromosome, telomeric region,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005925~focal adhesion,GO:0016607~nuclear speck,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0043197~dendritic spine,GO:0070688~MLL5-L complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0008022~protein C-terminus binding,GO:0008157~protein phosphatase 1 binding,GO:0016791~phosphatase activity,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	PF00149:Calcineurin-like phosphoesterase,	SSF56300:Metallo-dependent phosphatases,	2.63818900529603	0.00170352085714069	FDR<0.01	2.76865254475788	975226.666666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	826	Cell cycle
Q9JMD0	Q9JMD0-4;Q9JMD0-3;Q9JMD0-2;Q9JMD0	Znf207	2.224	3.1872	1104610	NA	3.29337373205111	NA	NA	10.7358340669487	NA	592643.333333333	4	Znf207	0	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (49 kDa zinc finger protein) (Zinc finger protein 207)		FUNCTION: Kinetochore- and microtubule-binding protein that plays a key role in spindle assembly. ZNF207/BuGZ is mainly composed of disordered low-complexity regions and undergoes phase transition or coacervation to form temperature-dependent liquid droplets. Coacervation promotes microtubule bundling and concentrates tubulin, promoting microtubule polymerization and assembly of spindle and spindle matrix by concentrating its building blocks (PubMed:26388440). Also acts as a regulator of mitotic chromosome alignment by mediating the stability and kinetochore loading of BUB3. Mechanisms by which BUB3 is protected are unclear: according to a first report, ZNF207/BuGZ may act by blocking ubiquitination and proteasomal degradation of BUB3. According to another report, the stabilization is independent of the proteasome (By similarity). {ECO:0000250|UniProtKB:O43670, ECO:0000269|PubMed:26388440}.		attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]	heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9832628}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:O43670}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:O43670}. Note=Localizes primarily to the nucleus in interphase, concentrates at kinetochores prior to nuclear envelope breakdown and during early prometaphase, and disappears from kinetochores upon microtubule-binding. {ECO:0000250|UniProtKB:O43670}.	22680;		IPR013087;		SM00355;	52793	COMPBIAS 99..113;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 134..161;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 253..269;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 276..292;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 319..372;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..485;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..92;  /note=Microtubule-binding region;  /evidence=ECO:0000250|UniProtKB:O43670; REGION 99..161;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 252..292;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 376..408;  /note=GLEBS;  /evidence=ECO:0000250|UniProtKB:O43670; REGION 462..495;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (6); Mutagenesis (1); Region (6); Zinc finger (2)		Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Reference proteome;Repeat;Zinc;Zinc-finger		DOMAIN: Mainly composed of disordered low-complexity regions outside of the C2H2-type zinc fingers. Coacervation depends on hydrophobic and aromatic Phe and Tyr in the disordered low-complexity region, that may promote coacervation by forming intermolecular hydrophobic interactions. {ECO:0000269|PubMed:26388440}.; DOMAIN: The GLEBS region mediates interaction with BUB3. {ECO:0000250|UniProtKB:O43670}.; DOMAIN: The microtubule-binding region is required for efficient loading of BUB3 onto kinetochores and proper mitosis. {ECO:0000250|UniProtKB:O43670}.			ZN_FING 11..34;  /note=C2H2-type 1; ZN_FING 35..58;  /note=C2H2-type 2	PS00028;	22680	GO:0000070~mitotic sister chromatid segregation,GO:0001578~microtubule bundle formation,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0046785~microtubule polymerization,GO:0050821~protein stabilization,GO:0051301~cell division,GO:0051983~regulation of chromosome segregation,GO:0090307~mitotic spindle assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:1990047~spindle matrix,	GO:0008017~microtubule binding,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,			1.99234373806311	0.00263268807340771	FDR<0.01	2.5796005939979	848626.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	881	Cell cycle
Q9JHU4	Q9JHU4	Dync1h1	2.5943	2.8084	371680	3.83685684687104	4.16111850865513	3.54371168361742	3.13008639038437	4.71764872387602	3.4367804240987	721416.333333333	0	Dync1h1	0	Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)		FUNCTION: Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Plays a role in mitotic spindle assembly and metaphase plate congression. {ECO:0000250|UniProtKB:Q14204}.		cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.	13424;		IPR003593;IPR035699;IPR035706;IPR041658;IPR042219;IPR042228;IPR042222;IPR043157;IPR041466;IPR041228;IPR043160;IPR024743;IPR024317;IPR004273;IPR013594;IPR013602;IPR027417;	PF12774;PF12780;PF12781;PF18198;PF08385;PF08393;PF17852;PF18199;PF03028;PF12777;	SM00382;	532045	COMPBIAS 2388..2406;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..1865;  /note=Stem;  /evidence=ECO:0000250; REGION 446..701;  /note=Interaction with DYNC1I2;  /evidence=ECO:0000250; REGION 649..800;  /note=Interaction with DYNC1LI2;  /evidence=ECO:0000250; REGION 1866..2097;  /note=AAA 1;  /evidence=ECO:0000250; REGION 2178..2450;  /note=AAA 2;  /evidence=ECO:0000250; REGION 2388..2408;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2554..2803;  /note=AAA 3;  /evidence=ECO:0000250; REGION 2897..3166;  /note=AAA 4;  /evidence=ECO:0000250; REGION 3187..3498;  /note=Stalk;  /evidence=ECO:0000250; REGION 3551..3780;  /note=AAA 5;  /evidence=ECO:0000250; REGION 4003..4219;  /note=AAA 6;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Coiled coil (10); Compositional bias (1); Helix (11); Initiator methionine (1); Modified residue (9); Natural variant (2); Nucleotide binding (4); Region (11); Sequence conflict (5); Turn (2)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Dynein;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Transport		DOMAIN: Dynein heavy chains probably consist of an N-terminal stem (which binds cargo and interacts with other dynein components), and the head or motor domain. The motor contains six tandemly-linked AAA domains in the head, which form a ring. A stalk-like structure (formed by two of the coiled coil domains) protrudes between AAA 4 and AAA 5 and terminates in a microtubule-binding site. A seventh domain may also contribute to this ring; it is not clear whether the N-terminus or the C-terminus forms this extra domain. There are four well-conserved and two non-conserved ATPase sites, one per AAA domain. Probably only one of these (within AAA 1) actually hydrolyzes ATP, the others may serve a regulatory function.					13424	GO:0003341~cilium movement,GO:0006810~transport,GO:0007018~microtubule-based movement,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0034063~stress granule assembly,GO:0051293~establishment of spindle localization,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0016020~membrane,GO:0030175~filopodium,GO:0030286~dynein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,GO:0051959~dynein light intermediate chain binding,	IPR003593:AAA+ ATPase domain,IPR004273:Dynein heavy chain domain,IPR011704:ATPase, dynein-related, AAA domain,IPR013594:Dynein heavy chain, domain-1,IPR013602:Dynein heavy chain, domain-2,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF03028:Dynein heavy chain and region D6 of dynein motor,PF07728:AAA domain (dynein-related subfamily),PF08385:Dynein heavy chain, N-terminal region 1,PF08393:Dynein heavy chain, N-terminal region 2,PF12777:Microtubule-binding stalk of dynein motor,PF12780:P-loop containing dynein motor region D4,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.79407243203627	9.64503617502366e-07	FDR<0.01	6.01569613913635	546548.166666667	Present in Nucleus	RBP	Others	Others	Others	Others	1008	Cell cycle
Q9ERH4	Q9ERH4-2;Q9ERH4	Nusap1	8.5377	9.2922	742895	NA	NA	NA	NA	8.72752661895619	NA	99548.3333333333	5	Nusap1	0	Nucleolar and spindle-associated protein 1 (NuSAP)		FUNCTION: Microtubule-associated protein with the capacity to bundle and stabilize microtubules. May associate with chromosomes and promote the organization of mitotic spindle microtubules around them. {ECO:0000269|PubMed:12963707, ECO:0000269|PubMed:17276916}.		establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of mitotic nuclear division [GO:0045840]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]	DNA binding [GO:0003677]; microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus, nucleolus. Cytoplasm, cytoskeleton, spindle. Chromosome. Note=Found in the cytoplasm and nucleolus during interphase and redistributes to the mitotic spindle in prometaphase. Localizes to the mitotic spindle and to the chromosomes during anaphase and telophase then disappears from around the chromosomes during cytokinesis.	108907;		IPR026756;	PF16006;		48573	COMPBIAS 41..82;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 83..97;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 98..128;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 158..176;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 251..270;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 390..419;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 41..190;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..312;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 243..367;  /note=Interaction with microtubules; REGION 354..427;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (6); Modified residue (9); Motif (1); Region (4); Sequence conflict (6)		Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The KEN box is required for the FZR1-dependent degradation of this protein subsequent to ubiquitination. {ECO:0000250}.	MOTIF 369..375;  /note=KEN box;  /evidence=ECO:0000250				108907	GO:0000070~mitotic sister chromatid segregation,GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0040001~establishment of mitotic spindle localization,GO:0045840~positive regulation of mitotic nuclear division,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,	GO:0003677~DNA binding,GO:0008017~microtubule binding,GO:0044822~poly(A) RNA binding,	IPR026756:Nucleolar and spindle-associated protein 1,			3.14514684263278	0.000139941271208465	FDR<0.01	3.85405418533088	421221.666666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1095	Cell cycle
Q91YT7	Q91YT7;P59326	Ythdf2	2.5634	10.199	278160	9.78569331637146	5.20860461482369	4.52120444886518	NA	NA	NA	102212	3	Ythdf2	0	YTH domain-containing family protein 2		FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, and regulates their stability (PubMed:28867294, PubMed:29855337, PubMed:32943573). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed:28867294, PubMed:29855337, PubMed:32943573). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT and ribonuclease P/MRP complexes, depending on the context (PubMed:29855337, PubMed:30065315, PubMed:32943573, PubMed:32905781). The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) share m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation (PubMed:32943573). M6A-containing mRNAs containing a binding site for RIDA/HRSP12 (5'-GGUUC-3') are preferentially degraded by endoribonucleolytic cleavage: cooperative binding of RIDA/HRSP12 and YTHDF2 to transcripts leads to recruitment of the ribonuclease P/MRP complex (By similarity). Other m6A-containing mRNAs undergo deadenylation via direct interaction between YTHDF2 and CNOT1, leading to recruitment of the CCR4-NOT and subsequent deadenylation of m6A-containing mRNAs (PubMed:32905781). Required maternally to regulate oocyte maturation: probably acts by binding to m6A-containing mRNAs, thereby regulating maternal transcript dosage during oocyte maturation, which is essential for the competence of oocytes to sustain early zygotic development (PubMed:28867294). Also required during spermatogenesis: regulates spermagonial adhesion by promoting degradation of m6A-containing transcripts coding for matrix metallopeptidases (PubMed:31959747). Also involved in hematopoietic stem cells specification by binding to m6A-containing mRNAs, leading to promote their degradation (PubMed:30065315, PubMed:30150673). Also acts as a regulator of neural development by promoting m6A-dependent degradation of neural development-related mRNA targets (PubMed:29855337). Inhibits neural specification of induced pluripotent stem cells by binding to methylated neural-specific mRNAs and promoting their degradation, thereby restraining neural differentiation (By similarity). Regulates circadian regulation of hepatic lipid metabolism: acts by promoting m6A-dependent degradation of PPARA transcripts (By similarity). Regulates the innate immune response to infection by inhibiting the type I interferon response: acts by binding to m6A-containing IFNB transcripts and promoting their degradation (PubMed:30559377). May also act as a promoter of cap-independent mRNA translation following heat shock stress: upon stress, relocalizes to the nucleus and specifically binds mRNAs with some m6A methylation mark at their 5'-UTR, protecting demethylation of mRNAs by FTO, thereby promoting cap-independent mRNA translation (By similarity). Regulates mitotic entry by promoting the phase-specific m6A-dependent degradation of WEE1 transcripts (By similarity). Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues: polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation (By similarity). The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules (By similarity). May also recognize and bind RNAs modified by C5-methylcytosine (m5C) and act as a regulator of rRNA processing (By similarity). {ECO:0000250|UniProtKB:Q9Y5A9, ECO:0000269|PubMed:28867294, ECO:0000269|PubMed:29855337, ECO:0000269|PubMed:30065315, ECO:0000269|PubMed:30150673, ECO:0000269|PubMed:30559377, ECO:0000269|PubMed:31959747, ECO:0000269|PubMed:32905781, ECO:0000269|PubMed:32943573}.		cell cycle [GO:0007049]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:28867294, ECO:0000305|PubMed:32943573}. Cytoplasm, P-body {ECO:0000250|UniProtKB:Q9Y5A9}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9Y5A9}. Nucleus {ECO:0000269|PubMed:32943573}. Note=Localizes to the cytosol and relocates to the nucleus following heat shock stress. Can partition into different structures: into P-bodies in unstressed cells, and into stress granules during stress. {ECO:0000250|UniProtKB:Q9Y5A9}.	213541;		IPR007275;	PF04146;		62280	COMPBIAS 1..25;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 291..325;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 368..382;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..45;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..384;  /note=Localization to mRNA processing bodies (P-bodies);  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; REGION 247..387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 385..579;  /note=Interaction with m6A-containing mRNAs;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; REGION 416..418;  /note=N6-methyladenosine binding;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; REGION 432..433;  /note=N6-methyladenosine binding;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9	NA			BINDING 422;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; BINDING 462;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; BINDING 486;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; BINDING 491;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9				5 out of 5	Binding site (4); Chain (1); Compositional bias (3); Domain (1); Initiator methionine (1); Modified residue (9); Region (6); Sequence conflict (4)		Acetylation;Cell cycle;Cell division;Cytoplasm;Differentiation;Immunity;Innate immunity;Mitosis;Nucleus;Oogenesis;Phosphoprotein;RNA-binding;Reference proteome;Spermatogenesis;Ubl conjugation	DOMAIN 410..544;  /note=YTH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00225	DOMAIN: The disordered regions have the ability to interact with each other and to 'phase separate' into liquid droplets within the cytosol following binding to mRNAs containing multiple m6A-modified residues. This leads to the partition of m6A-containing mRNAs into membraneless compartments, where mRNAs may be stored, degraded or used to transport mRNAs to dendritic arbors in neurons. {ECO:0000250|UniProtKB:Q9Y5A9}.				PS50882;	213541	GO:0043488~regulation of mRNA stability,GO:1903679~positive regulation of cap-independent translational initiation,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:1990247~N6-methyladenosine-containing RNA binding,	IPR007275:YTH domain,	PF04146:YT521-B-like domain,		2.51133851424972	0.000117134357874852	FDR<0.01	3.93131569889122	190186	Present in Nucleus	RBP	Others	Others	Others	Others	1295	Cell cycle
Q62093	Q62093	Srsf2	1.9156	2.5336	161545000	2.4982512241431	1.97304816210564	3.49247371913526	1.64891336609175	1.74675540184108	1.7022145811701	44590683.3333333	0	Srsf2	0	Serine/arginine-rich splicing factor 2 (Protein PR264) (Putative myelin regulatory factor 1) (MRF-1) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)		FUNCTION: Necessary for the splicing of pre-mRNA. It is required for formation of the earliest ATP-dependent splicing complex and interacts with spliceosomal components bound to both the 5'- and 3'-splice sites during spliceosome assembly. It also is required for ATP-dependent interactions of both U1 and U2 snRNPs with pre-mRNA (By similarity). Can bind to the myelin basic protein (MBP) gene MB3 regulatory region and increase transcription of the mbp promoter in cells derived from the CNS. The phosphorylated form (by SRPK2) is required for cellular apoptosis in response to cisplatin treatment (By similarity). {ECO:0000250, ECO:0000269|PubMed:7527040}.		mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to vitamin E [GO:0033197]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	pre-mRNA binding [GO:0036002]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Phosphorylation by SRPK2 provokes its redistribution from the nuclear specke to nucleoplasm. {ECO:0000250}.	20382;		IPR012677;IPR035979;IPR000504;IPR003954;IPR034893;	PF00076;	SM00360;SM00361;	25476	COMPBIAS 118..187;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 192..212;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 92..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (1); Frameshift (1); Initiator methionine (1); Modified residue (13); Region (1); Sequence conflict (4)		Acetylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	DOMAIN 14..92;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	20382	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007067~mitotic nuclear division,GO:0008380~RNA splicing,GO:0033197~response to vitamin E,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.08477315311215	0.000178379899314036	FDR<0.01	3.74865408554748	103067841.666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	25	Cell cycle
P11499	P11499	Hsp90ab1	30.567	25.758	13602500	3.65617344886841	3.17077810894794	2.12657366451174	1.31776612286851	6.47752299520663	7.08817692089595	52946166.6666667	0	Hsp90ab1	0	Heat shock protein HSP 90-beta (Heat shock 84 kDa) (HSP 84) (HSP84) (Tumor-specific transplantation 84 kDa antigen) (TSTA)		FUNCTION: Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle. Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. They first alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression. Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation. Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery. Main chaperone involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription. Involved in the translocation into ERGIC (endoplasmic reticulum-Golgi intermediate compartment) of leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1; the translocation process is mediated by the cargo receptor TMED10. {ECO:0000250|UniProtKB:P08238}.		axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein ubiquitination [GO:0031396]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to organic substance [GO:0010033]; response to salt stress [GO:0009651]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062]	apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm head plasma membrane [GO:1990913]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27496612, ECO:0000269|PubMed:27686098}. Melanosome {ECO:0000250|UniProtKB:P08238}. Nucleus {ECO:0000250|UniProtKB:P08238}. Secreted {ECO:0000250|UniProtKB:P08238}. Cell membrane {ECO:0000250|UniProtKB:P08238}. Dynein axonemal particle {ECO:0000250|UniProtKB:Q6AZV1}. Note=Translocates with BIRC2 from the nucleus to the cytoplasm during differentiation. Secreted when associated with TGFB1 processed form (LAP). {ECO:0000250|UniProtKB:P08238}.	15516;		IPR003594;IPR036890;IPR019805;IPR037196;IPR001404;IPR020575;IPR020568;	PF02518;PF00183;	SM00387;	83281	COMPBIAS 241..270;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..527;  /note=Interaction with TP53;  /evidence=ECO:0000250|UniProtKB:P08238; REGION 2..214;  /note=Interaction with BIRC2;  /evidence=ECO:0000250|UniProtKB:P08238; REGION 9..231;  /note=Interaction with NR3C1;  /evidence=ECO:0000269|PubMed:27686098; REGION 215..552;  /note=Interaction with AHSA1;  /evidence=ECO:0000250|UniProtKB:P08238; REGION 222..270;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 264..608;  /note=Interaction with NR3C1;  /evidence=ECO:0000269|PubMed:27686098; REGION 620..723;  /note=Interaction with NR1D1;  /evidence=ECO:0000269|PubMed:27686098; REGION 694..724;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation. Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation. After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state. {ECO:0000250|UniProtKB:P08238}.	BINDING 46;  /note=ATP;  /evidence=ECO:0000250; BINDING 88;  /note=ATP;  /evidence=ECO:0000250; BINDING 107;  /note=ATP;  /evidence=ECO:0000250; BINDING 133;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250; BINDING 392;  /note=ATP;  /evidence=ECO:0000250				5 out of 5	Binding site (5); Chain (1); Compositional bias (1); Glycosylation (2); Initiator methionine (1); Modified residue (22); Motif (1); Region (8); Sequence conflict (14); Site (1)		ATP-binding;Acetylation;Cell membrane;Chaperone;Cytoplasm;Direct protein sequencing;Glycoprotein;Membrane;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;Secreted;Stress response;Ubl conjugation		DOMAIN: The TPR repeat-binding motif mediates interaction with TPR repeat-containing proteins. {ECO:0000250|UniProtKB:P07900}.	MOTIF 720..724;  /note=TPR repeat-binding			PS00298;	15516	GO:0001890~placenta development,GO:0006457~protein folding,GO:0006950~response to stress,GO:0009651~response to salt stress,GO:0010033~response to organic substance,GO:0019062~virion attachment to host cell,GO:0031396~regulation of protein ubiquitination,GO:0032092~positive regulation of protein binding,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035690~cellular response to drug,GO:0042220~response to cocaine,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045793~positive regulation of cell size,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:0071353~cellular response to interleukin-4,GO:0071407~cellular response to organic cyclic compound,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0097435~fibril organization,GO:1903660~negative regulation of complement-dependent cytotoxicity,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0008180~COP9 signalosome,GO:0009986~cell surface,GO:0016020~membrane,GO:0016234~inclusion body,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0042470~melanosome,GO:0070062~extracellular exosome,GO:1990913~sperm head plasma membrane,GO:1990917~ooplasm,	GO:0000166~nucleotide binding,GO:0001948~glycoprotein binding,GO:0002134~UTP binding,GO:0002135~CTP binding,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008144~drug binding,GO:0017098~sulfonylurea receptor binding,GO:0019887~protein kinase regulator activity,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0023026~MHC class II protein complex binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0030911~TPR domain binding,GO:0032564~dATP binding,GO:0042826~histone deacetylase binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001404:Heat shock protein Hsp90,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR019805:Heat shock protein Hsp90, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020575:Heat shock protein Hsp90, N-terminal,	PF00183:Hsp90 protein,PF02518:Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,	2.52043814864407	0.000304567673304093	FDR<0.01	3.51631619440342	33274333.3333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	70	Cell cycle
P68040	P68040	Gnb2l1	22.649	11.887	4847000	10.1417821139531	7.8064012490242	7.43881574053411	10.7464482988372	4.34140835286967	7.06863646002686	2721790	0	Gnb2l1	0	Receptor of activated protein C kinase 1 (12-3) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein kinase C 1) (p205) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]		FUNCTION: Scaffolding protein involved in the recruitment, assembly and/or regulation of a variety of signaling molecules. Interacts with a wide variety of proteins and plays a role in many cellular processes. Component of the 40S ribosomal subunit involved in translational repression. Involved in the initiation of the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation, by promoting ubiquitination of a subset of 40S ribosomal subunits (By similarity). Binds to and stabilizes activated protein kinase C (PKC), increasing PKC-mediated phosphorylation. May recruit activated PKC to the ribosome, leading to phosphorylation of EIF6. Inhibits the activity of SRC kinases including SRC, LCK and YES1. Inhibits cell growth by prolonging the G0/G1 phase of the cell cycle. Enhances phosphorylation of BMAL1 by PRKCA and inhibits transcriptional activity of the BMAL1-CLOCK heterodimer. Facilitates ligand-independent nuclear translocation of AR following PKC activation, represses AR transactivation activity and is required for phosphorylation of AR by SRC. Modulates IGF1R-dependent integrin signaling and promotes cell spreading and contact with the extracellular matrix. Involved in PKC-dependent translocation of ADAM12 to the cell membrane. Promotes the ubiquitination and proteasome-mediated degradation of proteins such as CLEC1B and HIF1A. Required for VANGL2 membrane localization, inhibits Wnt signaling, and regulates cellular polarization and oriented cell division during gastrulation. Required for PTK2/FAK1 phosphorylation and dephosphorylation. Regulates internalization of the muscarinic receptor CHRM2. Promotes apoptosis by increasing oligomerization of BAX and disrupting the interaction of BAX with the anti-apoptotic factor BCL2L. Inhibits TRPM6 channel activity. Regulates cell surface expression of some GPCRs such as TBXA2R. Plays a role in regulation of FLT1-mediated cell migration. Involved in the transport of ABCB4 from the Golgi to the apical bile canalicular membrane (By similarity). {ECO:0000250|UniProtKB:P63244, ECO:0000269|PubMed:18258429, ECO:0000269|PubMed:20093473, ECO:0000269|PubMed:7968370}.		activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; translation [GO:0006412]	cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]	BH3 domain binding [GO:0051434]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P63244}; Peripheral membrane protein {ECO:0000250|UniProtKB:P63244}. Cytoplasm {ECO:0000269|PubMed:20093473}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:P63244}. Nucleus {ECO:0000269|PubMed:20093473}. Perikaryon {ECO:0000269|PubMed:16414032}. Cell projection, dendrite {ECO:0000269|PubMed:16414032}. Note=Recruited to the plasma membrane through interaction with KRT1 which binds to membrane-bound ITGB1. PKC activation induces translocation from the perinuclear region to the cell periphery (By similarity). In the brain, detected mainly in cell bodies and dendrites with little expression in axonal fibers or nuclei (PubMed:16414032). {ECO:0000250|UniProtKB:P63244, ECO:0000269|PubMed:16414032}.	14694;		IPR020472;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	35077			NA							5 out of 5	Chain (2); Frameshift (1); Initiator methionine (1); Modified residue (14); Repeat (7); Sequence conflict (8)		Acetylation;Apoptosis;Biological rhythms;Cell cycle;Cell membrane;Cell projection;Cytoplasm;Developmental protein;Direct protein sequencing;Gastrulation;Growth regulation;Membrane;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Translation regulation;WD repeat		DOMAIN: The 7 WD repeats mediate protein-protein interactions with binding partners. {ECO:0000250|UniProtKB:P63244}.		REPEAT 13..44;  /note=WD 1; REPEAT 61..91;  /note=WD 2; REPEAT 103..133;  /note=WD 3; REPEAT 146..178;  /note=WD 4; REPEAT 190..220;  /note=WD 5; REPEAT 231..260;  /note=WD 6; REPEAT 281..311;  /note=WD 7		PS00678;PS50082;PS50294;	14694	GO:0001649~osteoblast differentiation,GO:0001934~positive regulation of protein phosphorylation,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007049~cell cycle,GO:0007275~multicellular organism development,GO:0007369~gastrulation,GO:0008104~protein localization,GO:0010629~negative regulation of gene expression,GO:0017148~negative regulation of translation,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0030335~positive regulation of cell migration,GO:0030822~positive regulation of cAMP catabolic process,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032464~positive regulation of protein homooligomerization,GO:0032880~regulation of protein localization,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0035556~intracellular signal transduction,GO:0040008~regulation of growth,GO:0042998~positive regulation of Golgi to plasma membrane protein transport,GO:0043065~positive regulation of apoptotic process,GO:0043473~pigmentation,GO:0043547~positive regulation of GTPase activity,GO:0048511~rhythmic process,GO:0050765~negative regulation of phagocytosis,GO:0051302~regulation of cell division,GO:0051343~positive regulation of cyclic-nucleotide phosphodiesterase activity,GO:0051726~regulation of cell cycle,GO:0051898~negative regulation of protein kinase B signaling,GO:0051901~positive regulation of mitochondrial depolarization,GO:0071333~cellular response to glucose stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:1903208~negative regulation of hydrogen peroxide-induced neuron death,GO:2000114~regulation of establishment of cell polarity,GO:2000543~positive regulation of gastrulation,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0001891~phagocytic cup,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0030425~dendrite,GO:0030496~midbody,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0044297~cell body,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:1990630~IRE1-RACK1-PP2A complex,	GO:0004872~receptor activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0008200~ion channel inhibitor activity,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0019899~enzyme binding,GO:0019903~protein phosphatase binding,GO:0030292~protein tyrosine kinase inhibitor activity,GO:0030971~receptor tyrosine kinase binding,GO:0035591~signaling adaptor activity,GO:0042169~SH2 domain binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	3.20500514517601	7.75058683050011e-08	FDR<0.01	7.11066541393245	3784395	Present in Nucleus	RBP	ChD	Others	ChD	Others	439	Cell cycle
Q9CQT2	Q9CQT2	Rbm7	4.2716	5.6515	3841150	10.6804515694924	10.9563826407073	NA	NA	NA	NA	747675	4	Rbm7	0	RNA-binding protein 7 (RNA-binding motif protein 7)		FUNCTION: RNA-binding subunit of the trimeric nuclear exosome targeting (NEXT) complex, a complex that functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. NEXT is involved in surveillance and turnover of aberrant transcripts and non-coding RNAs. Binds preferentially polyuridine sequences and associates with newly synthesized RNAs, including pre-mRNAs and short-lived exosome substrates such as promoter upstream transcripts (PROMPTs), enhancer RNAs (eRNAs), and 3'-extended products from small nuclear RNAs (snRNAs). Participates in several biological processes including DNA damage response (DDR) and stress response. During stress response, activation of the p38MAPK-MK2 pathway decreases RBM7-RNA-binding and subsequently the RNA exosome degradation activities, thereby modulating the turnover of non-coding transcriptome. Participates in DNA damage response (DDR), through its interaction with MEPCE and LARP7, the core subunits of 7SK snRNP complex, that release the positive transcription elongation factor b (P-TEFb) complex from the 7SK snRNP. In turn, activation of P-TEFb complex induces the transcription of P-TEFb-dependent DDR genes to promote cell viability. {ECO:0000250|UniProtKB:Q9Y580}.		meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	14-3-3 protein binding [GO:0071889]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9Y580}. Nucleus {ECO:0000269|PubMed:25525152}. Note=Excluded from the nucleolus. {ECO:0000250|UniProtKB:Q9Y580}.	67010;	cd12592;	IPR012677;IPR035979;IPR034500;IPR000504;	PF00076;	SM00360;	30148	COMPBIAS 173..202;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 203..224;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 25..35;  /note=ZCCHC8 binding;  /evidence=ECO:0000250|UniProtKB:Q9Y580; REGION 59..76;  /note=ZCCHC8 binding;  /evidence=ECO:0000250|UniProtKB:Q9Y580; REGION 91..125;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 166..224;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 237..265;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (1); Initiator methionine (1); Modified residue (5); Mutagenesis (1); Region (5); Sequence conflict (1)		Acetylation;Meiosis;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 10..87;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domain mediates RNA binding; the RNA must have four nucleotides for efficient binding. Mediates the interaction of NEXT complex with promoter upstream transcripts (PROMPTs) and potentially aberrant forms of other non coding RNAs, such as snRNAs. The RRM domain exhibits specificity for polyuridine sequences. {ECO:0000250|UniProtKB:Q9Y580}.				PS50102;	67010	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0051321~meiotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.86600269548137	0.000109919729678286	FDR<0.01	3.95892434832831	2294412.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	580	Cell cycle
Q68ED3	Q68ED3	Papd5	5.865	5.8154	413929	4.91303920605286	5.60978346235835	NA	NA	5.35532587157929	5.0612410162972	259028.333333333	2	Papd5	0	Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2)		FUNCTION: Terminal nucleotidyltransferase that catalyzes preferentially the transfert of ATP and GTP on RNA 3' poly(A) tail creating a heterogeneous 3' poly(A) tail leading to mRNAs stabilization by protecting mRNAs from active deadenylation (By similarity). Also functions as a catalytic subunit of a TRAMP-like complex which has a poly(A) RNA polymerase activity and is involved in a post-transcriptional quality control mechanism. Polyadenylation with short oligo(A) tails is required for the degradative activity of the exosome on several of its nuclear RNA substrates. Doesn't need a cofactor for polyadenylation activity (in vitro). Plays a role in replication-dependent histone mRNA degradation, probably through terminal uridylation of mature histone mRNAs. May play a role in sister chromatid cohesion (By similarity). {ECO:0000250|UniProtKB:Q8NDF8}.		carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8NDF8}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8NDF8}. Cytoplasm {ECO:0000250|UniProtKB:Q8NDF8}. Note=Predominantly expressed in the cytoplasm. {ECO:0000250|UniProtKB:Q8NDF8}.	214627;		IPR043519;IPR002058;IPR002934;IPR040136;	PF01909;PF03828;		69704	COMPBIAS 22..37;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 492..525;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..612;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 484..633;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.7.19; 2.7.7.-	METAL 191;  /note=Magnesium or manganese; catalytic;  /evidence=ECO:0000250; METAL 193;  /note=Magnesium or manganese; catalytic;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (3); Cross-link (4); Domain (1); Erroneous initiation (1); Metal binding (2); Modified residue (1); Motif (1); Region (2); Sequence conflict (2)		Cell cycle;Cell division;Cytoplasm;DNA-binding;DNA-directed DNA polymerase;Isopeptide bond;Magnesium;Manganese;Metal-binding;Mitosis;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;mRNA processing;rRNA processing	DOMAIN 322..382;  /note=PAP-associated		MOTIF 618..624;  /note=Basic, involved in binding of the RNA primer;  /evidence=ECO:0000250				214627	GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0051301~cell division,GO:0071044~histone mRNA catabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0004652~polynucleotide adenylyltransferase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR002058:PAP/25A-associated,IPR002934:Nucleotidyl transferase domain,	PF01909:Nucleotidyltransferase domain,PF03828:Cid1 family poly A polymerase,		2.43950598576276	1.18269666563574e-06	FDR<0.01	5.92712662758915	336478.666666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1147	Cell cycle
Q62318	Q62318;Q62318-2	Trim28	43.934	43.175	224780000	69.9056274030059	71.4387769681383	76.7165324127349	18.6842547784982	35.5000177500089	33.0414670411366	71473166.6666667	0	Trim28	0	Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-A-interacting protein) (KRIP-1) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)		FUNCTION: Nuclear corepressor for KRAB domain-containing zinc finger proteins (KRAB-ZFPs). Mediates gene silencing by recruiting CHD3, a subunit of the nucleosome remodeling and deacetylation (NuRD) complex, and SETDB1 (which specifically methylates histone H3 at 'Lys-9' (H3K9me)) to the promoter regions of KRAB target genes. Enhances transcriptional repression by coordinating the increase in H3K9me, the decrease in histone H3 'Lys-9 and 'Lys-14' acetylation (H3K9ac and H3K14ac, respectively) and the disposition of HP1 proteins to silence gene expression. Recruitment of SETDB1 induces heterochromatinization. May play a role as a coactivator for CEBPB and NR3C1 in the transcriptional activation of ORM1. Also corepressor for ERBB4. Inhibits E2F1 activity by stimulating E2F1-HDAC1 complex formation and inhibiting E2F1 acetylation. May serve as a partial backup to prevent E2F1-mediated apoptosis in the absence of RB1. Important regulator of CDKN1A/p21(CIP1). Has E3 SUMO-protein ligase activity toward itself via its PHD-type zinc finger. Specifically sumoylates IRF7, thereby inhibiting its transactivation activity. Ubiquitinates p53/TP53 leading to its proteosomal degradation; the function is enhanced by MAGEC2 and MAGEA2, and possibly MAGEA3 and MAGEA6. Mediates the nuclear localization of KOX1, ZNF268 and ZNF300 transcription factors. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells. Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs). In ESCs, in collaboration with SETDB1, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (PubMed:20164836). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing. The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (By similarity). Acts as a corepressor for ZFP568 (PubMed:22110054, PubMed:27658112). {ECO:0000250|UniProtKB:Q13263, ECO:0000269|PubMed:20164836, ECO:0000269|PubMed:21518874, ECO:0000269|PubMed:22110054, ECO:0000269|PubMed:27658112, ECO:0000269|PubMed:9742105}.	PATHWAY: Protein modification; protein sumoylation.	chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; in utero embryonic development [GO:0001701]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]	chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10330177, ECO:0000269|PubMed:11154279, ECO:0000269|PubMed:12154074, ECO:0000269|PubMed:22110054}. Note=Associated with centromeric heterochromatin during cell differentiation through CBX1. {ECO:0000269|PubMed:10330177}.	21849;	cd16765;	IPR003649;IPR001487;IPR036427;IPR037373;IPR042713;IPR019786;IPR000315;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;	PF00628;PF00643;PF14634;	SM00502;SM00336;SM00297;SM00249;SM00184;	88847		REGION 13..56;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 247..377;  /note=Leucine zipper alpha helical coiled-coil region; REGION 248..377;  /note=Interaction with MAGEC2;  /evidence=ECO:0000250; REGION 367..371;  /note=Involved in binding PPP1CA;  /evidence=ECO:0000250; REGION 412..480;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 476..513;  /note=HP1 box; REGION 581..602;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27	METAL 154;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 157;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 178;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 182;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 210;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 213;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 233;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 238;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024		5 out of 5	Alternative sequence (2); Beta strand (4); Chain (1); Cross-link (28); Domain (1); Helix (1); Initiator methionine (1); Metal binding (8); Modified residue (34); Motif (1); Mutagenesis (1); Region (7); Sequence conflict (2); Turn (2); Zinc finger (4)		3D-structure;Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;Citrullination;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 697..801;  /note=Bromo	DOMAIN: The HP1 box is both necessary and sufficient for HP1 binding. {ECO:0000250|UniProtKB:Q13263}.; DOMAIN: The PHD-type zinc finger enhances CEBPB transcriptional activity. The PHD-type zinc finger, the HP1 box and the bromo domain, function together to assemble the machinery required for repression of KRAB domain-containing proteins. Acts as an intramolecular SUMO E3 ligase for autosumoylation of bromodomain. {ECO:0000250|UniProtKB:Q13263}.; DOMAIN: The RING-finger-B Box-coiled-coil/tripartite motif (RBCC/TRIM motif) is required for interaction with the KRAB domain of KRAB-zinc finger proteins. Binds four zinc ions per molecule. The RING finger and the N-terminal of the leucine zipper alpha helical coiled-coil region of RBCC are required for oligomerization. {ECO:0000250|UniProtKB:Q13263}.; DOMAIN: Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain. {ECO:0000250|UniProtKB:Q13263}.	MOTIF 481..494;  /note=PxVxL motif		ZN_FING 66..122;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 149..196;  /note=B box-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 205..246;  /note=B box-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 625..672;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS50119;PS01359;PS50016;PS50089;	21849	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001837~epithelial to mesenchymal transition,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007265~Ras protein signal transduction,GO:0007566~embryo implantation,GO:0016569~covalent chromatin modification,GO:0016925~protein sumoylation,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043045~DNA methylation involved in embryo development,GO:0043388~positive regulation of DNA binding,GO:0045087~innate immune response,GO:0045739~positive regulation of DNA repair,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0051259~protein oligomerization,GO:0060028~convergent extension involved in axis elongation,GO:0060669~embryonic placenta morphogenesis,GO:0090309~positive regulation of methylation-dependent chromatin silencing,GO:1901536~negative regulation of DNA demethylation,GO:1902187~negative regulation of viral release from host cell,GO:2000653~regulation of genetic imprinting,	GO:0000785~chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0004672~protein kinase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0035851~Krueppel-associated box domain binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070087~chromo shadow domain binding,GO:1990841~promoter-specific chromatin binding,	IPR000315:Zinc finger, B-box,IPR001487:Bromodomain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003649:B-box, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF00643:B-box zinc finger,PF14634:zinc-RING finger domain,	SSF57903:FYVE/PHD zinc finger,	5.48206659964191	2.69730136794251e-10	FDR<0.01	9.56907052736154	148126583.333333	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	14	Chromatin modification
Q9JI13	Q9JI13;Q9JI13-2	Utp3	3.3877	4.2204	10622850	6.47710343934193	4.01767778224186	3.75685626267939	2.24300742435457	19.6236189878137	11.596488583257	12699503.3333333	0	Utp3	0	Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Crl-1) (Disrupter of silencing SAS10) (UTP3 homolog)		FUNCTION: Essential for gene silencing: has a role in the structure of silenced chromatin. Plays a role in the developing brain. {ECO:0000250|UniProtKB:Q12136, ECO:0000269|PubMed:11404095}.		brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]	nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11404095}.	65961;		IPR007146;IPR018972;	PF09368;PF04000;		53399	COMPBIAS 69..110;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 410..439;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 17..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 62..158;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 410..469;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (2); Cross-link (1); Modified residue (5); Region (3); Sequence conflict (2)		Acetylation;Alternative splicing;Chromatin regulator;Citrullination;Developmental protein;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							65961	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0007275~multicellular organism development,GO:0007420~brain development,GO:0016569~covalent chromatin modification,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007146:Sas10/Utp3/C1D,IPR018972:Sas10 C-terminal domain,	PF04000:Sas10/Utp3/C1D family,PF09368:Sas10 C-terminal domain,		2.43056152092171	1.60650572764275e-05	FDR<0.01	4.79411772172827	11661176.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	203	Chromatin modification
P13864	P13864;P13864-2	Dnmt1	6.209	7.0268	10535750	8.90075656430797	7.83883358156306	5.98157674362962	6.19271736437949	8.33541718763024	9.89315393747527	3687925	0	Dnmt1	0	DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (Met-1) (EC 2.1.1.37) (DNA methyltransferase MmuI) (DNA MTase MmuI) (M.MmuI) (MCMT)		FUNCTION: Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance. Associates with chromatin during G2 and M phases to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development. DNA methylation is coordinated with methylation of histones. Mediates transcriptional repression by direct binding to HDAC2. In association with DNMT3B and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (By similarity). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (By similarity). Promotes tumor growth (By similarity). {ECO:0000250|UniProtKB:P26358, ECO:0000269|PubMed:11290321, ECO:0000269|PubMed:15550930, ECO:0000269|PubMed:17576694}.		cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; DNA hypermethylation [GO:0044026]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation on cytosine [GO:0032776]; DNA methylation on cytosine within a CG sequence [GO:0010424]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; response to drug [GO:0042493]; S-adenosylmethionine metabolic process [GO:0046500]	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]	chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11290321}. Cytoplasm {ECO:0000269|PubMed:11290321}. Note=It is nucleoplasmic through most of the cell cycle and associates with replication foci during S-phase. In germ cells, spermatogonia, preleptotene and leptotene spermatocytes all express high levels of nuclear protein, while the protein is not detected in pachytene spermatocytes, despite the fact they expressed high levels of mRNA. In females, the protein is not detected in non-growing oocytes, in contrast to the growing oocytes. During the growing, the protein is no longer detectable in nuclei but accumulates to very high levels first throughout the cytoplasm. At the time of ovulation, all the protein is cytoplasmic and is actively associated with the oocyte cortex. After fecondation, in the preimplantation embryo, the protein remains cytoplasmic and after implantation, it is exclusively nuclear in all tissue types. Isoform 2 is sequestered in the cytoplasm of maturing oocytes and of preimplantation embryos, except for the 8-cell stage, while isoform 1 is exclusively nuclear.	13433;		IPR001025;IPR043151;IPR018117;IPR001525;IPR031303;IPR022702;IPR010506;IPR017198;IPR029063;IPR002857;	PF01426;PF06464;PF00145;PF12047;PF02008;	SM00439;SM01137;	183189	COMPBIAS 144..170;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 173..206;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 232..306;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..337;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 338..353;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1122..1136;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..343;  /note=Interaction with the PRC2/EED-EZH2 complex; REGION 1..145;  /note=Interaction with DNMT3A;  /evidence=ECO:0000250; REGION 1..120;  /note=Interaction with DMAP1;  /evidence=ECO:0000269|PubMed:10888872; REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 96..369;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 147..217;  /note=Interaction with DNMT3B;  /evidence=ECO:0000250; REGION 161..172;  /note=Interaction with PCNA; REGION 305..609;  /note=Interaction with the PRC2/EED-EZH2 complex; REGION 328..556;  /note=DNA replication foci-targeting sequence;  /evidence=ECO:0000250; REGION 696..813;  /note=Interaction with HDAC1;  /evidence=ECO:0000269|PubMed:10615135; REGION 696..757;  /note=Autoinhibitory linker; REGION 702..732;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1097..1136;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1112..1125;  /note=7 X 2 AA tandem repeats of K-G; REGION 1124..1620;  /note=Interaction with the PRC2/EED-EZH2 complex; REGION 1142..1620;  /note=Catalytic; REGION 1153..1154;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9, ECO:0007744|PDB:4DA4; REGION 1171..1172;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9, ECO:0007744|PDB:4DA4; REGION 1193..1194;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9	NA	ACT_SITE 1229;  /evidence=ECO:0000269|PubMed:17576694	ACTIVITY REGULATION: Allosterically regulated. The binding of 5-methylcytosine-containing DNA to the N-terminal parts of DNMT1 causes an allosteric activation of the catalytic domain by a direct interaction of its Zn-binding domain with the catalytic domain. {ECO:0000269|PubMed:1628623}.	BINDING 1149;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:4DA4; BINDING 1582;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9, ECO:0007744|PDB:4DA4	2.1.1.37	METAL 359;  /note=Zinc;  /evidence=ECO:0000250; METAL 362;  /note=Zinc;  /evidence=ECO:0000250; METAL 420;  /note=Zinc;  /evidence=ECO:0000250; METAL 424;  /note=Zinc;  /evidence=ECO:0000250		5 out of 5	Active site (1); Alternative sequence (1); Beta strand (60); Binding site (2); Chain (1); Compositional bias (6); Cross-link (2); Domain (4); Erroneous initiation (1); Helix (42); Metal binding (4); Modified residue (32); Motif (1); Mutagenesis (5); Region (19); Repeat (7); Sequence conflict (20); Turn (17); Zinc finger (1)	MISCELLANEOUS: There are three 5' exons, one specific to the oocyte (1c), one specific to the pachytene spermatocyte and also found in skeletal muscle (1b) and one found in somatic cells (1a). Three different mRNAs can be produced which give rise to two different translation products: isoform 1 (mRNAs-1a) and isoform 2 (mRNA-1b or -1c). Association of DNMT1 with the replication machinery is not strictly required for maintaining global methylation but still enhances methylation efficiency by 2-fold. Pre-existing cytosine methylation at CpG and non-CpG sites enhances methylation activity.	3D-structure;Acetylation;Activator;Allosteric enzyme;Alternative splicing;Chromatin regulator;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 16..109;  /note=DMAP1-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01260; DOMAIN 758..884;  /note=BAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 976..1103;  /note=BAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 1142..1601;  /note=SAM-dependent MTase C5-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01016	DOMAIN: The N-terminal part is required for homodimerization and acts as a regulatory domain.; DOMAIN: The CXXC-type zinc finger specifically binds to unmethylated CpG dinucleotides, positioning the autoinhibitory linker between the DNA and the active site, thus providing a mechanism to ensure that only hemimethylated CpG dinucleotides undergo methylation. {ECO:0000269|PubMed:21163962}.	MOTIF 175..202;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 1112..1113;  /note=1; REPEAT 1114..1115;  /note=2; REPEAT 1116..1117;  /note=3; REPEAT 1118..1119;  /note=4; REPEAT 1120..1121;  /note=5; REPEAT 1122..1123;  /note=6; REPEAT 1124..1125;  /note=7; approximate	ZN_FING 649..695;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509	PS51038;PS00094;PS00095;PS51912;PS51679;PS51058;	13433	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007265~Ras protein signal transduction,GO:0008152~metabolic process,GO:0010216~maintenance of DNA methylation,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0016458~gene silencing,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0032776~DNA methylation on cytosine,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043045~DNA methylation involved in embryo development,GO:0044026~DNA hypermethylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0046500~S-adenosylmethionine metabolic process,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0071230~cellular response to amino acid stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090116~C-5 methylation of cytosine,GO:0090309~positive regulation of methylation-dependent chromatin silencing,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005721~pericentric heterochromatin,GO:0005737~cytoplasm,GO:0043025~neuronal cell body,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0009008~DNA-methyltransferase activity,GO:0016740~transferase activity,GO:0019904~protein domain specific binding,GO:0030331~estrogen receptor binding,GO:0042826~histone deacetylase binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,GO:1990841~promoter-specific chromatin binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001525:C-5 cytosine methyltransferase,IPR002857:Zinc finger, CXXC-type,IPR010506:DMAP1-binding,IPR017198:DNA (cytosine-5)-methyltransferase 1, eukaryote,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR022702:DNA (cytosine-5)-methyltransferase 1, replication foci domain,	PF00145:C-5 cytosine-specific DNA methylase,PF01426:BAH domain,PF02008:CXXC zinc finger domain,PF06464:DMAP1-binding Domain,PF12047:Cytosine specific DNA methyltransferase replication foci domain,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.89357238764692	6.31521866119148e-09	FDR<0.01	8.1996116076257	7111837.5	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	278	Chromatin modification
Q80U70	Q80U70	Suz12	6.2212	9.0396	8403250	8.40336134453782	9.93739441518434	1.47050173519205	3.38535495446698	6.58414537792995	5.41184110834506	3152093.33333333	0	Suz12	0	Polycomb protein Suz12 (Suppressor of zeste 12 protein homolog)		FUNCTION: Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems (By similarity). Genes repressed by the PRC2/EED-EZH2 complex include HOXA7, HOXB6 and HOXC8. {ECO:0000250|UniProtKB:Q15022, ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:15516932, ECO:0000269|PubMed:17339329}.		histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of chemokine production [GO:0032682]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284]; response to retinoic acid [GO:0032526]; spinal cord development [GO:0021510]	chromatin silencing complex [GO:0005677]; ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16415857}. Chromosome {ECO:0000269|PubMed:16415857}. Note=Localizes to the inactive X chromosome in trophoblast stem cells.	52615;		IPR019135;	PF09733;		83026	COMPBIAS 700..719;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 81..108;  /note=Interaction with JARID2 and EPOP;  /evidence=ECO:0000250|UniProtKB:Q15022; REGION 148..365;  /note=Interaction with AEBP2 and PHF19;  /evidence=ECO:0000250|UniProtKB:Q15022; REGION 565..641;  /note=VEFS-box; REGION 689..741;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (6); Modified residue (4); Region (5); Sequence caution (1); Zinc finger (1)		Chromatin regulator;Chromosome;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 450..473;  /note=C2H2-type	PS00028;	52615	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0016574~histone ubiquitination,GO:0032682~negative regulation of chemokine production,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0045596~negative regulation of cell differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0098532~histone H3-K27 trimethylation,	GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0032993~protein-DNA complex,GO:0035098~ESC/E(Z) complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0035064~methylated histone binding,GO:0042054~histone methyltransferase activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR019135:Polycomb protein, VEFS-Box,	PF09733:VEFS-Box of polycomb protein,		2.45850215479351	6.38241061693274e-06	FDR<0.01	5.19501525859887	5777671.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	332	Chromatin modification
Q61188	Q61188-2;Q61188;P70351-2	Ezh2	3.9477	4.3369	9424600	7.75674837108284	4.53083231389606	8.86132033673017	2.72643001254158	3.7015102161682	4.87876274576767	2127001.66666667	0	Ezh2	0	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2)		FUNCTION: Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2. Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXA7, HOXB6 and HOXC8. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-ARNTL/BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription. {ECO:0000250|UniProtKB:Q15910, ECO:0000269|PubMed:12689588, ECO:0000269|PubMed:15516932, ECO:0000269|PubMed:15520282, ECO:0000269|PubMed:16717091, ECO:0000269|PubMed:18086877, ECO:0000269|PubMed:19026780}.		B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of cell population proliferation [GO:0042127]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of gliogenesis [GO:0014013]; regulation of neurogenesis [GO:0050767]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]	chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12123576}. Chromosome. Note=Localizes to the inactive X chromosome in trophoblast stem cells. {ECO:0000269|PubMed:12123576}.	14056;	cd00167;cd19218;	IPR026489;IPR021654;IPR044439;IPR041343;IPR041355;IPR001005;IPR001214;IPR033467;	PF11616;PF18118;PF18264;PF00856;	SM01114;SM00717;SM00317;	85292	COMPBIAS 180..195;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 196..217;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 359..374;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 375..407;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..340;  /note=Interaction with DNMT1, DNMT3A and DNMT3B;  /evidence=ECO:0000250; REGION 39..68;  /note=Interaction with EED; REGION 180..217;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 329..522;  /note=Interaction with CDYL;  /evidence=ECO:0000250; REGION 340..426;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.356			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Erroneous gene model prediction (1); Glycosylation (1); Helix (1); Modified residue (8); Mutagenesis (6); Region (5); Sequence conflict (2)		3D-structure;Alternative splicing;Biological rhythms;Chromatin regulator;Chromosome;Glycoprotein;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation	DOMAIN 503..605;  /note=CXC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00970; DOMAIN 612..727;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190					PS51633;PS50280;	14056	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001932~regulation of protein phosphorylation,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010468~regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0014013~regulation of gliogenesis,GO:0014834~skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0021695~cerebellar cortex development,GO:0021766~hippocampus development,GO:0032259~methylation,GO:0032355~response to estradiol,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0035984~cellular response to trichostatin A,GO:0036333~hepatocyte homeostasis,GO:0042127~regulation of cell proliferation,GO:0042752~regulation of circadian rhythm,GO:0043406~positive regulation of MAP kinase activity,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043547~positive regulation of GTPase activity,GO:0045605~negative regulation of epidermal cell differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0048511~rhythmic process,GO:0050767~regulation of neurogenesis,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0070301~cellular response to hydrogen peroxide,GO:0070314~G1 to G0 transition,GO:0070734~histone H3-K27 methylation,GO:0071168~protein localization to chromatin,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0097421~liver regeneration,GO:0098532~histone H3-K27 trimethylation,GO:1900006~positive regulation of dendrite development,GO:1904772~response to tetrachloromethane,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0035098~ESC/E(Z) complex,GO:0045120~pronucleus,	GO:0000975~regulatory region DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0031490~chromatin DNA binding,GO:0042054~histone methyltransferase activity,GO:0043021~ribonucleoprotein complex binding,GO:0043565~sequence-specific DNA binding,GO:0070878~primary miRNA binding,GO:1990841~promoter-specific chromatin binding,	IPR001005:SANT/Myb domain,IPR001214:SET domain,IPR021654:WD repeat binding protein EZH2,IPR026489:CXC domain,	PF00856:SET domain,PF11616:WD repeat binding protein EZH2,		2.25025859635865	8.63588778418445e-07	FDR<0.01	6.06369300957844	5775800.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	334	Chromatin modification
Q9CY21	Q9CY21	Wbscr22	NA	3.4253	2793815	NA	1.6480980947986	NA	NA	NA	NA	236528.833333333	5	Wbscr22	1	Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog) (rRNA methyltransferase and ribosome maturation factor)		FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the N(7) position of a guanine in 18S rRNA. Requires the methyltransferase adapter protein TRM112 for full rRNA methyltransferase activity. Involved in the pre-rRNA processing steps leading to small-subunit rRNA production independently of its RNA-modifying catalytic activity. Important for biogenesis end export of the 40S ribosomal subunit independent on its methyltransferase activity. Locus-specific steroid receptor coactivator. Potentiates transactivation by glucocorticoid (NR3C1), mineralocorticoid (NR3C2), androgen (AR) and progesterone (PGR) receptors. Required for the maintenance of open chromatin at the TSC22D3/GILZ locus to facilitate NR3C1 loading on the response elements. Required for maintenance of dimethylation on histone H3 'Lys-79' (H3K79me2), although direct histone methyltransferase activity is not observed in vitro. {ECO:0000250|UniProtKB:O43709}.		chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]	protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43709}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P25627}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:O43709}. Cytoplasm {ECO:0000250|UniProtKB:O43709}. Note=Localized diffusely throughout the nucleus and the cytoplasm. Localizes to a polarized perinuclear structure, overlapping partially with the Golgi and lysosomes. Localization is not affected by glucocorticoid treatment. {ECO:0000250|UniProtKB:O43709}.	66138;		IPR039769;IPR022238;IPR013216;IPR029063;	PF08241;PF12589;		31587	COMPBIAS 212..231;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 232..281;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 212..281;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.-			4 out of 5	Chain (1); Compositional bias (2); Region (1)		Chromatin regulator;Cytoplasm;Methyltransferase;Nucleus;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;rRNA processing							66138	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0008152~metabolic process,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR013216:Methyltransferase type 11,IPR022238:Uncharacterised protein family, methyltransferase, Williams-Beuren syndrome,	PF08241:Methyltransferase domain,PF12589:Methyltransferase involved in Williams-Beuren syndrome,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	1.24851623213676	0.0706517973481363	FDR<0.1	1.15087678542974	1515171.91666667	Present in Nucleus	RBP	Others	Others	Others	Others	697	Chromatin modification
Q9DB85	Q9DB85	Rrp8	7.3	4.3306	1992000	3.58924661713506	8.0032012805122	NA	NA	7.68344218209758	7.41015190811412	949078.333333333	2	Rrp8	0	Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1 homolog)		FUNCTION: Essential component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. In the complex, RRP8 binds to H3K9me2 and probably acts as a methyltransferase. Its substrates are however unknown (By similarity). {ECO:0000250}.		cellular response to glucose starvation [GO:0042149]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; positive regulation of cell cycle arrest [GO:0071158]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]	methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=Localizes at rDNA locus. {ECO:0000250}.	101867;		IPR007823;IPR042036;IPR029063;	PF05148;		51066	COMPBIAS 140..186;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 187..203;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 47..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 282;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 317;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 335;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 347;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 348;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 364;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O43159	2.1.1.-			4 out of 5	Binding site (6); Chain (1); Compositional bias (2); Frameshift (1); Modified residue (5); Region (1); Sequence conflict (15)		Chromatin regulator;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;rRNA processing							101867	GO:0000183~chromatin silencing at rDNA,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0042149~cellular response to glucose starvation,GO:0046015~regulation of transcription by glucose,GO:0071158~positive regulation of cell cycle arrest,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005677~chromatin silencing complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0033553~rDNA heterochromatin,	GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,GO:0035064~methylated histone binding,GO:0044822~poly(A) RNA binding,	IPR007823:Methyltransferase-related,IPR023576:UbiE/COQ5 methyltransferase, conserved site,	PF05148:Hypothetical methyltransferase,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.60966292257915	3.52040617805594e-06	FDR<0.01	5.45340722552426	1470539.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	704	Chromatin modification
Q6ZQ88	Q6ZQ88	Kdm1a	8.249	10.424	998765	2.34109797495025	3.97930760047752	NA	NA	3.54070035052933	3.81024957134692	893035	2	Kdm1a	0	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)		FUNCTION: Histone demethylase that can demethylate both 'Lys-4' (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a coactivator or a corepressor, depending on the context. Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed. Acts as a corepressor by mediating demethylation of H3K4me, a specific tag for epigenetic transcriptional activation. Demethylates both mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me. May play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity. Also acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and mediating demethylation of H3K9me, a specific tag for epigenetic transcriptional repression. The presence of PRKCB in ANDR-containing complexes, which mediates phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A. Demethylates di-methylated 'Lys-370' of p53/TP53 which prevents interaction of p53/TP53 with TP53BP1 and represses p53/TP53-mediated transcriptional activation (By similarity). Demethylates and stabilizes the DNA methylase DNMT1. Required for gastrulation during embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Effector of SNAI1-mediated transcription repression of E-cadherin/CDH1, CDN7 and KRT8. Required for the maintenance of the silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7. {ECO:0000250|UniProtKB:O60341, ECO:0000269|PubMed:17707228, ECO:0000269|PubMed:19098913}.		cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromatin silencing [GO:0006342]; granulocyte differentiation [GO:0030851]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection extension [GO:1990138]; pituitary gland development [GO:0021983]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neurogenesis [GO:0050767]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; MRF binding [GO:0043426]; nuclear receptor coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O60341}.	99982;		IPR002937;IPR036188;IPR017366;IPR009057;IPR007526;IPR036388;	PF01593;PF04433;		92851	COMPBIAS 106..152;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 301..853;  /note=Demethylase activity;  /evidence=ECO:0000250	NA		ACTIVITY REGULATION: The N-terminal sequences of INSM1 and SNAI1 compete with histone H3 for the same binding site and thereby inhibit histone demethylation (in vitro). {ECO:0000250|UniProtKB:O60341}.	BINDING 290;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 309;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 311;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 317;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 802;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341	1.14.99.66			5 out of 5	Binding site (5); Chain (1); Coiled coil (2); Compositional bias (1); Cross-link (3); Domain (1); Erroneous initiation (2); Modified residue (9); Nucleotide binding (2); Region (2); Sequence conflict (1)		Chromatin regulator;Coiled coil;Developmental protein;FAD;Flavoprotein;Isopeptide bond;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 175..274;  /note=SWIRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00247	DOMAIN: The SWIRM domain may act as an anchor site for a histone tail. {ECO:0000250}.				PS50934;	99982	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006482~protein demethylation,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0010976~positive regulation of neuron projection development,GO:0016569~covalent chromatin modification,GO:0021983~pituitary gland development,GO:0021987~cerebral cortex development,GO:0030851~granulocyte differentiation,GO:0032091~negative regulation of protein binding,GO:0033169~histone H3-K9 demethylation,GO:0033184~positive regulation of histone ubiquitination,GO:0034644~cellular response to UV,GO:0034720~histone H3-K4 demethylation,GO:0035563~positive regulation of chromatin binding,GO:0042551~neuron maturation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045793~positive regulation of cell size,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046098~guanine metabolic process,GO:0046886~positive regulation of hormone biosynthetic process,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0055001~muscle cell development,GO:0055114~oxidation-reduction process,GO:0060992~response to fungicide,GO:0071320~cellular response to cAMP,GO:0071480~cellular response to gamma radiation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1903758~negative regulation of transcription from RNA polymerase II promoter by histone modification,GO:1903827~regulation of cellular protein localization,GO:1990138~neuron projection extension,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2000648~positive regulation of stem cell proliferation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0043234~protein complex,GO:1990391~DNA repair complex,	GO:0001085~RNA polymerase II transcription factor binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016491~oxidoreductase activity,GO:0019899~enzyme binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0032451~demethylase activity,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0032454~histone demethylase activity (H3-K9 specific),GO:0034648~histone demethylase activity (H3-dimethyl-K4 specific),GO:0042162~telomeric DNA binding,GO:0043426~MRF binding,GO:0044212~transcription regulatory region DNA binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050681~androgen receptor binding,GO:0061752~telomeric repeat-containing RNA binding,	IPR002937:Amine oxidase,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016040:NAD(P)-binding domain,IPR017366:Histone lysine-specific demethylase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	PF01593:Flavin containing amine oxidoreductase,PF04433:SWIRM domain,	SSF46689:Homeodomain-like,SSF51905:FAD/NAD(P)-binding domain,	2.23327988461019	7.47109055246834e-05	FDR<0.01	4.12661599974412	945900	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	840	Chromatin modification
P54103	P54103	Dnajc2	NA	4.8158	343510	10.7399849640211	6.39304436772791	6.21349571268796	NA	4.92465281197676	8.67001907404196	987683.333333333	1	Dnajc2	1	DnaJ homolog subfamily C member 2 (Mouse Id associate 1) (MIDA1) (Zuotin-related factor 1)		FUNCTION: Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus. When cytosolic, acts as a molecular chaperone: component of the ribosome-associated complex (RAC), a complex involved in folding or maintaining nascent polypeptides in a folding-competent state. In the RAC complex, stimulates the ATPase activity of the ribosome-associated pool of Hsp70-type chaperones HSPA14 that bind to the nascent polypeptide chain. When nuclear, mediates the switching from polycomb-repressed genes to an active state: specifically recruited at histone H2A ubiquitinated at 'Lys-119' (H2AK119ub), and promotes the displacement of the polycomb PRC1 complex from chromatin, thereby facilitating transcription activation. {ECO:0000250|UniProtKB:Q99543}.		'de novo' cotranslational protein folding [GO:0051083]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of translational fidelity [GO:0006450]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin modification-dependent histone binding [GO:0061649]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:8666407}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q99543}.	22791;	cd06257;cd00167;	IPR001623;IPR018253;IPR009057;IPR036869;IPR017930;IPR032003;IPR001005;IPR017884;IPR044634;	PF00226;PF00249;PF16717;	SM00271;SM00717;	71722	COMPBIAS 422..437;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..453;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 160..250;  /note=ZRF1-UBD; REGION 422..453;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (3); Modified residue (6); Region (2); Sequence conflict (3)		Acetylation;Activator;Chaperone;Chromatin regulator;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	DOMAIN 88..161;  /note=J;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00286; DOMAIN 449..511;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 549..604;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624	DOMAIN: The ZRF1-UBD region specifically recognizes and binds H2AK119ub. The ZRF1-UBD region is also involved in protein-protein interactions with other proteins, suggesting that it may be masked by some regulator, thereby preventing its association with H2AK119ub. {ECO:0000250|UniProtKB:Q99543}.				PS00636;PS50076;PS51293;	22791	GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0030308~negative regulation of cell growth,GO:0045893~positive regulation of transcription, DNA-templated,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0044822~poly(A) RNA binding,	IPR001005:SANT/Myb domain,IPR001623:DnaJ domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,IPR017930:Myb domain,IPR018253:DnaJ domain, conserved site,	PF00226:DnaJ domain,PF00249:Myb-like DNA-binding domain,	SSF46565:Chaperone J-domain,SSF46689:Homeodomain-like,	2.73677683258381	1.87263381725102e-06	FDR<0.01	5.7275471381053	665596.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	949	Chromatin modification
Q3U319	Q3U319	Rnf40	1.5023	10.101	353910	2.54576003665894	NA	NA	NA	NA	NA	54492.8333333333	5	Rnf40	0	E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)		FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role in histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. {ECO:0000250|UniProtKB:O75150}.	PATHWAY: Protein modification; protein ubiquitination.	histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511]	axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]	metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75150}.	233900;		IPR013956;IPR001841;IPR013083;IPR017907;		SM00184;	113967	COMPBIAS 604..619;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 633..647;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 122..142;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 519..647;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Chain (1); Coiled coil (4); Compositional bias (2); Cross-link (2); Erroneous initiation (1); Modified residue (6); Region (3); Sequence conflict (2); Zinc finger (1)		Acetylation;Chromatin regulator;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 948..987;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS00518;PS50089;	233900	GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010390~histone monoubiquitination,GO:0016569~covalent chromatin modification,GO:0033523~histone H2B ubiquitination,GO:0043434~response to peptide hormone,GO:1900364~negative regulation of mRNA polyadenylation,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902916~positive regulation of protein polyubiquitination,GO:2001168~positive regulation of histone H2B ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0033503~HULC complex,GO:0043005~neuron projection,GO:0043234~protein complex,GO:0043679~axon terminus,	GO:0003730~mRNA 3'-UTR binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0017075~syntaxin-1 binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,			1.75723186599362	0.026274844333336	FDR<0.1	1.58045984829205	204201.416666667	Present in Nucleus	RBP	DBD	DBD	ChD	Others	1277	Chromatin modification
Q5DTM8	Q5DTM8;Q5DTM8-2	Rnf20	5.3555	23.224	254995	NA	2.3930887596621	2.29821658393087	NA	1.37523207041188	4.3905865823674	137312.833333333	2	Rnf20	0	E3 ubiquitin-protein ligase BRE1A (BRE1-A) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A)		FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role in histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. Recruited to the MDM2 promoter, probably by being recruited by p53/TP53, and thereby acts as a transcriptional coactivator. Mediates the polyubiquitination of PA2G4 leading to its proteasome-mediated degradation. {ECO:0000250|UniProtKB:Q5VTR2}.	PATHWAY: Protein modification; protein ubiquitination.	histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]	HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5VTR2}.	109331;		IPR013956;IPR001841;IPR013083;IPR017907;		SM00184;	113520	COMPBIAS 128..152;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 510..527;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 528..544;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 552..620;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..37;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 128..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 507..620;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (3); Compositional bias (4); Erroneous initiation (1); Modified residue (8); Region (3); Sequence conflict (4); Zinc finger (1)		Acetylation;Alternative splicing;Chromatin regulator;Coiled coil;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 920..959;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS00518;PS50089;	109331	GO:0000209~protein polyubiquitination,GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010390~histone monoubiquitination,GO:0016569~covalent chromatin modification,GO:0016574~histone ubiquitination,GO:0030336~negative regulation of cell migration,GO:0031062~positive regulation of histone methylation,GO:0033523~histone H2B ubiquitination,GO:0045893~positive regulation of transcription, DNA-templated,GO:1900364~negative regulation of mRNA polyadenylation,GO:2001168~positive regulation of histone H2B ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0033503~HULC complex,	GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0003730~mRNA 3'-UTR binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,			2.00200721802236	0.00254082461604791	FDR<0.01	2.59502531169554	196153.916666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1286	Chromatin modification
Q6P1G2	Q6P1G2;Q6P1G2-2;Q6P1G2-3	Kdm2b	6.8503	5.5332	275485	NA	NA	8.90392663164456	NA	2.20541208124738	3.21874597656753	109973.666666667	3	Kdm2b	0	Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B)		FUNCTION: Histone demethylase that demethylates 'Lys-4' and 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation (By similarity). May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex (By similarity). {ECO:0000250|UniProtKB:Q8NHM5}.		embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]	histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8NHM5}. Nucleus {ECO:0000250|UniProtKB:Q8NHM5}. Chromosome {ECO:0000250|UniProtKB:Q8NHM5}.	30841;		IPR041667;IPR001810;IPR041070;IPR003347;IPR006553;IPR032675;IPR002857;IPR011011;IPR001965;IPR019787;IPR013083;	PF13621;PF00646;PF17811;PF16866;PF02008;	SM00558;SM00367;SM00249;	149733	COMPBIAS 378..402;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 451..476;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 724..787;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 788..816;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 841..879;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 915..936;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 946..976;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 378..476;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 700..816;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 828..1005;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Histone demethylase activity is inhibited by fumarate. {ECO:0000250|UniProtKB:Q8NHM5}.	BINDING 208;  /note=Substrate;  /evidence=ECO:0000250; BINDING 228;  /note=Substrate;  /evidence=ECO:0000250	1.14.11.27	METAL 211;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 213;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 283;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 586;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 589;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 592;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 597;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 600;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 603;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 619;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 624;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 635;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 638;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 661;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 664;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 669;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 672;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 692;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 695;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5		5 out of 5	Alternative sequence (5); Binding site (2); Chain (1); Coiled coil (1); Compositional bias (7); Cross-link (2); Domain (2); Metal binding (19); Modified residue (10); Region (3); Repeat (6); Sequence conflict (1); Zinc finger (2)		Alternative splicing;Chromatin regulator;Chromosome;Coiled coil;DNA-binding;Dioxygenase;Iron;Isopeptide bond;Leucine-rich repeat;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger;rRNA-binding	DOMAIN 147..315;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; DOMAIN 1032..1078;  /note=F-box	DOMAIN: The LRR repeats are required for the interaction with the PCGF1-BCORL1 heterodimeric complex. {ECO:0000250|UniProtKB:Q8NHM5}.; DOMAIN: The JmjC domain mediates demethylation activity (By similarity). It is also required for repression of ribosomal RNA genes (By similarity). {ECO:0000250|UniProtKB:Q8NHM5}.; DOMAIN: The CXXC zinc finger mediates binding to DNA containing unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides. {ECO:0000250|UniProtKB:Q8NHM5}.; DOMAIN: The F-box domain mediates interaction with UBB. {ECO:0000250|UniProtKB:Q8NHM5}.		REPEAT 1106..1127;  /note=LRR 1; REPEAT 1129..1155;  /note=LRR 2; REPEAT 1195..1220;  /note=LRR 3; REPEAT 1221..1250;  /note=LRR 4; REPEAT 1251..1275;  /note=LRR 5; REPEAT 1276..1309;  /note=LRR 6	ZN_FING 579..625;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509; ZN_FING 632..698;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51184;PS51058;PS50016;	30841	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0016569~covalent chromatin modification,GO:0021555~midbrain-hindbrain boundary morphogenesis,GO:0021592~fourth ventricle development,GO:0021670~lateral ventricle development,GO:0021678~third ventricle development,GO:0021993~initiation of neural tube closure,GO:0030307~positive regulation of cell growth,GO:0030900~forebrain development,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0035518~histone H2A monoubiquitination,GO:0043524~negative regulation of neuron apoptotic process,GO:0048596~embryonic camera-type eye morphogenesis,GO:0055114~oxidation-reduction process,GO:0070544~histone H3-K36 demethylation,GO:1902459~positive regulation of stem cell population maintenance,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0031519~PcG protein complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0019843~rRNA binding,GO:0032452~histone demethylase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR001810:F-box domain, cyclin-like,IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR003347:JmjC domain,IPR006553:Leucine-rich repeat, cysteine-containing subtype,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	PF00646:F-box domain,PF02008:CXXC zinc finger domain,PF02373:JmjC domain, hydroxylase,	SSF57903:FYVE/PHD zinc finger,	2.24525398385472	0.000239308462891706	FDR<0.01	3.62104194274812	192729.333333333	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1292	Chromatin modification
Q99L90	Q99L90	Mcrs1	3.7701	5.7145	1732950	NA	8.97263346792284	NA	NA	4.00962309542903	10.7793467715856	371771.666666667	3	Mcrs1	0	Microspherule protein 1 (58 kDa microspherule protein)		FUNCTION: Modulates the transcription repressor activity of DAXX by recruiting it to the nucleolus. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. Putative regulatory component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. May also be an inhibitor of TERT telomerase activity. Binds to G-quadruplex structures in mRNA. Binds to RNA homomer poly(G) and poly(U). {ECO:0000250|UniProtKB:Q96EZ8}.		DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]	G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96EZ8}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96EZ8}. Cytoplasm {ECO:0000250|UniProtKB:Q96EZ8}. Note=In microspherules in the nucleolus. {ECO:0000250|UniProtKB:Q96EZ8}.	51812;	cd00060;	IPR000253;IPR037912;IPR025999;IPR008984;	PF00498;PF13325;	SM00240;	51692	COMPBIAS 9..24;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..130;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (1); Domain (1); Modified residue (8); Motif (1); Region (1); Sequence conflict (5)		Acetylation;Chromatin regulator;Coiled coil;Cytoplasm;DNA damage;DNA recombination;DNA repair;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 363..419;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086		MOTIF 113..123;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50006;	51812	GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0016569~covalent chromatin modification,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,GO:1904751~positive regulation of protein localization to nucleolus,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0030425~dendrite,GO:0031011~Ino80 complex,GO:0043204~perikaryon,GO:0071339~MLL1 complex,	GO:0002151~G-quadruplex RNA binding,GO:0008266~poly(U) RNA binding,GO:0034046~poly(G) binding,GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR025999:Microspherule protein, N-terminal domain,	PF00498:FHA domain,PF13325:N-terminal region of micro-spherule protein,	SSF49879:SMAD/FHA domain,	2.60568520399111	4.47447337004623e-05	FDR<0.01	4.34925807229036	1052360.83333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	801	Chromatin modification
Q61937	Q61937	Npm1	18.178	22.873	1786775000	27.5793596072699	17.3819332186126	14.1474732612755	5.12767921238847	42.9074058182442	42.3872499152255	572885000	0	Npm1	0	Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)		FUNCTION: Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade. In complex with MYC enhances the transcription of MYC target genes. {ECO:0000250|UniProtKB:P06748}.		cell aging [GO:0007569]; cellular response to UV [GO:0034644]; cell volume homeostasis [GO:0006884]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of gene expression [GO:0010629]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of DNA replication [GO:0045740]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; posttranscriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; regulation of neuron apoptotic process [GO:0043523]; regulation of protein stability [GO:0031647]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA export from nucleus [GO:0006407]; rRNA transcription [GO:0009303]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; granular component [GO:0001652]; large ribosomal subunit [GO:0015934]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; spindle pole centrosome [GO:0031616]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein N-terminus binding [GO:0047485]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P06748}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P06748}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P06748}. Note=Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Colocalizes with the methylated form of RPS10 in the granular component (GC) region of the nucleolus. Colocalized with nucleolin and APEX1 in nucleoli. NEK2 is required for its localization to the centrosome during mitosis (By similarity). {ECO:0000250|UniProtKB:P06748}.	18148;		IPR032569;IPR038101;IPR004301;IPR024057;IPR036824;	PF16276;PF03066;		32560	COMPBIAS 160..185;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 200..216;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 217..234;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..185;  /note=Required for interaction with SENP3;  /evidence=ECO:0000250; REGION 1..117;  /note=Necessary for interaction with APEX1;  /evidence=ECO:0000250; REGION 138..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 241..292;  /note=Required for nucleolar localization;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (8); Chain (1); Compositional bias (3); Cross-link (17); Helix (1); Modified residue (33); Motif (2); Region (4); Site (2); Turn (1)		3D-structure;ADP-ribosylation;Acetylation;Chaperone;Cytoplasm;Cytoskeleton;DNA-binding;Direct protein sequencing;Disulfide bond;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation			MOTIF 152..157;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 190..196;  /note=Nuclear localization signal;  /evidence=ECO:0000255				18148	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006407~rRNA export from nucleus,GO:0006884~cell volume homeostasis,GO:0006913~nucleocytoplasmic transport,GO:0006950~response to stress,GO:0007098~centrosome cycle,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009303~rRNA transcription,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010824~regulation of centrosome duplication,GO:0010825~positive regulation of centrosome duplication,GO:0010826~negative regulation of centrosome duplication,GO:0016049~cell growth,GO:0019827~stem cell population maintenance,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031398~positive regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032071~regulation of endodeoxyribonuclease activity,GO:0042273~ribosomal large subunit biogenesis,GO:0042274~ribosomal small subunit biogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045727~positive regulation of translation,GO:0045740~positive regulation of DNA replication,GO:0045860~positive regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046599~regulation of centriole replication,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050821~protein stabilization,GO:0051054~positive regulation of DNA metabolic process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051726~regulation of cell cycle,GO:0060699~regulation of endoribonuclease activity,GO:0060735~regulation of eIF2 alpha phosphorylation by dsRNA,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,GO:1902751~positive regulation of cell cycle G2/M phase transition,GO:1904751~positive regulation of protein localization to nucleolus,GO:2000381~negative regulation of mesoderm development,	GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0031616~spindle pole centrosome,	GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008134~transcription factor binding,GO:0019843~rRNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030957~Tat protein binding,GO:0042393~histone binding,GO:0042803~protein homodimerization activity,GO:0043023~ribosomal large subunit binding,GO:0043024~ribosomal small subunit binding,GO:0043422~protein kinase B binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051059~NF-kappaB binding,GO:0051082~unfolded protein binding,	IPR004301:Nucleoplasmin,IPR024057:Nucleoplasmin core domain,	PF03066:Nucleoplasmin,	SSF69203:Nucleoplasmin-like core domain,	4.32677758938023	3.92839983419296e-08	FDR<0.01	7.40578431595981	1179830000	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	2	Chromatin remodelling
Q9CPP0	Q9CPP0	Npm3	19.994	13.054	43206000	11.9746138187043	3.44423779017703	17.2744390125931	7.33837234901299	12.4543858119637	5.80720092915215	15118033.3333333	0	Npm3	0	Nucleoplasmin-3		FUNCTION: Plays a role in the regulation of diverse cellular processes such as ribosome biogenesis, chromatin remodeling or protein chaperoning. Modulates the histone chaperone function and the RNA-binding activity of nucleolar phosphoprotein B23/NPM. Efficiently mediates chromatin remodeling when included in a pentamer containing NPM3 and NPM. {ECO:0000250|UniProtKB:O75607}.		chromatin remodeling [GO:0006338]; rRNA processing [GO:0006364]; rRNA transcription [GO:0009303]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75607}. Nucleus, nucleolus {ECO:0000250|UniProtKB:O75607}. Note=Mainly found in the granular component of the nucleolus. {ECO:0000250|UniProtKB:O75607}.	18150;		IPR004301;IPR024057;IPR036824;	PF03066;		19023			NA							4 out of 5	Chain (1); Initiator methionine (1); Modified residue (5)		Acetylation;Chaperone;Methylation;Nucleus;Phosphoprotein;Reference proteome							18150	GO:0006364~rRNA processing,GO:0009303~rRNA transcription,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004301:Nucleoplasmin,IPR024057:Nucleoplasmin core domain,	PF03066:Nucleoplasmin,	SSF69203:Nucleoplasmin-like core domain,	3.31955740283285	2.10972402746758e-07	FDR<0.01	6.6757743509519	29162016.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	82	Chromatin remodelling
Q60973	Q60973	Rbbp7	8.3843	6.9143	7798900	NA	4.75217411965974	NA	NA	NA	6.12857755714899	767556.666666667	4	Rbbp7	0	Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46)		FUNCTION: Core histone-binding subunit that may target chromatin remodeling factors, histone acetyltransferases and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal DNA. Component of several complexes which regulate chromatin metabolism. These include the type B histone acetyltransferase (HAT) complex, which is required for chromatin assembly following DNA replication; the core histone deacetylase (HDAC) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the NuRD complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; and the PRC2/EED-EZH2 complex, which promotes repression of homeotic genes during development; and the NURF (nucleosome remodeling factor) complex (By similarity). {ECO:0000250|UniProtKB:Q16576}.		cellular heat acclimation [GO:0070370]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to steroid hormone [GO:0048545]	cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus.	245688;		IPR020472;IPR022052;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12265;PF00400;	SM00320;	47790			NA							5 out of 5	Chain (1); Cross-link (5); Initiator methionine (1); Modified residue (8); Repeat (7)		Acetylation;Chaperone;Chromatin regulator;DNA replication;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;WD repeat				REPEAT 47..122;  /note=WD 1; REPEAT 128..173;  /note=WD 2; REPEAT 181..217;  /note=WD 3; REPEAT 228..269;  /note=WD 4; REPEAT 275..312;  /note=WD 5; REPEAT 318..369;  /note=WD 6; REPEAT 376..403;  /note=WD 7		PS00678;PS50082;PS50294;	245688	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006260~DNA replication,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0030308~negative regulation of cell growth,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048545~response to steroid hormone,GO:0070370~cellular heat acclimation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0035098~ESC/E(Z) complex,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,	PF00400:WD domain, G-beta repeat,PF12265:Histone-binding protein RBBP4 or subunit C of CAF1 complex,	SSF50978:WD40 repeat-like,	2.68035337522741	6.10733895583316e-05	FDR<0.01	4.21414797609667	4283228.33333333	Present in Nucleus	RBP	DBD	DBD	ChD	Others	402	Chromatin remodelling
Q9Z204	Q9Z204;Q9Z204-5	Hnrnpc	NA	2.5199	3748000	6.78288001085261	10.3606543789306	6.69344042838019	2.94759181748511	NA	28.3704039945529	4121383.33333333	1	Hnrnpc	1	Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2)		FUNCTION: Binds pre-mRNA and nucleates the assembly of 40S hnRNP particles. Interacts with poly-U tracts in the 3'-UTR or 5'-UTR of mRNA and modulates the stability and the level of translation of bound mRNA molecules. Single HNRNPC tetramers bind 230-240 nucleotides. Trimers of HNRNPC tetramers bind 700 nucleotides. May play a role in the early steps of spliceosome assembly and pre-mRNA splicing. N6-methyladenosine (m6A) has been shown to alter the local structure in mRNAs and long non-coding RNAs (lncRNAs) via a mechanism named 'm(6)A-switch', facilitating binding of HNRNPC, leading to regulation of mRNA splicing. {ECO:0000250|UniProtKB:P07910}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA modification [GO:0090367]; negative regulation of telomere maintenance via telomerase [GO:0032211]	actin cytoskeleton [GO:0015629]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleoplasmic periphery of the nuclear pore complex [GO:1990826]; nucleus [GO:0005634]; pronucleus [GO:0045120]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]	deaminase binding [GO:1990827]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07910}. Note=Component of ribonucleosomes. {ECO:0000250|UniProtKB:P07910}.	15381;		IPR017347;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	34385	COMPBIAS 158..189;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 236..265;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 266..313;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 139..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 219..313;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (13); Domain (1); Initiator methionine (1); Modified residue (18); Motif (1); Region (2); Sequence conflict (1)		Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 16..87;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 155..161;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;	15381	GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0043044~ATP-dependent chromatin remodeling,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0090367~negative regulation of mRNA modification,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043234~protein complex,GO:0045120~pronucleus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:1990826~nucleoplasmic periphery of the nuclear pore complex,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0004857~enzyme inhibitor activity,GO:0008266~poly(U) RNA binding,GO:0019904~protein domain specific binding,GO:0031492~nucleosomal DNA binding,GO:0042802~identical protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,GO:1990247~N6-methyladenosine-containing RNA binding,GO:1990827~deaminase binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.76615119436574	0.000150264495264731	FDR<0.01	3.82314362308667	3934691.66666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	430	Chromatin remodelling
O54941	O54941	Smarce1	0.98471	1.0518	4135500	4.91062659595364	3.17118031331262	6.22471210706505	2.87224264705882	7.03779294813147	2.93194945319143	1506138.33333333	0	Smarce1	0	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	DNA_BIND 66..134;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:12110891). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (PubMed:17640523). Also specifically interacts with the CoREST corepressor resulting in repression of neuronal specific gene promoters in non-neuronal cells (By similarity). Required for the coactivation of estrogen responsive promoters by SWI/SNF complexes and the SRC/p160 family of histone acetyltransferases (HATs)(PubMed:12145209). {ECO:0000250|UniProtKB:Q969G3, ECO:0000269|PubMed:12110891, ECO:0000269|PubMed:12145209, ECO:0000269|PubMed:17640523}.		ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267}.	57376;		IPR030089;IPR009071;IPR036910;	PF00505;	SM00398;	46638	COMPBIAS 1..18;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 42..56;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 294..311;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 324..353;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..398;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 42..70;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 153..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..411;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (5); Cross-link (7); DNA binding (1); Erroneous termination (1); Frameshift (1); Modified residue (3); Region (4); Sequence caution (1)		Chromatin regulator;Coiled coil;DNA-binding;Isopeptide bond;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The HMG domain is essential for CD4 silencing and CD8 activation; mutation of this domain blocks thymus development. {ECO:0000269|PubMed:12110891}.				PS50118;	57376	GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0022008~neurogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,GO:0016922~ligand-dependent nuclear receptor binding,GO:0031492~nucleosomal DNA binding,GO:0047485~protein N-terminus binding,	IPR009071:High mobility group (HMG) box domain,	PF00505:HMG (high mobility group) box,	SSF47095:HMG-box,	1.56734078766473	0.00083069699537518	FDR<0.01	3.08055736037182	2820819.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	522	Chromatin remodelling
Q91YE5	Q91YE5-2;Q91YE5;Q91YE5-3	Baz2a	7.3345	7.7147	2804250	8.12875955129247	9.05059281382931	4.07830342577488	4.07896883667809	7.67224182906245	4.49478604818411	2203256.66666667	0	Baz2a	0	Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5)	DNA_BIND 641..653;  /note=A.T hook 1; DNA_BIND 662..674;  /note=A.T hook 2; DNA_BIND 1176..1188;  /note=A.T hook 3; DNA_BIND 1390..1402;  /note=A.T hook 4	FUNCTION: Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription. Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac. Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing. {ECO:0000269|PubMed:11532953, ECO:0000269|PubMed:12198165, ECO:0000269|PubMed:16085498}.		chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; histone H4 deacetylation [GO:0070933]; histone H4-K20 methylation [GO:0034770]; negative regulation of transcription by RNA polymerase I [GO:0016479]; rDNA heterochromatin assembly [GO:0000183]; RNA polymerase I preinitiation complex assembly [GO:0001188]	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]	DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11532953, ECO:0000269|PubMed:12198165, ECO:0000269|PubMed:16085498, ECO:0000269|PubMed:18600236, ECO:0000269|PubMed:19578370}. Note=Colocalizes with the basal RNA polymerase I transcription factor UBF in the nucleolus.		cd05503;	IPR017956;IPR037374;IPR001487;IPR036427;IPR018359;IPR018501;IPR016177;IPR001739;IPR028940;IPR028942;IPR028941;IPR011011;IPR001965;IPR019787;IPR013083;	PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;	SM00384;SM00297;SM00571;SM00391;SM00249;	209618	COMPBIAS 28..59;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 384..409;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 479..506;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 645..704;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 728..791;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1147..1177;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1190..1230;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1269..1286;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1332..1368;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..59;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 384..433;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 479..526;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 638..791;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1039..1063;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1147..1247;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1269..1397;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1720..1778;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (9); Cross-link (5); DNA binding (4); Domain (3); Modified residue (16); Mutagenesis (3); Region (8); Sequence conflict (1); Zinc finger (1)		Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;Coiled coil;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 538..609;  /note=MBD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00338; DOMAIN 839..904;  /note=DDT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00063; DOMAIN 1794..1864;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035	DOMAIN: The bromo domain and the PHD-type zinc finger recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac). These 2 domains play a central role in the recruitment of chromatin silencing proteins such as DNMT1, DNMT3B and HDAC1.; DOMAIN: The MBD (methyl-CpG-binding) domain, also named TAM domain, specifically recognizes and binds a conserved stem-loop structure the association within pRNA. Binding to pRNA induces a conformational change of BAZ2A/TIP5 and is essential for targeting the NoRC complex to the nucleolus.			ZN_FING 1662..1712;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS00633;PS50014;PS50827;PS50982;PS50016;	NA	GO:0000183~chromatin silencing at rDNA,GO:0006306~DNA methylation,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016479~negative regulation of transcription from RNA polymerase I promoter,GO:0016569~covalent chromatin modification,GO:0016575~histone deacetylation,GO:0034770~histone H4-K20 methylation,GO:0051567~histone H3-K9 methylation,GO:0070869~heterochromatin assembly involved in chromatin silencing,GO:0070933~histone H4 deacetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005677~chromatin silencing complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0033553~rDNA heterochromatin,	GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR001739:Methyl-CpG DNA binding,IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016177:DNA-binding, integrase-type,IPR017956:AT hook, DNA-binding motif,IPR018359:Bromodomain, conserved site,IPR018501:DDT domain superfamily,IPR019787:Zinc finger, PHD-finger,	PF00439:Bromodomain,PF00628:PHD-finger,PF01429:Methyl-CpG binding domain,PF02178:AT hook motif,PF02791:DDT domain,PF15612:WSTF, HB1, Itc1p, MBD9 motif 1,PF15613:WSTF, HB1, Itc1p, MBD9 motif 2,	SSF47370:Bromodomain,SSF54171:DNA-binding domain,SSF57903:FYVE/PHD zinc finger,	2.64842880272746	8.88976446933098e-08	FDR<0.01	7.0511097453318	2503753.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	553	Chromatin remodelling
P70288	P70288	Hdac2	3.361	3.3429	1648700	6.97252823873937	3.9332913782253	3.09185913489781	1.80258129641647	3.84941104011086	10.3126804719083	1772478.33333333	0	Hdac2	0	Histone deacetylase 2 (HD2) (EC 3.5.1.98) (YY1 transcription factor-binding protein)		FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes (By similarity). Forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR. Interacts in the late S-phase of DNA-replication with DNMT1 in the other transcriptional repressor complex composed of DNMT1, DMAP1, PCNA, CAF1. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. May be involved in the transcriptional repression of circadian target genes, such as PER1, mediated by CRY1 through histone deacetylation. Involved in MTA1-mediated transcriptional corepression of TFF1 and CDKN1A. {ECO:0000250|UniProtKB:Q92769, ECO:0000269|PubMed:15226430, ECO:0000269|PubMed:17707228, ECO:0000269|PubMed:20071335}.		cardiac muscle cell development [GO:0055013]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin maintenance [GO:0070829]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H3-K27 methylation [GO:0070734]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein deacetylation [GO:0006476]; regulation of protein deacetylation [GO:0090311]; regulation of protein kinase B signaling [GO:0051896]; regulation of sarcomere organization [GO:0060297]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; RNA polymerase II transcription repressor complex [GO:0090571]; Sin3 complex [GO:0016580]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase activity (H4-K16 specific) [GO:0034739]; histone deacetylase binding [GO:0042826]; Krueppel-associated box domain binding [GO:0035851]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92769}. Cytoplasm {ECO:0000250|UniProtKB:Q92769}.	15182;		IPR000286;IPR003084;IPR023801;IPR037138;IPR023696;	PF00850;		55302	COMPBIAS 398..480;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 9..322;  /note=Histone deacetylase; REGION 389..488;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 142;  /evidence=ECO:0000250			3.5.1.98			5 out of 5	Active site (1); Chain (1); Compositional bias (1); Cross-link (7); Modified residue (8); Mutagenesis (3); Region (2); Sequence conflict (1)		Acetylation;Biological rhythms;Chromatin regulator;Cytoplasm;Hydrolase;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-nitrosylation;Transcription;Transcription regulation;Ubl conjugation							15182	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0001975~response to amphetamine,GO:0003300~cardiac muscle hypertrophy,GO:0006325~chromatin organization,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0008284~positive regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010870~positive regulation of receptor biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0016358~dendrite development,GO:0016569~covalent chromatin modification,GO:0016575~histone deacetylation,GO:0021766~hippocampus development,GO:0030182~neuron differentiation,GO:0031000~response to caffeine,GO:0032496~response to lipopolysaccharide,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0034605~cellular response to heat,GO:0035094~response to nicotine,GO:0035984~cellular response to trichostatin A,GO:0042220~response to cocaine,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042733~embryonic digit morphogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048149~behavioral response to ethanol,GO:0048511~rhythmic process,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051896~regulation of protein kinase B signaling,GO:0055013~cardiac muscle cell development,GO:0055093~response to hyperoxia,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060297~regulation of sarcomere organization,GO:0060789~hair follicle placode formation,GO:0061000~negative regulation of dendritic spine development,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070301~cellular response to hydrogen peroxide,GO:0070734~histone H3-K27 methylation,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0071300~cellular response to retinoic acid,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090311~regulation of protein deacetylation,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903351~cellular response to dopamine,GO:2000757~negative regulation of peptidyl-lysine acetylation,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0017053~transcriptional repressor complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,GO:0090571~RNA polymerase II transcription repressor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001226~RNA polymerase II transcription corepressor binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016787~hydrolase activity,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0034739~histone deacetylase activity (H4-K16 specific),GO:0035851~Krueppel-associated box domain binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,	IPR000286:Histone deacetylase superfamily,IPR003084:Histone deacetylase,IPR023801:Histone deacetylase domain,	PF00850:Histone deacetylase domain,		2.00711672356986	1.4175579933514e-05	FDR<0.01	4.84845916476147	1710589.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	667	Chromatin remodelling
Q9JJF3	Q9JJF3	No66	25.944	6.7601	412150	NA	6.15081805880182	NA	NA	3.53356890459364	NA	182044.5	4	No66	0	Ribosomal oxygenase 1 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66) (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66)		FUNCTION: Oxygenase that can act as both a histone lysine demethylase and a ribosomal histidine hydroxylase Also catalyzes the hydroxylation of 60S ribosomal protein L8 on 'His-216'. Acts as a regulator of osteoblast differentiation via its interaction with SP7/OSX by demethylating H3K4me and H3K36me, thereby inhibiting SP7/OSX-mediated promoter activation. May also play a role in ribosome biogenesis and in the replication or remodeling of certain heterochromatic region. Participates in MYC-induced transcriptional activation (By similarity). Specifically demethylates 'Lys-4' (H3K4me) and 'Lys-36' (H3K36me) of histone H3, thereby playing a central role in histone code. Preferentially demethylates trimethylated H3 'Lys-4' (H3K4me3) and monomethylated H3 'Lys-4' (H3K4me1) residues, while it has weaker activity for dimethylated H3 'Lys-36' (H3K36me2). {ECO:0000250, ECO:0000269|PubMed:19927124}.		chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000269|PubMed:14742713, ECO:0000269|PubMed:19927124}.	71952;		IPR003347;IPR039994;IPR013109;	PF08007;	SM00558;	67557	COMPBIAS 60..90;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.14.11.-; 1.14.11.27	METAL 302;  /note=Iron; catalytic;  /evidence=ECO:0000305; METAL 304;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 367;  /note=Iron; catalytic;  /evidence=ECO:0000305		5 out of 5	Chain (1); Compositional bias (1); Domain (1); Metal binding (3); Modified residue (4); Mutagenesis (2); Region (1); Sequence conflict (1)		Acetylation;Chromatin regulator;Dioxygenase;Iron;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	DOMAIN 256..401;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538					PS51184;	71952	GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0018193~peptidyl-amino acid modification,GO:0034720~histone H3-K4 demethylation,GO:0042254~ribosome biogenesis,GO:0043687~post-translational protein modification,GO:0045668~negative regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0055114~oxidation-reduction process,GO:0070544~histone H3-K36 demethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0030685~nucleolar preribosome,	GO:0003723~RNA binding,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR003347:JmjC domain,	PF08007:Cupin superfamily protein,		2.97406948881738	0.000554127507160019	FDR<0.01	3.25639029071485	297097.25	Present in Nucleus	RBP	Others	Others	Others	Others	1185	Chromatin remodelling
P08113	P08113	Hsp90b1	5.6801	8.3876	241345	7.40137665605803	10.0453043224945	7.25531451788435	3.8704183922282	0.557506829458661	6.62998077305576	5430988.33333333	0	Hsp90b1	0	Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Endoplasmic reticulum resident protein 99) (ERp99) (Heat shock protein 90 kDa beta member 1) (Polymorphic tumor rejection antigen 1) (Tumor rejection antigen gp96)		FUNCTION: Molecular chaperone that functions in the processing and transport of secreted proteins (PubMed:20865800). When associated with CNPY3, required for proper folding of Toll-like receptors (PubMed:20865800). Functions in endoplasmic reticulum associated degradation (ERAD) (By similarity). Has ATPase activity (PubMed:20865800). May participate in the unfolding of cytosolic leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1 to facilitate their translocation into the ERGIC (endoplasmic reticulum-Golgi intermediate compartment) and secretion; the translocation process is mediated by the cargo receptor TMED10 (By similarity). {ECO:0000250|UniProtKB:P14625, ECO:0000269|PubMed:20865800}.		actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:20865800}. Sarcoplasmic reticulum lumen {ECO:0000250|UniProtKB:P41148}. Melanosome {ECO:0000250|UniProtKB:P14625}.	22027;		IPR003594;IPR036890;IPR019805;IPR037196;IPR001404;IPR020575;IPR020568;	PF02518;PF00183;	SM00387;	92476	COMPBIAS 290..314;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 753..802;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 290..323;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 749..802;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 107;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P41148; BINDING 149;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P41148; BINDING 162;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P41148; BINDING 199;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P41148				5 out of 5	Binding site (4); Chain (1); Compositional bias (2); Disulfide bond (1); Glycosylation (6); Modified residue (9); Motif (1); Mutagenesis (1); Region (2); Signal peptide (1); Site (1)		ATP-binding;Acetylation;Calcium;Chaperone;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Nucleotide-binding;Phosphoprotein;Reference proteome;Sarcoplasmic reticulum;Signal			MOTIF 799..802;  /note=Prevents secretion from ER			PS00014;PS00298;	22027	GO:0001666~response to hypoxia,GO:0006457~protein folding,GO:0006898~receptor-mediated endocytosis,GO:0006950~response to stress,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030970~retrograde protein transport, ER to cytosol,GO:0031247~actin rod assembly,GO:0043066~negative regulation of apoptotic process,GO:0043666~regulation of phosphoprotein phosphatase activity,GO:0071318~cellular response to ATP,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005790~smooth endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030496~midbody,GO:0031012~extracellular matrix,GO:0034663~endoplasmic reticulum chaperone complex,GO:0042470~melanosome,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019903~protein phosphatase binding,GO:0046790~virion binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0051082~unfolded protein binding,	IPR001404:Heat shock protein Hsp90,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR019805:Heat shock protein Hsp90, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020575:Heat shock protein Hsp90, N-terminal,	PF00183:Hsp90 protein,PF02518:Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,	2.31100139378335	0.000160878820410878	FDR<0.01	3.79350112671592	2836166.66666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	520	Portein transport
Q8CIE6	Q8CIE6	Copa	3.2505	NA	58411.5	NA	3.252878797736	NA	NA	2.06151562628845	2.33885302647582	264007.833333333	3	Copa	1	Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]		FUNCTION: The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). {ECO:0000250}.; FUNCTION: Xenin stimulates exocrine pancreatic secretion. It inhibits pentagastrin-stimulated secretion of acid, to induce exocrine pancreatic secretion and to affect small and large intestinal motility. In the gut, xenin interacts with the neurotensin receptor (By similarity). {ECO:0000250}.		endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]	axon [GO:0030424]; cell body [GO:0044297]; COPI-coated vesicle [GO:0030137]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]	hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cytoplasmic vesicle, COPI-coated vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=The coatomer is cytoplasmic or polymerized on the cytoplasmic side of the Golgi, as well as on the vesicles/buds originating from it. {ECO:0000250}.; SUBCELLULAR LOCATION: [Xenin]: Secreted {ECO:0000250}.	12847;		IPR024977;IPR016391;IPR010714;IPR006692;IPR020472;IPR011048;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12894;PF04053;PF06957;PF00400;	SM00320;	138432			NA							5 out of 5	Chain (1); Modified residue (6); Peptide (2); Repeat (6); Sequence conflict (2)		3D-structure;Cytoplasm;Cytoplasmic vesicle;ER-Golgi transport;Golgi apparatus;Hormone;Membrane;Methylation;Phosphoprotein;Protein transport;Reference proteome;Repeat;Secreted;Transport;WD repeat				REPEAT 7..37;  /note=WD 1; REPEAT 49..79;  /note=WD 2; REPEAT 91..121;  /note=WD 3; REPEAT 133..163;  /note=WD 4; REPEAT 203..233;  /note=WD 5; REPEAT 247..277;  /note=WD 6		PS00678;PS50082;PS50294;	12847	GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0030157~pancreatic juice secretion,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0030117~membrane coat,GO:0030126~COPI vesicle coat,GO:0031410~cytoplasmic vesicle,GO:0070062~extracellular exosome,	GO:0005179~hormone activity,GO:0005198~structural molecule activity,	IPR001680:WD40 repeat,IPR006692:Coatomer, WD associated region,IPR010714:Coatomer, alpha subunit, C-terminal,IPR011048:Cytochrome cd1-nitrite reductase-like, C-terminal haem d1,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016391:Coatomer alpha subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF04053:Coatomer WD associated region ,PF06957:Coatomer (COPI) alpha subunit C-terminus,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF50978:WD40 repeat-like,SSF51004:C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase,	1.41797133129855	0.00271277806511308	FDR<0.01	2.56658573481905	161209.666666667	Unexpected	RBP	ChD	Others	ChD	Others	1325	Portein transport
P80317	P80317;Q61390	Cct6a	14.239	14.91	5533100	13.2633030930023	11.356667499489	12.4026392816391	4.163890739507	6.73355329607434	6.29049506196138	4427841.66666667	0	Cct6a	0	T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)		FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. The TRiC complex plays a role in the folding of actin and tubulin. {ECO:0000250|UniProtKB:P40227}.		binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P40227}.	12466;	cd03342;	IPR012722;IPR017998;IPR002194;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		58004			NA							5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (8)		ATP-binding;Acetylation;Chaperone;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation						PS00750;PS00751;PS00995;	12466	GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0001669~acrosomal vesicle,GO:0002199~zona pellucida receptor complex,GO:0005737~cytoplasm,GO:0005832~chaperonin-containing T-complex,GO:0005874~microtubule,GO:0031012~extracellular matrix,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044183~protein binding involved in protein folding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,GO:0071987~WD40-repeat domain binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012722:T-complex protein 1, zeta subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	3.25748364658221	5.77649067646232e-08	FDR<0.01	7.2383359232935	4980470.83333333	Unexpected	RBP	Others	Others	Others	Others	374	Protein folding
P35564	P35564	Canx	4.3126	NA	145440	2.9302311952413	2.2783195115283	3.64923548516586	1.62948720037804	4.36871996505024	4.99525450821719	8635855	0	Canx	1	Calnexin		FUNCTION: Calcium-binding protein that interacts with newly synthesized glycoproteins in the endoplasmic reticulum. It may act in assisting protein assembly and/or in the retention within the ER of unassembled protein subunits. It seems to play a major role in the quality control apparatus of the ER by the retention of incorrectly folded proteins. Associated with partial T-cell antigen receptor complexes that escape the ER of immature thymocytes, it may function as a signaling complex regulating thymocyte maturation. Additionally it may play a role in receptor-mediated endocytosis at the synapse. {ECO:0000269|PubMed:21747946, ECO:0000269|PubMed:7628443}.		aging [GO:0007568]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]	apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:7628443}; Single-pass type I membrane protein {ECO:0000255}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P27824}. Melanosome {ECO:0000250|UniProtKB:P27824}. Note=The palmitoylated form preferentially localizes to the perinuclear rough ER (By similarity). When bound to CD3 epsilon chains, calnexin's ER retention signal can be masked, permitting it to escape ER retention. {ECO:0000250|UniProtKB:P27824}.	12330;		IPR001580;IPR018124;IPR009033;IPR013320;	PF00262;		67278	COMPBIAS 275..327;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 328..347;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 519..584;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 261..347;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..410;  /note=P domain (Extended arm);  /evidence=ECO:0000250; REGION 279..346;  /note=4 X approximate repeats; REGION 327..360;  /note=Interaction with PPIB;  /evidence=ECO:0000250; REGION 349..406;  /note=4 X approximate repeats; REGION 504..591;  /note=Sufficient to mediate interaction with SGIP1;  /evidence=ECO:0000269|PubMed:21747946; REGION 514..591;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 165;  /note=Carbohydrate;  /evidence=ECO:0000250; BINDING 167;  /note=Carbohydrate;  /evidence=ECO:0000250; BINDING 186;  /note=Carbohydrate;  /evidence=ECO:0000250; BINDING 217;  /note=Carbohydrate;  /evidence=ECO:0000250		METAL 75;  /note=Calcium; via carbonyl oxygen;  /evidence=ECO:0000250; METAL 118;  /note=Calcium; via carbonyl oxygen;  /evidence=ECO:0000250; METAL 437;  /note=Calcium;  /evidence=ECO:0000250		5 out of 5	Binding site (4); Chain (1); Compositional bias (3); Disulfide bond (2); Lipidation (2); Metal binding (3); Modified residue (5); Region (7); Repeat (8); Sequence conflict (5); Signal peptide (1); Topological domain (2); Transmembrane (1)		Acetylation;Calcium;Chaperone;Disulfide bond;Endoplasmic reticulum;Lectin;Lipoprotein;Membrane;Metal-binding;Palmitate;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix;Ubl conjugation				REPEAT 279..291;  /note=1-1; REPEAT 296..308;  /note=1-2; REPEAT 315..327;  /note=1-3; REPEAT 334..346;  /note=1-4; REPEAT 349..359;  /note=2-1; REPEAT 368..378;  /note=2-2; REPEAT 382..392;  /note=2-3; REPEAT 396..406;  /note=2-4		PS00803;PS00804;PS00805;	12330	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006457~protein folding,GO:0007568~aging,GO:0048488~synaptic vesicle endocytosis,GO:0061077~chaperone-mediated protein folding,GO:0072583~clathrin-mediated endocytosis,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005790~smooth endoplasmic reticulum,GO:0005791~rough endoplasmic reticulum,GO:0005840~ribosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0031012~extracellular matrix,GO:0032839~dendrite cytoplasm,GO:0042470~melanosome,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0044233~ER-mitochondrion membrane contact site,GO:0070062~extracellular exosome,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0001948~glycoprotein binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0034185~apolipoprotein binding,GO:0035255~ionotropic glutamate receptor binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051082~unfolded protein binding,	IPR001580:Calreticulin/calnexin,IPR009033:Calreticulin/calnexin, P domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR018124:Calreticulin/calnexin, conserved site,	PF00262:Calreticulin family,	SSF49899:Concanavalin A-like lectins/glucanases,SSF63887:P-domain of calnexin/calreticulin,	1.69533194010533	5.23420697524662e-05	FDR<0.01	4.28114910813285	4390647.5	Present in Nucleus	RBP	Others	Others	Others	Others	400	Protein folding
P80316	P80316	Cct5	5.551	5.5353	3885500	8.75350140056022	5.01705799719045	7.91514959632737	NA	5.57755591499805	7.60861294985924	2451638.33333333	1	Cct5	0	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)		FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin. {ECO:0000250|UniProtKB:P48643}.		binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P48643}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P48643}.	12465;	cd03339;	IPR012718;IPR017998;IPR002194;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		59624			NA							5 out of 5	Chain (1); Cross-link (7); Erroneous initiation (1); Initiator methionine (1); Modified residue (4); Sequence conflict (6)		ATP-binding;Acetylation;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation						PS00750;PS00751;PS00995;	12465	GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0009615~response to virus,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031681~G-protein beta-subunit binding,GO:0048487~beta-tubulin binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012718:T-complex protein 1, epsilon subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	2.68428488464432	1.46381755735748e-07	FDR<0.01	6.83451304812076	3168569.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	489	Protein folding
P80318	P80318	Cct3	7.9914	5.9545	3394600	7.98977309044423	7.03680247695447	7.18803910293272	5.33134296529296	6.54150585464774	8.05088157153208	875058.833333333	0	Cct3	0	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Matricin) (mTRiC-P5)		FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin. {ECO:0000250|UniProtKB:P49368}.		binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]	cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.	12462;	cd03337;	IPR012719;IPR017998;IPR002194;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		60630		REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 526..545;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (9); Chain (1); Cross-link (4); Disulfide bond (1); Erroneous initiation (1); Helix (5); Modified residue (10); Region (2); Sequence conflict (9)		3D-structure;ATP-binding;Acetylation;Chaperone;Cytoplasm;Direct protein sequencing;Disulfide bond;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation						PS00750;PS00751;PS00995;	12462	GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0046931~pore complex assembly,GO:0050821~protein stabilization,GO:1901998~toxin transport,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005737~cytoplasm,GO:0005832~chaperonin-containing T-complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044183~protein binding involved in protein folding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012719:T-complex protein 1, gamma subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	2.79554624837344	6.4767731656632e-09	FDR<0.01	8.18864131286209	2134829.41666667	Unexpected	RBP	Others	Others	Others	Others	603	Protein folding
P80315	P80315	Cct4	4.0771	5.7537	1983250	5.35503909178537	0.350324049746015	NA	NA	3.94011032308905	9.3222709051925	374365	2	Cct4	0	T-complex protein 1 subunit delta (TCP-1-delta) (A45) (CCT-delta)		FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin. {ECO:0000250|UniProtKB:P50991}.		binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]	cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytosol [GO:0005829]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23807208}. Melanosome {ECO:0000250|UniProtKB:P50991}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:23807208}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:23807208}.	12464;	cd03338;	IPR012717;IPR017998;IPR002194;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		58066		REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Modified residue (10); Region (1); Sequence conflict (3)		ATP-binding;Acetylation;Cell projection;Chaperone;Cilium;Cytoplasm;Cytoskeleton;Direct protein sequencing;Methylation;Nucleotide-binding;Phosphoprotein;Reference proteome						PS00750;PS00751;PS00995;	12464	GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0050821~protein stabilization,GO:0051973~positive regulation of telomerase activity,GO:0090666~scaRNA localization to Cajal body,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0002199~zona pellucida receptor complex,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0042470~melanosome,GO:0042995~cell projection,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012717:T-complex protein 1, delta subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	1.776434975208	0.0105319410375577	FDR<0.1	1.97749158093086	1178807.5	Present in Nucleus	RBP	Others	Others	Others	Others	776	Protein folding
P27773	P27773	Pdia3	4.6759	10.423	461059.5	NA	2.45561476315596	11.1860576976856	2.67838011570602	3.13234142521535	2.15007525263384	216085.833333333	1	Pdia3	0	Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)				cellular response to interleukin-7 [GO:0098761]; cellular response to vitamin D [GO:0071305]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein folding [GO:1903334]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]	acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; TAP complex [GO:0042825]	identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; peptidase activity [GO:0008233]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase (glutathione) activity [GO:0019153]	SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000250|UniProtKB:P30101}. Endoplasmic reticulum lumen {ECO:0000250}. Melanosome {ECO:0000250|UniProtKB:P30101}.	14827;	cd03069;	IPR005788;IPR041868;IPR005792;IPR036249;IPR017937;IPR013766;	PF00085;		56678	COMPBIAS 489..505;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 484..505;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 57;  /note=Nucleophile;  /evidence=ECO:0000250; ACT_SITE 60;  /note=Nucleophile;  /evidence=ECO:0000250; ACT_SITE 406;  /note=Nucleophile;  /evidence=ECO:0000250; ACT_SITE 409;  /note=Nucleophile;  /evidence=ECO:0000250			5.3.4.1			5 out of 5	Active site (4); Chain (1); Compositional bias (1); Disulfide bond (4); Domain (2); Modified residue (8); Motif (1); Region (1); Sequence conflict (8); Signal peptide (1); Site (6)		Acetylation;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Isomerase;Methylation;Phosphoprotein;Redox-active center;Reference proteome;Repeat;Signal	DOMAIN 25..133;  /note=Thioredoxin 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00691; DOMAIN 343..485;  /note=Thioredoxin 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00691		MOTIF 502..505;  /note=Prevents secretion from ER;  /evidence=ECO:0000250			PS00194;PS51352;	14827	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006457~protein folding,GO:0034976~response to endoplasmic reticulum stress,GO:0045454~cell redox homeostasis,GO:0071305~cellular response to vitamin D,GO:1903334~positive regulation of protein folding,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0001669~acrosomal vesicle,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005758~mitochondrial intermembrane space,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005790~smooth endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016324~apical plasma membrane,GO:0042470~melanosome,GO:0042825~TAP complex,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003756~protein disulfide isomerase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0016853~isomerase activity,GO:0019153~protein-disulfide reductase (glutathione) activity,GO:0042288~MHC class I protein binding,GO:0044822~poly(A) RNA binding,	IPR005788:Disulphide isomerase,IPR005792:Protein disulphide isomerase,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,	PF00085:Thioredoxin,	SSF52833:Thioredoxin-like,	2.07994944643029	0.000126041427326968	FDR<0.01	3.89948668740286	338572.666666667	Present in Nucleus	RBP	Others	Others	Others	Others	1145	Protein folding
Q922K7	Q922K7	Nop2	10.326	11.761	30488500	9.87654320987654	5.6041246357319	5.74382538770821	2.15058388352438	12.7129417747267	19.2381685263563	14439400	0	Nop2	0	Probable 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)		FUNCTION: Involved in ribosomal large subunit assembly. S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the C(5) position of cytosine 4447 in 28S rRNA. May play a role in the regulation of the cell cycle and the increased nucleolar activity that is associated with the cell proliferation. {ECO:0000250|UniProtKB:P46087}.		blastocyst formation [GO:0001825]; maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.			IPR018314;IPR031341;IPR001678;IPR011023;IPR012586;IPR023267;IPR023273;IPR029063;	PF01189;PF17125;PF08062;		86752	COMPBIAS 118..135;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 178..193;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 649..668;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..194;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 377..383;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; REGION 576..793;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 502;  /note=Nucleophile;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023		BINDING 401;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 428;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 445;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023	2.1.1.-			5 out of 5	Active site (1); Binding site (3); Chain (1); Compositional bias (3); Cross-link (3); Modified residue (12); Region (3); Sequence conflict (3)		Acetylation;Citrullination;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;Ubl conjugation;rRNA processing						PS01153;PS51686;	NA	GO:0000470~maturation of LSU-rRNA,GO:0006364~rRNA processing,GO:0008284~positive regulation of cell proliferation,GO:0032259~methylation,GO:0070475~rRNA base methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0009383~rRNA (cytosine-C5-)-methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR011023:Nop2p,IPR012586:P120R,IPR018314:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p, conserved site,IPR023267:RNA (C5-cytosine) methyltransferase,IPR023273:RNA (C5-cytosine) methyltransferase, NOP2,	PF01189:NOL1/NOP2/sun family,PF08062:P120R (NUC006) repeat,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	3.03443868883817	1.32701564641669e-06	FDR<0.01	5.87712395647816	22463950	Present in Nucleus	RBP	RBD	Others	Others	RBD	104	RNA processing
P63276	P63276	Rps17	27.797	28.754	106269500	34.4317047137004	22.8096986838804	6.85729959541932	18.0534743911466	13.2353914367017	15.7222816175083	97451000	0	Rps17	0	40S ribosomal protein S17				erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]		20068;		IPR001210;IPR018273;IPR036401;	PF00833;		15524			NA							3 out of 5	Chain (1); Cross-link (2); Modified residue (3)		Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00712;	20068	GO:0000028~ribosomal small subunit assembly,GO:0006364~rRNA processing,GO:0006412~translation,GO:0034101~erythrocyte homeostasis,GO:0042274~ribosomal small subunit biogenesis,	GO:0005622~intracellular,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001210:Ribosomal protein S17e,IPR018273:Ribosomal protein S17e, conserved site,	PF00833:Ribosomal S17,	SSF116820:Rps17e-like,	4.23908775521168	7.11113862614193e-09	FDR<0.01	8.14806085504252	101860250	Present in Nucleus	RBP	Others	Others	Others	Others	26	RNA processing
P32067	P32067	Ssb	46.416	24.249	95684500	20.2347227842979	23.6596791747504	20.2646564127505	18.6877464446562	101.205355787428	39.1358797745773	35452266.6666667	0	Ssb	0	Lupus La protein homolog (La autoantigen homolog) (La ribonucleoprotein)		FUNCTION: Binds to the 3' poly(U) terminus of nascent RNA polymerase III transcripts, protecting them from exonuclease digestion and facilitating their folding and maturation.		IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA processing [GO:0008033]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	20823;		IPR006630;IPR014886;IPR002344;IPR012677;IPR035979;IPR000504;IPR036388;IPR036390;	PF05383;PF00076;PF08777;	SM00715;SM00360;	47756	COMPBIAS 373..415;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 349..415;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Domain (3); Modified residue (8); Region (1)		Acetylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 7..99;  /note=HTH La-type RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00332; DOMAIN 111..187;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 226..346;  /note=xRRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01288					PS50961;PS50102;PS51939;	20823	GO:0006396~RNA processing,GO:0008033~tRNA processing,GO:0075522~IRES-dependent viral translational initiation,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002344:Lupus La protein,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014886:RNA-binding motif,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF05383:La domain,PF08777:RNA binding motif,	SSF46785:Winged helix DNA-binding domain,SSF54928:RNA-binding domain, RBD,	4.94449996742368	2.92255016042382e-09	FDR<0.01	8.53423802620262	65568383.3333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	41	RNA processing
Q9D6Z1	Q9D6Z1	Nop56	9.0635	11.565	61690000	16.6417041105009	10.2692599971246	12.1964605871376	4.16875104218776	30.2535245356084	21.582889085533	46924333.3333333	0	Nop56	0	Nucleolar protein 56 (Nucleolar protein 5A)		FUNCTION: Involved in the early to middle stages of 60S ribosomal subunit biogenesis. Core component of box C/D small nucleolar ribonucleoprotein (snoRNP) particles. Required for the biogenesis of box C/D snoRNAs such U3, U8 and U14 snoRNAs (By similarity). {ECO:0000250}.		ribosome biogenesis [GO:0042254]	box C/D RNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]	histone methyltransferase binding [GO:1990226]; snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:21683323}. Nucleus, nucleoplasm {ECO:0000250}.	67134;		IPR029012;IPR012974;IPR042239;IPR002687;IPR036070;IPR012976;	PF01798;PF08156;	SM00931;	64464	COMPBIAS 470..489;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 497..558;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 458..580;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Cross-link (4); Domain (1); Modified residue (16); Region (1); Sequence conflict (3)		Acetylation;Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation	DOMAIN 292..410;  /note=Nop;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00690					PS51358;	67134	GO:0000154~rRNA modification,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0070761~pre-snoRNP complex,	GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990226~histone methyltransferase binding,	IPR002687:Nop domain,IPR012974:NOP5, N-terminal,IPR012976:NOSIC,	PF01798:Putative snoRNA binding domain,PF08156:NOP5NT (NUC127) domain,	SSF89124:Nop domain,	3.64345081084197	8.83213381946827e-08	FDR<0.01	7.05393435938205	54307166.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	45	RNA processing
P14148	P14148	Rpl7	30.677	21.67	45894500	32.0934561442922	43.5028494366381	76.3242253091131	62.8259094050386	54.8335800844437	45.2939577860313	37170466.6666667	0	Rpl7	0	60S ribosomal protein L7		FUNCTION: Component of the large ribosomal subunit (By similarity). Binds to G-rich structures in 28S rRNA and in mRNAs. Plays a regulatory role in the translation apparatus; inhibits cell-free translation of mRNAs (By similarity). {ECO:0000250|UniProtKB:P18124}.		maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	A band [GO:0031672]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		19989;	cd01657;	IPR036919;IPR023106;IPR018038;IPR016082;IPR012988;IPR039699;IPR005998;IPR035808;	PF00327;PF08079;		31420		REGION 7..76;  /note=6 X 12 AA tandem repeats	NA							5 out of 5	Chain (1); Modified residue (5); Region (1); Repeat (6); Sequence conflict (5)		3D-structure;Acetylation;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein				REPEAT 7..18;  /note=1; REPEAT 19..29;  /note=2; REPEAT 30..40;  /note=3; REPEAT 41..52;  /note=4; REPEAT 53..64;  /note=5; REPEAT 65..76;  /note=6		PS00634;	19989	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0008097~5S rRNA binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR005998:Ribosomal protein L7, eukaryotic,IPR012988:Ribosomal protein L30, N-terminal,IPR016082:Ribosomal protein L30, ferredoxin-like fold domain,IPR018038:Ribosomal protein L30, conserved site,	PF00327:Ribosomal protein L30p/L7e,PF08079:Ribosomal L30 N-terminal domain,	SSF55129:Ribosomal protein L30p/L7e,	5.41619366840902	1.28299804934734e-10	FDR<0.01	9.89177400391995	41532483.3333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	58	RNA processing
P62082	P62082	Rps7	9.4645	9.0224	38196650	14.7386107385518	14.5755597014925	3.25499641950394	NA	61.1807892321811	14.3866261922916	40019383.3333333	1	Rps7	0	40S ribosomal protein S7		FUNCTION: Required for rRNA maturation. {ECO:0000250|UniProtKB:P62081}.		cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	centrosome [GO:0005813]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040]; synapse [GO:0045202]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; poly(U) RNA binding [GO:0008266]; protein kinase binding [GO:0019901]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P62081}. Note=Colocalizes with NEK6 in the centrosome. {ECO:0000250|UniProtKB:P62081}.	20115;		IPR000554;	PF01251;		22127			NA							5 out of 5	Chain (1); Cross-link (2); Modified residue (2)		Acetylation;Cytoplasm;Cytoskeleton;Isopeptide bond;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00948;	20115	GO:0001843~neural tube closure,GO:0006364~rRNA processing,GO:0006412~translation,GO:0030154~cell differentiation,GO:0042274~ribosomal small subunit biogenesis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005840~ribosome,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0030686~90S preribosome,GO:0031012~extracellular matrix,GO:0032040~small-subunit processome,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0008266~poly(U) RNA binding,GO:0044822~poly(A) RNA binding,	IPR000554:Ribosomal protein S7e,	PF01251:Ribosomal protein S7e,		3.66390924647914	4.86690330061595e-06	FDR<0.01	5.3127472825681	39108016.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	61	RNA processing
Q8CGZ0	Q8CGZ0	Cherp	0.96254	1.0958	49664500	2.96348980559507	2.4140012070006	4.58905052544629	2.04792135981978	2.28655050990076	2.0064608037882	14384783.3333333	0	Cherp	0	Calcium homeostasis endoplasmic reticulum protein (SR-related CTD-associated factor 6)		FUNCTION: Involved in calcium homeostasis, growth and proliferation. {ECO:0000250|UniProtKB:Q8IWX8}.		cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]	ion channel binding [GO:0044325]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8IWX8}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q8IWX8}. Endoplasmic reticulum {ECO:0000250|UniProtKB:Q8IWX8}. Note=Distributed throughout the cytoplasm and also localizes to the perinuclear region. Colocalizes with ITPR1 (By similarity). {ECO:0000250|UniProtKB:Q8IWX8}.	27967;		IPR039037;IPR006569;IPR008942;IPR000467;IPR000061;IPR035967;	PF04818;PF01585;PF01805;	SM00443;SM00648;	106169	COMPBIAS 79..93;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 328..346;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 360..388;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 389..404;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 418..459;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 485..506;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 527..544;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 609..630;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 772..825;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 77..102;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 328..646;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 731..887;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (9); Cross-link (2); Domain (2); Modified residue (12); Region (3); Repeat (1); Sequence conflict (1)		Acetylation;Cytoplasm;Endoplasmic reticulum;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 149..289;  /note=CID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00724; DOMAIN 850..900;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092			REPEAT 15..57;  /note=SURP motif;  /evidence=ECO:0000255		PS51391;PS50174;PS50128;	27967	GO:0006396~RNA processing,GO:0006874~cellular calcium ion homeostasis,GO:0008285~negative regulation of cell proliferation,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051533~positive regulation of NFAT protein import into nucleus,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,	IPR000061:SWAP/Surp,IPR000467:G-patch domain,IPR006569:CID domain,IPR006903:RNA polymerase II-binding domain,IPR008942:ENTH/VHS,	PF01585:G-patch domain,PF01805:Surp module,PF04818:RNA polymerase II-binding domain.,	SSF109905:Surp module (SWAP domain),SSF48464:ENTH/VHS domain,	1.04322602141968	0.00226979527021507	FDR<0.01	2.64401331330275	32024641.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	76	RNA processing
Q9ESX5	Q9ESX5	Dkc1	5.8896	6.0179	43663000	3.85089340727049	2.6115797445875	3.74826642677762	1.6465512983057	11.0857370906592	9.41265060240964	15788033.3333333	0	Dkc1	0	H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)		FUNCTION: Catalytic subunit of H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA (PubMed:12522253, PubMed:15240872). This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs (PubMed:12522253, PubMed:15240872). Required for ribosome biogenesis and telomere maintenance (By similarity). Also required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme (By similarity). {ECO:0000250|UniProtKB:O60832, ECO:0000269|PubMed:12522253, ECO:0000269|PubMed:15240872}.		box H/ACA RNA 3'-end processing [GO:0000495]; box H/ACA RNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O60832}. Nucleus, Cajal body {ECO:0000250|UniProtKB:P40615}. Note=Also localized to Cajal bodies (coiled bodies). {ECO:0000250|UniProtKB:P40615}.	245474;		IPR012960;IPR020103;IPR002501;IPR002478;IPR015947;IPR004802;IPR032819;IPR004521;	PF08068;PF01472;PF16198;PF01509;	SM01136;SM00359;	57402	COMPBIAS 447..466;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..21;  /note=Nucleolar localization;  /evidence=ECO:0000250; REGION 446..509;  /note=Nuclear and nucleolar localization;  /evidence=ECO:0000250; REGION 447..509;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 125;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:P60340			5.4.99.-			5 out of 5	Active site (1); Chain (1); Compositional bias (1); Cross-link (8); Domain (1); Initiator methionine (1); Modified residue (9); Mutagenesis (2); Region (4); Sequence conflict (1)		Acetylation;Isomerase;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing	DOMAIN 297..372;  /note=PUA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00161					PS50890;	245474	GO:0000154~rRNA modification,GO:0000454~snoRNA guided rRNA pseudouridine synthesis,GO:0000495~box H/ACA snoRNA 3'-end processing,GO:0001522~pseudouridine synthesis,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0007004~telomere maintenance via telomerase,GO:0008283~cell proliferation,GO:0009451~RNA modification,GO:0031118~rRNA pseudouridine synthesis,GO:0031120~snRNA pseudouridine synthesis,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033979~box H/ACA snoRNA metabolic process,GO:0042254~ribosome biogenesis,GO:0051973~positive regulation of telomerase activity,GO:0090669~telomerase RNA stabilization,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,GO:1990481~mRNA pseudouridine synthesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031429~box H/ACA snoRNP complex,GO:0072588~box H/ACA RNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003720~telomerase activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0009982~pseudouridine synthase activity,GO:0016853~isomerase activity,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR002478:Pseudouridine synthase/archaeosine transglycosylase,IPR002501:Pseudouridine synthase II,IPR004521:Uncharacterised domain CHP00451,IPR004802:tRNA pseudouridine synthase B family,IPR012960:Dyskerin-like,IPR015947:PUA-like domain,IPR020103:Pseudouridine synthase, catalytic domain,	PF01472:PUA domain,PF01509:TruB family pseudouridylate synthase (N terminal domain),PF08068:DKCLD (NUC011) domain,	SSF55120:Pseudouridine synthase,SSF88697:PUA domain-like,	2.22605631683008	1.74793912637839e-05	FDR<0.01	4.75747369615144	29725516.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	80	RNA processing
Q9CRB2	Q9CRB2	Nhp2	6.4343	4.9908	48307000	19.2307692307692	NA	NA	8.95335303071	9.33184023889511	18.3368478958467	8728140	2	Nhp2	0	H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2)		FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme (By similarity). {ECO:0000250}.		cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U3 snoRNA binding [GO:0034511]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}. Note=Also localized to Cajal bodies (coiled bodies). {ECO:0000250}.	52530;		IPR002415;IPR029064;IPR004038;IPR018492;	PF01248;		17247			NA							4 out of 5	Chain (1); Cross-link (4); Modified residue (1)		Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing							52530	GO:0000469~cleavage involved in rRNA processing,GO:0000470~maturation of LSU-rRNA,GO:0006364~rRNA processing,GO:0006412~translation,GO:0031118~rRNA pseudouridine synthesis,GO:0031120~snRNA pseudouridine synthesis,GO:0042254~ribosome biogenesis,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031429~box H/ACA snoRNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR002415:H/ACA ribonucleoprotein complex, subunit Nhp2, eukaryote,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR018492:Ribosomal protein L7Ae/L8/Nhp2 family,	PF01248:Ribosomal protein L7Ae/L30e/S12e/Gadd45 family,	SSF55315:L30e-like,	3.3086103830066	2.73519673589392e-06	FDR<0.01	5.56301143048585	28517570	Present in Nucleus	RBP	ChD	Others	ChD	Others	85	RNA processing
Q9DBE9	Q9DBE9	Ftsj3	3.2706	4.8579	29689500	2.88875408036514	2.18799229826711	4.61212065307628	1.76146271864156	7.78149560345498	7.01114772488256	20568300	0	Ftsj3	0	pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)		FUNCTION: RNA 2'-O-methyltransferase involved in the processing of the 34S pre-rRNA to 18S rRNA and in 40S ribosomal subunit formation. {ECO:0000255|HAMAP-Rule:MF_03163}.		enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]	RNA 2'-O-methyltransferase activity [GO:0062105]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-Rule:MF_03163}.	56095;		IPR015507;IPR012920;IPR024576;IPR002877;IPR029063;IPR028589;	PF11861;PF01728;PF07780;		95532	COMPBIAS 336..363;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 454..470;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 609..639;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 809..826;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 332..367;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 453..482;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 537..639;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 802..838;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 157;  /note=Proton acceptor;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163		BINDING 56;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 58;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 76;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 92;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 117;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163	2.1.1.-			5 out of 5	Active site (1); Binding site (5); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (5); Modified residue (10); Region (4); Sequence conflict (12)		Citrullination;Coiled coil;Direct protein sequencing;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;Ubl conjugation;rRNA processing							56095	GO:0000453~enzyme-directed rRNA 2'-O-methylation,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001510~RNA methylation,GO:0006364~rRNA processing,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0030688~preribosome, small subunit precursor,	GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0008650~rRNA (uridine-2'-O-)-methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR002877:Ribosomal RNA methyltransferase FtsJ domain,IPR012920:Ribosomal RNA methyltransferase, Spb1, C-terminal,IPR015507:Ribosomal RNA large subunit methyltransferase E,IPR024576:Ribosomal RNA methyltransferase Spb1, domain of unknown function DUF3381,	PF01728:FtsJ-like methyltransferase,PF07780:Spb1 C-terminal domain,PF11861:Domain of unknown function (DUF3381),	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	1.93023068329268	2.05761669259842e-05	FDR<0.01	4.68663552548897	25128900	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	93	RNA processing
Q9DCA5	Q9DCA5	Brix1	19.357	10.148	23633500	15.3301344452791	11.7699677502884	7.02148574638394	25.2295892622868	19.1692065865394	19.6386488609584	18987120	0	Brix1	0	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)		FUNCTION: Required for biogenesis of the 60S ribosomal subunit. {ECO:0000250}.		ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	67832;		IPR007109;IPR026532;	PF04427;	SM00879;	41241	COMPBIAS 1..27;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 34..50;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 334..353;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (3); Domain (1); Erroneous initiation (2); Modified residue (2); Region (2); Sequence conflict (3)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation	DOMAIN 60..249;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	67832	GO:0000027~ribosomal large subunit assembly,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,IPR026532:Ribosome biogenesis protein BRX1,	PF04427:Brix domain,	SSF52954:Class II aaRS ABD-related,	3.89230094250752	4.90141680148235e-09	FDR<0.01	8.30967836484359	21310310	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	110	RNA processing
Q810V0	Q810V0	Mphosph10	1.7192	2.0948	23678500	2.82445982205903	2.31304790322208	4.68406014333224	1.72550643613901	5.18054188468114	5.04413619167718	8260245	0	Mphosph10	0	U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)		FUNCTION: Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing (By similarity). {ECO:0000250}.		negative regulation of phosphatase activity [GO:0010923]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O00566}. Chromosome {ECO:0000250|UniProtKB:O00566}. Note=Fibrillar region of the nucleolus. After dissolution of the nucleolus in early M phase becomes associated with chromosomes through metaphase and anaphase. In telophase localized to small cellular prenucleolar bodies that not always contain fibrillarin. The reassociation with nucleolus is preceeded by the arrival of fibrillarin. {ECO:0000250|UniProtKB:O00566}.	67973;		IPR012173;	PF04006;		78735	COMPBIAS 111..140;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 141..180;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 225..246;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 277..320;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..365;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 560..575;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 576..593;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..642;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 111..202;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 215..256;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 268..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 560..644;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 657..681;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (4); Compositional bias (8); Cross-link (6); Modified residue (11); Region (5); Sequence conflict (4)		Acetylation;Chromosome;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing							67973	GO:0006364~rRNA processing,GO:0010923~negative regulation of phosphatase activity,GO:0030490~maturation of SSU-rRNA,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0044822~poly(A) RNA binding,	IPR012173:U3 small nucleolar ribonucleoprotein complex, subunit Mpp10p,	PF04006:Mpp10 protein,		1.5348512145776	8.50361096077833e-05	FDR<0.01	4.07039661695278	15969372.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	144	RNA processing
P62858	P62858	Rps28	3.6739	3.8047	25639500	11.8636627872489	10.3955507042986	NA	NA	2.21813100281703	7.42115027829314	5350433.33333333	2	Rps28	0	40S ribosomal protein S28				cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62857}. Cytoplasm {ECO:0000250|UniProtKB:P62857}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:Q6QAT1}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:P62857, ECO:0000250|UniProtKB:Q6QAT1}.	54127;	cd04457;	IPR012340;IPR000289;IPR028626;	PF01200;		7841			NA							3 out of 5	Chain (1); Modified residue (2)		Acetylation;Cytoplasm;Endoplasmic reticulum;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00961;	54127	GO:0000028~ribosomal small subunit assembly,GO:0006364~rRNA processing,GO:0006412~translation,GO:0030490~maturation of SSU-rRNA,GO:0042254~ribosome biogenesis,GO:0042274~ribosomal small subunit biogenesis,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000289:Ribosomal protein S28e,IPR012340:Nucleic acid-binding, OB-fold,	PF01200:Ribosomal protein S28e,	SSF50249:Nucleic acid-binding proteins,	2.46540905479013	7.66454143860591e-05	FDR<0.01	4.1155138234111	15494966.6666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	149	RNA processing
Q9D0R4	Q9D0R4	Ddx56	9.294	7.1394	20383000	9.13575735428467	10.307153164296	2.85494047449111	22.144960914144	15.0452863117985	3.98867217103426	9678656.66666667	0	Ddx56	0	Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 56)		FUNCTION: May play a role in later stages of the processing of the pre-ribosomal particles leading to mature 60S ribosomal subunits. Has intrinsic ATPase activity (By similarity). {ECO:0000250}.		positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	52513;		IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	61212		REGION 324..344;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 508..546;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Domain (2); Modified residue (2); Motif (2); Nucleotide binding (1); Region (2)		ATP-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;rRNA processing	DOMAIN 38..218;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 230..424;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 7..35;  /note=Q motif; MOTIF 166..169;  /note=DEAD box			PS51192;PS51194;PS51195;	52513	GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,GO:0010976~positive regulation of neuron projection development,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.06233953044596	1.06040163391312e-06	FDR<0.01	5.97452961175854	15030828.3333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	155	RNA processing
Q91YU8	Q91YU8	Ppan	13.997	4.0769	14704400	12.3771567195584	7.66166104811523	10.4532530523499	17.5555633580282	12.3871223476074	8.90947968638631	13628716.6666667	0	Ppan	0	Suppressor of SWI4 1 homolog (Ssf-1) (Peter Pan homolog)		FUNCTION: May have a role in cell growth. {ECO:0000250}.		regulation of cell growth by extracellular stimulus [GO:0001560]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]	rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	235036;		IPR007109;	PF04427;	SM00879;	52756	COMPBIAS 390..406;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 240..264;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 323..470;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Domain (1); Modified residue (4); Region (2); Sequence conflict (1)		Acetylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 29..292;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	235036	GO:0000027~ribosomal large subunit assembly,GO:0001560~regulation of cell growth by extracellular stimulus,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,	GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,	PF04427:Brix domain,	SSF52954:Class II aaRS ABD-related,	3.33845379443144	3.40812403717505e-08	FDR<0.01	7.46748460766109	14166558.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	164	RNA processing
Q9CR57	Q9CR57	Rpl14	24.168	17.249	19796500	27.6060070671378	22.1199787648204	18.9300723128762	16.2744523646779	15.2125960295124	19.8664971392244	8513180	0	Rpl14	0	60S ribosomal protein L14		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P50914}.		ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynaptic density [GO:0014069]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		67115;	cd06088;	IPR014722;IPR002784;IPR039660;IPR041985;IPR008991;	PF01929;		23564		REGION 162..217;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 173..192;  /note=4 X 5 AA tandem repeats of Q-K-A-[APS]-X; REGION 195..200;  /note=2 X 3 AA tandem repeats of K-G-Q	NA							3 out of 5	Chain (1); Cross-link (1); Modified residue (5); Region (3); Repeat (6); Sequence conflict (1)		3D-structure;Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Ubl conjugation				REPEAT 173..177;  /note=1-1; approximate; REPEAT 178..182;  /note=1-2; REPEAT 183..187;  /note=1-3; REPEAT 188..192;  /note=1-4; REPEAT 195..197;  /note=2-1; REPEAT 198..200;  /note=2-2			67115	GO:0006364~rRNA processing,GO:0006412~translation,GO:0042273~ribosomal large subunit biogenesis,GO:0098609~cell-cell adhesion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002784:Ribosomal protein L14,IPR008991:Translation protein SH3-like domain,IPR014722:Ribosomal protein L2 domain 2,	PF01929:Ribosomal protein L14,	SSF50104:Translation proteins SH3-like domain,	4.30803257676348	1.07153657985995e-10	FDR<0.01	9.96999299852774	14154840	Present in Nucleus	RBP	Others	Others	Others	Others	166	RNA processing
Q6NVF9	Q6NVF9	Cpsf6	4.0381	6.0663	18091000	9.67024465718983	9.41796948577887	14.6124059326368	4.63972532826057	5.28122524425667	63.1074088097943	8923566.66666667	0	Cpsf6	0	Cleavage and polyadenylation specificity factor subunit 6		FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation. The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs. CPSF6 enhances NUDT21/CPSF5 binding to 5'-UGUA-3' elements localized upstream of pA signals and promotes RNA looping, and hence activates directly the mRNA 3'-processing machinery. Plays a role in mRNA export. {ECO:0000250|UniProtKB:Q16630}.		messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q16630}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q16630}. Nucleus speckle {ECO:0000250|UniProtKB:Q16630}. Cytoplasm {ECO:0000250|UniProtKB:Q16630}. Note=Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm). Colocalizes with PSPC1 in punctate subnuclear structures often located adjacent to nuclear speckles, called paraspeckles, and corresponding to interchromatin granules-associated zones (IGAZs). Distribution in speckles and paraspeckles varies during the cell cycle. Associates at sites of active transcription on nascent perichromatin fibrils (PFs) and perichromatin granules. Nuclear import is mediated via interaction with TNPO3 independently of CPSF6 phosphorylation status. {ECO:0000250|UniProtKB:Q16630}.	432508;		IPR034769;IPR034772;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	59153	COMPBIAS 219..366;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..394;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 485..501;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 513..551;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..213;  /note=Necessary for interaction with NXF1;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 81..161;  /note=Necessary for interaction with NUDT21/CPSF5;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 81..161;  /note=Necessary for nuclear paraspeckles localization;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 169..411;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 404..551;  /note=Sufficient for nuclear speckle localization;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 405..551;  /note=Necessary for RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 477..551;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 481..551;  /note=Necessary for interaction with SRSF3, SRSF7 and TRA2B/SFRS10;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 490..551;  /note=Arg/Ser-rich domain;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 510..551;  /note=Sufficient for nuclear targeting;  /evidence=ECO:0000250|UniProtKB:Q16630	NA							5 out of 5	Chain (1); Compositional bias (4); Domain (1); Modified residue (8); Motif (1); Region (10); Sequence conflict (3)		Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	DOMAIN 81..161;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: Contains an Arg/Ser-rich domain composed of arginine-serine dipeptide repeats within the C-terminal region that is necessary and sufficient for activating mRNA 3'-processing and alternative polyadenylation (APA). {ECO:0000250|UniProtKB:Q16630}.	MOTIF 202..206;  /note=GAR;  /evidence=ECO:0000250|UniProtKB:Q16630			PS50102;	432508	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005849~mRNA cleavage factor complex,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0042382~paraspeckles,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.19840416396375	6.47538061095108e-06	FDR<0.01	5.18873469946636	13507283.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	174	RNA processing
P62852	P62852	Rps25	39.44	25.576	13295000	49.468216670789	40.1380749779241	60.4448742746615	30.3149725649498	49.5392846527296	55.561729081009	9918600	0	Rps25	0	40S ribosomal protein S25				ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]		75617;		IPR004977;IPR036388;	PF03297;		13742	COMPBIAS 1..28;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..38;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Modified residue (7); Region (1)		Acetylation;Reference proteome;Ribonucleoprotein;Ribosomal protein							75617	GO:0000028~ribosomal small subunit assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0015935~small ribosomal subunit,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR004977:Ribosomal protein S25,	PF03297:S25 ribosomal protein,		5.39995791648215	2.86744588555774e-11	FDR<0.01	10.5425047693554	11606800	Present in Nucleus	RBP	Others	Others	Others	Others	205	RNA processing
Q9DBY8	Q9DBY8	Nvl	18.122	15.751	19115500	22.3069887795846	8.48320325755005	14.8392170829067	6.86436024162548	7.58495145631068	15.8285451984108	3482850	0	Nvl	0	Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)		FUNCTION: Participates in the assembly of the telomerase holoenzyme and effecting of telomerase activity via its interaction with TERT. Involved in both early and late stages of the pre-rRNA processing pathways. Spatiotemporally regulates 60S ribosomal subunit biogenesis in the nucleolus. Catalyzes the release of specific assembly factors, such as WDR74, from pre-60S ribosomal particles through the ATPase activity. {ECO:0000250|UniProtKB:O15381}.		positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; preribosome binding [GO:1990275]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21474449}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:O15381}. Note=Associates with pre-ribosomal particles in the nucleus. {ECO:0000250|UniProtKB:O15381}.	67459;		IPR003593;IPR041569;IPR003959;IPR003960;IPR038100;IPR031996;IPR027417;	PF00004;PF17862;PF16725;	SM00382;	94476	COMPBIAS 94..108;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 109..161;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 181..220;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 496..520;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..219;  /note=Interaction with RPL5;  /evidence=ECO:0000250|UniProtKB:O15381; REGION 83..234;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 266..473;  /note=Interaction with WDR74;  /evidence=ECO:0000250|UniProtKB:O15381; REGION 496..523;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Beta strand (1); Chain (1); Compositional bias (4); Cross-link (1); Helix (3); Modified residue (7); Motif (3); Nucleotide binding (2); Region (4); Sequence conflict (1); Turn (1)		3D-structure;ATP-binding;Acetylation;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Ubl conjugation			MOTIF 49..52;  /note=Nucleolar localization signal;  /evidence=ECO:0000269|PubMed:21474449; MOTIF 85..88;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:O15381; MOTIF 217..231;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:O15381			PS00674;	67459	GO:0042254~ribosome biogenesis,GO:0051973~positive regulation of telomerase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,GO:1990275~preribosome binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.66239248080979	1.18873494776771e-08	FDR<0.01	7.92491496922829	11299175	Present in Nucleus	RBP	Others	Others	Others	Others	208	RNA processing
Q9D0D4	Q9D0D4	Dimt1	11.996	12.181	16469500	8.9142449634516	10.5846987594733	15.4249575813667	NA	4.69792351780513	11.0755463013213	5155615	1	Dimt1	0	Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)		FUNCTION: Specifically dimethylates two adjacent adenosines in the loop of a conserved hairpin near the 3'-end of 18S rRNA in the 40S particle. Involved in the pre-rRNA processing steps leading to small-subunit rRNA production independently of its RNA-modifying catalytic activity. {ECO:0000250|UniProtKB:Q9UNQ2}.		positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UNQ2}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9UNQ2}.	66254;		IPR001737;IPR020596;IPR020598;IPR011530;IPR029063;	PF00398;	SM00650;	35274			NA			BINDING 37;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01026; BINDING 39;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01026; BINDING 64;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01026; BINDING 85;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01026; BINDING 113;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01026; BINDING 128;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01026	2.1.1.183			4 out of 5	Binding site (6); Chain (1); Sequence caution (1)		Methyltransferase;Nucleus;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase;rRNA processing						PS01131;PS51689;	66254	GO:0000154~rRNA modification,GO:0006364~rRNA processing,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,	GO:0000179~rRNA (adenine-N6,N6-)-dimethyltransferase activity,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0052909~18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,	IPR001737:Ribosomal RNA adenine methylase transferase,IPR011530:Ribosomal RNA adenine dimethylase,IPR020596:Ribosomal RNA adenine methylase transferase, conserved site,IPR020598:Ribosomal RNA adenine methylase transferase, N-terminal,	PF00398:Ribosomal RNA adenine dimethylase,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	3.34279812935627	8.75767113250497e-08	FDR<0.01	7.05761136743574	10812557.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	214	RNA processing
Q9D903	Q9D903	Ebna1bp2	20.175	20.461	9551350	20.6134564643799	12.6837559138012	8.12149760415821	11.0668437361664	17.3175166681098	10.6722446932263	11569200	0	Ebna1bp2	0	Probable rRNA-processing protein EBP2		FUNCTION: Required for the processing of the 27S pre-rRNA. {ECO:0000250}.		ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	69072;		IPR008610;	PF05890;		34703	COMPBIAS 1..18;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..93;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 256..273;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 276..306;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 75..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 150..169;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (3); Modified residue (8); Region (4)		Acetylation;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation							69072	GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0034399~nuclear periphery,	GO:0044822~poly(A) RNA binding,	IPR008610:Eukaryotic rRNA processing,	PF05890:Eukaryotic rRNA processing protein EBP2,		3.84244947143879	2.42379106304492e-09	FDR<0.01	8.61550482018131	10560275	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	218	RNA processing
Q8K301	Q8K301	Ddx52	11.37	13.122	9968550	14.4139988757081	5.69216757741348	9.81932443047918	3.93654292800063	12.1610117961814	14.8069177919924	7858016.66666667	0	Ddx52	0	Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)				maturation of SSU-rRNA [GO:0030490]	nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	78394;		IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	67474			NA				3.6.4.13			3 out of 5	Chain (1); Domain (2); Modified residue (2); Motif (2); Nucleotide binding (1); Sequence conflict (6)		ATP-binding;Acetylation;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 197..375;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 386..547;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 166..194;  /note=Q motif; MOTIF 319..322;  /note=DEAD box			PS51192;PS51194;PS51195;	78394	GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.29304959202046	5.68218050945356e-08	FDR<0.01	7.24548497388404	8913283.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	241	RNA processing
Q5SSI6	Q5SSI6	Utp18	9.5533	4.8013	7810000	12.6023944549464	11.8788829098512	15.6137775973519	3.04497426996742	15.7693884631154	8.33541718763024	7956143.33333333	0	Utp18	0	U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50)		FUNCTION: Involved in nucleolar processing of pre-18S ribosomal RNA. {ECO:0000250}.		rRNA processing [GO:0006364]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	217109;		IPR015943;IPR001680;IPR017986;IPR036322;		SM00320;	61218	COMPBIAS 1..19;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 31..45;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 60..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 110..138;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..81;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 104..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 183..214;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (4); Cross-link (4); Modified residue (8); Region (3); Repeat (6)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat;rRNA processing				REPEAT 245..284;  /note=WD 1; REPEAT 289..329;  /note=WD 2; REPEAT 376..415;  /note=WD 3; REPEAT 417..458;  /note=WD 4; REPEAT 467..508;  /note=WD 5; REPEAT 515..551;  /note=WD 6		PS50082;PS50294;	217109	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,		SSF50978:WD40 repeat-like,	3.1693580574526	3.05260938356033e-07	FDR<0.01	6.51532876511427	7883071.66666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	257	RNA processing
Q6P5B0	Q6P5B0	Rrp12	11.794	32.217	7889550	7.5086349301697	9.83767830791933	7.65345170671973	6.96378830083565	10.7874865156419	13.270695649866	5567378.33333333	0	Rrp12	0	RRP12-like protein				rRNA processing [GO:0006364]	cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.	107094;		IPR011989;IPR016024;IPR012978;	PF08161;		143131	COMPBIAS 1054..1069;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1090..1110;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1136..1168;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1181..1206;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1227..1241;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..47;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1047..1241;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1273..1295;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (5); Cross-link (1); Modified residue (8); Region (3); Sequence caution (1); Sequence conflict (4); Transmembrane (1)		Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Ubl conjugation							107094		GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR012978:Uncharacterised domain NUC173,IPR016024:Armadillo-type fold,	PF08161:NUC173 domain,	SSF48371:ARM repeat,	3.45925522716906	4.06096924354056e-08	FDR<0.01	7.39137029970257	6728464.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	293	RNA processing
P14131	P14131	Rps16	7.8934	8.8767	9413300	4.455533772946	13.7940547623974	10.1876566352208	12.1503730164516	5.05484506899863	10.0714062704575	3390810	0	Rps16	0	40S ribosomal protein S16				cellular response to leukemia inhibitory factor [GO:1990830]; liver regeneration [GO:0097421]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		20055;		IPR020568;IPR014721;IPR000754;IPR020574;	PF00380;		16445			NA							3 out of 5	Chain (1); Modified residue (2); Sequence conflict (2)		Acetylation;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00360;	20055	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006412~translation,GO:0042274~ribosomal small subunit biogenesis,GO:0097421~liver regeneration,	GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000754:Ribosomal protein S9,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020574:Ribosomal protein S9, conserved site,	PF00380:Ribosomal protein S9/S16,	SSF54211:Ribosomal protein S5 domain 2-like,	3.0867228021879	4.09040698438107e-08	FDR<0.01	7.38823347872188	6402055	Present in Nucleus	RBP	Others	Others	Others	Others	303	RNA processing
Q80Y44	Q80Y44	Ddx10	6.7955	6.1982	6985250	6.56900742297839	4.36357289348519	3.50250429056776	1.82368603421235	11.5966230633639	6.17817867292722	4705253.33333333	0	Ddx10	0	Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10)		FUNCTION: Putative ATP-dependent RNA helicase. {ECO:0000250}.		anterior head development [GO:0097065]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		77591;		IPR011545;IPR025313;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF13959;PF00271;	SM00487;SM01178;SM00490;	100739	COMPBIAS 20..39;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 559..579;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 593..612;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 757..778;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 793..851;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 525..612;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 734..860;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 96;  /note=ATP;  /evidence=ECO:0000250	3.6.4.13			4 out of 5	Binding site (1); Chain (1); Compositional bias (5); Cross-link (1); Domain (2); Erroneous initiation (1); Modified residue (6); Motif (2); Nucleotide binding (2); Region (3)		ATP-binding;Acetylation;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 100..274;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 300..449;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The Q motif is unique to and characteristic of the DEAD box family of RNA helicases and controls ATP binding and hydrolysis.	MOTIF 69..97;  /note=Q motif; MOTIF 222..225;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	77591	GO:0010501~RNA secondary structure unwinding,		GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF13959:Domain of unknown function (DUF4217),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.38445911801867	3.43276414614555e-06	FDR<0.01	5.46435603448461	5845251.66666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	328	RNA processing
P61358	P61358	Rpl27	41.036	27.294	6971600	18.1162702222866	3.69453578157904	75.763315402682	11.304033279074	14.5217972176237	17.5079223348565	4644583.33333333	0	Rpl27	0	60S ribosomal protein L27		FUNCTION: Component of the large ribosomal subunit (By similarity). Required for proper rRNA processing and maturation of 28S and 5.8S rRNAs (By similarity). {ECO:0000250|UniProtKB:A1XQU5, ECO:0000250|UniProtKB:P61353}.		response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P61353}. Cytoplasm {ECO:0000250|UniProtKB:P61353}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:A1XQU5}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:A1XQU5, ECO:0000250|UniProtKB:P61353}.	108167922;19942;	cd06090;	IPR005824;IPR041991;IPR038655;IPR001141;IPR018262;IPR008991;	PF00467;PF01777;	SM00739;	15798			NA							4 out of 5	Chain (1); Domain (1); Modified residue (2)		3D-structure;Acetylation;Cytoplasm;Endoplasmic reticulum;Reference proteome;Ribonucleoprotein;Ribosomal protein	DOMAIN 5..40;  /note=KOW					PS01107;	108167922	GO:0006412~translation,	GO:0005634~nucleus,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001141:Ribosomal protein L27e,IPR005824:KOW,IPR008991:Translation protein SH3-like domain,IPR014722:Ribosomal protein L2 domain 2,IPR018262:Ribosomal protein L27e, conserved site,	PF00467:KOW motif,PF01777:Ribosomal L27e protein family,	SSF50104:Translation proteins SH3-like domain,	4.24077683306003	4.44525510596362e-07	FDR<0.01	6.35210331052432	5808091.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	330	RNA processing
P62843	P62843	Rps15	3.8044	NA	1669850	NA	10.0784100300337	10.3383750142153	NA	24.0355726475183	21.0039907582441	8783866.66666667	2	Rps15	1	40S ribosomal protein S15 (RIG protein)				liver regeneration [GO:0097421]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleoplasm [GO:0005654]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		20054;		IPR002222;IPR020934;IPR023575;IPR005713;	PF00203;		17040			NA							3 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (1)		Acetylation;Isopeptide bond;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00323;	20054	GO:0000028~ribosomal small subunit assembly,GO:0000056~ribosomal small subunit export from nucleus,GO:0001649~osteoblast differentiation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0042274~ribosomal small subunit biogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR002222:Ribosomal protein S19/S15,IPR005713:Ribosomal protein S19A/S15e,IPR020934:Ribosomal protein S19 conserved site,IPR023575:Ribosomal protein S19, superfamily,	PF00203:Ribosomal protein S19,	SSF54570:Ribosomal protein S19,	3.52209869213878	2.94519278489813e-05	FDR<0.01	4.53088627212402	5226858.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	361	RNA processing
Q5XG71	Q5XG71	Utp20	18.942	18.281	6086550	6.32111251580278	12.073649260489	8.42957093483942	3.51877265209895	13.3148700468683	7.18597298074159	4341990	0	Utp20	0	Small subunit processome component 20 homolog (Down-regulated in metastasis protein)		FUNCTION: Involved in 18S pre-rRNA processing. Associates with U3 snoRNA (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=Colocalizes with NCL in the nucleolus. {ECO:0000250}.			IPR016024;IPR011430;	PF07539;		317744	COMPBIAS 771..786;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 878..897;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1721..1737;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 771..795;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 866..908;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1718..1752;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2598..2617;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Erroneous initiation (1); Frameshift (1); Modified residue (2); Region (4); Repeat (2); Sequence caution (1); Sequence conflict (4)		Coiled coil;Nucleus;Phosphoprotein;Reference proteome;Repeat;rRNA processing				REPEAT 165..202;  /note=HEAT 1; REPEAT 1841..1878;  /note=HEAT 2			NA	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030686~90S preribosome,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR011430:Down-regulated-in-metastasis protein,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	PF07539:Down-regulated in metastasis,	SSF48371:ARM repeat,	3.27005496139233	2.01267400055804e-07	FDR<0.01	6.69622656352376	5214270	Present in Nucleus	RBP	Others	Others	Others	Others	362	RNA processing
P47962	P47962	Rpl5	22.982	12.543	4734300	10.3227937609035	9.68054211035818	23.5921390992521	NA	5.71559213534522	8.99685110211426	5338913.33333333	1	Rpl5	0	60S ribosomal protein L5		FUNCTION: Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polypeptide chain. The nascent polypeptides leave the ribosome through a tunnel in the LSU and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel. As part of the 5S RNP/5S ribonucleoprotein particle it is an essential component of the LSU, required for its formation and the maturation of rRNAs. It also couples ribosome biogenesis to p53/TP53 activation. As part of the 5S RNP it accumulates in the nucleoplasm and inhibits MDM2, when ribosome biogenesis is perturbed, mediating the stabilization and the activation of TP53. Interacts with RRP1B. {ECO:0000250|UniProtKB:P46777}.		negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of gene expression [GO:0010628]; positive regulation of isoleucine-tRNA ligase activity [GO:1905017]; positive regulation of methionine-tRNA ligase activity [GO:1905020]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of threonine-tRNA ligase activity [GO:1905023]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P46777}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P46777}.	100503670;		IPR005485;IPR025607;	PF14204;PF17144;		34401	COMPBIAS 271..297;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 253..297;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Initiator methionine (1); Modified residue (7); Region (1)		3D-structure;Acetylation;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding							100503670	GO:0000027~ribosomal large subunit assembly,GO:0006364~rRNA processing,GO:0006412~translation,GO:0010922~positive regulation of phosphatase activity,GO:0042273~ribosomal large subunit biogenesis,GO:0071241~cellular response to inorganic substance,GO:1905017~positive regulation of isoleucine-tRNA ligase activity,GO:1905020~positive regulation of methionine-tRNA ligase activity,GO:1905023~positive regulation of threonine-tRNA ligase activity,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0008097~5S rRNA binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR005485:Ribosomal protein L5 eukaryotic/L18 archaeal,IPR025607:Ribosomal protein L5 eukaryotic/L18 archaeal, C-terminal,	PF14204:Ribosomal L18 C-terminal region,		3.57980712100959	1.98310295252599e-07	FDR<0.01	6.70265473886917	5036606.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	372	RNA processing
Q9CR47	Q9CR47	Nsa2	4.3156	9.9849	3976250	17.3469564764862	9.23105326317733	10.1772883632885	NA	3.75079704437193	6.8662455369404	5832856.66666667	1	Nsa2	0	Ribosome biogenesis protein NSA2 homolog (L-name-related protein 42) (LNR42) (TGF-beta-inducible nuclear protein 1)		FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. May play a part in the quality control of pre-60S particles (By similarity). {ECO:0000250}.		maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]	nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	59050;	cd11381;	IPR039411;IPR022309;	PF01201;		30036	COMPBIAS 20..38;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 20..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Frameshift (1); Modified residue (1); Motif (1); Region (1); Sequence conflict (4)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing			MOTIF 11..18;  /note=Nuclear localization signal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00768				59050	GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030529~intracellular ribonucleoprotein complex,GO:0030687~preribosome, large subunit precursor,	GO:0044822~poly(A) RNA binding,	IPR022309:Ribosomal protein S8e/ribosomal biogenesis NSA2,	PF01201:Ribosomal protein S8e,		2.96948786063583	1.37521383586918e-06	FDR<0.01	5.86162976691189	4904553.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	378	RNA processing
Q9CX11	Q9CX11	Utp23	NA	14.21	5056000	4.58947175180137	NA	NA	NA	5.42269941977116	NA	4297908.33333333	4	Utp23	1	rRNA-processing protein UTP23 homolog		FUNCTION: Involved in rRNA-processing and ribosome biogenesis. {ECO:0000250}.		endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	78581;		IPR006984;IPR029060;	PF04900;		28380		REGION 180..249;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Cross-link (1); Modified residue (1); Region (1); Sequence conflict (1)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation;rRNA processing							78581	GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,GO:0070181~small ribosomal subunit rRNA binding,	IPR006984:Protein of unknown function DUF652,	PF04900:Fcf1,	SSF88723:PIN domain-like,	2.82205798748229	0.000967690406507125	FDR<0.01	3.01426356443889	4676954.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	387	RNA processing
Q9JJT0	Q9JJT0	Rcl1	5.8357	8.1671	4310900	8.07167648720639	8.27609037490689	NA	NA	8.59697386519945	12.5082867399652	4635946.66666667	2	Rcl1	0	RNA 3'-terminal phosphate cyclase-like protein		FUNCTION: Does not have cyclase activity. Plays a role in 40S-ribosomal-subunit biogenesis in the early pre-rRNA processing steps at sites A0, A1 and A2 that are required for proper maturation of the 18S RNA (By similarity). {ECO:0000250}.		endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]	endoribonuclease activity [GO:0004521]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	59028;	cd00875;	IPR013791;IPR023797;IPR037136;IPR000228;IPR016443;IPR020719;IPR013792;IPR036553;	PF01137;PF05189;		40841			NA							3 out of 5	Chain (1)		Nucleus;Reference proteome;Ribosome biogenesis						PS01287;	59028	GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003963~RNA-3'-phosphate cyclase activity,GO:0004521~endoribonuclease activity,	IPR000228:RNA 3'-terminal phosphate cyclase,IPR013791:RNA 3'-terminal phosphate cyclase, insert domain,IPR013792:RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta,IPR016443:RNA 3'-terminal phosphate cyclase type 2,IPR020719:RNA 3'-terminal phosphate cyclase-like, conserved site,IPR023797:RNA 3'-terminal phosphate cyclase domain,	PF01137:RNA 3'-terminal phosphate cyclase,PF05189:RNA 3'-terminal phosphate cyclase (RTC), insert domain,	SSF55205:EPT/RTPC-like,	3.06419809607262	4.07371128885107e-07	FDR<0.01	6.39000975346592	4473423.33333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	397	RNA processing
Q6P9R1	Q6P9R1	Ddx51	12.214	8.5752	5118250	7.21604849184587	3.98819494296881	9.91571641051066	2.67701780216838	3.1769228325444	5.80113702285648	3503058.16666667	0	Ddx51	0	ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)		FUNCTION: ATP-binding RNA helicase involved in the biogenesis of 60S ribosomal subunits. {ECO:0000250}.		rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	69663;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;	PF00270;PF00271;	SM00487;SM00490;	70368	COMPBIAS 33..48;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 86..109;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..131;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (2); Domain (2); Initiator methionine (1); Modified residue (3); Motif (2); Nucleotide binding (1); Region (1); Sequence conflict (1)		ATP-binding;Acetylation;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;rRNA processing	DOMAIN 215..424;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 467..615;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The Q motif is unique to and characteristic of the DEAD box family of RNA helicases and controls ATP binding and hydrolysis.	MOTIF 193..201;  /note=Q motif; MOTIF 343..346;  /note=DEAD box			PS00039;PS51192;PS51194;	69663	GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.56148607704183	1.77775708173357e-06	FDR<0.01	5.75012758266284	4310654.08333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	401	RNA processing
Q91WM3	Q91WM3	Rrp9	7.7562	8.6365	6021800	3.33366670000333	0.412405146816232	25.0953623770327	8.99604174163368	12.4965634450526	NA	2352109.25	1	Rrp9	0	U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K)		FUNCTION: Component of a nucleolar small nuclear ribonucleoprotein particle (snoRNP) thought to participate in the processing and modification of pre-ribosomal RNA (pre-rRNA). {ECO:0000250|UniProtKB:O43818}.		rRNA processing [GO:0006364]	box C/D RNP complex [GO:0031428]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O43818}.	27966;		IPR020472;IPR039241;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	52107	COMPBIAS 24..64;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Modified residue (8); Motif (1); Region (1); Repeat (7)		Acetylation;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation;WD repeat;rRNA processing		DOMAIN: The WD domains are required for nucleolar localization and U3 small nucleolar RNAs binding. {ECO:0000250|UniProtKB:O43818}.	MOTIF 8..40;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 144..183;  /note=WD 1; REPEAT 197..236;  /note=WD 2; REPEAT 239..278;  /note=WD 3; REPEAT 281..320;  /note=WD 4; REPEAT 322..360;  /note=WD 5; REPEAT 374..413;  /note=WD 6; REPEAT 419..460;  /note=WD 7		PS00678;PS50082;PS50294;	27966	GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0030515~snoRNA binding,GO:0034511~U3 snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.56959137423286	0.001417241722224	FDR<0.01	2.84855607094164	4186954.625	Present in Nucleus	RBP	ChD	Others	ChD	Others	411	RNA processing
Q9CSH3	Q9CSH3	Dis3	8.2618	6.9986	4804150	7.76880049720323	10.3270579244679	1.09910642647528	0.239641496321503	7.31207955542556	5.07356671740233	3218776.66666667	0	Dis3	0	Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)		FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. DIS3 has both 3'-5' exonuclease and endonuclease activities. {ECO:0000250|UniProtKB:Q9Y2L1}.		CUT catabolic process [GO:0071034]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y2L1}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9Y2L1}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9Y2L1}. Nucleus {ECO:0000250|UniProtKB:Q9Y2L1}. Note=Predominantly located in the nucleus. According to, found in the nucleolus. According to, excluded from nucleolus supporting the existence of a nucleolar RNA exosome complex devoid of DIS3. {ECO:0000250|UniProtKB:Q9Y2L1}.	72662;		IPR041505;IPR012340;IPR029060;IPR002716;IPR001900;IPR022966;IPR033771;IPR033770;	PF17849;PF13638;PF00773;PF17216;PF17215;	SM00670;SM00955;	108838			NA				3.1.13.-; 3.1.26.-			4 out of 5	Chain (1); Domain (1); Modified residue (3); Sequence caution (1); Sequence conflict (1)		Acetylation;Cytoplasm;Endonuclease;Exonuclease;Exosome;Hydrolase;Magnesium;Manganese;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;rRNA processing	DOMAIN 64..182;  /note=PINc					PS01175;	72662	GO:0006364~rRNA processing,GO:0006402~mRNA catabolic process,GO:0016075~rRNA catabolic process,GO:0071034~CUT catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004527~exonuclease activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0016787~hydrolase activity,	IPR002716:PIN domain,IPR012340:Nucleic acid-binding, OB-fold,IPR022966:Ribonuclease II/R, conserved site,	PF13638:PIN domain,	SSF50249:Nucleic acid-binding proteins,SSF88723:PIN domain-like,	1.93351682236873	0.00555230764698317	FDR<0.01	2.25552647812858	4011463.33333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	423	RNA processing
Q9D0I8	Q9D0I8	Mrto4	10.683	7.3499	5532500	6.35445129313084	5.13980263157895	NA	3.74812593703148	11.8310992274292	7.48334954725735	2332773.33333333	1	Mrto4	0	mRNA turnover protein 4 homolog (Ribosome assembly factor Mrto4)		FUNCTION: Component of the ribosome assembly machinery. Nuclear paralog of the ribosomal protein P0, it binds pre-60S subunits at an early stage of assembly in the nucleolus, and is replaced by P0 in cytoplasmic pre-60S subunits and mature 80S ribosomes. {ECO:0000250|UniProtKB:P33201}.		nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P33201}. Cytoplasm {ECO:0000250|UniProtKB:P33201}. Note=Shuttles between the nucleus and the cytoplasm. {ECO:0000250|UniProtKB:P33201}.	69902;	cd05796;	IPR033867;IPR043141;IPR001790;IPR043164;IPR040637;	PF00466;PF17777;		27546	COMPBIAS 223..239;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 216..239;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Modified residue (3); Region (1); Sequence conflict (1)		Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis							69902	GO:0000027~ribosomal large subunit assembly,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030687~preribosome, large subunit precursor,GO:0031965~nuclear membrane,	GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR001790:Ribosomal protein L10/acidic P0,	PF00466:Ribosomal protein L10,		2.81411655450676	5.56097757811617e-07	FDR<0.01	6.25484885599666	3932636.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	431	RNA processing
Q6PAC3	Q6PAC3	Dcaf13	12.563	14.646	6315050	7.34969866235484	8.32639467110741	6.43624895410954	4.13393964448119	13.72514033956	4.37885886937864	1362853.33333333	0	Dcaf13	0	DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1)		FUNCTION: Possible role in ribosomal RNA processing. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex (By similarity). {ECO:0000250}.	PATHWAY: Protein modification; protein ubiquitination.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]	cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	estrogen receptor binding [GO:0030331]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NV06}. Note=In the nucleolus, localizes predominantly in the granular component, but also detected in the fibrillar center and dense fibrillar component. {ECO:0000250|UniProtKB:Q9NV06}.	223499;		IPR007287;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF04158;PF00400;	SM00320;	51456			NA							3 out of 5	Chain (1); Modified residue (1); Repeat (7); Sequence conflict (1)		Acetylation;Nucleus;Reference proteome;Repeat;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation pathway;WD repeat;rRNA processing				REPEAT 64..104;  /note=WD 1; REPEAT 107..146;  /note=WD 2; REPEAT 149..191;  /note=WD 3; REPEAT 194..234;  /note=WD 4; REPEAT 236..276;  /note=WD 5; REPEAT 280..319;  /note=WD 6; REPEAT 323..362;  /note=WD 7		PS00678;PS50082;PS50294;	223499	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0016567~protein ubiquitination,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR007287:Sof1-like protein,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,PF04158:Sof1-like domain ,	SSF50978:WD40 repeat-like,	3.0127452944333	1.7499902960156e-07	FDR<0.01	6.75696435954146	3838951.66666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	435	RNA processing
O54825	O54825	Bysl	57.334	12.635	3369800	12.1204775468153	6.52315720808872	87.3820342537574	NA	12.0182196209454	25.5937755937756	3805146.66666667	1	Bysl	0	Bystin		FUNCTION: Required for processing of 20S pre-rRNA precursor and biogenesis of 40S ribosomal subunits. {ECO:0000269|PubMed:17055491, ECO:0000269|PubMed:17242206}.		blastocyst formation [GO:0001825]; cell population proliferation [GO:0008283]; in utero embryonic development [GO:0001701]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]	apical part of cell [GO:0045177]; cell projection [GO:0042995]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; preribosome, small subunit precursor [GO:0030688]	snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17242206}. Nucleus, nucleolus {ECO:0000269|PubMed:17242206}. Note=Associated with 40S ribosomal subunits.	53414;		IPR007955;	PF05291;		49784	COMPBIAS 31..52;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 65..83;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Erroneous initiation (3); Modified residue (6); Region (1); Sequence conflict (1)		Cytoplasm;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis							53414	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001701~in utero embryonic development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0007155~cell adhesion,GO:0008283~cell proliferation,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,GO:0042995~cell projection,GO:0043231~intracellular membrane-bounded organelle,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR007955:Bystin,	PF05291:Bystin,		4.35996499724716	1.73802331017943e-06	FDR<0.01	5.75994440313798	3587473.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	456	RNA processing
P54823	P54823	Ddx6	6.2392	7.4854	6465700	6.4057395426302	6.67423079490089	1.09357741981344	2.48576897263168	5.80753818456356	5.90807042419946	674055	0	Ddx6	0	Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK homolog)		FUNCTION: Essential for the formation of P-bodies, cytosolic membrane-less ribonucleoprotein granules involved in RNA metabolism through the coordinated storage of mRNAs encoding regulatory functions (By similarity). Plays a role in P-bodies to coordinate the storage of translationally inactive mRNAs in the cytoplasm and prevent their degradation (By similarity). In the process of mRNA degradation, plays a role in mRNA decapping (By similarity). Blocks autophagy in nutrient-rich conditions by repressing the expression of ATG-related genes through degradation of their transcripts (PubMed:26098573). {ECO:0000250|UniProtKB:P26196, ECO:0000269|PubMed:26098573}.		negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; spermatid differentiation [GO:0048515]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]	adherens junction [GO:0005912]; chromatoid body [GO:0033391]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; sperm annulus [GO:0097227]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000250|UniProtKB:P26196}. Cytoplasm {ECO:0000250|UniProtKB:P26196}. Nucleus {ECO:0000250|UniProtKB:P26196}. Note=Imported in the nucleus via interaction with EIF4ENIF1/4E-T via a piggy-back mechanism. Upon cellular stress, relocalizes to stress granules. {ECO:0000250|UniProtKB:P26196}.	13209;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	54192	COMPBIAS 1..23;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 34..57;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 286..316;  /note=Gyf binding;  /evidence=ECO:0000250|UniProtKB:P26196; REGION 307..483;  /note=RecA-like domain 2;  /evidence=ECO:0000250|UniProtKB:P26196	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (2); Domain (2); Modified residue (1); Motif (2); Nucleotide binding (1); Region (3); Sequence conflict (8)		ATP-binding;Cytoplasm;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 127..298;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 308..468;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 96..124;  /note=Q motif; MOTIF 246..249;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	13209	GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0010501~RNA secondary structure unwinding,GO:0019074~viral RNA genome packaging,GO:0019827~stem cell population maintenance,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0045665~negative regulation of neuron differentiation,GO:0098609~cell-cell adhesion,	GO:0000792~heterochromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0001520~outer dense fiber,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016442~RISC complex,GO:0043186~P granule,GO:0043231~intracellular membrane-bounded organelle,GO:0097227~sperm annulus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.18834606495506	2.75065969939767e-05	FDR<0.01	4.56056313546108	3569877.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	460	RNA processing
Q921Y2	Q921Y2	Imp3	5.8321	3.3488	5348300	NA	NA	4.05169968801912	NA	5.68763508133318	6.57938022238305	1494682.83333333	3	Imp3	0	U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3)		FUNCTION: Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]	rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	102462;	cd00165;	IPR022801;IPR001912;IPR002942;IPR036986;	PF00163;PF01479;	SM01390;SM00363;	21777			NA							3 out of 5	Chain (1); Domain (1)		Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;rRNA processing;rRNA-binding	DOMAIN 109..175;  /note=S4 RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00182					PS50889;	102462	GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0003723~RNA binding,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0030519~snoRNP binding,GO:0044822~poly(A) RNA binding,	IPR001912:Ribosomal protein S4/S9, N-terminal,IPR002942:RNA-binding S4 domain,IPR022801:Ribosomal protein S4/S9,	PF00163:Ribosomal protein S4/S9 N-terminal domain,PF01479:S4 domain,		2.30639350247494	3.33272474172233e-05	FDR<0.01	4.47720055435256	3421491.41666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	471	RNA processing
Q8BGA5	Q8BGA5	Krr1	5.7323	14.672	3334050	3.62581580855693	12.9255745417884	NA	2.9871254891418	7.8082298742875	10.1216623818296	2774941.66666667	1	Krr1	0	KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2 homolog) (KRR-R motif-containing protein 1)		FUNCTION: Required for 40S ribosome biogenesis. Involved in nucleolar processing of pre-18S ribosomal RNA and ribosome assembly (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13601}. Nucleus {ECO:0000250|UniProtKB:Q13601}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q13601}.	52705;		IPR041174;IPR004087;IPR036612;IPR024166;	PF17903;	SM00322;	43538	COMPBIAS 9..32;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 249..279;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 307..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (3); Domain (1); Frameshift (1); Modified residue (1); Region (3); Sequence conflict (3)		Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing	DOMAIN 153..205;  /note=KH						52705	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0045171~intercellular bridge,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR024166:Ribosomal RNA assembly KRR1,		SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.83252823175409	4.79277147929501e-06	FDR<0.01	5.31941327779877	3054495.83333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	499	RNA processing
O35218	O35218	Cpsf2	5.841	7.8619	4970000	3.24401479270746	3.09779746600167	2.46445030435961	NA	3.36745689655172	6.42384531380484	826480.5	1	Cpsf2	0	Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit)		FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Involved in the histone 3' end pre-mRNA processing (By similarity). {ECO:0000250}.		mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	51786;	cd16293;	IPR022712;IPR027075;IPR025069;IPR035639;IPR001279;IPR036866;IPR011108;	PF10996;PF13299;PF16661;PF07521;	SM01027;	88383	COMPBIAS 429..446;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 407..449;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (1)		Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing							51786	GO:0006378~mRNA polyadenylation,GO:0006379~mRNA cleavage,GO:0006397~mRNA processing,GO:0006398~mRNA 3'-end processing by stem-loop binding and cleavage,	GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0016020~membrane,	GO:0003723~RNA binding,	IPR001279:Beta-lactamase-like,IPR011108:RNA-metabolising metallo-beta-lactamase,IPR022712:Beta-Casp domain,IPR025069:Cleavage and polyadenylation specificity factor 2, C-terminal,IPR027075:Cleavage and polyadenylation specificity factor subunit 2,	PF07521:RNA-metabolising metallo-beta-lactamase,PF10996:Beta-Casp domain,PF13299:Cleavage and polyadenylation factor 2 C-terminal,	SSF56281:Metallo-hydrolase/oxidoreductase,	2.0837827345867	1.31129685137478e-05	FDR<0.01	4.88229898159721	2898240.25	Present in Nucleus	RBP	RBD	Others	Others	RBD	513	RNA processing
Q9CTH6	Q9CTH6	Fcf1	14.192	10.221	2954650	NA	9.68992248062015	NA	NA	NA	7.43328625585371	2168916.66666667	4	Fcf1	0	rRNA-processing protein FCF1 homolog		FUNCTION: Essential protein involved in pre-rRNA processing and 40S ribosomal subunit assembly. {ECO:0000250}.		endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	73736;	cd09864;	IPR006984;IPR037503;IPR029060;IPR002716;	PF04900;	SM00670;	23341	COMPBIAS 22..46;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 22..47;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Domain (1); Erroneous termination (1); Region (1)		Nucleus;Reference proteome;Ribosome biogenesis;rRNA processing	DOMAIN 67..166;  /note=PINc						73736	GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR002716:PIN domain,IPR006984:Protein of unknown function DUF652,	PF04900:Fcf1,	SSF88723:PIN domain-like,	3.33773893729818	1.62014128072722e-05	FDR<0.01	4.79044711214571	2561783.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	547	RNA processing
O35130	O35130	Emg1	9.3387	9.3377	1536600	5.15198351365276	10.5708245243129	4.67420772179116	NA	11.2193151730018	7.37300007373	3050933.5	1	Emg1	0	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)		FUNCTION: S-adenosyl-L-methionine-dependent pseudouridine N(1)-methyltransferase that methylates pseudouridine at position 1248 (Psi1248) in 18S rRNA. Involved the biosynthesis of the hypermodified N1-methyl-N3-(3-amino-3-carboxypropyl) pseudouridine (m1acp3-Psi) conserved in eukaryotic 18S rRNA. Is not able to methylate uridine at this position. Has also an essential role in 40S ribosomal subunit biogenesis independent on its methyltransferase activity, facilitating the incorporation of ribosomal protein S19 during the formation of pre-ribosomes. {ECO:0000250|UniProtKB:Q06287, ECO:0000250|UniProtKB:Q92979}.		blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q92979}.	14791;	cd18088;	IPR029028;IPR005304;IPR029026;	PF03587;		26974		REGION 1..33;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 219..224;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q06287	NA			BINDING 176;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q06287; BINDING 201;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:Q06287; BINDING 206;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q06287	2.1.1.-			4 out of 5	Binding site (3); Chain (1); Modified residue (2); Region (2); Site (5)		Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;rRNA processing;rRNA-binding							14791	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001824~blastocyst development,GO:0006364~rRNA processing,GO:0017126~nucleologenesis,GO:0032259~methylation,GO:0042254~ribosome biogenesis,GO:0070475~rRNA base methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0070037~rRNA (pseudouridine) methyltransferase activity,	IPR005304:Ribosomal biogenesis, methyltransferase, EMG1/NEP1,	PF03587:EMG1/NEP1 methyltransferase,	SSF75217:alpha/beta knot,	2.97261704086031	1.93825111679496e-07	FDR<0.01	6.71258995712358	2293766.75	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	582	RNA processing
Q9CWW6	Q9CWW6	Pin4	6.9052	7.2312	718690	10.5899670652024	11.1558584990908	NA	NA	20.166575917075	13.000182002548	3843358	2	Pin4	0	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Rotamase Pin4)		FUNCTION: Involved as a ribosomal RNA processing factor in ribosome biogenesis. Binds to tightly bent AT-rich stretches of double-stranded DNA (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]	bent DNA binding [GO:0003681]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Colocalizes in the nucleolus during interphase and on the spindle apparatus during mitosis with NPM1. {ECO:0000250}.	69713;		IPR043323;IPR000297;			13815		REGION 1..41;  /note=Necessary for association with the pre-rRNP complexes;  /evidence=ECO:0000250; REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..25;  /note=Necessary for nuclear localization and DNA-binding;  /evidence=ECO:0000250	NA				5.2.1.8			4 out of 5	Chain (1); Domain (1); Modified residue (1); Region (3)		Cytoplasm;Cytoskeleton;DNA-binding;Isomerase;Nucleus;Phosphoprotein;Reference proteome;Rotamase	DOMAIN 35..129;  /note=PpiC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00278					PS50198;	69713		GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000297:Peptidyl-prolyl cis-trans isomerase, PpiC-type,			3.42677137880772	5.50061362917201e-07	FDR<0.01	6.25958885943337	2281024	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	583	RNA processing
Q8C4J7	Q8C4J7	Tbl3	6.9647	10.761	2915100	2.16529891951584	5.30419561873442	6.47752299520663	NA	5.9509640561771	5.03676840938854	1322506.66666667	1	Tbl3	0	Transducin beta-like protein 3				endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	U3 snoRNA binding [GO:0034511]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	213773;		IPR020472;IPR013934;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF08625;PF00400;	SM00320;	88266			NA							2 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (2); Repeat (13); Sequence conflict (5)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat				REPEAT 64..105;  /note=WD 1; REPEAT 107..146;  /note=WD 2; REPEAT 149..190;  /note=WD 3; REPEAT 193..232;  /note=WD 4; REPEAT 245..284;  /note=WD 5; REPEAT 290..329;  /note=WD 6; REPEAT 332..372;  /note=WD 7; REPEAT 374..413;  /note=WD 8; REPEAT 419..459;  /note=WD 9; REPEAT 477..516;  /note=WD 10; REPEAT 519..560;  /note=WD 11; REPEAT 562..602;  /note=WD 12; REPEAT 604..642;  /note=WD 13		PS00678;PS50082;PS50294;	213773	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR013934:Small-subunit processome, Utp13,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,PF08625:Utp13 specific WD40 associated domain,	SSF50978:WD40 repeat-like,SSF50998:Quinoprotein alcohol dehydrogenase-like,	2.47865223944655	4.38303287444783e-06	FDR<0.01	5.35822527195664	2118803.33333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	605	RNA processing
O88796	O88796	Rpp30	NA	5.4719	3814400	2.96903298595647	5.09761941173472	5.30757390796667	9.01875901875902	10.7119137905178	NA	211740	1	Rpp30	1	Ribonuclease P protein subunit p30 (RNaseP protein p30) (EC 3.1.26.5) (RNase P subunit 2)		FUNCTION: Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends. Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences. {ECO:0000250|UniProtKB:P78346}.		RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]	multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; ribonuclease MRP complex [GO:0000172]	ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000305}.	54364;		IPR016195;IPR002738;	PF01876;		29473			NA				3.1.26.5			3 out of 5	Chain (1); Initiator methionine (1); Modified residue (2)		Acetylation;Hydrolase;Nucleus;Phosphoprotein;Reference proteome;rRNA processing;tRNA processing							54364	GO:0008033~tRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005634~nucleus,GO:0005655~nucleolar ribonuclease P complex,	GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004526~ribonuclease P activity,GO:0004540~ribonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR002738:RNase P subunit p30,IPR016195:Polymerase/histidinol phosphatase-like,	PF01876:RNase P subunit p30,	SSF89550:PHP domain-like,	2.56233074841072	1.05097783580919e-05	FDR<0.01	4.97840644276078	2013070	Present in Nucleus	RBP	RBD	Others	Others	RBD	614	RNA processing
Q8BGQ7	Q8BGQ7	Aars	9.0137	12.498	2147650	5.0932056636447	6.23130608175474	6.2582139057513	4.96993191193281	5.79105860551309	6.20385880017371	1863408.33333333	0	Aars	0	Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein sticky) (Sti)		FUNCTION: Catalyzes the attachment of alanine to tRNA(Ala) in a two-step reaction: alanine is first activated by ATP to form Ala-AMP and then transferred to the acceptor end of tRNA(Ala) (PubMed:16906134, PubMed:20010690, PubMed:25422440, PubMed:27622773). Also edits incorrectly charged tRNA(Ala) via its editing domain (PubMed:16906134, PubMed:20010690, PubMed:25422440, PubMed:29769718). {ECO:0000255|HAMAP-Rule:MF_03133, ECO:0000269|PubMed:16906134, ECO:0000269|PubMed:20010690, ECO:0000269|PubMed:25422440, ECO:0000269|PubMed:27622773, ECO:0000269|PubMed:29769718}.		alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]	alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03133}.	234734;		IPR002318;IPR018162;IPR018165;IPR018164;IPR023033;IPR003156;IPR018163;IPR009000;IPR012947;	PF02272;PF01411;PF07973;	SM00863;	106909			NA			BINDING 77;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P49588; BINDING 95;  /note=ATP; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:P49588; BINDING 176;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P49588; BINDING 216;  /note=L-alanine;  /evidence=ECO:0000250|UniProtKB:P49588; BINDING 239;  /note=L-alanine;  /evidence=ECO:0000250|UniProtKB:P49588; BINDING 243;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P49588	6.1.1.7	METAL 605;  /note=Zinc;  /evidence=ECO:0000255|HAMAP-Rule:MF_03133; METAL 609;  /note=Zinc;  /evidence=ECO:0000255|HAMAP-Rule:MF_03133; METAL 723;  /note=Zinc;  /evidence=ECO:0000255|HAMAP-Rule:MF_03133; METAL 727;  /note=Zinc;  /evidence=ECO:0000255|HAMAP-Rule:MF_03133		5 out of 5	Binding site (6); Chain (1); Metal binding (4); Modified residue (4); Mutagenesis (2); Natural variant (1); Nucleotide binding (1); Sequence conflict (2)	MISCELLANEOUS: Was named 'sticky' because of the sticky characteristics of the fur in mice homozygous for the Glu-734 variant. {ECO:0000303|PubMed:16906134}.	ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Disease variant;Ligase;Metal-binding;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Ubl conjugation;Zinc;tRNA-binding		DOMAIN: Consists of three domains; the N-terminal catalytic domain, the editing domain and the C-terminal C-Ala domain. The editing domain removes incorrectly charged amino acids, while the C-Ala domain, along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs. {ECO:0000255|HAMAP-Rule:MF_03133}.				PS50860;	234734	GO:0001942~hair follicle development,GO:0006400~tRNA modification,GO:0006412~translation,GO:0006419~alanyl-tRNA aminoacylation,GO:0006457~protein folding,GO:0021680~cerebellar Purkinje cell layer development,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0034620~cellular response to unfolded protein,GO:0043039~tRNA aminoacylation,GO:0043200~response to amino acid,GO:0043524~negative regulation of neuron apoptotic process,GO:0043588~skin development,GO:0050885~neuromuscular process controlling balance,GO:0050905~neuromuscular process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0002161~aminoacyl-tRNA editing activity,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004813~alanine-tRNA ligase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016597~amino acid binding,GO:0016874~ligase activity,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0046872~metal ion binding,	IPR002318:Alanine-tRNA ligase, class IIc,IPR003156:Phosphoesterase, DHHA1,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR012947:Threonyl/alanyl tRNA synthetase, SAD,IPR018162:Alanine-tRNA ligase, class IIc, anti-codon-binding domain,IPR018163:Threonyl/alanyl tRNA synthetase, class II-like, putative editing domain,IPR018164:Alanyl-tRNA synthetase, class IIc, N-terminal,IPR018165:Alanyl-tRNA synthetase, class IIc, core domain,IPR023033:Alanine-tRNA ligase, eukaryota/bacteria,	PF01411:tRNA synthetases class II (A),PF02272:DHHA1 domain,PF07973:Threonyl and Alanyl tRNA synthetase second additional domain,	SSF101353:Putative anticodon-binding domain of alanyl-tRNA synthetase (AlaRS),SSF50447:Translation proteins,SSF55186:ThrRS/AlaRS common domain,	2.7412279172743	4.56838148736526e-08	FDR<0.01	7.34023763704332	2005529.16666667	Unexpected	RBP	ChD	Others	ChD	RBD	617	RNA processing
Q8VDG3	Q8VDG3	Parn	8.5777	7.0148	3404450	5.34988230258934	0.640450877417702	3.18167356029271	3.31873091729723	3.34090605372177	1.21375426331185	500388	0	Parn	0	Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Polyadenylate-specific ribonuclease)		FUNCTION: 3'-exoribonuclease that has a preference for poly(A) tails of mRNAs, thereby efficiently degrading poly(A) tails. Exonucleolytic degradation of the poly(A) tail is often the first step in the decay of eukaryotic mRNAs and is also used to silence certain maternal mRNAs translationally during oocyte maturation and early embryonic development. Interacts with both the 3'-end poly(A) tail and the 5'-end cap structure during degradation, the interaction with the cap structure being required for an efficient degradation of poly(A) tails. Involved in nonsense-mediated mRNA decay, a critical process of selective degradation of mRNAs that contain premature stop codons. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly via its interaction with KHSRP. Probably mediates the removal of poly(A) tails of AREs mRNAs, which constitutes the first step of destabilization (By similarity). Also able to recognize poly(A) tails of microRNAs such as MIR21 and H/ACA box snoRNAs (small nucleolar RNAs) leading to leading to microRNAs degradation or snoRNA increased stability (By similarity). {ECO:0000250|UniProtKB:O95453}.		box H/ACA RNA 3'-end processing [GO:0000495]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]	3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O95453}. Cytoplasm {ECO:0000250|UniProtKB:O95453}. Nucleus, nucleolus {ECO:0000250|UniProtKB:O95453}. Note=Some nuclear fraction is nucleolar. {ECO:0000250|UniProtKB:O95453}.	74108;	cd02637;	IPR012677;IPR034042;IPR014789;IPR001374;IPR036867;IPR035979;IPR006941;IPR012337;IPR036397;	PF04857;PF01424;PF08675;		71559		REGION 551..612;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.13.4	METAL 28;  /note=Divalent metal cation; catalytic;  /evidence=ECO:0000250|UniProtKB:O95453; METAL 30;  /note=Divalent metal cation; catalytic;  /evidence=ECO:0000250|UniProtKB:O95453; METAL 285;  /note=Divalent metal cation; catalytic;  /evidence=ECO:0000250|UniProtKB:O95453; METAL 375;  /note=Divalent metal cation; catalytic;  /evidence=ECO:0000250|UniProtKB:O95453		5 out of 5	Beta strand (21); Chain (1); Domain (1); Helix (22); Metal binding (4); Modified residue (10); Region (1); Sequence conflict (6); Site (1); Turn (2)		3D-structure;Acetylation;Cytoplasm;Exonuclease;Hydrolase;Magnesium;Metal-binding;Nonsense-mediated mRNA decay;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 171..238;  /note=R3H;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00382					PS51061;	74108	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006402~mRNA catabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0019901~protein kinase binding,GO:0043169~cation binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001374:Single-stranded nucleic acid binding R3H,IPR006941:Ribonuclease CAF1,IPR012337:Ribonuclease H-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014789:Poly(A)-specific ribonuclease, RNA-binding,	PF01424:R3H domain,PF04857:CAF1 family ribonuclease,PF08675:RNA binding domain,	SSF53098:Ribonuclease H-like,SSF54928:RNA-binding domain, RBD,SSF82708:R3H domain,	1.63847413371824	0.00158587474431091	FDR<0.01	2.79973111714627	1952419	Present in Nucleus	RBP	RBD	Others	Others	RBD	629	RNA processing
Q8VHZ7	Q8VHZ7	Imp4	8.8286	8.1166	2140525	NA	7.07313622860376	NA	NA	3.50963394517952	1.330902218614	1505610	3	Imp4	0	U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4)		FUNCTION: Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]	rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	27993;		IPR007109;IPR044281;	PF04427;	SM00879;	33656			NA							3 out of 5	Chain (1); Domain (1); Frameshift (1); Sequence conflict (1)		Nucleus;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;rRNA processing	DOMAIN 83..264;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	27993	GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0003723~RNA binding,GO:0030515~snoRNA binding,GO:0030519~snoRNP binding,GO:0042134~rRNA primary transcript binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,	PF04427:Brix domain,	SSF52954:Class II aaRS ABD-related,	2.24182707802827	0.000932024180911997	FDR<0.01	3.03057281994171	1823067.5	Present in Nucleus	RBP	Others	Others	Others	Others	649	RNA processing
Q9CRA8	Q9CRA8	Exosc5	6.9135	13.785	3106650	NA	2.40124864929764	NA	NA	1.35696257497218	NA	356790	4	Exosc5	0	Exosome complex component RRP46 (Exosome component 5) (Ribosomal RNA-processing protein 46)		FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes (By similarity). {ECO:0000250}.		defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	27998;		IPR001247;IPR015847;IPR036345;IPR027408;IPR020568;	PF01138;PF03725;		25194		REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (2); Region (1); Sequence conflict (1)		Cytoplasm;Exosome;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;rRNA processing							27998	GO:0006364~rRNA processing,GO:0006401~RNA catabolic process,GO:0016075~rRNA catabolic process,GO:0031125~rRNA 3'-end processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045006~DNA deamination,GO:0051607~defense response to virus,GO:0071028~nuclear mRNA surveillance,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,	GO:0003723~RNA binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027408:PNPase/RNase PH domain,	PF01138:3' exoribonuclease family, domain 1,PF03725:3' exoribonuclease family, domain 2,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55666:Ribonuclease PH domain 2-like,	2.06965234119562	0.00866974439123092	FDR<0.01	2.06199370657389	1731720	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	665	RNA processing
Q4FZF3	Q4FZF3	Ddx49	47.303	3.0785	1915350	8.34097923096171	6.8073519400953	23.515026101679	3.74798545781642	21.0743714568713	10.4311181115504	1078956.66666667	0	Ddx49	0	Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49)				positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364]	nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		234374;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	54094		REGION 438..480;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			3 out of 5	Chain (1); Domain (2); Motif (2); Nucleotide binding (1); Region (1)		ATP-binding;Helicase;Hydrolase;Nucleotide-binding;RNA-binding;Reference proteome	DOMAIN 33..207;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 218..382;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 2..30;  /note=Q motif; MOTIF 152..155;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	234374	GO:0010501~RNA secondary structure unwinding,		GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.40690797470283	5.53175352081359e-06	FDR<0.01	5.25713717905718	1497153.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	700	RNA processing
Q99J36	Q99J36	Thumpd1	NA	2.4682	1530495	4.67530038804993	5.82852480037303	3.64205849145937	NA	7.67931193365074	10.347360905601	1434230	1	Thumpd1	1	THUMP domain-containing protein 1		FUNCTION: Functions as a tRNA-binding adapter to mediate NAT10-dependent tRNA acetylation. {ECO:0000250|UniProtKB:Q9NXG2}.		tRNA modification [GO:0006400]		RNA binding [GO:0003723]		233802;	cd11717;	IPR004114;IPR040183;	PF02926;	SM00981;	38885	COMPBIAS 278..294;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 75..96;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 270..350;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (6); Region (3)		Acetylation;Phosphoprotein;Reference proteome	DOMAIN 147..254;  /note=THUMP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00529					PS51165;	233802	GO:0006400~tRNA modification,		GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004114:THUMP,	PF02926:THUMP domain,		2.37476187334629	3.15784987788136e-05	FDR<0.01	4.50060851991272	1482362.5	Unexpected	RBP	Others	Others	Others	Others	702	RNA processing
Q8BNV1	Q8BNV1	Trmt2a	5.0275	8.3463	2247615	NA	3.021787084882	NA	NA	3.69576465370685	6.79255535932618	230952.166666667	3	Trmt2a	0	tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein)				RNA processing [GO:0006396]		RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]		15547;	cd12439;	IPR041698;IPR012677;IPR035979;IPR029063;IPR034262;IPR010280;	PF13649;		63301		REGION 1..46;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 401;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01024; BINDING 451;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01024	2.1.1.-			3 out of 5	Binding site (2); Chain (1); Coiled coil (1); Domain (1); Erroneous initiation (1); Modified residue (1); Region (1); Sequence conflict (10)	MISCELLANEOUS: Htf9a (RanBP1) and Trmt2a are transcribed with opposite polarity from complementary DNA strands from a shared bidirectional TATA-less promoter.	Coiled coil;Methyltransferase;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase	DOMAIN 63..136;  /note=RRM					PS51687;	15547	GO:0006396~RNA processing,GO:0032259~methylation,		GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR010280:(Uracil-5)-methyltransferase,IPR012677:Nucleotide-binding, alpha-beta plait,	PF05958:tRNA (Uracil-5-)-methyltransferase,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,SSF54928:RNA-binding domain, RBD,	2.32724145470134	7.14305151631038e-05	FDR<0.01	4.14611621769449	1239283.58333333	Unexpected	RBP	RBD	Others	Others	RBD	757	RNA processing
Q3TX08	Q3TX08	Trmt1	5.9082	2.4189	1747120	6.48466377018352	13.7245752243968	NA	NA	2.0550338053061	4.48008601765154	491517.333333333	2	Trmt1	0	tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)		FUNCTION: Dimethylates a single guanine residue at position 26 of most tRNAs using S-adenosyl-L-methionine as donor of the methyl groups. {ECO:0000250}.		tRNA N2-guanine methylation [GO:0002940]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]		212528;		IPR029063;IPR002905;IPR042296;IPR000571;IPR036855;	PF02005;PF00642;	SM00356;	72350		REGION 534..574;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 632..663;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.216			3 out of 5	Chain (1); Domain (1); Modified residue (3); Region (2); Sequence conflict (4); Zinc finger (1)		Metal-binding;Methyltransferase;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase;Zinc;Zinc-finger;tRNA processing;tRNA-binding	DOMAIN 56..498;  /note=Trm1 methyltransferase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00958				ZN_FING 599..626;  /note=C3H1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS51626;PS50103;	212528	GO:0002940~tRNA N2-guanine methylation,GO:0008033~tRNA processing,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0004809~tRNA (guanine-N2-)-methyltransferase activity,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR002905:tRNA (guanine(26)-N(2))-dimethyltransferase,	PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),PF02005:N2,N2-dimethylguanosine tRNA methyltransferase,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,SSF90229:CCCH zinc finger,	2.25257995278639	0.000192079135618933	FDR<0.01	3.71651980732823	1119318.66666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	789	RNA processing
Q9QXK7	Q9QXK7	Cpsf3	3.3928	6.0301	1993850	3.00598190398894	2.13611312855129	NA	NA	5.71004396733855	NA	231934	3	Cpsf3	0	Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)		FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Has endonuclease activity, and functions as mRNA 3'-end-processing endonuclease. Also involved in the histone 3'-end pre-mRNA processing. U7 snRNP-dependent protein that induces both the 3' endoribonucleolytic cleavage of histone pre-mRNAs and acts as a 5' to 3' exonuclease for degrading the subsequent downstream cleavage product (DCP) of mature histone mRNAs. Cleavage occurs after the 5'-ACCCA-3' sequence in the histone pre-mRNA leaving a 3'hydroxyl group on the upstream fragment containing the stem loop (SL) and 5' phosphate on the downstream cleavage product (DCP) starting with CU nucleotides. The U7-dependent 5' to 3' exonuclease activity is processive and degrades the DCP RNA substrate even after complete removal of the U7-binding site. Binds to the downstream cleavage product (DCP) of histone pre-mRNAs and the cleaved DCP RNA substrate in a U7 snRNP dependent manner. Required for the selective processing of microRNAs (miRNAs) during embryonic stem cell differentiation via its interaction with ISY1 (PubMed:26255770, PubMed:29804889). Required for the biogenesis of all miRNAs from the pri-miR-17-92 primary transcript except miR-92a (PubMed:26255770). Only required for the biogenesis of miR-290 and miR-96 from the pri-miR-290-295 and pri-miR-96-183 primary transcripts, respectively (PubMed:29804889). {ECO:0000269|PubMed:16213211, ECO:0000269|PubMed:18955505, ECO:0000269|PubMed:19470752, ECO:0000269|PubMed:26255770, ECO:0000269|PubMed:29804889}.		mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]	5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UKF6}.	54451;		IPR022712;IPR021718;IPR001279;IPR036866;IPR011108;	PF10996;PF11718;PF00753;PF07521;	SM01027;SM01098;SM00849;	77505			NA	ACT_SITE 396;  /note=Proton donor;  /evidence=ECO:0000255			3.1.27.-	METAL 71;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 73;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 75;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 76;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 158;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 179;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 179;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UKF6; METAL 418;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UKF6		5 out of 5	Active site (1); Chain (1); Cross-link (3); Initiator methionine (1); Metal binding (8); Modified residue (3); Mutagenesis (1); Sequence conflict (3)		Acetylation;Endonuclease;Hydrolase;Isopeptide bond;Metal-binding;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ubl conjugation;Zinc;mRNA processing							54451	GO:0006397~mRNA processing,GO:0006398~mRNA 3'-end processing by stem-loop binding and cleavage,	GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0008409~5'-3' exonuclease activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001279:Beta-lactamase-like,IPR011108:RNA-metabolising metallo-beta-lactamase,IPR021718:Pre-mRNA 3'-end-processing endonuclease polyadenylation factor C-term,IPR022712:Beta-Casp domain,	PF00753:Metallo-beta-lactamase superfamily,PF07521:RNA-metabolising metallo-beta-lactamase,PF10996:Beta-Casp domain,PF11718:Pre-mRNA 3'-end-processing endonuclease polyadenylation factor C-term,	SSF56281:Metallo-hydrolase/oxidoreductase,	1.91019690961639	0.000319930391708073	FDR<0.01	3.49494450225982	1112892	Present in Nucleus	RBP	RBD	Others	Others	RBD	792	RNA processing
Q7TND5	Q7TND5	Rpf1	4.6714	2.6951	730635	5.67794685441744	10.4678062618417	6.11209583766273	NA	4.48329970858552	5.24548887956357	1395755.16666667	1	Rpf1	0	Ribosome production factor 1 (Brix domain-containing protein 5) (Ribosome biogenesis protein RPF1)		FUNCTION: May be required for ribosome biogenesis. {ECO:0000250}.		maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]	RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	70285;		IPR007109;IPR044281;	PF04427;	SM00879;	40037	COMPBIAS 10..24;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..58;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 71..105;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 303..320;  /note=RNA-binding;  /evidence=ECO:0000250	NA							3 out of 5	Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (2); Region (3); Sequence caution (1); Sequence conflict (2)		Nucleus;RNA-binding;Reference proteome;Ribosome biogenesis;rRNA processing;rRNA-binding	DOMAIN 142..325;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	70285	GO:0000027~ribosomal large subunit assembly,GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,	GO:0003723~RNA binding,GO:0019843~rRNA binding,GO:0042134~rRNA primary transcript binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,	PF04427:Brix domain,	SSF52954:Class II aaRS ABD-related,	2.38782224396232	2.69744470345934e-06	FDR<0.01	5.56904744941748	1063195.08333333	Present in Nucleus	RBP	Others	Others	Others	Others	799	RNA processing
O08756	O08756	Hsd17b10	1.5619	1.4665	539430	NA	NA	NA	NA	6.06354596167839	2.53923112081662	1488935	4	Hsd17b10	0	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)		FUNCTION: Mitochondrial dehydrogenase involved in pathways of fatty acid, branched-chain amino acid and steroid metabolism (By similarity). Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid beta-oxidation, a major degradation pathway of fatty acids. Catalyzes the third step in the beta-oxidation cycle, namely the reversible conversion of (S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA. Preferentially accepts straight medium- and short-chain acyl-CoA substrates with highest efficiency for (3S)-hydroxybutanoyl-CoA (By similarity). Acts as 3-hydroxy-2-methylbutyryl-CoA dehydrogenase in branched-chain amino acid catabolic pathway. Catalyzes the oxidation of 3-hydroxy-2-methylbutanoyl-CoA into 2-methyl-3-oxobutanoyl-CoA, a step in isoleucine degradation pathway (By similarity). Has hydroxysteroid dehydrogenase activity toward steroid hormones and bile acids. Catalyzes the oxidation of 3alpha-, 17beta-, 20beta- and 21-hydroxysteroids and 7alpha- and 7beta-hydroxy bile acids. Oxidizes allopregnanolone/brexanolone at the 3alpha-hydroxyl group, which is known to be critical for the activation of gamma-aminobutyric acid receptors (GABAARs) chloride channel. Has phospholipase C-like activity toward cardiolipin and its oxidized species (By similarity). Likely oxidizes the 2'-hydroxyl in the head group of cardiolipin to form a ketone intermediate that undergoes nucleophilic attack by water and fragments into diacylglycerol, dihydroxyacetone and orthophosphate. Has higher affinity for cardiolipin with oxidized fatty acids and may degrade these species during the oxidative stress response to protect cells from apoptosis (By similarity). By interacting with intracellular amyloid-beta, it may contribute to the neuronal dysfunction associated with Alzheimer disease (AD) (By similarity). Essential for structural and functional integrity of mitochondria (PubMed:20077426). {ECO:0000250|UniProtKB:Q99714, ECO:0000269|PubMed:20077426}.; FUNCTION: In addition to mitochondrial dehydrogenase activity, moonlights as a component of mitochondrial ribonuclease P, a complex that cleaves tRNA molecules in their 5'-ends. Together with TRMT10C/MRPP1, forms a subcomplex of the mitochondrial ribonuclease P, named MRPP1-MRPP2 subcomplex, which displays functions that are independent of the ribonuclease P activity. The MRPP1-MRPP2 subcomplex catalyzes the formation of N(1)-methylguanine and N(1)-methyladenine at position 9 (m1G9 and m1A9, respectively) in tRNAs; HSD17B10/MRPP2 acting as a non-catalytic subunit. The MRPP1-MRPP2 subcomplex also acts as a tRNA maturation platform: following 5'-end cleavage by the mitochondrial ribonuclease P complex, the MRPP1-MRPP2 subcomplex enhances the efficiency of 3'-processing catalyzed by ELAC2, retains the tRNA product after ELAC2 processing and presents the nascent tRNA to the mitochondrial CCA tRNA nucleotidyltransferase TRNT1 enzyme. Associates with mitochondrial DNA complexes at the nucleoids to initiate RNA processing and ribosome assembly. {ECO:0000250|UniProtKB:Q99714}.	PATHWAY: Amino-acid degradation; L-isoleucine degradation. {ECO:0000250|UniProtKB:Q99714}.; PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000250|UniProtKB:Q99714}.; PATHWAY: Steroid metabolism. {ECO:0000250|UniProtKB:Q99714}.; PATHWAY: Lipid metabolism; bile acid biosynthesis. {ECO:0000250|UniProtKB:Q99714}.	androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289]	endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]	17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetoacetyl-CoA reductase activity [GO:0018454]; amyloid-beta binding [GO:0001540]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen receptor binding [GO:0030331]; identical protein binding [GO:0042802]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; NAD binding [GO:0051287]; steroid binding [GO:0005496]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q99714}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000250|UniProtKB:Q99714}.			IPR036291;IPR020904;IPR002347;	PF00106;		27419			NA	ACT_SITE 168;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10001		BINDING 155;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q99714	1.1.1.35; 1.1.1.62; 1.1.1.239; 1.1.1.178; 1.1.1.53; 1.1.1.159			5 out of 5	Active site (1); Binding site (1); Chain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (10); Nucleotide binding (1)		Acetylation;Direct protein sequencing;Fatty acid metabolism;Lipid metabolism;Mitochondrion;Mitochondrion nucleoid;NAD;Oxidoreductase;Reference proteome;Steroid metabolism;tRNA processing						PS00061;	NA	GO:0008033~tRNA processing,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,GO:0042645~mitochondrial nucleoid,	GO:0001540~beta-amyloid binding,GO:0003857~3-hydroxyacyl-CoA dehydrogenase activity,GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0005496~steroid binding,GO:0016491~oxidoreductase activity,GO:0018454~acetoacetyl-CoA reductase activity,GO:0030283~testosterone dehydrogenase [NAD(P)] activity,GO:0030331~estrogen receptor binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0047015~3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,GO:0051287~NAD binding,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	PF00106:short chain dehydrogenase,	SSF51735:NAD(P)-binding Rossmann-fold domains,	1.28505815079822	0.0196725888905866	FDR<0.1	1.70613848365404	1014182.5	Present in Nucleus	RBP	Others	Others	Others	Others	814	RNA processing
Q8K4F6	Q8K4F6	Nsun5	8.7404	1.55	1440845	NA	9.84348853233586	NA	NA	NA	2.27448482918619	513276.666666667	4	Nsun5	0	28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein homolog)		FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that specifically methylates the C(5) position of cytosine 3438 (m5C3438) in 28S rRNA (PubMed:31722427). m5C3782 promotes protein translation without affecting ribosome biogenesis and fidelity (By similarity). Required for corpus callosum and cerebral cortex development (PubMed:31174389, PubMed:31462248). {ECO:0000250|UniProtKB:Q96P11, ECO:0000269|PubMed:31174389, ECO:0000269|PubMed:31462248, ECO:0000269|PubMed:31722427}.		cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96P11}.	100609;		IPR001678;IPR023267;IPR029063;	PF01189;		51030		REGION 234..240;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; REGION 430..465;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 359;  /note=Nucleophile;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023		BINDING 258;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 263;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 305;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023	2.1.1.-			5 out of 5	Active site (1); Binding site (3); Chain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (2); Region (2); Sequence conflict (4)		Acetylation;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase;rRNA processing						PS51686;	100609	GO:0006364~rRNA processing,GO:0032259~methylation,GO:0070475~rRNA base methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR023267:RNA (C5-cytosine) methyltransferase,	PF01189:NOL1/NOP2/sun family,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.06116925753561	0.00610687888100964	FDR<0.01	2.21418069337089	977060.833333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	825	RNA processing
Q9D7H3	Q9D7H3	RtcA	10.316	5.3257	1079900	NA	NA	NA	NA	3.84881841274729	5.33475593491598	569583.333333333	4	RtcA	0	RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1)		FUNCTION: Catalyzes the conversion of 3'-phosphate to a 2',3'-cyclic phosphodiester at the end of RNA. The mechanism of action of the enzyme occurs in 3 steps: (A) adenylation of the enzyme by ATP; (B) transfer of adenylate to an RNA-N3'P to produce RNA-N3'PP5'A; (C) and attack of the adjacent 2'-hydroxyl on the 3'-phosphorus in the diester linkage to produce the cyclic end product. The biological role of this enzyme is unknown but it is likely to function in some aspects of cellular RNA processing (By similarity). {ECO:0000250}.		RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	66368;		IPR013791;IPR023797;IPR037136;IPR000228;IPR017770;IPR020719;IPR013792;IPR036553;	PF01137;PF05189;		39254			NA	ACT_SITE 320;  /note=Tele-AMP-histidine intermediate;  /evidence=ECO:0000250		BINDING 104;  /note=ATP;  /evidence=ECO:0000250	6.5.1.4			3 out of 5	Active site (1); Binding site (1); Chain (1); Nucleotide binding (1); Sequence conflict (1)		ATP-binding;Ligase;Nucleotide-binding;Nucleus;Reference proteome						PS01287;	66368	GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003963~RNA-3'-phosphate cyclase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000228:RNA 3'-terminal phosphate cyclase,IPR013791:RNA 3'-terminal phosphate cyclase, insert domain,IPR013792:RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta,IPR017770:RNA 3'-terminal phosphate cyclase type 1,IPR020719:RNA 3'-terminal phosphate cyclase-like, conserved site,IPR023797:RNA 3'-terminal phosphate cyclase domain,	PF01137:RNA 3'-terminal phosphate cyclase,PF05189:RNA 3'-terminal phosphate cyclase (RTC), insert domain,	SSF52913:RNA 3'-terminal phosphate cyclase, RPTC, insert domain,SSF55205:EPT/RTPC-like,	2.53490520292937	0.000181673359221125	FDR<0.01	3.74070875343788	824741.666666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	886	RNA processing
Q8VCY6	Q8VCY6	Utp6	9.5288	7.8151	760435	5.55709919422062	6.60196738628111	4.37732545414752	NA	7.63358778625954	9.13075237399562	706327.666666667	1	Utp6	0	U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein)		FUNCTION: Involved in nucleolar processing of pre-18S ribosomal RNA. {ECO:0000250}.		maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]	chromosome [GO:0005694]; nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	216987;		IPR003107;IPR011990;IPR013949;	PF08640;	SM00386;	70429			NA							2 out of 5	Chain (1); Repeat (5); Sequence conflict (1)		Nucleus;Reference proteome;Repeat;rRNA processing				REPEAT 121..153;  /note=HAT 1; REPEAT 156..188;  /note=HAT 2; REPEAT 304..335;  /note=HAT 3; REPEAT 488..520;  /note=HAT 4; REPEAT 524..557;  /note=HAT 5			216987	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0030515~snoRNA binding,	IPR003107:RNA-processing protein, HAT helix,IPR011990:Tetratricopeptide-like helical,IPR013949:U3 small nucleolar RNA-associated protein 6,	PF08640:U3 small nucleolar RNA-associated protein 6,	SSF48452:TPR-like,	2.80984736540452	1.61034794490661e-07	FDR<0.01	6.79308027662239	733381.333333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	919	RNA processing
Q9D1C9	Q9D1C9	Rrp7a	10.306	19.379	1083430	NA	3.93406506943625	NA	NA	5.45226541628046	7.02148574638394	363685	3	Rrp7a	0	Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14 homolog)				blastocyst formation [GO:0001825]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]	CURI complex [GO:0032545]; cytoplasm [GO:0005737]; UTP-C complex [GO:0034456]	RNA binding [GO:0003723]		74778;	cd12294;	IPR012677;IPR035979;IPR040447;IPR040446;IPR024326;IPR034890;	PF17799;PF12923;		32399		REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Domain (1); Modified residue (1); Region (1); Sequence conflict (1)		Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 61..90;  /note=RRM						74778	GO:0000028~ribosomal small subunit assembly,GO:0001825~blastocyst formation,GO:0006364~rRNA processing,	GO:0005737~cytoplasm,GO:0032545~CURI complex,GO:0034456~UTP-C complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR012677:Nucleotide-binding, alpha-beta plait,IPR024326:Ribosomal RNA-processing protein 7,	PF12923:Ribosomal RNA-processing protein 7 (RRP7),	SSF54928:RNA-binding domain, RBD,	2.97529755301641	4.54240555403504e-05	FDR<0.01	4.34271409380261	723557.5	Unexpected	RBP	RBD	Others	Others	RBD	922	RNA processing
Q8K2D3	Q8K2D3	Edc3	NA	2.0901	624877.5	NA	8.13338755591704	NA	3.72522723886157	8.61994655633135	5.30644733351021	664102.166666667	2	Edc3	1	Enhancer of mRNA-decapping protein 3 (YjeF domain-containing protein 1)		FUNCTION: Binds single-stranded RNA. Involved in the process of mRNA degradation and in the positive regulation of mRNA decapping (By similarity). {ECO:0000250|UniProtKB:Q96F86}.		deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; P-body assembly [GO:0033962]	cytoplasmic ribonucleoprotein granule [GO:0036464]; P-body [GO:0000932]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; phosphodiesterase decapping endonuclease activity [GO:1990174]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000250}. Note=Processing bodies (PB). {ECO:0000250}.	353190;	cd01737;	IPR025762;IPR019050;IPR025609;IPR034107;IPR004443;IPR036652;	PF09532;PF12701;PF03853;	SM01199;SM01271;	55957	COMPBIAS 98..148;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 155..180;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..79;  /note=Required for P-body targeting and interaction with DCP1A;  /evidence=ECO:0000250; REGION 98..194;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 191..296;  /note=Required for interaction with DDX6;  /evidence=ECO:0000250	NA							3 out of 5	Chain (1); Compositional bias (2); Domain (2); Modified residue (4); Region (3); Sequence conflict (2)		Cytoplasm;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 192..228;  /note=DFDF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00845; DOMAIN 283..487;  /note=YjeF N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00719	DOMAIN: The DFDF domain is unstructured by itself. It assumes a helical fold upon interaction with DDX6 (By similarity). {ECO:0000250}.				PS51512;PS51385;	353190	GO:0031087~deadenylation-independent decapping of nuclear-transcribed mRNA,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0042802~identical protein binding,GO:1990174~phosphodiesterase decapping endonuclease activity,	IPR004443:YjeF N-terminal domain,IPR019050:FDF domain,IPR025609:Lsm14 N-terminal,IPR025762:DFDF domain,	PF03853:YjeF-related protein N-terminus,PF09532:FDF domain,PF12701:Scd6-like Sm domain,	SSF64153:YjeF N-terminal domain-like,	2.3000363972507	0.000230080067047822	FDR<0.01	3.63812100473908	644489.833333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	959	RNA processing
Q99LI7	Q99LI7	Cstf3	7.6056	3.8428	1043945	NA	NA	NA	NA	NA	7.41015190811412	157311.833333333	5	Cstf3	0	Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77)		FUNCTION: One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs. {ECO:0000250}.		mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	228410;		IPR003107;IPR008847;IPR011990;	PF05843;	SM00386;	82877	COMPBIAS 685..702;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 683..704;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Beta strand (3); Chain (1); Compositional bias (1); Helix (29); Initiator methionine (1); Modified residue (2); Region (1); Repeat (9); Turn (6)		3D-structure;Acetylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;mRNA processing				REPEAT 45..77;  /note=HAT 1; REPEAT 79..110;  /note=HAT 2; REPEAT 117..152;  /note=HAT 3; REPEAT 163..196;  /note=HAT 4; REPEAT 221..261;  /note=HAT 5; REPEAT 271..303;  /note=HAT 6; REPEAT 319..352;  /note=HAT 7; REPEAT 354..387;  /note=HAT 8; REPEAT 458..494;  /note=HAT 9			228410	GO:0006379~mRNA cleavage,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0031123~RNA 3'-end processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR003107:RNA-processing protein, HAT helix,IPR008847:Suppressor of forked,IPR011990:Tetratricopeptide-like helical,	PF05843:Suppressor of forked protein (Suf),	SSF48452:TPR-like,	2.58624102545811	0.000756185988622053	FDR<0.01	3.12137137394585	600628.416666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	978	RNA processing
Q6PAQ4	Q6PAQ4	Rexo4	10.462	10.714	677595	3.89650872817955	NA	7.06514059629787	NA	8.67302688638335	9.00900900900901	188377	2	Rexo4	0	RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog)		FUNCTION: May function as an exonuclease.		DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; rRNA processing [GO:0006364]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	227656;	cd06144;	IPR013520;IPR034920;IPR037431;IPR012337;IPR036397;	PF00929;	SM00479;	47599	COMPBIAS 113..137;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 42..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.-.-			5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Domain (1); Erroneous initiation (2); Modified residue (1); Region (1); Sequence caution (1)		Exonuclease;Hydrolase;Isopeptide bond;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 230..381;  /note=Exonuclease						227656		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR012337:Ribonuclease H-like domain,IPR013520:Exonuclease, RNase T/DNA polymerase III,	PF00929:Exonuclease,	SSF53098:Ribonuclease H-like,	2.97988606412354	1.51324970116708e-06	FDR<0.01	5.82008940317883	432986	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1087	RNA processing
Q9CZJ1	Q9CZJ1	Utp11l	6.2937	18.955	448005	3.07436898576567	10.9231122131318	4.82160077145612	4.63220307578284	NA	NA	247553.833333333	2	Utp11l	0	Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein)		FUNCTION: Involved in nucleolar processing of pre-18S ribosomal RNA. {ECO:0000250}.		nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	67205;		IPR007144;	PF03998;		30551	COMPBIAS 8..26;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (11); Modified residue (2); Region (1)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;rRNA processing							67205	GO:0006364~rRNA processing,GO:0007399~nervous system development,GO:0042274~ribosomal small subunit biogenesis,GO:0043065~positive regulation of apoptotic process,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR007144:Small-subunit processome, Utp11,	PF03998:Utp11 protein,		2.74153800940071	3.23043459741952e-05	FDR<0.01	4.49073904715356	347779.416666667	Present in Nucleus	RBP	Others	Others	Others	Others	1138	RNA processing
Q80UU2	Q80UU2	Rpp38	25.853	23.678	313480	NA	NA	NA	35.4534496206481	NA	NA	307657.666666667	5	Rpp38	0	Ribonuclease P protein subunit p38 (RNaseP protein p38) (EC 3.1.26.5)		FUNCTION: Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends. Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences. {ECO:0000250|UniProtKB:P78345}.		rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]	fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]	ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P78345}.			IPR029064;IPR004038;IPR042848;	PF01248;		31129	COMPBIAS 263..280;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 202..227;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 254..280;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.26.5			3 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (4)		Acetylation;Hydrolase;Nucleus;Phosphoprotein;Reference proteome;rRNA processing;tRNA processing							NA	GO:0008033~tRNA processing,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0005634~nucleus,GO:0005655~nucleolar ribonuclease P complex,GO:0005730~nucleolus,	GO:0004526~ribonuclease P activity,GO:0016787~hydrolase activity,	IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,	PF01248:Ribosomal protein L7Ae/L30e/S12e/Gadd45 family,	SSF55315:L30e-like,	4.80186307378205	1.54722851190639e-05	FDR<0.01	4.81044554012669	310568.833333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	1176	RNA processing
Q8C1Z8	Q8C1Z8	Trmt10a	NA	5.1042	132595	5.18645298480369	4.9813200498132	NA	NA	0.861623298293986	NA	418198.333333333	3	Trmt10a	1	tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A)		FUNCTION: S-adenosyl-L-methionine-dependent guanine N(1)-methyltransferase that catalyzes the formation of N(1)-methylguanine at position 9 (m1G9) in tRNAs. Probably not able to catalyze formation of N(1)-methyladenine at position 9 (m1A9) in tRNAs. {ECO:0000250|UniProtKB:Q8TBZ6}.		magnesium ion homeostasis [GO:0010960]; mitochondrial tRNA processing [GO:0090646]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8TBZ6}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8TBZ6}.	108943;		IPR028564;IPR038459;IPR016653;IPR007356;IPR016009;	PF01746;		37966	COMPBIAS 18..63;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 74..91;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..91;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 281..328;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.221			5 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Domain (1); Erroneous initiation (3); Modified residue (1); Region (2); Sequence caution (1); Sequence conflict (12)		Coiled coil;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;S-adenosyl-L-methionine;Transferase	DOMAIN 88..278;  /note=SAM-dependent MTase TRM10-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01012					PS51675;	108943	GO:0010960~magnesium ion homeostasis,GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR007356:tRNA (guanine-N1-)-methyltransferase, eukaryotic,IPR016009:tRNA (guanine-N1-)-methyltransferase,IPR016653:tRNA (guanine(9)-N(1))-methyltransferase TRM10,	PF01746:tRNA (Guanine-1)-methyltransferase,		1.70702258743811	0.0126333546059783	FDR<0.1	1.89848131346521	275396.666666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	1210	RNA processing
Q8C7E9	Q8C7E9	Cstf2t	5.1894	4.2659	316375	8.03406443319675	NA	NA	NA	NA	0.818531554391422	178195.166666667	4	Cstf2t	0	Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant) (CSTF 64 kDa subunit tau variant) (TauCstF-64)		FUNCTION: May play a significant role in AAUAAA-independent mRNA polyadenylation in germ cells. Directly involved in the binding to pre-mRNAs. {ECO:0000269|PubMed:11113135}.		mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14681198}.	83410;		IPR038192;IPR025742;IPR026896;IPR012677;IPR035979;IPR000504;	PF14327;PF14304;PF00076;	SM00360;	65862	COMPBIAS 209..233;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 241..257;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 417..433;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 561..590;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 201..296;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 365..433;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 428..466;  /note=8 X 5 AA tandem repeats of M-E-T-R-[AG]; REGION 508..565;  /note=12 X 5 AA tandem repeats of G-[AT]-G-[MI]-Q; REGION 519..590;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Domain (1); Erroneous initiation (1); Frameshift (1); Modified residue (1); Region (5); Repeat (20); Sequence conflict (4)		Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;mRNA processing	DOMAIN 16..94;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176			REPEAT 428..432;  /note=1-1; approximate; REPEAT 433..437;  /note=1-2; approximate; REPEAT 438..442;  /note=1-3; approximate; REPEAT 443..446;  /note=1-4; approximate; REPEAT 447..451;  /note=1-5; approximate; REPEAT 452..456;  /note=1-6; REPEAT 457..461;  /note=1-7; approximate; REPEAT 462..466;  /note=1-8; approximate; REPEAT 508..512;  /note=2-1; approximate; REPEAT 513..517;  /note=2-2; REPEAT 518..522;  /note=2-3; approximate; REPEAT 523..527;  /note=2-4; REPEAT 528..532;  /note=2-5; approximate; REPEAT 533..537;  /note=2-6; REPEAT 538..542;  /note=2-7; approximate; REPEAT 543..547;  /note=2-8; REPEAT 548..551;  /note=2-9; approximate; REPEAT 552..556;  /note=2-10; approximate; REPEAT 557..560;  /note=2-11; approximate; REPEAT 561..565;  /note=2-12		PS50102;	83410	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0031124~mRNA 3'-end processing,GO:0098789~pre-mRNA cleavage required for polyadenylation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR025742:Cleavage stimulation factor subunit 2, hinge domain,IPR026896:Transcription termination and cleavage factor C-terminal domain,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF14304:Transcription termination and cleavage factor C-terminal,PF14327:Hinge domain of cleavage stimulation factor subunit 2,	SSF54928:RNA-binding domain, RBD,	1.79641446521066	0.0145457299634134	FDR<0.1	1.8372644792208	247285.083333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	1236	RNA processing
Q6PGC1	Q6PGC1	Dhx29	4.9024	2.3326	143270	NA	NA	4.39232222075811	NA	10.0933636134242	7.06264566706688	287209.333333333	3	Dhx29	0	ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29)		FUNCTION: ATP-binding RNA helicase involved in translation initiation. Part of the 43S pre-initiation complex that is required for efficient initiation on mRNAs of higher eukaryotes with structured 5'-UTRs by promoting efficient NTPase-dependent 48S complex formation. Specifically binds to the 40S ribosome near the mRNA entrance. Does not possess a processive helicase activity. {ECO:0000255|HAMAP-Rule:MF_03068}.		formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255]	cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282]; mitochondrion [GO:0005739]	ATP binding [GO:0005524]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03068}.	218629;		IPR011545;IPR034730;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	153975	COMPBIAS 184..203;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 204..222;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..74;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 174..222;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..257;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 500..524;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Domain (2); Modified residue (3); Motif (1); Nucleotide binding (1); Region (4)		ATP-binding;Coiled coil;Cytoplasm;Helicase;Hydrolase;Initiation factor;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome	DOMAIN 581..754;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03068; DOMAIN 848..1025;  /note=Helicase C-terminal;  /evidence=ECO:0000255|HAMAP-Rule:MF_03068		MOTIF 701..704;  /note=DEAH box;  /evidence=ECO:0000255|HAMAP-Rule:MF_03068			PS00690;PS51192;PS51194;	218629	GO:0006396~RNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0016282~eukaryotic 43S preinitiation complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.36119097484529	0.000150388736879274	FDR<0.01	3.82278468830785	215239.666666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1270	RNA processing
Q8K4P0	Q8K4P0	Wdr33	2.5168	4.6583	212280	4.11725955204216	NA	NA	NA	NA	4.4674767691208	141842.333333333	4	Wdr33	0	pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa)		FUNCTION: Essential for both cleavage and polyadenylation of pre-mRNA 3' ends. {ECO:0000250}.		mRNA polyadenylation [GO:0006378]	collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11162572}.	74320;		IPR015943;IPR001680;IPR017986;IPR036322;	PF00400;	SM00320;	145267	COMPBIAS 570..610;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 611..625;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 736..750;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 874..897;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 961..976;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 990..1035;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1071..1112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1130..1147;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1165..1207;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1230..1249;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1271..1286;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1291..1321;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 566..1330;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (12); Cross-link (3); Domain (1); Initiator methionine (1); Modified residue (11); Region (1); Repeat (7)		Acetylation;Collagen;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat;mRNA processing	DOMAIN 617..769;  /note=Collagen-like			REPEAT 117..156;  /note=WD 1; REPEAT 159..198;  /note=WD 2; REPEAT 200..239;  /note=WD 3; REPEAT 242..283;  /note=WD 4; REPEAT 286..325;  /note=WD 5; REPEAT 329..369;  /note=WD 6; REPEAT 373..412;  /note=WD 7		PS50082;PS50294;	74320	GO:0006379~mRNA cleavage,GO:0006397~mRNA processing,	GO:0005581~collagen trimer,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0016021~integral component of membrane,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR008160:Collagen triple helix repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF00400:WD domain, G-beta repeat,PF01391:Collagen triple helix repeat (20 copies),	SSF50978:WD40 repeat-like,	1.93813468898954	0.000543565257622265	FDR<0.01	3.26474830930732	177061.166666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	1305	RNA processing
Q6ZWU9	Q6ZWU9	Rps27	1.8072	2.4935	145415	4.18340026773762	3.86951979259374	2.29016374670789	NA	NA	4.45454140496236	190239	2	Rps27	0	40S ribosomal protein S27		FUNCTION: Component of the small ribosomal subunit (By similarity). Required for proper rRNA processing and maturation of 18S rRNAs (By similarity). {ECO:0000250|UniProtKB:P42677}.		ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		100043813;57294;		IPR000592;IPR011332;	PF01667;		9461		REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Modified residue (1); Region (1); Zinc finger (1)		Metal-binding;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Zinc;Zinc-finger					ZN_FING 38..60;  /note=C4-type;  /evidence=ECO:0000255	PS01168;	100043813	GO:0000028~ribosomal small subunit assembly,GO:0006412~translation,	GO:0005840~ribosome,GO:0022627~cytosolic small ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000592:Ribosomal protein S27e,IPR011332:Ribosomal protein, zinc-binding domain,IPR023407:Ribosomal protein S27e, zinc-binding domain,	PF01667:Ribosomal protein S27,	SSF57829:Zn-binding ribosomal proteins,	1.58991443802681	0.000216802638386736	FDR<0.01	3.66393543694072	167827	Unexpected	RBP	Others	Others	Others	Others	1312	RNA processing
O55142	O55142	Rpl35a	2.4662	1.7676	264445.5	NA	NA	NA	NA	13.1106274746309	NA	7585.33333333333	5	Rpl35a	0	60S ribosomal protein L35a		FUNCTION: Required for the proliferation and viability of hematopoietic cells. Plays a role in 60S ribosomal subunit formation. The protein was found to bind to both initiator and elongator tRNAs and consequently was assigned to the P site or P and A site. {ECO:0000250}.		cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]	ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]		57808;		IPR038661;IPR001780;IPR018266;IPR009000;	PF01247;		12554			NA							3 out of 5	Chain (1); Modified residue (3)		3D-structure;Acetylation;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS01105;	57808	GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0042273~ribosomal large subunit biogenesis,	GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR001780:Ribosomal protein L35A,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR018266:Ribosomal protein L35Ae, conserved site,	PF01247:Ribosomal protein L35Ae,	SSF50447:Translation proteins,	1.94558215586162	0.0220652592391451	FDR<0.1	1.65629096577089	136015.416666667	Present in Nucleus	RBP	Others	Others	Others	Others	1347	RNA processing
Q6PE54	Q6PE54	Dhx40	14.198	NA	55091.7	NA	NA	NA	NA	5.74448529411765	NA	39980.6666666667	5	Dhx40	1	Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40)		FUNCTION: Probable ATP-dependent RNA helicase. {ECO:0000250}.				ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		67487;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	88530	COMPBIAS 10..43;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..53;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			3 out of 5	Chain (1); Compositional bias (1); Domain (2); Erroneous initiation (2); Frameshift (3); Motif (1); Nucleotide binding (1); Region (1)		ATP-binding;Helicase;Hydrolase;Nucleotide-binding;Reference proteome	DOMAIN 63..231;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 263..442;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 173..176;  /note=DEAH box			PS00690;PS51192;PS51194;	67487	GO:0006396~RNA processing,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.1748967235041	0.00264006284701305	FDR<0.01	2.57838573457483	47536.1833333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1430	RNA processing
Q3TSG4	Q3TSG4	Alkbh5	4.1951	3.0881	168625	5.57196188778069	5.54047315640756	NA	NA	5.3058842256062	19.5236235845373	289796.666666667	2	Alkbh5	0	RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5)		FUNCTION: Dioxygenase that demethylates RNA by oxidative demethylation: specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed:29279410). Can also demethylate N(6)-methyladenosine in single-stranded DNA (in vitro) (By similarity). Requires molecular oxygen, alpha-ketoglutarate and iron (By similarity). Demethylation of m6A mRNA affects mRNA processing and export (By similarity). Required for the late meiotic and haploid phases of spermatogenesis by mediating m6A demethylation in spermatocytes and round spermatids: m6A demethylation of target transcripts is required for correct splicing and the production of longer 3'-UTR mRNAs in male germ cells (PubMed:23177736, PubMed:29279410). {ECO:0000250|UniProtKB:Q6P6C2, ECO:0000269|PubMed:23177736, ECO:0000269|PubMed:29279410}.		cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; oxidative single-stranded RNA demethylation [GO:0035553]; regulation of mRNA stability [GO:0043488]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; oxidative RNA demethylase activity [GO:0035515]; RNA N6-methyladenosine dioxygenase activity [GO:1990931]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:29279410}.	268420;		IPR027450;IPR037151;IPR032860;	PF13532;		44411	COMPBIAS 59..83;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 294..313;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 317..354;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..28;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 47..83;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 194..196;  /note=Alpha-ketoglutarate binding;  /evidence=ECO:0000250|UniProtKB:Q6P6C2; REGION 294..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 278;  /note=Alpha-ketoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6P6C2	1.14.11.-	METAL 205;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6P6C2; METAL 207;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6P6C2; METAL 267;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6P6C2		5 out of 5	Binding site (1); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (1); Initiator methionine (1); Metal binding (3); Modified residue (10); Region (4); Sequence conflict (5)		Acetylation;Coiled coil;Differentiation;Dioxygenase;Iron;Isopeptide bond;Metal-binding;Methylation;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Spermatogenesis;Ubl conjugation							268420	GO:0001666~response to hypoxia,GO:0002230~positive regulation of defense response to virus by host,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0035553~oxidative single-stranded RNA demethylation,GO:0055114~oxidation-reduction process,GO:0098792~xenophagy,	GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0016491~oxidoreductase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0035515~oxidative RNA demethylase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR027450:Alpha-ketoglutarate-dependent dioxygenase AlkB-like,	PF13532:2OG-Fe(II) oxygenase superfamily,		2.55639356385029	4.43890001536866e-05	FDR<0.01	4.35272463719196	229210.833333333	Present in Nucleus	RBP	Others	Others	Others	Others	1253	RNA processing
Q8K224	Q8K224	Nat10	9.1735	13.177	13626750	12.3321288954112	5.6980056980057	5.63031360846799	9.25411808254673	8.47601288353958	10.1083616367459	10522096.6666667	0	Nat10	0	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)		FUNCTION: RNA cytidine acetyltransferase that catalyzes the formation of N(4)-acetylcytidine (ac4C) modification on mRNAs, 18S rRNA and tRNAs. Catalyzes ac4C modification of a broad range of mRNAs, enhancing mRNA stability and translation. mRNA ac4C modification is frequently present within wobble cytidine sites and promotes translation efficiency. Mediates the formation of ac4C at position 1842 in 18S rRNA (By similarity). May also catalyze the formation of ac4C at position 1337 in 18S rRNA (By similarity). Required for early nucleolar cleavages of precursor rRNA at sites A0, A1 and A2 during 18S rRNA synthesis (By similarity). Catalyzes the formation of ac4C in serine and leucine tRNAs (By similarity). Requires the tRNA-binding adapter protein THUMPD1 for full tRNA acetyltransferase activity but not for 18S rRNA acetylation. In addition to RNA acetyltransferase activity, also able to acetylate lysine residues of proteins, such as histones, microtubules, p53/TP53 and MDM2, in vitro. The relevance of the protein lysine acetyltransferase activity is however unsure in vivo. Activates telomerase activity by stimulating the transcription of TERT, and may also regulate telomerase function by affecting the balance of telomerase subunit assembly, disassembly, and localization (By similarity). Involved in the regulation of centrosome duplication by acetylating CENATAC during mitosis, promoting SASS6 proteasome degradation (By similarity). {ECO:0000250|UniProtKB:P53914, ECO:0000250|UniProtKB:Q9H0A0, ECO:0000255|HAMAP-Rule:MF_03211}.		negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]	midbody [GO:0030496]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697]	ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-Rule:MF_03211}.	98956;		IPR016181;IPR000182;IPR007807;IPR033688;IPR032672;IPR013562;IPR027992;	PF08351;PF13718;PF05127;PF13725;		115419	COMPBIAS 990..1008;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1009..1024;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 629..631;  /note=Acetyl-CoA binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03211; REGION 636..642;  /note=Acetyl-CoA binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03211; REGION 702..1024;  /note=Required for localization to the nucleolus and midbody;  /evidence=ECO:0000250|UniProtKB:Q9H0A0; REGION 990..1024;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 470;  /note=ATP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03211; BINDING 725;  /note=Acetyl-CoA;  /evidence=ECO:0000255|HAMAP-Rule:MF_03211	2.3.1.-			5 out of 5	Binding site (2); Chain (1); Compositional bias (2); Domain (1); Modified residue (5); Nucleotide binding (1); Region (4); Sequence conflict (5)		ATP-binding;Acetylation;Acyltransferase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;rRNA processing;tRNA processing	DOMAIN 558..753;  /note=N-acetyltransferase;  /evidence=ECO:0000255|HAMAP-Rule:MF_03211					PS51186;	98956	GO:0000154~rRNA modification,GO:0006364~rRNA processing,GO:0008033~tRNA processing,GO:0016072~rRNA metabolic process,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0034470~ncRNA processing,GO:0042274~ribosomal small subunit biogenesis,GO:0051391~tRNA acetylation,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0008080~N-acetyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0044822~poly(A) RNA binding,	IPR000182:GNAT domain,IPR007807:Helicase domain,IPR013562:Domain of unknown function DUF1726,IPR016181:Acyl-CoA N-acyltransferase,	PF05127:Helicase,PF08351:Domain of unknown function (DUF1726),PF13718:GNAT acetyltransferase 2,PF13725:Possible tRNA binding domain,	SSF55729:Acyl-CoA N-acyltransferases (Nat),	3.14705040048265	1.11774179011871e-08	FDR<0.01	7.95165851136754	12074423.3333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	197	RNA processing
B1AQJ2	B1AQJ2	Usp36	4.381	9.8877	280630	1.31145821038413	2.92115794701019	5.47045951859956	NA	12.3201261580919	4.92538048564252	474896.666666667	1	Usp36	0	Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36)		FUNCTION: Deubiquitinase essential for the regulation of nucleolar structure and function. Required for cell and organism viability. Plays an important role in ribosomal RNA processing and protein synthesis, which is mediated, at least in part, through deubiquitination of DHX33, NPM1 and FBL, regulating their protein stability (PubMed:29273634). Functions as a transcriptional repressor by deubiquiting histone H2B at the promoters of genes critical for cellular differentiation, such as CDKN1A, thereby preventing histone H3 'Lys-4' trimethylation (H3K4). Specifically deubiquitinates MYC in the nucleolus, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 3 of FBXW7 (FBW7gamma) in the nucleolus and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm. Interacts to and regulates the actions of E3 ubiquitin-protein ligase NEDD4L over substrates such as NTRK1, KCNQ2 and KCNQ3, affecting their expression an functions. Deubiquitinates SOD2, regulates SOD2 protein stability. Deubiquitinase activity is required to control selective autophagy activation by ubiquitinated proteins (By similarity). {ECO:0000250|UniProtKB:Q9P275, ECO:0000269|PubMed:29273634}.		histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent deubiquitinase [GO:0004843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9P275}. Cytoplasm {ECO:0000250|UniProtKB:Q9P275}.	72344;		IPR038765;IPR001394;IPR018200;IPR028889;	PF00443;		119913	COMPBIAS 539..574;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 602..623;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 694..710;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 746..787;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 797..811;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 851..885;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 903..917;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 943..958;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 72..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 428..464;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 483..574;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 589..640;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 664..710;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 722..973;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 131;  /note=Nucleophile;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-ProRule:PRU10093; ACT_SITE 382;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-ProRule:PRU10093			3.4.19.12			5 out of 5	Active site (2); Chain (1); Compositional bias (8); Domain (1); Erroneous initiation (1); Modified residue (7); Region (6); Sequence conflict (3)		Cytoplasm;Hydrolase;Nucleus;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation;Ubl conjugation pathway	DOMAIN 122..423;  /note=USP					PS00972;PS00973;PS50235;	72344	GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0016579~protein deubiquitination,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,	PF00443:Ubiquitin carboxyl-terminal hydrolase,		2.24992138793668	0.000112422550740387	FDR<0.01	3.94914656528123	377763.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	1117	RNA processing
P63242	P63242;Q8BGY2	Eif5a	14.43	14.825	75592500	12.5043765317861	15.7091914479162	30.7323519468945	12.3157259504661	14.6106979530412	15.9892552204918	32371916.6666667	0	Eif5a	0	Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D)		FUNCTION: mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis. Regulates also TNF-alpha-mediated apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:15377278}.		aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to thyroid hormone stimulus [GO:0097067]; mRNA export from nucleus [GO:0006406]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein export from nucleus [GO:0006611]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; synapse [GO:0045202]	protein N-terminus binding [GO:0047485]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17707773}. Nucleus {ECO:0000269|PubMed:17707773}. Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Nucleus, nuclear pore complex {ECO:0000250}. Note=The N-terminal extension contributes in signaling this protein to nuclear localization.	276770;		IPR001884;IPR012340;IPR014722;IPR019769;IPR020189;IPR008991;	PF01287;	SM01376;	16832		REGION 2..19;  /note=Nuclear localization regulation	NA							5 out of 5	Chain (1); Erroneous gene model prediction (1); Initiator methionine (1); Modified residue (4); Region (1); Sequence conflict (4)		Acetylation;Cytoplasm;Direct protein sequencing;Elongation factor;Endoplasmic reticulum;Hypusine;Membrane;Nuclear pore complex;Nucleus;Protein biosynthesis;Protein transport;RNA-binding;Reference proteome;Translocation;Transport;mRNA transport						PS00302;	276770	GO:0006406~mRNA export from nucleus,GO:0006412~translation,GO:0006414~translational elongation,GO:0006452~translational frameshifting,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006915~apoptotic process,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0015031~protein transport,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045901~positive regulation of translational elongation,GO:0045905~positive regulation of translational termination,GO:0051028~mRNA transport,GO:0051149~positive regulation of muscle cell differentiation,GO:0097067~cellular response to thyroid hormone stimulus,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005634~nucleus,GO:0005642~annulate lamellae,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003746~translation elongation factor activity,GO:0017070~U6 snRNA binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0047485~protein N-terminus binding,	IPR001884:Translation elongation factor IF5A,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR019769:Translation elongation factor, IF5A, hypusine site,IPR020189:Translation elongation factor, IF5A C-terminal,	PF01287:Eukaryotic elongation factor 5A hypusine, DNA-binding OB fold,	SSF50104:Translation proteins SH3-like domain,SSF50249:Nucleic acid-binding proteins,	3.97386973810672	6.75049048650841e-10	FDR<0.01	9.17066467045119	53982208.3333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	47	RNA transport
Q9ERU9	Q9ERU9	Ranbp2	2.0682	4.5201	675820	6.51126448756349	5.12137662603708	4.16250416250416	4.08329930583912	2.98071477540314	4.57059280588692	357681.666666667	0	Ranbp2	0	E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2)		FUNCTION: E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I. Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates. Binds single-stranded RNA (in vitro). May bind DNA. Component of the nuclear export pathway. Specific docking site for the nuclear export factor exportin-1 (By similarity). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB. Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle. Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity. {ECO:0000250|UniProtKB:P49792}.	PATHWAY: Protein modification; protein sumoylation.	centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]	annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]	metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO transferase activity [GO:0019789]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P49792}. Nucleus membrane {ECO:0000250|UniProtKB:P49792}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P49792}. Nucleus envelope {ECO:0000250|UniProtKB:P49792}. Note=Detected in diffuse and discrete intranuclear foci. Cytoplasmic filaments. {ECO:0000250|UniProtKB:P49792}.	19386;		IPR029000;IPR020892;IPR002130;IPR022011;IPR011993;IPR000156;IPR013026;IPR011990;IPR019734;IPR001876;IPR036443;	PF12185;PF00160;PF00638;PF00641;	SM00160;SM00028;SM00547;	341121	COMPBIAS 773..795;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1149..1168;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1587..1607;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1656..1675;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1744..1758;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1828..1846;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2030..2057;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2111..2132;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2323..2345;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2598..2615;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2651..2665;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 773..802;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1000..3035;  /note=20 X 2 AA repeats of F-G;  /evidence=ECO:0000305; REGION 1147..1171;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1587..1609;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1648..1675;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1744..1772;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1819..1846;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1984..2124;  /note=Interaction with BICD2;  /evidence=ECO:0000250|UniProtKB:P49792; REGION 2030..2060;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2111..2144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2316..2348;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2394..2430;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2443..2463;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2468..2472;  /note=Interaction with sumoylated RANGAP1;  /evidence=ECO:0000250; REGION 2470..2596;  /note=2 X 50 AA approximate repeats; REGION 2470..2545;  /note=Required for E3 SUMO-ligase activity;  /evidence=ECO:0000250; REGION 2470..2522;  /note=Interaction with UBE2I;  /evidence=ECO:0000250; REGION 2523..2596;  /note=Interaction with SUMO1;  /evidence=ECO:0000250; REGION 2598..2666;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.-			5 out of 5	Chain (1); Compositional bias (11); Cross-link (14); Domain (5); Modified residue (45); Region (19); Repeat (29); Sequence conflict (11); Zinc finger (6)		Acetylation;Disulfide bond;Isopeptide bond;Membrane;Metal-binding;Methylation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;RNA-binding;Reference proteome;Repeat;TPR repeat;Transferase;Translocation;Transport;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger;mRNA transport	DOMAIN 1165..1301;  /note=RanBD1 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00164; DOMAIN 1849..1985;  /note=RanBD1 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00164; DOMAIN 2146..2282;  /note=RanBD1 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00164; DOMAIN 2740..2875;  /note=RanBD1 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00164; DOMAIN 2896..3052;  /note=PPIase cyclophilin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00156	DOMAIN: Contains FG repeats. FG repeats are interaction sites for karyopherins (importins, exportins) and form probably an affinity gradient, guiding the transport proteins unidirectionally with their cargo through the NPC. FG repeat regions are highly flexible and lack ordered secondary structure. The overall conservation of FG repeats regarding exact sequence, spacing, and repeat unit length is limited. {ECO:0000305}.; DOMAIN: The PPIase cyclophilin-type domain has high structural similarity with PPIA, but has extremely low and barely detectable proline isomerase activity (in vitro) (By similarity). Only about half of the residues that surround the PPIA active site cleft are conserved. {ECO:0000250|UniProtKB:P49792}.		REPEAT 26..59;  /note=TPR 1; REPEAT 60..93;  /note=TPR 2; REPEAT 94..128;  /note=TPR 3; REPEAT 165..201;  /note=TPR 4; REPEAT 288..319;  /note=TPR 5; REPEAT 583..616;  /note=TPR 6; REPEAT 648..681;  /note=TPR 7; REPEAT 1000..1001;  /note=1;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1099..1100;  /note=2;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1117..1118;  /note=3;  /evidence=ECO:0000305; REPEAT 1449..1450;  /note=4;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1538..1539;  /note=5;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1696..1697;  /note=6;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1737..1738;  /note=7;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1775..1776;  /note=8;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 1798..1799;  /note=9;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2097..2098;  /note=10;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2354..2355;  /note=11;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2373..2374;  /note=12;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2383..2384;  /note=13;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2470..2522;  /note=1; REPEAT 2546..2596;  /note=2; REPEAT 2674..2675;  /note=14;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2676..2677;  /note=15;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2697..2698;  /note=16;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 2714..2715;  /note=17;  /evidence=ECO:0000305; REPEAT 2935..2936;  /note=18;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 3018..3019;  /note=19;  /evidence=ECO:0000250|UniProtKB:P49792; REPEAT 3034..3035;  /note=20;  /evidence=ECO:0000250|UniProtKB:P49792	ZN_FING 1345..1375;  /note=RanBP2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 1410..1439;  /note=RanBP2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 1469..1498;  /note=RanBP2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 1494..1527;  /note=RanBP2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 1558..1587;  /note=RanBP2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 1617..1646;  /note=RanBP2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS00170;PS50072;PS50196;PS50005;PS50293;PS01358;PS50199;	19386	GO:0000413~protein peptidyl-prolyl isomerization,GO:0001975~response to amphetamine,GO:0006457~protein folding,GO:0006607~NLS-bearing protein import into nucleus,GO:0006810~transport,GO:0015031~protein transport,GO:0016925~protein sumoylation,GO:0033132~negative regulation of glucokinase activity,GO:0046907~intracellular transport,GO:0051028~mRNA transport,GO:0090526~regulation of gluconeogenesis involved in cellular glucose homeostasis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005739~mitochondrion,GO:0005875~microtubule associated complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0042405~nuclear inclusion body,GO:0044614~nuclear pore cytoplasmic filaments,GO:0044615~nuclear pore nuclear basket,GO:1990723~cytoplasmic periphery of the nuclear pore complex,	GO:0003723~RNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008536~Ran GTPase binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0046872~metal ion binding,	IPR000156:Ran binding domain,IPR001876:Zinc finger, RanBP2-type,IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR011990:Tetratricopeptide-like helical,IPR011993:Pleckstrin homology-like domain,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR022011:Nup358/RanBP2 E3 ligase domain,	PF00160:Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD,PF00638:RanBP1 domain,PF00641:Zn-finger in Ran binding protein and others,PF12185:Nup358/RanBP2 E3 ligase domain,	SSF48452:TPR-like,SSF50729:PH domain-like,SSF50891:Cyclophilin-like,SSF90209:Ran binding protein zinc finger-like,	2.01742830711148	1.6174951082034e-06	FDR<0.01	5.79115702409573	516750.833333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	1029	RNA transport
Q99JX7	Q99JX7	Nxf1	7.4662	6.4357	8173600	9.28591326957006	8.75196919306844	9.14076782449726	5.0251256281407	8.99685110211426	9.35541210590327	9107150	0	Nxf1	0	Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP)		FUNCTION: Involved in the nuclear export of mRNA species bearing retroviral constitutive transport elements (CTE) and in the export of mRNA from the nucleus to the cytoplasm (TAP/NFX1 pathway). The NXF1-NXT1 heterodimer is involved in the export of HSP70 mRNA in conjunction with ALYREF/THOC4 and THOC5 components of the TREX complex. ALYREF/THOC4-bound mRNA is thought to be transferred to the NXF1-NXT1 heterodimer for export. Also involved in nuclear export of m6A-containing mRNAs: interaction between SRSF3 and YTHDC1 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export. {ECO:0000250|UniProtKB:Q9UBU9}.		mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UBU9}. Nucleus speckle {ECO:0000250|UniProtKB:Q9UBU9}. Cytoplasm {ECO:0000250|UniProtKB:Q9UBU9}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:Q9UBU9}. Nucleus envelope {ECO:0000250|UniProtKB:Q9UBU9}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9UBU9}. Note=Localized predominantly in the nucleoplasm and at both the nucleoplasmic and cytoplasmic faces of the nuclear pore complex. Shuttles between the nucleus and the cytoplasm. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. The association with the TREX complex seems to occur in regions surrounding nuclear speckles known as perispeckles. Nucleus; nuclear rim. {ECO:0000250|UniProtKB:Q9UBU9}.	53319;	cd00780;cd14342;	IPR001611;IPR032675;IPR002075;IPR032710;IPR018222;IPR012677;IPR030217;IPR035979;IPR005637;IPR015245;IPR009060;	PF02136;PF09162;PF03943;	SM00804;	70300	COMPBIAS 1..20;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 80..103;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..113;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..197;  /note=Interaction with ALYREF/THOC4 and LUZP4;  /evidence=ECO:0000250|UniProtKB:Q9UBU9; REGION 2..117;  /note=RNA-binding (RBD);  /evidence=ECO:0000250; REGION 2..59;  /note=Minor non-specific RNA-binding;  /evidence=ECO:0000250; REGION 60..117;  /note=Major non-specific RNA-binding;  /evidence=ECO:0000250; REGION 60..117;  /note=RNA binding;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (3); Initiator methionine (1); Modified residue (4); Motif (2); Region (6); Repeat (4); Sequence conflict (1)		Acetylation;Cytoplasm;Leucine-rich repeat;Methylation;Nitration;Nuclear pore complex;Nucleus;Protein transport;RNA-binding;Reference proteome;Repeat;Translocation;Transport;mRNA transport	DOMAIN 118..197;  /note=RRM; DOMAIN 385..535;  /note=NTF2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00137; DOMAIN 564..618;  /note=TAP-C;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00611	DOMAIN: The minimal CTE binding domain consists of an RNP-type RNA binding domain (RBD) and leucine-rich repeats. {ECO:0000250|UniProtKB:Q9UBU9}.; DOMAIN: The nucleoporin binding domain consists of a NTF2 domain (also called NTF2-like domain) and a TAP-C domain (also called UBA-like domain). It has 2 nucleoporin-FG-repeats binding sites (one in the NTF2 and the other in the TAP-C domain) which contribute to nucleoporin association and act synergistically to export cellular mRNAs. {ECO:0000250|UniProtKB:Q9UBU9}.; DOMAIN: The NTF2 domain is functional only in the presence of NXT1 and is essential for the export of mRNA from the nucleus. It inhibits RNA binding activity through an intramolecular interaction with the N-terminal RNA binding domain (RBD); the inhibition is removed by an association with the TREX complex, specifically involving ALYREF/THOC4 and THOC5. {ECO:0000250|UniProtKB:Q9UBU9}.; DOMAIN: The TAP-C domain mediates direct interactions with nucleoporin-FG-repeats and is necessary and sufficient for localization of NXF1 to the nuclear rim. The conserved loop 594-NWD-596 of the TAP-C domain has a critical role in the interaction with nucleoporins. {ECO:0000250|UniProtKB:Q9UBU9}.; DOMAIN: The leucine-rich repeats are essential for the export of mRNA from the nucleus. {ECO:0000250|UniProtKB:Q9UBU9}.; DOMAIN: The RNA-binding domain is a non-canonical RNP-type domain. {ECO:0000250|UniProtKB:Q9UBU9}.	MOTIF 66..99;  /note=Nuclear localization signal;  /evidence=ECO:0000250; MOTIF 82..109;  /note=Nuclear export signal;  /evidence=ECO:0000250	REPEAT 265..290;  /note=LRR 1; REPEAT 291..314;  /note=LRR 2; REPEAT 315..342;  /note=LRR 3; REPEAT 343..370;  /note=LRR 4		PS51450;PS50177;PS51281;	53319	GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0042405~nuclear inclusion body,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR002075:Nuclear transport factor 2,IPR005637:TAP C-terminal (TAP-C) domain,IPR009060:UBA-like,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015245:Nuclear RNA export factor Tap, RNA-binding domain,IPR018222:Nuclear transport factor 2, Eukaryote,	PF02136:Nuclear transport factor 2 (NTF2) domain,PF03943:TAP C-terminal domain,PF09162:Tap, RNA-binding,	SSF46934:UBA-like,SSF52058:L domain-like,SSF54427:NTF2-like,SSF54928:RNA-binding domain, RBD,	2.98097738383178	6.81797181044811e-09	FDR<0.01	8.16634479873519	8640375	Present in Nucleus	RBP	RBD	Others	Others	RBD	245	RNA transport
Q8BG81	Q8BG81	Poldip3	5.702	20.235	2607800	26.4956812039638	4.71497948983922	29.9616490891659	NA	17.8533171463258	9.15499404925387	1022576.33333333	1	Poldip3	0	Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR)		FUNCTION: Is involved in regulation of translation. Is preferentially associated with CBC-bound spliced mRNA-protein complexes during the pioneer round of mRNA translation. Contributes to enhanced translational efficiency of spliced over nonspliced mRNAs. Recruits activated ribosomal protein S6 kinase beta-1 I/RPS6KB1 to newly synthesized mRNA. Involved in nuclear mRNA export; probably mediated by association with the TREX complex (By similarity). {ECO:0000250}.		poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]	protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Nucleocytoplasmic shuttling protein. {ECO:0000250}.	73826;	cd12681;	IPR012677;IPR034784;IPR035979;IPR000504;	PF00076;	SM00360;	46132		REGION 256..277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 369..394;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Cross-link (5); Domain (1); Initiator methionine (1); Modified residue (10); Region (2)		Acetylation;Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Translation regulation;Transport;Ubl conjugation;mRNA transport	DOMAIN 280..351;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	73826	GO:0006417~regulation of translation,GO:0006810~transport,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0045727~positive regulation of translation,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.72470144495102	1.3680806860529e-06	FDR<0.01	5.86388828823418	1815188.16666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	651	RNA transport
Q6NZF1	Q6NZF1	Zc3h11a	4.676	5.3728	641545	24.403933914147	6.84369011771147	4.96007142502852	NA	6.53039900737935	14.8546472764004	439735.833333333	1	Zc3h11a	0	Zinc finger CCCH domain-containing protein 11A		FUNCTION: Involved in nuclear mRNA export; probably mediated by association with the TREX complex. {ECO:0000250}.		poly(A)+ mRNA export from nucleus [GO:0016973]		metal ion binding [GO:0046872]; mRNA binding [GO:0003729]		70579;		IPR041686;IPR000571;	PF15663;	SM00356;	86492	COMPBIAS 103..151;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 234..252;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 275..293;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 302..331;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 345..362;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 366..381;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 383..411;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 460..475;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 488..503;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 506..528;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 701..715;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 723..747;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 103..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 223..331;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 345..443;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..531;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 545..571;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 690..750;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (1); Compositional bias (12); Cross-link (5); Erroneous initiation (1); Frameshift (1); Modified residue (6); Region (6); Sequence caution (1); Sequence conflict (8); Zinc finger (3)		Coiled coil;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Transport;Ubl conjugation;Zinc;Zinc-finger;mRNA transport					ZN_FING 2..29;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 31..57;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 60..87;  /note=C3H1-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50103;	70579	GO:0006810~transport,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0005622~intracellular,	GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,		SSF90229:CCCH zinc finger,	2.99216282965291	3.33587395671014e-06	FDR<0.01	5.4767903671888	540640.416666667	Unexpected	RBP	DBD	DBD	Others	Others	1011	RNA transport
Q61655	Q61655	Ddx19a	2.5483	2.4506	435960	NA	NA	NA	NA	2.35023149780253	1.40242619732137	206210.166666667	4	Ddx19a	0	ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (mDEAD5) (DEAD box protein 19A) (Eukaryotic translation initiation factor 4A-related sequence 1)		FUNCTION: ATP-dependent RNA helicase involved in mRNA export from the nucleus. Rather than unwinding RNA duplexes, DDX19 functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins. {ECO:0000250|UniProtKB:Q9UMR2}.		poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of apoptotic process [GO:0043065]	cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UMR2}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UMR2}. Note=Associates with the nuclear pore complex cytoplasmic fibrils. {ECO:0000250|UniProtKB:Q9UMR2}.	13680;		IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	53933		REGION 2..299;  /note=N-terminal lobe;  /evidence=ECO:0000250; REGION 34..53;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 54..67;  /note=N-terminal helix;  /evidence=ECO:0000250; REGION 300..478;  /note=C-terminal lobe;  /evidence=ECO:0000250	NA			BINDING 118;  /note=ATP;  /evidence=ECO:0000250; BINDING 428;  /note=ATP;  /evidence=ECO:0000250; BINDING 431;  /note=ATP;  /evidence=ECO:0000250	3.6.4.13			4 out of 5	Binding site (3); Chain (1); Cross-link (2); Domain (2); Initiator methionine (1); Modified residue (2); Motif (2); Nucleotide binding (1); Region (4); Sequence conflict (2)		ATP-binding;Acetylation;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 124..294;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 305..473;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The N-terminal extension helix acts as an autoinhibitory domain, preventing ATP hydrolysis, unless the N-terminus of the protein is displaced by RNA binding, allowing cleft closure to bring key side chains into position for catalysis. {ECO:0000250}.	MOTIF 91..119;  /note=Q motif; MOTIF 241..244;  /note=DEAD box			PS51192;PS51194;PS51195;	13680	GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0010501~RNA secondary structure unwinding,GO:0015031~protein transport,GO:0043065~positive regulation of apoptotic process,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.09084946723705	0.0116067829548535	FDR<0.1	1.93528813672656	321085.083333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1162	RNA transport
O88477	O88477	Igf2bp1	14.555	26.002	23044500	23.5799004928199	17.8024638609984	20.9546959473618	14.9293840136156	15.2664763445949	16.9707254985151	10703700	0	Igf2bp1	0	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (Coding region determinant-binding protein) (CRD-BP) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zipcode-binding protein 1) (ZBP-1)		FUNCTION: RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Regulates localized beta-actin/ACTB mRNA translation, a crucial process for cell polarity, cell migration and neurite outgrowth. Co-transcriptionally associates with the ACTB mRNA in the nucleus. This binding involves a conserved 54-nucleotide element in the ACTB mRNA 3'-UTR, known as the 'zipcode'. The RNP thus formed is exported to the cytoplasm, binds to a motor protein and is transported along the cytoskeleton to the cell periphery. During transport, prevents ACTB mRNA from being translated into protein. When the RNP complex reaches its destination near the plasma membrane, IGF2BP1 is phosphorylated. This releases the mRNA, allowing ribosomal 40S and 60S subunits to assemble and initiate ACTB protein synthesis. Monomeric ACTB then assembles into the subcortical actin cytoskeleton (By similarity). During neuronal development, key regulator of neurite outgrowth, growth cone guidance and neuronal cell migration, presumably through the spatiotemporal fine tuning of protein synthesis, such as that of ACTB (By similarity). May regulate mRNA transport to activated synapses (By similarity). Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells (By similarity). Binds to the oncofetal H19 transcript and regulates its localization (By similarity). Binds to and stabilizes BTRC/FBW1A mRNA (By similarity). Binds to the adenine-rich autoregulatory sequence (ARS) located in PABPC1 mRNA and represses its translation. PABPC1 mRNA-binding is stimulated by PABPC1 protein. Prevents BTRC/FBW1A mRNA degradation by disrupting microRNA-dependent interaction with AGO2 (By similarity). During cellular stress, such as oxidative stress or heat shock, stabilizes target mRNAs that are recruited to stress granules, including CD44, IGF2, MAPK4, MYC, PTEN, RAPGEF2 and RPS6KA5 transcripts (By similarity). Interacts with GAP43 transcript and transports it to axons. Binds to the 3'-UTR of IGF2 mRNA by a mechanism of cooperative and sequential dimerization and regulates IGF2 mRNA subcellular localization and translation. Binds to MYC mRNA, in the coding region instability determinant (CRD) of the open reading frame (ORF), hence prevents MYC cleavage by endonucleases and possibly microRNA targeting to MYC-CRD. Binds to and stabilizes ABCB1/MDR-1 mRNA. Binds to the neuron-specific TAU mRNA and regulates its localization. Plays a direct role in the transport and translation of transcripts required for axonal regeneration in adult sensory neurons. During interstinal wound repair, interacts with and stabilizes PTGS2 transcript. PTGS2 mRNA stabilization may be crucial for colonic mucosal wound healing. {ECO:0000250, ECO:0000269|PubMed:15355996, ECO:0000269|PubMed:17264115, ECO:0000269|PubMed:21964071, ECO:0000269|PubMed:22465430}.		CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]; RNA localization [GO:0006403]	axon [GO:0030424]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasm, perinuclear region {ECO:0000250}. Cell projection, lamellipodium {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Cell projection, growth cone {ECO:0000250}. Cell projection, filopodium {ECO:0000250}. Cell projection, axon {ECO:0000250}. Note=In the nucleus, located in discrete foci, coinciding with the sites of ACTB transcription (By similarity). In the cytoplasm, localizes in cytoplasmic mRNP granules. Colocalizes with microtubules in growth cone filopodia and along neurites in neuronal cells (By similarity). Cytoplasmic colocalization with ACTB mRNA is partially lost at the cell periphery, suggesting release of the transcript (By similarity). In hippocampal neurons, predominantly located within dendrites, particularly at dendritic branching points in young cells, compared to axons (By similarity). In axons, predominantly found in axonal branches and their growth cones (By similarity). In neuronal processes, exhibits fast retrograde and anterograde movements, when associated with ACTB mRNA; this motility is lost when the association is inhibited (By similarity). Dendritic levels are regulated by neuronal activity and glutaminergic signals: they are increased by KCl-induced depolarization, which induces rapid efflux from the cell body into dendrites, and decreased by NMDA receptor agonists (By similarity). In motile cells, such as migrating fibroblasts, localizes to leading edges where it colocalizes with microtubules and microfilaments and to retracting tails (By similarity). In motile cells, transported towards the leading edge into the cortical region of the lamellipodia where it is connected to microfilaments (By similarity). In response to cellular stress, such as oxidative stress or heat shock, recruited to stress granules, but not to processing bodies (By similarity). {ECO:0000250}.	140486;	cd12625;cd12628;	IPR034837;IPR034842;IPR004087;IPR004088;IPR036612;IPR012677;IPR035979;IPR000504;	PF00013;PF00076;	SM00322;SM00360;	63451		REGION 156..190;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 187..570;  /note=Necessary for interaction with IGF2BP1 and binding to TAU mRNA; REGION 312..323;  /note=Sufficient for nuclear export;  /evidence=ECO:0000250; REGION 485..495;  /note=Sufficient for nuclear export;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Domain (6); Modified residue (4); Region (4); Sequence conflict (2)		Cell junction;Cell projection;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Synapse;Translation regulation;Transport;mRNA transport	DOMAIN 2..75;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 81..156;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 195..260;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 276..343;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 405..470;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 487..553;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: Domain KH3 and KH4 are the major RNA-binding modules, although KH1 and KH2 may also contribute. KH1 and KH2, and possibly KH3 and KH4, promote the formation of higher ordered protein-RNA complexes, which may be essential for IGF2BP1 cytoplasmic retention. KH domains are required for RNA-dependent homo- and heterooligomerization and for localization to stress granules. KH3 and KH4 mediate association with the cytoskeleton. Two nuclear export signals (NES) have been identified in KH2 and KH4 domains, respectively. Only KH2 NES is XPO1-dependent. Both NES may be redundant, since individual in vitro mutations do not affect subcellular location of the full-length protein.				PS50084;PS50102;	140486	GO:0006403~RNA localization,GO:0006417~regulation of translation,GO:0006810~transport,GO:0010610~regulation of mRNA stability involved in response to stress,GO:0017148~negative regulation of translation,GO:0022013~pallium cell proliferation in forebrain,GO:0051028~mRNA transport,GO:0070934~CRD-mediated mRNA stabilization,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030027~lamellipodium,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,GO:0070937~CRD-mediated mRNA stability complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00013:KH domain,PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54791:Eukaryotic type KH-domain (KH-domain type I),SSF54928:RNA-binding domain, RBD,	4.19800504137416	1.68681347771165e-10	FDR<0.01	9.77293293761187	16874100	Present in Nucleus	RBP	RBD	Others	Others	RBD	140	RNA transport
Q99J95	Q99J95;Q99J95-2;Q99J95-3	Cdk9	15.08	12.206	7727350	7.33675715333822	5.48365869708269	3.82526203044909	NA	5.78536303153023	5.45345476359274	667296.333333333	1	Cdk9	0	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9)		FUNCTION: Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation. {ECO:0000250|UniProtKB:P50750}.		cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; P-TEFb complex [GO:0070691]; transcription elongation factor complex [GO:0008023]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; snRNA binding [GO:0017069]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22767893}. Cytoplasm {ECO:0000250}. Nucleus, PML body {ECO:0000250}. Note=Accumulates on chromatin in response to replication stress. Complexed with CCNT1 in nuclear speckles, but uncomplexed form in the cytoplasm. The translocation from nucleus to cytoplasm is XPO1/CRM1-dependent. Associates with PML body when acetylated (By similarity). {ECO:0000250}.	107951;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	42762	COMPBIAS 345..372;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 166..191;  /note=T-loop;  /evidence=ECO:0000250; REGION 343..372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 149;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activation by Thr-186 phosphorylation is calcium Ca(2+) signaling pathway-dependent; actively inactivated by dephosphorylation mediated by PPP1CA, PPM1A and PPM1B. Reversibly repressed by acetylation at Lys-44 and Lys-48 (By similarity). {ECO:0000250|UniProtKB:P50750}.	BINDING 48;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 167;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.22; 2.7.11.23			5 out of 5	Active site (1); Alternative sequence (2); Binding site (2); Chain (1); Compositional bias (1); Domain (1); Frameshift (1); Modified residue (11); Nucleotide binding (2); Region (2); Sequence conflict (2)		ATP-binding;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Ubl conjugation	DOMAIN 19..315;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	107951	GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0016310~phosphorylation,GO:0031056~regulation of histone modification,GO:0031297~replication fork processing,GO:0033129~positive regulation of histone phosphorylation,GO:0042493~response to drug,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051147~regulation of muscle cell differentiation,GO:0071157~negative regulation of cell cycle arrest,GO:0071345~cellular response to cytokine stimulus,GO:1900364~negative regulation of mRNA polyadenylation,GO:1903839~positive regulation of mRNA 3'-UTR binding,GO:2001168~positive regulation of histone H2B ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008023~transcription elongation factor complex,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016020~membrane,GO:0016605~PML body,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001223~transcription coactivator binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0017069~snRNA binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,GO:0097322~7SK snRNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.82421442301745	1.35852568092298e-06	FDR<0.01	5.86693214747228	4197323.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	409	Replication & Repair
P11103	P11103;P11103-2	Parp1	12.076	14.409	51952000	17.7000548701701	19.3270327206664	40.7913522333265	23.4422617094097	57.867021584399	69.5120255804254	17183966.6666667	0	Parp1	0	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)		FUNCTION: Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair. Mediates glutamate, aspartate, serine or tyrosine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units. Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage. Mainly mediates glutamate and aspartate ADP-ribosylation of target proteins in absence of HPF1. Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 conferring serine specificity by completing the PARP1 active site. Also catalyzes tyrosine ADP-ribosylation of target proteins following interaction with HPF1. PARP1 initiates the repair of DNA breaks: recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones, thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks. In addition to base excision repair (BER) pathway, also involved in double-strand breaks (DSBs) repair: together with TIMELESS, accumulates at DNA damage sites and promotes homologous recombination repair by mediating poly-ADP-ribosylation. Mediates the poly(ADP-ribosyl)ation of a number of proteins, including itself, APLF and CHFR. In addition to proteins, also able to ADP-ribosylate DNA: catalyzes ADP-ribosylation of DNA strand break termini containing terminal phosphates and a 2'-OH group in single- and double-stranded DNA, respectively. Required for PARP9 and DTX3L recruitment to DNA damage sites. PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites. Acts as a regulator of transcription: positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150. Plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and EEF1A1. Involved in the synthesis of ATP in the nucleus, together with NMNAT1, PARG and NUDT5. Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming. {ECO:0000250|UniProtKB:P09874}.		apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to UV [GO:0034644]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of single strand break repair [GO:1903516]; regulation of SMAD protein complex assembly [GO:0010990]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09874}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P09874}. Chromosome {ECO:0000250|UniProtKB:P09874}. Note=Localizes to sites of DNA damage. {ECO:0000250|UniProtKB:P09874}.			IPR001357;IPR036420;IPR012982;IPR038650;IPR008288;IPR012317;IPR004102;IPR036616;IPR036930;IPR008893;IPR001510;IPR036957;	PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;	SM00292;SM01335;SM00773;SM01336;	113100		REGION 200..226;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 373..523;  /note=Automodification domain;  /evidence=ECO:0000250|UniProtKB:P09874; REGION 489..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 987;  /note=For poly [ADP-ribose] polymerase activity;  /evidence=ECO:0000250|UniProtKB:P09874		BINDING 870;  /note=NAD; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; BINDING 877;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; BINDING 903;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q9UGN5	2.4.2.30; 2.4.2.-			5 out of 5	Active site (1); Alternative sequence (1); Binding site (3); Chain (1); Cross-link (11); Domain (4); Erroneous initiation (1); Initiator methionine (1); Modified residue (33); Motif (2); Nucleotide binding (1); Region (3); Sequence conflict (9); Zinc finger (2)		ADP-ribosylation;Acetylation;Alternative initiation;Chromosome;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Glycosyltransferase;Isopeptide bond;Metal-binding;NAD;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-nitrosylation;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 385..476;  /note=BRCT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 553..629;  /note=WGR;  /evidence=ECO:0000255; DOMAIN 661..778;  /note=PARP alpha-helical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00398; DOMAIN 787..1013;  /note=PARP catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00397	DOMAIN: The N-terminal disordered region does not act as a key DNA-binding domain. The WGR and PARP catalytic domains function together to recruit PARP1 to sites of DNA breaks. The N-terminal disordered region is only required for activation on specific types of DNA damage. {ECO:0000250|UniProtKB:Q9UGN5}.; DOMAIN: The WGR domain bridges two nucleosomes, with the broken DNA aligned in a position suitable for ligation. The bridging induces structural changes in PARP1 that signal the recognition of a DNA break to the catalytic domain of PARP1, promoting HPF1 recruitment and subsequent activation of PARP1, licensing serine ADP-ribosylation of target proteins. {ECO:0000250|UniProtKB:Q9UGN5}.	MOTIF 207..209;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P09874; MOTIF 221..226;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P09874		ZN_FING 9..93;  /note=PARP-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00264; ZN_FING 113..203;  /note=PARP-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00264	PS50172;PS51060;PS51059;PS00347;PS50064;	NA	GO:0000723~telomere maintenance,GO:0006259~DNA metabolic process,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006471~protein ADP-ribosylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007005~mitochondrion organization,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010332~response to gamma radiation,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010990~regulation of SMAD protein complex assembly,GO:0016540~protein autoprocessing,GO:0023019~signal transduction involved in regulation of gene expression,GO:0032042~mitochondrial DNA metabolic process,GO:0032869~cellular response to insulin stimulus,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0034599~cellular response to oxidative stress,GO:0036211~protein modification process,GO:0040009~regulation of growth rate,GO:0042769~DNA damage response, detection of DNA damage,GO:0043504~mitochondrial DNA repair,GO:0044030~regulation of DNA methylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048148~behavioral response to cocaine,GO:0051103~DNA ligation involved in DNA repair,GO:0051901~positive regulation of mitochondrial depolarization,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0070212~protein poly-ADP-ribosylation,GO:0071294~cellular response to zinc ion,GO:0071451~cellular response to superoxide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900182~positive regulation of protein localization to nucleus,GO:1901216~positive regulation of neuron death,GO:1903376~regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903516~regulation of single strand break repair,GO:1903827~regulation of cellular protein localization,GO:1904044~response to aldosterone,GO:1904357~negative regulation of telomere maintenance via telomere lengthening,GO:1904646~cellular response to beta-amyloid,GO:1904762~positive regulation of myofibroblast differentiation,GO:1905077~negative regulation of interleukin-17 secretion,GO:1990966~ATP generation from poly-ADP-D-ribose,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2001170~negative regulation of ATP biosynthetic process,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030331~estrogen receptor binding,GO:0042802~identical protein binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,GO:0051287~NAD binding,GO:0070412~R-SMAD binding,GO:1990404~protein ADP-ribosylase activity,	IPR001357:BRCT domain,IPR001510:Zinc finger, PARP-type,IPR004102:Poly(ADP-ribose) polymerase, regulatory domain,IPR008288:NAD+ ADP-ribosyltransferase,IPR008893:WGR domain,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,IPR012982:PADR1,	PF00533:BRCA1 C Terminus (BRCT) domain,PF00644:Poly(ADP-ribose) polymerase catalytic domain,PF00645:Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region,PF02877:Poly(ADP-ribose) polymerase, regulatory domain,PF05406:WGR domain,PF08063:PADR1 (NUC008) domain,	SSF142921:WGR domain-like,SSF47587:Domain of poly(ADP-ribose) polymerase,SSF52113:BRCT domain,	4.71703633785684	1.13634160887884e-08	FDR<0.01	7.94449109067705	34567983.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	69	Replication & Repair
Q00899	Q00899;Q3TTC2	Yy1	NA	17.084	887845	NA	3.77828994597045	NA	NA	NA	NA	151257	5	Yy1	1	Transcriptional repressor protein YY1 (Delta transcription factor) (NF-E1) (UCR-motif DNA-binding protein) (Yin and yang 1) (YY-1)		FUNCTION: Multifunctional transcription factor that exhibits positive and negative control on a large number of cellular and viral genes by binding to sites overlapping the transcription start site. Binds to the consensus sequence 5'-CCGCCATNTT-3'; some genes have been shown to contain a longer binding motif allowing enhanced binding; the initial CG dinucleotide can be methylated greatly reducing the binding affinity. The effect on transcription regulation is depending upon the context in which it binds and diverse mechanisms of action include direct activation or repression, indirect activation or repression via cofactor recruitment, or activation or repression by disruption of binding sites or conformational DNA changes. Its activity is regulated by transcription factors and cytoplasmic proteins that have been shown to abrogate or completely inhibit YY1-mediated activation or repression. Binds to the upstream conserved region (UCR) (5'-CGCCATTTT-3') of Moloney murine leukemia virus (MuLV). Acts synergistically with the SMAD1 and SMAD4 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression (PubMed:15329343). Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions (PubMed:15329343). Proposed to recruit the PRC2/EED-EZH2 complex to target genes that are transcriptional repressed. Involved in DNA repair. In vitro, binds to DNA recombination intermediate structures (Holliday junctions). Involved in spermatogenesis and may play a role in meiotic DNA double-strand break repair. Plays a role in regulating enhancer activation (By similarity). {ECO:0000250|UniProtKB:P25490, ECO:0000269|PubMed:15329343, ECO:0000269|PubMed:18026119, ECO:0000269|PubMed:19786570}.; FUNCTION: Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair; proposed to target the INO80 complex to YY1-responsive elements. {ECO:0000250}.		anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cell development [GO:0048468]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; gene expression [GO:0010467]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21454521}. Nucleus matrix {ECO:0000269|PubMed:19786570}. Cytoplasm {ECO:0000269|PubMed:21454521}. Note=Associated with the nuclear matrix. In testis, localized to heterochromatin of spermatocytes. {ECO:0000269|PubMed:19786570}.	22632;		IPR017114;IPR036236;IPR013087;	PF00096;	SM00355;	44717	COMPBIAS 39..55;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 66..83;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..170;  /note=Interaction with the SMAD1/SMAD4 complex;  /evidence=ECO:0000250; REGION 32..83;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 159..203;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 257..341;  /note=Involved in nuclear matrix association;  /evidence=ECO:0000250; REGION 295..414;  /note=Binding to DNA;  /evidence=ECO:0000250; REGION 333..371;  /note=Involved in repression of activated transcription;  /evidence=ECO:0000250; REGION 371..397;  /note=Involved in masking transactivation domain;  /evidence=ECO:0000250	NA					METAL 298;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 303;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 316;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 320;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 327;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 330;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 343;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 347;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 355;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 360;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 373;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 377;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 385;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 390;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 403;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 407;  /note=Zinc 4;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (2); Cross-link (8); Metal binding (16); Modified residue (3); Region (7); Sequence conflict (2); Zinc finger (4)		ADP-ribosylation;Activator;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Differentiation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Spermatogenesis;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 296..320;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 325..347;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 353..377;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 383..407;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	22632	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006403~RNA localization,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0009952~anterior/posterior pattern specification,GO:0010225~response to UV-C,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030154~cell differentiation,GO:0034644~cellular response to UV,GO:0034696~response to prostaglandin F,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048593~camera-type eye morphogenesis,GO:0051276~chromosome organization,GO:0071347~cellular response to interleukin-1,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0031011~Ino80 complex,GO:0031519~PcG protein complex,	GO:0000400~four-way junction DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR017114:Transcription factor yin/yang,	PF00096:Zinc finger, C2H2 type,		3.00615365818601	0.0075034852108773	FDR<0.01	2.12473696910452	519551	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1026	Replication & Repair
P62806	P62806	Hist1h4a	120.6	106.18	2783250000	21.8316777644362	48.8209734902114	89.3096365097794	35.0311777481959	60.00600060006	56.5834889379279	1280971666.66667	0	Hist1h4a	0	Histone H4	DNA_BIND 17..21	FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.		DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.	100041230;319155;319156;319157;319158;319159;319160;319161;320332;326619;326620;69386;97122;	cd00076;	IPR035425;IPR009072;IPR001951;IPR019809;IPR004823;	PF15511;	SM00417;SM00803;	11367		REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (3); Chain (1); Cross-link (8); DNA binding (1); Helix (4); Initiator methionine (1); Modified residue (72); Region (1); Sequence conflict (3)		3D-structure;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Isopeptide bond;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation						PS00047;	100041230	GO:0000183~chromatin silencing at rDNA,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006352~DNA-templated transcription, initiation,GO:0032776~DNA methylation on cytosine,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051290~protein heterotetramerization,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0019904~protein domain specific binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,	IPR001951:Histone H4,IPR004823:TATA box binding protein associated factor (TAF),IPR009072:Histone-fold,IPR019809:Histone H4, conserved site,		SSF47113:Histone-fold,	5.88036127844113	4.31568136644902e-10	FDR<0.01	9.36495062745096	2032110833.33333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1	Replication & Repair
Q01320	Q01320	Top2a	1.6725	2.275	69554500	2.60960334029228	1.97055983604942	3.35660580021482	1.40311491511155	4.71231327458649	4.27094900486888	29340233.3333333	0	Top2a	0	DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)		FUNCTION: Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:1331984). May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (PubMed:24321095). {ECO:0000269|PubMed:1331984, ECO:0000269|PubMed:24321095}.		apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]	centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; sequence-specific DNA binding [GO:0043565]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11388}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P11388}. Nucleus {ECO:0000250|UniProtKB:P11388}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P11388}.	21973;	cd00187;cd03365;	IPR012542;IPR003594;IPR036890;IPR020568;IPR014721;IPR001241;IPR013760;IPR002205;IPR013758;IPR013757;IPR013759;IPR013506;IPR018522;IPR031660;IPR006171;IPR034157;	PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;	SM00433;SM00434;	172790	COMPBIAS 1229..1245;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1254..1272;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1312..1328;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1329..1344;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1363..1377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1403..1428;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1461..1520;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 341..343;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P11388; REGION 989..998;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P11388; REGION 1090..1118;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1183..1211;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1229..1528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1429..1435;  /note=Interaction with PLSCR1;  /evidence=ECO:0000250|UniProtKB:P11388	NA	ACT_SITE 804;  /note=O-(5'-phospho-DNA)-tyrosine intermediate;  /evidence=ECO:0000250|UniProtKB:P06786		BINDING 90;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P11388; BINDING 119;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P11388	5.6.2.2	METAL 460;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 540;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 540;  /note=Magnesium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 542;  /note=Magnesium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995		5 out of 5	Active site (1); Binding site (2); Chain (1); Compositional bias (7); Cross-link (41); Domain (1); Metal binding (4); Modified residue (25); Nucleotide binding (3); Region (6); Sequence conflict (7); Site (10)	MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both negative and positive supercoils, whereas prokaryotic enzymes relax only negative supercoils.	ATP-binding;Acetylation;Biological rhythms;Cytoplasm;DNA-binding;Isomerase;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Topoisomerase;Ubl conjugation	DOMAIN 454..571;  /note=Toprim;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995					PS00177;PS50880;	21973	GO:0000712~resolution of meiotic recombination intermediates,GO:0000819~sister chromatid segregation,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006259~DNA metabolic process,GO:0006265~DNA topological change,GO:0006266~DNA ligation,GO:0006268~DNA unwinding involved in DNA replication,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007059~chromosome segregation,GO:0016925~protein sumoylation,GO:0030261~chromosome condensation,GO:0030263~apoptotic chromosome condensation,GO:0040016~embryonic cleavage,GO:0042752~regulation of circadian rhythm,GO:0043065~positive regulation of apoptotic process,GO:0044774~mitotic DNA integrity checkpoint,GO:0045070~positive regulation of viral genome replication,GO:0045870~positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,	GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005814~centriole,GO:0009330~DNA topoisomerase complex (ATP-hydrolyzing),GO:0043234~protein complex,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003916~DNA topoisomerase activity,GO:0003918~DNA topoisomerase type II (ATP-hydrolyzing) activity,GO:0005080~protein kinase C binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008144~drug binding,GO:0008301~DNA binding, bending,GO:0016853~isomerase activity,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043130~ubiquitin binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001241:DNA topoisomerase, type IIA,IPR002205:DNA topoisomerase, type IIA, subunit A/C-terminal,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR006171:Toprim domain,IPR012542:DTHCT,IPR013506:DNA topoisomerase, type IIA, subunit B, domain 2,IPR013757:Type IIA DNA topoisomerase subunit A, alpha-helical domain,IPR013758:DNA topoisomerase, type IIA, subunit A/ C-terminal, alpha-beta,IPR013759:DNA topoisomerase, type IIA, central domain,IPR013760:DNA topoisomerase, type IIA-like domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR018522:DNA topoisomerase, type IIA, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR024946:Arginine repressor C-terminal-like domain,	PF00204:DNA gyrase B,PF00521:DNA gyrase/topoisomerase IV, subunit A,PF01751:Toprim domain,PF02518:Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase,PF08070:DTHCT (NUC029) region,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,SSF56719:Type II DNA topoisomerase,	1.35711715749907	0.00016315726968478	FDR<0.01	3.78739357088838	49447366.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	54	Replication & Repair
Q99K48	Q99K48;Q99K48-2	Nono	13.295	23.467	38817500	15.001950253533	30.08876184745	14.9142431021626	7.91577614185071	13.3761369716426	16.6328465453578	10163815	0	Nono	0	Non-POU domain-containing octamer-binding protein (NonO protein)		FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes. Binds the conventional octamer sequence in double-stranded DNA. Also binds single-stranded DNA and RNA at a site independent of the duplex site. Involved in pre-mRNA splicing, probably as a heterodimer with SFPQ. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. Together with PSPC1, required for the formation of nuclear paraspeckles. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1. The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends. In vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. NONO is involved in transcriptional regulation. The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. NONO binds to an enhancer element in long terminal repeats of endogenous intracisternal A particles (IAPs) and activates transcription. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Important for the functional organization of GABAergic synapses. Plays a specific and important role in the regulation of synaptic RNAs and GPHN/gephyrin scaffold structure, through the regulation of GABRA2 transcript (PubMed:26571461).Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:Q15233, ECO:0000269|PubMed:22966205, ECO:0000269|PubMed:26571461, ECO:0000269|PubMed:8355702, ECO:0000269|PubMed:9001221}.		activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]	fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15860628, ECO:0000269|PubMed:26571461}. Nucleus, nucleolus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Detected in punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles. {ECO:0000250}.	53610;	cd12588;	IPR012975;IPR012677;IPR034552;IPR035979;IPR000504;	PF08075;PF00076;	SM00360;	54541		REGION 1..53;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 56..375;  /note=DBHS;  /evidence=ECO:0000250; REGION 445..473;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (5); Chain (1); Coiled coil (1); Cross-link (11); Domain (2); Erroneous termination (1); Frameshift (1); Helix (3); Modified residue (12); Region (3); Sequence conflict (9); Turn (1)		3D-structure;Acetylation;Activator;Alternative splicing;Biological rhythms;Coiled coil;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 76..143;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 150..231;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	53610	GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0042382~paraspeckles,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08075:NOPS (NUC059) domain,	SSF54928:RNA-binding domain, RBD,	3.9730633576479	2.86647994378796e-09	FDR<0.01	8.54265109255412	24490657.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	95	Replication & Repair
Q8VIJ6	Q8VIJ6	Sfpq	17.987	29.652	27401500	41.0829464689207	35.8692922988629	18.7578548517192	10.0435891770283	20.453662228222	24.995625765491	13753316.6666667	0	Sfpq	0	Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)		FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes. Essential pre-mRNA splicing factor required early in spliceosome formation and for splicing catalytic step II, probably as a heteromer with NONO. Binds to pre-mRNA in spliceosome C complex, and specifically binds to intronic polypyrimidine tracts. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45, a phosphorylated form is sequestered by THRAP3 from the pre-mRNA in resting T-cells; T-cell activation and subsequent reduced phosphorylation is proposed to lead to release from THRAP3 allowing binding to pre-mRNA splicing regulatotry elements which represses exon inclusion. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. May be involved in a pre-mRNA coupled splicing and polyadenylation process as component of a snRNP-free complex with SNRPA/U1A. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. SFPQ may be involved in homologous DNA pairing; in vitro, promotes the invasion of ssDNA between a duplex DNA and produces a D-loop formation. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1; in vitro, stimulates dissociation of TOP1 from DNA after cleavage and enhances its jumping between separate DNA helices. The SFPQ-NONO heteromer binds DNA. The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends; in vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. SFPQ is involved in transcriptional regulation. Functions as transcriptional activator (By similarity). Transcriptional repression is mediated by an interaction of SFPQ with SIN3A and subsequent recruitment of histone deacetylases (HDACs). The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. SFPQ isoform Long binds to the DNA binding domains (DBD) of nuclear hormone receptors, like RXRA and probably THRA, and acts as transcriptional corepressor in absence of hormone ligands. Binds the DNA sequence 5'-CTGAGTC-3' in the insulin-like growth factor response element (IGFRE) and inhibits IGF-I-stimulated transcriptional activity (By similarity). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation (PubMed:21680841, PubMed:22966205). Required for the assembly of nuclear speckles (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (By similarity). {ECO:0000250|UniProtKB:P23246, ECO:0000269|PubMed:21680841, ECO:0000269|PubMed:22966205}.		activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]	chromatin [GO:0000785]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:P23246}. Nucleus matrix {ECO:0000269|PubMed:21680841}. Cytoplasm {ECO:0000250|UniProtKB:P23246}. Note=Predominantly in nuclear matrix. {ECO:0000250|UniProtKB:P23246}.	71514;	cd12948;cd12587;	IPR012975;IPR012677;IPR034526;IPR034525;IPR035979;IPR000504;	PF08075;PF00076;	SM00360;	75442	COMPBIAS 49..106;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 115..203;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 571..603;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..265;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 9..27;  /note=3 X 3 AA repeats of R-G-G; REGION 571..699;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (3); Domain (2); Modified residue (28); Region (3); Repeat (3); Sequence conflict (2)		Acetylation;Activator;Biological rhythms;Coiled coil;Cytoplasm;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 289..361;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 363..444;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The coiled coil domain mediates interaction with NONO, and can also mediate formation of long, linear homooligomers (in vitro). The coiled coil domain is required for optimal DNA binding, and optimal transcription activation. {ECO:0000250|UniProtKB:P23246}.		REPEAT 9..11;  /note=1; REPEAT 19..21;  /note=2; REPEAT 25..27;  /note=3		PS50102;	71514	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0045876~positive regulation of sister chromatid cohesion,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0070932~histone H3 deacetylation,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0031012~extracellular matrix,GO:0042382~paraspeckles,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08075:NOPS (NUC059) domain,	SSF54928:RNA-binding domain, RBD,	4.51745028696917	1.3979107083015e-09	FDR<0.01	8.85452056831166	20577408.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	114	Replication & Repair
P28352	P28352	Apex1	8.9056	11.846	16833500	4.5716375605742	10.8479871559832	9.82800982800983	6.89940665102801	9.08843042806507	12.8349933258035	19000500	0	Apex1	0	DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.-.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial]		FUNCTION: Multifunctional protein that plays a central role in the cellular response to oxidative stress. The two major activities of APEX1 are DNA repair and redox regulation of transcriptional factors. Functions as a apurinic/apyrimidinic (AP) endodeoxyribonuclease in the DNA base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents. Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Does also incise at AP sites in the DNA strand of DNA/RNA hybrids, single-stranded DNA regions of R-loop structures, and single-stranded RNA molecules. Has a 3'-5' exoribonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules during short-patch BER. Possesses a DNA 3' phosphodiesterase activity capable of removing lesions (such as phosphoglycolate) blocking the 3' side of DNA strand breaks. May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation. Acts as a loading factor for POLB onto non-incised AP sites in DNA and stimulates the 5'-terminal deoxyribose 5'-phosphate (dRp) excision activity of POLB. Plays a role in the protection from granzymes-mediated cellular repair leading to cell death. Also involved in the DNA cleavage step of class switch recombination (CSR). On the other hand, APEX1 also exerts reversible nuclear redox activity to regulate DNA binding affinity and transcriptional activity of transcriptional factors by controlling the redox status of their DNA-binding domain, such as the FOS/JUN AP-1 complex after exposure to IR. Involved in calcium-dependent down-regulation of parathyroid hormone (PTH) expression by binding to negative calcium response elements (nCaREs). Together with HNRNPL or the dimer XRCC5/XRCC6, associates with nCaRE, acting as an activator of transcriptional repression. Stimulates the YBX1-mediated MDR1 promoter activity, when acetylated at Lys-6 and Lys-7, leading to drug resistance. Acts also as an endoribonuclease involved in the control of single-stranded RNA metabolism. Plays a role in regulating MYC mRNA turnover by preferentially cleaving in between UA and CA dinucleotides of the MYC coding region determinant (CRD). In association with NMD1, plays a role in the rRNA quality control process during cell cycle progression. Associates, together with YBX1, on the MDR1 promoter. Together with NPM1, associates with rRNA. Binds DNA and RNA. {ECO:0000269|PubMed:18025127, ECO:0000269|PubMed:19556307}.		aging [GO:0007568]; base-excision repair [GO:0006284]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to peptide hormone stimulus [GO:0071375]; DNA demethylation [GO:0080111]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]	3'-5' exonuclease activity [GO:0008408]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus {ECO:0000250}. Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00764}. Endoplasmic reticulum {ECO:0000250}. Cytoplasm. Note=Colocalized with SIRT1 in the nucleus. Colocalized with YBX1 in nuclear speckles after genotoxic stress. Together with OGG1 is recruited to nuclear speckles in UVA-irradiated cells. Colocalized with nucleolin and NPM1 in the nucleolus. Its nucleolar localization is cell cycle dependent and requires active rRNA transcription. Colocalized with calreticulin in the endoplasmic reticulum. Translocation from the nucleus to the cytoplasm is stimulated in presence of nitric oxide (NO) and function in a CRM1-dependent manner, possibly as a consequence of demasking a nuclear export signal (amino acid position 63-79). S-nitrosylation at Cys-92 and Cys-309 regulates its nuclear-cytosolic shuttling. Ubiquitinated form is localized predominantly in the cytoplasm. Detected in the cytoplasm of B-cells stimulated to switch (By similarity). {ECO:0000250}.; SUBCELLULAR LOCATION: [DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial]: Mitochondrion. Note=Translocation from the cytoplasm to the mitochondria is mediated by ROS signaling and cleavage mediated by granzyme A. Tom20-dependent translocated mitochondrial APEX1 level is significantly increased after genotoxic stress (By similarity). The cleaved APEX2 is only detected in mitochondria. {ECO:0000250}.	11792;		IPR004808;IPR020847;IPR020848;IPR036691;IPR005135;	PF03372;		35490	COMPBIAS 1..40;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..58;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..32;  /note=Necessary for interaction with YBX1, binding to RNA, association together with NPM1 to rRNA, endoribonuclease activity on abasic RNA and localization in the nucleoli;  /evidence=ECO:0000250; REGION 22..32;  /note=Necessary for interaction with NPM1 and for efficient rRNA binding;  /evidence=ECO:0000250; REGION 288..317;  /note=Mitochondrial targeting sequence (MTS);  /evidence=ECO:0000250	NA	ACT_SITE 170;  /evidence=ECO:0000250; ACT_SITE 209;  /note=Proton donor/acceptor;  /evidence=ECO:0000250	ACTIVITY REGULATION: NPM1 stimulates endodeoxyribonuclease activity on double-stranded DNA with AP sites, but inhibits endoribonuclease activity on single-stranded RNA containing AP sites. {ECO:0000250}.		3.1.-.-	METAL 69;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 95;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 209;  /note=Magnesium 2;  /evidence=ECO:0000250; METAL 211;  /note=Magnesium 2;  /evidence=ECO:0000250; METAL 307;  /note=Magnesium 1;  /evidence=ECO:0000250		5 out of 5	Active site (2); Chain (2); Compositional bias (1); Disulfide bond (1); Initiator methionine (1); Metal binding (5); Modified residue (13); Motif (2); Mutagenesis (3); Region (4); Site (5)	MISCELLANEOUS: The specific activity of the cleaved mitochondrial endodeoxyribonuclease appeared to be about 3-fold higher than of the full-length form. Extract of mitochondria, but not of nuclei or cytosol, cleaves recombinant APEX1 to generate a mitochondrial APEX1-sized product (By similarity). {ECO:0000250}.	3D-structure;Acetylation;Activator;Cleavage on pair of basic residues;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Disulfide bond;Endonuclease;Endoplasmic reticulum;Exonuclease;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;S-nitrosylation;Transcription;Transcription regulation;Ubl conjugation		DOMAIN: The N-terminus contains the redox activity while the C-terminus exerts the DNA AP-endodeoxyribonuclease activity; both function are independent in their actions. An unconventional mitochondrial targeting sequence (MTS) is harbored within the C-terminus, that appears to be masked by the N-terminal sequence containing the nuclear localization signal (NLS), that probably blocks the interaction between the MTS and Tom proteins (By similarity). {ECO:0000250}.	MOTIF 8..12;  /note=Nuclear localization signal (NLS);  /evidence=ECO:0000250; MOTIF 63..79;  /note=Nuclear export signal (NES);  /evidence=ECO:0000250			PS00726;PS00727;PS00728;PS51435;	11792	GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007568~aging,GO:0014912~negative regulation of smooth muscle cell migration,GO:0042493~response to drug,GO:0043488~regulation of mRNA stability,GO:0045454~cell redox homeostasis,GO:0045739~positive regulation of DNA repair,GO:0070301~cellular response to hydrogen peroxide,GO:0071320~cellular response to cAMP,GO:0071375~cellular response to peptide hormone stimulus,GO:0080111~DNA demethylation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0016607~nuclear speck,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004527~exonuclease activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008309~double-stranded DNA exodeoxyribonuclease activity,GO:0008311~double-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0016491~oxidoreductase activity,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0016890~site-specific endodeoxyribonuclease activity, specific for altered base,GO:0031490~chromatin DNA binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,	IPR004808:Exodeoxyribonuclease III xth,IPR005135:Endonuclease/exonuclease/phosphatase,IPR020847:AP endonuclease, family 1, binding site,IPR020848:AP endonuclease, family 1, conserved site,	PF03372:Endonuclease/Exonuclease/phosphatase family,	SSF56219:DNase I-like,	3.16281510005097	1.34056387949372e-08	FDR<0.01	7.87271248652956	17917000	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	129	Replication & Repair
Q99ME9	Q99ME9	Gtpbp4	14.124	20.969	13974300	5.49752611324904	13.5622643556568	30.1932367149758	6.36415706739642	6.10910868104344	12.0576354976789	12032330	0	Gtpbp4	0	GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1)		FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. {ECO:0000250}.		maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	69237;		IPR031167;IPR006073;IPR024926;IPR041623;IPR010674;IPR012973;IPR027417;IPR005225;	PF06858;PF17835;PF08155;		74113	COMPBIAS 494..540;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 575..589;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 602..622;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 494..634;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (3); Domain (1); Initiator methionine (1); Modified residue (7); Nucleotide binding (3); Region (1); Sequence conflict (8)		Acetylation;GTP-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation	DOMAIN 169..340;  /note=OBG-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01047					PS51710;	69237	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001649~osteoblast differentiation,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0022408~negative regulation of cell-cell adhesion,GO:0030336~negative regulation of cell migration,GO:0031397~negative regulation of protein ubiquitination,GO:0033342~negative regulation of collagen binding,GO:0042254~ribosome biogenesis,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR005225:Small GTP-binding protein domain,IPR006073:GTP binding domain,IPR010674:Nucleolar GTP-binding protein 1, Rossman-fold domain,IPR012973:NOG, C-terminal,IPR024926:Nucleolar GTP-binding protein 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF06858:Nucleolar GTP-binding protein 1 (NOG1),PF08155:NOGCT (NUC087) domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.52744145972256	1.49832495145917e-07	FDR<0.01	6.82439398815779	13003315	Present in Nucleus	RBP	Others	Others	Others	Others	180	Replication & Repair
Q6A068	Q6A068	Cdc5l	24.065	8.4352	12105250	7.27431439586819	9.37294966726029	7.21448668927206	6.14703712810425	5.89796520200531	10.4914180200596	6433990	0	Cdc5l	0	Cell division cycle 5-like protein (Cdc5-like protein)	DNA_BIND 31..54;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DNA_BIND 82..104;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625	FUNCTION: DNA-binding protein involved in cell cycle control. May act as a transcription activator. Plays role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR). {ECO:0000250|UniProtKB:Q99459}.		cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in DNA damage checkpoint [GO:0072422]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00625, ECO:0000269|PubMed:10570151}. Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00625, ECO:0000269|PubMed:10570151}. Cytoplasm {ECO:0000269|PubMed:10570151}. Note=May shuttle between cytoplasm and nucleus. {ECO:0000269|PubMed:10570151}.	71702;	cd00167;	IPR021786;IPR009057;IPR017930;IPR001005;	PF11831;	SM00717;	92190	COMPBIAS 108..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 246..261;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..437;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 108..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 200..206;  /note=Required for interaction with CTNNBL1;  /evidence=ECO:0000250|UniProtKB:Q99459; REGION 246..278;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 260..606;  /note=Interaction with PPP1R8;  /evidence=ECO:0000250|UniProtKB:Q99459; REGION 408..460;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 501..659;  /note=Interaction with DAPK3;  /evidence=ECO:0000250|UniProtKB:O08837; REGION 706..800;  /note=Interaction with PLRG1;  /evidence=ECO:0000250|UniProtKB:Q99459	NA							5 out of 5	Chain (1); Coiled coil (3); Compositional bias (3); Cross-link (3); DNA binding (2); Domain (2); Erroneous initiation (1); Modified residue (14); Motif (1); Region (7)		Activator;Cell cycle;Coiled coil;Cytoplasm;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 1..56;  /note=HTH myb-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DOMAIN 57..108;  /note=HTH myb-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625		MOTIF 165..271;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS51294;	71702	GO:0000278~mitotic cell cycle,GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0030154~cell differentiation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0071352~cellular response to interleukin-2,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:1904568~cellular response to wortmannin,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990646~cellular response to prolactin,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0032993~protein-DNA complex,GO:0048471~perinuclear region of cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008157~protein phosphatase 1 binding,GO:0019901~protein kinase binding,GO:0043522~leucine zipper domain binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0071987~WD40-repeat domain binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017930:Myb domain,IPR021786:Domain of unknown function DUF3351,	PF11831:pre-mRNA splicing factor component,	SSF46689:Homeodomain-like,	3.14734303128693	6.29825081722016e-08	FDR<0.01	7.20078004830956	9269620	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	234	Replication & Repair
Q8VI84	Q8VI84	Noc3l	17.666	8.9332	3876800	10.8456340899971	3.03886711034127	2.38441546054985	NA	6.7145638890754	8.34097923096171	9687341.66666667	1	Noc3l	0	Nucleolar complex protein 3 homolog (NOC3 protein homolog) (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)		FUNCTION: May be required for adipogenesis. {ECO:0000269|PubMed:15564382}.		DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444]	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:15564382}. Nucleus speckle {ECO:0000269|PubMed:15564382}.	57753;		IPR016024;IPR005612;IPR011501;IPR016903;	PF03914;PF07540;		93211	COMPBIAS 38..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 174..191;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 27..93;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 167..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (1); Region (2); Sequence conflict (4)		Coiled coil;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation							57753	GO:0045444~fat cell differentiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0003682~chromatin binding,GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR011501:Nucleolar complex-associated,IPR016024:Armadillo-type fold,IPR016903:Nucleolar complex-associated protein 3,	PF03914:CBF/Mak21 family,PF07540:Nucleolar complex-associated protein,	SSF48371:ARM repeat,	2.77225753666905	1.35562787854572e-05	FDR<0.01	4.86785950845809	6782070.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	292	Replication & Repair
Q810D6	Q810D6	Grwd1	5.7642	11.339	10095600	4.30718869793686	2.40396172892928	4.13890153553247	1.12418917855497	2.73897562311695	11.2277550103857	3280368.33333333	0	Grwd1	0	Glutamate-rich WD repeat-containing protein 1 (Protein A301)		FUNCTION: Histone binding-protein that regulates chromatin dynamics and minichromosome maintenance (MCM) loading at replication origins, possibly by promoting chromatin openness. {ECO:0000250|UniProtKB:Q9BQ67}.		DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9BQ67}. Nucleus {ECO:0000250|UniProtKB:Q9BQ67}. Chromosome {ECO:0000250|UniProtKB:Q9BQ67}. Note=Present in the nucleus throughout interphase and is detached from chromatin at the onset of mitosis and rebinds at telophase when the pre-replication complexes (pre-RC) is formed (By similarity). {ECO:0000250|UniProtKB:Q9BQ67}.	101612;		IPR020472;IPR022052;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12265;PF00400;	SM00320;	49224	COMPBIAS 121..138;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 111..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (2); Repeat (5); Sequence conflict (1)		Chromosome;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat				REPEAT 212..252;  /note=WD 1; REPEAT 259..299;  /note=WD 2; REPEAT 306..345;  /note=WD 3; REPEAT 351..391;  /note=WD 4; REPEAT 412..445;  /note=WD 5		PS00678;PS50082;PS50294;	101612		GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,	PF00400:WD domain, G-beta repeat,PF12265:Histone-binding protein RBBP4 or subunit C of CAF1 complex,	SSF50978:WD40 repeat-like,	2.07040864123333	0.000126514844501631	FDR<0.01	3.89785851395923	6687984.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	295	Replication & Repair
P62908	P62908	Rps3	6.6189	8.4445	6605550	9.90295107942167	7.89079144638207	6.51890482398957	4.29959583799123	6.48130144533022	12.656305371336	3199800	0	Rps3	0	40S ribosomal protein S3 (EC 4.2.99.18)		FUNCTION: Involved in translation as a component of the 40S small ribosomal subunit (By similarity). Has endonuclease activity and plays a role in repair of damaged DNA (PubMed:7775413). Cleaves phosphodiester bonds of DNAs containing altered bases with broad specificity and cleaves supercoiled DNA more efficiently than relaxed DNA (By similarity). Displays high binding affinity for 7,8-dihydro-8-oxoguanine (8-oxoG), a common DNA lesion caused by reactive oxygen species (ROS) (By similarity). Has also been shown to bind with similar affinity to intact and damaged DNA (By similarity). Stimulates the N-glycosylase activity of the base excision protein OGG1 (By similarity). Enhances the uracil excision activity of UNG1 (By similarity). Also stimulates the cleavage of the phosphodiester backbone by APEX1 (By similarity). When located in the mitochondrion, reduces cellular ROS levels and mitochondrial DNA damage (By similarity). Has also been shown to negatively regulate DNA repair in cells exposed to hydrogen peroxide (By similarity). Plays a role in regulating transcription as part of the NF-kappa-B p65-p50 complex where it binds to the RELA/p65 subunit, enhances binding of the complex to DNA and promotes transcription of target genes (By similarity). Represses its own translation by binding to its cognate mRNA (By similarity). Binds to and protects TP53/p53 from MDM2-mediated ubiquitination (By similarity). Involved in spindle formation and chromosome movement during mitosis by regulating microtubule polymerization (By similarity). Involved in induction of apoptosis through its role in activation of CASP8 (PubMed:14988002). Induces neuronal apoptosis by interacting with the E2F1 transcription factor and acting synergistically with it to up-regulate pro-apoptotic proteins BCL2L11/BIM and HRK/Dp5 (By similarity). Interacts with TRADD following exposure to UV radiation and induces apoptosis by caspase-dependent JNK activation (By similarity). {ECO:0000250|UniProtKB:P23396, ECO:0000269|PubMed:14988002, ECO:0000269|PubMed:7775413}.		apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; synapse [GO:0045202]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein-containing complex binding [GO:0044877]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14988002}. Nucleus {ECO:0000269|PubMed:14988002}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P23396}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:P23396}; Peripheral membrane protein {ECO:0000250|UniProtKB:P23396}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P23396}. Note=In normal cells, located mainly in the cytoplasm with small amounts in the nucleus but translocates to the nucleus in cells undergoing apoptosis. Nuclear translocation is also induced by DNA damaging agents such as hydrogen peroxide (By similarity). Accumulates in the mitochondrion in response to increased ROS levels (By similarity). Localizes to the spindle during mitosis (By similarity). Localized in cytoplasmic mRNP granules containing untranslated mRNAs (By similarity). {ECO:0000250|UniProtKB:P23396, ECO:0000269|PubMed:14988002}.	27050;		IPR015946;IPR004044;IPR009019;IPR001351;IPR036419;IPR018280;IPR005703;	PF07650;PF00189;		26674		REGION 200..243;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				4.2.99.18			5 out of 5	Chain (1); Cross-link (5); Domain (1); Initiator methionine (1); Modified residue (16); Region (1)		Acetylation;Apoptosis;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Isopeptide bond;Lyase;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Mitosis;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	DOMAIN 21..92;  /note=KH type-2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00118					PS50823;PS00548;	27050	GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0010628~positive regulation of gene expression,GO:0017148~negative regulation of translation,GO:0031116~positive regulation of microtubule polymerization,GO:0031397~negative regulation of protein ubiquitination,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0042769~DNA damage response, detection of DNA damage,GO:0042981~regulation of apoptotic process,GO:0043507~positive regulation of JUN kinase activity,GO:0045738~negative regulation of DNA repair,GO:0045739~positive regulation of DNA repair,GO:0051225~spindle assembly,GO:0051301~cell division,GO:0061481~response to TNF agonist,GO:0070301~cellular response to hydrogen peroxide,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902231~positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902546~positive regulation of DNA N-glycosylase activity,GO:1905053~positive regulation of base-excision repair,GO:1990090~cellular response to nerve growth factor stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001272~positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005844~polysome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032587~ruffle membrane,GO:0070062~extracellular exosome,GO:0071159~NF-kappaB complex,GO:0072686~mitotic spindle,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008134~transcription factor binding,GO:0008534~oxidized purine nucleobase lesion DNA N-glycosylase activity,GO:0015631~tubulin binding,GO:0016829~lyase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030544~Hsp70 protein binding,GO:0032183~SUMO binding,GO:0032357~oxidized purine DNA binding,GO:0032358~oxidized pyrimidine DNA binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0044822~poly(A) RNA binding,GO:0051018~protein kinase A binding,GO:0051879~Hsp90 protein binding,GO:0070181~small ribosomal subunit rRNA binding,GO:0097100~supercoiled DNA binding,	IPR001351:Ribosomal protein S3, C-terminal,IPR004044:K Homology domain, type 2,IPR005703:Ribosomal protein S3, eukaryotic/archaeal,IPR009019:K homology domain, prokaryotic type,IPR015946:K homology domain-like, alpha/beta,IPR018280:Ribosomal protein S3, conserved site,	PF07650:KH domain,	SSF54814:Prokaryotic type KH domain (KH-domain type II),SSF54821:Ribosomal protein S3 C-terminal domain,	2.90744132622407	2.89690226272958e-08	FDR<0.01	7.53806615701345	4902675	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	379	Replication & Repair
Q60520	Q60520;Q60520-1	Sin3a	10.977	8.8788	3876550	6.87899841783036	3.83832955897593	2.67924123888115	5.09917903217582	7.81494216942795	8.07623970279438	3291271.66666667	0	Sin3a	0	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)		FUNCTION: Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in the control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (PubMed:22476904). Required for cortical neuron differentiation and callosal axon elongation (PubMed:27399968). {ECO:0000269|PubMed:10734093, ECO:0000269|PubMed:21680841, ECO:0000269|PubMed:22476904, ECO:0000269|PubMed:27399968, ECO:0000269|PubMed:7889570, ECO:0000269|PubMed:8649810}.		activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulator inhibitor activity [GO:0140416]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21454521}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96ST3}. Note=Recruited to the nucleolus by SAP30L. {ECO:0000250|UniProtKB:Q96ST3, ECO:0000269|PubMed:21454521}.	20466;		IPR013194;IPR003822;IPR036600;IPR039774;IPR031693;IPR037969;	PF02671;PF08295;PF16879;	SM00761;	145088	COMPBIAS 216..243;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 247..263;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 264..282;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 283..297;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..430;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 85..110;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 119..196;  /note=Interaction with HCFC1;  /evidence=ECO:0000250|UniProtKB:Q96ST3; REGION 205..479;  /note=Interaction with REST;  /evidence=ECO:0000269|PubMed:10734093; REGION 205..297;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 398..443;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 459..526;  /note=Interaction with SAP30;  /evidence=ECO:0000269|PubMed:9702189; REGION 524..851;  /note=Interaction with NCOR1; REGION 525..660;  /note=Interactions with SUDS3 and SAP130;  /evidence=ECO:0000250; REGION 688..830;  /note=Interactions with HDAC1 and ARID4B;  /evidence=ECO:0000250; REGION 835..865;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 889..968;  /note=Interaction with OGT;  /evidence=ECO:0000250; REGION 1137..1157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (1); Chain (1); Coiled coil (1); Compositional bias (5); Cross-link (3); Domain (3); Erroneous initiation (1); Helix (21); Modified residue (11); Mutagenesis (7); Region (13); Sequence caution (3); Sequence conflict (13); Turn (5)		3D-structure;Acetylation;Alternative splicing;Biological rhythms;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 119..189;  /note=PAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 300..383;  /note=PAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 457..526;  /note=PAH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810					PS51477;	20466	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0001701~in utero embryonic development,GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0007568~aging,GO:0010243~response to organonitrogen compound,GO:0010817~regulation of hormone levels,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016575~histone deacetylation,GO:0031937~positive regulation of chromatin silencing,GO:0034613~cellular protein localization,GO:0042754~negative regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0051595~response to methylglyoxal,GO:0071333~cellular response to glucose stimulus,GO:1900181~negative regulation of protein localization to nucleus,GO:1901675~negative regulation of histone H3-K27 acetylation,GO:1903351~cellular response to dopamine,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0000776~kinetochore,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,GO:0045171~intercellular bridge,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0032403~protein complex binding,GO:0033558~protein deacetylase activity,	IPR003822:Paired amphipathic helix,IPR013194:Histone deacetylase interacting,	PF02671:Paired amphipathic helix repeat,PF08295:Sin3 family co-repressor,	SSF47762:PAH2 domain,	2.63518276730767	5.13146206660523e-07	FDR<0.01	6.28975887718991	3583910.83333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	458	Replication & Repair
P23475	P23475	Xrcc6	17.17	9.7591	5140250	2.13196887325445	5.10204081632653	13.8366172238211	NA	5.37952552584862	7.2950102130143	1015810.33333333	1	Xrcc6	0	X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70)		FUNCTION: Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together. The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. Required for osteocalcin gene expression. Probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. 5'-dRP lyase activity allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (By similarity). {ECO:0000250|UniProtKB:P12956, ECO:0000269|PubMed:12145306}.		activation of innate immune response [GO:0002218]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of smooth muscle cell proliferation [GO:0048660]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; V(D)J recombination [GO:0033151]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	14375;		IPR006165;IPR006164;IPR027388;IPR005160;IPR005161;IPR003034;IPR036361;IPR016194;IPR036465;	PF02735;PF03730;PF03731;PF02037;	SM00559;SM00513;	69484	COMPBIAS 9..23;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 537..557;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..557;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 548..607;  /note=Interaction with DEAF1;  /evidence=ECO:0000250	NA	ACT_SITE 29;  /note=Schiff-base intermediate with DNA; for 5'-deoxyribose-5-phosphate lyase activity;  /evidence=ECO:0000250			3.6.4.-; 4.2.99.-			5 out of 5	Active site (1); Chain (1); Compositional bias (2); Cross-link (2); Domain (2); Initiator methionine (1); Modified residue (12); Region (3); Sequence conflict (9)	MISCELLANEOUS: In osteoblasts from XRCC6 knockout mice, osteocalcin gene expression is nearly abolished.	ADP-ribosylation;ATP-binding;Acetylation;Activator;Chromosome;DNA damage;DNA recombination;DNA repair;DNA-binding;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Lyase;Multifunctional enzyme;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 259..466;  /note=Ku; DOMAIN 571..605;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186					PS50800;	14375	GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007420~brain development,GO:0008152~metabolic process,GO:0010212~response to ionizing radiation,GO:0032508~DNA duplex unwinding,GO:0033151~V(D)J recombination,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048660~regulation of smooth muscle cell proliferation,GO:0050769~positive regulation of neurogenesis,GO:0051290~protein heterotetramerization,GO:0071475~cellular hyperosmotic salinity response,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0097680~double-strand break repair via classical nonhomologous end joining,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043234~protein complex,GO:0043564~Ku70:Ku80 complex,GO:0070419~nonhomologous end joining complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003824~catalytic activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0042162~telomeric DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0044877~macromolecular complex binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR002035:von Willebrand factor, type A,IPR003034:SAP domain,IPR005160:Ku70/Ku80 C-terminal arm,IPR005161:Ku70/Ku80, N-terminal alpha/beta,IPR006164:Ku70/Ku80 beta-barrel domain,IPR006165:Ku70,IPR016194:SPOC like C-terminal domain,IPR027388:Ku70, bridge and pillars domain,	PF02037:SAP domain,PF02735:Ku70/Ku80 beta-barrel domain,PF03730:Ku70/Ku80 C-terminal arm,PF03731:Ku70/Ku80 N-terminal alpha/beta domain,	SSF100939:SPOC domain-like,SSF53300:vWA-like,	2.84523362248899	1.04303693121624e-05	FDR<0.01	4.98170031406679	3078030.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	497	Replication & Repair
Q3UHX0	Q3UHX0;Q3UHX0-2	Nol8	3.5799	4.772	3293550	3.14119679597927	2.51673629637087	3.70466417219279	2.16043381511007	5.82580833090591	4.9176297024834	2182566.66666667	0	Nol8	0	Nucleolar protein 8		FUNCTION: Plays an essential role in the survival of diffuse-type gastric cancer cells. Acts as a nucleolar anchoring protein for DDX47. May be involved in regulation of gene expression at the post-transcriptional level or in ribosome biogenesis in cancer cells (By similarity). {ECO:0000250}.		cellular response to leukemia inhibitory factor [GO:1990830]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=Localizes in the nucleolar-organizing region during ribosome biogenesis. {ECO:0000250}.	70930;	cd12226;	IPR034138;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	128635	COMPBIAS 483..511;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 593..615;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 622..648;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 718..734;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 768..785;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 795..809;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 816..836;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 857..888;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 986..1006;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1061..1082;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 379..401;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 427..452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 472..511;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 592..659;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 686..741;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 766..888;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 932..963;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 986..1017;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1055..1086;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (10); Cross-link (3); Domain (1); Erroneous initiation (2); Modified residue (20); Region (9); Sequence conflict (2)		Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing	DOMAIN 8..89;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	70930	GO:0006260~DNA replication,GO:0006364~rRNA processing,GO:0030307~positive regulation of cell growth,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.86480835814841	3.17109571904521e-06	FDR<0.01	5.49879064866173	2738058.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	529	Replication & Repair
Q9DBR1	Q9DBR1-2;Q9DBR1	Xrn2	9.1051	10.02	3414350	6.27667587245795	12.2899947153023	6.35606686582343	2.08094891270419	6.00600600600601	9.12325517744731	2050095	0	Xrn2	0	5'-3' exoribonuclease 2 (EC 3.1.13.-) (Protein Dhm1)		FUNCTION: Possesses 5'->3' exoribonuclease activity. May promote the termination of transcription by RNA polymerase II. During transcription termination, cleavage at the polyadenylation site liberates a 5' fragment which is subsequently processed to form the mature mRNA and a 3' fragment which remains attached to the elongating polymerase. The processive degradation of this 3' fragment by this protein may promote termination of transcription. Binds to RNA polymerase II (RNAp II) transcription termination R-loops formed by G-rich pause sites (By similarity). {ECO:0000250|UniProtKB:Q9H0D6}.		DNA catabolic process, exonucleolytic [GO:0000738]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]	aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H0D6}.	24128;		IPR027073;IPR004859;IPR041412;IPR017151;	PF17846;PF03159;		108687	COMPBIAS 440..455;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..485;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 493..508;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 919..933;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 408..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 907..951;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.13.-			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Erroneous initiation (1); Modified residue (23); Region (2); Sequence conflict (16); Zinc finger (1)	MISCELLANEOUS: [Isoform 2]: May result from the retention of an intron in the cDNA. {ECO:0000305}.	Acetylation;Alternative splicing;DNA-binding;Exonuclease;Hydrolase;Metal-binding;Methylation;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Transcription termination;Zinc;Zinc-finger;mRNA processing					ZN_FING 262..278;  /note=CCHC-type		24128	GO:0000738~DNA catabolic process, exonucleolytic,GO:0006139~nucleobase-containing compound metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006353~DNA-templated transcription, termination,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007017~microtubule-based process,GO:0007283~spermatogenesis,GO:0016049~cell growth,GO:0016070~RNA metabolic process,GO:0021766~hippocampus development,GO:0030182~neuron differentiation,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016235~aggresome,	GO:0000175~3'-5'-exoribonuclease activity,GO:0001147~transcription termination site sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004534~5'-3' exoribonuclease activity,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR004859:Putative 5-3 exonuclease,IPR017151:5'-3' exoribonuclease 2,IPR027073:5'-3' exoribonuclease,	PF03159:XRN 5'-3' exonuclease N-terminus,		2.78527862532764	7.29240743576728e-07	FDR<0.01	6.13712907477265	2732222.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	532	Replication & Repair
Q9EPU0	Q9EPU0-2;Q9EPU0	Upf1	11.51	5.8111	3670200	6.87663320038509	6.72449734382355	9.01875901875902	3.71085052694077	4.64964895150416	5.98874116660678	1578836.66666667	0	Upf1	0	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (mUpf1)		FUNCTION: RNA-dependent helicase and ATPase required for nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:27149095). Is recruited to mRNAs upon translation termination and undergoes a cycle of phosphorylation and dephosphorylation; its phosphorylation appears to be a key step in NMD. Recruited by release factors to stalled ribosomes together with the SMG1C protein kinase complex to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) (located 50-55 or more nucleotides downstream from the termination codon) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD. Phosphorylated UPF1 is recognized by EST1B/SMG5, SMG6 and SMG7 which are thought to provide a link to the mRNA degradation machinery involving exonucleolytic and endonucleolytic pathways, and to serve as adapters to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation. UPF1 can also activate NMD without UPF2 or UPF3, and in the absence of the NMD-enhancing downstream EJC indicative for alternative NMD pathways. Plays a role in replication-dependent histone mRNA degradation at the end of phase S; the function is independent of UPF2. For the recognition of premature termination codons (PTC) and initiation of NMD a competitive interaction between UPF1 and PABPC1 with the ribosome-bound release factors is proposed. The ATPase activity of UPF1 is required for disassembly of mRNPs undergoing NMD (By similarity). Essential for embryonic viability (By similarity). Together with UPF2 and dependent on TDRD6, mediates the degradation of mRNA hardoring long 3'UTR by inducing the NMD machinery (PubMed:27149095). {ECO:0000250|UniProtKB:Q92900, ECO:0000269|PubMed:27149095}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27149095}. Cytoplasm, P-body {ECO:0000250|UniProtKB:Q92900}. Nucleus {ECO:0000250|UniProtKB:Q92900}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:27149095}. Note=Hyperphosphorylated form is targeted to the P-body, while unphosphorylated protein is distributed throughout the cytoplasm (By similarity). Localized in the chromatoid bodies of round spermatids (PubMed:27149095). {ECO:0000250|UniProtKB:Q92900, ECO:0000269|PubMed:27149095}.	19704;	cd21407;cd18808;cd21400;	IPR041679;IPR041677;IPR006935;IPR027417;IPR040812;IPR018999;	PF13086;PF13087;PF18141;PF04851;PF09416;		123967	COMPBIAS 1032..1053;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..410;  /note=Sufficient for interaction with RENT2;  /evidence=ECO:0000250; REGION 39..69;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1004..1053;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1066..1091;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1105..1124;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 481;  /note=ATP;  /evidence=ECO:0000250; BINDING 671;  /note=ATP;  /evidence=ECO:0000250; BINDING 708;  /note=ATP;  /evidence=ECO:0000250; BINDING 839;  /note=ATP;  /evidence=ECO:0000250	3.6.4.-			5 out of 5	Alternative sequence (1); Binding site (4); Chain (1); Compositional bias (1); Modified residue (9); Motif (2); Nucleotide binding (1); Region (5); Sequence conflict (10); Zinc finger (1)		ATP-binding;Alternative splicing;Cytoplasm;Helicase;Hydrolase;Metal-binding;Methylation;Nonsense-mediated mRNA decay;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Zinc;Zinc-finger		DOMAIN: The [ST]-Q motif constitutes a recognition sequence for kinases from the PI3/PI4-kinase family. {ECO:0000250|UniProtKB:Q92900}.	MOTIF 1084..1085;  /note=[ST]-Q motif 1; MOTIF 1102..1103;  /note=[ST]-Q motif 2		ZN_FING 116..267;  /note=UPF1-type		19704	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000294~nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,GO:0000723~telomere maintenance,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006449~regulation of translational termination,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0032201~telomere maintenance via semi-conservative replication,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071044~histone mRNA catabolic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035145~exon-exon junction complex,GO:0044530~supraspliceosomal complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042162~telomeric DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR006935:Helicase/UvrB domain,IPR018999:RNA helicase UPF1, UPF2-interacting domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF04851:Type III restriction enzyme, res subunit,PF09416:RNA helicase (UPF2 interacting domain),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.68235117928751	9.88638815844514e-08	FDR<0.01	7.00496234231126	2624518.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	540	Replication & Repair
P42669	P42669	Pura	10.037	1.4434	3585520	NA	11.8033096480253	NA	NA	9.67024465718983	15.045739046702	1266670	3	Pura	0	Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha)		FUNCTION: This is a probable transcription activator that specifically binds the purine-rich single strand of the PUR element located upstream of the c-Myc gene. May play a role in the initiation of DNA replication and in recombination.		cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]	SUBCELLULAR LOCATION: Nucleus.	19290;		IPR006628;IPR030500;	PF04845;	SM00712;	34884	COMPBIAS 294..309;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..321;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (2); Region (2)		Acetylation;Activator;DNA-binding;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							19290	GO:0006268~DNA unwinding involved in DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007093~mitotic cell cycle checkpoint,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0030154~cell differentiation,GO:0042127~regulation of cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005662~DNA replication factor A complex,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0032422~purine-rich negative regulatory element binding,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,	IPR006628:PUR-alpha/beta/gamma, DNA/RNA-binding,	PF04845:PurA ssDNA and RNA-binding protein,		2.92053647543534	0.00037036217581352	FDR<0.01	3.43137337316251	2426095	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	567	Replication & Repair
Q9CU62	Q9CU62	Smc1a	7.3946	8.4052	2816550	5.14218131331311	6.55222120298781	7.86472670074715	5.55092978073827	13.594714375051	12.2244905443566	1957141.66666667	0	Smc1a	0	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Chromosome segregation protein SmcB) (Sb1.8)		FUNCTION: Involved in chromosome cohesion during cell cycle and in DNA repair. Involved in DNA repair via its interaction with BRCA1 and its related phosphorylation by ATM, and works as a downstream effector in the ATM/NBS1 branch of S-phase checkpoint (By similarity). Central component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. Involved in DNA repair via its interaction with BRCA1 and its related phosphorylation by ATM, or via its phosphorylation by ATR. Works as a downstream effector both in the ATM/NBS1 branch and in the ATR/MSH2 branch of S-phase checkpoint. {ECO:0000250}.		cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]	cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere. Note=Associates with chromatin. The phosphorylated form on Ser-957 and Ser-966 associates with chromatin during G1/S/G2 phases but not during M phase, suggesting that phosphorylation does not regulate cohesin function (By similarity). Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of the cohesin complex is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. In germ cells, cohesin complex dissociates from chromatin at prophase I, and may be replaced by a meiosis-specific cohesin complex. {ECO:0000250}.	24061;	cd03275;	IPR027417;IPR003395;IPR024704;IPR028468;IPR029683;IPR010935;IPR036277;	PF06470;PF02463;	SM00968;	143235	COMPBIAS 949..969;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 284..308;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 348..369;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 947..969;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (10); Chain (1); Coiled coil (4); Compositional bias (1); Domain (1); Helix (14); Modified residue (9); Nucleotide binding (1); Region (3); Sequence conflict (6); Turn (3)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;DNA damage;DNA repair;Meiosis;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 515..629;  /note=SMC hinge	DOMAIN: The flexible SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC3, forming a V-shaped heterodimer. The two heads of the heterodimer are then connected by different ends of the cleavable RAD21 protein, forming a ring structure (By similarity). {ECO:0000250}.					24061	GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0007126~meiotic nuclear division,GO:0009314~response to radiation,GO:0019827~stem cell population maintenance,GO:0032876~negative regulation of DNA endoreduplication,GO:0042770~signal transduction in response to DNA damage,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0008278~cohesin complex,GO:0008280~cohesin core heterodimer,GO:0030893~meiotic cohesin complex,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0036033~mediator complex binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR003395:RecF/RecN/SMC,IPR010935:SMCs flexible hinge,IPR024704:Structural maintenance of chromosomes protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,PF06470:SMC proteins Flexible Hinge Domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF75553:Smc hinge domain,	2.98211515621029	2.94078084925694e-08	FDR<0.01	7.53153733846629	2386845.83333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	571	Replication & Repair
Q8BK35	Q8BK35	Gltscr2	3.4436	7.0537	1901550	0.94948727687049	4.15144470275656	1.65705574335521	1.25406001931252	2.49233606659522	6.37267397399949	1156971.66666667	0	Gltscr2	0	Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein)		FUNCTION: Nucleolar protein which is involved in the integration of the 5S RNP into the ribosomal large subunit during ribosome biogenesis. In ribosome biogenesis, may also play a role in rRNA transcription (By similarity). Also functions as a nucleolar sensor that regulates the activation of p53/TP53 in response to ribosome biogenesis perturbation, DNA damage and other stress conditions. DNA damage or perturbation of ribosome biogenesis disrupt the interaction between NOP53 and RPL11 allowing RPL11 transport to the nucleoplasm where it can inhibit MDM2 and allow p53/TP53 activation (PubMed:21804542). It may also positively regulate the function of p53/TP53 in cell cycle arrest and apoptosis through direct interaction, preventing its MDM2-dependent ubiquitin-mediated proteasomal degradation. Originally identified as a tumor suppressor, it may also play a role in cell proliferation and apoptosis by positively regulating the stability of PTEN, thereby antagonizing the PI3K-AKT/PKB signaling pathway. May also inhibit cell proliferation and increase apoptosis through its interaction with NF2. May negatively regulate NPM1 by regulating its nucleoplasmic localization, oligomerization and ubiquitin-mediated proteasomal degradation. Thereby, may prevent NPM1 interaction with MYC and negatively regulate transcription mediated by the MYC-NPM1 complex. May also regulate cellular aerobic respiration. In the cellular response to viral infection, may play a role in the attenuation of interferon-beta through the inhibition of DDX58/RIG-1 (By similarity). {ECO:0000250|UniProtKB:Q9NZM5, ECO:0000269|PubMed:21804542}.		cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]	5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21804542}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9NZM5}. Note=In the nucleolus may be more specifically localized to the fibrillar center. Mainly nucleolar it relocalizes to the nucleoplasm under specific conditions including ribosomal stress enabling it to interact and regulate nucleoplasmic proteins like p53/TP53. Also detected in the cytosol. {ECO:0000250|UniProtKB:Q9NZM5}.	68077;		IPR011687;	PF07767;		55793	COMPBIAS 336..356;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..51;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 148..437;  /note=Mediates interaction with CDKN2A/isoform tumor suppressor ARF;  /evidence=ECO:0000250|UniProtKB:Q9NZM5; REGION 304..356;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 348..392;  /note=Mediates interaction with human herpesvirus 8 protein ORF16;  /evidence=ECO:0000250|UniProtKB:Q9NZM5; REGION 353..401;  /note=Nucleolar localization signal;  /evidence=ECO:0000250|UniProtKB:Q9NZM5; REGION 402..484;  /note=Nucleolar localization signal;  /evidence=ECO:0000250|UniProtKB:Q9NZM5	NA							5 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (3); Region (6); Sequence conflict (2)		Acetylation;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis							68077		GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0044822~poly(A) RNA binding,	IPR011687:P60-like,	PF07767:Nop53 (60S ribosomal biogenesis),		1.45321973093299	0.00141992876614193	FDR<0.01	2.84773344241094	1529260.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	696	Replication & Repair
Q80TP3	Q80TP3	Ubr5	6.175	4.4435	955545	1.74803782753859	1.52994094427955	2.124675986912	1.2805900959162	1.50335247602153	1.40142384662817	1748068.33333333	0	Ubr5	0	E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog)		FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Ubiquitinates acetylated PCK1. Also acts as a regulator of DNA damage response by acting as a suppressor of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites, thereby acting as a guard against excessive spreading of ubiquitinated chromatin at damaged chromosomes (By similarity). Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. Involved in maturation and/or transcriptional regulation of mRNA by activating CDK9 by polyubiquitination. May play a role in control of cell cycle progression. May have tumor suppressor function. Plays an essential role in extraembryonic development. Regulates DNA topoisomerase II binding protein (TopBP1) for the DNA damage response. {ECO:0000250, ECO:0000269|PubMed:15282321, ECO:0000269|PubMed:16055722}.	PATHWAY: Protein modification; protein ubiquitination.	cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 production [GO:0032700]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of protein stability [GO:0031647]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	70790;	cd14423;	IPR024725;IPR000569;IPR035983;IPR036053;IPR002004;IPR009091;IPR003126;	PF11547;PF00632;PF00658;	SM00119;SM00517;SM00396;	308352	COMPBIAS 87..151;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 322..338;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 577..596;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 605..626;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1011..1025;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1046..1066;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1516..1545;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1557..1571;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1572..1602;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1616..1645;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1654..1679;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1687..1734;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1870..1884;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1990..2008;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2323..2364;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2467..2484;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 77..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 322..347;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 577..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 993..1029;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1046..1069;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1293..1312;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1509..1734;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1853..1884;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1978..2015;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2111..2137;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2317..2387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2467..2494;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 2761;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00104			2.3.2.26			5 out of 5	Active site (1); Chain (1); Compositional bias (16); Domain (2); Initiator methionine (1); Modified residue (34); Region (12); Sequence conflict (1); Zinc finger (1)	MISCELLANEOUS: A cysteine residue is required for ubiquitin-thioester formation.	Acetylation;DNA damage;DNA repair;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 2371..2448;  /note=PABC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00641; DOMAIN 2455..2792;  /note=HECT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00104				ZN_FING 1171..1239;  /note=UBR-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00508	PS50237;PS51309;PS51157;	70790	GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0010628~positive regulation of gene expression,GO:0031647~regulation of protein stability,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035413~positive regulation of catenin import into nucleus,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0050847~progesterone receptor signaling pathway,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1901315~negative regulation of histone H2A K63-linked ubiquitination,GO:1905077~negative regulation of interleukin-17 secretion,GO:2000780~negative regulation of double-strand break repair,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016874~ligase activity,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0043130~ubiquitin binding,GO:0046872~metal ion binding,	IPR000569:HECT,IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein,IPR003126:Zinc finger, N-recognin,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,IPR024725:E3 ubiquitin ligase EDD, ubiquitin-associated domain,	PF00632:HECT-domain (ubiquitin-transferase),PF00658:Poly-adenylate binding protein, unique domain,PF11547:E3 ubiquitin ligase EDD,	SSF50985:RCC1/BLIP-II,SSF56204:Hect, E3 ligase catalytic domain,SSF63570:PABC (PABP) domain,	1.08955953174011	0.00312533238596798	FDR<0.01	2.505103787691	1351806.66666667	Present in Nucleus	RBP	DBD	DBD	ChD	Others	729	Replication & Repair
P27641	P27641	Xrcc5	31.191	10.788	2077150	NA	NA	NA	NA	8.67678958785249	4.63306152705708	583151.666666667	4	Xrcc5	0	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku autoantigen protein p86 homolog) (Ku80) (Nuclear factor IV)		FUNCTION: Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together. The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. In association with NAA15, the XRCC5/6 dimer binds to the osteocalcin promoter and activates osteocalcin expression. The XRCC5/6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription. As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome. Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:P13010}.		activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]	chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded telomeric DNA binding [GO:0003691]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13010}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P13010}. Chromosome {ECO:0000250|UniProtKB:P13010}.	22596;	cd00873;	IPR006164;IPR024193;IPR005160;IPR036494;IPR005161;IPR014893;IPR016194;IPR036465;	PF02735;PF03730;PF03731;PF08785;	SM00559;	83057		REGION 138..165;  /note=Leucine-zipper; REGION 708..732;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.-			5 out of 5	Chain (1); Cross-link (7); Domain (1); Modified residue (10); Motif (1); Region (2); Sequence conflict (23)		ADP-ribosylation;ATP-binding;Acetylation;Activator;Chromosome;DNA damage;DNA recombination;DNA repair;DNA-binding;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 251..460;  /note=Ku	DOMAIN: The EEXXXDDL motif is required for the interaction with catalytic subunit PRKDC and its recruitment to sites of DNA damage. {ECO:0000250|UniProtKB:P13010}.	MOTIF 720..728;  /note=EEXXXDL motif				22596	GO:0000237~leptotene,GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0032508~DNA duplex unwinding,GO:0042493~response to drug,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048660~regulation of smooth muscle cell proliferation,GO:0050769~positive regulation of neurogenesis,GO:0060218~hematopoietic stem cell differentiation,GO:0071398~cellular response to fatty acid,GO:0071475~cellular hyperosmotic salinity response,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:1904430~negative regulation of t-circle formation,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043234~protein complex,GO:0043564~Ku70:Ku80 complex,GO:0070419~nonhomologous end joining complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0031625~ubiquitin protein ligase binding,GO:0042162~telomeric DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0044877~macromolecular complex binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR002035:von Willebrand factor, type A,IPR005160:Ku70/Ku80 C-terminal arm,IPR005161:Ku70/Ku80, N-terminal alpha/beta,IPR006164:Ku70/Ku80 beta-barrel domain,IPR014893:Ku, C-terminal,IPR016194:SPOC like C-terminal domain,IPR024193:Ku80,	PF02735:Ku70/Ku80 beta-barrel domain,PF03730:Ku70/Ku80 C-terminal arm,PF03731:Ku70/Ku80 N-terminal alpha/beta domain,PF08785:Ku C terminal domain like,	SSF100939:SPOC domain-like,SSF101420:C-terminal domain of Ku80,SSF53300:vWA-like,	3.43088515230094	0.000180482478313832	FDR<0.01	3.74356495409618	1330150.83333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	736	Replication & Repair
Q7TMY8	Q7TMY8-3;Q7TMY8;Q7TMY8-2;Q7TMY8-4	Huwe1	9.3562	6.8725	174945	1.8288556849979	1.79417252763026	2.0633872565203	1.47531793101413	2.71179086668836	2.616773518252	2440303.33333333	0	Huwe1	0	E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)		FUNCTION: E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins. Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1. Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair. Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4. Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (By similarity). Binds to an upstream initiator-like sequence in the preprodynorphin gene (By similarity). Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN. May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation. Mediates polyubiquitination of PA2G4 (By similarity). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (By similarity). {ECO:0000250|UniProtKB:Q7Z6Z7, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:18488021}.	PATHWAY: Protein modification; protein ubiquitination.	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17823942}. Nucleus {ECO:0000269|PubMed:17823942}. Note=Mainly expressed in the cytoplasm of most tissues, except in the nucleus of spermatogonia, primary spermatocytes and neuronal cells.	59026;	cd00078;cd14288;	IPR016024;IPR010309;IPR010314;IPR000569;IPR035983;IPR025527;IPR015940;IPR009060;IPR041918;IPR004170;IPR037197;	PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;	SM00119;SM00165;	482635	COMPBIAS 737..756;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 987..1001;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1291..1310;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1699..1721;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2019..2035;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2036..2060;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2262..2293;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2384..2402;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2406..2471;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2704..2718;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2719..2769;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2815..2867;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2877..2891;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2905..2934;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2991..3009;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3041..3059;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3244..3260;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3471..3505;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3539..3557;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3784..3801;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3815..3832;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3897..3914;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3932..3951;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 706..758;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 978..1001;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1018..1038;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1291..1320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1396..1415;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1690..1735;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2019..2065;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2262..2343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2355..2479;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2704..2970;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2991..3012;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3036..3059;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3243..3266;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3352..3383;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3405..3429;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3471..3514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3539..3566;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3738..3759;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3782..3850;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3897..3951;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 4344;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00104			2.3.2.26			5 out of 5	Active site (1); Alternative sequence (5); Chain (1); Compositional bias (23); Domain (4); Modified residue (52); Region (20); Sequence conflict (7)		Acetylation;Alternative splicing;Biological rhythms;Cytoplasm;DNA damage;DNA repair;DNA-binding;Differentiation;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway	DOMAIN 1316..1355;  /note=UBA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00212; DOMAIN 1370..1389;  /note=UIM;  /evidence=ECO:0000305; DOMAIN 1603..1680;  /note=WWE;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00248; DOMAIN 4041..4377;  /note=HECT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00104	DOMAIN: The HECT domain mediates inhibition of the transcriptional activity of p53. {ECO:0000250|UniProtKB:Q7Z6Z7}.				PS50237;PS50030;PS50918;	59026	GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0016574~histone ubiquitination,GO:0030154~cell differentiation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000569:HECT,IPR004170:WWE domain,IPR009060:UBA-like,IPR010309:E3 ubiquitin ligase, domain of unknown function DUF908,IPR010314:E3 ubiquitin ligase, domain of unknown function DUF913,IPR011989:Armadillo-like helical,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR016024:Armadillo-type fold,IPR025527:Domain of unknown function DUF4414,	PF00627:UBA/TS-N domain,PF00632:HECT-domain (ubiquitin-transferase),PF02825:WWE domain,PF06012:Domain of Unknown Function (DUF908),PF06025:Domain of Unknown Function (DUF913),PF14377:Domain of unknown function (DUF4414),	SSF46934:UBA-like,SSF48371:ARM repeat,SSF56204:Hect, E3 ligase catalytic domain,	1.51926163164356	0.000593983441082455	FDR<0.01	3.22622566199988	1307624.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	742	Replication & Repair
Q01853	Q01853	Vcp	9.1705	5.706	1644850	0.690512360171247	3.53681827827686	7.11035267349261	7.74893452150329	2.6581605528974	4.96007142502852	853939.666666667	0	Vcp	0	Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)		FUNCTION: Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A. Component of the VCP/p97-AMFR/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation. Plays a role in the regulation of stress granules (SGs) clearance process upon arsenite-induced response (By similarity). Also involved in DNA damage response: recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168-dependent manner and promotes the recruitment of TP53BP1 at DNA damage sites. Recruited to stalled replication forks by SPRTN: may act by mediating extraction of DNA polymerase eta (POLH) to prevent excessive translesion DNA synthesis and limit the incidence of mutations induced by DNA damage. Together with SPRTN metalloprotease, involved in the repair of covalent DNA-protein cross-links (DPCs) during DNA synthesis. Involved in interstrand cross-link repair in response to replication stress by mediating unloading of the ubiquitinated CMG helicase complex. Required for cytoplasmic retrotranslocation of stressed/damaged mitochondrial outer-membrane proteins and their subsequent proteasomal degradation. Essential for the maturation of ubiquitin-containing autophagosomes and the clearance of ubiquitinated protein by autophagy. Acts as a negative regulator of type I interferon production by interacting with DDX58/RIG-I: interaction takes place when DDX58/RIG-I is ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit RNF125 and promote ubiquitination and degradation of DDX58/RIG-I. May play a role in the ubiquitin-dependent sorting of membrane proteins to lysosomes where they undergo degradation. May more particularly play a role in caveolins sorting in cells. By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway. {ECO:0000250|UniProtKB:P23787, ECO:0000250|UniProtKB:P46462, ECO:0000250|UniProtKB:P55072}.		activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; ER-associated misfolded protein catabolic process [GO:0071712]; flavin adenine dinucleotide catabolic process [GO:0072389]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-DNA covalent cross-linking repair [GO:0106300]; protein ubiquitination [GO:0016567]; regulation of aerobic respiration [GO:1903715]; regulation of protein localization to chromatin [GO:1905634]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral genome replication [GO:0019079]	ATPase complex [GO:1904949]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; synapse [GO:0045202]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P55072}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P55072}. Nucleus {ECO:0000250|UniProtKB:P55072}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:P55072}. Note=Recruited to the cytoplasmic surface of the endoplasmic reticulum via interaction with AMFR/gp78. Following DNA double-strand breaks, recruited to the sites of damage. Recruited to stalled replication forks via interaction with SPRTN. Recruited to damaged lysosomes decorated with K48-linked ubiquitin chains. Colocalizes with TIA1, ZFAND1 and G3BP1 in cytoplasmic stress granules (SGs) in response to arsenite-induced stress treatment (By similarity). {ECO:0000250|UniProtKB:P55072}.	269523;		IPR003593;IPR005938;IPR041569;IPR009010;IPR003959;IPR003960;IPR004201;IPR029067;IPR003338;IPR027417;IPR015415;	PF00004;PF17862;PF02933;PF02359;PF09336;	SM00382;SM01072;SM01073;	89322	COMPBIAS 768..794;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 708..727;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 768..806;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 797..806;  /note=Interaction with UBXN6;  /evidence=ECO:0000250	NA			BINDING 348;  /note=ATP 1;  /evidence=ECO:0000250|UniProtKB:P55072; BINDING 384;  /note=ATP 1;  /evidence=ECO:0000305|PubMed:11163219, ECO:0000305|PubMed:14988733	3.6.4.6			5 out of 5	Beta strand (28); Binding site (2); Chain (1); Compositional bias (1); Cross-link (2); Helix (38); Initiator methionine (1); Modified residue (18); Motif (1); Mutagenesis (1); Nucleotide binding (2); Region (3); Sequence conflict (7); Turn (5)		3D-structure;ATP-binding;Acetylation;Autophagy;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Endoplasmic reticulum;Hydrolase;Isopeptide bond;Lipid-binding;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transport;Ubl conjugation;Ubl conjugation pathway		DOMAIN: The N-terminal domain shows evolutionary conservation with that of PEX1, and is able to bind phospholipids with a preference for phosphatidylinositol mono- and bisphosphates.; DOMAIN: The PIM (PUB-interaction motif) motif mediates interaction with the PUB domain of RNF31. {ECO:0000250|UniProtKB:P55072}.	MOTIF 802..806;  /note=PIM motif;  /evidence=ECO:0000250|UniProtKB:P55072			PS00674;	269523	GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006734~NADH metabolic process,GO:0006810~transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006914~autophagy,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0010918~positive regulation of mitochondrial membrane potential,GO:0016567~protein ubiquitination,GO:0018279~protein N-linked glycosylation via asparagine,GO:0019079~viral genome replication,GO:0019985~translesion synthesis,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030970~retrograde protein transport, ER to cytosol,GO:0031334~positive regulation of protein complex assembly,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034214~protein hexamerization,GO:0036503~ERAD pathway,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045732~positive regulation of protein catabolic process,GO:0046034~ATP metabolic process,GO:0051260~protein homooligomerization,GO:0070842~aggresome assembly,GO:0071712~ER-associated misfolded protein catabolic process,GO:0072389~flavin adenine dinucleotide catabolic process,GO:0097352~autophagosome maturation,GO:1903006~positive regulation of protein K63-linked deubiquitination,GO:1903007~positive regulation of Lys63-specific deubiquitinase activity,GO:1903715~regulation of aerobic respiration,GO:1903862~positive regulation of oxidative phosphorylation,GO:2001171~positive regulation of ATP biosynthetic process,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0034098~VCP-NPL4-UFD1 AAA ATPase complex,GO:0035861~site of double-strand break,GO:0036513~Derlin-1 retrotranslocation complex,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:1990730~VCP-NSFL1C complex,	GO:0000166~nucleotide binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008289~lipid binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0031593~polyubiquitin binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0035800~deubiquitinase activator activity,GO:0036435~K48-linked polyubiquitin binding,GO:0042288~MHC class I protein binding,GO:0042802~identical protein binding,GO:0043531~ADP binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0044822~poly(A) RNA binding,GO:1904288~BAT3 complex binding,GO:1990381~ubiquitin-specific protease binding,	IPR003338:CDC48, N-terminal subdomain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR004201:CDC48, domain 2,IPR005938:ATPase, AAA-type, CDC48,IPR009010:Aspartate decarboxylase-like domain,IPR015415:Vps4 oligomerisation, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),PF02359:Cell division protein 48 (CDC48), N-terminal domain,PF02933:Cell division protein 48 (CDC48), domain 2,PF09336:Vps4 C terminal oligomerisation domain,	SSF50692:ADC-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54585:Cdc48 domain 2-like,	2.0627974495166	0.000201423446068942	FDR<0.01	3.69588997814332	1249394.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	754	Replication & Repair
Q99NH0	Q99NH0;Q99NH0-2;Q99NH0-3	Ankrd17	4.755	5.0922	741420	2.5409086289257	2.19751241594515	3.49895031490553	1.99044585987261	2.57665550115949	2.3497896938224	1722518.33333333	0	Ankrd17	0	Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)		FUNCTION: Could play pivotal roles in cell cycle and DNA regulation. Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways. Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too. Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (PubMed:19619540). {ECO:0000250|UniProtKB:O75179, ECO:0000269|PubMed:19619540}.		blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O75179}. Nucleus {ECO:0000250|UniProtKB:O75179}. Note=Detected around the nucleolus. {ECO:0000250|UniProtKB:O75179}.	81702;		IPR002110;IPR020683;IPR036770;IPR004087;IPR004088;IPR036612;	PF00023;PF12796;PF00013;	SM00248;SM00322;	274213	COMPBIAS 79..94;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 111..127;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 773..792;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1528..1563;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1592..1649;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1667..1702;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1940..1991;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2007..2025;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2047..2109;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2123..2164;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2269..2296;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2378..2401;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2433..2447;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..127;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 770..792;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1475..1496;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1513..1713;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1902..1991;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2007..2195;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2269..2327;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2378..2447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (6); Chain (1); Coiled coil (1); Compositional bias (13); Cross-link (1); Domain (1); Erroneous initiation (1); Modified residue (19); Region (8); Repeat (25); Sequence caution (1); Sequence conflict (3)		ANK repeat;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 1721..1785;  /note=KH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117			REPEAT 229..258;  /note=ANK 1; REPEAT 262..291;  /note=ANK 2; REPEAT 296..325;  /note=ANK 3; REPEAT 329..358;  /note=ANK 4; REPEAT 362..391;  /note=ANK 5; REPEAT 396..425;  /note=ANK 6; REPEAT 429..458;  /note=ANK 7; REPEAT 462..491;  /note=ANK 8; REPEAT 495..524;  /note=ANK 9; REPEAT 529..558;  /note=ANK 10; REPEAT 559..588;  /note=ANK 11; REPEAT 592..621;  /note=ANK 12; REPEAT 625..654;  /note=ANK 13; REPEAT 659..688;  /note=ANK 14; REPEAT 692..721;  /note=ANK 15; REPEAT 1078..1107;  /note=ANK 16; REPEAT 1111..1140;  /note=ANK 17; REPEAT 1145..1174;  /note=ANK 18; REPEAT 1178..1207;  /note=ANK 19; REPEAT 1213..1242;  /note=ANK 20; REPEAT 1247..1276;  /note=ANK 21; REPEAT 1280..1309;  /note=ANK 22; REPEAT 1315..1344;  /note=ANK 23; REPEAT 1348..1377;  /note=ANK 24; REPEAT 1381..1410;  /note=ANK 25		PS50297;PS50088;PS50084;	81702	GO:0001955~blood vessel maturation,GO:0002376~immune system process,GO:0006275~regulation of DNA replication,GO:0007492~endoderm development,GO:0042742~defense response to bacterium,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045787~positive regulation of cell cycle,GO:0051151~negative regulation of smooth muscle cell differentiation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1900245~positive regulation of MDA-5 signaling pathway,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002110:Ankyrin repeat,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR020683:Ankyrin repeat-containing domain,	PF00013:KH domain,PF12796:Ankyrin repeats (3 copies),	SSF48403:Ankyrin repeat,SSF54791:Eukaryotic type KH-domain (KH-domain type I),	1.55962441878018	2.0306847229998e-05	FDR<0.01	4.69235749840219	1231969.16666667	DNA.Chromatin.binder	RBP	ChD	Others	ChD	RBD	763	Replication & Repair
Q99LX0	Q99LX0	Park7	3.6334	12.455	1683845	NA	NA	NA	NA	NA	2.36764845155791	544415	5	Park7	0	Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124)		FUNCTION: Multifunctional protein with controversial molecular function which plays an important role in cell protection against oxidative stress and cell death acting as oxidative stress sensor and redox-sensitive chaperone and protease (PubMed:15784737, PubMed:17015834, PubMed:20800516, PubMed:21068725). It is involved in neuroprotective mechanisms like the stabilization of NFE2L2 and PINK1 proteins, male fertility as a positive regulator of androgen signaling pathway as well as cell growth and transformation through, for instance, the modulation of NF-kappa-B signaling pathway (PubMed:17015834, PubMed:21097510). Has been described as a protein and nucleotide deglycase that catalyzes the deglycation of the Maillard adducts formed between amino groups of proteins or nucleotides and reactive carbonyl groups of glyoxals. But this function is rebuted by other works. As a protein deglycase, repairs methylglyoxal- and glyoxal-glycated proteins, and releases repaired proteins and lactate or glycolate, respectively. Deglycates cysteine, arginine and lysine residues in proteins, and thus reactivates these proteins by reversing glycation by glyoxals. Acts on early glycation intermediates (hemithioacetals and aminocarbinols), preventing the formation of advanced glycation endproducts (AGE) that cause irreversible damage. Also functions as a nucleotide deglycase able to repair glycated guanine in the free nucleotide pool (GTP, GDP, GMP, dGTP) and in DNA and RNA. Is thus involved in a major nucleotide repair system named guanine glycation repair (GG repair), dedicated to reversing methylglyoxal and glyoxal damage via nucleotide sanitization and direct nucleic acid repair. Protects histones from adduction by methylglyoxal, controls the levels of methylglyoxal-derived argininine modifications on chromatin. Able to remove the glycations and restore histone 3, histone glycation disrupts both local and global chromatin architecture by altering histone-DNA interactions as well as histone acetylation and ubiquitination levels. Displays a very low glyoxalase activity that may reflect its deglycase activity (PubMed:22523093). Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death (PubMed:17766438). Required for correct mitochondrial morphology and function as well as for autophagy of dysfunctional mitochondria (PubMed:20186336). Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking (PubMed:21068725). Regulates astrocyte inflammatory responses, may modulate lipid rafts-dependent endocytosis in astrocytes and neuronal cells (PubMed:23847046, PubMed:19276172). In pancreatic islets, involved in the maintenance of mitochondrial reactive oxygen species (ROS) levels and glucose homeostasis in an age- and diet dependent manner. Protects pancreatic beta cells from cell death induced by inflammatory and cytotoxic setting (PubMed:26422139). Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress (By similarity). Metal-binding protein able to bind copper as well as toxic mercury ions, enhances the cell protection mechanism against induced metal toxicity (PubMed:23792957). In macrophages, interacts with the NADPH oxidase subunit NCF1 to direct NADPH oxidase-dependent ROS production, and protects against sepsis (PubMed:26021615). {ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:15784737, ECO:0000269|PubMed:17015834, ECO:0000269|PubMed:17766438, ECO:0000269|PubMed:19276172, ECO:0000269|PubMed:20186336, ECO:0000269|PubMed:20800516, ECO:0000269|PubMed:21068725, ECO:0000269|PubMed:22523093, ECO:0000269|PubMed:22611253, ECO:0000269|PubMed:23792957, ECO:0000269|PubMed:23847046, ECO:0000269|PubMed:26021615, ECO:0000269|PubMed:26422139}.		adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]	axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]	androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein-containing complex binding [GO:0044877]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23847046}; Lipid-anchor {ECO:0000269|PubMed:23847046}. Cytoplasm {ECO:0000250|UniProtKB:Q99497}. Membrane raft {ECO:0000269|PubMed:23847046}. Nucleus {ECO:0000250|UniProtKB:Q99497}. Mitochondrion {ECO:0000269|PubMed:31536960}. Endoplasmic reticulum {ECO:0000269|PubMed:31536960}. Note=Under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. Translocates to the mitochondrion and subsequently to the nucleus in response to oxidative stress and exerts an increased cytoprotective effect against oxidative damage (By similarity). Membrane raft localization in astrocytes and neuronal cells requires palmitoylation (PubMed:23847046). {ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:23847046}.	57320;		IPR029062;IPR006287;IPR002818;	PF01965;		20021			NA	ACT_SITE 106;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q99497; ACT_SITE 126;  /evidence=ECO:0000250|UniProtKB:Q99497			3.1.2.-; 3.5.1.-; 3.5.1.124			5 out of 5	Active site (2); Chain (1); Cross-link (1); Initiator methionine (1); Lipidation (3); Modified residue (5); Mutagenesis (3); Propeptide (1); Sequence conflict (1)		Acetylation;Autophagy;Cell membrane;Chaperone;Copper;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Endoplasmic reticulum;Fertilization;Hydrolase;Inflammatory response;Isopeptide bond;Lipoprotein;Membrane;Mitochondrion;Nucleus;Oxidation;Palmitate;Phosphoprotein;Protease;RNA-binding;Reference proteome;Stress response;Tumor suppressor;Ubl conjugation;Zymogen							57320	GO:0001933~negative regulation of protein phosphorylation,GO:0001963~synaptic transmission, dopaminergic,GO:0006469~negative regulation of protein kinase activity,GO:0006508~proteolysis,GO:0006517~protein deglycosylation,GO:0006914~autophagy,GO:0006954~inflammatory response,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007338~single fertilization,GO:0008283~cell proliferation,GO:0008344~adult locomotory behavior,GO:0009438~methylglyoxal metabolic process,GO:0010273~detoxification of copper ion,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0018323~enzyme active site formation via L-cysteine sulfinic acid,GO:0019243~methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,GO:0019249~lactate biosynthetic process,GO:0031397~negative regulation of protein ubiquitination,GO:0032091~negative regulation of protein binding,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032757~positive regulation of interleukin-8 production,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033234~negative regulation of protein sumoylation,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0036471~cellular response to glyoxal,GO:0042177~negative regulation of protein catabolic process,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046295~glycolate biosynthetic process,GO:0046826~negative regulation of protein export from nucleus,GO:0050727~regulation of inflammatory response,GO:0050787~detoxification of mercury ion,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051881~regulation of mitochondrial membrane potential,GO:0051899~membrane depolarization,GO:0060081~membrane hyperpolarization,GO:0060548~negative regulation of cell death,GO:0060765~regulation of androgen receptor signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0090073~positive regulation of protein homodimerization activity,GO:1900182~positive regulation of protein localization to nucleus,GO:1901215~negative regulation of neuron death,GO:1901671~positive regulation of superoxide dismutase activity,GO:1901984~negative regulation of protein acetylation,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902958~positive regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903094~negative regulation of protein K48-linked deubiquitination,GO:1903122~negative regulation of TRAIL-activated apoptotic signaling pathway,GO:1903168~positive regulation of pyrroline-5-carboxylate reductase activity,GO:1903178~positive regulation of tyrosine 3-monooxygenase activity,GO:1903181~positive regulation of dopamine biosynthetic process,GO:1903189~glyoxal metabolic process,GO:1903190~glyoxal catabolic process,GO:1903197~positive regulation of L-dopa biosynthetic process,GO:1903200~positive regulation of L-dopa decarboxylase activity,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,GO:1903208~negative regulation of hydrogen peroxide-induced neuron death,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903384~negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,GO:1903428~positive regulation of reactive oxygen species biosynthetic process,GO:1905259~negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,GO:2000157~negative regulation of ubiquitin-specific protease activity,GO:2000277~positive regulation of oxidative phosphorylation uncoupler activity,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000825~positive regulation of androgen receptor activity,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001268~negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016605~PML body,GO:0030424~axon,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0098793~presynapse,	GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005102~receptor binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008233~peptidase activity,GO:0016532~superoxide dismutase copper chaperone activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016787~hydrolase activity,GO:0019172~glyoxalase III activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019955~cytokine binding,GO:0036470~tyrosine 3-monooxygenase activator activity,GO:0036478~L-dopa decarboxylase activator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044388~small protein activating enzyme binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0045340~mercury ion binding,GO:0050681~androgen receptor binding,GO:0051920~peroxiredoxin activity,GO:0070491~repressing transcription factor binding,GO:0097110~scaffold protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1903135~cupric ion binding,GO:1903136~cuprous ion binding,GO:1990381~ubiquitin-specific protease binding,GO:1990422~glyoxalase (glycolic acid-forming) activity,	IPR002818:ThiJ/PfpI,IPR006287:DJ-1,	PF01965:DJ-1/PfpI family,	SSF52317:Class I glutamine amidotransferase-like,	2.24780940078966	0.00670130580258105	FDR<0.01	2.17384056332909	1114130	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	790	Replication & Repair
O70445	O70445	Bard1	4.4527	4.7099	1690700	3.18056041474508	2.14288775553936	NA	NA	0.491062659595364	3.6613942589338	201003.833333333	2	Bard1	0	BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1)		FUNCTION: E3 ubiquitin-protein ligase. The BRCA1-BARD1 heterodimer specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Plays a central role in the control of the cell cycle in response to DNA damage. Acts by mediating ubiquitin E3 ligase activity that is required for its tumor suppressor function. Also forms a heterodimer with CSTF1/CSTF-50 to modulate mRNA processing and RNAP II stability by inhibiting pre-mRNA 3' cleavage. {ECO:0000250|UniProtKB:Q99728}.	PATHWAY: Protein modification; protein ubiquitination.	DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; protein K6-linked ubiquitination [GO:0085020]; regulation of phosphorylation [GO:0042325]	BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15077185}. Cytoplasm {ECO:0000269|PubMed:15077185}. Note=Can translocate to the cytoplasm. Localizes at sites of DNA damage at double-strand breaks (DSBs); recruitment to DNA damage sites is mediated by the BRCA1-A complex. {ECO:0000250|UniProtKB:Q99728}.	12021;	cd16496;	IPR002110;IPR020683;IPR036770;IPR039503;IPR001357;IPR036420;IPR001841;IPR013083;IPR017907;	PF12796;PF14835;	SM00248;SM00292;	84254	COMPBIAS 204..229;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 310..328;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 369..406;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 20..113;  /note=Required for BRCA1 binding;  /evidence=ECO:0000250; REGION 183..229;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 299..328;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 369..410;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 542..546;  /note=Flexible linker;  /evidence=ECO:0000250	NA				2.3.2.27			5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Domain (2); Modified residue (2); Region (5); Repeat (4); Zinc finger (1)		ANK repeat;Cytoplasm;DNA damage;DNA repair;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 549..641;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 655..765;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033			REPEAT 415..447;  /note=ANK 1; REPEAT 448..480;  /note=ANK 2; REPEAT 481..513;  /note=ANK 3; REPEAT 514..534;  /note=ANK 4; degenerate	ZN_FING 44..81;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS50297;PS50088;PS50172;PS00518;PS50089;	12021	GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016567~protein ubiquitination,GO:0042325~regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0046826~negative regulation of protein export from nucleus,GO:0085020~protein K6-linked ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031436~BRCA1-BARD1 complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070531~BRCA1-A complex,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR002110:Ankyrin repeat,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR020683:Ankyrin repeat-containing domain,	PF12796:Ankyrin repeats (3 copies),	SSF48403:Ankyrin repeat,SSF52113:BRCT domain,	1.33426437963868	0.0125606460976224	FDR<0.1	1.90098802067722	945851.916666667	Present in Nucleus	RBP	DBD	DBD	ChD	Others	841	Replication & Repair
P48754	P48754	Brca1	3.7089	5.139	1109255	4.69373386528984	3.69180787831801	6.5078745281791	2.22836259916214	13.0771946801972	7.86348981678069	455179.333333333	0	Brca1	0	Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1)		FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Required for FANCD2 targeting to sites of DNA damage. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator. {ECO:0000250|UniProtKB:P38398}.	PATHWAY: Protein modification; protein ubiquitination.	cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; mitochondrial matrix [GO:0005759]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P38398}. Chromosome {ECO:0000269|PubMed:22549958, ECO:0000269|PubMed:23039116}. Cytoplasm {ECO:0000250|UniProtKB:P38398}. Note=Localizes at sites of DNA damage at double-strand breaks (DSBs); recruitment to DNA damage sites is mediated by the BRCA1-A complex. Translocated to the cytoplasm during UV-induced apoptosis. {ECO:0000250|UniProtKB:P38398}.	12189;		IPR011364;IPR031099;IPR025994;IPR001357;IPR036420;IPR018957;IPR001841;IPR013083;IPR017907;	PF00533;PF12820;PF00097;	SM00292;SM00184;	198795	COMPBIAS 173..195;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..339;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 494..508;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 520..561;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 640..655;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 659..691;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 699..729;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 885..899;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 947..975;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 976..990;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1147..1163;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1247..1289;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1329..1343;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1472..1507;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 165..198;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 321..362;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 492..581;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 640..767;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 864..899;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 947..995;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1030..1056;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1147..1185;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1205..1230;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1244..1289;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1313..1343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1353..1380;  /note=Interaction with PALB2;  /evidence=ECO:0000250; REGION 1437..1547;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Chain (1); Compositional bias (14); Cross-link (7); Domain (2); Modified residue (21); Region (13); Sequence conflict (32); Zinc finger (1)		Acetylation;Activator;Cell cycle;Chromosome;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Fatty acid biosynthesis;Fatty acid metabolism;Isopeptide bond;Lipid biosynthesis;Lipid metabolism;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 1585..1679;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 1698..1797;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033	DOMAIN: The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites. {ECO:0000250|UniProtKB:P38398}.; DOMAIN: The RING-type zinc finger domain interacts with BAP1. {ECO:0000250|UniProtKB:P38398}.			ZN_FING 24..65;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS50172;PS00518;PS50089;	12189	GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007098~centrosome cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010212~response to ionizing radiation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0016567~protein ubiquitination,GO:0031052~chromosome breakage,GO:0031398~positive regulation of protein ubiquitination,GO:0031572~G2 DNA damage checkpoint,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035066~positive regulation of histone acetylation,GO:0035067~negative regulation of histone acetylation,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043627~response to estrogen,GO:0044030~regulation of DNA methylation,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051298~centrosome duplication,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0051574~positive regulation of histone H3-K9 methylation,GO:0051865~protein autoubiquitination,GO:0070512~positive regulation of histone H4-K20 methylation,GO:0071158~positive regulation of cell cycle arrest,GO:0071356~cellular response to tumor necrosis factor,GO:0071681~cellular response to indole-3-methanol,GO:0085020~protein K6-linked ubiquitination,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031436~BRCA1-BARD1 complex,GO:0043234~protein complex,GO:0070531~BRCA1-A complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR011364:Breast cancer type 1 susceptibility protein (BRCA1),IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR025994:BRCA1, serine-rich domain,	PF00097:Zinc finger, C3HC4 type (RING finger),PF00533:BRCA1 C Terminus (BRCT) domain,PF12820:Serine-rich domain associated with BRCT,	SSF52113:BRCT domain,	2.36373298633055	3.29515609908528e-06	FDR<0.01	5.48212400705917	782217.166666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	902	Replication & Repair
Q6ZWY3	Q6ZWY3	Rps27l	11.953	9.399	976470	NA	NA	NA	NA	3.40599455040872	3.89408099688474	202630	4	Rps27l	0	40S ribosomal protein S27-like				activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint [GO:0031571]; positive regulation of translation [GO:0045727]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]		67941;		IPR000592;IPR011332;	PF01667;		9477		REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Region (1); Zinc finger (1)		Metal-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Zinc;Zinc-finger					ZN_FING 38..60;  /note=C4-type;  /evidence=ECO:0000255	PS01168;	67941	GO:0000028~ribosomal small subunit assembly,GO:0006281~DNA repair,GO:0006412~translation,GO:0006974~cellular response to DNA damage stimulus,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0008494~translation activator activity,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000592:Ribosomal protein S27e,IPR011332:Ribosomal protein, zinc-binding domain,IPR023407:Ribosomal protein S27e, zinc-binding domain,	PF01667:Ribosomal protein S27,	SSF57829:Zn-binding ribosomal proteins,	2.63529178501442	0.000402650670788767	FDR<0.01	3.39507157306574	589550	Present in Nucleus	RBP	Others	Others	Others	Others	984	Replication & Repair
Q9CWI3	Q9CWI3	Bccip	4.2976	NA	683820	NA	8.25695648583932	2.71061476742925	1.99060434747989	5.68052715291979	NA	471016.666666667	2	Bccip	1	BRCA2 and CDKN1A-interacting protein		FUNCTION: During interphase, required for microtubule organizing and anchoring activities. During mitosis, required for the organization and stabilization of the spindle pole (PubMed:28394342). May promote cell cycle arrest by enhancing the inhibition of CDK2 activity by CDKN1A. May be required for repair of DNA damage by homologous recombination in conjunction with BRCA2. May not be involved in non-homologous end joining (NHEJ) (By similarity). {ECO:0000250|UniProtKB:Q9P287, ECO:0000269|PubMed:28394342}.		cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]	centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	kinase regulator activity [GO:0019207]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9P287}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:28394342}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:28394342}. Note=Colocalizes with BRCA2 in discrete nuclear foci (By similarity). In interphase, preferential localizes to the mother centriole (PubMed:28394342). Recruited to the spindle pole matrix and centrosome by microtubules and dynein/dynactin activity (By similarity). {ECO:0000250|UniProtKB:Q9P287, ECO:0000269|PubMed:28394342}.	66165;		IPR025602;	PF13862;		35942	COMPBIAS 24..57;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 61..169;  /note=Interaction with BRCA2;  /evidence=ECO:0000250; REGION 163..261;  /note=Interaction with CDKN1A;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (3); Region (3); Sequence conflict (2)		Cell cycle;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Nucleus;Phosphoprotein;Reference proteome							66165	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0061101~neuroendocrine cell differentiation,	GO:0005634~nucleus,GO:0019908~nuclear cyclin-dependent protein kinase holoenzyme complex,	GO:0019207~kinase regulator activity,GO:0044822~poly(A) RNA binding,	IPR025602:BCP1 family,	PF13862:p21-C-terminal region-binding protein,		2.01739854431316	0.000486788864644695	FDR<0.01	3.31265936486817	577418.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	990	Replication & Repair
P02340	P02340	Tp53	2.9077	2.1153	629355	NA	4.20327014417217	NA	NA	2.21508472699081	2.86631506535198	491996.333333333	3	Tp53	0	Cellular tumor antigen p53 (Tumor suppressor p53)	DNA_BIND 99..289;  /evidence=ECO:0000250	FUNCTION: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (By similarity). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (By similarity). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression (By similarity). Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis, but seems to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000250|UniProtKB:P04637, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492}.		apoptotic process [GO:0006915]; autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac septum morphogenesis [GO:0060411]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to heat [GO:0034605]; cellular response to ionizing radiation [GO:0071479]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; central nervous system development [GO:0007417]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; chromosome organization [GO:0051276]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA strand renaturation [GO:0000733]; double-strand break repair [GO:0006302]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; gastrulation [GO:0007369]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; in utero embryonic development [GO:0001701]; mitochondrial DNA repair [GO:0043504]; mitotic cell cycle arrest [GO:0071850]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of mitophagy [GO:1901525]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell aging [GO:0090343]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; protein-containing complex assembly [GO:0065003]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; Ras protein signal transduction [GO:0007265]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; regulation of intracellular pH [GO:0051453]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron apoptotic process [GO:0043523]; regulation of thymocyte apoptotic process [GO:0070243]; regulation of tissue remodeling [GO:0034103]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to amino acid [GO:0043200]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; response to retinoic acid [GO:0032526]; response to salt stress [GO:0009651]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to vitamin B3 [GO:0033552]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; wound healing [GO:0042060]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04637}. Nucleus {ECO:0000250|UniProtKB:P04637}. Nucleus, PML body {ECO:0000250|UniProtKB:P04637}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P04637}. Mitochondrion matrix {ECO:0000250|UniProtKB:P04637}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P04637}. Note=Interaction with BANP promotes nuclear localization. Recruited into PML bodies together with CHEK2. Translocates to mitochondria upon oxidative stress. Translocates to mitochondria in response to mitomycin C treatment (By similarity). {ECO:0000250|UniProtKB:P04637}.	22059;	cd08367;	IPR008967;IPR012346;IPR011615;IPR036674;IPR010991;IPR013872;IPR002117;	PF00870;PF08563;PF07710;		43458	COMPBIAS 348..365;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 4..317;  /note=Interaction with CCAR2;  /evidence=ECO:0000250|UniProtKB:P04637; REGION 4..45;  /note=Transcription activation (acidic); REGION 63..107;  /note=Interaction with WWOX;  /evidence=ECO:0000250; REGION 97..367;  /note=Interaction with HIPK1;  /evidence=ECO:0000269|PubMed:12702766; REGION 97..297;  /note=Required for interaction with ZNF385A;  /evidence=ECO:0000250; REGION 110..233;  /note=Required for interaction with FBXO42;  /evidence=ECO:0000250; REGION 113..289;  /note=Interaction with AXIN1;  /evidence=ECO:0000269|PubMed:15526030; REGION 256..294;  /note=Interaction with E4F1;  /evidence=ECO:0000250; REGION 270..277;  /note=Interaction with DNA; REGION 316..357;  /note=Interaction with HIPK2;  /evidence=ECO:0000250; REGION 322..353;  /note=Oligomerization; REGION 348..390;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 356..360;  /note=Interaction with USP7;  /evidence=ECO:0000250; REGION 365..384;  /note=Basic (repression of DNA-binding)	NA					METAL 173;  /note=Zinc; METAL 176;  /note=Zinc; METAL 235;  /note=Zinc; METAL 239;  /note=Zinc		5 out of 5	Beta strand (12); Chain (1); Compositional bias (1); Cross-link (4); DNA binding (1); Helix (6); Metal binding (4); Modified residue (25); Motif (3); Natural variant (3); Region (14); Sequence conflict (2); Site (1); Turn (4)		3D-structure;Acetylation;Activator;Apoptosis;Biological rhythms;Cell cycle;Cytoplasm;Cytoskeleton;DNA-binding;Disease variant;Endoplasmic reticulum;Isopeptide bond;Metal-binding;Methylation;Mitochondrion;Necrosis;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Zinc		DOMAIN: The [KR]-[STA]-K motif is specifically recognized by the SETD7 methyltransferase. {ECO:0000250}.	MOTIF 302..318;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250; MOTIF 336..347;  /note=Nuclear export signal;  /evidence=ECO:0000250; MOTIF 367..369;  /note=[KR]-[STA]-K motif			PS00348;	22059	GO:0000060~protein import into nucleus, translocation,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000733~DNA strand renaturation,GO:0001701~in utero embryonic development,GO:0001756~somitogenesis,GO:0001836~release of cytochrome c from mitochondria,GO:0002309~T cell proliferation involved in immune response,GO:0002326~B cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002687~positive regulation of leukocyte migration,GO:0002931~response to ischemia,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006979~response to oxidative stress,GO:0006983~ER overload response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007265~Ras protein signal transduction,GO:0007275~multicellular organism development,GO:0007369~gastrulation,GO:0007406~negative regulation of neuroblast proliferation,GO:0007417~central nervous system development,GO:0007507~heart development,GO:0007569~cell aging,GO:0007623~circadian rhythm,GO:0008104~protein localization,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0009303~rRNA transcription,GO:0009411~response to UV,GO:0009651~response to salt stress,GO:0009792~embryo development ending in birth or egg hatching,GO:0010038~response to metal ion,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0012501~programmed cell death,GO:0016032~viral process,GO:0021549~cerebellum development,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031000~response to caffeine,GO:0031052~chromosome breakage,GO:0031065~positive regulation of histone deacetylation,GO:0031497~chromatin assembly,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032461~positive regulation of protein oligomerization,GO:0032526~response to retinoic acid,GO:0033077~T cell differentiation in thymus,GO:0033552~response to vitamin B3,GO:0033554~cellular response to stress,GO:0034097~response to cytokine,GO:0034103~regulation of tissue remodeling,GO:0034605~cellular response to heat,GO:0034614~cellular response to reactive oxygen species,GO:0034644~cellular response to UV,GO:0035264~multicellular organism growth,GO:0035690~cellular response to drug,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042493~response to drug,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043200~response to amino acid,GO:0043504~mitochondrial DNA repair,GO:0043523~regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045471~response to ethanol,GO:0045787~positive regulation of cell cycle,GO:0045861~negative regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0048147~negative regulation of fibroblast proliferation,GO:0048511~rhythmic process,GO:0048512~circadian behavior,GO:0048568~embryonic organ development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050821~protein stabilization,GO:0051262~protein tetramerization,GO:0051276~chromosome organization,GO:0051402~neuron apoptotic process,GO:0051453~regulation of intracellular pH,GO:0051726~regulation of cell cycle,GO:0051974~negative regulation of telomerase activity,GO:0055093~response to hyperoxia,GO:0060411~cardiac septum morphogenesis,GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070243~regulation of thymocyte apoptotic process,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0070266~necroptotic process,GO:0071158~positive regulation of cell cycle arrest,GO:0071417~cellular response to organonitrogen compound,GO:0071456~cellular response to hypoxia,GO:0071479~cellular response to ionizing radiation,GO:0071480~cellular response to gamma radiation,GO:0071494~cellular response to UV-C,GO:0071850~mitotic cell cycle arrest,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072363~regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090343~positive regulation of cell aging,GO:0090399~replicative senescence,GO:0090403~oxidative stress-induced premature senescence,GO:0097252~oligodendrocyte apoptotic process,GO:1900119~positive regulation of execution phase of apoptosis,GO:1901525~negative regulation of macromitophagy,GO:1902108~regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902253~regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1903205~regulation of hydrogen peroxide-induced cell death,GO:1904024~negative regulation of glucose catabolic process to lactate via pyruvate,GO:1990144~intrinsic apoptotic signaling pathway in response to hypoxia,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000269~regulation of fibroblast apoptotic process,GO:2000279~negative regulation of DNA biosynthetic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000772~regulation of cellular senescence,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0016605~PML body,GO:0035861~site of double-strand break,GO:0043234~protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035033~histone deacetylase regulator activity,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,GO:0051721~protein phosphatase 2A binding,GO:0097371~MDM2/MDM4 family protein binding,	IPR002117:p53 tumour suppressor family,IPR008967:p53-like transcription factor, DNA-binding,IPR010991:p53, tetramerisation domain,IPR011615:p53, DNA-binding domain,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013872:p53 transactivation domain,	PF00870:P53 DNA-binding domain,PF07710:P53 tetramerisation motif,PF08563:P53 transactivation motif,	SSF47719:p53 tetramerization domain,SSF49417:p53-like transcription factors,	1.471762395605	0.000692303440641271	FDR<0.01	3.15970351000664	560675.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	999	Replication & Repair
P59328	P59328-3;P59328;P59328-2	Wdhd1	3.8896	1.5238	493145	8.64154856550294	4.76689865573458	3.45399281569494	1.25672347056754	9.35979034069637	4.75014250427513	586085	0	Wdhd1	0	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	DNA_BIND 1004..1073;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Acts as a replication initiation factor that brings together the MCM2-7 helicase and the DNA polymerase alpha/primase complex in order to initiate DNA replication. {ECO:0000250}.		DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]	chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	218973;		IPR024977;IPR009071;IPR036910;IPR022100;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12894;PF00505;PF12341;PF00400;	SM00398;SM00320;	124254	COMPBIAS 816..834;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 848..872;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 913..946;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 989..1005;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 816..885;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 911..1005;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1054..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (4); Cross-link (3); DNA binding (1); Modified residue (9); Region (3); Repeat (7); Sequence conflict (2)		Acetylation;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat				REPEAT 11..50;  /note=WD 1; REPEAT 52..91;  /note=WD 2; REPEAT 93..131;  /note=WD 3; REPEAT 134..173;  /note=WD 4; REPEAT 184..223;  /note=WD 5; REPEAT 228..267;  /note=WD 6; REPEAT 271..310;  /note=WD 7		PS50118;PS00678;PS50082;PS50294;	218973	GO:0006396~RNA processing,GO:0033044~regulation of chromosome organization,GO:0070829~heterochromatin maintenance,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0070063~RNA polymerase binding,	IPR001680:WD40 repeat,IPR009071:High mobility group (HMG) box domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR022100:Protein of unknown function DUF3639,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF00505:HMG (high mobility group) box,PF12341:Protein of unknown function (DUF3639) ,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF47095:HMG-box,SSF50978:WD40 repeat-like,	1.94050193803063	0.000130094870908813	FDR<0.01	3.88573982549768	539615	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1013	Replication & Repair
Q9WUP7	Q9WUP7;Q9WUP7-2	Uchl5	NA	6.9362	283030	NA	NA	NA	NA	1.37816979051819	4.40121473526693	184646.5	4	Uchl5	1	Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)		FUNCTION: Protease that specifically cleaves 'Lys-48'-linked polyubiquitin chains. Deubiquitinating enzyme associated with the 19S regulatory subunit of the 26S proteasome. Putative regulatory component of the INO80 complex; however is inactive in the INO80 complex and is activated by a transient interaction of the INO80 complex with the proteasome via ADRM1 (By similarity). {ECO:0000250}.		DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of smoothened signaling pathway [GO:0045880]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent deubiquitinase [GO:0004843]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Associates with the proteasome 19S subunit in the cytoplasm. Associates with the INO80 complex in the nucleus (By similarity). {ECO:0000250}.	56207;	cd02255;	IPR038765;IPR001578;IPR036959;IPR017390;IPR033837;IPR041507;	PF01088;PF18031;		37617		REGION 313..329;  /note=Interaction with ADRM1;  /evidence=ECO:0000250	NA	ACT_SITE 88;  /note=Nucleophile;  /evidence=ECO:0000250; ACT_SITE 164;  /note=Proton donor;  /evidence=ECO:0000250	ACTIVITY REGULATION: Activated by ADRM1. Inhibited by interaction with NFRKB (By similarity). {ECO:0000250}.		3.4.19.12			5 out of 5	Active site (2); Alternative sequence (1); Beta strand (9); Chain (1); Helix (13); Modified residue (3); Region (1); Sequence conflict (3); Site (1)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA recombination;DNA repair;Hydrolase;Nucleus;Protease;Proteasome;Reference proteome;Thiol protease;Transcription;Transcription regulation;Ubl conjugation pathway							56207	GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0016579~protein deubiquitination,GO:0021670~lateral ventricle development,GO:0030901~midbrain development,GO:0048853~forebrain morphogenesis,GO:0061136~regulation of proteasomal protein catabolic process,	GO:0000502~proteasome complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031011~Ino80 complex,GO:0031597~cytosolic proteasome complex,	GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0004866~endopeptidase inhibitor activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0070628~proteasome binding,	IPR001578:Peptidase C12, ubiquitin carboxyl-terminal hydrolase 1,IPR017390:Ubiquitinyl hydrolase, UCH37 type,	PF01088:Ubiquitin carboxyl-terminal hydrolase, family 1,		1.79826696657488	0.0162886535992983	FDR<0.1	1.78811481247241	233838.25	Present in Nucleus	RBP	Others	Others	Others	Others	1247	Replication & Repair
Q9CWY8	Q9CWY8	Rnaseh2a	7.477	6.5955	416489	NA	NA	NA	NA	NA	2.353273403304	36183.3333333333	5	Rnaseh2a	0	Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)		FUNCTION: Catalytic subunit of RNase HII, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging-strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:19923215}.		DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	69724;		IPR004649;IPR001352;IPR024567;IPR023160;IPR012337;IPR036397;	PF01351;		33513		REGION 255..284;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.26.4	METAL 34;  /note=Divalent metal cation;  /evidence=ECO:0000305; METAL 35;  /note=Divalent metal cation;  /evidence=ECO:0000305; METAL 142;  /note=Divalent metal cation;  /evidence=ECO:0000305		5 out of 5	Beta strand (11); Chain (1); Helix (13); Metal binding (3); Modified residue (3); Mutagenesis (5); Region (1); Sequence conflict (1); Turn (3)		3D-structure;Acetylation;Endonuclease;Hydrolase;Metal-binding;Nuclease;Nucleus;Phosphoprotein;Reference proteome							69724	GO:0006298~mismatch repair,GO:0006401~RNA catabolic process,GO:0016070~RNA metabolic process,GO:0043137~DNA replication, removal of RNA primer,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032299~ribonuclease H2 complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001352:Ribonuclease HII/HIII,IPR004649:Ribonuclease H2, subunit A,IPR012337:Ribonuclease H-like domain,IPR023160:Ribonuclease HII, helix-loop-helix cap domain,IPR024567:Ribonuclease HII/HIII domain,	PF01351:Ribonuclease HII,	SSF53098:Ribonuclease H-like,	2.28620350297456	0.00304482090503607	FDR<0.01	2.51643824728136	226336.166666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	1257	Replication & Repair
Q6PFD9	Q6PFD9	Nup98	2.3226	4.1737	268435	6.22975330176925	7.35510444248308	4.31741645799154	NA	4.87234457220815	3.43218012081274	172719	1	Nup98	0	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]		FUNCTION: Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. NUP98 and NUP96 are involved in the bidirectional transport across the NPC. May anchor NUP153 and TPR to the NPC. In cooperation with DHX9, plays a role in transcription and alternative splicing activation of a subset of genes. Involved in the localization of DHX9 in discrete intranuclear foci (GLFG-body). {ECO:0000250|UniProtKB:P52948}.		mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]	intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:P52948}; Peripheral membrane protein {ECO:0000250|UniProtKB:P52948}; Nucleoplasmic side {ECO:0000250|UniProtKB:P52948}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P52948}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P52948}. Note=Localized to the nucleoplasmic side of the nuclear pore complex (NPC), at or near the nucleoplasmic basket. Dissociates from the dissasembled NPC structure early during prophase of mitosis. Colocalized with NUP153 and TPR to the nuclear basket of NPC. Colocalized with DHX9 in diffuse and discrete intranuclear foci (GLFG-body). Remains localized to the nuclear membrane after poliovirus (PV) infection. {ECO:0000250|UniProtKB:P52948}.	269966;		IPR037665;IPR021967;IPR037637;IPR007230;IPR036903;	PF04096;PF12110;		197241	COMPBIAS 886..901;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 912..927;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..156;  /note=FG repeats 1; REGION 157..213;  /note=GLEBS; interaction with RAE1;  /evidence=ECO:0000250; REGION 214..480;  /note=FG repeats 2; REGION 512..535;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 663..682;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 886..937;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 881;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:P52948			3.4.21.-			5 out of 5	Active site (1); Beta strand (9); Chain (2); Compositional bias (2); Cross-link (3); Domain (1); Helix (4); Modified residue (22); Mutagenesis (1); Region (6); Sequence caution (3); Site (1); Turn (4)		3D-structure;Acetylation;Autocatalytic cleavage;Hydrolase;Isopeptide bond;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Protease;Protein transport;Reference proteome;Repeat;Serine protease;Translocation;Transport;Ubl conjugation;mRNA transport	DOMAIN 738..880;  /note=Peptidase S59;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00765	DOMAIN: Contains G-L-F-G repeats. The FG repeat domains have a direct role in the transport (By similarity). {ECO:0000250}.				PS51434;	269966	GO:0000059~protein import into nucleus, docking,GO:0000973~posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0006260~DNA replication,GO:0006405~RNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0015031~protein transport,GO:0034398~telomere tethering at nuclear periphery,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0042405~nuclear inclusion body,GO:0044614~nuclear pore cytoplasmic filaments,GO:0044615~nuclear pore nuclear basket,	GO:0003723~RNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0008139~nuclear localization sequence binding,GO:0017056~structural constituent of nuclear pore,GO:0042277~peptide binding,	IPR007230:Peptidase S59, nucleoporin,IPR021967:Nuclear protein 96,IPR025574:Nucleoporin FG repeat,	PF04096:Nucleoporin autopeptidase,PF12110:Nuclear protein 96,PF13634:Nucleoporin FG repeat region,	SSF82215:C-terminal autoproteolytic domain of nucleoporin nup98,	2.13841402483171	5.60068560433198e-06	FDR<0.01	5.25175880585939	220577	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1263	Replication & Repair
Q8CGK3	Q8CGK3	Lonp1	NA	3.2647	119452.05	3.84852216748768	3.10587942976054	NA	3.72384002383258	3.50446819695111	3.00571085061617	289226.166666667	1	Lonp1	1	Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)		FUNCTION: ATP-dependent serine protease that mediates the selective degradation of misfolded, unassembled or oxidatively damaged polypeptides as well as certain short-lived regulatory proteins in the mitochondrial matrix. May also have a chaperone function in the assembly of inner membrane protein complexes. Participates in the regulation of mitochondrial gene expression and in the maintenance of the integrity of the mitochondrial genome. Binds to mitochondrial promoters and RNA in a single-stranded, site-specific, and strand-specific manner. May regulate mitochondrial DNA replication and/or gene expression using site-specific, single-stranded DNA binding to target the degradation of regulatory proteins binding to adjacent sites in mitochondrial promoters. {ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:12657466}.		aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:12657466}.	74142;		IPR003593;IPR003959;IPR004815;IPR008269;IPR027065;IPR003111;IPR027503;IPR027417;IPR008268;IPR015947;IPR020568;IPR014721;	PF00004;PF05362;PF02190;	SM00382;SM00464;	105843		REGION 68..94;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..240;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 844;  /evidence=ECO:0000255|HAMAP-Rule:MF_03120; ACT_SITE 887;  /evidence=ECO:0000255|HAMAP-Rule:MF_03120			3.4.21.53			5 out of 5	Active site (2); Chain (1); Domain (2); Nucleotide binding (1); Region (2); Sequence conflict (11); Transit peptide (1)		ATP-binding;DNA-binding;Direct protein sequencing;Hydrolase;Mitochondrion;Nucleotide-binding;Protease;Reference proteome;Serine protease;Transit peptide	DOMAIN 112..357;  /note=Lon N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01123; DOMAIN 748..938;  /note=Lon proteolytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01122					PS51787;PS51786;PS01046;	74142	GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0007005~mitochondrion organization,GO:0007568~aging,GO:0009725~response to hormone,GO:0010044~response to aluminum ion,GO:0030163~protein catabolic process,GO:0034599~cellular response to oxidative stress,GO:0043623~cellular protein complex assembly,GO:0051131~chaperone-mediated protein complex assembly,GO:0051260~protein homooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070407~oxidation-dependent protein catabolic process,GO:0090296~regulation of mitochondrial DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0004176~ATP-dependent peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005524~ATP binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0043531~ADP binding,GO:0043565~sequence-specific DNA binding,GO:0051880~G-quadruplex DNA binding,GO:0070182~DNA polymerase binding,GO:0070361~mitochondrial light strand promoter anti-sense binding,GO:0070362~mitochondrial heavy strand promoter anti-sense binding,GO:0070363~mitochondrial light strand promoter sense binding,GO:0070364~mitochondrial heavy strand promoter sense binding,	IPR003111:Peptidase S16, lon N-terminal,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR004815:Lon protease, bacterial/eukaryotic-type,IPR008268:Peptidase S16, active site,IPR008269:Peptidase S16, Lon C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR015947:PUA-like domain,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027065:Lon protease,IPR027417:P-loop containing nucleoside triphosphate hydrolase,IPR027503:Lon protease homolog, chloroplastic/mitochondrial,	PF00004:ATPase family associated with various cellular activities (AAA),PF02190:ATP-dependent protease La (LON) domain,PF05362:Lon protease (S16) C-terminal proteolytic domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54211:Ribosomal protein S5 domain 2-like,SSF88697:PUA domain-like,	1.76332494414631	1.8606247249982e-05	FDR<0.01	4.73034121219826	204339.108333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1276	Replication & Repair
A2AKX3	A2AKX3;A2AKX3-2	Setx	7.884	2.4332	85899	NA	2.2878059940517	NA	NA	NA	NA	28148.6666666667	5	Setx	0	Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog)		FUNCTION: Probable RNA/DNA helicase involved in diverse aspects of RNA metabolism and genomic integrity. Plays a role in transcription regulation by its ability to modulate RNA Polymerase II (Pol II) binding to chromatin and through its interaction with proteins involved in transcription. Contributes to the mRNA splicing efficiency and splice site selection. Required for the resolution of R-loop RNA-DNA hybrid formation at G-rich pause sites located downstream of the poly(A) site, allowing XRN2 recruitment and XRN2-mediated degradation of the downstream cleaved RNA and hence efficient RNA polymerase II (RNAp II) transcription termination (By similarity). Required for the 3' transcriptional termination of PER1 and CRY2, thus playing an important role in the circadian rhythm regulation (PubMed:22767893). Involved in DNA double-strand breaks damage response generated by oxidative stress. In association with RRP45, targets the RNA exosome complex to sites of transcription-induced DNA damage (By similarity). Plays a role in the development and maturation of germ cells: essential for male meiosis, acting at the interface of transcription and meiotic recombination, and in the process of gene silencing during meiotic sex chromosome inactivation (MSCI) (PubMed:23593030). Plays a role in neurite outgrowth in hippocampal cells through FGF8-activated signaling pathways. Inhibits retinoic acid-induced apoptosis. May be involved in telomeric stability through the regulation of telomere repeat-containing RNA (TERRA) transcription (By similarity). {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:22767893, ECO:0000269|PubMed:23593030}.		cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]	axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7Z333}. Nucleus, nucleoplasm {ECO:0000269|PubMed:16644229}. Nucleus, nucleolus {ECO:0000269|PubMed:16644229}. Cytoplasm {ECO:0000269|PubMed:16644229}. Chromosome {ECO:0000269|PubMed:23593030}. Chromosome, telomere {ECO:0000250|UniProtKB:Q7Z333}. Cell projection, axon {ECO:0000250|UniProtKB:Q7Z333}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q7Z333}. Note=Most abundant in the nucleus (By similarity). Detected in granules (By similarity). Colocalized in cycling cells with FBL in the nucleolus. Localizes with telomeric DNA in a transcription-dependent manner. Under replication stress, colocalizes with a variety of DNA damage signaling and repair response proteins at distinct nuclear foci in mitotic S/G2- and G1-phase cells in a transcription- and RNA/DNA hybrid-dependent manner. Localizes at limited number of nuclear foci. Colocalizes with EXOSC9 in nuclear foci upon induction of transcription-related DNA damage at the S phase (By similarity). At pachytene stage, colocalizes predominantly to the heterochromatic XY-body of sex chromosomes with DNA damage response proteins in a BRCA1-dependent manner (PubMed:23593030). May be detected in the nucleolus only in cycling cells (PubMed:16644229). {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:16644229, ECO:0000269|PubMed:23593030}.	269254;	cd18808;	IPR041679;IPR041677;IPR027417;	PF13086;PF13087;		297589	COMPBIAS 705..729;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 840..867;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1192..1214;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2596..2612;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 705..734;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 825..876;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1001..1023;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1122..1245;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1591..1627;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2450..2472;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2486..2506;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2569..2624;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2632..2646;  /note=Necessary for nuclear localization;  /evidence=ECO:0000250	NA				3.6.4.-			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Cross-link (5); Frameshift (1); Modified residue (12); Motif (1); Nucleotide binding (1); Region (9); Sequence caution (1); Sequence conflict (2)		ATP-binding;Alternative splicing;Biological rhythms;Cell projection;Chromosome;Coiled coil;Cytoplasm;DNA damage;DNA recombination;DNA repair;Differentiation;Helicase;Hydrolase;Isopeptide bond;Neurogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spermatogenesis;Telomere;Ubl conjugation		DOMAIN: The N-terminus domain is necessary for S/G2 nuclear foci localization. {ECO:0000250|UniProtKB:Q7Z333}.	MOTIF 2046..2063;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250				269254	GO:0000165~MAPK cascade,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006353~DNA-templated transcription, termination,GO:0006369~termination of RNA polymerase II transcription,GO:0006376~mRNA splice site selection,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0007623~circadian rhythm,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010976~positive regulation of neuron projection development,GO:0030154~cell differentiation,GO:0033120~positive regulation of RNA splicing,GO:0034599~cellular response to oxidative stress,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0060566~positive regulation of DNA-templated transcription, termination,GO:0070301~cellular response to hydrogen peroxide,GO:0071300~cellular response to retinoic acid,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2000806~positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,	GO:0000228~nuclear chromosome,GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030424~axon,GO:0030426~growth cone,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0001147~transcription termination site sequence-specific DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,	IPR026121:Probable helicase senataxin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.81858246748925	0.0106271594093817	FDR<0.1	1.97358280487379	57023.8333333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1423	Replication & Repair
Q6NVF4	Q6NVF4	Helb	4.7259	NA	49430	NA	1.64425005754875	NA	NA	25.7181801815704	25.7479787836655	57832	3	Helb	1	DNA helicase B (EC 3.6.4.12)		FUNCTION: 5'-3' DNA helicase involved in DNA damage response by acting as an inhibitor of DNA end resection (PubMed:26774285). Recruitment to single-stranded DNA (ssDNA) following DNA damage leads to inhibit the nucleases catalyzing resection, such as EXO1, BLM and DNA2, possibly via the 5'-3' ssDNA translocase activity of HELB (PubMed:26774285). As cells approach S phase, DNA end resection is promoted by the nuclear export of HELB following phosphorylation (PubMed:26774285). Acts independently of TP53BP1 (PubMed:26774285). Unwinds duplex DNA with 5'-3' polarity. Has single-strand DNA-dependent ATPase and DNA helicase activities. Prefers ATP and dATP as substrates. During S phase, may facilitate cellular recovery from replication stress (PubMed:11557815, PubMed:7596831, PubMed:7794903). {ECO:0000269|PubMed:11557815, ECO:0000269|PubMed:26774285, ECO:0000269|PubMed:7596831, ECO:0000269|PubMed:7794903}.		cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]	cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26774285}. Cytoplasm {ECO:0000269|PubMed:26774285}. Chromosome {ECO:0000250|UniProtKB:Q8NG08}. Note=Predominantly nuclear. Phosphorylation at Ser-942 by CDK2 during the G1/S transition results in its nuclear export into the cytoplasm as cells approach and progress through S phase. Following DNA damage, recruited to sites of double-strand breaks by the RPA complex. {ECO:0000250|UniProtKB:Q8NG08}.	117599;		IPR027044;IPR027417;IPR027785;	PF13538;		121471	COMPBIAS 1..22;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 23..38;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 932..950;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 971..1014;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1040..1064;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..38;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 380..420;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 932..1014;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1040..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (5); Erroneous initiation (1); Modified residue (5); Motif (1); Mutagenesis (2); Region (4); Sequence conflict (2)		ATP-binding;Chromosome;Cytoplasm;Direct protein sequencing;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome			MOTIF 1022..1046;  /note=Nuclear export signal;  /evidence=ECO:0000269|PubMed:26774285				117599	GO:0000398~mRNA splicing, via spliceosome,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006974~cellular response to DNA damage stimulus,GO:1903775~regulation of DNA double-strand break processing,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0005634~nucleus,GO:0005658~alpha DNA polymerase:primase complex,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0035861~site of double-strand break,	GO:0000166~nucleotide binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0043141~ATP-dependent 5'-3' DNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR027044:DNA helicase B,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF13538:UvrD-like helicase C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.08228068977972	0.00328671703148686	FDR<0.01	2.4832376847087	53631	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1426	Replication & Repair
P63158	P63158	Hmgb1	0.90895	1.0786	136419000	2.57393632081542	2.12734273618823	3.09798940487624	1.63441422594142	6.03500301750151	5.03600745329103	18737283.3333333	0	Hmgb1	0	High mobility group protein B1 (High mobility group protein 1) (HMG-1)	DNA_BIND 9..79;  /note=HMG box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267; DNA_BIND 95..163;  /note=HMG box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability. Proposed to be an universal biosensor for nucleic acids. Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. In the cytoplasm functions as sensor and/or chaperone for immunogenic nucleic acids implicating the activation of TLR9-mediated immune responses, and mediates autophagy. Acts as danger associated molecular pattern (DAMP) molecule that amplifies immune responses during tissue injury. Released to the extracellular environment can bind DNA, nucleosomes, IL-1 beta, CXCL12, AGER isoform 2/sRAGE, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), and activates cells through engagement of multiple surface receptors. In the extracellular compartment fully reduced HMGB1 (released by necrosis) acts as a chemokine, disulfide HMGB1 (actively secreted) as a cytokine, and sulfonyl HMGB1 (released from apoptotic cells) promotes immunological tolerance (PubMed:23519706, PubMed:23446148, PubMed:23994764, PubMed:25048472). Has proangiogenic activity (PubMed:16365390). May be involved in platelet activation. Binds to phosphatidylserine and phosphatidylethanolamide. Bound to RAGE mediates signaling for neuronal outgrowth. May play a role in accumulation of expanded polyglutamine (polyQ) proteins (By similarity). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P12682, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:16365390, ECO:0000305|PubMed:23446148, ECO:0000305|PubMed:23519706, ECO:0000305|PubMed:23994764, ECO:0000305|PubMed:25048472}.; FUNCTION: Nuclear functions are attributed to fully reduced HGMB1. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA, DNA-containing cruciforms or bent structures, supercoiled DNA and ZDNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity. May be involved in nucleotide excision repair (NER), mismatch repair (MMR) and base excision repair (BER) pathways, and double strand break repair such as non-homologous end joining (NHEJ) (PubMed:17803946, PubMed:18650382). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS). In vitro can displace histone H1 from highly bent DNA. Can restructure the canonical nucleosome leading to relaxation of structural constraints for transcription factor-binding (By similarity). Enhances binding of sterol regulatory element-binding proteins (SREBPs) such as SREBF1 to their cognate DNA sequences and increases their transcriptional activities (PubMed:16040616). Facilitates binding of TP53 to DNA (By similarity). Proposed to be involved in mitochondrial quality control and autophagy in a transcription-dependent fashion implicating HSPB1; however, this function has been questioned (PubMed:21641551, PubMed:24606906). Can modulate the activity of the telomerase complex and may be involved in telomere maintenance (PubMed:22544226). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:16040616, ECO:0000269|PubMed:17803946, ECO:0000269|PubMed:18650382, ECO:0000269|PubMed:21641551, ECO:0000269|PubMed:22544226, ECO:0000269|PubMed:24606906}.; FUNCTION: In the cytoplasm proposed to dissociate the BECN1:BCL2 complex via competitive interaction with BECN1 leading to autophagy activation (PubMed:21395369). Can protect BECN1 and ATG5 from calpain-mediated cleavage and thus proposed to control their proautophagic and proapoptotic functions and to regulate the extent and severity of inflammation-associated cellular injury (PubMed:25642769). In myeloid cells has a protective role against endotoxemia and bacterial infection by promoting autophagy (PubMed:24302768). Involved in endosomal translocation and activation of TLR9 in response to CpG-DNA in macrophages (PubMed:17548579). {ECO:0000250|UniProtKB:P09429, ECO:0000269|PubMed:17548579, ECO:0000269|PubMed:20819940, ECO:0000269|PubMed:21395369, ECO:0000269|PubMed:24302768, ECO:0000269|PubMed:25642769}.; FUNCTION: In the extracellular compartment (following either active secretion or passive release) involved in regulation of the inflammatory response. Fully reduced HGMB1 (which subsequently gets oxidized after release) in association with CXCL12 mediates the recruitment of inflammatory cells during the initial phase of tissue injury; the CXCL12:HMGB1 complex triggers CXCR4 homodimerization (PubMed:22370717). Induces the migration of monocyte-derived immature dendritic cells and seems to regulate adhesive and migratory functions of neutrophils implicating AGER/RAGE and ITGAM (PubMed:17268551). Can bind to various types of DNA and RNA including microbial unmethylated CpG-DNA to enhance the innate immune response to nucleic acids. Proposed to act in promiscuous DNA/RNA sensing which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (PubMed:19890330). Promotes extracellular DNA-induced AIM2 inflammasome activation implicating AGER/RAGE. Disulfide HMGB1 binds to transmembrane receptors, such as AGER/RAGE, TLR2, TLR4 and probably TREM1, thus activating their signal transduction pathways (PubMed:17568691, PubMed:19264983, PubMed:21419643). Mediates the release of cytokines/chemokines such as TNF, IL-1, IL-6, IL-8, CCL2, CCL3, CCL4 and CXCL10 (PubMed:12110890, PubMed:17548579). Promotes secretion of interferon-gamma by macrophage-stimulated natural killer (NK) cells in concert with other cytokines like IL-2 or IL-12. TLR4 is proposed to be the primary receptor promoting macrophage activation and signaling through TLR4 seems to implicate LY96/MD-2. In bacterial LPS- or LTA-mediated inflammatory responses binds to the endotoxins and transfers them to CD14 for signaling to the respective TLR4:LY96 and TLR2 complexes (By similarity). Contributes to tumor proliferation by association with ACER/RAGE (By similarity). Can bind to IL1-beta and signals through the IL1R1:IL1RAP receptor complex (By similarity). Binding to class A CpG activates cytokine production in plasmacytoid dendritic cells implicating TLR9, MYD88 and AGER/RAGE and can activate autoreactive B cells. Via HMGB1-containing chromatin immune complexes may also promote B cell responses to endogenous TLR9 ligands through a B-cell receptor (BCR)-dependent and ACER/RAGE-independent mechanism (By similarity). Inhibits phagocytosis of apoptotic cells by macrophages; the function is dependent on poly-ADP-ribosylation and involves binding to phosphatidylserine on the cell surface of apoptotic cells (PubMed:22204001, PubMed:18768881). In adaptive immunity may be involved in enhancing immunity through activation of effector T-cells and suppression of regulatory T (TReg) cells (PubMed:21419643). In contrast, without implicating effector or regulatory T-cells, required for tumor infiltration and activation of T-cells expressing the lymphotoxin LTA:LTB heterotrimer thus promoting tumor malignant progression (PubMed:23108142). Also reported to limit proliferation of T-cells (By similarity). Released HMGB1:nucleosome complexes formed during apoptosis can signal through TLR2 to induce cytokine production (By similarity). Involved in induction of immunological tolerance by apoptotic cells; its pro-inflammatory activities when released by apoptotic cells are neutralized by reactive oxygen species (ROS)-dependent oxidation specifically on Cys-106 (By similarity). During macrophage activation by activated lymphocyte-derived self apoptotic DNA (ALD-DNA) promotes recruitment of ALD-DNA to endosomes (PubMed:25660970). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:12110890, ECO:0000269|PubMed:17268551, ECO:0000269|PubMed:17568691, ECO:0000269|PubMed:18768881, ECO:0000269|PubMed:19264983, ECO:0000269|PubMed:21419643, ECO:0000269|PubMed:22204001, ECO:0000269|PubMed:22370717, ECO:0000269|PubMed:23108142, ECO:0000269|PubMed:25660970, ECO:0000305|PubMed:19890330}.		activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; base-excision repair [GO:0006284]; cellular response to interleukin-7 [GO:0098761]; cellular response to lipopolysaccharide [GO:0071222]; chromatin assembly [GO:0031497]; chromatin silencing [GO:0006342]; DNA geometric change [GO:0032392]; endothelial cell chemotaxis [GO:0035767]; endothelial cell proliferation [GO:0001935]; eye development [GO:0001654]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; lung development [GO:0030324]; macrophage activation involved in immune response [GO:0002281]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; neutrophil clearance [GO:0097350]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mismatch repair [GO:0032425]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; regulation of nucleotide-excision repair [GO:2000819]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucocorticoid [GO:0051384]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]	alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	bent DNA binding [GO:0003681]; bubble DNA binding [GO:0000405]; calcium-dependent protein kinase regulator activity [GO:0010858]; crossed form four-way junction DNA binding [GO:0000402]; C-X-C chemokine binding [GO:0019958]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; four-way junction DNA binding [GO:0000400]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; open form four-way junction DNA binding [GO:0000401]; phosphatidylserine binding [GO:0001786]; protein kinase activator activity [GO:0030295]; repressing transcription factor binding [GO:0070491]; single-stranded RNA binding [GO:0003727]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17114460, ECO:0000269|PubMed:20819940}. Cytoplasm {ECO:0000269|PubMed:17114460, ECO:0000269|PubMed:20819940}. Secreted {ECO:0000269|PubMed:22105604}. Chromosome {ECO:0000269|PubMed:12110890}. Cell membrane {ECO:0000269|PubMed:2461949}; Peripheral membrane protein {ECO:0000269|PubMed:2461949}; Extracellular side {ECO:0000269|PubMed:2461949}. Endosome {ECO:0000269|PubMed:19890330}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000305|PubMed:17548579}. Note=In basal state predominantly nuclear. Shuttles between the cytoplasm and the nucleus (PubMed:17114460). Translocates from the nucleus to the cytoplasm upon autophagy stimulation (PubMed:20819940). Release from macrophages in the extracellular milieu requires the activation of NLRC4 or NLRP3 inflammasomes (PubMed:20802146). Passively released to the extracellular milieu from necrotic cells by diffusion, involving the fully reduced form which subsequently gets oxidized (PubMed:12110890). Also released from apoptotic cells (PubMed:25660970). Actively secreted from a variety of immune and non-immune cells such as macrophages, monocytes, neutrophils, dendritic cells and natural killer cells in response to various stimuli, involving a nonconventional secretory process via secretory lysosomes (PubMed:17548579). Secreted by plasma cells in response to LPS (PubMed:21319304). Associated with the plasma membrane of filipodia in process-growing cells, and also deposited into the substrate-attached material (By similarity). Colocalizes with DDX58 on endosomal membranes (PubMed:19890330). {ECO:0000250|UniProtKB:P09429, ECO:0000269|PubMed:12110890, ECO:0000269|PubMed:17114460, ECO:0000269|PubMed:17548579, ECO:0000269|PubMed:19890330, ECO:0000269|PubMed:20802146, ECO:0000269|PubMed:20819940, ECO:0000269|PubMed:21319304, ECO:0000269|PubMed:22105604, ECO:0000269|PubMed:2461949, ECO:0000269|PubMed:25660970}.	15289;		IPR009071;IPR036910;IPR017967;IPR031076;	PF00505;PF09011;	SM00398;	24894	COMPBIAS 76..94;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..187;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 188..215;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..97;  /note=Sufficient for interaction with HAVCR2;  /evidence=ECO:0000269|PubMed:22842346; REGION 1..10;  /note=Heparin-binding;  /evidence=ECO:0000250|UniProtKB:P10103; REGION 3..15;  /note=LPS binding (delipidated);  /evidence=ECO:0000250|UniProtKB:P09429; REGION 27..43;  /note=NLS 1;  /evidence=ECO:0000250|UniProtKB:P63159; REGION 76..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..96;  /note=LPS binding (Lipid A);  /evidence=ECO:0000250|UniProtKB:P09429; REGION 89..108;  /note=Cytokine-stimulating activity;  /evidence=ECO:0000250|UniProtKB:P09429; REGION 150..183;  /note=Binding to AGER/RAGE;  /evidence=ECO:0000250|UniProtKB:P63159; REGION 161..215;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..184;  /note=NLS 2;  /evidence=ECO:0000250|UniProtKB:P63159	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (8); DNA binding (2); Disulfide bond (1); Helix (6); Modified residue (26); Motif (2); Region (10); Sequence conflict (2); Site (2)	MISCELLANEOUS: Plays a role in acute sepsis; administration of antibodies to HMGB1 attenuates endotoxin lethality; administration of HMGB1 itself is lethal (PubMed:10398600). Overexpression in ALD-DNA-immunized mice significantly enhances the severity of modeled SLE (PubMed:26078984). {ECO:0000269|PubMed:10398600, ECO:0000269|PubMed:26078984}.	3D-structure;ADP-ribosylation;Acetylation;Adaptive immunity;Autophagy;Cell membrane;Chemotaxis;Chromosome;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Disulfide bond;Endosome;Heparin-binding;Immunity;Inflammatory response;Innate immunity;Isopeptide bond;Membrane;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Secreted		DOMAIN: HMG box 2 mediates proinflammatory cytokine-stimulating activity and binding to TLR4. However, not involved in mediating immunogenic activity in the context of apoptosis-induced immune tolerance. {ECO:0000250|UniProtKB:P09429}.; DOMAIN: The acidic C-terminal domain forms a flexible structure which can reversibly interact intramolecularily with the HMG boxes and modulate binding to DNA and other proteins. {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P63159}.	MOTIF 27..43;  /note=Nuclear localization signal (NLS) 1;  /evidence=ECO:0000250|UniProtKB:P63159; MOTIF 178..184;  /note=Nuclear localization signal (NLS) 2;  /evidence=ECO:0000250|UniProtKB:P63159			PS00353;PS50118;	15289	GO:0001654~eye development,GO:0001773~myeloid dendritic cell activation,GO:0001934~positive regulation of protein phosphorylation,GO:0001935~endothelial cell proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002250~adaptive immune response,GO:0002270~plasmacytoid dendritic cell activation,GO:0002281~macrophage activation involved in immune response,GO:0002643~regulation of tolerance induction,GO:0002840~regulation of T cell mediated immune response to tumor cell,GO:0006284~base-excision repair,GO:0006310~DNA recombination,GO:0006914~autophagy,GO:0006954~inflammatory response,GO:0010506~regulation of autophagy,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0031497~chromatin assembly,GO:0032392~DNA geometric change,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034137~positive regulation of toll-like receptor 2 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0034165~positive regulation of toll-like receptor 9 signaling pathway,GO:0035767~endothelial cell chemotaxis,GO:0043277~apoptotic cell clearance,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045819~positive regulation of glycogen catabolic process,GO:0045931~positive regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050930~induction of positive chemotaxis,GO:0051106~positive regulation of DNA ligation,GO:0051384~response to glucocorticoid,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090303~positive regulation of wound healing,GO:0097350~neutrophil clearance,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1903672~positive regulation of sprouting angiogenesis,GO:2000426~negative regulation of apoptotic cell clearance,GO:2000819~regulation of nucleotide-excision repair,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0043005~neuron projection,	GO:0000400~four-way junction DNA binding,GO:0000401~open form four-way junction DNA binding,GO:0000402~crossed form four-way junction DNA binding,GO:0000405~bubble DNA binding,GO:0001786~phosphatidylserine binding,GO:0003677~DNA binding,GO:0003681~bent DNA binding,GO:0003690~double-stranded DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0005125~cytokine activity,GO:0008201~heparin binding,GO:0008301~DNA binding, bending,GO:0010858~calcium-dependent protein kinase regulator activity,GO:0030295~protein kinase activator activity,GO:0097100~supercoiled DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR017967:HMG box A DNA-binding domain, conserved site,	PF00505:HMG (high mobility group) box,PF09011:HMG-box domain,	SSF47095:HMG-box,	1.2112753017056	0.00311318278379312	FDR<0.01	2.50679537990781	77578141.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	30	Replication & Repair
Q3UPF5	Q3UPF5-2;Q3UPF5	Zc3hav1	1.3457	3.9305	126251.5	NA	NA	NA	NA	1.78412132024978	3.47186057007951	39164.8333333333	4	Zc3hav1	0	Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13)		FUNCTION: Antiviral protein which inhibits the replication of viruses by recruiting the cellular RNA degradation machineries to degrade the viral mRNAs. Binds to a ZAP-responsive element (ZRE) present in the target viral mRNA, recruits cellular poly(A)-specific ribonuclease PARN to remove the poly(A) tail, and the 3'-5' exoribonuclease complex exosome to degrade the RNA body from the 3'-end. It also recruits the decapping complex DCP1-DCP2 through RNA helicase p72 (DDX17) to remove the cap structure of the viral mRNA to initiate its degradation from the 5'-end. Its target viruses belong to families which include retroviridae: human immunodeficiency virus type 1 (HIV-1) and moloney and murine leukemia virus (MoMLV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), togaviridae: sindbis virus (SINV) and Ross river virus (RRV). Specifically targets the multiply spliced but not unspliced or singly spliced HIV-1 mRNAs for degradation. Isoform 1 is a more potent viral inhibitor than isoform 2. Isoform 2 acts as a positive regulator of DDX58/RIG-I signaling resulting in activation of the downstream effector IRF3 leading to the expression of type I IFNs and IFN stimulated genes (ISGs). {ECO:0000269|PubMed:21102435}.		cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of ATPase activity [GO:0032781]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ADP-ribosylation [GO:0006471]; regulation of defense response to virus by host [GO:0050691]; response to virus [GO:0009615]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	DEAD/H-box RNA helicase binding [GO:0017151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8K3Y6}. Nucleus {ECO:0000250|UniProtKB:Q8K3Y6}. Note=Localizes in the cytoplasm at steady state, but shuttles between nucleus and cytoplasm in a XPO1-dependent manner. {ECO:0000250|UniProtKB:Q8K3Y6}.	78781;		IPR012317;IPR036388;IPR004170;IPR037197;IPR041360;IPR040954;IPR000571;	PF18606;PF00644;PF02825;PF18633;		106688	COMPBIAS 228..250;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 338..353;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..491;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 523..566;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..254;  /note=N-terminal domain; REGION 221..283;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 224..254;  /note=Binding to EXOSC5;  /evidence=ECO:0000250; REGION 302..354;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 461..491;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 523..570;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (6); Chain (1); Compositional bias (4); Domain (2); Helix (10); Modified residue (13); Motif (3); Region (6); Turn (2); Zinc finger (4)		3D-structure;Alternative splicing;Antiviral defense;Cytoplasm;Immunity;Innate immunity;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Zinc;Zinc-finger	DOMAIN 684..771;  /note=WWE;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00248; DOMAIN 805..946;  /note=PARP catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00397	DOMAIN: The N-terminal domain is sufficient to bind to viral RNAs and promote their degradation. The second and fourth zinc fingers are involved in binding to specific viral RNAs. Contains a divergent PARP homology ADP-ribosyltransferase domain which lacks the structural requirements for NAD[+] binding. It is therefore inactive. {ECO:0000250|UniProtKB:Q7Z2W4}.	MOTIF 69..76;  /note=Nuclear localization signal;  /evidence=ECO:0000250; MOTIF 283..290;  /note=Nuclear export signal;  /evidence=ECO:0000250; MOTIF 412..413;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 73..86;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 87..113;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 150..172;  /note=C3H1-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 173..194;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS51059;PS50918;PS50103;	78781	GO:0002376~immune system process,GO:0009615~response to virus,GO:0032481~positive regulation of type I interferon production,GO:0032781~positive regulation of ATPase activity,GO:0039507~suppression by virus of host molecular function,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0050691~regulation of defense response to virus by host,GO:0051607~defense response to virus,GO:0061014~positive regulation of mRNA catabolic process,GO:0071360~cellular response to exogenous dsRNA,GO:0098609~cell-cell adhesion,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005913~cell-cell adherens junction,	GO:0003723~RNA binding,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0017151~DEAD/H-box RNA helicase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000571:Zinc finger, CCCH-type,IPR004170:WWE domain,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,	PF00644:Poly(ADP-ribose) polymerase catalytic domain,PF02825:WWE domain,		1.25849810110772	0.0132286750024565	FDR<0.1	1.87848365301121	82708.1666666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	1399	Splicing
Q61598	Q61598;Q61598-2	Gdi2	4.6631	3.3013	5914250	1.61246109937598	4.63649851632047	6.9204152249135	6.86907542244814	11.7810607667114	4.00753416422875	2191091.66666667	0	Gdi2	0	Rab GDP dissociation inhibitor beta (Rab GDI beta) (GDI-3) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)		FUNCTION: Regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them.		positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]	cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; myelin sheath [GO:0043209]; synapse [GO:0045202]	GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.	14569;		IPR036188;IPR018203;IPR000806;	PF00996;		50537			NA							4 out of 5	Alternative sequence (1); Chain (1); Modified residue (6); Sequence conflict (2)		Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;GTPase activation;Membrane;Phosphoprotein;Reference proteome							14569	GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0055114~oxidation-reduction process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005093~Rab GDP-dissociation inhibitor activity,GO:0005096~GTPase activator activity,GO:0016491~oxidoreductase activity,GO:0031267~small GTPase binding,GO:0044822~poly(A) RNA binding,	IPR000806:Rab GDI protein,IPR018203:GDP dissociation inhibitor,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	PF00996:GDP dissociation inhibitor,	SSF51905:FAD/NAD(P)-binding domain,	2.24733881897511	9.3910973141651e-06	FDR<0.01	5.02728365910303	4052670.83333333	Unexpected	RBP	Others	Others	Others	Others	420	Splicing
Q8BFY9	Q8BFY9-2;Q8BFY9	Tnpo1	5.7129	8.0402	4875350	3.91910957830381	5.90632567479771	3.23153982872839	4.01880802154081	8.44523266615995	9.38878978499671	2678306.66666667	0	Tnpo1	0	Transportin-1 (Importin beta-2) (Karyopherin beta-2)		FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates (PubMed:11493596). Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Involved in nuclear import of M9-containing proteins. In vitro, binds directly to the M9 region of the heterogeneous nuclear ribonucleoproteins (hnRNP), A1 and A2 and mediates their nuclear import. Appears also to be involved in hnRNP A1/A2 nuclear export. Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A (By similarity). In vitro, mediates nuclear import of SRP19 (By similarity). Mediates the import of histones H2A, H2B, H3 and H4 (PubMed:11493596). Mediates nuclear import of ADAR/ADAR1 in a RanGTP-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q92973, ECO:0000269|PubMed:11493596}.		protein import into nucleus [GO:0006606]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	238799;		IPR011989;IPR016024;IPR001494;IPR040122;	PF03810;	SM00913;	102357	COMPBIAS 359..374;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 347..374;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (2); Region (1); Repeat (20); Sequence conflict (1); Site (2)		Alternative splicing;Cytoplasm;Nucleus;Protein transport;Reference proteome;Repeat;Transport	DOMAIN 41..109;  /note=Importin N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00115			REPEAT 19..46;  /note=HEAT 1;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 51..89;  /note=HEAT 2;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 98..131;  /note=HEAT 3;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 137..174;  /note=HEAT 4;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 181..211;  /note=HEAT 5;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 224..251;  /note=HEAT 6;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 263..290;  /note=HEAT 7;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 306..397;  /note=HEAT 8;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 405..433;  /note=HEAT 9;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 445..472;  /note=HEAT 10;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 486..519;  /note=HEAT 11;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 527..560;  /note=HEAT 12;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 568..606;  /note=HEAT 13;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 614..665;  /note=HEAT 14;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 676..707;  /note=HEAT 15;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 715..748;  /note=HEAT 16;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 756..791;  /note=HEAT 17;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 799..832;  /note=HEAT 18;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 841..872;  /note=HEAT 19;  /evidence=ECO:0000250|UniProtKB:Q92973; REPEAT 875..895;  /note=HEAT 20;  /evidence=ECO:0000250|UniProtKB:Q92973		PS50166;	238799	GO:0000059~protein import into nucleus, docking,GO:0000060~protein import into nucleus, translocation,GO:0006607~NLS-bearing protein import into nucleus,GO:0006610~ribosomal protein import into nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0015031~protein transport,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0044822~poly(A) RNA binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	PF03810:Importin-beta N-terminal domain,	SSF48371:ARM repeat,	2.50778841207682	3.35577280240311e-07	FDR<0.01	6.47420745010875	3776828.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	440	Splicing
Q924C1	Q924C1;Q924C1-2;Q924C1-3	Xpo5	3.1701	3.9355	1882100	12.1415215754838	11.3524129553737	2.75611167764518	NA	8.64902266043937	7.98403193612774	1301051.66666667	1	Xpo5	0	Exportin-5 (Exp5) (Ran-binding protein 21)		FUNCTION: Mediates the nuclear export of proteins bearing a double-stranded RNA binding domain (dsRBD) and double-stranded RNAs (cargos). XPO5 in the nucleus binds cooperatively to the RNA and to the GTPase Ran in its active GTP-bound form. Proteins containing dsRBDs can associate with this trimeric complex through the RNA. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause disassembly of the complex and release of the cargo from the export receptor. XPO5 then returns to the nuclear compartment by diffusion through the nuclear pore complex, to mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Overexpression may in some circumstances enhance RNA-mediated gene silencing (RNAi) (By similarity). Mediates nuclear export of ADAR/ADAR1 in a RanGTP-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q9HAV4}.; FUNCTION: Mediates the nuclear export of micro-RNA precursors, which form short hairpins. Also mediates the nuclear export of synthetic short hairpin RNAs used for RNA interference. In some circumstances can also mediate the nuclear export of deacylated and aminoacylated tRNAs. Specifically recognizes dsRNAs that lack a 5'-overhang in a sequence-independent manner, have only a short 3'-overhang, and that have a double-stranded length of at least 15 base-pairs. Binding is dependent on Ran-GTP (By similarity). {ECO:0000250|UniProtKB:Q9HAV4}.		positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]	mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9HAV4}. Cytoplasm {ECO:0000250|UniProtKB:Q9HAV4}. Note=Shuttles between the nucleus and the cytoplasm. {ECO:0000250|UniProtKB:Q9HAV4}.	72322;		IPR011989;IPR016024;IPR013598;IPR001494;IPR040018;	PF08389;	SM00913;	136973		REGION 1..108;  /note=Necessary for interaction with Ran;  /evidence=ECO:0000250|UniProtKB:Q9HAV4; REGION 533..640;  /note=Necessary for interaction with ILF3;  /evidence=ECO:0000250|UniProtKB:Q9HAV4; REGION 641..642;  /note=Pre-siRNA binding;  /evidence=ECO:0000250|UniProtKB:Q9HAV4	NA							5 out of 5	Alternative sequence (4); Chain (1); Modified residue (1); Region (3); Sequence conflict (2); Site (4)		Acetylation;Alternative splicing;Cytoplasm;Nucleus;Protein transport;RNA-binding;RNA-mediated gene silencing;Reference proteome;Transport;tRNA-binding							72322	GO:0006405~RNA export from nucleus,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0031047~gene silencing by RNA,GO:0035281~pre-miRNA export from nucleus,GO:0046825~regulation of protein export from nucleus,GO:1900370~positive regulation of RNA interference,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0042565~RNA nuclear export complex,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005049~nuclear export signal receptor activity,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0044822~poly(A) RNA binding,GO:0070883~pre-miRNA binding,GO:0090631~pre-miRNA transporter activity,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR016024:Armadillo-type fold,	PF08389:Exportin 1-like protein,	SSF48371:ARM repeat,	2.61716694895392	1.01417492127422e-05	FDR<0.01	4.99388713297852	1591575.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	684	Splicing
Q8BKC5	Q8BKC5;Q8BKC5-2	Ipo5	6.5023	8.2864	1449100	8.89046941678521	8.68809730668984	17.6208348751564	3.62739408009286	6.17970584600173	3.8127192313558	976018.333333333	0	Ipo5	0	Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5)		FUNCTION: Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Mediates the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. Binds to CPEB3 and mediates its nuclear import following neuronal stimulation (PubMed:22730302). {ECO:0000269|PubMed:11493596, ECO:0000269|PubMed:17143267, ECO:0000269|PubMed:22730302}.		cellular response to amino acid stimulus [GO:0071230]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17143267}. Nucleus {ECO:0000269|PubMed:17143267}.	70572;		IPR016024;IPR000357;IPR001494;IPR040122;IPR041653;IPR040928;IPR041389;IPR034085;	PF02985;PF18808;PF18816;PF18829;	SM01349;	123591		REGION 325..375;  /note=Ran-GTP binding;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Domain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (2); Region (1); Repeat (24); Sequence conflict (4)		Acetylation;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	DOMAIN 28..99;  /note=Importin N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00115			REPEAT 5..38;  /note=HEAT 1;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 43..77;  /note=HEAT 2;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 95..122;  /note=HEAT 3;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 130..157;  /note=HEAT 4;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 167..201;  /note=HEAT 5;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 210..246;  /note=HEAT 6;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 254..289;  /note=HEAT 7;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 298..350;  /note=HEAT 8;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 352..386;  /note=HEAT 9;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 390..430;  /note=HEAT 10;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 432..472;  /note=HEAT 11;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 475..523;  /note=HEAT 12;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 525..568;  /note=HEAT 13;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 570..615;  /note=HEAT 14;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 617..692;  /note=HEAT 15;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 695..737;  /note=HEAT 16;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 741..780;  /note=HEAT 17;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 787..853;  /note=HEAT 18;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 856..895;  /note=HEAT 19;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 903..935;  /note=HEAT 20;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 943..983;  /note=HEAT 21;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 990..1021;  /note=HEAT 22;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 1032..1067;  /note=HEAT 23;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588; REPEAT 1070..1093;  /note=HEAT 24;  /evidence=ECO:0000250|UniProtKB:P32337, ECO:0000305|PubMed:23541588		PS50166;	70572	GO:0000059~protein import into nucleus, docking,GO:0000060~protein import into nucleus, translocation,GO:0006607~NLS-bearing protein import into nucleus,GO:0006610~ribosomal protein import into nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0042307~positive regulation of protein import into nucleus,GO:0071230~cellular response to amino acid stimulus,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0044822~poly(A) RNA binding,	IPR000357:HEAT,IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	PF02985:HEAT repeat,PF03810:Importin-beta N-terminal domain,	SSF48371:ARM repeat,	2.82243722081996	3.97229747472363e-07	FDR<0.01	6.40095823580771	1212559.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	768	Splicing
Q62261	Q62261;Q62261-2;P15508	Sptbn1	3.3349	4.2003	604230	9.05059281382931	12.7414504867234	5.35819535980282	4.32675666320526	NA	3.3306687982947	145166	1	Sptbn1	0	Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain)		FUNCTION: Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane.		actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]	axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]	actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}. Endomembrane system {ECO:0000269|PubMed:15262991}. Cytoplasm, myofibril, sarcomere, M line {ECO:0000269|PubMed:15262991}. Note=Colocalizes with ANK2 in a distinct intracellular compartment of neonatal cardiomyocytes. {ECO:0000269|PubMed:15262991}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:9927192}. Cell membrane {ECO:0000269|PubMed:9927192}; Peripheral membrane protein; Cytoplasmic side.	20742;	cd00014;	IPR001589;IPR001715;IPR036872;IPR011993;IPR041681;IPR001605;IPR001849;IPR018159;IPR016343;IPR002017;	PF00307;PF15410;PF00435;	SM00033;SM00233;SM00150;	274223	COMPBIAS 2089..2105;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2108..2167;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2308..2339;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2340..2356;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..275;  /note=Actin-binding; REGION 1563..2093;  /note=Interaction with ANK2;  /evidence=ECO:0000250; REGION 2089..2193;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2148..2176;  /note=Mediates interaction with CAMSAP1;  /evidence=ECO:0000250; REGION 2308..2363;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Beta strand (9); Chain (1); Compositional bias (4); Domain (3); Glycosylation (1); Helix (10); Initiator methionine (1); Modified residue (39); Region (5); Repeat (17); Sequence conflict (16); Turn (3)		3D-structure;Acetylation;Actin capping;Actin-binding;Alternative splicing;Calmodulin-binding;Cell membrane;Cytoplasm;Cytoskeleton;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Repeat	DOMAIN 54..158;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 173..278;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 2196..2306;  /note=PH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00145			REPEAT 303..411;  /note=Spectrin 1;  /evidence=ECO:0000255; REPEAT 423..525;  /note=Spectrin 2;  /evidence=ECO:0000255; REPEAT 530..636;  /note=Spectrin 3;  /evidence=ECO:0000255; REPEAT 639..742;  /note=Spectrin 4;  /evidence=ECO:0000255; REPEAT 745..847;  /note=Spectrin 5;  /evidence=ECO:0000255; REPEAT 850..952;  /note=Spectrin 6;  /evidence=ECO:0000255; REPEAT 957..1060;  /note=Spectrin 7;  /evidence=ECO:0000255; REPEAT 1063..1166;  /note=Spectrin 8;  /evidence=ECO:0000255; REPEAT 1170..1259;  /note=Spectrin 9;  /evidence=ECO:0000255; REPEAT 1276..1376;  /note=Spectrin 10;  /evidence=ECO:0000255; REPEAT 1381..1482;  /note=Spectrin 11;  /evidence=ECO:0000255; REPEAT 1486..1590;  /note=Spectrin 12;  /evidence=ECO:0000255; REPEAT 1592..1696;  /note=Spectrin 13;  /evidence=ECO:0000255; REPEAT 1698..1801;  /note=Spectrin 14;  /evidence=ECO:0000255; REPEAT 1805..1907;  /note=Spectrin 15;  /evidence=ECO:0000255; REPEAT 1914..2014;  /note=Spectrin 16;  /evidence=ECO:0000255; REPEAT 2018..2097;  /note=Spectrin 17;  /evidence=ECO:0000255		PS00019;PS00020;PS50021;PS50003;	20742	GO:0000281~mitotic cytokinesis,GO:0007009~plasma membrane organization,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007184~SMAD protein import into nucleus,GO:0043001~Golgi to plasma membrane protein transport,GO:0051693~actin filament capping,GO:0071709~membrane assembly,GO:0072661~protein targeting to plasma membrane,GO:1900042~positive regulation of interleukin-2 secretion,GO:1903076~regulation of protein localization to plasma membrane,GO:1903078~positive regulation of protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0008091~spectrin,GO:0012505~endomembrane system,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030673~axolemma,GO:0030863~cortical cytoskeleton,GO:0031430~M band,GO:0032437~cuticular plate,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005543~phospholipid binding,GO:0030506~ankyrin binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001605:Pleckstrin homology domain, spectrin-type,IPR001715:Calponin homology domain,IPR001849:Pleckstrin homology domain,IPR002017:Spectrin repeat,IPR011993:Pleckstrin homology-like domain,IPR016343:Spectrin, beta subunit,IPR018159:Spectrin/alpha-actinin,	PF00307:Calponin homology (CH) domain,PF00435:Spectrin repeat,	SSF47576:Calponin-homology domain, CH-domain,SSF50729:PH domain-like,	2.41835012195273	7.20682619668972e-06	FDR<0.01	5.14225595147029	374698	Present in Nucleus	RBP	Others	Others	Others	Others	1119	Splicing
Q99L48	Q99L48	Nmd3	NA	5.2147	34039.5	NA	NA	3.78773531305632	NA	2.67787804943363	12.6815040263775	47996.5	3	Nmd3	1	60S ribosomal export protein NMD3		FUNCTION: Acts as an adapter for the XPO1/CRM1-mediated export of the 60S ribosomal subunit. {ECO:0000250}.		positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q96D46}. Nucleus {ECO:0000250|UniProtKB:Q96D46}. Note=Shuttles between the nucleus/nucleolus and the cytoplasm in a XPO1/CRM1-dependent manner. {ECO:0000250|UniProtKB:Q96D46}.	97112;		IPR039768;IPR007064;	PF04981;		57611		REGION 425..503;  /note=Necessary for the nuclear export of the 60S ribosomal subunit;  /evidence=ECO:0000250	NA							3 out of 5	Alternative sequence (2); Chain (1); Modified residue (5); Motif (2); Region (1)		Acetylation;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transport			MOTIF 405..422;  /note=Nuclear and nucleolar localization signal;  /evidence=ECO:0000250; MOTIF 480..489;  /note=Nuclear export signal;  /evidence=ECO:0000250				97112	GO:0000055~ribosomal large subunit export from nucleus,GO:0006810~transport,GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0030674~protein binding, bridging,GO:0043023~ribosomal large subunit binding,GO:0044822~poly(A) RNA binding,	IPR007064:NMD3,	PF04981:NMD3 family ,		2.34741599803086	0.000966400942068086	FDR<0.01	3.01484265536329	41018	Present in Nucleus	RBP	Others	Others	Others	Others	1435	Splicing
P63038	P63038;P63038-2	Hspd1	3.5944	3.711	1219730	5.54508151269824	6.54964631909877	6.06317831807433	4.14147270769486	7.31314904197748	6.01865783930184	7125446.66666667	0	Hspd1	0	60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (HSP-65) (Heat shock protein 60) (HSP-60) (Hsp60) (Mitochondrial matrix protein P1)		FUNCTION: Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix. The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein. {ECO:0000250|UniProtKB:P10809}.		activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to heat [GO:0034605]; cellular response to interleukin-7 [GO:0098761]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of tumor necrosis factor production [GO:0032760]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to drug [GO:0042493]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110]	cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; intracellular membrane-bounded organelle [GO:0043231]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; zymogen granule [GO:0042588]	apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; modification-dependent protein binding [GO:0140030]; p53 binding [GO:0002039]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250|UniProtKB:P10809}.	15510;	cd03344;	IPR018370;IPR001844;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		60955			NA			BINDING 75;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P10809; BINDING 440;  /note=ATP; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:P10809; BINDING 520;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P10809	5.6.1.7			5 out of 5	Alternative sequence (1); Binding site (3); Chain (1); Cross-link (1); Modified residue (46); Nucleotide binding (1); Sequence caution (1); Sequence conflict (7); Transit peptide (1)		ATP-binding;Acetylation;Alternative splicing;Chaperone;Direct protein sequencing;Isomerase;Isopeptide bond;Mitochondrion;Nucleotide-binding;Phosphoprotein;Reference proteome;Transit peptide;Ubl conjugation						PS00296;	15510	GO:0001666~response to hypoxia,GO:0002236~detection of misfolded protein,GO:0002368~B cell cytokine production,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002842~positive regulation of T cell mediated immune response to tumor cell,GO:0002931~response to ischemia,GO:0006457~protein folding,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006986~response to unfolded protein,GO:0008637~apoptotic mitochondrial changes,GO:0009408~response to heat,GO:0009409~response to cold,GO:0014823~response to activity,GO:0032496~response to lipopolysaccharide,GO:0032727~positive regulation of interferon-alpha production,GO:0032729~positive regulation of interferon-gamma production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0033198~response to ATP,GO:0042026~protein refolding,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043032~positive regulation of macrophage activation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0043627~response to estrogen,GO:0048291~isotype switching to IgG isotypes,GO:0050729~positive regulation of inflammatory response,GO:0050821~protein stabilization,GO:0050870~positive regulation of T cell activation,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051384~response to glucocorticoid,GO:0071866~negative regulation of apoptotic process in bone marrow,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1904469~positive regulation of tumor necrosis factor secretion,GO:2000778~positive regulation of interleukin-6 secretion,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005769~early endosome,GO:0005782~peroxisomal matrix,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005905~clathrin-coated pit,GO:0009986~cell surface,GO:0016020~membrane,GO:0019907~cyclin-dependent protein kinase activating kinase holoenzyme complex,GO:0030061~mitochondrial crista,GO:0030135~coated vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0042588~zymogen granule,GO:0043209~myelin sheath,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0046696~lipopolysaccharide receptor complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001530~lipopolysaccharide binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003725~double-stranded RNA binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0043559~insulin binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0051087~chaperone binding,GO:0051787~misfolded protein binding,	IPR001844:Chaperonin Cpn60,IPR002423:Chaperonin Cpn60/TCP-1,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR018370:Chaperonin Cpn60, conserved site,IPR027409:GroEL-like apical domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	2.37879216746756	1.23737844347133e-07	FDR<0.01	6.90749745415002	4172588.33333333	Unexpected	RBP	Others	Others	Others	Others	412	Splicing
P11983	P11983;P11983-2	Tcp1	4.0956	4.3829	3915550	4.18182578513779	12.6599906316069	13.9489468545125	30.252609287551	6.54878847413229	2.15912771240419	1848880	0	Tcp1	0	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Tailless complex polypeptide 1A) (TCP-1-A) (Tailless complex polypeptide 1B) (TCP-1-B)		FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin. {ECO:0000250|UniProtKB:P17987}.		binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; myelin sheath [GO:0043209]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P17987}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P17987}.	21454;	cd03335;	IPR012715;IPR017998;IPR002194;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		60449			NA							5 out of 5	Alternative sequence (2); Chain (1); Frameshift (2); Modified residue (8); Sequence conflict (32)		ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Phosphoprotein;Reference proteome						PS00750;PS00751;PS00995;	21454	GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0044053~translocation of peptides or proteins into host cell cytoplasm,GO:0050821~protein stabilization,GO:0051973~positive regulation of telomerase activity,GO:0090666~scaRNA localization to Cajal body,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,GO:2000109~regulation of macrophage apoptotic process,	GO:0000242~pericentriolar material,GO:0000792~heterochromatin,GO:0001669~acrosomal vesicle,GO:0002199~zona pellucida receptor complex,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012715:T-complex protein 1, alpha subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	2.80438082029227	1.63167898117318e-05	FDR<0.01	4.78736528088773	2882215	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	515	Splicing
P62849	P62849-2;P62849-3;P62849	Rps24	32.442	16.643	29436500	16.7361215711871	21.4169450869528	21.0450996485468	NA	17.951709900368	12.2857669390012	14230933.3333333	1	Rps24	0	40S ribosomal protein S24		FUNCTION: Required for processing of pre-rRNA and maturation of 40S ribosomal subunits. {ECO:0000250}.		erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; small ribosomal subunit [GO:0015935]	structural constituent of ribosome [GO:0003735]; translation initiation factor binding [GO:0031369]		20088;		IPR012678;IPR001976;IPR018098;	PF01282;		15423	COMPBIAS 94..118;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 92..133;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (1); Modified residue (2); Region (1)		Acetylation;Alternative splicing;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00529;	20088	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006412~translation,GO:0034101~erythrocyte homeostasis,GO:0042274~ribosomal small subunit biogenesis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003735~structural constituent of ribosome,GO:0031369~translation initiation factor binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,	IPR001976:Ribosomal protein S24e,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012678:Ribosomal protein L23/L15e core domain,IPR018098:Ribosomal S24e conserved site,	PF01282:Ribosomal protein S24e,	SSF54189:Ribosomal proteins S24e, L23 and L15e,	4.24894091598373	3.78821724489017e-09	FDR<0.01	8.42156512324013	21833716.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	107	Splicing
Q640M1	Q640M1;Q640M1-2	Utp14a	20.379	25.627	19901500	15.1025462893044	11.7594487170441	6.08790941190795	7.60919190381981	18.7895755434885	14.0924464487035	4387806.66666667	0	Utp14a	0	U3 small nucleolar RNA-associated protein 14 homolog A (Juvenile spermatogonial depletion-like X-linked protein) (Jsd-like X-linked protein)		FUNCTION: May be required for ribosome biogenesis. {ECO:0000250}.		rRNA processing [GO:0006364]	cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	72554;		IPR006709;			87265	COMPBIAS 397..433;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 437..457;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 460..488;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 496..551;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 23..49;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 338..554;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 730..767;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (3); Erroneous initiation (1); Frameshift (1); Modified residue (10); Region (3); Sequence caution (1)	MISCELLANEOUS: The mouse genome also contains the Utp14b gene, an autosomal retrotransposed copy of this X-linked gene. Evolution of autosomal retrogenes from X-linked progenitors compensates for X-chromosome silencing during male meiosis.	Alternative splicing;Citrullination;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation							72554	GO:0006364~rRNA processing,GO:0030490~maturation of SSU-rRNA,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR006709:Small-subunit processome, Utp14,	PF04615:Utp14 protein,		3.76043417100719	1.67607820408491e-08	FDR<0.01	7.77570572149919	12144653.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	195	Splicing
Q921N6	Q921N6;Q921N6-2	Ddx27	5.8397	7.8672	11978800	4.66483183281243	2.64711332292135	4.29110882251974	1.57433208961098	11.8133490844654	12.8546270229969	8529883.33333333	0	Ddx27	0	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)		FUNCTION: Probable ATP-dependent RNA helicase. Component of the nucleolar ribosomal RNA (rRNA) processing machinery that regulates 3' end formation of ribosomal 47S rRNA. {ECO:0000250|UniProtKB:Q96GQ7}.		rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96GQ7}. Chromosome {ECO:0000250|UniProtKB:Q96GQ7}. Note=Associates with 60S and 90S pre-ribosomal particles. {ECO:0000250|UniProtKB:Q96GQ7}.	228889;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	85939	COMPBIAS 81..129;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 130..144;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 689..722;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 729..743;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..149;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 605..624;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 679..760;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (4); Domain (2); Erroneous initiation (1); Modified residue (5); Motif (4); Nucleotide binding (1); Region (4); Sequence conflict (1)		ATP-binding;Alternative splicing;Chromosome;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;rRNA processing	DOMAIN 215..389;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 419..569;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The C-terminal domain regulates nucleolar localization. {ECO:0000250|UniProtKB:Q96GQ7}.	MOTIF 55..57;  /note=Required for interaction with the PEBOW complex;  /evidence=ECO:0000250|UniProtKB:Q96GQ7; MOTIF 157..166;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 184..212;  /note=Q motif; MOTIF 337..340;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	228889	GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.39383023725914	1.95408248304134e-05	FDR<0.01	4.70905710838917	10254341.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	223	Splicing
Q8R5K4	Q8R5K4-2;Q8R5K4	Nol6	13.117	15.041	11783550	7.87153652392947	8.31946755407654	14.4383482529599	NA	9.22679461155195	15.5579065280976	3913185	1	Nol6	0	Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap)				rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]	condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11895476}. Chromosome {ECO:0000269|PubMed:11895476}. Note=Localizes to condensed chromosomes in mitosis.	230082;		IPR005554;IPR035082;IPR035367;IPR035368;IPR035369;IPR035370;IPR035371;IPR043519;	PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;		129228	COMPBIAS 36..53;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..30;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 36..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (1); Erroneous initiation (4); Modified residue (3); Region (2); Sequence conflict (4)		Alternative splicing;Chromosome;Coiled coil;Nucleus;Phosphoprotein;RNA-binding;Reference proteome							230082	GO:0006364~rRNA processing,GO:0006409~tRNA export from nucleus,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0032040~small-subunit processome,GO:0032545~CURI complex,GO:0034456~UTP-C complex,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR005554:Nrap protein,	PF03813:Nrap protein,		3.52493861934585	2.25143938931902e-08	FDR<0.01	7.64753974012393	7848367.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	259	Splicing
Q9D824	Q9D824-4;Q9D824-3;Q9D824-2;Q9D824	Fip1l1	2.5067	2.6577	14676450	NA	1.99720391451967	NA	NA	NA	NA	240458.333333333	5	Fip1l1	0	Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)		FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. FIP1L1 contributes to poly(A) site recognition and stimulates poly(A) addition. Binds to U-rich RNA sequence elements surrounding the poly(A) site. May act to tether poly(A) polymerase to the CPSF complex (By similarity). {ECO:0000250}.		mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	66899;		IPR007854;	PF05182;		64959	COMPBIAS 231..268;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 331..389;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 418..432;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..548;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..332;  /note=Necessary for stimulating PAPOLA activity;  /evidence=ECO:0000250; REGION 1..110;  /note=Sufficient for interaction with PAPOLA;  /evidence=ECO:0000250; REGION 1..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 136..219;  /note=Sufficient for interaction with CPSF4;  /evidence=ECO:0000250; REGION 211..282;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 320..581;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 428..581;  /note=Sufficient for interaction with CPSF1 and CSTF3;  /evidence=ECO:0000250; REGION 442..477;  /note=Arg/Asp/Glu-rich domain;  /evidence=ECO:0000250|UniProtKB:Q6UN15; REGION 478..535;  /note=Sufficient for interaction with AHCYL1;  /evidence=ECO:0000269|PubMed:19224921	NA							4 out of 5	Alternative sequence (4); Chain (1); Compositional bias (4); Modified residue (10); Region (9)		Alternative splicing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing							66899	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,	GO:0005634~nucleus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007854:Pre-mRNA polyadenylation factor Fip1,	PF05182:Fip1 motif,		1.2446497494404	0.0156743722440252	FDR<0.1	1.80480984356998	7458454.16666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	270	Splicing
A2BE28	A2BE28-2;A2BE28	Las1l	2.7024	2.8075	4004500	3.1562667676672	2.17155266015201	4.14628078613484	1.75879838894068	6.25039064941559	7.04274948940066	8509458.33333333	0	Las1l	0	Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog)		FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. Required for maturation of the 28S rRNA (By similarity). Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. {ECO:0000250, ECO:0000269|PubMed:22872859}.		maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]	Las1 complex [GO:0090730]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]	endonuclease activity [GO:0004519]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:22872859}. Note=Localizes mainly to the granular component, the region implicated in the later steps of rRNA processing and subunit assembly and export (By similarity). Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions. {ECO:0000250}.	76130;		IPR007174;	PF04031;		89414	COMPBIAS 185..223;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 224..247;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..516;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 540..557;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 558..605;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 613..646;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 185..247;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 501..646;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 733..759;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Modified residue (3); Region (3)		Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;rRNA processing							76130	GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0000478~endonucleolytic cleavage involved in rRNA processing,GO:0006325~chromatin organization,GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0030687~preribosome, large subunit precursor,GO:0071339~MLL1 complex,	GO:0044822~poly(A) RNA binding,	IPR007174:Las1-like,	PF04031:Las1-like ,		1.75337080059587	3.06585866353135e-05	FDR<0.01	4.51344787005022	6256979.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	310	Splicing
Q9CY66	Q9CY66-3;Q9CY66-2;Q9CY66	Gar1	23.057	19.014	9776200	18.8746909269361	10.5941181456056	NA	3.6330608537693	13.62100904435	5.29969791721872	2262886.66666667	1	Gar1	0	H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1)		FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme (By similarity). {ECO:0000250}.		snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}. Note=Also localized to Cajal bodies (coiled bodies). {ECO:0000250}.	68147;		IPR038664;IPR007504;IPR009000;	PF04410;		23474		REGION 1..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4..68;  /note=RGG-box 1; REGION 167..231;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 180..231;  /note=RGG-box 2	NA							4 out of 5	Alternative sequence (2); Chain (1); Cross-link (1); Region (4); Sequence conflict (1)		Alternative splicing;Isopeptide bond;Nucleus;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing		DOMAIN: Interaction with SMN1 requires at least one of the RGG-box regions. {ECO:0000250}.					68147	GO:0000454~snoRNA guided rRNA pseudouridine synthesis,GO:0001522~pseudouridine synthesis,GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0000784~nuclear chromosome, telomeric region,GO:0001651~dense fibrillar component,GO:0005634~nucleus,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031429~box H/ACA snoRNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR007504:H/ACA ribonucleoprotein complex, subunit Gar1/Naf1,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR021154:H/ACA ribonucleoprotein complex, subunit Gar1, eukaryote,	PF04410:Gar1/Naf1 RNA binding region,	SSF50447:Translation proteins,	3.49350758824391	1.62611693693808e-06	FDR<0.01	5.78884822673649	6019543.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	320	Splicing
Q3TZX8	Q3TZX8-3;Q3TZX8-2;Q3TZX8	Nol9	15.524	11.926	1946250	7.82840144042587	4.18182578513779	9.16926462497708	6.9357747260369	53.1152068837308	4.83863163497363	2641505	0	Nol9	0	Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9)		FUNCTION: Polynucleotide 5'-kinase involved in rRNA processing. The kinase activity is required for the processing of the 32S precursor into 5.8S and 28S rRNAs, more specifically for the generation of the major 5.8S(S) form. In vitro, has both DNA and RNA 5'-kinase activities. Probably binds RNA (By similarity). {ECO:0000250}.		cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; RNA processing [GO:0006396]	intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q5SY16}. Nucleus {ECO:0000269|PubMed:22872859}. Note=Colocalizes with pre-60S rRNP particles. {ECO:0000250}.	74035;		IPR032319;	PF16575;		80840	COMPBIAS 98..121;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 80..133;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.1.-			5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (1); Cross-link (1); Initiator methionine (1); Modified residue (3); Nucleotide binding (1); Region (1); Sequence caution (1); Sequence conflict (4)		ATP-binding;Acetylation;Alternative splicing;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transferase;Ubl conjugation;rRNA processing							74035	GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000460~maturation of 5.8S rRNA,GO:0006364~rRNA processing,GO:0016310~phosphorylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0051731~polynucleotide 5'-hydroxyl-kinase activity,				3.32022908927792	1.98313597371696e-06	FDR<0.01	5.70264750737289	2293877.5	Present in Nucleus	RBP	Others	Others	Others	Others	581	Splicing
Q5SFM8	Q5SFM8;Q5SFM8-3;Q5SFM8-2	Rbm27	7.9791	5.9087	1221650	6.70690811535882	5.5386319579064	9.40822278671559	2.88983932493353	10.1894213427619	5.80012760280726	2720993.33333333	0	Rbm27	0	RNA-binding protein 27 (Peri-implantation stem cell protein 1) (RNA-binding motif protein 27)				mRNA processing [GO:0006397]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15741184}. Nucleus speckle {ECO:0000269|PubMed:15741184}. Note=Incorporated into the nuclear speckles and to speckles proximal to the nuclear periphery. Also localizes to punctate structures in the cytoplasm termed cytospeckles.	225432;	cd12517;	IPR012677;IPR002483;IPR035979;IPR034451;IPR000504;IPR000571;	PF01480;PF00076;PF00642;	SM00360;	118552	COMPBIAS 88..143;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 166..181;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 182..210;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 218..272;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 319..360;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 367..381;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 385..400;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 578..594;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1026..1052;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 80..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 160..278;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 319..416;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 572..594;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 754..775;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 943..982;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1014..1060;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (9); Domain (1); Erroneous initiation (1); Frameshift (2); Modified residue (5); Region (7); Sequence conflict (3); Zinc finger (1)		Alternative splicing;Coiled coil;Cytoplasm;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Zinc;Zinc-finger	DOMAIN 600..674;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domain mediates integration into cytospeckles.			ZN_FING 273..301;  /note=C3H1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50102;PS50103;	225432	GO:0006397~mRNA processing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR002483:PWI domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),PF01480:PWI domain,	SSF54928:RNA-binding domain, RBD,	2.67803008165436	1.63466298641102e-07	FDR<0.01	6.78657177097226	1971321.66666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	624	Splicing
Q6NZN0	Q6NZN0-5;Q6NZN0-3;Q6NZN0-4;Q6NZN0-2;Q6NZN0	Rbm26	3.694	4.012	1860550	4.31573950196366	3.14129547025193	3.62910542551261	1.48106458922674	7.14898484415213	8.64229539365656	1981236.66666667	0	Rbm26	0	RNA-binding protein 26 (Protein expressed in male leptotene and zygotene spermatocytes 393) (MLZ-393) (RNA-binding motif protein 26)				mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]	nucleus [GO:0005634]	metal ion binding [GO:0046872]; RNA binding [GO:0003723]		74213;	cd12516;cd12258;	IPR012677;IPR002483;IPR035979;IPR034861;IPR039511;IPR034859;IPR000504;IPR000571;	PF01480;	SM00360;SM00356;	114143	COMPBIAS 106..124;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 135..170;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 183..226;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 334..392;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 653..667;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 866..882;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 974..1004;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 106..236;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 334..404;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 465..520;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 647..667;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 858..889;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 970..1012;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (3); Chain (1); Coiled coil (3); Compositional bias (7); Cross-link (3); Domain (2); Erroneous initiation (3); Frameshift (3); Modified residue (5); Region (6); Sequence conflict (5); Zinc finger (1)		Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Isopeptide bond;Metal-binding;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 537..611;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 896..965;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176				ZN_FING 288..316;  /note=C3H1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50102;PS50103;	74213	GO:0006397~mRNA processing,GO:0010923~negative regulation of phosphatase activity,		GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR002483:PWI domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF01480:PWI domain,	SSF54928:RNA-binding domain, RBD,	2.00323429629898	1.50033868874408e-05	FDR<0.01	4.82381069157822	1920893.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	633	Splicing
Q91XI1	Q91XI1;Q91XI1-2	Dus3l	10.96	4.5503	2428300	4.12354129726609	4.51895702471869	NA	8.48968503268529	8.22706705059646	4.49216117874309	951484.666666667	1	Dus3l	0	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)		FUNCTION: Catalyzes the synthesis of dihydrouridine, a modified base found in the D-loop of most tRNAs. {ECO:0000250}.				flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150]		224907;	cd02801;	IPR013785;IPR035587;IPR018517;IPR041367;IPR000571;	PF01207;PF18044;		71078		REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 41..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 85..105;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 383;  /note=Proton donor;  /evidence=ECO:0000250|UniProtKB:Q5SMC7		BINDING 352;  /note=FMN;  /evidence=ECO:0000250|UniProtKB:Q5SMC7; BINDING 422;  /note=FMN;  /evidence=ECO:0000250|UniProtKB:Q5SMC7; BINDING 452;  /note=FMN;  /evidence=ECO:0000250|UniProtKB:Q5SMC7	1.3.1.-			3 out of 5	Active site (1); Alternative sequence (2); Binding site (3); Chain (1); Cross-link (1); Modified residue (3); Nucleotide binding (3); Region (3); Sequence conflict (1); Zinc finger (2)		Alternative splicing;FMN;Flavoprotein;Isopeptide bond;Metal-binding;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger;tRNA processing					ZN_FING 107..137;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 145..175;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS01136;PS50103;	224907	GO:0008033~tRNA processing,GO:0055114~oxidation-reduction process,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0016491~oxidoreductase activity,GO:0017150~tRNA dihydrouridine synthase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,	IPR000571:Zinc finger, CCCH-type,IPR001269:tRNA-dihydrouridine synthase,IPR013785:Aldolase-type TIM barrel,IPR018517:tRNA-dihydrouridine synthase, conserved site,	PF01207:Dihydrouridine synthase (Dus),		2.59335859660885	1.20530725538372e-06	FDR<0.01	5.91890222918193	1689892.33333333	Unexpected	RBP	DBD	DBD	Others	RBD	671	Splicing
Q8R3F9	Q8R3F9;Q8R3F9-2	Tut1	2.4932	2.6908	1463650	6.53936698927544	2.74070216789541	NA	NA	6.24180762748892	3.44815696010482	377960	2	Tut1	0	Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52)		FUNCTION: Poly(A) polymerase that creates the 3'-poly(A) tail of specific pre-mRNAs. Localizes to nuclear speckles together with PIP5K1A and mediates polyadenylation of a select set of mRNAs, such as HMOX1. In addition to polyadenylation, it is also required for the 3'-end cleavage of pre-mRNAs: binds to the 3'UTR of targeted pre-mRNAs and promotes the recruitment and assembly of the CPSF complex on the 3'UTR of pre-mRNAs. In addition to adenylyltransferase activity, also has uridylyltransferase activity. However, the ATP ratio is higher than UTP in cells, suggesting that it functions primarily as a poly(A) polymerase. Acts as a specific terminal uridylyltransferase for U6 snRNA in vitro: responsible for a controlled elongation reaction that results in the restoration of the four 3'-terminal UMP-residues found in newly transcribed U6 snRNA. Not involved in replication-dependent histone mRNA degradation. {ECO:0000250|UniProtKB:Q9H6E5}.		mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; RNA 3'-end processing [GO:0031123]; snRNA processing [GO:0016180]; U6 snRNA 3'-end processing [GO:0034477]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; mRNA 3'-UTR binding [GO:0003730]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; U6 snRNA binding [GO:0017070]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H6E5}. Nucleus speckle {ECO:0000250|UniProtKB:Q9H6E5}.	70044;	cd12279;	IPR003604;IPR043519;IPR012677;IPR002058;IPR035979;IPR000504;IPR034388;IPR036236;	PF03828;PF00076;	SM00360;SM00451;	94603	COMPBIAS 262..310;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..335;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 667..689;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 114..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 226..247;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 259..335;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 601..869;  /note=KA1; binds the bulging loops of U6 snRNA but is dispensable for terminal uridylyltransferase activity;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; REGION 640..689;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 735..757;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 775..796;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 803..822;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Adenylyltransferase activity is specifically phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). {ECO:0000250|UniProtKB:Q9H6E5}.	BINDING 205;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 216;  /note=UTP;via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 218;  /note=UTP;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 395;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 395;  /note=UTP;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 417;  /note=UTP;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 435;  /note=UTP;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; BINDING 552;  /note=UTP; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:Q9H6E5	2.7.7.19; 2.7.7.52	METAL 216;  /note=Magnesium; catalytic;  /evidence=ECO:0000250|UniProtKB:Q9H6E5; METAL 218;  /note=Magnesium; catalytic;  /evidence=ECO:0000250|UniProtKB:Q9H6E5		5 out of 5	Alternative sequence (2); Binding site (8); Chain (1); Compositional bias (3); Domain (2); Metal binding (2); Modified residue (2); Region (8); Zinc finger (1)		ATP-binding;Alternative splicing;Magnesium;Manganese;Metal-binding;Nucleotide-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transferase;Zinc;Zinc-finger;mRNA processing	DOMAIN 56..128;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 494..552;  /note=PAP-associated;  /evidence=ECO:0000255	DOMAIN: The zinc-finger domain is required for terminal uridylyltransferase activity. Together with the RRM domain, binds the 5'-area of U6 snRNA. {ECO:0000250|UniProtKB:Q9H6E5}.; DOMAIN: The RRM domain is required for terminal uridylyltransferase activity. Together with the zinc-finger domain, binds the 5'-area of U6 snRNA. {ECO:0000250|UniProtKB:Q9H6E5}.; DOMAIN: The proline-rich region is dispensable for terminal uridylyltransferase activity. {ECO:0000250|UniProtKB:Q9H6E5}.			ZN_FING 16..46;  /note=Matrin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00130	PS50102;	70044	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0016180~snRNA processing,GO:0098789~pre-mRNA cleavage required for polyadenylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0016607~nuclear speck,GO:0045171~intercellular bridge,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0004652~polynucleotide adenylyltransferase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0019899~enzyme binding,GO:0046872~metal ion binding,GO:0050265~RNA uridylyltransferase activity,	IPR000504:RNA recognition motif domain,IPR002058:PAP/25A-associated,IPR003604:Zinc finger, U1-type,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF03828:Cid1 family poly A polymerase,	SSF54928:RNA-binding domain, RBD,	1.88958661187302	9.69580863813842e-05	FDR<0.01	4.01341596457018	920805	Present in Nucleus	RBP	DBD	DBD	Others	RBD	854	Splicing
Q8BIQ5	Q8BIQ5;Q8BIQ5-2	Cstf2	13.24	15.355	1464585	NA	7.42280285035629	3.03140535952468	3.07768065985473	2.31636978527252	2.31229911901404	371712.5	1	Cstf2	0	Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64)		FUNCTION: One of the multiple factors required for polyadenylation and 3'-end cleavage of mammalian pre-mRNAs. This subunit is directly involved in the binding to pre-mRNAs (By similarity). {ECO:0000250}.		cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]	cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14681198}. Note=Localized with DDX1 in cleavage bodies. {ECO:0000250}.	108062;		IPR033105;IPR038192;IPR025742;IPR026896;IPR012677;IPR035979;IPR000504;	PF14327;PF14304;PF00076;	SM00360;	61341	COMPBIAS 514..536;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 108..248;  /note=Interactions with CSTF3 and SYMPK;  /evidence=ECO:0000250; REGION 311..331;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 347..414;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 413..472;  /note=12 X 5 AA tandem repeats of M-E-A-R-[AG]; REGION 511..536;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 517..580;  /note=Interaction with RPO2TC1;  /evidence=ECO:0000250	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (1); Domain (1); Modified residue (6); Region (6); Repeat (12); Sequence conflict (1)		Alternative splicing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;mRNA processing	DOMAIN 16..94;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176			REPEAT 413..417;  /note=1; approximate; REPEAT 418..422;  /note=2; REPEAT 423..427;  /note=3; REPEAT 428..432;  /note=4; approximate; REPEAT 433..437;  /note=5; approximate; REPEAT 438..442;  /note=6; REPEAT 443..447;  /note=7; REPEAT 448..452;  /note=8; REPEAT 453..457;  /note=9; REPEAT 458..462;  /note=10; REPEAT 463..467;  /note=11; REPEAT 468..472;  /note=12; approximate		PS50102;	108062	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0031124~mRNA 3'-end processing,GO:0098789~pre-mRNA cleavage required for polyadenylation,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0071920~cleavage body,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR025742:Cleavage stimulation factor subunit 2, hinge domain,IPR026896:Transcription termination and cleavage factor C-terminal domain,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF14304:Transcription termination and cleavage factor C-terminal,PF14327:Hinge domain of cleavage stimulation factor subunit 2,	SSF54928:RNA-binding domain, RBD,	2.31463654624159	0.000155711470413709	FDR<0.01	3.80767939415061	918148.75	Present in Nucleus	RBP	RBD	Others	Others	RBD	855	Splicing
Q8CE96	Q8CE96-4;Q8CE96-3;Q8CE96	Trmt6	NA	10.008	984200	5.02411575562701	5.02209722780233	1.59217921569252	NA	4.50227364819234	4.36471563877613	732628.333333333	1	Trmt6	1	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6)		FUNCTION: Substrate-binding subunit of tRNA (adenine-N(1)-)-methyltransferase, which catalyzes the formation of N(1)-methyladenine at position 58 (m1A58) in initiator methionyl-tRNA. Together with the TRMT61A catalytic subunit, part of a mRNA N(1)-methyltransferase complex that mediates methylation of adenosine residues at the N(1) position of a small subset of mRNAs: N(1) methylation takes place in tRNA T-loop-like structures of mRNAs and is only present at low stoichiometries. {ECO:0000250|UniProtKB:Q9UJA5}.		mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488]	nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P41814}.	66926;		IPR017423;	PF04189;		55518	COMPBIAS 324..354;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 81..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 95..105;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5; REGION 146..155;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5; REGION 176..183;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5; REGION 275..354;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 415..423;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5; REGION 434..441;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5; REGION 474..497;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 349;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5; BINDING 377;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9UJA5				4 out of 5	Alternative sequence (3); Binding site (2); Chain (1); Compositional bias (1); Erroneous initiation (1); Frameshift (1); Modified residue (1); Region (8); Sequence conflict (5)		Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;tRNA processing							66926	GO:0008033~tRNA processing,GO:0030488~tRNA methylation,	GO:0005634~nucleus,GO:0031515~tRNA (m1A) methyltransferase complex,	GO:0044822~poly(A) RNA binding,	IPR017423:tRNA (adenine-N(1)-)-methyltransferase, non-catalytic TRM6 subunit,	PF04189:Gcd10p family,		2.15796426663951	0.000119410491040608	FDR<0.01	3.92295751574524	858414.166666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	880	Splicing
Q8BTV2	Q8BTV2-2;Q8BTV2;Q8BTV2-3	Cpsf7	3.9593	9.7439	529100	7.09924747976714	15.8012830641848	2.09200644337985	6.49434991557345	7.06514059629787	13.4005145797599	1093335.5	0	Cpsf7	0	Cleavage and polyadenylation specificity factor subunit 7		FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation. The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs. CPSF7 activates directly the mRNA 3'-processing machinery. Binds to pA signals in RNA substrates. {ECO:0000250|UniProtKB:Q8N684}.		messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8N684}. Cytoplasm {ECO:0000250|UniProtKB:Q8N684}. Note=Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm). {ECO:0000250|UniProtKB:Q8N684}.	269061;	cd12644;	IPR034772;IPR034770;IPR034773;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	52011	COMPBIAS 427..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 34..68;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 176..220;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 409..471;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 418..469;  /note=Arg/Ser-rich domain;  /evidence=ECO:0000250|UniProtKB:Q8N684	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (1); Domain (1); Modified residue (4); Region (4); Sequence conflict (1)		Alternative splicing;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;mRNA processing	DOMAIN 82..162;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: Contains an Arg/Ser-rich domain composed of arginine-serine dipeptide repeats within the C-terminal region that is necessary and sufficient for activating mRNA 3'-processing. {ECO:0000250|UniProtKB:Q8N684}.				PS50102;	269061	GO:0006397~mRNA processing,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005849~mRNA cleavage factor complex,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.80104847573083	2.26258659417297e-06	FDR<0.01	5.6453947903982	811217.75	Present in Nucleus	RBP	RBD	Others	Others	RBD	891	Splicing
Q8BJ05	Q8BJ05;Q8BJ05-2	Zc3h14	7.1772	11.156	516160	5.83192395171167	7.87463579809434	NA	NA	13.0546598608373	NA	650199.333333333	3	Zc3h14	0	Zinc finger CCCH domain-containing protein 14		FUNCTION: Involved in poly(A) tail length control in neuronal cells. Binds the polyadenosine RNA oligonucleotides. {ECO:0000250|UniProtKB:Q6PJT7}.		negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488]	axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:19303045, ECO:0000269|PubMed:21734151}. Note=Colocalizes with poly(A) RNA in nuclear speckles. {ECO:0000269|PubMed:21734151}.	75553;		IPR040366;IPR000571;		SM00356;	82409	COMPBIAS 78..100;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 134..153;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 78..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 308..351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 399..431;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (4); Chain (1); Compositional bias (2); Cross-link (11); Modified residue (13); Region (3); Sequence conflict (2); Zinc finger (5)		Acetylation;Alternative splicing;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 595..620;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 621..640;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 641..656;  /note=C3H1-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 681..698;  /note=C3H1-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 700..718;  /note=C3H1-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50103;	75553	GO:0043488~regulation of mRNA stability,GO:1900364~negative regulation of mRNA polyadenylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0008143~poly(A) binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,			3.11016942577104	4.82680588319899e-06	FDR<0.01	5.31634016659475	583179.666666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	987	Splicing
Q7TQH0	Q7TQH0-2;Q7TQH0-3;Q7TQH0	Atxn2l	2.4863	5.0993	860105	9.20301859009755	11.6437478895707	NA	NA	NA	2.21685251280232	190175.666666667	3	Atxn2l	0	Ataxin-2-like protein		FUNCTION: Involved in the regulation of stress granule and P-body formation. {ECO:0000250|UniProtKB:Q8WWM7}.		regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cytoplasm {ECO:0000250|UniProtKB:Q8WWM7}. Nucleus speckle {ECO:0000250|UniProtKB:Q8WWM7}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q8WWM7}. Note=Predominantly cytoplasmic but is also detected in nuclear speckles. Component of cytoplasmic stress granules. Inhibition of methylation alters nuclear localization. Methylation does not seem to be required for localization to stress granules under stress conditions. {ECO:0000250|UniProtKB:Q8WWM7}.	233871;		IPR009818;IPR009604;IPR025852;	PF06741;PF07145;PF14438;	SM01272;	110649	COMPBIAS 314..330;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 417..432;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 477..503;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 656..704;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 868..922;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 925..939;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1026..1043;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 96..119;  /note=Interaction with MPL;  /evidence=ECO:0000250; REGION 314..522;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 554..573;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 578..704;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 736..772;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 824..852;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 868..944;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 999..1049;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (7); Cross-link (1); Modified residue (28); Region (9)		Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Membrane;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							233871	GO:0010603~regulation of cytoplasmic mRNA processing body assembly,GO:0034063~stress granule assembly,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR009604:LsmAD domain,IPR009818:Ataxin-2, C-terminal,IPR025852:SM domain found in ataxin-2,	PF06741:LsmAD domain,PF07145:Ataxin-2 C-terminal region,PF14438:Ataxin 2 SM domain,		2.3112806273995	0.000583465890751884	FDR<0.01	3.233984527607	525140.333333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	1022	Splicing
Q9D0L8	Q9D0L8;Q9D0L8-2;Q9D0L8-3	Rnmt	5.6195	6.5824	403765	12.5330559350286	8.72828838264816	NA	NA	9.64413154595429	4.3624307464119	475386.666666667	2	Rnmt	0	mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase)		FUNCTION: Catalytic subunit of the mRNA-capping methyltransferase RNMT:RAMAC complex that methylates the N7 position of the added guanosine to the 5'-cap structure of mRNAs. Binds RNA containing 5'-terminal GpppC. {ECO:0000250|UniProtKB:O43148}.		7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830]	fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]	mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43148}.	67897;		IPR004971;IPR016899;IPR039753;IPR029063;	PF03291;		53291	COMPBIAS 65..129;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..132;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 165..166;  /note=mRNA cap binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00895	NA		ACTIVITY REGULATION: Methyltransferase activity is activated by RAMAC. {ECO:0000250|UniProtKB:O43148}.	BINDING 169;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00895; BINDING 194;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00895; BINDING 216;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00895; BINDING 250;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:O43148; BINDING 273;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O43148; BINDING 278;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43148	2.1.1.56			5 out of 5	Alternative sequence (2); Binding site (6); Chain (1); Compositional bias (1); Domain (1); Erroneous initiation (1); Modified residue (5); Motif (1); Region (2); Sequence conflict (2); Site (6)		Alternative splicing;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase;mRNA capping;mRNA processing	DOMAIN 117..465;  /note=mRNA cap 0 methyltransferase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00895		MOTIF 113..115;  /note=Nuclear localization signal;  /evidence=ECO:0000250			PS51562;	67897	GO:0006370~7-methylguanosine mRNA capping,GO:0006397~mRNA processing,GO:0032259~methylation,GO:0036265~RNA (guanine-N7)-methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005845~mRNA cap binding complex,GO:0043235~receptor complex,	GO:0003723~RNA binding,GO:0004482~mRNA (guanine-N7-)-methyltransferase activity,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,	IPR004971:mRNA (guanine-N(7))-methyltransferase domain,IPR016899:mRNA (guanine-N(7))-methyltransferase,	PF03291:mRNA capping enzyme,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.89620068701351	2.073499236813e-06	FDR<0.01	5.68329612014947	439575.833333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	1083	Splicing
Q99PU8	Q99PU8-2;Q99PU8;Q99PU8-3	Dhx30	4.6629	NA	99618.5	4.76326569496046	6.29405840886203	2.96471983397569	NA	NA	3.19601137780051	318796.166666667	2	Dhx30	1	ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)		FUNCTION: RNA-dependent helicase (PubMed:25219788). Plays an important role in the assembly of the mitochondrial large ribosomal subunit (By similarity). Required for optimal function of the zinc-finger antiviral protein ZC3HAV1 (By similarity). Associates with mitochondrial DNA (By similarity). Involved in nervous system development and differentiation through its involvement in the up-regulation of a number of genes which are required for neurogenesis, including GSC, NCAM1, neurogenin, and NEUROD (PubMed:25219788). {ECO:0000250|UniProtKB:Q5BJS0, ECO:0000250|UniProtKB:Q7L2E3, ECO:0000269|PubMed:25219788}.		central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25219788}. Mitochondrion {ECO:0000250|UniProtKB:Q7L2E3}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000250|UniProtKB:Q7L2E3}. Note=Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. Relocalizes to stress granules upon heat stress. {ECO:0000250|UniProtKB:Q7L2E3}.	72831;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	136668		REGION 176..223;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Alternative sequence (2); Chain (1); Domain (3); Modified residue (4); Motif (1); Nucleotide binding (1); Region (1); Sequence conflict (13)		ATP-binding;Alternative splicing;Cytoplasm;Helicase;Hydrolase;Mitochondrion;Mitochondrion nucleoid;Nucleotide-binding;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis	DOMAIN 76..144;  /note=DRBM; DOMAIN 467..635;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 677..850;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 582..585;  /note=DEAH box			PS00690;PS51192;PS51194;	72831	GO:0006396~RNA processing,GO:0042254~ribosome biogenesis,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.07426748046558	8.32093598092713e-05	FDR<0.01	4.0798278193236	209207.333333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1273	Splicing
Q61183	Q61183;Q61183-4;Q61183-3;Q61183-2;Q9WVP6	Papola	NA	7.6052	287500	NA	NA	4.71053747232559	NA	NA	1.97796546472299	97356.3333333333	4	Papola	1	Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase)		FUNCTION: Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus. {ECO:0000250|UniProtKB:P51003, ECO:0000269|PubMed:18084034, ECO:0000269|PubMed:18281463}.		mRNA polyadenylation [GO:0006378]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	18789;		IPR043519;IPR011068;IPR007012;IPR007010;IPR014492;IPR002934;	PF01909;PF04928;PF04926;		82309	COMPBIAS 1..21;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 523..600;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 611..648;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 649..666;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 687..718;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 508..643;  /note=Ser/Thr-rich; REGION 523..725;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 671..739;  /note=Required for interaction with NUDT21;  /evidence=ECO:0000269|PubMed:11716503	NA			BINDING 109;  /note=ATP;  /evidence=ECO:0000250; BINDING 167;  /note=ATP;  /evidence=ECO:0000250; BINDING 228;  /note=ATP;  /evidence=ECO:0000250; BINDING 237;  /note=ATP;  /evidence=ECO:0000250	2.7.7.19	METAL 113;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250; METAL 113;  /note=Magnesium 2; catalytic;  /evidence=ECO:0000250; METAL 115;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250; METAL 115;  /note=Magnesium 2; catalytic;  /evidence=ECO:0000250; METAL 167;  /note=Magnesium 2; catalytic;  /evidence=ECO:0000250		5 out of 5	Alternative sequence (6); Binding site (4); Chain (1); Compositional bias (5); Cross-link (6); Metal binding (5); Modified residue (9); Motif (2); Mutagenesis (3); Nucleotide binding (3); Region (4); Sequence conflict (1); Site (5)		ATP-binding;Acetylation;Alternative splicing;Isopeptide bond;Magnesium;Manganese;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transferase;Ubl conjugation;mRNA processing			MOTIF 490..507;  /note=Nuclear localization signal 1;  /evidence=ECO:0000250; MOTIF 644..659;  /note=Nuclear localization signal 2;  /evidence=ECO:0000250				18789	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0031123~RNA 3'-end processing,GO:0031440~regulation of mRNA 3'-end processing,GO:0043631~RNA polyadenylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004652~polynucleotide adenylyltransferase activity,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,	IPR002934:Nucleotidyl transferase domain,IPR007010:Poly(A) polymerase, RNA-binding domain,IPR007012:Poly(A) polymerase, central domain,IPR011068:Nucleotidyltransferase, class I, C-terminal-like,IPR014492:Poly(A) polymerase,	PF01909:Nucleotidyltransferase domain,PF04926:Poly(A) polymerase predicted RNA binding domain,PF04928:Poly(A) polymerase central domain,	SSF55003:PAP/Archaeal CCA-adding enzyme, C-terminal domain,	2.04896503524814	0.00596091068677636	FDR<0.01	2.22468738522148	192428.166666667	Present in Nucleus	RBP	ChD	Others	ChD	RBD	1293	Splicing
Q8CCS6	Q8CCS6-2;Q8CCS6	Pabpn1	17.93	14.092	17729000	23.7880013321281	6.55350940428599	5.72934570872006	NA	45.533193698206	5.44454728589318	5125868.33333333	1	Pabpn1	0	Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1)		FUNCTION: Involved in the 3'-end formation of mRNA precursors (pre-mRNA) by the addition of a poly(A) tail of 200-250 nt to the upstream cleavage product. Stimulates poly(A) polymerase (PAPOLA) conferring processivity on the poly(A) tail elongation reaction and controls also the poly(A) tail length. Increases the affinity of poly(A) polymerase for RNA. Is also present at various stages of mRNA metabolism including nucleocytoplasmic trafficking and nonsense-mediated decay (NMD) of mRNA. Cooperates with SKIP to synergistically activate E-box-mediated transcription through MYOD1 and may regulate the expression of muscle-specific genes. Binds to poly(A) and to poly(G) with high affinity. May protect the poly(A) tail from degradation. Subunit of the trimeric poly(A) tail exosome targeting (PAXT) complex, a complex that directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor MTREX, which links to RNA-binding protein adapters (By similarity). {ECO:0000250|UniProtKB:Q28165, ECO:0000250|UniProtKB:Q86U42}.		cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA polyadenylation [GO:0006378]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]	cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	poly(A) binding [GO:0008143]; protein self-association [GO:0043621]; RNA polymerase binding [GO:0070063]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q86U42}. Nucleus {ECO:0000250|UniProtKB:Q86U42}. Nucleus speckle {ECO:0000250|UniProtKB:Q86U42}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles between the nucleus and the cytoplasm but predominantly found in the nucleus. Its nuclear import may involve the nucleocytoplasmic transport receptor transportin and a RAN-GTP-sensitive import mechanism. It is exported to the cytoplasm by a carrier-mediated pathway that is independent of mRNA traffic. Nucleus; nuclear speckle (By similarity). Colocalizes with SKIP and poly(A) RNA in nuclear speckles (By similarity). {ECO:0000250|UniProtKB:Q28165, ECO:0000250|UniProtKB:Q86U42}.	54196;		IPR012677;IPR034911;IPR035979;IPR000504;	PF00076;	SM00360;	32297	COMPBIAS 95..111;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..141;  /note=Interaction with SKIP;  /evidence=ECO:0000250; REGION 115..143;  /note=Stimulates PAPOLA;  /evidence=ECO:0000250; REGION 255..302;  /note=Strong poly(A) affinity and self-association;  /evidence=ECO:0000250; REGION 282..302;  /note=Interaction with PAPOLA;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (24); Region (5)	MISCELLANEOUS: [Isoform 2]: May be due to a competing donor splice site. {ECO:0000305}.	Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	DOMAIN 168..245;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domain is essential for specific adenine bases recognition in the poly(A) tail but not sufficient for poly(A) binding. {ECO:0000250}.				PS50102;	54196	GO:0000165~MAPK cascade,GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0071222~cellular response to lipopolysaccharide,GO:1904247~positive regulation of polynucleotide adenylyltransferase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0042405~nuclear inclusion body,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0043621~protein self-association,GO:0044822~poly(A) RNA binding,GO:0070063~RNA polymerase binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.6767953037256	2.76163544960387e-06	FDR<0.01	5.55883365112836	11427434.1666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	207	Splicing
P97379	P97379-2;P97379	G3bp2	10.995	14.116	3402550	15.5426724070937	8.6051114361931	9.80296049406921	5.76734529096257	10.2245306940411	9.67305088024763	2235405	0	G3bp2	0	Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2)		FUNCTION: Scaffold protein that plays an essential role in cytoplasmic stress granule formation which acts as a platform for antiviral signaling. {ECO:0000250|UniProtKB:Q9UN86}.		innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UN86}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9UN86}.	23881;	cd00780;cd12464;	IPR034377;IPR034376;IPR002075;IPR032710;IPR018222;IPR012677;IPR039539;IPR035979;IPR000504;	PF02136;PF00076;	SM00360;	54088	COMPBIAS 140..159;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 198..226;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 244..264;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 286..304;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..433;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 140..170;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 187..318;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 408..482;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (5); Cross-link (1); Domain (2); Erroneous initiation (1); Modified residue (10); Region (3); Sequence conflict (1)		Alternative splicing;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Methylation;Phosphoprotein;RNA-binding;Reference proteome;Transport;Ubl conjugation;mRNA transport	DOMAIN 11..133;  /note=NTF2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00137; DOMAIN 331..409;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50177;PS50102;	23881	GO:0006810~transport,GO:0007264~small GTPase mediated signal transduction,GO:0051028~mRNA transport,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02136:Nuclear transport factor 2 (NTF2) domain,	SSF54427:NTF2-like,SSF54928:RNA-binding domain, RBD,	3.34880628710748	5.13139902847722e-09	FDR<0.01	8.28976421237099	2818977.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	523	Splicing
Q91Z49	Q91Z49;Q91Z49-2;Q91Z49-3	Fyttd1	4.1392	4.1519	2400750	NA	3.66959010678507	NA	NA	1.16732425933276	2.35754532380885	724073.333333333	3	Fyttd1	0	UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3)		FUNCTION: Required for mRNA export from the nucleus to the cytoplasm. Acts as an adapter that uses the DDX39B/UAP56-NFX1 pathway to ensure efficient mRNA export and delivering to the nuclear pore. Associates with spliced and unspliced mRNAs simultaneously with ALYREF/THOC4 (By similarity). {ECO:0000250}.		mRNA export from nucleus [GO:0006406]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}. Nucleus speckle {ECO:0000250}.	69823;		IPR009782;			35887		REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (3); Chain (1); Cross-link (2); Modified residue (5); Motif (1); Region (1); Sequence conflict (4)		Acetylation;Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transport;Ubl conjugation;mRNA transport			MOTIF 26..44;  /note=UAP56-binding motif				69823	GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0051028~mRNA transport,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR009782:Protein of unknown function DUF1346,			1.48784669079555	0.00274554924758229	FDR<0.01	2.56137076183936	1562411.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	689	Splicing
Q5SF07	Q5SF07;Q5SF07-2	Igf2bp2	NA	6.3084	1681050	NA	NA	NA	NA	NA	6.24258692802297	63191.3333333333	5	Igf2bp2	1	Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)		FUNCTION: RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific. Binds to beta-actin/ACTB and MYC transcripts (By similarity). {ECO:0000250}.		mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Localizes at the connecting piece and the tail of the spermatozoa. In response to cellular stress, such as oxidative stress, recruited to stress granules (By similarity). {ECO:0000250}.	319765;	cd12626;	IPR028743;IPR034843;IPR004087;IPR004088;IPR036612;IPR012677;IPR035979;IPR000504;	PF00013;PF00076;	SM00322;SM00360;	65584		REGION 157..182;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Domain (6); Modified residue (4); Region (1); Sequence conflict (1)		Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Translation regulation;Transport;mRNA transport	DOMAIN 3..76;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 82..157;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 186..251;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 267..334;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 420..485;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 502..568;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: Domain KH3 and KH4 are the major RNA-binding modules, although KH1 and KH2 may also contribute. The contribution to RNA-binding of individual KH domains may be target-specific. KH1 and KH2, and possibly KH3 and KH4, promote the formation of higher ordered protein-RNA complexes, which may be essential for IGF2BP1 cytoplasmic retention. KH domains are required for RNA-dependent homo- and heterooligomerization and for localization to stress granules (By similarity). {ECO:0000250}.				PS50084;PS50102;	319765	GO:0006417~regulation of translation,GO:0006810~transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00013:KH domain,PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54791:Eukaryotic type KH-domain (KH-domain type I),SSF54928:RNA-binding domain, RBD,	2.64970907328269	0.00298552794206565	FDR<0.01	2.52497885982699	872120.666666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	874	Splicing
Q9QYS9	Q9QYS9-8;Q9QYS9-4;Q9QYS9-3;Q9QYS9-2;Q9QYS9;Q9QYS9-7;Q9QYS9-6;Q9QYS9-5	Qki	6.9274	3.2398	8677150	2.57426762086186	3.40761943706127	NA	NA	6.09979260705136	6.07939692382516	695100	2	Qki	0	Protein quaking (MqkI) (qkI)		FUNCTION: RNA-binding protein that plays a central role in myelinization (PubMed:10864952, PubMed:11917126). Also required for visceral endoderm function and blood vessel development (PubMed:11892011, PubMed:16470614). Binds to the 5'-NACUAAY-N(1,20)-UAAY-3' RNA core sequence (PubMed:16041388). Acts by regulating pre-mRNA splicing, mRNA export, mRNA stability and protein translation, as well as cellular processes including apoptosis, cell cycle, glial cell fate and development (PubMed:10535969, PubMed:12467586, PubMed:11297509, PubMed:11917126, PubMed:15568022). Required to protect and promote stability of mRNAs such as MBP and CDKN1B which promotes oligodendrocyte differentiation (PubMed:10535969, PubMed:15568022). Participates in mRNA transport by regulating the nuclear export of MBP mRNA (PubMed:12467586). May also play a role in smooth muscle development (PubMed:14706070). {ECO:0000269|PubMed:10535969, ECO:0000269|PubMed:10864952, ECO:0000269|PubMed:11297509, ECO:0000269|PubMed:11892011, ECO:0000269|PubMed:11917126, ECO:0000269|PubMed:12467586, ECO:0000269|PubMed:14706070, ECO:0000269|PubMed:15568022, ECO:0000269|PubMed:16041388, ECO:0000269|PubMed:16470614}.; FUNCTION: Isoform 1 is involved in regulation of mRNA splicing of MAG pre-mRNA by acting as a negative regulator of MAG exon 12 alternative splicing. {ECO:0000269|PubMed:11917126}.; FUNCTION: Isoform 3 can induce apoptosis, while heterodimerization with other isoforms results in nuclear translocation of isoform 3 and suppression of apoptosis. {ECO:0000269|PubMed:11297509}.; FUNCTION: Isoform 4 acts as a translational repressor for GLI1. {ECO:0000269|PubMed:16198329}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; axon ensheathment [GO:0008366]; long-chain fatty acid biosynthetic process [GO:0042759]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; mRNA transport [GO:0051028]; muscle cell differentiation [GO:0042692]; myelination [GO:0042552]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]; spermatid development [GO:0007286]; vasculogenesis [GO:0001570]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus.; SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm. Nucleus. Note=Isoform 1 localizes predominantly in the nucleus and at lower levels in cytoplasm. It shuttles between the cytoplasm and the nucleus.; SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm. Nucleus. Note=Isoform 3 localizes predominantly in the cytoplasm and at much lower levels in nucleus.; SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm. Nucleus. Note=Isoform 4 localizes both in the cytoplasm and nucleus.	19317;		IPR004087;IPR004088;IPR036612;IPR032367;IPR032377;	PF00013;PF16551;PF16544;	SM00322;	37671		REGION 11..82;  /note=Qua1 domain; involved in homodimerization;  /evidence=ECO:0000250|UniProtKB:Q17339; REGION 182..213;  /note=Qua2 domain; involved in RNA binding;  /evidence=ECO:0000250|UniProtKB:Q96PU8	NA							5 out of 5	Alternative sequence (8); Chain (1); Domain (1); Helix (3); Modified residue (5); Motif (2); Mutagenesis (11); Region (2); Sequence conflict (1); Site (6)		3D-structure;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;SH3-binding;Translation regulation;Transport;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 87..153;  /note=KH	DOMAIN: The KH domain and the Qua2 region are involved in RNA binding. {ECO:0000250|UniProtKB:Q96PU8}.	MOTIF 276..279;  /note=SH3-binding; MOTIF 324..330;  /note=Nuclear localization signal				19317	GO:0001570~vasculogenesis,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0006810~transport,GO:0007275~multicellular organism development,GO:0007286~spermatid development,GO:0008366~axon ensheathment,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010976~positive regulation of neuron projection development,GO:0030154~cell differentiation,GO:0042552~myelination,GO:0042692~muscle cell differentiation,GO:0042759~long-chain fatty acid biosynthetic process,GO:0048255~mRNA stabilization,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0051028~mRNA transport,GO:0061158~3'-UTR-mediated mRNA destabilization,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0017124~SH3 domain binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.13897223510857	3.15467665102267e-05	FDR<0.01	4.50104514858251	4686125	Present in Nucleus	RBP	RBD	Others	Others	RBD	386	Splicing
O70551	O70551;Q9Z0G2	Srpk1	8.2921	11.444	1715100	6.9204152249135	6.40861317610869	11.2357025684816	4.56412596987677	6.81106116332925	6.17474529175671	1032275	0	Srpk1	0	SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)		FUNCTION: Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Plays a central role in the regulatory network for splicing, controlling the intranuclear distribution of splicing factors in interphase cells and the reorganization of nuclear speckles during mitosis. Can influence additional steps of mRNA maturation, as well as other cellular activities, such as chromatin reorganization in somatic and sperm cells and cell cycle progression. Phosphorylates SFRS2, ZRSR2, LBR and PRM1. Phosphorylates SRSF1 using a directional (C-terminal to N-terminal) and a dual-track mechanism incorporating both processive phosphorylation (in which the kinase stays attached to the substrate after each round of phosphorylation) and distributive phosphorylation steps (in which the kinase and substrate dissociate after each phosphorylation event). The RS domain of SRSF1 binds first to a docking groove in the large lobe of the kinase domain of SRPK1. This induces certain structural changes in SRPK1 and/or RRM2 domain of SRSF1, allowing RRM2 to bind the kinase and initiate phosphorylation. The cycles continue for several phosphorylation steps in a processive manner (steps 1-8) until the last few phosphorylation steps (approximately steps 9-12). During that time, a mechanical stress induces the unfolding of the beta-4 motif in RRM2, which then docks at the docking groove of SRPK1. This also signals RRM2 to begin to dissociate, which facilitates SRSF1 dissociation after phosphorylation is completed. Can mediate hepatitis B virus (HBV) core protein phosphorylation. It plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles. Can induce splicing of exon 10 in MAPT/TAU (By similarity). {ECO:0000250, ECO:0000269|PubMed:10390541, ECO:0000269|PubMed:9446799}.		cell differentiation [GO:0030154]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q96SB4}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q96SB4}. Nucleus matrix {ECO:0000250|UniProtKB:Q96SB4}. Microsome {ECO:0000250|UniProtKB:Q96SB4}. Nucleus speckle {ECO:0000250|UniProtKB:Q96SB4}. Chromosome {ECO:0000250|UniProtKB:Q96SB4}. Note=Shuttles between the nucleus and the cytoplasm (By similarity). Inhibition of the Hsp90 ATPase activity, osmotic stress and interaction with HHV-1 ICP27 protein can induce its translocation to the nucleus (By similarity). KAT5/TIP60 inhibits its nuclear translocation (By similarity). Preferentially localizes to the promoter of gene coding regions (By similarity). {ECO:0000250|UniProtKB:Q96SB4}.	20815;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	73088	COMPBIAS 21..43;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 276..314;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..342;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 395..445;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 238..354;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 395..464;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 213;  /note=Proton acceptor;  /evidence=ECO:0000250|UniProtKB:Q9UPE1, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activated by phosphorylation on Ser-51 and Ser-548. {ECO:0000250|UniProtKB:Q96SB4}.	BINDING 109;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q9UPE1, ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Compositional bias (4); Domain (1); Modified residue (7); Nucleotide binding (1); Region (3); Sequence conflict (4)		ATP-binding;Chromosome;Chromosome partition;Cytoplasm;Differentiation;Direct protein sequencing;Endoplasmic reticulum;Kinase;Microsome;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;mRNA processing;mRNA splicing	DOMAIN 80..646;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	20815	GO:0006397~mRNA processing,GO:0006468~protein phosphorylation,GO:0007059~chromosome segregation,GO:0008380~RNA splicing,GO:0016310~phosphorylation,GO:0030154~cell differentiation,GO:0035556~intracellular signal transduction,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.88921800813892	2.62693668501077e-08	FDR<0.01	7.58055039454618	1373687.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	724	Splicing
Q9JLI8	Q9JLI8;Q9JLI8-2	Sart3	8.8194	9.6192	2762300	5.69313976658127	4.73529690311583	4.4762757385855	1.88253012048193	8.02632635042941	2.91825955000438	1557201.66666667	0	Sart3	0	Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (mSART-3) (Tumor-rejection antigen SART3)		FUNCTION: U6 snRNP-binding protein that functions as a recycling factor of the splicing machinery. Promotes the initial reassembly of U4 and U6 snRNPs following their ejection from the spliceosome during its maturation. Also binds U6atac snRNPs and may function as a recycling factor for U4atac/U6atac spliceosomal snRNP, an initial step in the assembly of U12-type spliceosomal complex. The U12-type spliceosomal complex plays a role in the splicing of introns with non-canonical splice sites. May also function as a substrate-targeting factor for deubiquitinases like USP4 and USP15. Recruits USP4 to ubiquitinated PRPF3 within the U4/U5/U6 tri-snRNP complex, promoting PRPF3 deubiquitination and thereby regulating the spliceosome U4/U5/U6 tri-snRNP spliceosomal complex disassembly. May also recruit the deubiquitinase USP15 to histone H2B and mediate histone deubiquitination, thereby regulating gene expression and/or DNA repair (By similarity). May play a role in hematopoiesis probably through transcription regulation of specific genes including MYC (PubMed:21447833). {ECO:0000250|UniProtKB:Q15020, ECO:0000269|PubMed:21447833}.		cell morphogenesis [GO:0000902]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of gene expression [GO:0010468]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]	ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone binding [GO:0042393]; RNA binding [GO:0003723]; U6atac snRNA binding [GO:0030624]; U6 snRNA binding [GO:0017070]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:12578909}. Nucleus, Cajal body {ECO:0000269|PubMed:12578909}. Nucleus speckle {ECO:0000250|UniProtKB:Q15020}. Cytoplasm {ECO:0000250|UniProtKB:Q15020}.	53890;	cd12391;cd12392;	IPR003107;IPR008669;IPR012677;IPR035979;IPR000504;IPR034217;IPR034218;IPR011990;	PF05391;PF00076;	SM00386;SM00360;	109619	COMPBIAS 591..606;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..92;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..352;  /note=Mediates interaction with PRPF3;  /evidence=ECO:0000250|UniProtKB:Q15020; REGION 488..521;  /note=Required for interaction with USP4;  /evidence=ECO:0000250|UniProtKB:Q15020; REGION 538..952;  /note=Necessary and sufficient for U6 snRNA binding;  /evidence=ECO:0000250|UniProtKB:Q15020; REGION 591..696;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 601..670;  /note=Required for nuclear localization;  /evidence=ECO:0000250|UniProtKB:Q15020; REGION 880..962;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (1); Domain (2); Erroneous initiation (1); Initiator methionine (1); Modified residue (7); Region (7); Repeat (9); Sequence conflict (2)		Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;mRNA processing;mRNA splicing	DOMAIN 704..782;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 801..878;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176			REPEAT 127..159;  /note=HAT 1;  /evidence=ECO:0000255; REPEAT 165..196;  /note=HAT 2;  /evidence=ECO:0000255; REPEAT 202..238;  /note=HAT 3;  /evidence=ECO:0000255; REPEAT 243..276;  /note=HAT 4;  /evidence=ECO:0000255; REPEAT 325..357;  /note=HAT 5;  /evidence=ECO:0000255; REPEAT 360..392;  /note=HAT 6;  /evidence=ECO:0000255; REPEAT 395..431;  /note=HAT 7;  /evidence=ECO:0000255; REPEAT 441..474;  /note=HAT 8;  /evidence=ECO:0000255; REPEAT 488..521;  /note=HAT 9;  /evidence=ECO:0000255		PS50102;	53890	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0000902~cell morphogenesis,GO:0006334~nucleosome assembly,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0048872~homeostasis of number of cells,GO:0071425~hematopoietic stem cell proliferation,GO:1903586~positive regulation of histone deubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005691~U6atac snRNP,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071001~U4/U6 snRNP,GO:0071002~U4atac/U6atac snRNP,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017070~U6 snRNA binding,GO:0030621~U4 snRNA binding,GO:0030624~U6atac snRNA binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,GO:1990381~ubiquitin-specific protease binding,	IPR000504:RNA recognition motif domain,IPR003107:RNA-processing protein, HAT helix,IPR008669:LSM-interacting domain,IPR011990:Tetratricopeptide-like helical,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF05391:Lsm interaction motif,	SSF48452:TPR-like,SSF54928:RNA-binding domain, RBD,	2.34801208811825	4.82350470924184e-06	FDR<0.01	5.31663729313293	2159750.83333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	599	Splicing
P49312	P49312;P49312-2	Hnrnpa1	10.179	17.73	163947000	16.5582103886212	10.0519686780656	61.8543947547473	18.0541262705591	52.2220481487284	18.5041264201917	44006316.6666667	0	Hnrnpa1	0	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (HDP-1) (Helix-destabilizing protein) (Single-strand-binding protein) (Topoisomerase-inhibitor suppressed) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]		FUNCTION: Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and may modulate splice site selection. May bind to specific miRNA hairpins. Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating factor APAF1. {ECO:0000250|UniProtKB:P09651}.		alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA transport [GO:0051028]; nuclear export [GO:0051168]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	miRNA binding [GO:0035198]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09651}. Cytoplasm {ECO:0000250|UniProtKB:P09651}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles continuously between the nucleus and the cytoplasm along with mRNA. Component of ribonucleosomes. {ECO:0000250|UniProtKB:P09651}.	15382;	cd12761;cd12580;	IPR021662;IPR034845;IPR034803;IPR012677;IPR035979;IPR000504;	PF11627;PF00076;	SM00360;	34196	COMPBIAS 184..199;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 303..320;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 4..94;  /note=Globular A domain; REGION 95..185;  /note=Globular B domain; REGION 182..216;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 218..240;  /note=RNA-binding RGG-box; REGION 268..305;  /note=Nuclear targeting sequence;  /evidence=ECO:0000250; REGION 274..320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (2); Compositional bias (2); Cross-link (7); Domain (2); Initiator methionine (1); Modified residue (33); Region (6)		Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 14..97;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 105..184;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	15382	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051028~mRNA transport,GO:0051168~nuclear export,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0061752~telomeric repeat-containing RNA binding,GO:0098505~G-rich strand telomeric DNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF11627:Nuclear factor hnRNPA1,	SSF54928:RNA-binding domain, RBD,	4.36449359260621	3.24835373407e-08	FDR<0.01	7.48833668374436	103976658.333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	23	Splicing
Q9D883	Q9D883;Q8BGJ9;Q8BGJ9-4;Q8BGJ9-2;Q8BGJ9-3	U2af1	3.9238	4.649	157840000	28.055999775552	17.5985076465516	16.3687553198455	5.64844103027564	33.5075727114328	30.7370750599373	30904183.3333333	0	U2af1	0	Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit)		FUNCTION: Plays a critical role in both constitutive and enhancer-dependent splicing by mediating protein-protein interactions and protein-RNA interactions required for accurate 3'-splice site selection. Recruits U2 snRNP to the branch point. Directly mediates interactions between U2AF2 and proteins bound to the enhancers and thus may function as a bridge between U2AF2 and the enhancer complex to recruit it to the adjacent intron (By similarity). {ECO:0000250}.		mRNA splicing, via spliceosome [GO:0000398]	nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]	metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18758164}. Nucleus speckle {ECO:0000269|PubMed:18758164}.	108121;		IPR012677;IPR035979;IPR000504;IPR003954;IPR009145;IPR000571;	PF00076;PF00642;	SM00360;SM00361;SM00356;	27815	COMPBIAS 185..205;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 221..239;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 183..239;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Domain (1); Initiator methionine (1); Modified residue (5); Region (1); Sequence conflict (1); Zinc finger (2)		Acetylation;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing	DOMAIN 65..147;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The C-terminal SR-rich domain is required for interactions with SR proteins and the splicing regulators TRA and TRA2, and the N-terminal domain is required for formation of the U2AF1/U2AF2 heterodimer. {ECO:0000250}.			ZN_FING 12..40;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 149..176;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50102;PS50103;	108121	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0089701~U2AF,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0046872~metal ion binding,GO:0050733~RS domain binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR003954:RNA recognition motif domain, eukaryote,IPR009145:U2 auxiliary factor small subunit,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),	SSF54928:RNA-binding domain, RBD,	3.70947990675976	1.55319272804454e-06	FDR<0.01	5.80877465146202	94372091.6666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	27	Splicing
Q9D0E1	Q9D0E1;Q9D0E1-2	Hnrnpm	22.733	28.173	45493500	60.960741282614	37.2967328062062	25.7698750161062	16.0999484801649	22.3638600022364	21.7533173809006	21030433.3333333	0	Hnrnpm	0	Heterogeneous nuclear ribonucleoprotein M (hnRNP M)		FUNCTION: Pre-mRNA binding protein in vivo, binds avidly to poly(G) and poly(U) RNA homopolymers in vitro. Involved in splicing. Acts as a receptor for carcinoembryonic antigen in Kupffer cells, may initiate a series of signaling events leading to tyrosine phosphorylation of proteins and induction of IL-1 alpha, IL-6, IL-10 and tumor necrosis factor alpha cytokines (By similarity). {ECO:0000250}.		alternative mRNA splicing, via spliceosome [GO:0000380]; positive regulation of protein import [GO:1904591]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]	catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	calcium-dependent protein binding [GO:0048306]; mRNA binding [GO:0003729]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	76936;	cd12661;	IPR024667;IPR024666;IPR034990;IPR012677;IPR035979;IPR000504;	PF11532;PF00076;	SM00360;	77649	COMPBIAS 40..57;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..65;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 399..607;  /note=27 X 6 AA repeats of [GEVSTPAN]-[ILMV]-[DE]-[RH]-[MLVI]-[GAV]	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Cross-link (22); Domain (3); Initiator methionine (1); Modified residue (24); Region (2); Repeat (27); Sequence conflict (1)		Acetylation;Alternative splicing;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 70..148;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 203..280;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 652..728;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176			REPEAT 399..404;  /note=1; REPEAT 406..411;  /note=2; REPEAT 414..419;  /note=3; REPEAT 425..430;  /note=4; REPEAT 432..437;  /note=5; REPEAT 439..444;  /note=6; REPEAT 445..450;  /note=7; REPEAT 452..457;  /note=8; REPEAT 460..465;  /note=9; REPEAT 467..472;  /note=10; REPEAT 474..479;  /note=11; REPEAT 481..486;  /note=12; REPEAT 492..497;  /note=13; REPEAT 499..504;  /note=14; REPEAT 506..511;  /note=15; REPEAT 513..518;  /note=16; REPEAT 520..525;  /note=17; REPEAT 527..532;  /note=18; REPEAT 539..544;  /note=19; REPEAT 546..551;  /note=20; REPEAT 553..558;  /note=21; REPEAT 561..566;  /note=22; REPEAT 567..571;  /note=23; REPEAT 574..579;  /note=24; REPEAT 580..584;  /note=25; REPEAT 587..592;  /note=26; REPEAT 602..607;  /note=27		PS50102;	76936	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:1900182~positive regulation of protein localization to nucleus,GO:1904591~positive regulation of protein import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0009986~cell surface,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0042382~paraspeckles,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,GO:0048306~calcium-dependent protein binding,GO:1990405~protein antigen binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024666:Heterogeneous nuclear ribonucleoprotein M, PY nuclear localisation signal,IPR024667:Heterogeneous nuclear ribonucleoprotein M,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF11532:Heterogeneous nuclear ribonucleoprotein M,	SSF54928:RNA-binding domain, RBD,	4.76207525027984	4.51703634814788e-10	FDR<0.01	9.3451464146995	33261966.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	71	Splicing
P62301	P62301	Rps13	29.757	22.652	41547500	8.0032012805122	22.5794797687861	NA	8.97827258035554	28.8933834151979	36.4923548516586	17106118.3333333	1	Rps13	0	40S ribosomal protein S13				negative regulation of RNA splicing [GO:0033119]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]		68052;	cd00353;	IPR012606;IPR000589;IPR023029;IPR009068;	PF08069;PF00312;	SM01386;SM01387;	17222			NA							3 out of 5	Chain (1); Cross-link (1); Modified residue (5)		Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00362;	68052	GO:0006412~translation,GO:0033119~negative regulation of RNA splicing,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0070181~small ribosomal subunit rRNA binding,GO:1990932~5.8S rRNA binding,	IPR000589:Ribosomal protein S15,IPR009068:S15/NS1, RNA-binding,IPR012606:Ribosomal protein S13/S15, N-terminal,IPR023029:Ribosomal protein S15P,	PF00312:Ribosomal protein S15,PF08069:Ribosomal S13/S15 N-terminal domain,	SSF47060:S15/NS1 RNA-binding domain,	4.30040981962089	8.70887916897099e-08	FDR<0.01	7.06003773500994	29326809.1666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	81	Splicing
P62317	P62317	Snrpd2	24.663	21.615	40818500	8.17527795945062	41.1201118467042	9.01875901875902	5.39112620626449	12.6468616812738	19.2797100331611	10280460	0	Snrpd2	0	Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. {ECO:0000250|UniProtKB:P62316}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	U1 snRNP binding [GO:1990446]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62316}. Nucleus {ECO:0000250|UniProtKB:P62316}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P62316}.	107686;	cd01720;	IPR001163;IPR010920;IPR027248;	PF01423;	SM00651;	13527	COMPBIAS 11..25;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Initiator methionine (1); Modified residue (3); Region (1); Sequence conflict (1)		Acetylation;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing							107686	GO:0000387~spliceosomal snRNP assembly,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0070062~extracellular exosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0044822~poly(A) RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027248:Small nuclear ribonucleoprotein Sm D2,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	3.87306399696693	1.08309195298644e-07	FDR<0.01	6.96533467081756	25549480	Present in Nucleus	RBP	RBD	Others	Others	RBD	89	Splicing
P62315	P62315	Snrpd1	7.1499	6.1487	6099350	1.46494389264891	19.3945035976804	0.543892091808985	52.4521374246001	304.989630352568	12.0643269915188	43537761.6666667	0	Snrpd1	0	Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. May act as a charged protein scaffold to promote snRNP assembly or strengthen snRNP-snRNP interactions through non-specific electrostatic contacts with RNA. {ECO:0000250|UniProtKB:P62314}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]	RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62314}. Nucleus {ECO:0000250|UniProtKB:P62314}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P62314}.	20641;	cd01724;	IPR027141;IPR001163;IPR010920;IPR034102;	PF01423;	SM00651;	13282	COMPBIAS 101..119;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..80;  /note=Sufficient for interaction with CLNS1A;  /evidence=ECO:0000250; REGION 88..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Region (2)		Cytoplasm;Isopeptide bond;Methylation;Nucleus;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing							20641	GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0002230~positive regulation of defense response to virus by host,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0071010~prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027141:U6 snRNA-associated Sm-like protein LSm4/Small nuclear ribonucleoprotein Sm D1/D3,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	3.37077997062617	0.00178313620331692	FDR<0.01	2.74881548234918	24818555.8333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	94	Splicing
P29341	P29341	Pabpc1	327.51	25.044	15369500	23.0941548694026	27.5862068965517	28.1579095567945	9.7012029491657	38.5089340727049	32.5234982274693	33289700	0	Pabpc1	0	Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1)		FUNCTION: Binds the poly(A) tail of mRNA, including that of its own transcript, and regulates processes of mRNA metabolism such as pre-mRNA splicing and mRNA stability. Its function in translational initiation regulation can either be enhanced by PAIP1 or repressed by PAIP2. Can probably bind to cytoplasmic RNA sequences other than poly(A) in vivo. Involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Involved in regulation of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons; for the recognition of premature termination codons (PTC) and initiation of NMD a competitive interaction between UPF1 and PABPC1 with the ribosome-bound release factors is proposed. By binding to long poly(A) tails, may protect them from uridylation by ZCCHC6/ZCCHC11 and hence contribute to mRNA stability. {ECO:0000250|UniProtKB:P11940}.		gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lamellipodium [GO:0030027]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11940}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:P11940}. Nucleus {ECO:0000250|UniProtKB:P11940}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:P11940}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs (By similarity). Shuttles between the cytoplasm and the nucleus (By similarity). During stress and in the absence of DDX3X, localizes to the nucleus (By similarity). At the leading edge of migrating fibroblasts, colocalizes with DDX3X (By similarity). Relocalizes to cytoplasmic stress granules upon cellular stress where it colocalizes with ENDOV (By similarity). {ECO:0000250|UniProtKB:P11940}.	18458;		IPR012677;IPR036053;IPR006515;IPR002004;IPR035979;IPR000504;IPR003954;	PF00658;PF00076;	SM00517;SM00360;SM00361;	70671		REGION 166..289;  /note=CSDE1-binding;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Domain (5); Modified residue (18); Region (1); Sequence conflict (1)		Acetylation;Cell projection;Cytoplasm;Methylation;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 11..89;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 99..175;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 191..268;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 294..370;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 542..619;  /note=PABC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00641	DOMAIN: The RNA-binding domains RRM1 and RRM2 and the C-terminus (last 138 amino acids) regions interact respectively with the PABPC1-interacting motif-1 (PAM1) and -2 (PAM2) of PAIP1, respectively. {ECO:0000250|UniProtKB:P11940}.; DOMAIN: The RNA-binding domains RRM2 and RRM3 and the C-terminus (last 138 amino acids) regions interact with the PABPC1-interacting motif-1 (PAM1) and -2 (PAM2) of PAIP2, respectively. {ECO:0000250|UniProtKB:P11940}.				PS51309;PS50102;	18458	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0031047~gene silencing by RNA,GO:0045070~positive regulation of viral genome replication,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:2000623~negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:1990124~messenger ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein,IPR003954:RNA recognition motif domain, eukaryote,IPR006515:Polyadenylate binding protein, human types 1, 2, 3, 4,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00658:Poly-adenylate binding protein, unique domain,	SSF54928:RNA-binding domain, RBD,SSF63570:PABC (PABP) domain,	5.0876603864284	1.78163015938279e-07	FDR<0.01	6.74918244418761	24329600	Present in Nucleus	RBP	RBD	Others	Others	RBD	97	Splicing
Q8VDW0	Q8VDW0;Q8VDW0-2	Ddx39a	17.458	18.918	22327500	11.6188550780206	7.6493536296183	8.05996614814218	4.73014521545811	8.37450799765514	8.85269121813031	24687293.3333333	0	Ddx39a	0	ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39)		FUNCTION: Involved in pre-mRNA splicing. Required for the export of mRNA out of the nucleus (By similarity). {ECO:0000250}.		mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Can translocate to the cytoplasm in the presence of MX1. {ECO:0000250}.	68278;		IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	49067	COMPBIAS 1..21;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..36;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Cross-link (6); Domain (2); Initiator methionine (1); Modified residue (5); Motif (2); Nucleotide binding (1); Region (1)		ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 75..248;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 260..421;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 44..72;  /note=Q motif; MOTIF 195..198;  /note=DECD box			PS51192;PS51194;PS51195;	68278	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.28825208760814	4.40012353641253e-08	FDR<0.01	7.35653513023447	23507396.6666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	103	Splicing
Q9CWZ3	Q9CWZ3-2;Q9CWZ3	Rbm8a	16.811	12.772	41675000	5.79777365491651	12.2125471709634	NA	4.38692695766615	12.8776366961135	15.4225786551511	1635721.66666667	1	Rbm8a	0	RNA-binding protein 8A (RNA-binding motif protein 8A) (Ribonucleoprotein RBM8A)		FUNCTION: Required for pre-mRNA splicing as component of the spliceosome (By similarity). Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Its removal from cytoplasmic mRNAs requires translation initiation from EJC-bearing spliced mRNAs. Associates preferentially with mRNAs produced by splicing. Does not interact with pre-mRNAs, introns, or mRNAs produced from intronless cDNAs. Associates with both nuclear mRNAs and newly exported cytoplasmic mRNAs (By similarity). {ECO:0000250|UniProtKB:Q9Y5S9}.		mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9Y5S9}. Nucleus speckle {ECO:0000250|UniProtKB:Q9Y5S9}. Cytoplasm {ECO:0000250|UniProtKB:Q9Y5S9}. Note=Nucleocytoplasmic shuttling protein. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. Colocalizes with the core EJC, ALYREF/THOC4, NXF1 and UAP56 in the nucleus and nuclear speckles. {ECO:0000250|UniProtKB:Q9Y5S9}.	60365;	cd12324;	IPR012677;IPR035979;IPR008111;IPR000504;IPR033744;	PF00076;	SM00360;	19889	COMPBIAS 1..29;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 36..65;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 156..174;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..70;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 151..174;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (12)		Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Translation regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 73..151;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	60365	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR008111:RNA-binding motif protein 8,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.37985945263764	3.42049385397367e-07	FDR<0.01	6.46591118558959	21655360.8333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	108	Splicing
Q5SU73	Q5SU73	Coil	3.3364	3.6519	31995500	2.89293256574189	1.87034751056746	3.59686353499748	1.66417041105009	2.56976923472272	2.38180302488984	7131400	0	Coil	0	Coilin (p80-coilin)		FUNCTION: Component of nuclear coiled bodies, also known as Cajal bodies or CBs, which are involved in the modification and assembly of nucleoplasmic snRNPs. {ECO:0000250|UniProtKB:P38432}.		spliceosomal snRNP assembly [GO:0000387]	Cajal body [GO:0015030]; female germ cell nucleus [GO:0001674]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10806077}. Nucleus, Cajal body {ECO:0000250|UniProtKB:P38432}.			IPR024822;IPR031722;	PF15862;		61917	COMPBIAS 119..199;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 200..221;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 234..254;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 286..325;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 363..377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 119..256;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 282..325;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 339..392;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 389..417;  /note=Required for interaction with SMN;  /evidence=ECO:0000250; REGION 390..416;  /note=8 X 2 AA tandem repeats of R-G	NA							5 out of 5	Chain (1); Compositional bias (5); Cross-link (8); Domain (1); Modified residue (9); Region (5); Repeat (8); Sequence conflict (16)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 457..556;  /note=Tudor; atypical	DOMAIN: The atypical Tudor domain at the C-terminus contains two large unstructured loops, and does not bind methylated residues. {ECO:0000250}.		REPEAT 390..391;  /note=1; REPEAT 394..395;  /note=2; REPEAT 405..406;  /note=3; REPEAT 407..408;  /note=4; REPEAT 410..411;  /note=5; REPEAT 412..413;  /note=6; REPEAT 414..415;  /note=7; REPEAT 416;  /note=8			NA		GO:0001674~female germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0015030~Cajal body,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0015036~disulfide oxidoreductase activity,GO:0042802~identical protein binding,	IPR024822:Coilin,			1.40475176028925	2.67069657339644e-05	FDR<0.01	4.57337545079745	19563450	Present in Nucleus	RBP	Others	Others	Others	Others	118	Splicing
P62309	P62309	Snrpg	10.936	5.6932	34591000	NA	22.4779715878439	NA	NA	15.5252984738632	NA	3920666.66666667	4	Snrpg	0	Small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. As part of the U7 snRNP it is involved in histone 3'-end processing. {ECO:0000250|UniProtKB:P62308}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62308}. Nucleus {ECO:0000250|UniProtKB:P62308}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P62308}.	68011;	cd01719;	IPR044641;IPR001163;IPR010920;IPR034098;	PF01423;	SM00651;	8496			NA							4 out of 5	Chain (1)		Cytoplasm;Direct protein sequencing;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing							68011	GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,	GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034719~SMN-Sm protein complex,GO:0043186~P granule,GO:0071004~U2-type prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR017132:U6 snRNA-associated Sm-like protein LSm7,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	3.6018105179588	4.56243194544996e-05	FDR<0.01	4.34080360054883	19255833.3333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	120	Splicing
O35286	O35286	Dhx15	6.9359	7.9177	23367500	12.7386912268634	10.6179655977915	9.28936367858802	4.80030721966206	21.2539851222104	10.236252712607	13487583.3333333	0	Dhx15	0	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (DEAH box protein 15)		FUNCTION: Pre-mRNA processing factor involved in disassembly of spliceosomes after the release of mature mRNA. In cooperation with TFIP11 seem to be involved in the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type post-mRNA release spliceosomal complex [GO:0071008]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9342318}. Nucleus, nucleolus {ECO:0000269|PubMed:9342318}.	13204;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	91007	COMPBIAS 1..63;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 81..111;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Domain (2); Frameshift (1); Modified residue (2); Motif (1); Nucleotide binding (1); Region (1); Sequence conflict (4)		ATP-binding;Acetylation;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 147..313;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 338..518;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 260..263;  /note=DEAH box			PS00690;PS51192;PS51194;	13204	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009636~response to toxic substance,GO:0043279~response to alkaloid,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005689~U12-type spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0071008~U2-type post-mRNA release spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.26284110957356	3.8132840023996e-08	FDR<0.01	7.41870084852076	18427541.6666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	124	Splicing
Q62376	Q62376;Q62376-2	Snrnp70	2.8975	3.0737	14911000	2.52003427246611	2.23648603314472	3.7096116036651	1.64368250628709	5.08517670989067	4.51385754265595	20515500	0	Snrnp70	0	U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70)		FUNCTION: Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. SNRNP70 binds to the loop I region of U1-snRNA. {ECO:0000250|UniProtKB:P08621}.; FUNCTION: [Isoform 2]: Truncated isoforms that lack the RRM domain cannot bind U1-snRNA. {ECO:0000250|UniProtKB:P08621}.		mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:17656373}. Nucleus, nucleoplasm {ECO:0000269|PubMed:17656373}. Note=Colocalizes with SCNM1 and LUC7L2 in nuclear speckles. {ECO:0000269|PubMed:17656373}.	20637;	cd12236;	IPR012677;IPR035979;IPR000504;IPR034143;IPR022023;	PF00076;PF12220;	SM00360;	51992	COMPBIAS 206..256;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 266..311;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 351..404;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 48..79;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..202;  /note=Required for interaction with U1 RNA;  /evidence=ECO:0000250|UniProtKB:P08621; REGION 187..439;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Initiator methionine (1); Modified residue (8); Region (3); Sequence conflict (2)		Acetylation;Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ubl conjugation	DOMAIN 103..181;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domain mediates interaction with U1 RNA. {ECO:0000250|UniProtKB:P08621}.				PS50102;	20637	GO:0000398~mRNA splicing, via spliceosome,GO:0043484~regulation of RNA splicing,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0071300~cellular response to retinoic acid,GO:0071356~cellular response to tumor necrosis factor,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005685~U1 snRNP,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071004~U2-type prespliceosome,GO:0071011~precatalytic spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0030619~U1 snRNA binding,GO:0044822~poly(A) RNA binding,GO:1990446~U1 snRNP binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR022023:U1 small nuclear ribonucleoprotein of 70kDa N-terminal,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF12220:U1 small nuclear ribonucleoprotein of 70kDa MW N terminal,	SSF54928:RNA-binding domain, RBD,	1.59729009025691	1.95323864566192e-05	FDR<0.01	4.70924469160085	17713250	Present in Nucleus	RBP	RBD	Others	Others	RBD	133	Splicing
Q99PV0	Q99PV0	Prpf8	21.291	36.312	18714500	11.0669662125522	12.4367281455595	12.6916438217078	7.21136511141559	14.2304189435337	17.6597322784587	16127116.6666667	0	Prpf8	0	Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)		FUNCTION: Plays role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes, both of the predominant U2-type spliceosome and the minor U12-type spliceosome. Functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs. Required for the assembly of the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome. Functions as scaffold that positions spliceosomal U2, U5 and U6 snRNAs at splice sites on pre-mRNA substrates, so that splicing can occur. Interacts with both the 5' and the 3' splice site. {ECO:0000250|UniProtKB:Q6P2Q9}.		cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	isopeptidase activity [GO:0070122]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metallopeptidase activity [GO:0008237]; pre-mRNA intronic binding [GO:0097157]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q6P2Q9}. Nucleus speckle {ECO:0000269|PubMed:15169873}.	192159;	cd13838;	IPR000555;IPR037518;IPR012591;IPR012592;IPR012984;IPR027652;IPR021983;IPR043173;IPR043172;IPR019581;IPR042516;IPR019580;IPR012337;IPR019582;	PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;	SM00232;	273616		REGION 812..1303;  /note=Reverse transcriptase homology domain; REGION 1304..1577;  /note=Linker; REGION 1513..1526;  /note=Important for branch point selection;  /evidence=ECO:0000250; REGION 1581..1752;  /note=Restriction endonuclease homology domain; REGION 1669..2034;  /note=Involved in interaction with pre-mRNA 5' splice site;  /evidence=ECO:0000250; REGION 1767..2020;  /note=RNase H homology domain; REGION 2301..2335;  /note=Required for interaction with EFTUD2 and SNRNP200;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Domain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (5); Region (7); Sequence conflict (2)		Acetylation;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 2103..2234;  /note=MPN;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01182	DOMAIN: The MPN (JAB/Mov34) domain has structural similarity with deubiquitinating enzymes, but lacks the residues that would bind the catalytic metal ion. {ECO:0000250}.; DOMAIN: Contains a region with structural similarity to reverse transcripase, presenting the classical thumb, fingers and palm architecture, but lacks enzyme activity, since the essential metal-binding residues are not conserved. {ECO:0000250}.; DOMAIN: Contains a region with structural similarity to type-2 restriction endonucleases, but the residues that would bind catalytic metal ions in endonucleases are instead involved in hydrogen bonds that stabilize the protein structure. {ECO:0000250}.; DOMAIN: Contains a region with structural similarity to RNase H, but lacks RNase H activity. {ECO:0000250}.				PS50249;	192159	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0071222~cellular response to lipopolysaccharide,GO:0071356~cellular response to tumor necrosis factor,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000386~second spliceosomal transesterification activity,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017070~U6 snRNA binding,GO:0030619~U1 snRNA binding,GO:0030620~U2 snRNA binding,GO:0030623~U5 snRNA binding,GO:0044822~poly(A) RNA binding,GO:0070530~K63-linked polyubiquitin binding,GO:0097157~pre-mRNA intronic binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR012337:Ribonuclease H-like domain,IPR012591:Pre-mRNA-processing-splicing factor 8,IPR012592:PROCN,IPR012984:PRO, C-terminal,IPR019580:Pre-mRNA-processing-splicing factor 8, U6-snRNA-binding,IPR019581:Pre-mRNA-processing-splicing factor 8, U5-snRNA-binding,IPR019582:RNA recognition motif, spliceosomal PrP8,IPR021983:PRP8 domain IV core,	PF01398:JAB1/Mov34/MPN/PAD-1 ubiquitin protease,PF08082:PRO8NT (NUC069), PrP8 N-terminal domain,PF08083:PROCN (NUC071) domain,PF08084:PROCT (NUC072) domain,PF10596:U6-snRNA interacting domain of PrP8,PF10597:U5-snRNA binding site 2 of PrP8,PF10598:RNA recognition motif of the spliceosomal PrP8,PF12134:PRP8 domain IV core,	SSF53098:Ribonuclease H-like,	3.89858081065409	1.02484277816851e-08	FDR<0.01	7.98934275491171	17420808.3333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	136	Splicing
Q921F4	Q921F4;Q921F4-4;Q921F4-5	Hnrnpll	1.093	1.3531	22788000	3.18451054072989	2.48638703100525	4.11065893862786	1.85604513901778	2.29526257803893	2.06445219760936	11241683.3333333	0	Hnrnpll	0	Heterogeneous nuclear ribonucleoprotein L-like		FUNCTION: RNA-binding protein that functions as regulator of alternative splicing for multiple target mRNAs, including PTPRC/CD45 and STAT5A. Required for alternative splicing of PTPRC. {ECO:0000269|PubMed:19100700}.		mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484]	nucleus [GO:0005634]	mRNA binding [GO:0003729]		72692;	cd12781;cd12786;cd12700;cd12705;	IPR006536;IPR034985;IPR034986;IPR034983;IPR034987;IPR012677;IPR021790;IPR035979;IPR000504;	PF00076;PF11835;	SM00360;	64125	COMPBIAS 10..40;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 41..55;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 76..93;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..120;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (4); Beta strand (10); Chain (1); Compositional bias (3); Cross-link (2); Domain (3); Erroneous initiation (1); Helix (4); Modified residue (5); Mutagenesis (1); Region (1); Sequence conflict (2); Turn (3)		3D-structure;Alternative splicing;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 125..199;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 215..293;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 384..458;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	72692	GO:0006397~mRNA processing,GO:0033120~positive regulation of RNA splicing,	GO:0005634~nucleus,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.09071301139853	0.000860460875888048	FDR<0.01	3.06526887173063	17014841.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	138	Splicing
Q8CCF0	Q8CCF0;Q8CCF0-2	Prpf31	7.5718	16.541	16593500	43.4952807620373	2.05444273240883	7.58898079987858	NA	4.91159135559921	6.4989926561383	14452710	1	Prpf31	0	U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (U4/U6 snRNP 61 kDa protein) (Protein 61K)		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Required for the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome. {ECO:0000250|UniProtKB:Q8WWY3}.		mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]	Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4 snRNP [GO:0005687]	identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; snRNP binding [GO:0070990]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8WWY3}. Nucleus speckle {ECO:0000250|UniProtKB:Q8WWY3}. Nucleus, Cajal body {ECO:0000250|UniProtKB:Q8WWY3}. Note=Predominantly found in speckles and in Cajal bodies. {ECO:0000250|UniProtKB:Q8WWY3}.	68988;		IPR029012;IPR042239;IPR002687;IPR036070;IPR012976;IPR027105;IPR019175;	PF01798;PF09785;	SM00931;	55430	COMPBIAS 9..40;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 334..357;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Coiled coil (2); Compositional bias (1); Cross-link (2); Domain (1); Erroneous translation (1); Frameshift (2); Modified residue (8); Motif (1); Region (2); Sequence caution (1); Sequence conflict (10); Site (5)	MISCELLANEOUS: [Isoform 4]: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. {ECO:0000305}.	Acetylation;Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 215..333;  /note=Nop;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00690	DOMAIN: Interacts with the snRNP via the Nop domain. {ECO:0000250|UniProtKB:Q8WWY3}.; DOMAIN: The coiled coil domain is formed by two non-contiguous helices. {ECO:0000250|UniProtKB:Q8WWY3}.	MOTIF 351..364;  /note=Nuclear localization signal (NLS);  /evidence=ECO:0000250|UniProtKB:Q8WWY3			PS51358;	68988	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0071166~ribonucleoprotein complex localization,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005687~U4 snRNP,GO:0005690~U4atac snRNP,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071339~MLL1 complex,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0030621~U4 snRNA binding,GO:0030622~U4atac snRNA binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070990~snRNP binding,	IPR002687:Nop domain,IPR012976:NOSIC,IPR019175:Prp31 C-terminal,IPR027105:U4/U6 small nuclear ribonucleoprotein Prp31,	PF01798:Putative snoRNA binding domain,PF09785:Prp31 C terminal domain,	SSF89124:Nop domain,	3.05292253423516	4.55314398261346e-05	FDR<0.01	4.3416886159194	15523105	Present in Nucleus	RBP	RBD	Others	Others	RBD	148	Splicing
Q99NB9	Q99NB9	Sf3b1	34.875	41.137	14740150	16.0051216389245	11.8132095308974	5.76435323956652	10.6826193782716	12.6249873750126	13.5934207843404	14090995	0	Sf3b1	0	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex. SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA. Together with other U2 snRNP complex components may also play a role in the selective processing of microRNAs (miRNAs) from the long primary miRNA transcript, pri-miR-17-92 (PubMed:26255770). May also be involved in the assembly of the 'E' complex. Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron. {ECO:0000250|UniProtKB:O75533, ECO:0000269|PubMed:26255770}.		anterior/posterior pattern specification [GO:0009952]; blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75533}.			IPR011989;IPR016024;IPR015016;IPR038737;	PF08920;		145816	COMPBIAS 104..119;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 204..224;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 342..356;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 100..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 124..148;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 172..360;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 223..491;  /note=Interaction with PPP1R8;  /evidence=ECO:0000250; REGION 547..550;  /note=Interaction with PHF5A;  /evidence=ECO:0000250|UniProtKB:O75533; REGION 1156..1157;  /note=Interaction with PHF5A;  /evidence=ECO:0000250|UniProtKB:O75533; REGION 1248..1304;  /note=Interaction with SF3B3 and SF3B5;  /evidence=ECO:0000250|UniProtKB:O75533	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (4); Modified residue (42); Region (7); Repeat (11); Site (9)		Acetylation;Citrullination;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing				REPEAT 529..568;  /note=HEAT 1; REPEAT 569..603;  /note=HEAT 2; REPEAT 604..641;  /note=HEAT 3; REPEAT 643..677;  /note=HEAT 4; REPEAT 680..718;  /note=HEAT 5; REPEAT 763..801;  /note=HEAT 6; REPEAT 843..881;  /note=HEAT 7; REPEAT 1010..1048;  /note=HEAT 8; REPEAT 1052..1090;  /note=HEAT 9; REPEAT 1122..1160;  /note=HEAT 10; REPEAT 1163..1201;  /note=HEAT 11			NA	GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001825~blastocyst formation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009952~anterior/posterior pattern specification,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034693~U11/U12 snRNP,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003682~chromatin binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR015016:Splicing factor 3B subunit 1,IPR016024:Armadillo-type fold,	PF08920:Splicing factor 3B subunit 1,	SSF48371:ARM repeat,	3.92708447244334	6.46605276203664e-08	FDR<0.01	7.1893607559311	14415572.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	157	Splicing
Q6P4T2	Q6P4T2	Snrnp200	12.582	16.702	15172200	10.3537889690732	11.2766269353511	11.7853649338252	7.34699875101021	19.7320389115807	82.8775070445881	13232150	0	Snrnp200	0	U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)		FUNCTION: Plays role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes. Involved in spliceosome assembly, activation and disassembly. Mediates changes in the dynamic network of RNA-RNA interactions in the spliceosome. Catalyzes the ATP-dependent unwinding of U4/U6 RNA duplices, an essential step in the assembly of a catalytically active spliceosome. {ECO:0000250|UniProtKB:O75643}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75643}.	320632;		IPR041094;IPR035892;IPR011545;IPR014001;IPR001650;IPR014756;IPR027417;IPR004179;IPR036390;	PF00270;PF00271;PF18149;PF02889;	SM00487;SM00490;SM00973;	244547	COMPBIAS 51..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 39..81;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (6); Domain (6); Modified residue (12); Motif (2); Nucleotide binding (2); Region (1)		ATP-binding;Acetylation;Coiled coil;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 490..673;  /note=Helicase ATP-binding 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 684..921;  /note=Helicase C-terminal 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542; DOMAIN 982..1286;  /note=SEC63 1; DOMAIN 1337..1512;  /note=Helicase ATP-binding 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 1545..1753;  /note=Helicase C-terminal 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542; DOMAIN 1812..2124;  /note=SEC63 2	DOMAIN: Contains two helicase domains. The N-terminal helicase domain has catalytic activity by itself, contrary to C-terminal helicase domain that may have a regulatory role and enhance the activity of the first helicase domain. {ECO:0000250|UniProtKB:O75643}.	MOTIF 615..618;  /note=DEAH box; MOTIF 1454..1457;  /note=DEAH box			PS51192;PS51194;	320632	GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001650:Helicase, C-terminal,IPR004179:Sec63 domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014756:Immunoglobulin E-set,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF02889:Sec63 Brl domain,	SSF46785:Winged helix DNA-binding domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF81296:E set domains,	3.9617556650197	1.77178215450489e-07	FDR<0.01	6.75158967686907	14202175	Present in Nucleus	RBP	DBD	DBD	Others	RBD	162	Splicing
Q9JII5	Q9JII5-2;Q9JII5	Dazap1	6.4299	11.342	23867600	22.8018971178402	5.57351465834355	6.66711114074272	NA	4.29239816285359	6.28259094050386	2625273.33333333	1	Dazap1	0	DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1)		FUNCTION: RNA-binding protein, which may be required during spermatogenesis. {ECO:0000250}.		cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Predominantly cytoplasmic. Nuclear at some stages of spermatozoides development. In midpachytene spermatocytes, it is localized in both the cytoplasm and the nuclei and is clearly excluded from the sex vesicles. In round spermatids, it localizes mainly in the nuclei, whereas in elongated spermatids, it localizes to the cytoplasm.	70248;	cd12574;cd12327;	IPR034134;IPR034131;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	43214	COMPBIAS 197..211;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 250..283;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 291..333;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 359..374;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 74..117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 186..406;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Domain (2); Modified residue (3); Region (2); Sequence conflict (2)		Acetylation;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Methylation;Nucleus;RNA-binding;Reference proteome;Repeat;Spermatogenesis	DOMAIN 10..97;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 113..190;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	70248	GO:0001893~maternal placenta development,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0030154~cell differentiation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005844~polysome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0035613~RNA stem-loop binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.95261058918183	1.88095617695964e-06	FDR<0.01	5.72562132264543	13246436.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	177	Splicing
Q9D554	Q9D554	Sf3a3	15.373	14.842	19680000	12.8445551930537	11.7104246199967	17.1659085057077	5.40423692174665	7.35781031565006	10.0884759339407	4881323.16666667	0	Sf3a3	0	Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3A complex that contributes to the assembly of the 17S U2 snRNP, and the subsequent assembly of the pre-spliceosome 'E' complex and the pre-catalytic spliceosome 'A' complex. Involved in pre-mRNA splicing as a component of pre-catalytic spliceosome 'B' complexes. {ECO:0000250|UniProtKB:Q12874}.		mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00130}.	75062;		IPR000690;IPR031776;IPR031774;IPR021966;IPR024598;	PF11931;PF16837;PF12108;		58842	COMPBIAS 356..373;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 342..374;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (9); Motif (1); Region (1); Zinc finger (1)		Acetylation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing			MOTIF 175..179;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q12874		ZN_FING 406..437;  /note=Matrin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00130	PS50171;	75062	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR021966:Splicing factor SF3a60 binding domain,IPR024598:Domain of unknown function DUF3449,	PF11931:Domain of unknown function (DUF3449),PF12108:Splicing factor SF3a60 binding domain,		3.47702812454832	1.13317797983092e-08	FDR<0.01	7.94570187337754	12280661.5833333	Present in Nucleus	RBP	DBD	DBD	Others	Others	192	Splicing
Q8CGC6	Q8CGC6	Rbm28	1.0492	1.1617	14031900	2.88650271331255	2.15903447978064	4.61936437546194	1.68307666414205	3.13430496787337	2.9618221129639	8173405	0	Rbm28	0	RNA-binding protein 28 (RNA-binding motif protein 28)		FUNCTION: Nucleolar component of the spliceosomal ribonucleoprotein complexes. {ECO:0000250}.		mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	68272;		IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	84214	COMPBIAS 84..104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 195..227;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 228..244;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 270..305;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 306..320;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 594..610;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 611..643;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 660..674;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 84..110;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 195..320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 587..716;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Beta strand (6); Chain (1); Compositional bias (8); Cross-link (1); Domain (4); Helix (2); Initiator methionine (1); Modified residue (5); Region (3); Sequence conflict (9); Turn (1)		3D-structure;Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 4..80;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 114..191;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 325..409;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 477..582;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	68272	GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.13733274110617	0.0013640712955169	FDR<0.01	2.86516292994319	11102652.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	211	Splicing
P70333	P70333	Hnrnph2	6.8475	24.197	20014000	15.790554090543	12.3806811850788	NA	5.51906838125724	NA	6.12782645995465	1671230	2	Hnrnph2	0	Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]		FUNCTION: This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Binds poly(RG) (By similarity). {ECO:0000250}.		regulation of RNA splicing [GO:0043484]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	56258;		IPR012677;IPR035979;IPR000504;IPR012996;	PF00076;PF08080;	SM00360;	49280		REGION 234..433;  /note=2 X 16 AA Gly-rich approximate repeats; REGION 354..392;  /note=2 X 19 AA perfect repeats	NA							3 out of 5	Chain (2); Cross-link (3); Domain (3); Initiator methionine (1); Modified residue (10); Region (2); Repeat (4)		Acetylation;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 11..90;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 111..188;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 289..364;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176			REPEAT 234..249;  /note=1-1; REPEAT 354..372;  /note=2-1; REPEAT 374..392;  /note=2-2; REPEAT 418..433;  /note=1-2		PS50102;	56258		GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012996:Zinc finger, CHHC-type,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08080:RNPHF zinc finger,	SSF54928:RNA-binding domain, RBD,	3.34385708782261	3.81670535142029e-06	FDR<0.01	5.41831136616868	10842615	Present in Nucleus	RBP	DBD	DBD	Others	RBD	212	Splicing
O35737	O35737	Hnrnph1	10.687	16.044	13660500	10.8419888544355	5.09502216334641	11.5329612031185	8.17728350641917	12.7110026438885	9.74753874646652	7594850	0	Hnrnph1	0	Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]		FUNCTION: This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation. Inhibits, together with CUGBP1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds poly(RG) (By similarity). {ECO:0000250}.		cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	59013;		IPR012677;IPR035979;IPR000504;IPR012996;	PF00076;PF08080;	SM00360;	49199		REGION 234..433;  /note=2 X 16 AA Gly-rich approximate repeats; REGION 354..392;  /note=2 X 19 AA perfect repeats	NA							4 out of 5	Chain (2); Cross-link (3); Domain (3); Initiator methionine (1); Modified residue (9); Region (2); Repeat (4)		Acetylation;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 11..90;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 111..188;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 289..364;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: Each quasi-RRM repeat bound poly(RG), while only the N-terminal QRRM bound poly(RC) and poly(RU). None of the repeats bound detectable amounts of poly(RA).		REPEAT 234..249;  /note=1-1; REPEAT 354..372;  /note=2-1; REPEAT 374..392;  /note=2-2; REPEAT 418..433;  /note=1-2		PS50102;	59013	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012996:Zinc finger, CHHC-type,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08080:RNPHF zinc finger,	SSF54928:RNA-binding domain, RBD,	3.34021869825613	8.27031097014648e-09	FDR<0.01	8.082478160329	10627675	Present in Nucleus	RBP	DBD	DBD	Others	RBD	216	Splicing
O08810	O08810	Eftud2	16.333	22.701	12155650	9.54107432496899	11.9578604995994	8.97666068222621	3.21078824851501	8.6475268073331	10.2643058763151	7262050	0	Eftud2	0	116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)		FUNCTION: Required for pre-mRNA splicing as component of the spliceosome, including pre-catalytic, catalytic and post-catalytic spliceosomal complexes (By similarity). Component of the U5 snRNP and the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome (By similarity). {ECO:0000250|UniProtKB:Q15029}.		mRNA splicing, via spliceosome [GO:0000398]	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U5 snRNA binding [GO:0030623]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15029}.	20624;	cd04098;cd04167;	IPR041095;IPR035647;IPR000640;IPR004161;IPR031950;IPR027417;IPR020568;IPR014721;IPR005225;IPR044121;IPR000795;IPR009000;IPR005517;IPR035655;	PF00679;PF14492;PF03764;PF16004;PF00009;PF03144;	SM00838;SM00889;	109361	COMPBIAS 14..48;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..52;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Domain (1); Modified residue (3); Nucleotide binding (3); Region (1); Sequence caution (1)		Acetylation;GTP-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 126..408;  /note=tr-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059					PS51722;	20624	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0035690~cellular response to drug,GO:0042220~response to cocaine,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0031012~extracellular matrix,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000640:Translation elongation factor EFG, V domain,IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR005225:Small GTP-binding protein domain,IPR005517:Translation elongation factor EFG/EF2, domain IV,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009022:Elongation factor G, III-V domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00679:Elongation factor G C-terminus,PF03144:Elongation factor Tu domain 2,PF03764:Elongation factor G, domain IV,PF14492:Elongation Factor G, domain II,	SSF50447:Translation proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54211:Ribosomal protein S5 domain 2-like,SSF54980:EF-G C-terminal domain-like,	3.33617488481955	1.52707343891276e-07	FDR<0.01	6.81614007666483	9708850	Present in Nucleus	RBP	Others	Others	Others	Others	228	Splicing
P62855	P62855	Rps26	8.5651	12.61	6690100	29.7778571853969	18.7329062230714	46.0511167395809	21.3228709113395	18.5329330219801	17.2140742270881	10635616.6666667	0	Rps26	0	40S ribosomal protein S26				cytoplasmic translation [GO:0002181]; negative regulation of RNA splicing [GO:0033119]	cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62854}. Cytoplasm {ECO:0000250|UniProtKB:P62854}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:P49171}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:P49171, ECO:0000250|UniProtKB:P62854}.	27370;		IPR000892;IPR038551;	PF01283;		13015	COMPBIAS 85..99;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 101..115;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 85..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Modified residue (1); Region (1); Sequence conflict (1)		Cytoplasm;Endoplasmic reticulum;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00733;	27370	GO:0006412~translation,GO:0033119~negative regulation of RNA splicing,GO:0098609~cell-cell adhesion,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0070062~extracellular exosome,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000892:Ribosomal protein S26e,	PF01283:Ribosomal protein S26e,		4.26695842013421	5.57053849930343e-09	FDR<0.01	8.25410281991213	8662858.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	243	Splicing
Q9CWX9	Q9CWX9	Ddx47	24.325	23.223	7721250	6.57375755982119	7.39699681929137	5.91401029037791	NA	17.1623732129679	16.0292373288879	8981208.33333333	1	Ddx47	0	Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47)		FUNCTION: Involved in apoptosis. May have a role in rRNA processing and mRNA splicing. Associates with pre-rRNA precursors (By similarity). {ECO:0000250}.		extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=Localizes in the nucleolar-organizing region during ribosome biogenesis. {ECO:0000250}.	67755;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	50639	COMPBIAS 412..439;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 412..455;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (1); Domain (2); Initiator methionine (1); Modified residue (3); Motif (2); Nucleotide binding (1); Region (2)		ATP-binding;Acetylation;Apoptosis;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing;rRNA processing	DOMAIN 55..226;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 237..397;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 24..52;  /note=Q motif; MOTIF 174..177;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	67755	GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0008380~RNA splicing,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.63049372080112	4.75637402505932e-07	FDR<0.01	6.32272400127108	8351229.16666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	250	Splicing
Q9CW46	Q9CW46;Q9CW46-2	Raver1	7.7799	9.2667	14266250	21.7438573602957	13.3044183973498	4.57749702462693	NA	6.22161388664219	5.36020583190395	2248923.33333333	1	Raver1	0	Ribonucleoprotein PTB-binding 1 (Protein raver-1)		FUNCTION: Cooperates with PTBP1 to modulate regulated alternative splicing events. Promotes exon skipping. Cooperates with PTBP1 to modulate switching between mutually exclusive exons during maturation of the TPM1 pre-mRNA. {ECO:0000269|PubMed:14633994}.		mRNA splicing, via spliceosome [GO:0000398]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11724819}. Cytoplasm {ECO:0000269|PubMed:11724819}. Note=Nuclear, in perinucleolar structures. Shuttles between nucleus and cytoplasm. Cytoplasm, at focal contacts and cell-cell contacts. Associated with myotubes during muscle differentiation.	71766;	cd12663;	IPR012677;IPR034635;IPR034633;IPR035979;IPR000504;	PF00076;	SM00360;	79382	COMPBIAS 22..45;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 556..576;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..45;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 307..401;  /note=Interaction with PTBP1;  /evidence=ECO:0000269|PubMed:11724819; REGION 390..505;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 525..647;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 672..731;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (6); Chain (1); Compositional bias (2); Domain (3); Erroneous initiation (1); Helix (2); Initiator methionine (1); Modified residue (10); Motif (2); Region (5); Sequence conflict (2); Turn (2)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 59..130;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 132..210;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 221..299;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 45..60;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 743..746;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;	71766	GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.08604471755473	1.11344159416387e-06	FDR<0.01	5.95333255904988	8257586.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	251	Splicing
Q8QZY9	Q8QZY9	Sf3b4	11.099	19.459	10016550	47.666714333381	3.40043525571273	4.6131844812474	NA	20.6701254676616	20.4319310218009	5753783.33333333	1	Sf3b4	0	Splicing factor 3B subunit 4		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex. SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA. May also be involved in the assembly of the 'E' complex. SF3B4 has been found in complex 'B' and 'C' as well. Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron. {ECO:0000250|UniProtKB:Q15427}.		mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]	nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15427}.	107701;	cd12334;cd12335;	IPR012677;IPR035979;IPR000504;IPR034158;IPR034159;	PF00076;	SM00360;	44356	COMPBIAS 232..274;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 327..424;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 207..424;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Domain (2); Initiator methionine (1); Modified residue (2); Region (1)		Acetylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 13..91;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 100..179;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	107701	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0048026~positive regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005689~U12-type spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.71762072056092	6.5703993354423e-06	FDR<0.01	5.1824082341071	7885166.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	256	Splicing
Q8BGT7	Q8BGT7	Smndc1	12.401	18.109	10654850	7.19942404607631	1.23941846485629	NA	NA	NA	7.95608242501392	4410461.66666667	3	Smndc1	0	Survival of motor neuron-related-splicing factor 30 (30 kDa splicing factor SMNrp) (SMN-related protein) (Survival motor neuron domain-containing protein 1)		FUNCTION: Necessary for spliceosome assembly. Overexpression causes apoptosis (By similarity). {ECO:0000250}.		apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}. Note=Detected in nuclear speckles containing snRNP and in Cajal (coiled) bodies. {ECO:0000250}.	76479;	cd04508;	IPR010304;IPR002999;	PF06003;	SM00333;	26753			NA							3 out of 5	Chain (1); Domain (1); Modified residue (2); Motif (1)		Acetylation;Apoptosis;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 72..132;  /note=Tudor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00211	DOMAIN: The Tudor domain mediates association with dimethylarginines, which are common in snRNP proteins. {ECO:0000250}.	MOTIF 142..160;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50304;	76479	GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002999:Tudor domain,IPR010304:Survival motor neuron,	PF06003:Survival motor neuron protein (SMN),		2.79212452365073	0.000773469406048653	FDR<0.01	3.11155685978882	7532655.83333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	269	Splicing
Q8R3C6	Q8R3C6;Q8R3C6-2	Rbm19	2.4867	3.401	8455250	3.63636363636364	2.50513552783206	3.36689000370358	1.59982082006815	11.9524293312616	11.2193151730018	5600926.66666667	0	Rbm19	0	Probable RNA-binding protein 19 (RNA-binding motif protein 19)		FUNCTION: Plays a role in embryo pre-implantation development. {ECO:0000269|PubMed:19087264}.		mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm. Cytoplasm. Chromosome. Note=Colocalizes with NPM1 during interphase. By late prophase, metaphase, anaphase and telophase, associates with the chromosome periphery. By telophase localizes to nucleolar precursor body (NPB) (By similarity). In discrete foci distributed throughout the cytoplasm and nucleoplasm during the 4 to 8 cell stages and the morula stage, but not in the periphery of the NPB. During blastocyst development, becomes increasingly localized to the nucleolus and less to the cytoplasm. At the late blastocyst stage, localized predominantly in the nucleolus. Localized in the nucleolus during interphase and to the perichromosomal sheath during mitosis. Does not colocalize in the cytoplasm with GW182 in P-bodies. May translocate to the nucleolus upon early embryonic development. {ECO:0000250}.	74111;	cd12564;cd12502;cd12567;cd12569;cd12318;cd12571;	IPR012677;IPR035979;IPR034419;IPR034420;IPR034423;IPR034421;IPR034418;IPR034417;IPR000504;IPR003954;	PF00076;	SM00360;SM00361;	106083	COMPBIAS 90..106;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 107..126;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 178..192;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 208..224;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 225..250;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 668..693;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 702..719;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 85..126;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 159..267;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 367..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 481..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 664..719;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (21); Chain (1); Compositional bias (7); Cross-link (1); Domain (6); Helix (10); Modified residue (6); Region (5); Turn (3)		3D-structure;Alternative splicing;Chromosome;Cytoplasm;Developmental protein;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 2..79;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 293..368;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 400..478;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 584..656;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 722..803;  /note=RRM 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 824..904;  /note=RRM 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	74111	GO:0007275~multicellular organism development,GO:0040019~positive regulation of embryonic development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.9705060262274	0.000109412667209315	FDR<0.01	3.96093239481576	7028088.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	282	Splicing
Q9Z315	Q9Z315	Sart1	9.0873	12.794	8862100	7.10530055421344	5.89622641509434	4.55643140292523	2.19804374107045	13.6770840456815	9.7143967359627	3894286.66666667	0	Sart1	0	U4/U6.U5 tri-snRNP-associated protein 1 (Hypoxia-associated factor) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (mSART-1)		FUNCTION: Plays a role in mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the spliceosome. May also bind to DNA. Appears to play a role in hypoxia-induced regulation of EPO gene expression. {ECO:0000269|PubMed:10887110}.		maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	20227;		IPR005011;	PF03343;		90885	COMPBIAS 44..104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 435..451;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 582..602;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..121;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 418..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 578..610;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (3); Cross-link (23); Modified residue (15); Region (3); Sequence conflict (4)		Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing							20227	GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0000481~maturation of 5S rRNA,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0045292~mRNA cis splicing, via spliceosome,GO:0045585~positive regulation of cytotoxic T cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005794~Golgi apparatus,GO:0015030~Cajal body,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071013~catalytic step 2 spliceosome,	GO:0044822~poly(A) RNA binding,	IPR005011:SART-1 protein,	PF03343:SART-1 family,		2.82848405238997	1.18080335314316e-06	FDR<0.01	5.9278224222474	6378193.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	305	Splicing
Q8BTI8	Q8BTI8-3;Q8BTI8;Q8BTI8-2	Srrm2	0.88127	1.1117	8478250	3.36292709174065	2.5651549353581	4.32058759991359	1.95713866327429	2.01930455151246	1.91523183881409	4010076.66666667	0	Srrm2	0	Serine/arginine repetitive matrix protein 2		FUNCTION: Required for pre-mRNA splicing as component of the spliceosome. {ECO:0000250|UniProtKB:Q9UQ35}.		mRNA splicing, via spliceosome [GO:0000398]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UQ35}. Nucleus speckle {ECO:0000250|UniProtKB:Q9UQ35}.	75956;		IPR013170;IPR024945;	PF08312;	SM01104;	294840	COMPBIAS 209..256;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 264..299;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 313..332;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 333..348;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 385..400;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 403..418;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 419..459;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 460..530;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 543..717;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 756..849;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 857..928;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 932..946;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 947..1005;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1024..1077;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1090..1110;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1241..1255;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1281..1301;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1353..1377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1392..1435;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1450..1514;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1598..1617;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1618..1659;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1727..1741;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1756..1776;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1792..1816;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1823..2016;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2026..2074;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2264..2286;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2311..2329;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2362..2377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2384..2398;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2406..2446;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2466..2522;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2544..2558;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2559..2606;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2621..2640;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2641..2672;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2673..2695;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 141..1007;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 197..259;  /note=Sufficient for RNA-binding;  /evidence=ECO:0000250; REGION 1024..1112;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1136..2092;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2263..2703;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (38); Cross-link (3); Erroneous initiation (1); Modified residue (265); Region (5); Sequence conflict (17)		Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing							75956	GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0071013~catalytic step 2 spliceosome,	GO:0044822~poly(A) RNA binding,	IPR013170:mRNA splicing factor, Cwf21,IPR024945:Spt5 C-terminal domain,	PF08312:cwf21 domain,		1.01381725616556	0.00325641473073683	FDR<0.01	2.48726028934782	6244163.33333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	311	Splicing
Q9QXA5	Q9QXA5	Lsm4	18.38	11.644	11687350	NA	9.79431929480901	NA	NA	NA	NA	519161.666666667	5	Lsm4	0	U6 snRNA-associated Sm-like protein LSm4		FUNCTION: Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex). The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA. {ECO:0000250|UniProtKB:Q9Y4Z0}.		mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; spliceosomal snRNP assembly [GO:0000387]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10629062}.	50783;	cd01723;	IPR034101;IPR027141;IPR001163;IPR010920;	PF01423;	SM00651;	15076		REGION 82..137;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (1); Region (1)		Acetylation;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing							50783	GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0002230~positive regulation of defense response to virus by host,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0043005~neuron projection,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0017070~U6 snRNA binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027141:U6 snRNA-associated Sm-like protein LSm4/Small nuclear ribonucleoprotein Sm D1/D3,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	3.67784164321555	9.27022058838166e-05	FDR<0.01	4.03290993153219	6103255.83333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	316	Splicing
Q9D0T1	Q9D0T1	Nhp2l1	21.567	14.589	6250450	13.2459103251871	6.30278583133745	11.7620767122643	7.33245343892066	8.02697062128753	22.6433892625048	5929710	0	Nhp2l1	0	NHP2-like protein 1 (Fertilization antigen 1) (FA-1) (High mobility group-like nuclear protein 2 homolog 1) (Sperm-specific antigen 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Binds to the 5'-stem-loop of U4 snRNA and thereby contributes to spliceosome assembly. The protein undergoes a conformational change upon RNA-binding. {ECO:0000250|UniProtKB:P55769}.		box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]	box C/D RNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]	ATPase binding [GO:0051117]; box C/D RNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P55769}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P55769}. Note=Concentrated in the dense fibrillar component of the nucleolus. {ECO:0000250|UniProtKB:P55769}.	20826;		IPR002415;IPR029064;IPR004038;IPR018492;IPR004037;	PF01248;		14174		REGION 36..48;  /note=Interaction with U4 snRNA and U4atac snRNA;  /evidence=ECO:0000250|UniProtKB:P55769; REGION 96..128;  /note=Important for U4 snRNA-binding;  /evidence=ECO:0000250|UniProtKB:P55769	NA							5 out of 5	Chain (2); Frameshift (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (1); Site (2)		Acetylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing						PS01082;	20826	GO:0000398~mRNA splicing, via spliceosome,GO:0000470~maturation of LSU-rRNA,GO:0007338~single fertilization,GO:0030490~maturation of SSU-rRNA,	GO:0001651~dense fibrillar component,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0043234~protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,	GO:0003723~RNA binding,GO:0030515~snoRNA binding,GO:0030621~U4 snRNA binding,GO:0030622~U4atac snRNA binding,GO:0034511~U3 snoRNA binding,GO:0034512~box C/D snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,	IPR002415:H/ACA ribonucleoprotein complex, subunit Nhp2, eukaryote,IPR004037:Ribosomal protein L7Ae conserved site,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR018492:Ribosomal protein L7Ae/L8/Nhp2 family,	PF01248:Ribosomal protein L7Ae/L30e/S12e/Gadd45 family,	SSF55315:L30e-like,	3.57715849532354	2.46900697183914e-08	FDR<0.01	7.60747768373069	6090080	Present in Nucleus	RBP	ChD	Others	ChD	Others	317	Splicing
Q61584	Q61584-4;Q61584-5;Q61584-3;Q61584;Q61584-6;Q61584-7;Q61584-2	Fxr1	19.649	20.116	6751000	8.2904990880451	9.12908526565638	5.51541558656445	4.26839679016561	6.98665548801789	9.86193293885601	4469630	0	Fxr1	0	Fragile X mental retardation syndrome-related protein 1 (mFxr1p)		FUNCTION: RNA-binding protein required for embryonic and postnatal development of muscle tissue. May regulate intracellular transport and local translation of certain mRNAs. {ECO:0000269|PubMed:15128702}.		cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]	axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ribonucleoprotein granule [GO:0035770]	G-quadruplex RNA binding [GO:0002151]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:30770808}. Note=Adjacent to Z-lines in muscles. {ECO:0000269|PubMed:30770808}.	14359;		IPR008395;IPR040148;IPR040472;IPR022034;IPR032172;IPR032177;IPR004087;IPR004088;IPR036612;IPR041560;	PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;	SM00322;	76222	COMPBIAS 438..473;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 496..518;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 596..610;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 611..631;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 650..665;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 380..677;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 471..486;  /note=RNA-binding RGG-box	NA							5 out of 5	Alternative sequence (5); Chain (1); Compositional bias (5); Cross-link (1); Domain (4); Initiator methionine (1); Modified residue (20); Region (2); Sequence conflict (1)		Acetylation;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Isopeptide bond;Methylation;Myogenesis;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 4..50;  /note=Agenet-like 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 63..115;  /note=Agenet-like 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 222..251;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 285..314;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The tandem Agenet-like domains preferentially recognize trimethylated histone peptides. {ECO:0000250}.				PS51641;PS50084;	14359	GO:0007275~multicellular organism development,GO:0007517~muscle organ development,GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0035770~ribonucleoprotein granule,GO:0043034~costamere,GO:0043197~dendritic spine,GO:0048471~perinuclear region of cytoplasm,	GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0033592~RNA strand annealing activity,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	PF00013:KH domain,PF05641:Agenet domain,PF12235:Fragile X-related 1 protein C terminal,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.19152764261228	1.93942423501258e-07	FDR<0.01	6.71232718175543	5610315	Present in Nucleus	RBP	RBD	Others	Others	RBD	340	Splicing
P57784	P57784	Snrpa1	14.656	13.589	5248600	NA	6.98275260107534	NA	NA	12.3664424218441	15.4789177140734	5625433.33333333	3	Snrpa1	0	U2 small nuclear ribonucleoprotein A' (U2 snRNP A')		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Associated with sn-RNP U2, where it contributes to the binding of stem loop IV of U2 snRNA. {ECO:0000250|UniProtKB:P09661}.		mRNA splicing, via spliceosome [GO:0000398]; spermatogenesis [GO:0007283]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	U2 snRNA binding [GO:0030620]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09661}.	68981;		IPR001611;IPR032675;IPR044640;IPR003603;		SM00446;	28357		REGION 179..199;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 222..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (2); Domain (1); Modified residue (5); Region (2); Repeat (4); Sequence conflict (2)		Acetylation;Isopeptide bond;Leucine-rich repeat;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 123..161;  /note=LRRCT			REPEAT 20..41;  /note=LRR 1; REPEAT 43..64;  /note=LRR 2; REPEAT 65..86;  /note=LRR 3; REPEAT 89..110;  /note=LRR 4		PS51450;	68981	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0030620~U2 snRNA binding,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR003603:U2A'/phosphoprotein 32 family A, C-terminal,		SSF52058:L domain-like,	3.60443481358532	1.5066432238366e-06	FDR<0.01	5.82198957732262	5437016.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	352	Splicing
Q9D0B0	Q9D0B0	Srsf9	12.648	11.8	9531700	5.93647966755714	2.39865675221876	NA	NA	NA	3.65751069821879	1148315	3	Srsf9	0	Serine/arginine-rich splicing factor 9 (Splicing factor, arginine/serine-rich 9)		FUNCTION: Plays a role in constitutive splicing and can modulate the selection of alternative splice sites. Represses the splicing of MAPT/Tau exon 10 (By similarity). {ECO:0000250}.		alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	108014;	cd12598;cd12768;	IPR012677;IPR035979;IPR000504;IPR034503;IPR034995;	PF00076;	SM00360;	25661	COMPBIAS 190..212;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 189..201;  /note=Interaction with SAFB1;  /evidence=ECO:0000250; REGION 190..222;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Beta strand (5); Chain (1); Compositional bias (1); Cross-link (1); Domain (2); Helix (2); Modified residue (9); Region (2); Sequence conflict (1); Turn (1)		3D-structure;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 15..90;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 112..188;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	108014	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009636~response to toxic substance,GO:0043279~response to alkaloid,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.58484975911849	0.000242704092860183	FDR<0.01	3.61492289984604	5340007.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	354	Splicing
Q99LF4	Q99LF4	Rtcb	18.832	10.722	9202700	NA	6.4968814968815	1.14935923222803	NA	2.19992960225273	1.68438073742189	717586.666666667	2	Rtcb	0	RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase) (Focal adhesion-associated protein) (FAAP)		FUNCTION: Catalytic subunit of the tRNA-splicing ligase complex that acts by directly joining spliced tRNA halves to mature-sized tRNAs by incorporating the precursor-derived splice junction phosphate into the mature tRNA as a canonical 3',5'-phosphodiester. May act as an RNA ligase with broad substrate specificity, and may function toward other RNAs (By similarity). Essential during post-implantation development of embryos. {ECO:0000255|HAMAP-Rule:MF_03144, ECO:0000269|PubMed:20510672}.		in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03144, ECO:0000269|PubMed:18508721}. Note=Enters into the nucleus in case of active transcription while it accumulates in cytosol when transcription level is low. {ECO:0000250}.	28088;		IPR001233;IPR036025;IPR027513;	PF01139;		55249			NA	ACT_SITE 428;  /note=GMP-histidine intermediate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144		BINDING 409;  /note=GMP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144; BINDING 504;  /note=GMP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144	6.5.1.8	METAL 119;  /note=Manganese 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144; METAL 122;  /note=Manganese 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144; METAL 122;  /note=Manganese 2;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144; METAL 227;  /note=Manganese 1; via tele nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144; METAL 259;  /note=Manganese 2; via tele nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144; METAL 353;  /note=Manganese 2; via tele nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03144		5 out of 5	Active site (1); Binding site (2); Chain (1); Cross-link (1); Metal binding (6); Modified residue (1); Nucleotide binding (4); Sequence conflict (5)	MISCELLANEOUS: Ligation probably proceeds through 3 nucleotidyl transfer steps, with 2',3'-cyclic phosphate termini being hydrolyzed to 3'-P termini in a step that precedes 3'-P activation with GMP. In the first nucleotidyl transfer step, RTCB reacts with GTP to form a covalent RTCB-histidine-GMP intermediate with release of PPi; in the second step, the GMP moiety is transferred to the RNA 3'-P; in the third step, the 5'-OH from the opposite RNA strand attacks the activated 3'-P to form a 3',5'-phosphodiester bond and release GMP. {ECO:0000255|HAMAP-Rule:MF_03144}.	Cytoplasm;GTP-binding;Isopeptide bond;Ligase;Manganese;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;tRNA processing						PS01288;	28088	GO:0001701~in utero embryonic development,GO:0001890~placenta development,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006396~RNA processing,GO:0008033~tRNA processing,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0072669~tRNA-splicing ligase complex,	GO:0000166~nucleotide binding,GO:0003972~RNA ligase (ATP) activity,GO:0005524~ATP binding,GO:0008452~RNA ligase activity,GO:0016874~ligase activity,GO:0017166~vinculin binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001233:RtcB family,IPR027513:tRNA-splicing ligase RtcB, eukaryotic,	PF01139:tRNA-splicing ligase RtcB,	SSF103365:Hypothetical protein PH1602,	2.07464487820747	0.00376856350261541	FDR<0.01	2.42382416220111	4960143.33333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	376	Splicing
Q6PE01	Q6PE01	Snrnp40	9.7169	6.4047	6416450	1.24787860636917	4.72746182574576	3.31707964308223	NA	1.41781627936652	21.6253622248173	3455991.66666667	1	Snrnp40	0	U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (WD repeat-containing protein 57)		FUNCTION: Required for pre-mRNA splicing as component of the activated spliceosome. Component of the U5 small nuclear ribonucleoprotein (snRNP) complex and the U4/U6-U5 tri-snRNP complex, building blocks of the spliceosome. {ECO:0000250|UniProtKB:Q96DI7}.		mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; U2-type catalytic step 2 spliceosome [GO:0071007]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96DI7}.	66585;		IPR020472;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	39276			NA							3 out of 5	Chain (1); Cross-link (2); Frameshift (1); Modified residue (1); Repeat (7); Sequence conflict (2)		Isopeptide bond;Methylation;Nucleus;Reference proteome;Repeat;Spliceosome;Ubl conjugation;WD repeat;mRNA processing;mRNA splicing				REPEAT 65..104;  /note=WD 1; REPEAT 108..147;  /note=WD 2; REPEAT 150..190;  /note=WD 3; REPEAT 192..231;  /note=WD 4; REPEAT 234..273;  /note=WD 5; REPEAT 284..323;  /note=WD 6; REPEAT 326..358;  /note=WD 7		PS00678;PS50082;PS50294;	66585	GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005737~cytoplasm,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.16977245230114	0.000962462039310857	FDR<0.01	3.01661639059134	4936220.83333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	377	Splicing
Q9CZU3	Q9CZU3	Skiv2l2	41.853	33.437	6815850	6.80457267283615	7.87587619122627	10.8828138603517	7.93713786808477	1.43441153266872	4.67224220903612	2800628.33333333	0	Skiv2l2	0	Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)		FUNCTION: Catalyzes the ATP-dependent unwinding of RNA duplexes with a single-stranded 3' RNA extension. Central subunit of many protein complexes, namely TRAMP-like, nuclear exosome targeting (NEXT) and poly(A) tail exosome targeting (PAXT). NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. NEXT is involved in surveillance and turnover of aberrant transcripts and non-coding RNAs. PAXT directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor ZCCHC8, which links to RNA-binding protein adapters. Associated with the RNA exosome complex and involved in the 3'-processing of the 7S pre-RNA to the mature 5.8S rRNA. May be involved in pre-mRNA splicing. In the context of NEXT complex can also in vitro unwind DNA:RNA heteroduplexes with a 3' poly (A) RNA tracking strand. Can promote unwinding and degradation of structured RNA substrates when associated with the nuclear exosome and its cofactors. Can displace a DNA strand while translocating on RNA to ultimately degrade the RNA within a DNA/RNA heteroduplex (By similarity). Plays a role in DNA damage response (By similarity). {ECO:0000250|UniProtKB:P42285}.		cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Nucleus {ECO:0000250|UniProtKB:P42285}. Nucleus speckle {ECO:0000250|UniProtKB:P42285}.	72198;		IPR011545;IPR014001;IPR001650;IPR027417;IPR025696;IPR016438;IPR012961;	PF00270;PF08148;PF00271;PF13234;	SM00487;SM01142;SM00490;	117636	COMPBIAS 19..48;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 56..77;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 16..77;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Activated when MTREX is incorporated into NEXT complex an the nuclear RNA exosome complex. {ECO:0000250|UniProtKB:P42285}.	BINDING 137;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:P42285; BINDING 162;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P42285; BINDING 164;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P42285; BINDING 165;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P42285; BINDING 166;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P42285	3.6.4.13			5 out of 5	Binding site (5); Chain (1); Compositional bias (2); Cross-link (4); Domain (2); Initiator methionine (1); Modified residue (4); Motif (1); Nucleotide binding (1); Region (1)		ATP-binding;Acetylation;DNA damage;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing;rRNA processing	DOMAIN 146..302;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 403..575;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 250..253;  /note=DEIH box			PS51192;PS51194;	72198	GO:0000460~maturation of 5.8S rRNA,GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0006401~RNA catabolic process,GO:0008380~RNA splicing,	GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012961:DSH, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016438:RNA helicase, ATP-dependent, SK12/DOB1,IPR025696:rRNA-processing arch domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08148:DSHCT (NUC185) domain,PF13234:rRNA-processing arch domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.17146878537524	3.01470073651162e-05	FDR<0.01	4.52075579295411	4808239.16666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	382	Splicing
P59708	P59708	Sf3b6	12.647	14.889	7956850	NA	4.73619399450602	7.59878419452888	NA	6.02700096432015	18.9347319788688	1465203.33333333	2	Sf3b6	0	Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex. SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Directly contacts the pre-mRNA branch site adenosine for the first catalytic step of splicing. Enters the spliceosome and associates with the pre-mRNA branch site as part of the 17S U2 or, in the case of the minor spliceosome, as part of the 18S U11/U12 snRNP complex, and thus may facilitate the interaction of these snRNP with the branch sites of U2 and U12 respectively. {ECO:0000250|UniProtKB:Q9Y3B4}.		blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9Y3B4}.	66055;	cd12241;	IPR012677;IPR035979;IPR000504;IPR034150;	PF00076;	SM00360;	14585		REGION 16..29;  /note=Interaction with pre-mRNA branch site;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); Cross-link (1); Domain (1); Modified residue (2); Region (1)		Acetylation;Isopeptide bond;Nucleus;RNA-binding;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 19..94;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	66055	GO:0000398~mRNA splicing, via spliceosome,GO:0001825~blastocyst formation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.26013307079665	3.14845151543265e-06	FDR<0.01	5.50190299022667	4711026.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	384	Splicing
P62305	P62305	Snrpe	NA	7.715	6664000	NA	1.71379605826907	15.5139780942629	4.93875938364283	3.00066014523195	2.24190113216007	2325053.33333333	1	Snrpe	1	Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. As part of the U7 snRNP it is involved in histone 3'-end processing. May indirectly play a role in hair development. {ECO:0000250|UniProtKB:P62304}.		hair cycle [GO:0042633]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; telomerase holoenzyme complex [GO:0005697]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62304}. Nucleus {ECO:0000250|UniProtKB:P62304}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P62304}.	20643;	cd01718;	IPR001163;IPR010920;IPR027078;	PF01423;	SM00651;	10804			NA							4 out of 5	Chain (1)		Cytoplasm;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing							20643	GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0042633~hair cycle,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0070062~extracellular exosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027078:Small nuclear ribonucleoprotein E,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	2.1224182713136	0.000690921355138297	FDR<0.01	3.16057138384615	4494526.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	396	Splicing
P62320	P62320	Snrpd3	4.1252	4.9847	6398600	28.4139341933284	23.4257871064468	4.72612127227185	10.8317717529056	9.06207521522429	23.5393813850572	2113048.33333333	0	Snrpd3	0	Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome (By similarity). As part of the U7 snRNP it is involved in histone pre-mRNA 3'-end processing (PubMed:19470752). {ECO:0000250|UniProtKB:P62318, ECO:0000269|PubMed:19470752}.		mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U7 snRNA binding [GO:0071209]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62318}. Nucleus {ECO:0000269|PubMed:19470752}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P62318}.	67332;	cd01721;	IPR027141;IPR001163;IPR010920;IPR034099;	PF01423;	SM00651;	13916		REGION 110..119;  /note=5 X 2 AA tandem repeats of [RM]-G	NA							5 out of 5	Chain (1); Initiator methionine (1); Modified residue (1); Region (1); Repeat (5)		Acetylation;Cytoplasm;Methylation;Nucleus;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing				REPEAT 110..111;  /note=1; REPEAT 112..113;  /note=2; REPEAT 114..115;  /note=3; REPEAT 116..117;  /note=4; REPEAT 118..119;  /note=5			67332	GO:0000245~spliceosomal complex assembly,GO:0000387~spliceosomal snRNP assembly,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006479~protein methylation,GO:0008380~RNA splicing,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0070062~extracellular exosome,GO:0071010~prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0097526~spliceosomal tri-snRNP complex,	GO:0003723~RNA binding,GO:0019899~enzyme binding,GO:0030620~U2 snRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,GO:0071208~histone pre-mRNA DCP binding,GO:0071209~U7 snRNA binding,GO:1990446~U1 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR027141:U6 snRNA-associated Sm-like protein LSm4/Small nuclear ribonucleoprotein Sm D1/D3,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	3.39440287692576	1.42823650836202e-06	FDR<0.01	5.84519986975059	4255824.16666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	404	Splicing
Q8JZX4	Q8JZX4	Rbm17	17.213	9.3833	7757750	69.4540908459508	10.3041793751546	25.3549695740365	NA	8.0147471347279	19.7277569540343	735045	1	Rbm17	0	Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17)		FUNCTION: Splice factor that binds to the single-stranded 3'AG at the exon/intron border and promotes its utilization in the second catalytic step. Involved in the regulation of alternative splicing and the utilization of cryptic splice sites (By similarity). {ECO:0000250}.		alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	76938;	cd12647;	IPR000467;IPR012677;IPR035979;IPR040052;IPR000504;IPR003954;IPR034653;	PF01585;PF00076;	SM00443;SM00361;	45304	COMPBIAS 114..170;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 183..202;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 57..88;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 114..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Cross-link (7); Domain (2); Initiator methionine (1); Modified residue (12); Region (2)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 235..283;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092; DOMAIN 310..389;  /note=RRM					PS50174;	76938	GO:0000375~RNA splicing, via transesterification reactions,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0043234~protein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,IPR016967:Splicing factor, SPF45,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF01585:G-patch domain,	SSF54928:RNA-binding domain, RBD,	4.11252517012056	5.48488019382173e-07	FDR<0.01	6.2608328542753	4246397.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	407	Splicing
P97376	P97376	Frg1	7.6459	5.5331	6110900	5.58098002009153	9.1066387396412	5.70645971239443	NA	5.65995019243831	5.23286237571952	1839031.66666667	1	Frg1	0	Protein FRG1 (FSHD region gene 1 protein)		FUNCTION: Binds to mRNA in a sequence-independent manner. May play a role in regulation of pre-mRNA splicing or in the assembly of rRNA into ribosomal subunits. May be involved in mRNA transport. May be involved in epigenetic regulation of muscle differentiation through regulation of activity of the histone-lysine N-methyltransferase KMT5B. {ECO:0000269|PubMed:23720823}.		mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, Cajal body {ECO:0000250|UniProtKB:Q14331}. Nucleus, nucleolus {ECO:0000269|PubMed:16341202, ECO:0000269|PubMed:20970242}. Cytoplasm {ECO:0000269|PubMed:20970242}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:20970242}. Note=Localization changes during myogenesis from mainly cytoplasmic in undifferentiated myoblasts, to strongly nucleolar in early myotubes and back to cytoplasmic 5 days post-differentiation. Localized at the Z-line in the sarcomere of matured myotubes 8 days post-differentiation. {ECO:0000269|PubMed:20970242}.	14300;		IPR008999;IPR010414;	PF06229;		29127		REGION 16..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Beta strand (17); Chain (1); Helix (1); Motif (2); Region (1); Sequence conflict (1); Turn (3)	MISCELLANEOUS: Overexpression of Frg1 leads to development of facioscapulohumeral muscular dystrophy (FSHD1)-like symptoms such as kyphosis, progressive muscle dystrophy and skeletal muscle atrophy. It also causes aberrant pre-mRNA splicing of Tnnt3 and Mtmr1, affects the localization and activity of KMT5B, and leads to increased levels of Eid3, resulting in inhibited muscle differentiation. These results suggest that human FSHD1 results from inappropriate overexpression of FRG1 which leads to abnormal alternative splicing of specific pre-mRNAs (PubMed:16341202, PubMed:23720823). {ECO:0000305|PubMed:16341202, ECO:0000305|PubMed:23720823}.	3D-structure;Actin-binding;Cytoplasm;Myogenesis;Nucleus;RNA-binding;Reference proteome;Ribosome biogenesis;Spliceosome;mRNA processing;mRNA splicing;rRNA processing			MOTIF 22..32;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 235..251;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255				14300	GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0007517~muscle organ development,GO:0008380~RNA splicing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0030018~Z disc,GO:0055120~striated muscle dense body,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0003779~actin binding,GO:0044822~poly(A) RNA binding,GO:0051015~actin filament binding,	IPR008999:Actin cross-linking,IPR010414:FRG1-like,	PF06229:FRG1-like family,	SSF50405:Actin-crosslinking proteins,	2.63874244478719	1.54236162169047e-07	FDR<0.01	6.81181378977904	3974965.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	427	Splicing
P27048	P27048;P63163	Snrpb;Snrpn	13.861	7.5587	5845850	9.01388137732108	11.3698380935055	6.00528465049243	2.99688324142891	9.09918107370337	15.7726218829356	1007486.66666667	0	Snrpb	0	Small nuclear ribonucleoprotein-associated protein B (snRNP-B) (snRPB) (Sm protein B) (Sm-B) (SmB)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome (By similarity) (PubMed:28263986). Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome (By similarity). As part of the U7 snRNP it is involved in histone pre-mRNA 3'-end processing (PubMed:19470752). {ECO:0000250|UniProtKB:P14678, ECO:0000269|PubMed:19470752, ECO:0000269|PubMed:28263986}.		brain development [GO:0007420]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; telomerase holoenzyme complex [GO:0005697]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]	histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U2 snRNP binding [GO:1990447]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P14678}. Nucleus {ECO:0000269|PubMed:19470752}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P14678}.	20638;		IPR001163;IPR010920;IPR017131;	PF01423;	SM00651;	23656	COMPBIAS 169..225;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 163..231;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 175..228;  /note=Repeat-rich region	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (8); Region (2); Repeat (4)		Cytoplasm;Methylation;Nucleus;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing				REPEAT 175..181; REPEAT 191..196; REPEAT 216..221; REPEAT 222..228			20638	GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0002230~positive regulation of defense response to virus by host,GO:0006397~mRNA processing,GO:0006479~protein methylation,GO:0008380~RNA splicing,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,GO:0034709~methylosome,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0070062~extracellular exosome,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0071204~histone pre-mRNA 3'end processing complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030620~U2 snRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,GO:0071208~histone pre-mRNA DCP binding,GO:1990446~U1 snRNP binding,GO:1990447~U2 snRNP binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR017131:Small ribonucleoprotein associated, SmB/SmN,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	3.09064608137273	1.96754638301884e-07	FDR<0.01	6.70607502077235	3426668.33333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	470	Splicing
Q9CYA6	Q9CYA6	Zcchc8	8.3541	8.0552	5418100	4.83325277912035	3.69235313665399	NA	NA	4.12592317531048	3.43831660019255	1231866.66666667	2	Zcchc8	0	Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8)		FUNCTION: Scaffolding subunit of the trimeric nuclear exosome targeting (NEXT) complex that is involved in the surveillance and turnover of aberrant transcripts and non-coding RNAs. NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. May be involved in pre-mRNA splicing. It is required for 3'-end maturation of telomerase RNA component (TERC), TERC 3'-end targeting to the nuclear RNA exosome, and for telomerase function. {ECO:0000250|UniProtKB:Q6NZY4}.		mRNA processing [GO:0006397]; ncRNA processing [GO:0034470]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]	RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q6NZY4}. Note=Excluded from nucleolus. {ECO:0000250|UniProtKB:Q6NZY4}.	70650;		IPR006568;IPR001878;	PF04046;PF00098;	SM00581;SM00343;	78026	COMPBIAS 409..435;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 468..503;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 548..562;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 632..648;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..47;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 289..302;  /note=RBM7 binding;  /evidence=ECO:0000250|UniProtKB:Q6NZY4; REGION 312..327;  /note=RBM7 binding;  /evidence=ECO:0000250|UniProtKB:Q6NZY4; REGION 409..518;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 533..667;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 661..709;  /note=MTREX binding;  /evidence=ECO:0000250|UniProtKB:Q6NZY4	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Initiator methionine (1); Modified residue (8); Region (6); Sequence conflict (5); Zinc finger (1)		Acetylation;Coiled coil;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing		DOMAIN: The C-terminal part (659-707) contributes to MTREX RNA helicase activity, in part, by enhancing its RNA-dependent ATPase activity. {ECO:0000250|UniProtKB:Q6NZY4}.			ZN_FING 230..247;  /note=CCHC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00047	PS50158;	70650	GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001878:Zinc finger, CCHC-type,IPR006568:PSP, proline-rich,	PF00098:Zinc knuckle,PF04046:PSP,		2.34272652731877	1.2337045850359e-05	FDR<0.01	4.908788821217	3324983.33333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	477	Splicing
Q922U1	Q922U1	Prpf3	15.325	10.993	4355150	13.8842608019549	1.92303994153959	21.5805602313436	NA	9.52199581032184	14.3893173707839	1953265	1	Prpf3	0	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3)		FUNCTION: Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex). {ECO:0000250|UniProtKB:O43395}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]	Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43395}. Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00627}.	70767;		IPR010541;IPR013881;IPR027104;IPR002483;IPR036483;	PF06544;PF08572;PF01480;	SM00311;	77455	COMPBIAS 73..122;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 73..135;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 161..183;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 416..550;  /note=Mediates interaction with SART3;  /evidence=ECO:0000250|UniProtKB:O43395	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (3); Domain (1); Modified residue (2); Region (3); Sequence conflict (1)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 1..87;  /note=PWI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00627					PS51025;	70767	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0043234~protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR002483:PWI domain,IPR010541:Domain of unknown function DUF1115,IPR013881:Pre-mRNA-splicing factor 3,IPR027104:U4/U6 small nuclear ribonucleoprotein Prp3,	PF01480:PWI domain,PF06544:Protein of unknown function (DUF1115),PF08572:pre-mRNA processing factor 3 (PRP3),	SSF101233:PWI domain,	3.38070660901652	4.85987856678295e-06	FDR<0.01	5.31337458226753	3154207.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	491	Splicing
Q8K4Z5	Q8K4Z5	Sf3a1	10.584	12.609	3416850	8.09847748623259	10.1550678866288	2.56114739403253	1.79784977167308	4.39637738503473	3.10212185134632	2491363.33333333	0	Sf3a1	0	Splicing factor 3A subunit 1 (SF3a120)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3A complex that contributes to the assembly of the 17S U2 snRNP, and the subsequent assembly of the pre-spliceosome 'E' complex and the pre-catalytic spliceosome 'A' complex. Involved in pre-mRNA splicing as a component of pre-catalytic spliceosome 'B' complexes. {ECO:0000250|UniProtKB:Q15459}.		mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15459}. Nucleus speckle {ECO:0000250|UniProtKB:Q15459}.	67465;	cd01800;	IPR022030;IPR035563;IPR000061;IPR035967;IPR000626;IPR029071;	PF12230;PF01805;PF00240;	SM00648;SM00213;	88545	COMPBIAS 1..18;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..338;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 367..383;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 486..502;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 529..545;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 549..582;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 318..411;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 486..516;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 528..582;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 664..684;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 678..700;  /note=Required and sufficient for nuclear import;  /evidence=ECO:0000250|UniProtKB:Q15459	NA							4 out of 5	Beta strand (6); Chain (1); Compositional bias (6); Cross-link (6); Domain (1); Helix (4); Modified residue (9); Region (6); Repeat (2); Sequence conflict (3); Site (1); Turn (1)		3D-structure;Acetylation;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 705..788;  /note=Ubiquitin-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00214	DOMAIN: SURP motif 2 mediates direct binding to SF3A3. {ECO:0000250}.		REPEAT 52..94;  /note=SURP motif 1; REPEAT 166..208;  /note=SURP motif 2		PS50128;PS50053;	67465	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000389~mRNA 3'-splice site recognition,GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000061:SWAP/Surp,IPR000626:Ubiquitin,IPR022030:Pre-mRNA splicing factor PRP21-like protein,	PF00240:Ubiquitin family,PF01805:Surp module,PF12230:Pre-mRNA splicing factor PRP21 like protein,	SSF109905:Surp module (SWAP domain),SSF54236:Ubiquitin-like,	2.42432588130348	2.18352368092321e-05	FDR<0.01	4.66084209367234	2954106.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	507	Splicing
Q9DAW6	Q9DAW6	Prpf4	4.7199	4.9647	4484000	NA	7.65520936997627	3.67107195301028	NA	4.56933973040896	7.92016473942658	1386476.66666667	2	Prpf4	0	U4/U6 small nuclear ribonucleoprotein Prp4 (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)		FUNCTION: Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex). {ECO:0000250|UniProtKB:O43172}.		mRNA splicing, via spliceosome [GO:0000398]	Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43172}. Nucleus speckle {ECO:0000250|UniProtKB:O43172}.	70052;		IPR020472;IPR014906;IPR036285;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF08799;PF00400;	SM00500;SM00320;	58370			NA							3 out of 5	Chain (1); Modified residue (1); Repeat (7)		Acetylation;Nucleus;Reference proteome;Repeat;Spliceosome;WD repeat;mRNA processing;mRNA splicing				REPEAT 228..267;  /note=WD 1; REPEAT 270..317;  /note=WD 2; REPEAT 320..359;  /note=WD 3; REPEAT 362..401;  /note=WD 4; REPEAT 404..443;  /note=WD 5; REPEAT 446..486;  /note=WD 6; REPEAT 489..521;  /note=WD 7		PS00678;PS50082;PS50294;	70052	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0015030~Cajal body,GO:0016607~nuclear speck,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071001~U4/U6 snRNP,GO:0097525~spliceosomal snRNP complex,	GO:0017070~U6 snRNA binding,GO:0030621~U4 snRNA binding,	IPR001680:WD40 repeat,IPR014906:Pre-mRNA processing factor 4 (PRP4)-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR027106:U4/U6 small nuclear ribonucleoprotein Prp4/ASTRA-associated protein 1,	PF00400:WD domain, G-beta repeat,PF08799:pre-mRNA processing factor 4 (PRP4) like,	SSF158230:PRP4-like,SSF50978:WD40 repeat-like,	2.4234370356667	4.76887513142835e-06	FDR<0.01	5.32158404901541	2935238.33333333	Present in Nucleus	RBP	ChD	Others	ChD	RBD	508	Splicing
P35922	P35922-3;P35922-2;P35922;P35922-5;P35922-4;P35922-6;P35922-9;P35922-8;P35922-7;P35922-11;P35922-10;P35922-12	Fmr1	3.2394	3.6569	4009850	9.67866821525358	8.63483291598308	9.80296049406921	NA	13.4053648270038	5.2667614683731	1531588.8	1	Fmr1	0	Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1 homolog) (FMRP) (Protein FMR-1) (mFmr1p)		FUNCTION: Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity through the regulation of alternative mRNA splicing, mRNA stability, mRNA dendritic transport and postsynaptic local protein synthesis of a subset of mRNAs (PubMed:11438589, PubMed:12032354, PubMed:15475576, PubMed:16631377, PubMed:16790844, PubMed:17417632, PubMed:17548835, PubMed:18539120, PubMed:18653529, PubMed:19640847, PubMed:19166269, PubMed:20159450, PubMed:21784246, PubMed:23235829, PubMed:24813610). Plays a role in the alternative splicing of its own mRNA (PubMed:18653529). Plays a role in mRNA nuclear export (PubMed:16790844). Together with export factor NXF2, is involved in the regulation of the NXF1 mRNA stability in neurons (PubMed:17548835). Stabilizes the scaffolding postsynaptic density protein DLG4/PSD-95 and the myelin basic protein MBP mRNAs in hippocampal neurons and glial cells, respectively; this stabilization is further increased in response to metabotropic glutamate receptor (mGluR) stimulation (PubMed:17417632). Plays a role in selective delivery of a subset of dendritic mRNAs to synaptic sites in response to mGluR activation in a kinesin-dependent manner (PubMed:18539120). Plays a role as a repressor of mRNA translation during the transport of dendritic mRNAs to postsynaptic dendritic spines (PubMed:11376146, PubMed:12581522, PubMed:14570712, PubMed:12927206, PubMed:15475576, PubMed:16908410, PubMed:18805096, PubMed:19640847, PubMed:21784246, PubMed:23235829). Component of the CYFIP1-EIF4E-FMR1 complex which blocks cap-dependent mRNA translation initiation (PubMed:18805096). Represses mRNA translation by stalling ribosomal translocation during elongation (PubMed:21784246). Reports are contradictory with regards to its ability to mediate translation inhibition of (MBP) mRNA in oligodendrocytes (PubMed:14613971, PubMed:23891804). Also involved in the recruitment of the RNA helicase MOV10 to a subset of mRNAs and hence regulates microRNA (miRNA)-mediated translational repression by AGO2 (PubMed:20159450, PubMed:25464849). Facilitates the assembly of miRNAs on specific target mRNAs (By similarity). Plays also a role as an activator of mRNA translation of a subset of dendritic mRNAs at synapses (PubMed:14614133, PubMed:14613971, PubMed:15548614, PubMed:19640847, PubMed:19166269, PubMed:21490210). In response to mGluR stimulation, FMR1-target mRNAs are rapidly derepressed, allowing for local translation at synapses (PubMed:16908410, PubMed:17507556, PubMed:19640847). Binds to a large subset of dendritic mRNAs that encode a myriad of proteins involved in pre- and postsynaptic functions (PubMed:11719188, PubMed:11376146, PubMed:14613971, PubMed:17507556, PubMed:21784246, PubMed:21490210, PubMed:24349419). Binds to 5'-ACU[GU]-3' and/or 5'-[AU]GGA-3' RNA consensus sequences within mRNA targets, mainly at coding sequence (CDS) and 3'-untranslated region (UTR) and less frequently at 5'-UTR (By similarity). Binds to intramolecular G-quadruplex structures in the 5'- or 3'-UTRs of mRNA targets (PubMed:25692235). Binds to G-quadruplex structures in the 3'-UTR of its own mRNA (By similarity). Binds also to RNA ligands harboring a kissing complex (kc) structure; this binding may mediate the association of FMR1 with polyribosomes (By similarity). Binds mRNAs containing U-rich target sequences (By similarity). Binds to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the 5'-UTR region of superoxide dismutase SOD1 mRNA (PubMed:19166269). Binds to the dendritic, small non-coding brain cytoplasmic RNA 1 (BC1); which may increase the association of the CYFIP1-EIF4E-FMR1 complex to FMR1 target mRNAs at synapses (PubMed:12581522, PubMed:18805096). Associates with export factor NXF1 mRNA-containing ribonucleoprotein particles (mRNPs) in a NXF2-dependent manner (PubMed:17548835). Binds to a subset of miRNAs in the brain (PubMed:20159450). May associate with nascent transcripts in a nuclear protein NXF1-dependent manner (By similarity). In vitro, binds to RNA homomer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (By similarity). Moreover, plays a role in the modulation of the sodium-activated potassium channel KCNT1 gating activity (PubMed:20512134). Negatively regulates the voltage-dependent calcium channel current density in soma and presynaptic terminals of dorsal root ganglion (DRG) neurons, and hence regulates synaptic vesicle exocytosis (By similarity). Modulates the voltage-dependent calcium channel CACNA1B expression at the plasma membrane by targeting the channels for proteosomal degradation (PubMed:24709664). Plays a role in regulation of MAP1B-dependent microtubule dynamics during neuronal development (PubMed:15475576). Recently, has been shown to play a translation-independent role in the modulation of presynaptic action potential (AP) duration and neurotransmitter release via large-conductance calcium-activated potassium (BK) channels in hippocampal and cortical excitatory neurons (PubMed:25561520). Finally, FMR1 may be involved in the control of DNA damage response (DDR) mechanisms through the regulation of ATR-dependent signaling pathways such as histone H2AX/H2A.x and BRCA1 phosphorylations (PubMed:24813610). {ECO:0000250|UniProtKB:Q06787, ECO:0000250|UniProtKB:Q80WE1, ECO:0000269|PubMed:11376146, ECO:0000269|PubMed:11438589, ECO:0000269|PubMed:11719188, ECO:0000269|PubMed:12032354, ECO:0000269|PubMed:12581522, ECO:0000269|PubMed:12927206, ECO:0000269|PubMed:14570712, ECO:0000269|PubMed:14613971, ECO:0000269|PubMed:14614133, ECO:0000269|PubMed:15475576, ECO:0000269|PubMed:15548614, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:17417632, ECO:0000269|PubMed:17507556, ECO:0000269|PubMed:17548835, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:18653529, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19166269, ECO:0000269|PubMed:19640847, ECO:0000269|PubMed:20159450, ECO:0000269|PubMed:20512134, ECO:0000269|PubMed:21490210, ECO:0000269|PubMed:21784246, ECO:0000269|PubMed:23235829, ECO:0000269|PubMed:23891804, ECO:0000269|PubMed:24349419, ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:24813610, ECO:0000269|PubMed:25561520, ECO:0000269|PubMed:25692235}.		anterograde axonal transport [GO:0008089]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; central nervous system development [GO:0007417]; dendritic spine development [GO:0060996]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein processing [GO:0010955]; negative regulation of receptor internalization [GO:0002091]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of modification of synaptic structure [GO:1905244]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; RNA splicing [GO:0008380]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell body [GO:0044297]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule cytoskeleton [GO:0015630]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; proximal dendrite [GO:1990635]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; Schaffer collateral - CA1 synapse [GO:0098685]; smooth endoplasmic reticulum [GO:0005790]; spine apparatus [GO:0097444]; synapse [GO:0045202]; terminal bouton [GO:0043195]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:8895584}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q06787}. Chromosome, centromere {ECO:0000269|PubMed:24813610}. Chromosome {ECO:0000269|PubMed:24813610}. Cytoplasm {ECO:0000269|PubMed:11438699, ECO:0000269|PubMed:14570712, ECO:0000269|PubMed:15317853, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:8895584}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:11438699, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:9285783}. Cytoplasm, Cytoplasmic ribonucleoprotein granule {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:15312650, ECO:0000269|PubMed:15329415, ECO:0000269|PubMed:16098134, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:9285783}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q06787}. Perikaryon {ECO:0000269|PubMed:14613971, ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19193898}. Cell projection, neuron projection {ECO:0000250|UniProtKB:Q06787}. Cell projection, axon {ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:19193898}. Cell projection, dendrite {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19193898}. Cell projection, dendritic spine {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:16631377}. Cell junction, synapse, synaptosome {ECO:0000269|PubMed:18805096}. Cell projection, filopodium {ECO:0000269|PubMed:16631377}. Cell projection, growth cone {ECO:0000269|PubMed:16631377}. Cell projection, filopodium tip {ECO:0000269|PubMed:16631377}. Cell junction, synapse {ECO:0000269|PubMed:16631377}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000269|PubMed:19193898}. Cell junction, synapse, presynaptic cell membrane {ECO:0000269|PubMed:19193898}. Cell membrane {ECO:0000269|PubMed:24709664}. Note=Colocalizes with H2AX/H2A.x in pericentromeric heterochromatin in response to DNA damaging agents (PubMed:24813610). Localizes on meiotic pachytene-stage chromosomes (PubMed:24813610). Forms nuclear foci representing sites of ongoing DNA replication in response to DNA damaging agents (PubMed:24813610). Shuttles between nucleus and cytoplasm in a XPO1/CRM1-dependent manner (PubMed:8895584, PubMed:8842725). Localizes to cytoplasmic granules, also referred to as messenger ribonucleoprotein particles or mRNPs, along dendrites and dendritic spines (PubMed:15028757, PubMed:16631377). FMR1-containing cytoplasmic granules colocalize to F-actin-rich structures, including filopodium, spines and growth cone during the development of hippocampal neurons (By similarity). FMR1-containing cytoplasmic granules are transported out of the soma along axon and dendrite to synaptic contacts in a microtubule- and kinesin-dependent manner (PubMed:15312650, PubMed:16098134, PubMed:18539120). Colocalizes with CACNA1B in the cytoplasm and at the cell membrane of neurons (PubMed:24709664). Colocalizes with CYFIP1, CYFIP2, NXF2 and ribosomes in the perinuclear region (PubMed:11438699, PubMed:16790844). Colocalizes with CYFIP1 and EIF4E in dendrites and probably at synapses (PubMed:18805096). Colocalizes with FXR1, kinesin, 60S acidic ribosomal protein RPLP0 and SMN in cytoplasmic granules in the soma and neurite cell processes (By similarity). Colocalizes with FXR1 and FXR2 in discrete granules, called fragile X granules (FXGs), along axon and presynaptic compartments (PubMed:19193898). Colocalizes with TDRD3 in cytoplasmic stress granules (SGs) in response to various cellular stress (By similarity). Interacts with SND1 (By similarity). {ECO:0000250|UniProtKB:Q06787, ECO:0000250|UniProtKB:Q80WE1, ECO:0000269|PubMed:11438699, ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:15312650, ECO:0000269|PubMed:16098134, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19193898, ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:24813610, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:8895584}.; SUBCELLULAR LOCATION: [Isoform 4]: Nucleus {ECO:0000269|PubMed:8842725}. Nucleus, nucleoplasm {ECO:0000269|PubMed:8842725}.			IPR008395;IPR040148;IPR040472;IPR032196;IPR022034;IPR004087;IPR004088;IPR036612;IPR041560;	PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;	SM00322;	68989	COMPBIAS 499..536;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 548..570;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 586..603;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..184;  /note=Required for nuclear localization;  /evidence=ECO:0000269|PubMed:8842725; REGION 172..211;  /note=Necessary for interaction with CYFIP1, CYFIP2, FXR1 and FXR2;  /evidence=ECO:0000250|UniProtKB:Q06787, ECO:0000269|PubMed:11438699; REGION 323..369;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 396..490;  /note=Required for nuclear export;  /evidence=ECO:0000250|UniProtKB:Q06787; REGION 418..614;  /note=Interaction with RANBP9;  /evidence=ECO:0000250|UniProtKB:Q06787; REGION 442..614;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..547;  /note=RNA-binding RGG-box	NA							5 out of 5	Alternative sequence (9); Chain (1); Compositional bias (3); Domain (4); Modified residue (18); Motif (3); Mutagenesis (4); Region (7)		Acetylation;Activator;Alternative splicing;Cell junction;Cell membrane;Cell projection;Centromere;Chromosome;Cytoplasm;DNA damage;Membrane;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Postsynaptic cell membrane;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repeat;Repressor;Ribonucleoprotein;Synapse;Synaptosome;Translation regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 4..50;  /note=Agenet-like 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 63..115;  /note=Agenet-like 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 222..251;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 285..314;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The N-terminal 134 amino acids are necessary for homodimerization and RNA-binding. The N-terminal 298 amino acids are sufficient to interact with KCNMB4 and to regulate presynaptic action potential (AP) duration in neurons. The two agenet-like domains are necessary for binding to histone H3 in a methylation-dependent manner. The KH domains are necessary for mediating miRNA annealing to specific RNA targets. The KH 2 domain is necessary for binding to kissing complex (kc) RNA ligands. The RGG box domain is necessary for binding to mRNA targets that contain G-quadruplex structures. The RGG-box domain is necessary for binding to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the superoxide dismutase SOD1 mRNA. The RGG box domain is necessary for binding to its own mRNA. The RGG-box domain is necessary for binding to homomer poly(G). {ECO:0000250|UniProtKB:Q06787}.	MOTIF 423..442;  /note=Nuclear export signal;  /evidence=ECO:0000269|PubMed:8842725; MOTIF 526..533;  /note=Nucleolar localization signal 1;  /evidence=ECO:0000250|UniProtKB:Q06787; MOTIF 595..599;  /note=Nucleolar localization signal 2;  /evidence=ECO:0000250|UniProtKB:Q06787			PS51641;PS50084;	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0002092~positive regulation of receptor internalization,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0006810~transport,GO:0006974~cellular response to DNA damage stimulus,GO:0007215~glutamate receptor signaling pathway,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0033129~positive regulation of histone phosphorylation,GO:0034644~cellular response to UV,GO:0043488~regulation of mRNA stability,GO:0044830~modulation by host of viral RNA genome replication,GO:0045727~positive regulation of translation,GO:0045947~negative regulation of translational initiation,GO:0046928~regulation of neurotransmitter secretion,GO:0051028~mRNA transport,GO:0051489~regulation of filopodium assembly,GO:0051491~positive regulation of filopodium assembly,GO:0060964~regulation of gene silencing by miRNA,GO:0060996~dendritic spine development,GO:0060998~regulation of dendritic spine development,GO:0060999~positive regulation of dendritic spine development,GO:0072711~cellular response to hydroxyurea,GO:0098586~cellular response to virus,GO:0098908~regulation of neuronal action potential,GO:1900453~negative regulation of long term synaptic depression,GO:1901254~positive regulation of intracellular transport of viral material,GO:1901386~negative regulation of voltage-gated calcium channel activity,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902416~positive regulation of mRNA binding,GO:2000301~negative regulation of synaptic vesicle exocytosis,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000766~negative regulation of cytoplasmic translation,GO:2001022~positive regulation of response to DNA damage stimulus,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005845~mRNA cap binding complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0010369~chromocenter,GO:0010494~cytoplasmic stress granule,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0019034~viral replication complex,GO:0019897~extrinsic component of plasma membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0032433~filopodium tip,GO:0032797~SMN complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044297~cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0071598~neuronal ribonucleoprotein granule,GO:0097386~glial cell projection,GO:0098793~presynapse,GO:0098794~postsynapse,GO:1902737~dendritic filopodium,GO:1990812~growth cone filopodium,GO:1990904~ribonucleoprotein complex,	GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008266~poly(U) RNA binding,GO:0030371~translation repressor activity,GO:0031369~translation initiation factor binding,GO:0033592~RNA strand annealing activity,GO:0034046~poly(G) binding,GO:0035064~methylated histone binding,GO:0035197~siRNA binding,GO:0035198~miRNA binding,GO:0035613~RNA stem-loop binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043022~ribosome binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0045502~dynein binding,GO:0046982~protein heterodimerization activity,GO:0048027~mRNA 5'-UTR binding,GO:1990825~sequence-specific mRNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	PF00013:KH domain,PF05641:Agenet domain,PF12235:Fragile X-related 1 protein C terminal,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.7694566878079	2.91821670646073e-06	FDR<0.01	5.53488246058323	2770719.4	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	527	Splicing
Q9R020	Q9R020;Q9R020-2	Zranb2	3.6482	3.9574	3297050	2.70760566431105	2.26362134142201	4.64295663478503	1.42103991701127	1.63730434213112	1.8482921780275	1032141.78333333	0	Zranb2	0	Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)		FUNCTION: Splice factor required for alternative splicing of TRA2B/SFRS10 transcripts. May interfere with constitutive 5'-splice site selection (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]	lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	53861;		IPR017337;IPR001876;IPR036443;	PF00641;	SM00547;	37350	COMPBIAS 117..132;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 151..180;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 181..198;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 211..242;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 277..291;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 292..309;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 117..330;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 151..324;  /note=Required for nuclear targeting;  /evidence=ECO:0000250	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Erroneous initiation (1); Frameshift (4); Modified residue (9); Region (2); Sequence conflict (2); Zinc finger (2)		Acetylation;Alternative splicing;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Zinc;Zinc-finger;mRNA processing;mRNA splicing		DOMAIN: The RanBP2-type zinc fingers mediate binding to RNA. {ECO:0000250}.			ZN_FING 9..40;  /note=RanBP2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 65..94;  /note=RanBP2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS01358;PS50199;	53861	GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001876:Zinc finger, RanBP2-type,IPR017337:Uncharacterised conserved protein UCP037956, zinc finger Ran-binding,	PF00641:Zn-finger in Ran binding protein and others,	SSF90209:Ran binding protein zinc finger-like,	1.34836177995508	0.000174153896132096	FDR<0.01	3.75906680515784	2164595.89166667	Present in Nucleus	RBP	DBD	DBD	Others	Others	598	Splicing
Q921M3	Q921M3;Q921M3-2	Sf3b3	7.8558	7.1066	2386850	8.92458723784025	7.37136960047177	5.21267723102585	9.96611520829181	11.4317069824866	5.61924027871432	1633703.33333333	0	Sf3b3	0	Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (Spliceosome-associated protein 130) (SAP 130)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex, a constituent of the spliceosome. SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA. May also be involved in the assembly of the 'E' complex. Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron. {ECO:0000250|UniProtKB:Q15393}.		mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]	catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]	protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15393}.	101943;		IPR004871;IPR018846;IPR015943;IPR036322;	PF03178;PF10433;		135550		REGION 105..119;  /note=Interaction with PHF5A, SF3B1 and SF3B5;  /evidence=ECO:0000250|UniProtKB:Q15393; REGION 145..168;  /note=Interaction with PHF5A, SF3B1 and SF3B5;  /evidence=ECO:0000250|UniProtKB:Q15393; REGION 193..231;  /note=Interaction with SF3B1 and SF3B5;  /evidence=ECO:0000250|UniProtKB:Q15393; REGION 786..804;  /note=Interaction with SF3B1 and SF3B5;  /evidence=ECO:0000250|UniProtKB:Q15393; REGION 1028..1049;  /note=Interaction with SF3B1;  /evidence=ECO:0000250|UniProtKB:Q15393; REGION 1100..1123;  /note=Interaction with SF3B5;  /evidence=ECO:0000250|UniProtKB:Q15393	NA							4 out of 5	Alternative sequence (1); Chain (1); Modified residue (2); Region (6); Sequence conflict (3); Site (6)		Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;mRNA processing;mRNA splicing		DOMAIN: The core of the protein consists of three beta-propeller domains. {ECO:0000250|UniProtKB:Q15393}.					101943	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0042177~negative regulation of protein catabolic process,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005689~U12-type spliceosomal complex,GO:0005730~nucleolus,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR004871:Cleavage/polyadenylation specificity factor, A subunit, C-terminal,IPR017986:WD40-repeat-containing domain,	PF03178:CPSF A subunit region,	SSF50978:WD40 repeat-like,	2.94337945673489	1.29177531836524e-08	FDR<0.01	7.88881301767194	2010276.66666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	615	Splicing
Q8BHD7	Q8BHD7-2;Q8BHD7	Ptbp3	NA	3.4699	2788800	9.6487842531841	12.9535356675605	NA	19.4310586040727	1.86171203038314	3.79737221842485	1123758.33333333	1	Ptbp3	1	Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)		FUNCTION: RNA-binding protein that mediates pre-mRNA alternative splicing regulation. Plays a role in the regulation of cell proliferation, differentiation and migration. Positive regulator of EPO-dependent erythropoiesis. Participates in cell differentiation regulation by repressing tissue-specific exons. Promotes Fas exon 6 skipping. Binds RNA, preferentially to both poly(G) and poly(U) (By similarity). {ECO:0000250}.		erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	nucleus [GO:0005634]	mRNA binding [GO:0003729]		230257;	cd12779;cd12693;cd12703;	IPR006536;IPR012677;IPR034798;IPR021790;IPR033110;IPR035979;IPR034326;IPR000504;	PF00076;PF11835;	SM00360;	56701		REGION 1..25;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 406..426;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Cross-link (2); Domain (4); Modified residue (4); Region (2)		Acetylation;Alternative splicing;Differentiation;Erythrocyte maturation;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 30..114;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 153..229;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 329..403;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 446..521;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	230257	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016070~RNA metabolic process,GO:0030154~cell differentiation,GO:0033119~negative regulation of RNA splicing,GO:0043249~erythrocyte maturation,GO:0045595~regulation of cell differentiation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.64373987321927	0.000236173757588501	FDR<0.01	3.62676836060763	1956279.16666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	628	Splicing
Q8CFQ3	Q8CFQ3	Aqr	4.9038	6.6092	3098580	15.965259595121	5.98766540925693	3.97503676909011	NA	5.44662309368192	3.74013539290122	688604.5	1	Aqr	0	RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa)		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Intron-binding spliceosomal protein required to link pre-mRNA splicing and snoRNP (small nucleolar ribonucleoprotein) biogenesis. Plays a key role in position-dependent assembly of intron-encoded box C/D small snoRNP, splicing being required for snoRNP assembly. May act by helping the folding of the snoRNA sequence. Binds to intron of pre-mRNAs in a sequence-independent manner, contacting the region between snoRNA and the branchpoint of introns (40 nucleotides upstream of the branchpoint) during the late stages of splicing. Has ATP-dependent RNA helicase activity and can unwind double-stranded RNA molecules with a 3' overhang (in vitro). {ECO:0000250|UniProtKB:O60306}.		mRNA splicing, via spliceosome [GO:0000398]	catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O60306}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:O60306}. Note=Localizes to speckle-like regions of the nucleoplasm. {ECO:0000250|UniProtKB:O60306}.	11834;	cd18808;	IPR032174;IPR026300;IPR041679;IPR041677;IPR027417;	PF13086;PF13087;PF16399;		170294	COMPBIAS 1413..1451;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..416;  /note=Helical region with structural similarity to ARM repeat domains;  /evidence=ECO:0000250|UniProtKB:O60306; REGION 417..1481;  /note=Required for assembly of the IB complex;  /evidence=ECO:0000250|UniProtKB:O60306; REGION 754..773;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1396..1481;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 801;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O60306; BINDING 806;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:O60306	3.6.4.13			4 out of 5	Binding site (2); Chain (1); Compositional bias (1); Erroneous initiation (1); Frameshift (1); Modified residue (1); Nucleotide binding (1); Region (4); Sequence conflict (2)		ATP-binding;Acetylation;Helicase;Hydrolase;Nucleotide-binding;Nucleus;RNA-binding;Reference proteome;Spliceosome;mRNA processing;mRNA splicing		DOMAIN: Contains an N-terminal domain with structural similarity to ARM repeat regions; this domain functions as scaffold for protein-protein interactions, but is not required for RNA binding or for ATP-dependent RNA helicase activity. {ECO:0000250|UniProtKB:O60306}.					11834	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016020~membrane,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR026300:CWF11 family,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.56237917773481	3.20828761570559e-06	FDR<0.01	5.49372670512767	1893592.25	Present in Nucleus	RBP	Others	Others	Others	Others	637	Splicing
Q91YE7	Q91YE7-2;Q91YE7	Rbm5	6.4943	4.3995	1670300	8.93974611121044	14.6965889217113	NA	NA	NA	16.8580050236855	1443466.66666667	3	Rbm5	0	RNA-binding protein 5 (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5)		FUNCTION: Component of the spliceosome A complex. Regulates alternative splicing of a number of mRNAs. May modulate splice site pairing after recruitment of the U1 and U2 snRNPs to the 5' and 3' splice sites of the intron. May both positively and negatively regulate apoptosis by regulating the alternative splicing of several genes involved in this process, including FAS and CASP2/caspase-2. In the case of FAS, promotes production of a soluble form of FAS that inhibits apoptosis. In the case of CASP2/caspase-2, promotes production of a catalytically active form of CASP2/Caspase-2 that induces apoptosis (By similarity). {ECO:0000250}.		apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	83486;	cd12752;cd12755;	IPR000467;IPR012677;IPR041591;IPR035979;IPR033094;IPR034991;IPR034993;IPR000504;IPR013087;IPR001876;IPR036443;	PF01585;PF17780;PF00076;PF00641;	SM00443;SM00360;SM00547;	92311	COMPBIAS 385..445;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 522..539;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..93;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 321..809;  /note=Required for interaction with U2AF2;  /evidence=ECO:0000250; REGION 385..468;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 452..535;  /note=Sufficient for interaction with ACIN1, PRPF8, SFRS3, SNRPB, SNRPN, SNRNP70 and SNRNP200;  /evidence=ECO:0000250; REGION 508..539;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Domain (3); Modified residue (8); Region (5); Sequence conflict (4); Zinc finger (2)		3D-structure;Alternative splicing;Apoptosis;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing	DOMAIN 98..178;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 231..315;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 743..789;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092				ZN_FING 181..210;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 647..672;  /note=C2H2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50174;PS50102;PS01358;PS50199;PS50157;	83486	GO:0000245~spliceosomal complex assembly,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0008380~RNA splicing,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00641:Zn-finger in Ran binding protein and others,PF01585:G-patch domain,	SSF54928:RNA-binding domain, RBD,SSF90209:Ran binding protein zinc finger-like,	3.18990376276365	1.88513241523159e-05	FDR<0.01	4.72465813872893	1556883.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	691	Splicing
O35492	O35492	Clk3	1.4695	1.7118	1447950	4.47848089927896	3.24380433372259	4.18532624618089	NA	9.34841544358231	7.2976720426184	1563538.83333333	1	Clk3	0	Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3)		FUNCTION: Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. {ECO:0000269|PubMed:9307018}.		peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]	acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasmic vesicle, secretory vesicle, acrosome.	102414;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	73798	COMPBIAS 175..226;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 237..266;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..136;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 175..286;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 431;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Leucettine L41 inhibits its kinase activity and affects the regulation of alternative splicing mediated by phosphorylation of SR proteins. {ECO:0000269|PubMed:21615147}.	BINDING 334;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.12.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (6); Frameshift (1); Modified residue (8); Nucleotide binding (1); Region (2); Sequence conflict (4)		ATP-binding;Cytoplasm;Cytoplasmic vesicle;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase	DOMAIN 304..620;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	102414	GO:0006468~protein phosphorylation,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0043484~regulation of RNA splicing,GO:0046777~protein autophosphorylation,	GO:0001669~acrosomal vesicle,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031410~cytoplasmic vesicle,GO:0045111~intermediate filament cytoskeleton,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	1.90700485935342	0.000252697943511843	FDR<0.01	3.5973982924097	1505744.41666667	Present in Nucleus	RBP	Others	Others	Others	Others	699	Splicing
Q9CQL1	Q9CQL1;P61327	Magohb;Magoh	NA	10.762	1909997	3.71650499869922	4.59981600735971	NA	NA	7.7095058206769	NA	1029715	3	Magohb	1	Protein mago nashi homolog 2		FUNCTION: Required for pre-mRNA splicing as component of the spliceosome. Plays a redundant role with MAGOH in the exon junction complex and in the nonsense-mediated decay (NMD) pathway. {ECO:0000250|UniProtKB:Q96A72}.		mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96A72}.	66441;	cd11295;	IPR004023;IPR036605;	PF02792;		17092			NA							3 out of 5	Chain (1); Erroneous initiation (1)		Nucleus;RNA-binding;Reference proteome;Spliceosome;Transport;mRNA processing;mRNA splicing;mRNA transport							66441	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004023:Mago nashi protein,	PF02792:Mago nashi protein,	SSF89817:Mago nashi protein,	2.6175088490273	0.000207794288447158	FDR<0.01	3.68236639388169	1469856	Present in Nucleus	RBP	Others	Others	Others	Others	706	Splicing
O35900	O35900	Lsm2	8.2373	5.8345	2513100	2.51509054325956	NA	NA	NA	NA	NA	419470	5	Lsm2	0	U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (snRNP core Sm-like protein Sm-x5)		FUNCTION: Plays role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex). The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA. {ECO:0000250|UniProtKB:Q9Y333}.		mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]	protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9Y333}.	27756;	cd01725;	IPR001163;IPR010920;IPR016654;	PF01423;	SM00651;	10835			NA							4 out of 5	Chain (1); Modified residue (1)		Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing							27756	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0008380~RNA splicing,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071011~precatalytic spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990726~Lsm1-7-Pat1 complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017160~Ral GTPase binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR016654:U6 snRNA-associated Sm-like protein LSm2,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	2.30579696552245	0.00270479208706221	FDR<0.01	2.56786611277994	1466285	Present in Nucleus	RBP	RBD	Others	Others	RBD	709	Splicing
Q62203	Q62203	Sf3a2	2.84	4.1729	446745	6.32671137542705	1.85960018596002	NA	NA	NA	NA	2465650	4	Sf3a2	0	Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3A complex that contributes to the assembly of the 17S U2 snRNP, and the subsequent assembly of the pre-spliceosome 'E' complex and the pre-catalytic spliceosome 'A' complex. Involved in pre-mRNA splicing as a component of pre-catalytic spliceosome 'B' complexes, including the Bact complex. Interacts directly with the duplex formed by U2 snRNA and the intron. {ECO:0000250|UniProtKB:Q15428}.		mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]	catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00130}.			IPR000690;IPR003604;IPR031781;IPR036236;	PF16835;	SM00451;	49911		REGION 1..27;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 208..475;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (3); Region (2); Zinc finger (1)		Acetylation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;Zinc;Zinc-finger;mRNA processing;mRNA splicing					ZN_FING 54..84;  /note=Matrin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00130	PS50171;	NA	GO:0000245~spliceosomal complex assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0010976~positive regulation of neuron projection development,	GO:0005634~nucleus,GO:0005686~U2 snRNP,GO:0016607~nuclear speck,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,			1.78084738365773	0.00239089284286947	FDR<0.01	2.6214398880387	1456197.5	Present in Nucleus	RBP	DBD	DBD	Others	Others	712	Splicing
A2A4P0	A2A4P0	Dhx8	1.8611	2.3402	985210	2.4165679901404	1.99549019216571	3.3725675356649	1.44877144181734	4.74946568511043	3.66770584999083	1519058.33333333	0	Dhx8	0	ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8)		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Facilitates nuclear export of spliced mRNA by releasing the RNA from the spliceosome. {ECO:0000250|UniProtKB:Q14562}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex disassembly [GO:0000390]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14562}.	217207;		IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR012340;IPR027417;IPR022967;IPR003029;	PF04408;PF00271;PF07717;PF00575;	SM00487;SM00847;SM00490;SM00316;	142572	COMPBIAS 180..220;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 221..250;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 251..284;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 361..391;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 152..289;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 361..396;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (4); Cross-link (2); Domain (3); Modified residue (2); Motif (1); Nucleotide binding (1); Region (2)		ATP-binding;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 289..360;  /note=S1 motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 599..762;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 780..960;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The RS domain confers a nuclear localization signal, and appears to facilitate the interaction with the spliceosome. {ECO:0000250}.	MOTIF 709..712;  /note=DEAH box			PS00690;PS51192;PS51194;PS50126;	217207	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR003029:Ribosomal protein S1, RNA-binding domain,IPR007502:Helicase-associated domain,IPR011709:Domain of unknown function DUF1605,IPR012340:Nucleic acid-binding, OB-fold,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR022967:RNA-binding domain, S1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00271:Helicase conserved C-terminal domain,PF00575:S1 RNA binding domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.35047633584911	0.000109309909828014	FDR<0.01	3.96134046395578	1252134.16666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	752	Splicing
Q62189	Q62189	Snrpa	NA	16.347	2022295	NA	9.25754489909276	NA	NA	NA	96.9932104752667	81508.8333333333	4	Snrpa	1	U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)		FUNCTION: Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. U1 snRNP is the first snRNP to interact with pre-mRNA. This interaction is required for the subsequent binding of U2 snRNP and the U4/U6/U5 tri-snRNP. SNRPA binds stem loop II of U1 snRNA. In a snRNP-free form (SF-A) may be involved in coupled pre-mRNA splicing and polyadenylation process. May bind preferentially to the 5'-UGCAC-3' motif on RNAs (By similarity). {ECO:0000250}.		mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA polyadenylation [GO:1900363]	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	53607;	cd12477;cd12480;	IPR012677;IPR035979;IPR000504;IPR034407;IPR034409;	PF00076;	SM00360;	31835	COMPBIAS 106..124;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 106..134;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Domain (2); Modified residue (2); Region (1)		Acetylation;Methylation;Nucleus;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 16..95;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 213..287;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	53607	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005685~U1 snRNP,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017069~snRNA binding,GO:0030619~U1 snRNA binding,GO:0035614~snRNA stem-loop binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024888:U1 small nuclear ribonucleoprotein A/U2 small nuclear ribonucleoprotein B'',	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	4.61379849672971	0.000574916508360096	FDR<0.01	3.2403952206865	1051901.91666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	802	Splicing
Q9CQI7	Q9CQI7	Snrpb2	7.9198	12.187	1566955	NA	23.1032252102393	NA	NA	NA	NA	423711.666666667	5	Snrpb2	0	U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Associated with sn-RNP U2, where it contributes to the binding of stem loop IV of U2 snRNA. {ECO:0000250|UniProtKB:P08579}.		mRNA splicing, via spliceosome [GO:0000398]	catalytic step 2 spliceosome [GO:0071013]; cytoplasmic ribonucleoprotein granule [GO:0036464]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]	snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P08579}.	20639;	cd12478;cd12481;	IPR012677;IPR035979;IPR000504;IPR034564;IPR034562;	PF00076;	SM00360;	25323	COMPBIAS 126..141;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 100..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Domain (2); Modified residue (2); Region (1); Sequence conflict (1)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 7..86;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 151..225;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	20639	GO:0000398~mRNA splicing, via spliceosome,GO:0002230~positive regulation of defense response to virus by host,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0098792~xenophagy,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005730~nucleolus,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017069~snRNA binding,GO:0035614~snRNA stem-loop binding,GO:0070990~snRNP binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024888:U1 small nuclear ribonucleoprotein A/U2 small nuclear ribonucleoprotein B'',	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.70758582800467	0.000173438305619797	FDR<0.01	3.76085497789751	995333.333333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	821	Splicing
Q62241	Q62241	Snrpc	15.824	17.834	1680350	NA	NA	0.426311975103381	NA	NA	4.46209450716166	220590	4	Snrpc	0	U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C)		FUNCTION: Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. SNRPC/U1-C is directly involved in initial 5' splice-site recognition for both constitutive and regulated alternative splicing. The interaction with the 5' splice-site seems to precede base-pairing between the pre-mRNA and the U1 snRNA. Stimulates commitment or early (E) complex formation by stabilizing the base pairing of the 5' end of the U1 snRNA and the 5' splice-site region. {ECO:0000255|HAMAP-Rule:MF_03153}.		mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387]	commitment complex [GO:0000243]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; U1 snRNP binding [GO:1990446]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03153}.	20630;		IPR000690;IPR003604;IPR013085;IPR017340;IPR036236;	PF06220;	SM00451;	17364	COMPBIAS 64..96;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 62..96;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (3); Region (1); Zinc finger (1)		Acetylation;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Zinc;Zinc-finger					ZN_FING 4..36;  /note=Matrin-type;  /evidence=ECO:0000255|HAMAP-Rule:MF_03153	PS50171;	20630	GO:0000387~spliceosomal snRNP assembly,GO:0000395~mRNA 5'-splice site recognition,GO:0000398~mRNA splicing, via spliceosome,	GO:0000243~commitment complex,GO:0005634~nucleus,GO:0005685~U1 snRNP,GO:0015030~Cajal body,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071004~U2-type prespliceosome,GO:0071010~prespliceosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0030619~U1 snRNA binding,GO:0030627~pre-mRNA 5'-splice site binding,GO:0046872~metal ion binding,GO:1990446~U1 snRNP binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR013085:Zinc finger, U1-C type,IPR017340:U1 small nuclear ribonucleoprotein C,	PF06220:U1 zinc finger,		2.26707584994196	0.0354275693948221	FDR<0.1	1.45065864260407	950470	Present in Nucleus	RBP	DBD	DBD	Others	Others	836	Splicing
Q9DC48	Q9DC48	Cdc40	4.5645	5.9527	1120135	6.99398517275143	6.06317831807433	NA	2.52264070028506	3.78587112894677	3.81985560945796	642393.333333333	1	Cdc40	0	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog)		FUNCTION: Required for pre-mRNA splicing as component of the activated spliceosome. {ECO:0000250|UniProtKB:O60508}.		mRNA splicing, via spliceosome [GO:0000398]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O60508}. Nucleus speckle {ECO:0000250|UniProtKB:O60508}.	71713;		IPR032847;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	65461		REGION 1..34;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 204..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Region (2); Repeat (7)		Nucleus;Reference proteome;Repeat;Spliceosome;WD repeat;mRNA processing;mRNA splicing				REPEAT 286..326;  /note=WD 1; REPEAT 330..369;  /note=WD 2; REPEAT 371..413;  /note=WD 3; REPEAT 416..455;  /note=WD 4; REPEAT 459..498;  /note=WD 5; REPEAT 504..545;  /note=WD 6; REPEAT 548..578;  /note=WD 7		PS00678;PS50082;PS50294;	71713	GO:0000350~generation of catalytic spliceosome for second transesterification step,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000386~second spliceosomal transesterification activity,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.19418116556245	3.40317410898044e-06	FDR<0.01	5.4681158314992	881264.166666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	870	Splicing
P63154	P63154	Crnkl1	7.2474	14.916	1231510	13.0941469163284	1.37519424618727	2.21867234646787	NA	1.80551041779511	6.31153749053269	302699.833333333	1	Crnkl1	0	Crooked neck-like protein 1 (Crooked neck homolog)		FUNCTION: Involved in pre-mRNA splicing process. {ECO:0000250|UniProtKB:Q9BZJ0}.		mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9BZJ0}. Nucleus speckle {ECO:0000250|UniProtKB:Q9BZJ0}. Note=Colocalizes with core spliceosomal snRNP proteins. {ECO:0000250|UniProtKB:Q9BZJ0}.	66877;		IPR003107;IPR013026;IPR011990;	PF02184;	SM00386;	83416		REGION 250..467;  /note=Mediates interaction with HSP90;  /evidence=ECO:0000269|PubMed:15189447; REGION 667..690;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (2); Motif (1); Region (2); Repeat (16)		Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;mRNA processing;mRNA splicing			MOTIF 618..626;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 61..93;  /note=HAT 1; REPEAT 95..127;  /note=HAT 2; REPEAT 129..161;  /note=HAT 3; REPEAT 163..194;  /note=HAT 4; REPEAT 196..227;  /note=HAT 5; REPEAT 229..264;  /note=HAT 6; REPEAT 266..300;  /note=HAT 7; REPEAT 310..342;  /note=HAT 8; REPEAT 344..378;  /note=HAT 9; REPEAT 388..424;  /note=HAT 10; REPEAT 459..491;  /note=HAT 11; REPEAT 493..527;  /note=HAT 12; REPEAT 529..560;  /note=HAT 13; REPEAT 565..606;  /note=HAT 14; REPEAT 608..646;  /note=HAT 15; REPEAT 648..673;  /note=HAT 16			66877	GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0002230~positive regulation of defense response to virus by host,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0071010~prespliceosome,GO:0071011~precatalytic spliceosome,GO:0071012~catalytic step 1 spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:0071014~post-mRNA release spliceosomal complex,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR003107:RNA-processing protein, HAT helix,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,	PF02184:HAT (Half-A-TPR) repeat,	SSF48452:TPR-like,	2.22669039402437	0.000587290416929113	FDR<0.01	3.23114708566949	767104.916666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	908	Splicing
Q8BHS3	Q8BHS3	Rbm22	6.5869	27.156	420653	NA	2.38589459117696	17.6391730755662	43.6700292589196	17.9791441927364	18.1847938753614	1108290	1	Rbm22	0	Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22)		FUNCTION: Required for pre-mRNA splicing as component of the activated spliceosome. Involved in the first step of pre-mRNA splicing. Binds directly to the internal stem-loop (ISL) domain of the U6 snRNA and to the pre-mRNA intron near the 5' splice site during the activation and catalytic phases of the spliceosome cycle. Involved in both translocations of the nuclear SLU7 to the cytoplasm and the cytosolic calcium-binding protein PDCD6 to the nucleus upon cellular stress responses. {ECO:0000250|UniProtKB:Q9NW64}.		cellular response to drug [GO:0035690]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]	calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9NW64}. Cytoplasm {ECO:0000250|UniProtKB:Q9NW64}. Note=Nearly exclusively nuclear. Translocated from the nucleus to the cytoplasm after heat shock cell treatment. May be shuttling between the nucleus and the cytosol. {ECO:0000250|UniProtKB:Q9NW64}.	66810;		IPR039171;IPR012677;IPR035979;IPR000504;IPR000571;IPR036855;	PF00076;	SM00360;SM00356;	46896	COMPBIAS 306..321;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 372..398;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 303..343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 372..420;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Cross-link (3); Domain (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (2); Zinc finger (1)		Acetylation;Cytoplasm;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Transport;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing	DOMAIN 232..305;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The C-terminus RRM domain and the zinc finger motif are necessary for RNA-binding. {ECO:0000250}.			ZN_FING 159..186;  /note=C3H1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50102;PS50103;	66810	GO:0000060~protein import into nucleus, translocation,GO:0000387~spliceosomal snRNP assembly,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0033120~positive regulation of RNA splicing,GO:0035690~cellular response to drug,GO:0045292~mRNA cis splicing, via spliceosome,GO:0090316~positive regulation of intracellular protein transport,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0071006~U2-type catalytic step 1 spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0017070~U6 snRNA binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,	IPR000504:RNA recognition motif domain,IPR000571:Zinc finger, CCCH-type,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,SSF90229:CCCH zinc finger,	3.81136068123615	7.15344853175512e-06	FDR<0.01	5.14548454319839	764471.5	Present in Nucleus	RBP	DBD	DBD	Others	RBD	911	Splicing
A2AIV2	A2AIV2;A2AIV2-2	Kiaa1429	2.0087	3.4928	307070.5	3.79809335713472	3.42923768046363	5.2734272003375	1.50452863117985	5.12032770097286	7.12352186921214	1203151.66666667	0	Kiaa1429	0	Protein virilizer homolog		FUNCTION: Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing. Acts as a key regulator of m6A methylation by promoting m6A methylation of mRNAs in the 3'-UTR near the stop codon: recruits the catalytic core components METTL3 and METTL14, thereby guiding m6A methylation at specific sites. Required for mRNA polyadenylation via its role in selective m6A methylation: m6A methylation of mRNAs in the 3'-UTR near the stop codon correlating with alternative polyadenylation (APA). {ECO:0000250|UniProtKB:Q69YN4}.		mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]		SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:Q69YN4}. Nucleus, nucleoplasm {ECO:0000269|PubMed:29547716}. Cytoplasm {ECO:0000269|PubMed:29547716}. Note=Mainly nuclear with some fraction located in the cytoplasm (PubMed:29547716). ZC3H13 is required to anchor component of the MACOM subcomplex, such as VIRMA, in the nucleus (PubMed:29547716). {ECO:0000269|PubMed:29547716}.	66185;		IPR031801;IPR026736;	PF15912;		201439	COMPBIAS 137..154;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 200..221;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 235..302;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1717..1746;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1778..1793;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 132..302;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1615..1634;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1662..1811;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Erroneous initiation (1); Initiator methionine (1); Modified residue (15); Region (3); Sequence conflict (4)		Acetylation;Alternative splicing;Cytoplasm;Developmental protein;Methylation;Nucleus;Phosphoprotein;Reference proteome;mRNA processing;mRNA splicing							66185	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0080009~mRNA methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0036396~MIS complex,	GO:0044822~poly(A) RNA binding,	IPR026736:Protein virilizer,			1.83633608552284	2.64091207538474e-05	FDR<0.01	4.57824605763854	755111.083333333	Present in Nucleus	RBP	Others	Others	Others	Others	913	Splicing
Q9CPW7	Q9CPW7	Zmat2	10.452	1.4063	983310	NA	10.7323774362497	NA	36.7701132519488	NA	NA	454126.833333333	4	Zmat2	0	Zinc finger matrin-type protein 2		FUNCTION: Involved in pre-mRNA splicing as a component of the spliceosome. {ECO:0000250|UniProtKB:Q96NC0}.		mRNA splicing, via spliceosome [GO:0000398]	nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96NC0}.	66492;		IPR003604;IPR040107;IPR022755;IPR036236;	PF12171;	SM00451;	23612		REGION 27..46;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 150..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Cross-link (10); Initiator methionine (1); Modified residue (1); Region (2); Zinc finger (1)		Acetylation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Spliceosome;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing					ZN_FING 80..104;  /note=Matrin-type		66492	GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR022755:Zinc finger, double-stranded RNA binding,	PF12171:Zinc-finger double-stranded RNA-binding,		3.12549275575633	0.00302618877204561	FDR<0.01	2.51910398440911	718718.416666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	925	Splicing
Q8CH02	Q8CH02	Sugp1	2.3302	3.014	1110375	4.46070122223214	NA	3.22539027222294	NA	8.0768920119538	7.12555223029785	222693.166666667	2	Sugp1	0	SURP and G-patch domain-containing protein 1 (Splicing factor 4)		FUNCTION: Plays a role in pre-mRNA splicing. {ECO:0000250}.		mRNA processing [GO:0006397]; RNA splicing [GO:0008380]	nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	70616;		IPR000467;IPR040169;IPR000061;IPR035967;	PF01585;PF01805;	SM00443;SM00648;	72649		REGION 48..69;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 97..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..335;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 360..393;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Beta strand (2); Chain (1); Domain (1); Helix (9); Modified residue (7); Motif (1); Region (4); Repeat (2); Sequence conflict (2); Turn (2)		3D-structure;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 560..607;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092		MOTIF 378..384;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 187..229;  /note=SURP motif 1; REPEAT 262..305;  /note=SURP motif 2		PS50174;PS50128;	70616	GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000061:SWAP/Surp,IPR000467:G-patch domain,	PF01585:G-patch domain,PF01805:Surp module,	SSF109905:Surp module (SWAP domain),	2.0842799229814	7.48512450855769e-05	FDR<0.01	4.12580097114861	666534.083333333	Present in Nucleus	RBP	Others	Others	Others	Others	948	Splicing
P62307	P62307	Snrpf	2.8057	NA	62865	NA	NA	NA	NA	4.80538202787122	3.69644771374709	785683.333333333	4	Snrpf	1	Small nuclear ribonucleoprotein F (snRNP-F) (Sm protein F) (Sm-F) (SmF)		FUNCTION: Plays role in pre-mRNA splicing as core component of the SMN-Sm complex that mediates spliceosomal snRNP assembly and as component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. Is also a component of the minor U12 spliceosome. As part of the U7 snRNP it is involved in histone 3'-end processing. {ECO:0000250|UniProtKB:P62306}.		mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNP [GO:0005687]; U7 snRNP [GO:0005683]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62306}. Nucleus {ECO:0000250|UniProtKB:P62306}. Note=SMN-mediated assembly into core snRNPs occurs in the cytosol before SMN-mediated transport to the nucleus to be included in spliceosomes. {ECO:0000250|UniProtKB:P62306}.	69878;	cd01722;	IPR016487;IPR001163;IPR010920;IPR034100;	PF01423;	SM00651;	9725			NA							4 out of 5	Chain (1); Initiator methionine (1); Modified residue (1)		Acetylation;Cytoplasm;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing							69878	GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0098779~mitophagy in response to mitochondrial depolarization,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005683~U7 snRNP,GO:0005685~U1 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0030529~intracellular ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034709~methylosome,GO:0034715~pICln-Sm protein complex,GO:0034719~SMN-Sm protein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003723~RNA binding,	IPR001163:Ribonucleoprotein LSM domain,IPR010920:Like-Sm (LSM) domain,IPR016487:Small nuclear ribonucleoprotein SmF,	PF01423:LSM domain ,	SSF50182:Sm-like ribonucleoproteins,	1.8797171310468	0.00289046675732281	FDR<0.01	2.53903202099369	424274.166666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	1090	Splicing
Q9WVR4	Q9WVR4	Fxr2	12.745	12.71	536865	NA	3.31411148671041	NA	NA	5.15171809798568	NA	130992	4	Fxr2	0	Fragile X mental retardation syndrome-related protein 2		FUNCTION: RNA-binding protein. {ECO:0000250}.		negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; translation regulator activity [GO:0045182]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.			IPR008395;IPR040148;IPR040472;IPR022034;IPR032172;IPR004087;IPR004088;IPR036612;IPR041560;	PF05641;PF12235;PF16096;PF00013;PF17904;PF18336;	SM00322;	73743	COMPBIAS 409..427;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 455..488;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..524;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 615..644;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 388..673;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (4); Domain (4); Modified residue (12); Region (1)		Cytoplasm;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 14..60;  /note=Agenet-like 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 73..125;  /note=Agenet-like 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 228..276;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 291..340;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The tandem Agenet-like domains preferentially recognize trimethylated histone peptides. {ECO:0000250}.				PS51641;PS50084;	NA	GO:0002230~positive regulation of defense response to virus by host,GO:0017148~negative regulation of translation,GO:0098792~xenophagy,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0016020~membrane,GO:0030425~dendrite,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	PF00013:KH domain,PF05641:Agenet domain,PF12235:Fragile X-related 1 protein C terminal,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.85835684511358	0.000309617349511363	FDR<0.01	3.50917471147126	333928.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	1148	Splicing
Q8BG05	Q8BG05	Hnrnpa3	6.0965	16.752	34921.5	21.0009030388307	13.5956385191631	22.393908856791	NA	8.82301041115229	22.8242758998471	434391.666666667	1	Hnrnpa3	0	Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3)		FUNCTION: Plays a role in cytoplasmic trafficking of RNA. Binds to the cis-acting response element, A2RE. May be involved in pre-mRNA splicing (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein granule [GO:0035770]; spliceosomal complex [GO:0005681]	mRNA binding [GO:0003729]; RNA transmembrane transporter activity [GO:0051033]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Component of ribonucleosomes. {ECO:0000250}.	229279;	cd12763;cd12582;	IPR034513;IPR034516;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	39652	COMPBIAS 11..34;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 204..225;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 335..379;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Cross-link (6); Domain (2); Modified residue (31); Region (3)		Acetylation;Alternative splicing;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 35..118;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 126..205;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	229279	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0035770~ribonucleoprotein granule,GO:0043005~neuron projection,GO:0071013~catalytic step 2 spliceosome,GO:1990124~messenger ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0051033~RNA transmembrane transporter activity,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF11627:Nuclear factor hnRNPA1,	SSF54928:RNA-binding domain, RBD,	3.85292811095346	9.40890611793468e-08	FDR<0.01	7.02646086483623	234656.583333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	1246	Splicing
Q3UZ01	Q3UZ01-2;Q3UZ01	Rnpc3	NA	4.181	233945	NA	4.89931899465974	NA	NA	NA	NA	119033.333333333	5	Rnpc3	1	RNA-binding region-containing protein 3 (RNA-binding motif protein 40) (RNA-binding protein 40)		FUNCTION: Participates in pre-mRNA U12-dependent splicing, performed by the minor spliceosome which removes U12-type introns. U12-type introns comprises less than 1% of all non-coding sequences. Binds to the 3'-stem-loop of m(7)G-capped U12 snRNA (By similarity). {ECO:0000250}.		mRNA splicing, via spliceosome [GO:0000398]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]	pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	67225;	cd12238;	IPR012677;IPR035979;IPR034147;IPR000504;	PF00076;	SM00360;	57972	COMPBIAS 213..229;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 230..246;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 106..133;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..282;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 337..363;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Domain (2); Erroneous initiation (1); Modified residue (3); Region (4); Sequence conflict (3)		Alternative splicing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 27..102;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 418..501;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	67225	GO:0000398~mRNA splicing, via spliceosome,GO:0032502~developmental process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005689~U12-type spliceosomal complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0030626~U12 snRNA binding,GO:0097157~pre-mRNA intronic binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.17821463596754	0.00699523550258613	FDR<0.01	2.15519765990668	176489.166666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	1306	Splicing
Q8R4X3	Q8R4X3	Rbm12	7.7938	6.5931	300095	NA	NA	NA	NA	NA	11.6993272886809	31815	5	Rbm12	0	RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus) (SWAN)				regulation of RNA splicing [GO:0043484]	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	75710;	cd12745;cd12747;cd12512;cd12749;cd12751;	IPR012677;IPR035979;IPR034591;IPR034594;IPR034855;IPR034856;IPR034854;IPR000504;	PF00076;	SM00360;	102796	COMPBIAS 886..900;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 393..424;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 849..913;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Beta strand (5); Chain (1); Compositional bias (1); Domain (3); Erroneous initiation (1); Helix (2); Modified residue (6); Region (2); Sequence conflict (35); Turn (3)		3D-structure;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 304..379;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 430..507;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 916..992;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	75710		GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.07721251530268	0.000231463703252206	FDR<0.01	3.63551710275912	165955	Present in Nucleus	RBP	RBD	Others	Others	RBD	1315	Splicing
Q66JV4	Q66JV4;Q66JV4-2;Q80YR9	Rbm12b2;Rbm12b1	2.4187	4.0129	294700	NA	NA	NA	NA	NA	9.58497076583916	25998.3333333333	5	Rbm12b2	0	RNA-binding protein 12B-B (RNA-binding motif protein 12B-B)				regulation of RNA splicing [GO:0043484]	nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]		77604;	cd12746;cd12513;	IPR012677;IPR035979;IPR034588;IPR034858;IPR000504;	PF00076;	SM00360;	96450	COMPBIAS 259..274;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 553..572;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 237..277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 546..572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 621..643;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Domain (4); Erroneous initiation (1); Modified residue (1); Region (3); Sequence conflict (2)		Alternative splicing;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 154..229;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 283..359;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 401..478;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 758..834;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	77604			GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.17988369153632	0.00465560356999791	FDR<0.01	2.33202400745874	160349.166666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	1329	Splicing
Q8BX17	Q8BX17	Gemin5	0.43521	3.7654	73620	12.6837559138012	3.80691335465205	3.23185314459311	11.3134970019233	2.03707476064372	NA	70397.9666666667	1	Gemin5	0	Gem-associated protein 5 (Gemin5)		FUNCTION: Required for the assembly of the SMN complex that plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. GEMIN5 acts as the snRNA-binding protein of the SMN complex. Binds to the 7-methylguanosine cap of RNA molecules (By similarity). Binds to the 3'-UTR of SMN1 mRNA and regulates its translation; does not affect mRNA stability (PubMed:25911097). May play a role in the regulation of protein synthesis via its interaction with ribosomes (By similarity). {ECO:0000250|UniProtKB:Q8TEQ6, ECO:0000269|PubMed:25911097}.		regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]	mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4atac snRNA binding [GO:0030622]; U4 snRNA binding [GO:0030621]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q8TEQ6}. Nucleus, gem {ECO:0000250|UniProtKB:Q8TEQ6}. Cytoplasm {ECO:0000250|UniProtKB:Q8TEQ6}. Note=Found both in the nucleoplasm and in nuclear bodies called gems (Gemini of Cajal bodies) that are often in proximity to Cajal (coiled) bodies. Also found in the cytoplasm. {ECO:0000250|UniProtKB:Q8TEQ6}.	216766;		IPR024977;IPR020472;IPR011047;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12894;PF00400;	SM00320;	166592		REGION 1..124;  /note=Important for interaction with U1 snRNA;  /evidence=ECO:0000250|UniProtKB:Q8TEQ6; REGION 13..15;  /note=Interaction with U4 snRNA;  /evidence=ECO:0000250|UniProtKB:Q8TEQ6; REGION 740..797;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 819..838;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1309..1338;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1378..1427;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Cross-link (1); Modified residue (6); Region (6); Repeat (13); Sequence conflict (1); Site (14)		Coiled coil;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Repeat;Translation regulation;Ubl conjugation;WD repeat;mRNA processing;mRNA splicing		DOMAIN: The WD repeat domain mediates binding to U1 snRNA and to U4 snRNA. The WD repeat domain also mediates binding to the 7-methylguanosine cap that is found both on mRNA and snRNA molecules. The regions that bind snRNA molecules and the isolated 7-methylguanosine cap overlap at least partially. Besides, the WD repeat domain mediates interaction with the 60S large ribosomal subunit. {ECO:0000250|UniProtKB:Q8TEQ6}.		REPEAT 62..104;  /note=WD 1; REPEAT 107..148;  /note=WD 2; REPEAT 150..189;  /note=WD 3; REPEAT 193..264;  /note=WD 4; REPEAT 280..321;  /note=WD 5; REPEAT 333..374;  /note=WD 6; REPEAT 377..417;  /note=WD 7; REPEAT 424..464;  /note=WD 8; REPEAT 468..509;  /note=WD 9; REPEAT 533..573;  /note=WD 10; REPEAT 576..622;  /note=WD 11; REPEAT 637..677;  /note=WD 12; REPEAT 680..720;  /note=WD 13		PS00678;PS50082;PS50294;	216766	GO:0000387~spliceosomal snRNP assembly,GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016604~nuclear body,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,	GO:0003723~RNA binding,GO:0017069~snRNA binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF50978:WD40 repeat-like,SSF50998:Quinoprotein alcohol dehydrogenase-like,	1.78927888478816	0.00590122382245481	FDR<0.01	2.22905791306586	72008.9833333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	1403	Splicing
P26369	P26369	U2af2	2.718	2.9291	169580000	4.61595273264402	3.09655044280671	4.273686909697	1.67224080267559	15.8579130986362	13.4271443149471	65943500	0	U2af2	0	Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (U2 snRNP auxiliary factor large subunit)		FUNCTION: Plays a role in pre-mRNA splicing and 3'-end processing. By recruiting PRPF19 and the PRP19C/Prp19 complex/NTC/Nineteen complex to the RNA polymerase II C-terminal domain (CTD), and thereby pre-mRNA, may couple transcription to splicing. Required for the export of mRNA out of the nucleus, even if the mRNA is encoded by an intron-less gene. Positively regulates pre-mRNA 3'-end processing by recruiting the CFIm complex to cleavage and polyadenylation signals. {ECO:0000250|UniProtKB:P26368}.		mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; RNA splicing [GO:0008380]	commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; U2-type prespliceosome [GO:0071004]	C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]	SUBCELLULAR LOCATION: Nucleus.	22185;		IPR012677;IPR035979;IPR000504;IPR006529;	PF00076;	SM00360;	53517	COMPBIAS 1..23;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 24..46;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 64..79;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..93;  /note=Required for interaction with PRPF19;  /evidence=ECO:0000250|UniProtKB:P26368; REGION 17..47;  /note=Necessary and sufficient to stimulate pre-mRNAs 3'-end cleavage in a CFIm complex-dependent manner;  /evidence=ECO:0000250|UniProtKB:P26368	NA							5 out of 5	Beta strand (6); Chain (1); Compositional bias (3); Cross-link (2); Domain (3); Erroneous initiation (1); Helix (4); Initiator methionine (1); Modified residue (7); Region (3); Turn (1)		3D-structure;Acetylation;Hydroxylation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 149..231;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 259..337;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 385..466;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	22185	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0033120~positive regulation of RNA splicing,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000243~commitment complex,GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0071004~U2-type prespliceosome,GO:0089701~U2AF,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008187~poly-pyrimidine tract binding,GO:0019899~enzyme binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0044822~poly(A) RNA binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000504:RNA recognition motif domain,IPR006529:U2 snRNP auxilliary factor, large subunit, splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.17522109409815	8.68232211857316e-05	FDR<0.01	4.06136410565192	117761750	Present in Nucleus	RBP	RBD	Others	Others	RBD	17	Splicing
O08583	O08583;O08583-2;Q9JJW6-2;Q9JJW6	Alyref;Alyref2	9.5165	11.431	49076500	5.37547707359028	6.8960761326805	3.21047900346732	26.7501270631036	8.41113634452014	11.7734320731837	16262643.3333333	0	Alyref	0	THO complex subunit 4 (Tho4) (Ally of AML-1 and LEF-1) (Aly/REF export factor) (REF1-I) (RNA and export factor-binding protein 1) (Transcriptional coactivator Aly/REF)		FUNCTION: Export adapter involved in nuclear export of spliced and unspliced mRNA. Binds mRNA which is thought to be transferred to the NXF1-NXT1 heterodimer for export (TAP/NFX1 pathway) (PubMed:9119228, PubMed:10786854, PubMed:11158589). Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm. TREX recruitment occurs via an interaction between ALYREF/THOC4 and the cap-binding protein NCBP1. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production; ALYREF/THOC4 mediates the recruitment of the TREX complex to the intronless viral mRNA. Required for TREX complex assembly and for linking DDX39B to the cap-binding complex (CBC). In conjunction with THOC5 functions in NXF1-NXT1 mediated nuclear export of HSP70 mRNA; both proteins enhance the RNA binding activity of NXF1 and are required for NXF1 localization to the nuclear rim. Involved in the nuclear export of intronless mRNA; proposed to be recruited to intronless mRNA by ATP-bound DDX39B. Involved in transcription elongation and genome stability. Involved in mRNA export of C5-methylcytosine (m5C)-containing mRNAs: specifically recognizes and binds m5C mRNAs and mediates their nucleo-cytoplasmic shuttling (By similarity). {ECO:0000250|UniProtKB:Q86V81, ECO:0000269|PubMed:10786854, ECO:0000269|PubMed:11158589, ECO:0000269|PubMed:9119228}.; FUNCTION: Acts as chaperone and promotes the dimerization of transcription factors containing basic leucine zipper (bZIP) domains and thereby promotes transcriptional activation. {ECO:0000250|UniProtKB:Q86V81}.		mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	C5-methylcytidine-containing RNA binding [GO:0062153]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9119228}. Nucleus speckle {ECO:0000250|UniProtKB:Q86V81}. Cytoplasm {ECO:0000269|PubMed:9119228}. Note=Colocalizes with the core EJC, ALYREF/THOC4, NXF1 and DDX39B in the nucleus and nuclear speckles. Localizes to regions surrounding nuclear speckles known as perispeckles in which TREX complex assembly seems to occur. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. {ECO:0000250|UniProtKB:Q86V81}.	21681;		IPR025715;IPR012677;IPR035979;IPR000504;	PF13865;PF00076;	SM01218;SM00360;	26940	COMPBIAS 1..17;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 185..200;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..83;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 16..37;  /note=Sufficient for RNA-binding, interaction with NXF1-NXT1 heterodimer;  /evidence=ECO:0000250; REGION 185..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (4); Chain (1); Compositional bias (2); Domain (1); Helix (2); Initiator methionine (1); Modified residue (18); Region (3)		3D-structure;Acetylation;Alternative splicing;Chaperone;Citrullination;Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Transport;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 105..182;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	21681	GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR025715:Friend of PRMT1 duplication,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF13865:C-terminal duplication domain of Friend of PRMT1,	SSF54928:RNA-binding domain, RBD,	3.12893818111174	5.43947197780752e-07	FDR<0.01	6.26444325623092	32669571.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	74	Splicing
Q7TMK9	Q7TMK9;Q7TMK9-2	Syncrip	26.056	27.031	17710000	9.14160343724289	11.251378293841	8.28706389326262	8.15261699005381	9.71911750413063	14.2476526992178	7591483.33333333	0	Syncrip	0	Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)		FUNCTION: Heterogeneous nuclear ribonucleoprotein (hnRNP) implicated in mRNA processing mechanisms. Component of the CRD-mediated complex that promotes MYC mRNA stability. Isoform 1 and isoform 2 are associated in vitro with pre-mRNA, splicing intermediates and mature mRNA protein complexes. Isoform 1 binds to apoB mRNA AU-rich sequences (By similarity). Isoform 1 is part of the APOB mRNA editosome complex and may modulate the postranscriptional C to U RNA-editing of the APOB mRNA through either by binding to A1CF (APOBEC1 complementation factor), to APOBEC1 or to RNA itself (By similarity). May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain (By similarity). Interacts in vitro preferentially with poly(A) and poly(U) RNA sequences. Isoform 2 may be involved in cytoplasmic vesicle-based mRNA transport through interaction with synaptotagmins. {ECO:0000250}.		cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10734137, ECO:0000269|PubMed:11994298}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:O43390}. Microsome {ECO:0000269|PubMed:11994298}. Cytoplasm {ECO:0000269|PubMed:10734137}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs (By similarity). Isoforms 1 and 2 are expressed predominantly in the nucleoplasm. According to PubMed:10734137, isoform 2 is predominantly found in cytoplasm. The tyrosine phosphorylated form bound to RNA is found in microsomes. {ECO:0000250|UniProtKB:O43390, ECO:0000269|PubMed:10734137}.	56403;	cd12483;cd12489;	IPR041337;IPR006535;IPR034544;IPR034548;IPR012677;IPR035979;IPR000504;	PF18360;PF00076;	SM00360;	69633	COMPBIAS 574..623;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 400..561;  /note=Interaction with APOBEC1;  /evidence=ECO:0000250; REGION 448..559;  /note=8 X 3 AA repeats of R-G-G; REGION 460..488;  /note=3 X 4 AA repeats of Y-Y-G-Y; REGION 497..623;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 518..549;  /note=Interaction with SMN;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (2); Domain (3); Erroneous initiation (2); Initiator methionine (1); Modified residue (18); Motif (1); Region (5); Repeat (11); Sequence conflict (14)	MISCELLANEOUS: [Isoform 2]: May be due to a competing donor splice site and to an exon inclusion. {ECO:0000305}.	Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Isopeptide bond;Methylation;Microsome;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 162..241;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 243..325;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 338..408;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The domain containing eight Arg-Gly-Gly repeats (RGG/RXR-box) may be involved in RNA-binding and protein-protein interactions. It is methylated by PRMT1, and essential for nuclear localization (By similarity). {ECO:0000250}.	MOTIF 564..578;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255	REPEAT 448..450;  /note=1-1; REPEAT 451..453;  /note=1-2; REPEAT 460..464;  /note=2-1; REPEAT 469..472;  /note=2-2; REPEAT 478..480;  /note=1-3; REPEAT 485..488;  /note=2-3; REPEAT 498..500;  /note=1-4; REPEAT 526..528;  /note=1-5; REPEAT 539..541;  /note=1-6; REPEAT 554..556;  /note=1-7; REPEAT 557..559;  /note=1-8		PS50102;	56403	GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0017148~negative regulation of translation,GO:0070934~CRD-mediated mRNA stabilization,GO:0071346~cellular response to interferon-gamma,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070937~CRD-mediated mRNA stability complex,GO:0071013~catalytic step 2 spliceosome,GO:0071204~histone pre-mRNA 3'end processing complex,GO:0097452~GAIT complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008143~poly(A) binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006535:HnRNP R/Q splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.66702071622908	2.12966003362789e-08	FDR<0.01	7.67168971923893	12650741.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	187	Splicing
Q3UYV9	Q3UYV9	Ncbp1	10.496	10.442	3529300	9.8173964264677	6.26959247648903	7.78391842453491	NA	5.24879277766114	7.23327305605787	3016426.66666667	1	Ncbp1	0	Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)		FUNCTION: Component of the cap-binding complex (CBC), which binds cotranscriptionally to the 5'-cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus via its interaction with ALYREF/THOC4/ALY, leading to the recruitment of the mRNA export machinery to the 5'-end of mRNA and to mRNA export in a 5' to 3' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC) via its interaction with UPF1, promoting the interaction between UPF1 and UPF2. The CBC complex is also involved in 'failsafe' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with SRRT/ARS2 and is required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of PARN, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, NCBP1/CBP80 does not bind directly capped RNAs (m7GpppG-capped RNA) but is required to stabilize the movement of the N-terminal loop of NCBP2/CBP20 and lock the CBC into a high affinity cap-binding state with the cap structure. Associates with NCBP3 to form an alternative cap-binding complex (CBC) which plays a key role in mRNA export and is particularly important in cellular stress situations such as virus infections. The conventional CBC with NCBP2 binds both small nuclear RNA (snRNA) and messenger (mRNA) and is involved in their export from the nucleus whereas the alternative CBC with NCBP3 does not bind snRNA and associates only with mRNA thereby playing a role only in mRNA export. NCBP1/CBP80 is required for cell growth and viability (By similarity). {ECO:0000250|UniProtKB:Q09161, ECO:0000269|PubMed:19632182}.		7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; spliceosomal complex assembly [GO:0000245]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]	mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA cap binding [GO:0000339]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22767893}. Cytoplasm {ECO:0000250|UniProtKB:Q09161}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250|UniProtKB:Q09161}.	433702;		IPR016024;IPR027159;IPR016021;IPR015172;IPR015174;IPR003890;	PF02854;PF09088;PF09090;	SM00543;	91927		REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 666..685;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Cross-link (1); Domain (1); Modified residue (6); Motif (1); Region (2); Sequence conflict (4)		3D-structure;Acetylation;Coiled coil;Cytoplasm;Isopeptide bond;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;RNA-mediated gene silencing;Reference proteome;Translation regulation;Transport;Ubl conjugation;mRNA capping;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 28..240;  /note=MIF4G		MOTIF 3..20;  /note=Nuclear localization signal;  /evidence=ECO:0000255				433702	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006370~7-methylguanosine mRNA capping,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0006810~transport,GO:0008380~RNA splicing,GO:0016070~RNA metabolic process,GO:0030307~positive regulation of cell growth,GO:0031047~gene silencing by RNA,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0045292~mRNA cis splicing, via spliceosome,GO:0051028~mRNA transport,GO:0098789~pre-mRNA cleavage required for polyadenylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005845~mRNA cap binding complex,GO:0005846~nuclear cap binding complex,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000339~RNA cap binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR003890:MIF4G-like, type 3,IPR015172:MIF4G-like, type 1,IPR015174:MIF4G-like, type 2,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,IPR027159:Nuclear cap-binding protein subunit 1,	PF02854:MIF4G domain,PF09088:MIF4G like,PF09090:MIF4G like,	SSF48371:ARM repeat,	2.98956240976182	8.22573303599866e-08	FDR<0.01	7.08482538951126	3272863.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	481	Splicing
B1AZI6	B1AZI6	Thoc2	0.9897	1.1321	1471850	3.35401643468053	2.38202996593697	3.66394313560254	1.49135758280763	2.66609789911486	2.66176901168517	2841031.66666667	0	Thoc2	0	THO complex subunit 2 (Tho2)		FUNCTION: Required for efficient export of polyadenylated RNA and spliced mRNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. Plays a role for proper neuronal development. {ECO:0000250|UniProtKB:Q8NI27}.		blastocyst development [GO:0001824]; cell morphogenesis [GO:0000902]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380]; stem cell division [GO:0017145]; viral mRNA export from host cell nucleus [GO:0046784]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Nucleus speckle {ECO:0000250}.	331401;		IPR040007;IPR021418;IPR021726;IPR032302;	PF11262;PF11732;PF16134;		182773	COMPBIAS 1201..1220;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1221..1236;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1237..1264;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1265..1381;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1398..1416;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1447..1509;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1518..1586;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1183..1594;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (7); Modified residue (8); Motif (1); Region (1)		Coiled coil;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transport;mRNA processing;mRNA splicing;mRNA transport			MOTIF 923..928;  /note=Nuclear localization signal;  /evidence=ECO:0000255				331401	GO:0000902~cell morphogenesis,GO:0001824~blastocyst development,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0010793~regulation of mRNA export from nucleus,GO:0010977~negative regulation of neuron projection development,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0017145~stem cell division,GO:0046784~viral mRNA export from host cell nucleus,GO:0048666~neuron development,GO:0048699~generation of neurons,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0000347~THO complex,GO:0000445~THO complex part of transcription export complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR021418:THO complex, subunitTHOC2, C-terminal,IPR021726:THO complex, subunitTHOC2, N-terminal,	PF11262:Transcription factor/nuclear export subunit protein 2,PF11732:Transcription- and export-related complex subunit,		1.05491054590226	0.0019466305226896	FDR<0.01	2.7107164712762	2156440.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	600	Splicing
Q8C5Q4	Q8C5Q4	Grsf1	NA	3.0932	250140	NA	17.7755657073786	NA	NA	6.55350940428599	NA	289180	4	Grsf1	1	G-rich sequence factor 1 (GRSF-1)		FUNCTION: Regulator of post-transcriptional mitochondrial gene expression, required for assembly of the mitochondrial ribosome and for recruitment of mRNA and lncRNA. Binds RNAs containing the 14 base G-rich element. Preferentially binds RNAs transcribed from three contiguous genes on the light strand of mtDNA, the ND6 mRNA, and the long non-coding RNAs for MT-CYB and MT-ND5, each of which contains multiple consensus binding sequences. Involved in the degradosome-mediated decay of non-coding mitochondrial transcripts (MT-ncRNA) and tRNA-like molecules. Acts by unwinding G-quadruplex RNA structures in MT-ncRNA, thus facilitating their degradation by the degradosome. G-quadruplexes (G4) are non-canonical 4 stranded structures formed by transcripts from the light strand of mtDNA. {ECO:0000250|UniProtKB:Q12849}.		anterior/posterior pattern specification [GO:0009952]; morphogenesis of embryonic epithelium [GO:0016331]; mRNA processing [GO:0006397]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; regulation of RNA splicing [GO:0043484]; tRNA processing [GO:0008033]	mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250|UniProtKB:Q12849}. Note=Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. {ECO:0000250|UniProtKB:Q12849}.	231413;	cd12730;cd12505;cd12733;	IPR034424;IPR033106;IPR034425;IPR034426;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	53076			NA							4 out of 5	Chain (1); Domain (3); Modified residue (2); Sequence conflict (4); Transit peptide (1)		Mitochondrion;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transit peptide;mRNA processing;tRNA processing	DOMAIN 149..245;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 249..325;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 400..479;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domains mediate RNA-binding. {ECO:0000250|UniProtKB:Q12849}.				PS50102;	231413	GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008033~tRNA processing,GO:0009952~anterior/posterior pattern specification,GO:0016331~morphogenesis of embryonic epithelium,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.83106378805496	0.00233196111673355	FDR<0.01	2.63227869530618	269660	Present in Nucleus	RBP	RBD	Others	Others	RBD	1218	Splicing
Q8VE80	Q8VE80	Thoc3	5.544	3.6987	520164.5	1.88171537173287	NA	NA	NA	NA	NA	16730	5	Thoc3	0	THO complex subunit 3 (Tho3)		FUNCTION: Required for efficient export of polyadenylated RNA and spliced mRNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway (By similarity). {ECO:0000250}.		mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]	chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Nucleus speckle {ECO:0000305}.	73666;		IPR024977;IPR020472;IPR040132;IPR013979;IPR015943;IPR001680;IPR017986;IPR036322;	PF12894;PF08662;PF00400;	SM00320;	38738			NA							3 out of 5	Chain (1); Initiator methionine (1); Modified residue (1); Repeat (6); Sequence conflict (3)		Acetylation;Nucleus;RNA-binding;Reference proteome;Repeat;Transport;WD repeat;mRNA processing;mRNA splicing;mRNA transport				REPEAT 53..94;  /note=WD 1; REPEAT 97..137;  /note=WD 2; REPEAT 139..178;  /note=WD 3; REPEAT 180..221;  /note=WD 4; REPEAT 222..261;  /note=WD 5; REPEAT 264..303;  /note=WD 6		PS50082;PS50294;	73666	GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0046784~viral mRNA export from host cell nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0000445~THO complex part of transcription export complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF08662:Eukaryotic translation initiation factor eIF2A,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF50978:WD40 repeat-like,	1.75666465627065	0.0080424639478033	FDR<0.01	2.09461087724666	268447.25	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	1222	Splicing
Q8BYK6	Q8BYK6;Q8BYK6-2;Q8BYK6-3	Ythdf3	NA	10.481	110215	3.26711970726607	4.37368789363191	12.8627289565754	NA	3.35199275969564	NA	466448.333333333	2	Ythdf3	1	YTH domain-containing family protein 3		FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, and regulates their stability (PubMed:32905781, PubMed:32943573). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed:32943573). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex or PAN3 (PubMed:32943573, PubMed:32905781). The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) share m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation (PubMed:32943573). Acts as a negative regulator of type I interferon response by down-regulating interferon-stimulated genes (ISGs) expression: acts by binding to FOXO3 mRNAs (PubMed:30591559). Binds to FOXO3 mRNAs independently of METTL3-mediated m6A modification (PubMed:30591559). Can also act as a regulator of mRNA stability in cooperation with YTHDF2 by binding to m6A-containing mRNA and promoting their degradation (By similarity). Recognizes and binds m6A-containing circular RNAs (circRNAs); circRNAs are generated through back-splicing of pre-mRNAs, a non-canonical splicing process promoted by dsRNA structures across circularizing exons (By similarity). Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues: polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation (By similarity). The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules (By similarity). May also recognize and bind N1-methyladenosine (m1A)-containing mRNAs: inhibits trophoblast invasion by binding to m1A-methylated transcripts of IGF1R, promoting their degradation (By similarity). {ECO:0000250|UniProtKB:Q7Z739, ECO:0000269|PubMed:30591559, ECO:0000269|PubMed:32905781, ECO:0000269|PubMed:32943573}.		mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of mRNA stability [GO:0043488]; regulation of trophoblast cell migration [GO:1901163]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]	mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:32943573}. Cytoplasm, P-body {ECO:0000250|UniProtKB:Q7Z739}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q7Z739}.	229096;		IPR007275;	PF04146;		63961	COMPBIAS 1..26;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 36..51;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 304..333;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 334..350;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..51;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 244..277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 304..350;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 422..424;  /note=N6-methyladenosine binding;  /evidence=ECO:0000250|UniProtKB:Q7Z739; REGION 438..439;  /note=N6-methyladenosine binding;  /evidence=ECO:0000250|UniProtKB:Q7Z739	NA			BINDING 428;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; BINDING 468;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q9Y5A9; BINDING 492;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q7Z739; BINDING 497;  /note=N6-methyladenosine;  /evidence=ECO:0000250|UniProtKB:Q7Z739				5 out of 5	Alternative sequence (2); Binding site (4); Chain (1); Compositional bias (4); Domain (1); Initiator methionine (1); Modified residue (2); Region (5); Sequence conflict (3)		Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 416..550;  /note=YTH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00225	DOMAIN: The disordered regions have the ability to interact with each other and to 'phase separate' into liquid droplets within the cytosol following binding to mRNAs containing multiple m6A-modified residues. This leads to the partition of m6A-containing mRNAs into membraneless compartments, where mRNAs may be stored, degraded or used to transport mRNAs to dendritic arbors in neurons. {ECO:0000250|UniProtKB:Q7Z739}.				PS50882;	229096			GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:1990247~N6-methyladenosine-containing RNA binding,	IPR007275:YTH domain,	PF04146:YT521-B-like domain,		2.53134358827876	0.000177795780255913	FDR<0.01	3.75007855063982	288331.666666667	Unexpected	RBP	Others	Others	Others	Others	1195	Splicing
P52480	P52480;P52480-2;P53657	Pkm	8.3964	7.7448	7082400	5.6538700740657	5.80080051047045	6.6476101841388	2.43795406894534	4.02430681315144	6.1511964077013	2217851.66666667	0	Pkm	0	Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme)		FUNCTION: Glycolytic enzyme that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP (By similarity). The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production (By similarity). The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival (By similarity). In addition to its role in glycolysis, also regulates transcription (By similarity). Stimulates POU5F1-mediated transcriptional activation (By similarity). Promotes in a STAT1-dependent manner, the expression of the immune checkpoint protein CD274 in ARNTL/BMAL1-deficient macrophages (PubMed:29996098). Also acts as a translation regulator for a subset of mRNAs, independently of its pyruvate kinase activity: associates with subpools of endoplasmic reticulum-associated ribosomes, binds directly to the mRNAs translated at the endoplasmic reticulum and promotes translation of these endoplasmic reticulum-destined mRNAs (PubMed:28575669). Plays a general role in caspase independent cell death of tumor cells (By similarity). {ECO:0000250|UniProtKB:P14618, ECO:0000269|PubMed:28575669, ECO:0000269|PubMed:29996098}.	PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 5/5.	animal organ regeneration [GO:0031100]; ATP biosynthetic process [GO:0006754]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; pyruvate biosynthetic process [GO:0042866]; skeletal muscle tissue regeneration [GO:0043403]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P14618}. Nucleus {ECO:0000250|UniProtKB:P14618}. Note=Translocates to the nucleus in response to different apoptotic stimuli. Nuclear translocation is sufficient to induce cell death that is caspase independent, isoform-specific and independent of its enzymatic activity. {ECO:0000250|UniProtKB:P14618}.	18746;	cd00288;	IPR001697;IPR015813;IPR040442;IPR011037;IPR018209;IPR015793;IPR015795;IPR036918;IPR015806;	PF00224;PF02887;		57845		REGION 307..531;  /note=Interaction with POU5F1;  /evidence=ECO:0000250|UniProtKB:P14618; REGION 389..433;  /note=Intersubunit contact; REGION 432..437;  /note=D-fructose 1,6-bisphosphate binding; part of allosteric site;  /evidence=ECO:0000250|UniProtKB:P14618; REGION 516..521;  /note=D-fructose 1,6-bisphosphate binding; part of allosteric site;  /evidence=ECO:0000250|UniProtKB:P14618	NA		ACTIVITY REGULATION: Allosterically activated by D-fructose 1,6-bisphosphate (FBP). Inhibited by oxalate and 3,3',5-triiodo-L-thyronine (T3). The activity of the tetrameric form is inhibited by PML. Selective binding to tyrosine-phosphorylated peptides releases the allosteric activator FBP, leading to inhibition of PKM enzymatic activity, this diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors. Glycolytic flux are highly dependent on de novo biosynthesis of serine and glycine, and serine is a natural ligand and allosteric activator (By similarity). {ECO:0000250|UniProtKB:P14618}.	BINDING 70;  /note=Serine;  /evidence=ECO:0000250|UniProtKB:P14618; BINDING 73;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P30613; BINDING 106;  /note=Serine;  /evidence=ECO:0000250|UniProtKB:P14618; BINDING 120;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P14618; BINDING 207;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P14618; BINDING 270;  /note=Substrate; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P30613; BINDING 295;  /note=Substrate; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P30613; BINDING 296;  /note=Substrate; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P30613; BINDING 328;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P30613; BINDING 464;  /note=Serine;  /evidence=ECO:0000250|UniProtKB:P14618; BINDING 482;  /note=D-fructose 1,6-bisphosphate; part of allosteric site;  /evidence=ECO:0000250|UniProtKB:P14618; BINDING 489;  /note=D-fructose 1,6-bisphosphate; part of allosteric site;  /evidence=ECO:0000250|UniProtKB:P14618	2.7.1.40	METAL 75;  /note=Potassium;  /evidence=ECO:0000250|UniProtKB:P14618; METAL 77;  /note=Potassium;  /evidence=ECO:0000250|UniProtKB:P14618; METAL 113;  /note=Potassium;  /evidence=ECO:0000250|UniProtKB:P14618; METAL 114;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:P14618; METAL 272;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:P14618; METAL 296;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:P14618		5 out of 5	Alternative sequence (1); Binding site (12); Chain (1); Cross-link (4); Metal binding (6); Modified residue (25); Mutagenesis (2); Nucleotide binding (1); Region (4); Sequence conflict (18); Site (2)	MISCELLANEOUS: There are 4 isozymes of pyruvate kinase in mammals (L, R, M1, M2) encoded by 2 different genes: PKLR and PKM. The L and R isozymes are generated from the PKLR by differential splicing of RNA; the M1 and M2 forms are produced from the PKM gene by differential splicing. L type is major isozyme in the liver, R is found in red cells, M1 is the main form in muscle, heart and brain, and M2 is found in early fetal tissues as well as in most cancer cells.	ATP-binding;Acetylation;Allosteric enzyme;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Kinase;Magnesium;Metal-binding;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Potassium;Pyruvate;Reference proteome;Transferase;Translation regulation;Ubl conjugation						PS00110;	18746	GO:0001889~liver development,GO:0006006~glucose metabolic process,GO:0006096~glycolytic process,GO:0006754~ATP biosynthetic process,GO:0008152~metabolic process,GO:0012501~programmed cell death,GO:0016310~phosphorylation,GO:0031100~organ regeneration,GO:0042866~pyruvate biosynthetic process,GO:0043403~skeletal muscle tissue regeneration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005929~cilium,GO:0031012~extracellular matrix,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003824~catalytic activity,GO:0004743~pyruvate kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0023026~MHC class II protein complex binding,GO:0030955~potassium ion binding,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001697:Pyruvate kinase,IPR011037:Pyruvate kinase-like, insert domain,IPR015793:Pyruvate kinase, barrel,IPR015794:Pyruvate kinase, alpha/beta,IPR015795:Pyruvate kinase, C-terminal,IPR015806:Pyruvate kinase, beta-barrel insert domain,IPR015813:Pyruvate/Phosphoenolpyruvate kinase-like domain,IPR018209:Pyruvate kinase, active site,	PF00224:Pyruvate kinase, barrel domain,PF02887:Pyruvate kinase, alpha/beta domain,	SSF50800:PK beta-barrel domain-like,SSF51621:Phosphoenolpyruvate/pyruvate domain,SSF52935:PK C-terminal domain-like,	2.46332546132308	4.01886969646533e-07	FDR<0.01	6.39589607467969	4650125.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	389	Splicing
Q9WUK2	Q9WUK2-2;Q9WUK2	Eif4h	22.347	5.7097	10020950	11.9447198365962	7.71307365985345	6.19540301096586	5.2578999947421	9.62741888899586	22.5484227378295	3748300	0	Eif4h	0	Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein homolog)		FUNCTION: Stimulates the RNA helicase activity of EIF4A in the translation initiation complex. Binds weakly mRNA (By similarity). {ECO:0000250}.		developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; sexual reproduction [GO:0019953]	perinuclear region of cytoplasm [GO:0048471]	ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm, perinuclear region.	22384;	cd12401;	IPR034229;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	27341	COMPBIAS 122..159;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 196..211;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 122..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Beta strand (6); Chain (1); Compositional bias (2); Domain (1); Helix (3); Initiator methionine (1); Modified residue (12); Region (2); Turn (1)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Initiation factor;Methylation;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome	DOMAIN 42..118;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	22384	GO:0001731~formation of translation preinitiation complex,GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0006413~translational initiation,GO:0019953~sexual reproduction,GO:0048589~developmental growth,GO:0097010~eukaryotic translation initiation factor 4F complex assembly,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0033592~RNA strand annealing activity,GO:0034057~RNA strand-exchange activity,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.28860246515162	2.01898898963906e-07	FDR<0.01	6.6948660494328	6884625	Present in Nucleus	RBP	RBD	Others	Others	RBD	291	Splicing
Q62448	Q62448;Q62448-2	Eif4g2	4.9717	10.037	827530	11.0974242878228	6.31273278202134	0.901631953836444	1.56722616640807	9.08100254268071	7.55972180223768	1843393.33333333	0	Eif4g2	0	Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Novel APOBEC-1 target 1) (Translation repressor NAT1) (p97)		FUNCTION: Appears to play a role in the switch from cap-dependent to IRES-mediated translation during mitosis, apoptosis and viral infection. Cleaved by some caspases and viral proteases. {ECO:0000250|UniProtKB:P78344, ECO:0000269|PubMed:9030685}.		cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; postsynaptic density [GO:0014069]	mRNA binding [GO:0003729]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]		13690;		IPR016024;IPR003891;IPR016021;IPR003890;IPR003307;	PF02847;PF02854;PF02020;	SM00515;SM00544;SM00543;	102106	COMPBIAS 38..63;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..71;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 497..540;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Cross-link (1); Domain (3); Erroneous initiation (1); Modified residue (11); Region (2); Sequence conflict (27)	MISCELLANEOUS: This gene has been shown to be extensively edited in the liver of APOBEC1 transgenic animals. Its aberrant editing could contribute to the potent oncogenesis induced by overexpression of APOBEC1. The aberrant edited sequence, called NAT1, is likely to be a fundamental translational repressor.	Acetylation;Alternative splicing;Initiation factor;Isopeptide bond;Methylation;Phosphoprotein;Protein biosynthesis;Reference proteome;Repressor;Translation regulation;Ubl conjugation	DOMAIN 78..308;  /note=MIF4G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00698; DOMAIN 542..665;  /note=MI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00698; DOMAIN 719..903;  /note=W2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00695					PS51366;PS51363;	13690	GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0007507~heart development,GO:0045727~positive regulation of translation,GO:0045773~positive regulation of axon extension,GO:0060999~positive regulation of dendritic spine development,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0030424~axon,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0008135~translation factor activity, RNA binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003307:W2 domain,IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	PF02020:eIF4-gamma/eIF5/eIF2-epsilon,PF02847:MA3 domain,PF02854:MIF4G domain,	SSF48371:ARM repeat,	2.29642772112023	0.000165692420514276	FDR<0.01	3.78069735762842	1335461.66666667	Unexpected	RBP	Others	Others	Others	Others	732	Splicing
Q9CZN7	Q9CZN7-2;Q9CZN7	Shmt2	3.0375	NA	784950	4.52652543907297	4.11624269366922	NA	NA	4.29608626541221	5.03752959548637	1699760	2	Shmt2	1	Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)		FUNCTION: Catalyzes the cleavage of serine to glycine accompanied with the production of 5,10-methylenetetrahydrofolate, an essential intermediate for purine biosynthesis (By similarity). Serine provides the major source of folate one-carbon in cells by catalyzing the transfer of one carbon from serine to tetrahydrofolate (By similarity). Contributes to the de novo mitochondrial thymidylate biosynthesis pathway via its role in glycine and tetrahydrofolate metabolism: thymidylate biosynthesis is required to prevent uracil accumulation in mtDNA (By similarity). Also required for mitochondrial translation by producing 5,10-methylenetetrahydrofolate; 5,10-methylenetetrahydrofolate providing methyl donors to produce the taurinomethyluridine base at the wobble position of some mitochondrial tRNAs (PubMed:29452640). Associates with mitochondrial DNA (By similarity). In addition to its role in mitochondria, also plays a role in the deubiquitination of target proteins as component of the BRISC complex: required for IFNAR1 deubiquitination by the BRISC complex (By similarity). {ECO:0000250|UniProtKB:P34897, ECO:0000269|PubMed:29452640}.	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion. {ECO:0000250|UniProtKB:P34897}.	folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:P34897}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000250|UniProtKB:P34897}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:P34897}. Cytoplasm {ECO:0000250|UniProtKB:P34897}. Nucleus {ECO:0000250|UniProtKB:P34897}. Note=Mainly localizes in the mitochondrion. Also found in the cytoplasm and nucleus as part of the BRISC complex. {ECO:0000250|UniProtKB:P34897}.	108037;	cd00378;	IPR015424;IPR015422;IPR015421;IPR001085;IPR019798;IPR039429;	PF00464;		55759			NA		ACTIVITY REGULATION: Hydroxymethyltransferase is inhibited by succinylation at Lys-280. {ECO:0000250|UniProtKB:P34897}.		2.1.2.1			5 out of 5	Alternative sequence (1); Chain (1); Modified residue (9); Sequence conflict (4); Transit peptide (1)	MISCELLANEOUS: In eukaryotes there are two forms of the enzymes: a cytosolic one and a mitochondrial one. {ECO:0000305}.	Acetylation;Alternative splicing;Cytoplasm;Membrane;Mitochondrion;Mitochondrion inner membrane;Mitochondrion nucleoid;Nucleus;One-carbon metabolism;Phosphoprotein;Pyridoxal phosphate;Reference proteome;Transferase;Transit peptide						PS00096;	108037	GO:0006544~glycine metabolic process,GO:0006545~glycine biosynthetic process,GO:0006563~L-serine metabolic process,GO:0006564~L-serine biosynthetic process,GO:0006730~one-carbon metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0019264~glycine biosynthetic process from serine,GO:0034340~response to type I interferon,GO:0035999~tetrahydrofolate interconversion,GO:0046653~tetrahydrofolate metabolic process,GO:0051262~protein tetramerization,GO:0051289~protein homotetramerization,GO:0070536~protein K63-linked deubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0015630~microtubule cytoskeleton,GO:0042645~mitochondrial nucleoid,GO:0070062~extracellular exosome,GO:0070552~BRISC complex,	GO:0003682~chromatin binding,GO:0004372~glycine hydroxymethyltransferase activity,GO:0008168~methyltransferase activity,GO:0008732~L-allo-threonine aldolase activity,GO:0016597~amino acid binding,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,	IPR001085:Serine hydroxymethyltransferase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR019798:Serine hydroxymethyltransferase, pyridoxal phosphate binding site,	PF00464:Serine hydroxymethyltransferase,	SSF53383:PLP-dependent transferases,	2.05167117791057	4.88007057178919e-05	FDR<0.01	4.31157389752249	1242355	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	756	Splicing
Q497V5	Q497V5;Q497V5-2	Srbd1	5.5594	6.604	1332000	4.09249028033558	4.13308534821244	14.6032302345279	NA	10.9635899178827	1.95894060492086	1134135	1	Srbd1	0	S1 RNA-binding domain-containing protein 1				nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412]		mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]			cd05685;	IPR041692;IPR012340;IPR012337;IPR010994;IPR022967;IPR003029;IPR044146;IPR023323;IPR023319;IPR018974;IPR032639;IPR006641;IPR037027;	PF17674;PF00575;PF09371;PF16921;	SM00316;SM00732;	110281	COMPBIAS 30..49;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 50..67;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 68..84;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 139..153;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (5); Domain (1); Modified residue (1); Region (1)		Alternative splicing;Coiled coil;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 906..979;  /note=S1 motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180					PS50126;	NA	GO:0006139~nucleobase-containing compound metabolic process,		GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR006641:YqgF/RNase H-like domain,IPR010994:RuvA domain 2-like,IPR012337:Ribonuclease H-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR018974:Tex-like protein, N-terminal,IPR022967:RNA-binding domain, S1,IPR023097:Tex RuvX-like domain,IPR023319:Tex-like protein, HTH domain,IPR023323:Tex-like domain,	PF00575:S1 RNA binding domain,PF09371:Tex-like protein N-terminal domain,	SSF47781:RuvA domain 2-like,SSF50249:Nucleic acid-binding proteins,SSF53098:Ribonuclease H-like,	2.51020072857969	2.30014478507693e-05	FDR<0.01	4.6382448259907	1233067.5	Unexpected	RBP	DBD	DBD	Others	RBD	761	Splicing
Q99PL5	Q99PL5;Q99PL5-12;Q99PL5-11;Q99PL5-10;Q99PL5-9;Q99PL5-8;Q99PL5-7;Q99PL5-6;Q99PL5-5;Q99PL5-4;Q99PL5-3;Q99PL5-2	Rrbp1	16.149	8.034	672790	8.75196919306844	5.40832882639264	7.28703636231145	2.84567883668649	15.03623733197	9.47149081265391	1055398.33333333	0	Rrbp1	0	Ribosome-binding protein 1 (Ribosome receptor protein) (RRp) (mRRp)		FUNCTION: Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane. {ECO:0000250}.		protein transport [GO:0015031]; signal transduction [GO:0007165]	integral component of endoplasmic reticulum membrane [GO:0030176]		SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type III membrane protein {ECO:0000250}.	81910;		IPR007794;IPR040248;	PF05104;		172879	COMPBIAS 60..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 133..149;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 188..373;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 389..415;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 423..437;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 439..514;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 530..556;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 564..578;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 580..766;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 824..842;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1573..1595;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 44..88;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 114..150;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 172..849;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 196..808;  /note=61 X 10 AA tandem repeats of [NSQ]-[NKQVGA]-[GSAQKRT]-[ASGDTK]-[KGTQSAV]-[KGAED]-[EQVGIPTDMA]-[EGVAS]-[AGVPETNS]-[AQNGPTVS]; REGION 1460..1481;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1571..1605;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (13); Chain (1); Compositional bias (11); Cross-link (2); Modified residue (8); Region (6); Repeat (61); Sequence conflict (2); Topological domain (2); Transmembrane (1)		Acetylation;Alternative splicing;Endoplasmic reticulum;Isopeptide bond;Membrane;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transmembrane;Transmembrane helix;Transport;Ubl conjugation				REPEAT 196..205;  /note=1; REPEAT 206..215;  /note=2; REPEAT 216..225;  /note=3; REPEAT 226..235;  /note=4; REPEAT 236..245;  /note=5; REPEAT 246..255;  /note=6; REPEAT 256..265;  /note=7; REPEAT 266..275;  /note=8; REPEAT 276..285;  /note=9; REPEAT 286..295;  /note=10; REPEAT 296..305;  /note=11; REPEAT 306..315;  /note=12; REPEAT 316..325;  /note=13; REPEAT 326..335;  /note=14; REPEAT 336..345;  /note=15; REPEAT 346..355;  /note=16; REPEAT 356..365;  /note=17; REPEAT 366..375;  /note=18; REPEAT 376..385;  /note=19; REPEAT 386..395;  /note=20; REPEAT 396..405;  /note=21; REPEAT 406..415;  /note=22; REPEAT 416..425;  /note=23; REPEAT 426..435;  /note=24; REPEAT 436..445;  /note=25; REPEAT 446..455;  /note=26; REPEAT 456..465;  /note=27; REPEAT 466..475;  /note=28; REPEAT 476..485;  /note=29; REPEAT 486..495;  /note=30; REPEAT 496..505;  /note=31; REPEAT 506..515;  /note=32; REPEAT 516..525;  /note=33; REPEAT 527..536;  /note=34; REPEAT 537..546;  /note=35; REPEAT 547..556;  /note=36; REPEAT 557..566;  /note=37; REPEAT 567..576;  /note=38; REPEAT 577..586;  /note=39; REPEAT 587..596;  /note=40; REPEAT 597..606;  /note=41; REPEAT 607..616;  /note=42; REPEAT 617..626;  /note=43; REPEAT 628..637;  /note=44; REPEAT 638..647;  /note=45; REPEAT 648..657;  /note=46; REPEAT 658..667;  /note=47; REPEAT 668..677;  /note=48; REPEAT 678..687;  /note=49; REPEAT 688..697;  /note=50; REPEAT 698..707;  /note=51; REPEAT 708..717;  /note=52; REPEAT 718..727;  /note=53; REPEAT 729..738;  /note=54; REPEAT 739..748;  /note=55; REPEAT 749..758;  /note=56; REPEAT 759..768;  /note=57; REPEAT 769..778;  /note=58; REPEAT 779..788;  /note=59; REPEAT 789..798;  /note=60; REPEAT 799..808;  /note=61			81910	GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0006810~transport,GO:0007165~signal transduction,GO:0015031~protein transport,	GO:0005783~endoplasmic reticulum,GO:0005840~ribosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007794:Ribosome receptor lysine/proline rich,	PF05104:Ribosome receptor lysine/proline rich region,		3.014043770817	3.61355592434447e-07	FDR<0.01	6.44206521963803	864094.166666667	Unexpected	RBP	Others	Others	Others	Others	876	Splicing
Q3TIV5	Q3TIV5;Q3TIV5-2;Q3TIV5-3	Zc3h15	3.4302	7.0982	788615	NA	NA	NA	1.01014182391208	2.7955606496883	5.16049127876974	171016.166666667	3	Zc3h15	0	Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Epo-immediate response gene protein FM22)		FUNCTION: Protects DRG1 from proteolytic degradation (PubMed:15676025). Stimulates DRG1 GTPase activity likely by increasing the affinity for the potassium ions (By similarity). {ECO:0000250|UniProtKB:Q8WU90, ECO:0000269|PubMed:15676025}.		cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547]	cytosol [GO:0005829]; nucleus [GO:0005634]	metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus {ECO:0000250|UniProtKB:Q8WU90}. Note=The DRG1-DFRP2/ZC3H15 complex associates with polysomes. {ECO:0000250|UniProtKB:Q8WU90}.	69082;		IPR032378;IPR041367;IPR000571;IPR036855;	PF16543;PF18044;	SM00356;	48327	COMPBIAS 11..30;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 407..426;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..30;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 53..74;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 236..260;  /note=Required for interaction with DRG1;  /evidence=ECO:0000269|PubMed:15676025; REGION 303..328;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 358..426;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Coiled coil (2); Compositional bias (2); Frameshift (1); Modified residue (3); Region (5); Sequence conflict (3); Zinc finger (2)		Alternative splicing;Coiled coil;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger					ZN_FING 99..126;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 174..212;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50103;	69082	GO:0019221~cytokine-mediated signaling pathway,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,	PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),	SSF90229:CCCH zinc finger,	1.69418996871819	0.00375347742834458	FDR<0.01	2.42556619143337	479815.583333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	1057	Splicing
Q91VU7	Q91VU7;Q91VU7-2	Pus7	NA	4.5205	157905	4.66744457409568	0.85099140498681	7.31368390258173	NA	13.8412135976082	NA	729166.666666667	2	Pus7	1	Pseudouridylate synthase 7 homolog (EC 5.4.99.-)		FUNCTION: Pseudouridylate synthase that catalyzes pseudouridylation of RNAs. Acts as a regulator of protein synthesis in embryonic stem cells by mediating pseudouridylation of RNA fragments derived from tRNAs (tRFs): pseudouridylated tRFs inhibit translation by targeting the translation initiation complex. Also catalyzes pseudouridylation of mRNAs: mediates pseudouridylation of mRNAs with the consensus sequence 5'-UGUAG-3'. In addition to mRNAs and tRNAs, binds other types of RNAs, such as snRNAs, Y RNAs and vault RNAs, suggesting that it can catalyze pseudouridylation of many RNA types. {ECO:0000250|UniProtKB:Q96PZ0}.		mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119]	nucleus [GO:0005634]	enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96PZ0}.	78697;		IPR020103;IPR001656;IPR020119;IPR011760;IPR042214;	PF01142;		74793	COMPBIAS 46..67;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 73..97;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..99;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 293;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q96PZ0			5.4.99.-			4 out of 5	Active site (1); Alternative sequence (1); Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (2); Modified residue (2); Region (1)		Alternative splicing;Isomerase;Nucleus;Phosphoprotein;Reference proteome;tRNA processing	DOMAIN 369..579;  /note=TRUD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00342					PS50984;PS01268;	78697	GO:0001522~pseudouridine synthesis,	GO:0005634~nucleus,	GO:0009982~pseudouridine synthase activity,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR001656:Pseudouridine synthase, TruD,IPR011760:Pseudouridine synthase, TruD, insertion domain,IPR020103:Pseudouridine synthase, catalytic domain,IPR020119:Pseudouridine synthase TruD, conserved site,	PF01142:tRNA pseudouridine synthase D (TruD),	SSF55120:Pseudouridine synthase,	2.16556570481137	0.00361567600660417	FDR<0.01	2.44181049270113	443535.833333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	1077	Splicing
Q8BFR5	Q8BFR5;Q8BFR5-2	Tufm	1.2558	1.8512	60288	3.3527794541675	4.83021784282471	4.49458402624837	1.54340041980491	2.38293816275468	3.82936355977637	703858.333333333	0	Tufm	0	Elongation factor Tu, mitochondrial		FUNCTION: Promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. Plays also a role in the regulation of autophagy and innate immunity. Recruits ATG5-ATG12 and NLRX1 at mitochondria and serves as a checkpoint of the RIG-I/DDX58-MAVS pathway. In turn, inhibits RLR-mediated type I interferon while promoting autophagy. {ECO:0000250|UniProtKB:P49411}.		mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414]	mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:P49411}.	233870;	cd01884;cd03697;	IPR041709;IPR004161;IPR033720;IPR031157;IPR027417;IPR000795;IPR009000;IPR009001;IPR004541;IPR004160;	PF00009;PF03144;PF03143;		49508		REGION 64..71;  /note=G1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 105..109;  /note=G2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 126..129;  /note=G3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 181..184;  /note=G4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 219..221;  /note=G5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059	NA							4 out of 5	Alternative sequence (1); Chain (1); Domain (1); Modified residue (10); Nucleotide binding (3); Region (5); Transit peptide (1)		Acetylation;Alternative splicing;Direct protein sequencing;Elongation factor;GTP-binding;Mitochondrion;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome;Transit peptide	DOMAIN 55..251;  /note=tr-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059					PS00301;PS51722;	233870	GO:0006412~translation,GO:0006414~translational elongation,GO:0070125~mitochondrial translational elongation,	GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0042645~mitochondrial nucleoid,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004160:Translation elongation factor EFTu/EF1A, C-terminal,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR004541:Translation elongation factor EFTu/EF1A, bacterial/organelle,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF03143:Elongation factor Tu C-terminal domain,PF03144:Elongation factor Tu domain 2,	SSF50447:Translation proteins,SSF50465:EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.40233243535402	0.000260387666365465	FDR<0.01	3.58437959059646	382073.166666667	Present in Nucleus	RBP	Others	Others	Others	Others	1116	Splicing
P10630	P10630;P10630-2	Eif4a2	7.5397	1.3933	495250	NA	2.78179592745076	NA	NA	NA	NA	253336.5	5	Eif4a2	0	Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)		FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.		cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]	perinuclear region of cytoplasm [GO:0048471]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]		13682;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	46402		REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Alternative sequence (1); Chain (1); Domain (2); Modified residue (1); Motif (2); Nucleotide binding (1); Region (1); Sequence conflict (4)		ATP-binding;Alternative splicing;Helicase;Hydrolase;Initiation factor;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome	DOMAIN 64..235;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 246..407;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 33..61;  /note=Q motif; MOTIF 183..186;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	13682	GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:1900260~negative regulation of RNA-directed RNA polymerase activity,	GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.62300987842769	0.0254754981373592	FDR<0.1	1.59387731522375	374293.25	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1120	Splicing
Q8R050	Q8R050-2;Q8R050;Q149F3	Gspt1	NA	4.558	182261.5	NA	3.64723904004668	NA	2.77484877074199	3.50140056022409	2.27169468423444	403790.166666667	2	Gspt1	1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)		FUNCTION: Involved in translation termination in response to the termination codons UAA, UAG and UGA (By similarity). Stimulates the activity of ETF1 (By similarity). Involved in regulation of mammalian cell growth. Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (By similarity). Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes (By similarity). {ECO:0000250|UniProtKB:P15170, ECO:0000250|UniProtKB:Q8IYD1}.		cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]	cytosol [GO:0005829]; translation release factor complex [GO:0018444]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation release factor activity [GO:0003747]		14852;		IPR009818;IPR004161;IPR031157;IPR027417;IPR000795;IPR009000;IPR009001;IPR004160;	PF00009;PF03144;PF03143;PF07145;		68625	COMPBIAS 11..26;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 118..141;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 153..167;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 90..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 218..225;  /note=G1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 274..278;  /note=G2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 295..298;  /note=G3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 357..360;  /note=G4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 399..401;  /note=G5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); Domain (1); Erroneous initiation (2); Nucleotide binding (3); Region (7); Sequence conflict (3)		3D-structure;Alternative splicing;Direct protein sequencing;GTP-binding;Nonsense-mediated mRNA decay;Nucleotide-binding;Protein biosynthesis;Reference proteome	DOMAIN 209..435;  /note=tr-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059					PS00301;PS51722;	14852	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0002184~cytoplasmic translational termination,GO:0006412~translation,GO:0006479~protein methylation,	GO:0005829~cytosol,GO:0018444~translation release factor complex,	GO:0000166~nucleotide binding,GO:0003747~translation release factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004160:Translation elongation factor EFTu/EF1A, C-terminal,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR005225:Small GTP-binding protein domain,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR009818:Ataxin-2, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF03143:Elongation factor Tu C-terminal domain,PF03144:Elongation factor Tu domain 2,PF07145:Ataxin-2 C-terminal region,	SSF50447:Translation proteins,SSF50465:EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.70386317870253	0.000256138068943863	FDR<0.01	3.59152586899913	293025.833333333	Unexpected	RBP	Others	Others	Others	Others	1190	Splicing
Q8BJW6	Q8BJW6;Q8BJW6-2	Eif2a	NA	18.477	212985	3.29652216911159	3.22622273841786	NA	NA	6.39222705190488	4.59685575066654	355062.166666667	2	Eif2a	1	Eukaryotic translation initiation factor 2A (eIF-2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally processed]		FUNCTION: Functions in the early steps of protein synthesis of a small number of specific mRNAs. Acts by directing the binding of methionyl-tRNAi to 40S ribosomal subunits. In contrast to the eIF-2 complex, it binds methionyl-tRNAi to 40S subunits in a codon-dependent manner, whereas the eIF-2 complex binds methionyl-tRNAi to 40S subunits in a GTP-dependent manner. {ECO:0000250|UniProtKB:Q9BY44}.		endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of signal transduction [GO:0009967]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to amino acid starvation [GO:1990928]; ribosome assembly [GO:0042255]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]	mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]		229317;		IPR011387;IPR013979;IPR015943;IPR036322;	PF08662;		64403	COMPBIAS 457..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 510..525;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 432..533;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (2); Coiled coil (1); Compositional bias (2); Erroneous initiation (1); Initiator methionine (1); Modified residue (6); Region (1); Repeat (3)		Acetylation;Alternative splicing;Coiled coil;Initiation factor;Phosphoprotein;Protein biosynthesis;Reference proteome;Repeat;Translation regulation;WD repeat				REPEAT 23..63;  /note=WD 1; REPEAT 125..163;  /note=WD 2; REPEAT 356..401;  /note=WD 3			229317	GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006468~protein phosphorylation,GO:0009967~positive regulation of signal transduction,GO:0032933~SREBP signaling pathway,GO:0042255~ribosome assembly,GO:1990928~response to amino acid starvation,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005850~eukaryotic translation initiation factor 2 complex,GO:0005913~cell-cell adherens junction,GO:0072562~blood microparticle,	GO:0000049~tRNA binding,GO:0003743~translation initiation factor activity,GO:0043022~ribosome binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR011387:Translation initiation factor 2A,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF08662:Eukaryotic translation initiation factor eIF2A,	SSF50978:WD40 repeat-like,	2.4990831013603	0.000294180495163188	FDR<0.01	3.53138612536719	284023.583333333	Unexpected	RBP	ChD	Others	ChD	Others	1201	Splicing
Q6A0A2	Q6A0A2-2;Q6A0A2-3;Q6A0A2	Larp4b	NA	5.1032	68136	5.27899487937497	6.72630658505415	10.5342996797573	NA	NA	NA	178789.333333333	3	Larp4b	1	La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5)		FUNCTION: Stimulates mRNA translation. {ECO:0000250|UniProtKB:Q92615}.		positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of translation [GO:0045727]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]	mRNA 3'-UTR binding [GO:0003730]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q92615}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs in response to arsenite treatment. {ECO:0000250|UniProtKB:Q92615}.	217980;		IPR006630;IPR035979;IPR036388;IPR036390;	PF05383;	SM00715;	81627	COMPBIAS 18..45;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 398..414;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 451..469;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 567..581;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 605..622;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 623..640;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 657..674;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 687..701;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..45;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 86..160;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 398..436;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 451..542;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 567..586;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 599..741;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (8); Domain (2); Erroneous initiation (1); Modified residue (21); Region (6); Sequence conflict (3)		Acetylation;Alternative splicing;Cytoplasm;Methylation;Phosphoprotein;RNA-binding;Reference proteome;Translation regulation	DOMAIN 152..241;  /note=HTH La-type RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00332; DOMAIN 242..309;  /note=RRM					PS50961;	217980	GO:0006417~regulation of translation,GO:0045727~positive regulation of translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF05383:La domain,	SSF46785:Winged helix DNA-binding domain,SSF54928:RNA-binding domain, RBD,	2.72462562262308	8.03816387071931e-05	FDR<0.01	4.09484314427191	123462.666666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1359	Splicing
Q9QXZ0	Q9QXZ0;Q9QXZ0-2;Q9QXZ0-4	Macf1	10.9	4.8065	30978.5	5.8844297987525	4.28614290000429	2.39348970799426	2.82310428547231	1.85442744552619	3.70192129715322	144998.5	0	Macf1	0	Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7)		FUNCTION: [Isoform 2]: F-actin-binding protein which plays a role in cross-linking actin to other cytoskeletal proteins and also binds to microtubules (PubMed:16815997, PubMed:18854161, PubMed:21295697). Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex (By similarity). Acts as a positive regulator of Wnt receptor signaling pathway and is involved in the translocation of AXIN1 and its associated complex (composed of APC, CTNNB1 and GSK3B) from the cytoplasm to the cell membrane (PubMed:16815997). Has actin-regulated ATPase activity and is essential for controlling focal adhesions (FAs) assembly and dynamics (PubMed:18854161). Interaction with CAMSAP3 at the minus ends of non-centrosomal microtubules tethers microtubules minus-ends to actin filaments, regulating focal adhesion size and cell migration (By similarity). May play role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with GOLGA4 (By similarity). Plays a key role in wound healing and epidermal cell migration (PubMed:21295697). Required for efficient upward migration of bulge cells in response to wounding and this function is primarily rooted in its ability to coordinate microtubule dynamics and polarize hair follicle stem cells (PubMed:21295697). As a regulator of actin and microtubule arrangement and stabilization, it plays an essential role in neurite outgrowth, branching and spine formation during brain development (PubMed:26526844). {ECO:0000250|UniProtKB:Q9UPN3, ECO:0000269|PubMed:16815997, ECO:0000269|PubMed:18854161, ECO:0000269|PubMed:21295697, ECO:0000269|PubMed:26526844}.		establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]	actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198]	SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:18854161, ECO:0000269|PubMed:21295697}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:18854161, ECO:0000269|PubMed:21295697}. Golgi apparatus {ECO:0000250|UniProtKB:Q9UPN3}. Cell membrane {ECO:0000250|UniProtKB:Q9UPN3}. Cell projection, ruffle membrane {ECO:0000250|UniProtKB:Q9UPN3}. Note=APC controls its localization to the cell membrane which is critical for its function in microtubule stabilization. Localizes to the tips of microtubules. Associated with the minus-end of microtubules via interaction with CAMSAP3. The phosphorylated form is found in the cytoplasm while the non-phosphorylated form associates with the microtubules. {ECO:0000250|UniProtKB:Q9UPN3}.; SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm {ECO:0000250|UniProtKB:Q9UPN3}. Golgi apparatus {ECO:0000250|UniProtKB:Q9UPN3}.		cd00014;cd00051;	IPR001589;IPR001715;IPR036872;IPR041615;IPR041573;IPR011992;IPR018247;IPR002048;IPR003108;IPR036534;IPR043197;IPR035915;IPR001101;IPR001452;IPR018159;IPR002017;	PF00307;PF13499;PF02187;PF00681;PF17902;PF00435;PF18373;	SM00033;SM00054;SM00243;SM00250;SM00150;	831878	COMPBIAS 8..28;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2141..2155;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2810..2837;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3079..3094;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 7190..7264;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 7301..7354;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..295;  /note=Actin-binding; REGION 1..47;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2120..2155;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2806..2841;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2951..2978;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3058..3099;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 6904..6937;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 7077..7354;  /note=C-terminal tail; REGION 7171..7354;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 7279..7294;  /note=4 X 4 AA tandem repeats of [GS]-S-R-[AR]	NA							5 out of 5	Alternative sequence (3); Calcium binding (2); Chain (1); Compositional bias (6); Domain (6); Erroneous gene model prediction (2); Erroneous initiation (1); Modified residue (26); Region (10); Repeat (49); Sequence conflict (34)	MISCELLANEOUS: [Isoform 3]: Incomplete sequence. {ECO:0000305}.	Acetylation;Actin-binding;Alternative splicing;Calcium;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Golgi apparatus;Leucine-rich repeat;Membrane;Metal-binding;Microtubule;Phosphoprotein;Reference proteome;Repeat;SH3 domain;Wnt signaling pathway	DOMAIN 78..181;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 194..298;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 868..925;  /note=SH3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00192; DOMAIN 7001..7036;  /note=EF-hand 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448; DOMAIN 7037..7072;  /note=EF-hand 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448; DOMAIN 7077..7155;  /note=GAR;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00792	DOMAIN: The C-terminal tail is required for phosphorylation by GSK3B and for microtubule-binding. {ECO:0000269|PubMed:21295697}.		REPEAT 148..171;  /note=LRR 1; REPEAT 377..399;  /note=LRR 3; REPEAT 441..464;  /note=LRR 4; REPEAT 1050..1073;  /note=LRR 5; REPEAT 1128..1154;  /note=LRR 6; REPEAT 1187..1210;  /note=LRR 7; REPEAT 1257..1282;  /note=LRR 8; REPEAT 1577..1619;  /note=Plectin 1; REPEAT 1654..1696;  /note=Plectin 2; REPEAT 1769..1809;  /note=Plectin 3; REPEAT 1811..1848;  /note=Plectin 4; REPEAT 1855..1885;  /note=Plectin 5; REPEAT 2276..2316;  /note=Plectin 6; REPEAT 2352..2393;  /note=Plectin 7; REPEAT 2394..2425;  /note=Plectin 8; REPEAT 2487..2528;  /note=Plectin 9; REPEAT 2671..2715;  /note=Plectin 10; REPEAT 3225..3244;  /note=LRR 9; REPEAT 3606..3630;  /note=LRR 10; REPEAT 3657..3681;  /note=LRR 11; REPEAT 3845..3920;  /note=Spectrin 1; REPEAT 3898..3920;  /note=LRR 12; REPEAT 3962..4070;  /note=Spectrin 2; REPEAT 4087..4112;  /note=LRR 13; REPEAT 4223..4249;  /note=LRR 14; REPEAT 4428..4536;  /note=Spectrin 3; REPEAT 4473..4496;  /note=LRR 15; REPEAT 4563..4583;  /note=LRR 16; REPEAT 4728..4751;  /note=LRR 17; REPEAT 4759..4863;  /note=Spectrin 4; REPEAT 5010..5035;  /note=LRR 18; REPEAT 5131..5153;  /note=LRR 19; REPEAT 5195..5300;  /note=Spectrin 5; REPEAT 5240..5263;  /note=LRR 20; REPEAT 5307..5409;  /note=Spectrin 6; REPEAT 5414..5506;  /note=Spectrin 7; REPEAT 5631..5735;  /note=Spectrin 8; REPEAT 5654..5678;  /note=LRR 21; REPEAT 5742..5844;  /note=Spectrin 9; REPEAT 5763..5787;  /note=LRR 22; REPEAT 5961..6066;  /note=Spectrin 10; REPEAT 6071..6175;  /note=Spectrin 11; REPEAT 6181..6284;  /note=Spectrin 12; REPEAT 6289..6395;  /note=Spectrin 13; REPEAT 6400..6503;  /note=Spectrin 14; REPEAT 6452..6475;  /note=LRR 23; REPEAT 6508..6614;  /note=Spectrin 15; REPEAT 6621..6722;  /note=Spectrin 16; REPEAT 6726..6830;  /note=Spectrin 17		PS00019;PS00020;PS50021;PS00018;PS50222;PS51460;PS50002;	NA	GO:0001707~mesoderm formation,GO:0006620~posttranslational protein targeting to membrane,GO:0006928~movement of cell or subcellular component,GO:0007163~establishment or maintenance of cell polarity,GO:0008104~protein localization,GO:0010632~regulation of epithelial cell migration,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0032886~regulation of microtubule-based process,GO:0042060~wound healing,GO:0043001~Golgi to plasma membrane protein transport,GO:0045773~positive regulation of axon extension,GO:0051893~regulation of focal adhesion assembly,	GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0032587~ruffle membrane,GO:0042995~cell projection,	GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001101:Plectin repeat,IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR003108:Growth-arrest-specific protein 2 domain,IPR011992:EF-hand-like domain,IPR018159:Spectrin/alpha-actinin,IPR018247:EF-Hand 1, calcium-binding site,	PF00307:Calponin homology (CH) domain,PF00435:Spectrin repeat,PF00681:Plectin repeat,PF02187:Growth-Arrest-Specific Protein 2 Domain,PF13499:EF-hand domain pair,	SSF143575:GAS2 domain-like,SSF47473:EF-hand,SSF47576:Calponin-homology domain, CH-domain,SSF75399:Plakin repeat,	1.9879339514465	2.0690993779296e-05	FDR<0.01	4.6842186498611	87988.5	Unexpected	RBP	Others	Others	Others	Others	1396	Splicing
Q60631	Q60631;Q60631-2	Grb2	8.2001	11.777	722225	2.81206940187284	6.25312656328164	NA	NA	25.7592540120038	NA	71215	3	Grb2	0	Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2)		FUNCTION: Adapter protein that provides a critical link between cell surface growth factor receptors and the Ras signaling pathway. {ECO:0000250|UniProtKB:P62993}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. {ECO:0000250|UniProtKB:P62993}.		actin cytoskeleton reorganization [GO:0031532]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770]	cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]	enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P62993}. Cytoplasm {ECO:0000250|UniProtKB:P62993}. Endosome {ECO:0000250|UniProtKB:P62993}. Golgi apparatus {ECO:0000269|PubMed:11571277}.	14784;	cd11949;cd11946;	IPR035643;IPR035641;IPR000980;IPR036860;IPR036028;IPR001452;	PF00017;PF00018;	SM00252;SM00326;	25238			NA							5 out of 5	Alternative sequence (1); Beta strand (6); Chain (1); Domain (3); Helix (1); Modified residue (5)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Endosome;Golgi apparatus;Nucleus;Phosphoprotein;Reference proteome;Repeat;SH2 domain;SH3 domain	DOMAIN 1..58;  /note=SH3 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00192; DOMAIN 60..152;  /note=SH2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00191; DOMAIN 156..215;  /note=SH3 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00192	DOMAIN: The SH3 domains mediate interaction with RALGPS1 and SHB. {ECO:0000250}.				PS50001;PS50002;	14784	GO:0007265~Ras protein signal transduction,GO:0007568~aging,GO:0008286~insulin receptor signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0030154~cell differentiation,GO:0030838~positive regulation of actin filament polymerization,GO:0031623~receptor internalization,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042770~signal transduction in response to DNA damage,GO:0043408~regulation of MAPK cascade,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0051291~protein heterooligomerization,GO:0060670~branching involved in labyrinthine layer morphogenesis,GO:0071479~cellular response to ionizing radiation,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0008180~COP9 signalosome,GO:0012506~vesicle membrane,GO:0016020~membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0070436~Grb2-EGFR complex,	GO:0001784~phosphotyrosine binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0043560~insulin receptor substrate binding,GO:0044822~poly(A) RNA binding,GO:0046875~ephrin receptor binding,GO:0051219~phosphoprotein binding,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,	PF00017:SH2 domain,PF00018:SH3 domain,PF07653:Variant SH3 domain,	SSF50044:SH3-domain,SSF55550:SH2 domain,	3.08335410157569	0.000124532110887113	FDR<0.01	3.90471865031139	396720	Present in Nucleus	RBP	Others	Others	Others	Others	1109	Splicing
Q9D024	Q9D024-2;Q9D024	Ccdc47	1.6295	NA	249105	4.25224305821321	NA	2.3835061375283	NA	2.58564964447317	NA	239137.666666667	3	Ccdc47	1	PAT complex subunit CCDC47 (Adipocyte-specific protein 4) (Calumin) (Coiled-coil domain-containing protein 47)		FUNCTION: Component of the PAT complex, an endoplasmic reticulum (ER)-resident membrane multiprotein complex that facilitates multi-pass membrane proteins insertion into membranes. The PAT complex acts as an intramembrane chaperone by directly interacting with nascent transmembrane domains (TMDs), releasing its substrates upon correct folding, and is needed for optimal biogenesis of multi-pass membrane proteins. WDR83OS/Asterix is the substrate-interacting subunit of the PAT complex, whereas CCDC47 is required to maintain the stability of WDR83OS/Asterix. The PAT complex favors the binding to TMDs with exposed hydrophilic amino acids within the lipid bilayer and provides a membrane-embedded partially hydrophilic environment in which the first transmembrane domain binds. Component of a ribosome-associated ER translocon complex involved in multi-pass membrane protein transport into the ER membrane and biogenesis. Involved in the regulation of calcium ion homeostasis in the ER. Required for proper protein degradation via the ERAD (ER-associated degradation) pathway (By similarity). Has an essential role in the maintenance of ER organization during embryogenesis (PubMed:25009997). {ECO:0000250|UniProtKB:Q96A33, ECO:0000269|PubMed:25009997}.		calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; protein insertion into ER membrane [GO:0045048]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]	calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q96A33}; Single-pass membrane protein {ECO:0000305}. Rough endoplasmic reticulum membrane {ECO:0000269|PubMed:25009997}.	67163;		IPR012879;	PF07946;		55844	COMPBIAS 63..106;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 424..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 46..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 424..483;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (2); Glycosylation (1); Region (2); Sequence conflict (3); Signal peptide (1); Transmembrane (1)		Alternative splicing;Chaperone;Coiled coil;Endoplasmic reticulum;Glycoprotein;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix							67163	GO:0001649~osteoblast differentiation,GO:0006983~ER overload response,GO:0007029~endoplasmic reticulum organization,GO:0009790~embryo development,GO:0009791~post-embryonic development,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0055074~calcium ion homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005791~rough endoplasmic reticulum,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0044822~poly(A) RNA binding,	IPR012879:Protein of unknown function DUF1682,	PF07946:Protein of unknown function (DUF1682),		1.35406638982903	0.00594460974466858	FDR<0.01	2.22587665093597	244121.333333333	Unexpected	RBP	Others	Others	Others	Others	1238	Splicing
Q9WV03	Q9WV03;Q9WTJ8	Fam50a	7.9424	6.1903	837015	NA	5.04999495000505	6.6657778962805	NA	5.09190895666785	6.55350940428599	331989	2	Fam50a	0	Protein FAM50A (Protein XAP-5)		FUNCTION: Probably involved in the regulation of pre-mRNA splicing. {ECO:0000250|UniProtKB:Q14320}.		chromatin organization [GO:0006325]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14320}.	108160;		IPR007005;	PF04921;		40252	COMPBIAS 14..31;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 150..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Initiator methionine (1); Modified residue (1); Motif (1); Region (2); Sequence conflict (1)		Acetylation;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation;mRNA processing;mRNA splicing			MOTIF 152..155;  /note=Nuclear localization signal;  /evidence=ECO:0000255				108160		GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0044822~poly(A) RNA binding,	IPR007005:XAP5 protein,	PF04921:XAP5, circadian clock regulator,		2.62551897376682	9.70103335029854e-07	FDR<0.01	6.01318200239047	584502	Present in Nucleus	RBP	Others	Others	Others	Others	986	Splicing
O88466	O88466;O88466-2;O88466-3	Znf106	5.2202	5.9962	381995	3.34918614776609	1.12972649321599	NA	NA	2.88076513121885	27.4438772709808	337000	2	Znf106	0	Zinc finger protein 106 (Zfp-106) (H3a minor histocompatibility antigen) (Son of insulin receptor mutant) (Zinc finger protein 474)		FUNCTION: RNA-binding protein (PubMed:27418600, PubMed:28072389). Specifically binds to 5'-GGGGCC-3' sequence repeats in RNA (PubMed:28072389). Essential for maintenance of peripheral motor neuron and skeletal muscle function (PubMed:26604141, PubMed:27418600, PubMed:28072389). Required for normal expression and/or alternative splicing of a number of genes in spinal cord and skeletal muscle, including the neurite outgrowth inhibitor RTN4 (PubMed:26604141, PubMed:27418600). Also contributes to normal mitochondrial respiratory function in motor neurons, via an unknown mechanism (PubMed:26604141). {ECO:0000269|PubMed:26604141, ECO:0000269|PubMed:27418600, ECO:0000269|PubMed:28072389}.		insulin receptor signaling pathway [GO:0008286]	cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]	metal ion binding [GO:0046872]; opioid peptide activity [GO:0001515]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:15833274, ECO:0000269|PubMed:27418600, ECO:0000269|PubMed:28072389, ECO:0000269|PubMed:9507006}. Nucleus speckle {ECO:0000269|PubMed:27418600, ECO:0000269|PubMed:28072389}. Note=Colocalizes with RBM39 in nuclear speckles. Inhibition of RNA synthesis, or overexpression of KNOP1, induces translocation from nuclear speckles to the nucleolus. {ECO:0000269|PubMed:27418600}.			IPR018391;IPR015943;IPR001680;IPR017986;IPR036322;IPR042622;IPR013087;	PF00400;	SM00564;SM00320;SM00355;	208964	COMPBIAS 76..90;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 91..108;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 120..164;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 165..179;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 287..314;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 338..355;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 502..525;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 538..552;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 553..576;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 578..592;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 593..615;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 898..920;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 983..1024;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1281..1298;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1308..1355;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1404..1418;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1446..1460;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1469..1487;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 68..187;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 287..326;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 338..362;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 410..437;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 453..525;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 537..617;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 635..661;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 696..728;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 894..920;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 968..1064;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1281..1461;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1468..1487;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1509..1531;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (18); Cross-link (34); Erroneous initiation (1); Frameshift (1); Modified residue (19); Natural variant (19); Region (13); Repeat (6); Sequence conflict (3); Zinc finger (3)	MISCELLANEOUS: [Isoform 2]: May be due to an intron retention. {ECO:0000305}.; MISCELLANEOUS: [Isoform 3]: May be due to an intron retention. {ECO:0000305}.	Alternative splicing;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;WD repeat;Zinc;Zinc-finger				REPEAT 1534..1573;  /note=WD 1; REPEAT 1575..1618;  /note=WD 2; REPEAT 1659..1700;  /note=WD 3; REPEAT 1703..1742;  /note=WD 4; REPEAT 1743..1780;  /note=WD 5; REPEAT 1783..1820;  /note=WD 6	ZN_FING 5..29;  /note=C2H2-type 1; atypical; ZN_FING 43..67;  /note=C2H2-type 2; atypical; ZN_FING 1818..1843;  /note=C2H2-type 3; atypical	PS50082;PS50294;PS00028;	NA	GO:0008286~insulin receptor signaling pathway,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0001515~opioid peptide activity,GO:0017124~SH3 domain binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001680:WD40 repeat,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR018391:Pyrrolo-quinoline quinone beta-propeller repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.19880035743897	0.00196496447731004	FDR<0.01	2.70664529640697	359497.5	Present in Nucleus	RBP	DBD	DBD	ChD	Others	1128	Splicing
Q80YR4	Q80YR4-2;Q80YR4-3;Q80YR4	Znf598	2.2513	NA	72637.5	7.28066982162359	NA	NA	NA	NA	NA	220552	5	Znf598	1	E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598)		FUNCTION: E3 ubiquitin-protein ligase that plays a key role in the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation. Required for ribosomes to terminally stall during translation of poly(A) sequences by mediating monoubiquitination of 40S ribosomal protein RPS10/eS10, RPS20/uS10 and RPS3/uS3. Stalling precludes synthesis of a long poly-lysine tail and initiates the RQC pathway to degrade the potentially detrimental aberrant nascent polypeptide. Also acts as a component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation. {ECO:0000250|UniProtKB:Q86UK7}.		protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]		metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]		213753;	cd16615;	IPR041888;IPR044288;IPR013087;IPR001841;		SM00355;	99192	COMPBIAS 295..315;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 358..395;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 489..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 569..583;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 292..338;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 350..441;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 467..557;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 569..619;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 719..744;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (4); Erroneous initiation (1); Modified residue (3); Region (5); Sequence conflict (1); Zinc finger (2)		Alternative splicing;Metal-binding;Phosphoprotein;Reference proteome;Transferase;Translation regulation;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 27..67;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 185..208;  /note=C2H2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50089;PS00028;	213753			GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001841:Zinc finger, RING-type,IPR007087:Zinc finger, C2H2,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015880:Zinc finger, C2H2-like,			2.01741475116898	0.0228203016544337	FDR<0.1	1.64167861907687	146594.75	Unexpected	RBP	DBD	DBD	ChD	Others	1338	Splicing
Q5SWD9	Q5SWD9;Q5SWD9-2;Q5SWD9-3	Tsr1	9.0491	9.2337	12512750	14.3422637829155	8.8386070355312	1.08428117579451	6.28219625581103	19.082148649938	5.16288915276989	12078700	0	Tsr1	0	Pre-rRNA-processing protein TSR1 homolog		FUNCTION: Required during maturation of the 40S ribosomal subunit in the nucleolus. {ECO:0000250}.		endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]	nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; U3 snoRNA binding [GO:0034511]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	104662;		IPR012948;IPR039761;IPR007034;IPR030387;	PF08142;PF04950;	SM00785;SM01362;	92105	COMPBIAS 62..78;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 432..446;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..83;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 428..447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (3); Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (1); Frameshift (1); Region (2); Sequence conflict (6)		Alternative splicing;Nucleus;Reference proteome;Ribosome biogenesis	DOMAIN 81..242;  /note=Bms1-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01051					PS51714;	104662	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000479~endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030688~preribosome, small subunit precursor,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0034511~U3 snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR007034:Ribosome biogenesis protein BMS1/TSR1, C-terminal,IPR012948:AARP2CN,	PF04950:Protein of unknown function (DUF663),PF08142:AARP2CN (NUC121) domain,		2.84513016609107	1.61083873776018e-05	FDR<0.01	4.79294793494169	12295725	Present in Nucleus	RBP	Others	Others	Others	Others	191	Splicing
Q9CYI4	Q9CYI4;Q9CYI4-2	Luc7l	3.4626	3.5956	12002500	3.49919518510743	2.78497228952572	4.28302210039404	1.92178341500913	5.23999161601341	5.14853524172373	7416766.66666667	0	Luc7l	0	Putative RNA-binding protein Luc7-like 1		FUNCTION: May bind to RNA via its Arg/Ser-rich domain.		mRNA splice site selection [GO:0006376]; negative regulation of striated muscle tissue development [GO:0045843]	nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RS domain binding [GO:0050733]		66978;		IPR004882;	PF03194;		43934	COMPBIAS 232..261;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 262..321;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 322..371;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 232..371;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (3); Modified residue (2); Region (1); Sequence conflict (3)		Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome							66978	GO:0006376~mRNA splice site selection,GO:0045843~negative regulation of striated muscle tissue development,	GO:0005634~nucleus,GO:0005685~U1 snRNP,GO:0071004~U2-type prespliceosome,	GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0050733~RS domain binding,	IPR004882:LUC7-related,	PF03194:LUC7 N_terminus,		1.83969697583313	3.15406510186001e-06	FDR<0.01	5.50112934680712	9709633.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	227	Splicing
Q91VE6	Q91VE6;Q91VE6-2	Nifk	24.298	28.574	12224900	8.48104486472733	26.077659269304	22.5321646650594	7.92455820588002	12.463854821019	15.7054906395276	6959778.33333333	0	Nifk	0	MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar protein interacting with the FHA domain of pKI-67) (mNIFK)				maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome {ECO:0000250}. Note=Localizes to mitotic chromosomes in conjunction with MKI67. {ECO:0000250}.	67949;		IPR021043;IPR012677;IPR035979;IPR000504;	PF12196;PF00076;	SM00360;	36265	COMPBIAS 217..238;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 271..288;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 203..317;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Cross-link (5); Domain (1); Initiator methionine (1); Modified residue (11); Region (1); Sequence conflict (1)		Acetylation;Alternative splicing;Chromosome;Citrullination;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 47..125;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	67949	GO:0010923~negative regulation of phosphatase activity,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021043:MKI67 FHA domain-interacting nucleolar phosphoprotein, FHA Ki67 binding,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF12196:FHA Ki67 binding domain of hNIFK,	SSF54928:RNA-binding domain, RBD,	4.04018766463652	1.00582735111262e-08	FDR<0.01	7.99747655893603	9592339.16666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	230	Splicing
Q9D7Z3	Q9D7Z3;Q9D7Z3-2	Nol7	6.4519	7.5567	7607550	4.14748455062005	9.34142923867352	1.51343170639425	1.19507152503077	6.80179567405795	1.66430889573105	5553926.66666667	0	Nol7	0	Nucleolar protein 7					chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	70078;		IPR039626;IPR012579;	PF08157;		28970	COMPBIAS 47..61;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 68..90;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..254;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Cross-link (2); Frameshift (1); Modified residue (1); Region (2)	MISCELLANEOUS: [Isoform 2]: May be due to intron retention. {ECO:0000305}.	Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							70078		GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0044822~poly(A) RNA binding,	IPR012579:NUC129,	PF08157:NUC129 domain,		1.90488997063843	0.000356588284227773	FDR<0.01	3.4478329297496	6580738.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	298	Splicing
Q9D6T0	Q9D6T0;Q9D6T0-2	Nosip	6.2561	3.9285	4746195	6.97155605131065	21.045542554087	5.64174894217207	NA	13.0186296590421	8.65126741067566	329166.583333333	1	Nosip	0	Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP)		FUNCTION: E3 ubiquitin-protein ligase that is essential for proper development of the forebrain, the eye and the face. Catalyzes monoubiquitination of serine/threonine-protein phosphatase 2A (PP2A) catalytic subunit PPP2CA/PPP2CB (PubMed:25546391). Negatively regulates nitric oxide production by inducing NOS1 and NOS3 translocation to actin cytoskeleton and inhibiting their enzymatic activity (By similarity). {ECO:0000250|UniProtKB:Q9Y314, ECO:0000269|PubMed:25546391}.	PATHWAY: Protein modification; protein ubiquitination.	multicellular organism development [GO:0007275]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ubiquitin protein ligase activity [GO:0061630]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y314}. Nucleus {ECO:0000250|UniProtKB:Q9Y314}. Note=Translocates from nucleus to cytoplasm in the G2 phase of the cell cycle. {ECO:0000250|UniProtKB:Q9Y314}.	66394;		IPR016818;IPR031790;IPR013083;	PF15906;		33209		REGION 55..75;  /note=U-box-like; REGION 131..154;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Alternative sequence (1); Chain (1); Modified residue (1); Motif (1); Region (2)		Alternative splicing;Cytoplasm;Developmental protein;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway		DOMAIN: The U-box-like region is a truncated U-box domain. It is unknown whether it is functional or not.	MOTIF 78..101;  /note=Nuclear localization signal;  /evidence=ECO:0000250				66394	GO:0007275~multicellular organism development,GO:0016567~protein ubiquitination,GO:0043086~negative regulation of catalytic activity,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051001~negative regulation of nitric-oxide synthase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,GO:0061630~ubiquitin protein ligase activity,	IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016818:Nitric oxide synthase-interacting,			3.01824647098948	1.57623143779725e-06	FDR<0.01	5.8023800147787	2537680.79166667	Present in Nucleus	RBP	DBD	DBD	ChD	Others	550	Splicing
P27546	P27546-3;P27546-2;P27546;P27546-4	Map4	15.711	25.11	1937800	7.46268656716418	8.02568218298555	13.1722802534347	10.1427079001552	3.88048117966628	3.13293022964379	3066360	0	Map4	0	Microtubule-associated protein 4 (MAP-4)		FUNCTION: Non-neuronal microtubule-associated protein. Promotes microtubule assembly.		cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175]	axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.	17758;		IPR027323;IPR001084;	PF00418;		117429	COMPBIAS 49..63;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 247..263;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 567..581;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 582..596;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 623..638;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 677..711;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 777..808;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 827..854;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 862..917;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 923..937;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1095..1125;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 49..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 245..265;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 315..361;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 455..478;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 508..529;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 563..964;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1047..1125;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (9); Chain (1); Compositional bias (11); Cross-link (1); Erroneous initiation (2); Initiator methionine (1); Modified residue (37); Region (7); Repeat (4); Sequence conflict (13)		Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Isopeptide bond;Microtubule;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation				REPEAT 896..926;  /note=Tau/MAP 1; REPEAT 965..995;  /note=Tau/MAP 2; REPEAT 996..1026;  /note=Tau/MAP 3; REPEAT 1027..1058;  /note=Tau/MAP 4		PS00229;PS51491;	17758	GO:0007052~mitotic spindle organization,GO:0031175~neuron projection development,GO:0051012~microtubule sliding,GO:0051294~establishment of spindle orientation,GO:0051301~cell division,GO:1902856~negative regulation of nonmotile primary cilium assembly,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005886~plasma membrane,GO:0005930~axoneme,GO:0014069~postsynaptic density,GO:0015630~microtubule cytoskeleton,GO:0043005~neuron projection,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0015631~tubulin binding,GO:0044822~poly(A) RNA binding,	IPR001084:Tau and MAP proteins tubulin-binding repeat,IPR027323:Microtubule-associated protein 4,IPR027324:Microtubule associated protein MAP2/MAP4/Tau,	PF00418:Tau and MAP protein, tubulin-binding repeat,		3.14922059063608	1.13622837464366e-06	FDR<0.01	5.94453436943537	2502080	Unexpected	RBP	Others	Others	Others	Others	554	Splicing
Q571H0	Q571H0;Q571H0-2	Urb1	14.267	10.729	2451850	4.68033323972667	6.96767001114827	6.21388181196794	1.39993280322545	5.4935999560512	7.2928821470245	2537805	0	Urb1	0	Nucleolar pre-ribosomal-associated protein 1 (URB1 ribosome biogenesis 1 homolog)				maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	207932;		IPR016024;IPR032436;IPR021714;IPR039844;	PF16201;PF11707;		254614		REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2020..2042;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Alternative sequence (2); Chain (1); Modified residue (2); Region (2); Sequence conflict (1)		Alternative splicing;Nucleus;Phosphoprotein;Reference proteome							207932		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,	IPR016024:Armadillo-type fold,IPR021714:Nucleolar pre-ribosomal-associated protein 1, N-terminal,	PF11707:Ribosome 60S biogenesis N-terminal,	SSF48371:ARM repeat,	2.59130433501463	7.09668150420029e-06	FDR<0.01	5.14894468527022	2494827.5	Present in Nucleus	RBP	Others	Others	Others	Others	555	Splicing
Q6ZPZ3	Q6ZPZ3-2;Q6ZPZ3	Zc3h4	1.38	1.7853	1514900	3.25807187306552	2.77708350690105	4.45871232388086	2.00948476810546	1.94533605680381	2.14445016297821	3097600	0	Zc3h4	0	Zinc finger CCCH domain-containing protein 4					cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]		330474;		IPR041367;IPR000571;IPR036855;	PF00642;PF18044;	SM00356;	140967	COMPBIAS 1..36;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 40..54;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 55..73;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 74..100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 101..128;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 143..159;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 163..178;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 198..216;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 217..239;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 278..302;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 303..324;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 325..342;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 370..387;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 485..501;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 504..560;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 605..626;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 630..658;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 663..691;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 740..757;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 784..811;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 817..849;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 910..924;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 929..943;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1032..1047;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1133..1149;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1161..1175;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1200..1220;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 485..567;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 601..691;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 719..970;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 994..1304;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (27); Modified residue (16); Region (5); Zinc finger (3)		Alternative splicing;Coiled coil;Metal-binding;Methylation;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger					ZN_FING 389..416;  /note=C3H1-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 418..445;  /note=C3H1-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723; ZN_FING 446..469;  /note=C3H1-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS50103;	330474			GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,	PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),	SSF90229:CCCH zinc finger,	1.21281296657186	0.000215069412032339	FDR<0.01	3.66742135218895	2306250	Present in Nucleus	RBP	DBD	DBD	Others	Others	577	Splicing
Q810A7	Q810A7;Q810A7-2	Ddx42	4.6929	6.1942	1902800	7.15409929889827	9.60153624579933	5.56575944787666	2.32174781175269	7.49400479616307	4.20168067226891	1898814.16666667	0	Ddx42	0	ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42)		FUNCTION: ATP-dependent RNA helicase. Binds to partially double-stranded RNAs (dsRNAs) in order to unwind RNA secondary structures. Unwinding is promoted in the presence of single-strand binding proteins. Mediates also RNA duplex formation thereby displacing the single-strand RNA binding protein. ATP and ADP modulate its activity: ATP binding and hydrolysis by DDX42 triggers RNA strand separation, whereas the ADP-bound form of the protein triggers annealing of complementary RNA strands. Involved in the survival of cells by interacting with TP53BP2 and thereby counteracting the apoptosis-stimulating activity of TP53BP2. Relocalizes TP53BP2 to the cytoplasm (By similarity). {ECO:0000250}.		protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]	Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus speckle {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}.	72047;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	101965	COMPBIAS 36..52;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 89..104;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 723..800;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 803..929;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 25..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 182..203;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 662..682;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 723..929;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 739..828;  /note=Necessary for interaction with TP53BP2;  /evidence=ECO:0000250	NA				3.6.4.13			5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (1); Domain (2); Erroneous initiation (1); Modified residue (8); Motif (2); Nucleotide binding (1); Region (5); Sequence conflict (3)		ATP-binding;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Direct protein sequencing;Helicase;Hydrolase;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 284..459;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 487..632;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 253..281;  /note=Q motif; MOTIF 407..410;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	72047	GO:0008104~protein localization,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.45399079216942	6.704978854529e-07	FDR<0.01	6.17360258744338	1900807.08333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	636	Splicing
Q80X50	Q80X50-4;Q80X50-2;Q80X50-3;Q80X50;Q80X50-5	Ubap2l	3.4755	3.6786	1495050	8.26173165895572	7.30513551026371	15.0929727119053	6.2570391690652	6.10687022900763	3.02462041013853	1658381.66666667	0	Ubap2l	0	Ubiquitin-associated protein 2-like		FUNCTION: Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs) (PubMed:25185265). {ECO:0000269|PubMed:25185265}.		binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]			74383;		IPR015940;IPR009060;IPR022166;	PF12478;	SM00165;	116799	COMPBIAS 114..155;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 210..228;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 464..478;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 479..513;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 689..806;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 894..921;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..33;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..229;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 461..513;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 550..676;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 689..814;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 885..921;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1060..1107;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (6); Beta strand (3); Chain (1); Compositional bias (6); Domain (1); Frameshift (1); Helix (4); Modified residue (18); Natural variant (1); Region (7); Sequence conflict (2)		3D-structure;Acetylation;Alternative splicing;Methylation;Phosphoprotein;Reference proteome	DOMAIN 49..89;  /note=UBA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00212					PS50030;	74383	GO:0007339~binding of sperm to zona pellucida,GO:0061484~hematopoietic stem cell homeostasis,	GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0031519~PcG protein complex,	GO:0044822~poly(A) RNA binding,	IPR009060:UBA-like,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR022166:Protein of unknown function DUF3697, ubiquitin-associated protein 2,	PF12478:Ubiquitin-associated protein 2 ,	SSF46934:UBA-like,	2.54502563674282	1.51521619705513e-06	FDR<0.01	5.81952539588167	1576715.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	687	Splicing
Q8BTU1	Q8BTU1-2;Q8BTU1	Cfap20	NA	6.1743	1242650	NA	3.63200523008753	2.00766929671345	NA	3.07540902940091	NA	1158198.33333333	3	Cfap20	1	Cilia- and flagella-associated protein 20 (Gene trap locus 3 protein)		FUNCTION: Cilium- and flagellum-specific protein that plays a role in axonemal structure organization and motility. Involved in the regulation of the size and morphology of cilia. Required for axonemal microtubules polyglutamylation (By similarity). {ECO:0000250}.		cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]	centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000250}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250}. Cell projection, cilium {ECO:0000250}.	14894;		IPR040441;IPR007714;	PF05018;		22748			NA							4 out of 5	Alternative sequence (1); Chain (1); Sequence conflict (1)		Alternative splicing;Cell projection;Cilium;Cytoplasm;Cytoskeleton;Microtubule;Nucleus;Reference proteome							14894	GO:0018095~protein polyglutamylation,GO:0060271~cilium morphogenesis,GO:0060296~regulation of cilium beat frequency involved in ciliary motility,GO:2000147~positive regulation of cell motility,GO:2000253~positive regulation of feeding behavior,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0036064~ciliary basal body,GO:0042995~cell projection,GO:0070062~extracellular exosome,	GO:0044822~poly(A) RNA binding,	IPR007714:Protein of unknown function DUF667,	PF05018:Protein of unknown function (DUF667),		1.77833545323646	0.00186280387524438	FDR<0.01	2.72983286726309	1200424.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	772	Splicing
Q3TLH4	Q3TLH4-5;Q3TLH4	Prrc2c	1.2786	4.2544	1007990	3.55770599117689	4.25133917183913	6.21388181196794	2.84916519459798	3.81621126545566	3.01905020680494	1214703.33333333	0	Prrc2c	0	Protein PRRC2C (BAT2 domain-containing protein 1) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C)		FUNCTION: Required for efficient formation of stress granules. {ECO:0000250|UniProtKB:Q9Y520}.		cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]	protein C-terminus binding [GO:0008022]	SUBCELLULAR LOCATION: Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9Y520}.	226562;		IPR009738;IPR033184;	PF07001;		310892	COMPBIAS 87..101;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 124..149;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 187..212;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 298..315;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 358..372;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 402..439;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 442..582;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 592..621;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 644..679;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 680..696;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 803..821;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 829..862;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 863..920;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 929..1032;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1033..1060;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1061..1075;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1106..1168;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1183..1329;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1355..1421;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1423..1441;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1449..1471;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1473..1492;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1518..1538;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1570..1589;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1595..1618;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1657..1680;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1687..1720;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1769..1803;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1872..1893;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1894..1908;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1909..1938;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1974..1996;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2029..2043;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2056..2088;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2216..2249;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2629..2655;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2778..2805;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 46..212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 264..705;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 777..1619;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1642..1742;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1762..1803;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1866..1938;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1960..1996;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2025..2108;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2209..2249;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2269..2293;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2617..2655;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2778..2846;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (37); Cross-link (1); Frameshift (2); Modified residue (40); Region (12); Sequence caution (6); Sequence conflict (14)		Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation							226562	GO:0002244~hematopoietic progenitor cell differentiation,	GO:0016020~membrane,	GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR009738:BAT2, N-terminal,	PF07001:BAT2 N-terminus,		1.75433189971027	2.22387541174563e-05	FDR<0.01	4.65288954690428	1111346.66666667	Unexpected	RBP	Others	Others	Others	Others	793	Splicing
Q5F2E7	Q5F2E7;Q5F2E7-2	Nufip2	31.339	4.5701	1163845	11.2292679640214	11.9514293909552	NA	NA	NA	NA	715219.833333333	4	Nufip2	0	Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (FMRP-interacting protein 2)		FUNCTION: Binds RNA. {ECO:0000250|UniProtKB:Q7Z417}.			cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12837692}. Cytoplasm {ECO:0000269|PubMed:12837692}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q7Z417}. Note=Localized in both nucleus and cytoplasm in most neurons. In the cortex, distributed in a diffuse way in the nucleus and in the cytoplasm. Localized in the cytoplasm in neurons of the dentate gyrus in the olfactive bulb, in the ependymal epithelium and in the granular layer of the cerebellum. In Purkinje cells, distributed in both cell compartments and in nuclear dots adjacent to the nucleolus (PubMed:12837692). {ECO:0000250|UniProtKB:Q7Z417, ECO:0000269|PubMed:12837692}.	68564;		IPR032747;	PF15293;		75657	COMPBIAS 11..56;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 70..92;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 205..220;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 307..327;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..100;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 205..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..337;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 369..401;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Cross-link (10); Erroneous initiation (1); Modified residue (21); Region (4); Sequence conflict (2)		Alternative splicing;Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							68564		GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,		PF15293:Nuclear fragile X mental retardation-interacting protein 2,		3.55760405504931	0.000139048917753798	FDR<0.01	3.85683238698956	939532.416666667	Present in Nucleus	RBP	Others	Others	Others	Others	846	Splicing
Q7TPM1	Q7TPM1;Q7TPM1-2	Prrc2b	3.5898	3.6094	768610	4.01171420548	3.43229792345976	4.46887429056621	2.47739378174161	3.80184769798122	4.71275743437485	763763.333333333	0	Prrc2b	0	Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B)				cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]				227723;		IPR009738;IPR033184;	PF07001;		160913	COMPBIAS 1..17;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 87..142;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 219..233;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 241..255;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 287..303;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..422;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 477..519;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 587..658;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 822..847;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 950..1011;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1025..1072;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1181..1205;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1459..1476;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 39..306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 320..341;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 385..519;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 531..658;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 792..847;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 893..918;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 950..1080;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1177..1205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1410..1443;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1455..1486;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Coiled coil (2); Compositional bias (13); Cross-link (2); Modified residue (15); Region (11); Sequence conflict (1)		Alternative splicing;Coiled coil;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation							227723	GO:0030154~cell differentiation,		GO:0044822~poly(A) RNA binding,	IPR009738:BAT2, N-terminal,	PF07001:BAT2 N-terminus,		1.88888286889132	5.60386423899614e-07	FDR<0.01	6.25151239461557	766186.666666667	Unexpected	RBP	Others	Others	Others	Others	909	Splicing
Q99J72	Q99J72-4;Q99J72;Q99J72-3;Q99J72-2	Apobec3	8.4138	5.3901	973800	NA	5.5297500552975	NA	NA	4.52529640691465	NA	345835.766666667	4	Apobec3	0	DNA dC->dU-editing enzyme APOBEC-3 (EC 3.5.4.38) (Apolipoprotein B mRNA-editing complex 3) (Arp3) (CEM-15) (CEM15)		FUNCTION: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity against HIV-1, simian immunodeficiency viruses (SIVs), mouse mammary tumor virus (MMTV) and friend murine leukemia virus (FrMLV) and may inhibit the mobility of LTR retrotransposons. {ECO:0000269|PubMed:16378963, ECO:0000269|PubMed:16527742, ECO:0000269|PubMed:17259974, ECO:0000269|PubMed:18786991}.		cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; hematopoietic progenitor cell differentiation [GO:0002244]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071]; regulation of defense response to virus [GO:0050688]; regulation of viral life cycle [GO:1903900]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]	cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16527742}.	80287;		IPR016192;IPR002125;IPR016193;			52213			NA	ACT_SITE 84;  /note=Proton donor;  /evidence=ECO:0000250			3.5.4.38	METAL 82;  /note=Zinc;  /evidence=ECO:0000250; METAL 116;  /note=Zinc;  /evidence=ECO:0000250; METAL 119;  /note=Zinc;  /evidence=ECO:0000250; METAL 299;  /note=Zinc;  /evidence=ECO:0000250; METAL 327;  /note=Zinc;  /evidence=ECO:0000250; METAL 330;  /note=Zinc;  /evidence=ECO:0000250		5 out of 5	Active site (1); Alternative sequence (3); Chain (1); Domain (2); Erroneous initiation (3); Metal binding (6); Mutagenesis (4); Natural variant (36); Sequence conflict (7)	MISCELLANEOUS: Probable human APOBEC3G ortholog.; MISCELLANEOUS: [Isoform 4]: Lacks exon V. Found in cell line MDTF. {ECO:0000305}.	Alternative splicing;Antiviral defense;Cytoplasm;Hydrolase;Immunity;Innate immunity;Metal-binding;Reference proteome;Repeat;Zinc	DOMAIN 49..165;  /note=CMP/dCMP-type deaminase 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01083; DOMAIN 249..368;  /note=CMP/dCMP-type deaminase 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01083	DOMAIN: The CMP/dCMP deaminase domain 1 confers deoxycytidine deaminase activity, whereas the CMP/dCMP deaminase domain 2 mediates RNA-dependent oligomerization and virion incorporation. {ECO:0000269|PubMed:17020885}.				PS00903;PS51747;	80287	GO:0002244~hematopoietic progenitor cell differentiation,GO:0002376~immune system process,GO:0010529~negative regulation of transposition,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0050688~regulation of defense response to virus,GO:0051607~defense response to virus,GO:1903900~regulation of viral life cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0016814~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0047844~deoxycytidine deaminase activity,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR013158:APOBEC-like, N-terminal,IPR016192:APOBEC/CMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,	PF08210:APOBEC-like N-terminal domain,	SSF53927:Cytidine deaminase-like,	2.53707403194419	9.50879544121107e-05	FDR<0.01	4.02187449529903	659817.883333333	Present in Nucleus	RBP	Others	Others	Others	Others	952	Splicing
Q9Z2Q2	Q9Z2Q2;Q9Z2Q2-3;Q9Z2Q2-2	Knop1	6.6944	4.3163	713690	4.89931899465974	6.74127005527841	2.13743721278187	2.15243548074646	2.98151460942159	3.94897918887967	489075	0	Knop1	0	Lysine-rich nucleolar protein 1 (Testis-specific gene 118 protein)					nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:10430019, ECO:0000269|PubMed:15833274}.	66356;		IPR028124;	PF15477;		53846	COMPBIAS 32..67;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..231;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 258..314;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 310..478;  /note=Interaction with ZNF106;  /evidence=ECO:0000269|PubMed:15833274; REGION 340..378;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (13); Erroneous initiation (1); Modified residue (6); Region (4); Sequence conflict (4)		Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							66356		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,		PF15477:Small acidic protein family,		1.95721609413749	7.49317911145616e-06	FDR<0.01	5.12533388622115	601382.5	Present in Nucleus	RBP	Others	Others	Others	Others	976	Splicing
Q3TFK5	Q3TFK5-2;Q3TFK5	Gpatch4	12.424	5.0512	820940	27.3224043715847	3.81912618392912	3.832445483463	NA	5.70743679013755	6.61419406045373	330947.333333333	1	Gpatch4	0	G patch domain-containing protein 4				hematopoietic progenitor cell differentiation [GO:0002244]		nucleic acid binding [GO:0003676]		66614;		IPR000467;	PF01585;	SM00443;	46554	COMPBIAS 117..131;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 201..237;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 250..268;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 290..309;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 317..354;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 362..376;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 116..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 191..415;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Cross-link (1); Domain (1); Frameshift (1); Modified residue (5); Region (2); Sequence conflict (3)		Acetylation;Alternative splicing;Isopeptide bond;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 11..57;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092					PS50174;	66614	GO:0002244~hematopoietic progenitor cell differentiation,		GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,	PF01585:G-patch domain,		2.83623039219323	1.19487150262154e-05	FDR<0.01	4.92267879655935	575943.666666667	Unexpected	RBP	Others	Others	Others	Others	991	Splicing
P97770	P97770;P97770-3;P97770-2	Thumpd3	4.4376	3.26	629495	4.88209734902114	4.98554192840762	NA	NA	4.23065532851039	NA	373775.666666667	3	Thumpd3	0	THUMP domain-containing protein 3 (GtROSA26asSor)				tRNA methylation [GO:0030488]	cytosol [GO:0005829]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]		14911;		IPR000241;IPR029063;IPR004114;	PF02926;PF01170;	SM00981;	56431	COMPBIAS 153..182;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 145..182;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Domain (1); Region (1); Sequence conflict (5)		Alternative splicing;Methyltransferase;RNA-binding;Reference proteome;Transferase	DOMAIN 171..287;  /note=THUMP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00529					PS51165;PS01261;	14911	GO:0030488~tRNA methylation,GO:0032259~methylation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016423~tRNA (guanine) methyltransferase activity,GO:0016740~transferase activity,	IPR000241:Putative RNA methylase domain,IPR004114:THUMP,	PF01170:Putative RNA methylase family UPF0020,PF02926:THUMP domain,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.10815682919847	3.71253775132921e-05	FDR<0.01	4.43032912148332	501635.333333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	1039	Splicing
O08715	O08715-2;O08715-5;O08715-3;O08715-6;O08715;O08715-4	Akap1	3.0469	5.2168	756310	4.87448208627833	8.94294401717045	NA	NA	NA	NA	221105	4	Akap1	0	A-kinase anchor protein 1, mitochondrial (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein) (S-AKAP)		FUNCTION: Differentially targeted protein that binds to type I and II regulatory subunits of protein kinase A (PubMed:9065479, PubMed:9182549). Anchors them to the cytoplasmic face of the mitochondrial outer membrane or allows them to reside in the endoplasmic reticulum (PubMed:9065479, PubMed:9182549). Involved in mitochondrial-mediated antiviral innate immunity (By similarity). Promotes translocation of NDUFS1 into mitochondria to regulate mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) activity (PubMed:32072193). Under diabetic conditions, myocardial AKAP1 expression decreases which blocks the translocation of NDUFS1 from the cytosol to mitochondria (PubMed:32072193). Reduction of NDUFS1 in mitochondria decreases ATP production and increases mitochondrial ROS level, which causes mitochondrial dysfunction and cell apoptosis, respectively, thereby leading to cardiac dysfunction (PubMed:32072193). {ECO:0000250|UniProtKB:Q92667, ECO:0000269|PubMed:32072193, ECO:0000269|PubMed:9065479, ECO:0000269|PubMed:9182549}.		antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein import into nucleus [GO:0042308]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial crista [GO:0030061]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]	beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; molecular adaptor activity [GO:0060090]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:24101730, ECO:0000269|PubMed:9182549}. Mitochondrion {ECO:0000269|PubMed:32072193}.; SUBCELLULAR LOCATION: [Isoform 2]: Endoplasmic reticulum {ECO:0000269|PubMed:10352013}. Note=Does not contain the classic KDEL endoplasmic reticulum-targeting sequence. This explains how it is able to switch its localization, either being in the endoplasmic reticulum or in the mitochondria depending on which N-terminal part begins the isoform. The longest N-terminal part only present in isoform 2 acts as a suppressor of mitochondrial targeting and as an activator of recessive endoplasmic reticulum targeting motif. {ECO:0000269|PubMed:10352013}.; SUBCELLULAR LOCATION: [Isoform 4]: Endoplasmic reticulum {ECO:0000269|PubMed:10352013}. Note=Does not contain the classic KDEL endoplasmic reticulum-targeting sequence. This explains how it is able to switch its localization, either being in the endoplasmic reticulum or in the mitochondria depending on which N-terminal part begins the isoform. The longest N-terminal part only present in isoform 4 acts as a suppressor of mitochondrial targeting and as an activator of recessive endoplasmic reticulum targeting motif. {ECO:0000269|PubMed:10352013}.; SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion outer membrane {ECO:0000269|PubMed:10352013}. Note=Does not contain the classic KDEL endoplasmic reticulum-targeting sequence. This explains how it is able to switch its localization, either being in the endoplasmic reticulum or in the mitochondria depending on which N-terminal part begins the isoform. {ECO:0000269|PubMed:10352013}.; SUBCELLULAR LOCATION: [Isoform 3]: Mitochondrion outer membrane {ECO:0000269|PubMed:10352013}. Note=Does not contain the classic KDEL endoplasmic reticulum-targeting sequence. This explains how it is able to switch its localization, either being in the endoplasmic reticulum or in the mitochondria depending on which N-terminal part begins the isoform. {ECO:0000269|PubMed:10352013}.; SUBCELLULAR LOCATION: [Isoform 5]: Mitochondrion outer membrane {ECO:0000269|PubMed:10352013}. Note=Does not contain the classic KDEL endoplasmic reticulum-targeting sequence. This explains how it is able to switch its localization, either being in the endoplasmic reticulum or in the mitochondria depending on which N-terminal part begins the isoform. {ECO:0000269|PubMed:10352013}.; SUBCELLULAR LOCATION: [Isoform 6]: Mitochondrion outer membrane {ECO:0000269|PubMed:10352013}. Note=Does not contain the classic KDEL endoplasmic reticulum-targeting sequence. This explains how it is able to switch its localization, either being in the endoplasmic reticulum or in the mitochondria depending on which N-terminal part begins the isoform. {ECO:0000269|PubMed:10352013}.	11640;	cd04508;	IPR004087;IPR004088;IPR036612;IPR035437;IPR002999;	PF00013;PF00567;	SM00322;SM00333;	92195	COMPBIAS 289..303;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 353..378;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 523..554;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 65..121;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 165..198;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 260..303;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 306..319;  /note=PKA-RII subunit binding domain; REGION 336..437;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 466..497;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 512..554;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (7); Chain (1); Compositional bias (3); Domain (2); Modified residue (8); Region (7); Sequence conflict (15); Transit peptide (1)		Alternative splicing;Endoplasmic reticulum;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;RNA-binding;Reference proteome;Transit peptide;Transmembrane	DOMAIN 561..625;  /note=KH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 712..771;  /note=Tudor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00211	DOMAIN: RII-alpha binding site, predicted to form an amphipathic helix, could participate in protein-protein interactions with a complementary surface on the R-subunit dimer.				PS50084;PS50304;	11640	GO:0010614~negative regulation of cardiac muscle hypertrophy,GO:0010738~regulation of protein kinase A signaling,GO:0035308~negative regulation of protein dephosphorylation,GO:0051534~negative regulation of NFAT protein import into nucleus,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005811~lipid particle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030061~mitochondrial crista,GO:0031594~neuromuscular junction,GO:0045211~postsynaptic membrane,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0030346~protein phosphatase 2B binding,GO:0032947~protein complex scaffold,GO:0034237~protein kinase A regulatory subunit binding,GO:0044822~poly(A) RNA binding,GO:0048487~beta-tubulin binding,	IPR002999:Tudor domain,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,PF00567:Tudor domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.3591265153777	0.000320985703181099	FDR<0.01	3.4935143107971	488707.5	Unexpected	RBP	ChD	Others	ChD	RBD	1050	Splicing
Q91WM1	Q91WM1;Q91WM1-2	Strbp	5.7714	4.0437	650050	NA	3.82073128796852	NA	NA	4.1317192083626	NA	95645.8333333333	4	Strbp	0	Spermatid perinuclear RNA-binding protein		FUNCTION: Involved in spermatogenesis and sperm function. Plays a role in regulation of cell growth (By similarity). Binds to double-stranded DNA and RNA (By similarity). Binds most efficiently to poly(I:C) RNA than to poly(dI:dC) DNA (By similarity). Binds also to single-stranded poly(G) RNA (By similarity). Binds non-specifically to the mRNA PRM1 3'-UTR and adenovirus VA RNA. {ECO:0000250, ECO:0000269|PubMed:11336498, ECO:0000269|PubMed:7744952}.		mechanosensory behavior [GO:0007638]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; single-stranded RNA binding [GO:0003727]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm, cytoskeleton. Note=Microtubule-associated that localizes to the manchette in developing spermatids.	20744;	cd19909;	IPR014720;IPR006561;IPR043519;IPR030446;IPR044472;	PF00035;PF07528;	SM00358;SM00572;	73705	COMPBIAS 476..509;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 349..371;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 467..514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Domain (3); Modified residue (2); Region (2)		Alternative splicing;Cytoplasm;Cytoskeleton;DNA-binding;Developmental protein;Differentiation;Methylation;RNA-binding;Reference proteome;Repeat;Spermatogenesis	DOMAIN 5..363;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040; DOMAIN 387..453;  /note=DRBM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 510..576;  /note=DRBM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266					PS50137;PS51703;	20744	GO:0006928~movement of cell or subcellular component,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007638~mechanosensory behavior,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0044822~poly(A) RNA binding,	IPR006561:DZF,IPR014720:Double-stranded RNA-binding-like domain,	PF00035:Double-stranded RNA binding motif,PF07528:DZF domain,		2.13129707516282	0.000221425770736506	FDR<0.01	3.65477183495984	372847.916666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1121	Splicing
Q8CCP0	Q8CCP0-4;Q8CCP0-3;Q8CCP0-2;Q8CCP0	Nemf	4.2704	NA	39513.5	6.78794461037198	6.44288383480446	5.13241634161363	2.82981493010357	6.3000063000063	2.99895036737142	571760.5	0	Nemf	1	Nuclear export mediator factor Nemf (Serologically defined colon cancer antigen 1 homolog)		FUNCTION: Component of the ribosome quality control complex (RQC), a ribosome-associated complex that mediates ubiquitination and extraction of incompletely synthesized nascent chains for proteasomal degradation. NEMF is responsible for selective recognition of stalled 60S subunits by recognizing an exposed, nascent chain-conjugated tRNA moiety. Nemf is important for the stable association of Ltn1 to the complex. May indirectly play a role in nuclear export. {ECO:0000250|UniProtKB:O60524}.		nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]	nucleus [GO:0005634]; RQC complex [GO:1990112]	ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	66244;		IPR021846;IPR008532;	PF11923;PF05670;		121188	COMPBIAS 731..754;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 795..840;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 867..884;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 892..916;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 943..963;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 420..451;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 694..718;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 731..973;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (6); Chain (1); Coiled coil (3); Compositional bias (5); Erroneous initiation (4); Frameshift (2); Modified residue (3); Region (3); Sequence caution (1); Sequence conflict (8)	MISCELLANEOUS: [Isoform 2]: Due to intron retention. {ECO:0000305}.	Alternative splicing;Coiled coil;Nucleus;Phosphoprotein;Reference proteome		DOMAIN: The N-terminal domain contains a nuclear export signal. The C-terminal domain may interact with cargo proteins (By similarity). {ECO:0000250}.					66244	GO:0051168~nuclear export,	GO:0005622~intracellular,GO:0005623~cell,GO:0005634~nucleus,		IPR008532:Domain of unknown function DUF814,IPR021846:Protein of unknown function DUF3441,	PF05670:Domain of unknown function (DUF814),PF11923:Domain of unknown function (DUF3441),		2.23502991627493	3.20361658710083e-06	FDR<0.01	5.49435946639252	305637	Present in Nucleus	RBP	Others	Others	Others	Others	1181	Splicing
Q9CXK9	Q9CXK9;Q9CXK9-2	Rbm33	1.3093	2.1373	112237.5	NA	4.15921474025704	NA	NA	11.7127563629549	1.64638864650389	106093.166666667	3	Rbm33	0	RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33)						nucleic acid binding [GO:0003676]		381626;		IPR012677;IPR035979;IPR039878;IPR000504;		SM00360;	137325	COMPBIAS 16..38;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 49..64;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 78..114;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 121..136;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 328..343;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 357..381;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 398..432;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 453..489;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 528..544;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 545..571;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 606..620;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 628..649;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 658..681;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 707..757;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 796..811;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 816..840;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 878..922;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..168;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 219..261;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 297..436;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 452..761;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 796..840;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 876..932;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 998..1080;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (17); Cross-link (1); Initiator methionine (1); Modified residue (11); Region (7); Sequence conflict (1)		Acetylation;Alternative splicing;Coiled coil;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation							381626		GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.56204199131188	0.0108025915841969	FDR<0.1	1.96647204305952	109165.333333333	Unexpected	RBP	RBD	Others	Others	RBD	1373	Splicing
B1AX39	B1AX39-3;B1AX39	Zcchc7	5.1404	6.5003	124336.5	NA	NA	NA	NA	9.8405825624877	NA	4539.16666666667	5	Zcchc7	0	Zinc finger CCHC domain-containing protein 7 (TRAMP-like complex RNA-binding factor ZCCHC7)					cytosol [GO:0005829]; nucleolus [GO:0005730]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	319885;		IPR001878;IPR036875;	PF00098;	SM00343;	63000	COMPBIAS 112..127;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 394..421;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 434..449;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 457..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 494..532;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 111..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 394..541;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Cross-link (12); Modified residue (1); Region (2); Sequence caution (5); Zinc finger (4)		Alternative splicing;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 236..253;  /note=CCHC-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00047; ZN_FING 258..275;  /note=CCHC-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00047; ZN_FING 299..316;  /note=CCHC-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00047; ZN_FING 343..360;  /note=CCHC-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00047	PS50158;	319885		GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001878:Zinc finger, CCHC-type,	PF00098:Zinc knuckle,	SSF57756:Retrovirus zinc finger-like domains,	2.78704355173568	0.000432950930885262	FDR<0.01	3.36356132224558	64437.8333333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	1415	Splicing
P15864	P15864	Hist1h1c	181.09	210.01	15548000	NA	67.2992798977051	NA	NA	194.791281142256	119.013615157574	13944483.3333333	3	Hist1h1c	0	Histone H1.2 (H1 VAR.1) (H1c)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12808097, ECO:0000269|PubMed:16377562}.		chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription by RNA polymerase II [GO:0006357]	euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in euchromatin. {ECO:0000250}.	50708;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	21267	COMPBIAS 171..212;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 98..212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (44); Mutagenesis (2); Region (2)		ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 36..109;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	50708	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,GO:0035327~transcriptionally active chromatin,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	7.1576329120805	2.11227184747843e-08	FDR<0.01	7.67525018923375	14746241.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	156	Transcription
P43274	P43274	Hist1h1e	43.944	85.79	8792900	23.4896175890257	18.9980432015502	96.6183574879227	75.4830917874396	46.3456458265746	30.6522805296714	17127566.6666667	0	Hist1h1e	0	Histone H1.4 (H1 VAR.2) (H1e)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation. {ECO:0000269|PubMed:12808097, ECO:0000269|PubMed:16377562}.		chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleosome [GO:0000786]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dATP binding [GO:0032564]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; nucleosomal DNA binding [GO:0031492]; nucleotide binding [GO:0000166]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in heterochromatin. Dysplays a punctuate staining pattern in the nucleus. {ECO:0000250}.	50709;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	21977	COMPBIAS 150..219;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..219;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (18); Region (2)		ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 36..109;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	50709	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	5.49833169566778	1.29389885998332e-09	FDR<0.01	8.88809966977846	12960233.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	182	Transcription
P43277	P43277	Hist1h1d	91.798	103.83	6806450	NA	73.7300007373	NA	NA	NA	203.90269763269	7593700	4	Hist1h1d	0	Histone H1.3 (H1 VAR.4) (H1d)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12808097}.		chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in euchromatin. {ECO:0000250}.	14957;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	22100	COMPBIAS 172..221;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (14); Region (2); Sequence conflict (1)		Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 37..110;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	14957	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	6.77359681810659	3.05517599827609e-07	FDR<0.01	6.51496376647593	7200075	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	275	Transcription
Q9R0L7	Q9R0L7	Akap8l	NA	5.3632	4373000	NA	2.54932952633457	3.9677816133	1.21159251720461	NA	3.3208248929034	168604.5	2	Akap8l	1	A-kinase anchor protein 8-like (AKAP8-like protein) (Neighbor of A-kinase-anchoring protein 95) (Neighbor of AKAP95)		FUNCTION: Could play a role in constitutive transport element (CTE)-mediated gene expression by association with DHX9. Increases CTE-dependent nuclear unspliced mRNA export. Proposed to target PRKACA to the nucleus but does not seem to be implicated in the binding of regulatory subunit II of PKA. May be involved in nuclear envelope breakdown and chromatin condensation. May be involved in anchoring nuclear membranes to chromatin in interphase and in releasing membranes from chromating at mitosis. May regulate the initiation phase of DNA replication when associated with TMPO isoform Beta. Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function seems to act redundantly with AKAP8. May be involved in regulation of pre-mRNA splicing (By similarity). {ECO:0000250|UniProtKB:Q9ULX6}.		cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear envelope disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone phosphorylation [GO:0033127]; regulation of mRNA export from nucleus [GO:0010793]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9ULX6}. Nucleus matrix {ECO:0000250|UniProtKB:Q9ULX6}. Nucleus speckle {ECO:0000250|UniProtKB:Q9ULX6}. Nucleus, PML body {ECO:0000250|UniProtKB:Q9ULX6}. Cytoplasm {ECO:0000250|UniProtKB:Q9ULX6}. Note=Colocalizes with PRPF40A in the nuclear matrix. Nuclear at steady state but shuttles between the nucleus and cytoplasm. The shuttling property has been questioned. Colocalizes with EBNA-LP in PML bodies. {ECO:0000250|UniProtKB:Q9ULX6}.			IPR007071;IPR034736;	PF04988;		71454	COMPBIAS 280..301;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 318..335;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 363..382;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 554..568;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 586..611;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..269;  /note=Sufficient for activation of CTE-mediated expression;  /evidence=ECO:0000250|UniProtKB:Q9ULX6; REGION 265..382;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 546..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Modified residue (10); Motif (3); Region (3); Zinc finger (2)		Acetylation;Cytoplasm;Direct protein sequencing;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger			MOTIF 275..280;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 281..297;  /note=Nuclear export signal (NES);  /evidence=ECO:0000250|UniProtKB:Q9ULX6; MOTIF 363..365;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 392..414;  /note=C2H2 AKAP95-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140; ZN_FING 485..508;  /note=C2H2 AKAP95-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140	PS51799;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007076~mitotic chromosome condensation,GO:0010793~regulation of mRNA export from nucleus,GO:0031065~positive regulation of histone deacetylation,GO:0033127~regulation of histone phosphorylation,GO:0044839~cell cycle G2/M phase transition,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051081~nuclear envelope disassembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0005521~lamin binding,GO:0016301~kinase activity,GO:0017151~DEAD/H-box RNA helicase binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),	PF04988:A-kinase anchoring protein 95 (AKAP95),		1.55399815380498	0.00239887063900363	FDR<0.01	2.61999317107413	2270802.25	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	584	Transcription
Q9DBR0	Q9DBR0	Akap8	11.532	10.669	2850350	2.08333333333333	7.39644970414201	6.29247420085578	5.29941706412295	1.73235166738848	4.04350814766892	1496890	0	Akap8	0	A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95)		FUNCTION: Anchoring protein that mediates the subcellular compartmentation of cAMP-dependent protein kinase (PKA type II). Acts as an anchor for a PKA-signaling complex onto mitotic chromosomes, which is required for maintenance of chromosomes in a condensed form throughout mitosis. Recruits condensin complex subunit NCAPD2 to chromosomes required for chromatin condensation; the function appears to be independent from PKA-anchoring (By similarity). Specifically involved in recruitment of CAPD2 to, and condensation of maternal but not paternal chromosomes (PubMed:12082153). May help to deliver cyclin D/E to CDK4 to facilitate cell cycle progression (PubMed:14641107). Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function may act redundantly with AKAP8L. Involved in nuclear retention of RPS6KA1 upon ERK activation thus inducing cell proliferation. May be involved in regulation of DNA replication by acting as scaffold for MCM2. Enhances HMT activity of the KMT2 family MLL4/WBP7 complex and is involved in transcriptional regulation. In a teratocarcinoma cell line is involved in retinoic acid-mediated induction of developmental genes implicating H3 'Lys-4' methylation. May be involved in recruitment of active CASP3 to the nucleus in apoptotic cells. May act as a carrier protein of GJA1 for its transport to the nucleus. May play a repressive role in the regulation of rDNA transcription. Preferentially binds GC-rich DNA in vitro. In cells, associates with ribosomal RNA (rRNA) chromatin, preferentially with rRNA promoter and transcribed regions (By similarity). Involved in modulation of Toll-like receptor signaling. Required for the cAMP-dependent suppression of TNF-alpha in early stages of LPS-induced macrophage activation; the function probably implicates targeting of PKA to NFKB1 (PubMed:19531803). {ECO:0000250|UniProtKB:O43823, ECO:0000250|UniProtKB:Q63014}.		cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; regulation of histone phosphorylation [GO:0033127]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:16751186}. Nucleus, nucleolus {ECO:0000250|UniProtKB:O43823}. Cytoplasm {ECO:0000269|PubMed:19531803}. Note=Associated with the nuclear matrix (By similarity). Exhibits partial localization to the nucleolus in interphase, possibly to the fibrillary center and/or to the dense fibrillary component (By similarity). Redistributed and detached from condensed chromatin during mitosis (By similarity). Localizes specifically to the vicinity of the meiotic spindle in metaphase II oocytes (PubMed:12082153). {ECO:0000250|UniProtKB:O43823, ECO:0000269|PubMed:12082153}.	56399;		IPR007071;IPR034736;	PF04988;		76294	COMPBIAS 194..218;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 280..379;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 624..645;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..210;  /note=Interaction with DPY30;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 1..195;  /note=Interaction with MCM2;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 105..124;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 109..201;  /note=Interaction with DDX5;  /evidence=ECO:0000250|UniProtKB:Q63014; REGION 185..218;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..379;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 384..447;  /note=Involved in chromatin-binding;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 522..565;  /note=Involved in condensin complex recruitment;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 568..585;  /note=RII-binding;  /evidence=ECO:0000250|UniProtKB:Q63014; REGION 572..589;  /note=Required for interaction with MYCBP;  /evidence=ECO:0000269|PubMed:12414807; REGION 624..659;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Modified residue (11); Motif (1); Region (11); Sequence conflict (6); Zinc finger (2)		Cytoplasm;DNA-binding;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transcription;Transcription regulation;Transport;Ubl conjugation;Zinc;Zinc-finger			MOTIF 286..303;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:O43823, ECO:0000250|UniProtKB:Q63014		ZN_FING 389..411;  /note=C2H2 AKAP95-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140; ZN_FING 478..501;  /note=C2H2 AKAP95-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140	PS51799;	56399	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0007076~mitotic chromosome condensation,GO:0015031~protein transport,GO:0031065~positive regulation of histone deacetylation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0033127~regulation of histone phosphorylation,GO:0044839~cell cycle G2/M phase transition,GO:0045087~innate immune response,GO:0071222~cellular response to lipopolysaccharide,GO:0071380~cellular response to prostaglandin E stimulus,	GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0001939~female pronucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016301~kinase activity,GO:0034237~protein kinase A regulatory subunit binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),	PF04988:A-kinase anchoring protein 95 (AKAP95),		2.3445563671418	1.95515017293785e-05	FDR<0.01	4.7088198793047	2173620	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	596	Transcription
P63166	P63166	Sumo1	2.514	4.5414	1914150	13.7353203763478	17.5855095401389	8.18799639728159	NA	NA	3.18278748527961	482855	2	Sumo1	0	Small ubiquitin-related modifier 1 (SUMO-1) (SMT3 homolog 3) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C)		FUNCTION: Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complex protein RANBP2. Covalently attached to the voltage-gated potassium channel KCNB1; this modulates the gating characteristics of KCNB1. Polymeric SUMO1 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. May also regulate a network of genes involved in palate development. Covalently attached to ZFHX3 (By similarity). {ECO:0000250|UniProtKB:P63165, ECO:0000269|PubMed:16990542}.		cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; negative regulation of action potential [GO:0045759]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; PML body organization [GO:0030578]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to nuclear pore [GO:0090204]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]	cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; synapse [GO:0045202]; XY body [GO:0001741]	enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein tag [GO:0031386]; small protein activating enzyme binding [GO:0044388]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:P63165}. Nucleus speckle {ECO:0000269|PubMed:18681895}. Cytoplasm {ECO:0000250|UniProtKB:P63165}. Nucleus, PML body {ECO:0000250|UniProtKB:P63165}. Cell membrane {ECO:0000250|UniProtKB:P63165}. Nucleus {ECO:0000250|UniProtKB:P63165}. Note=Recruited by BCL11A into the nuclear body (PubMed:18681895). In the presence of ZFHX3, sequesterd to nuclear body (NB)-like dots in the nucleus some of which overlap or closely associate with PML body (By similarity). {ECO:0000250|UniProtKB:P63165, ECO:0000269|PubMed:18681895}.	22218;		IPR022617;IPR000626;IPR029071;	PF11976;	SM00213;	11557			NA							5 out of 5	Chain (1); Cross-link (11); Domain (1); Initiator methionine (1); Modified residue (4); Propeptide (1); Site (1)		Acetylation;Cell membrane;Cytoplasm;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Stress response;Ubl conjugation;Ubl conjugation pathway	DOMAIN 20..97;  /note=Ubiquitin-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00214					PS50053;	22218	GO:0006355~regulation of transcription, DNA-templated,GO:0016925~protein sumoylation,GO:0030578~PML body organization,GO:0031334~positive regulation of protein complex assembly,GO:0031647~regulation of protein stability,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045759~negative regulation of action potential,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050821~protein stabilization,GO:0060021~palate development,GO:0086004~regulation of cardiac muscle cell contraction,GO:0090204~protein localization to nuclear pore,GO:1901896~positive regulation of calcium-transporting ATPase activity,GO:1902260~negative regulation of delayed rectifier potassium channel activity,GO:1903169~regulation of calcium ion transmembrane transport,	GO:0000792~heterochromatin,GO:0001650~fibrillar center,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,GO:0016604~nuclear body,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0045202~synapse,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0015459~potassium channel regulator activity,GO:0031386~protein tag,GO:0031625~ubiquitin protein ligase binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,	IPR000626:Ubiquitin,IPR022617:Small ubiquitin-related modifier, SUMO,	PF00240:Ubiquitin family,PF11976:Ubiquitin-2 like Rad60 SUMO-like,	SSF54236:Ubiquitin-like,	2.68884282512423	0.00010091520876258	FDR<0.01	3.99604337703445	1198502.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	773	Transcription
Q80U78	Q80U78-2;Q80U78-3;Q80U78;Q80U78-4;Q80U58-3;Q80U58-2;Q80U58	Pum1	3.1595	5.5228	714415	4.74991687645466	5.49601538884309	NA	NA	NA	NA	116970	4	Pum1	0	Pumilio homolog 1		FUNCTION: Sequence-specific RNA-binding protein that acts as a post-transcriptional repressor by binding the 3'-UTR of mRNA targets. Binds to an RNA consensus sequence, the Pumilio Response Element (PRE), 5'-UGUANAUA-3', that is related to the Nanos Response Element (NRE). Mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation. Also mediates deadenylation-independent repression by promoting accessibility of miRNAs. Following growth factor stimulation, phosphorylated and binds to the 3'-UTR of CDKN1B/p27 mRNA, inducing a local conformational change that exposes miRNA-binding sites, promoting association of miR-221 and miR-222, efficient suppression of CDKN1B/p27 expression, and rapid entry to the cell cycle (By similarity). Acts as a post-transcriptional repressor of E2F3 mRNAs by binding to its 3'-UTR and facilitating miRNA regulation (By similarity). Represses a program of genes necessary to maintain genomic stability such as key mitotic, DNA repair and DNA replication factors. Its ability to repress those target mRNAs is regulated by the lncRNA NORAD (non-coding RNA activated by DNA damage) which, due to its high abundance and multitude of PUMILIO binding sites, is able to sequester a significant fraction of PUM1 and PUM2 in the cytoplasm (By similarity). Involved in neuronal functions by regulating ATXN1 mRNA levels: acts by binding to the 3'-UTR of ATXN1 transcripts, leading to their down-regulation independently of the miRNA machinery (PubMed:25768905). In testis, acts as a post-transcriptional regulator of spermatogenesis by binding to the 3'-UTR of mRNAs coding for regulators of p53/TP53 (PubMed:22342750). Involved in embryonic stem cell renewal by facilitating the exit from the ground state: acts by targeting mRNAs coding for naive pluripotency transcription factors and accelerates their down-regulation at the onset of differentiation (PubMed:24412312). Binds specifically to miRNA MIR199A precursor, with PUM2, regulates miRNA MIR199A expression at a postranscriptional level (By similarity). {ECO:0000250|UniProtKB:Q14671, ECO:0000269|PubMed:22342750, ECO:0000269|PubMed:24412312, ECO:0000269|PubMed:25768905}.		adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]	miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22342750}. Cytoplasm, P-body {ECO:0000250|UniProtKB:Q14671}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q14671}.	80912;	cd07920;	IPR011989;IPR016024;IPR033133;IPR033712;IPR001313;	PF00806;	SM00025;	126619	COMPBIAS 33..61;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 239..272;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 620..647;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 758..773;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 22..73;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 233..272;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 491..525;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 614..647;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 743..773;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 864..868;  /note=Adenine-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 900..904;  /note=Uracil-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 936..940;  /note=Adenine-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 974..978;  /note=Non-specific-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 1010..1014;  /note=Adenine-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 1046..1050;  /note=Uracil-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 1082..1086;  /note=Guanine-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 1083..1086;  /note=Guanine-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671; REGION 1125..1129;  /note=Uracil-nucleotide binding in RNA target;  /evidence=ECO:0000250|UniProtKB:Q14671	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (4); Domain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (18); Region (14); Repeat (8); Sequence conflict (4)		Acetylation;Alternative splicing;Cytoplasm;Differentiation;Methylation;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spermatogenesis;Translation regulation	DOMAIN 829..1171;  /note=PUM-HD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00318	DOMAIN: The pumilio repeats mediate the association with RNA by packing together to form a right-handed superhelix that approximates a half donut. RNA-binding occurs on the concave side of the surface. PUM1 is composed of 8 pumilio repeats of 36 residues; each repeat binds a single nucleotide in its RNA target. Residues at positions 12 and 16 of the pumilio repeat bind each RNA base via hydrogen bonding or van der Waals contacts with the Watson-Crick edge, while the amino acid at position 13 makes a stacking interaction. The recognition of RNA by pumilio repeats is base specific: cysteine and glutamine at position 12 and 16, respectively, bind adenine; asparagine and glutamine bind uracil; and serine and glutamate bind guanine. {ECO:0000250|UniProtKB:Q14671}.		REPEAT 849..884;  /note=Pumilio 1; REPEAT 885..920;  /note=Pumilio 2; REPEAT 921..958;  /note=Pumilio 3; REPEAT 959..994;  /note=Pumilio 4; REPEAT 995..1030;  /note=Pumilio 5; REPEAT 1031..1066;  /note=Pumilio 6; REPEAT 1067..1102;  /note=Pumilio 7; REPEAT 1106..1145;  /note=Pumilio 8		PS50302;PS50303;	80912	GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0008344~adult locomotory behavior,GO:0010608~posttranscriptional regulation of gene expression,GO:0016441~posttranscriptional gene silencing,GO:0030154~cell differentiation,GO:0043488~regulation of mRNA stability,GO:0048863~stem cell differentiation,GO:0051726~regulation of cell cycle,GO:0051983~regulation of chromosome segregation,GO:0061157~mRNA destabilization,GO:1900246~positive regulation of RIG-I signaling pathway,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,	GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0044822~poly(A) RNA binding,	IPR001313:Pumilio RNA-binding repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	PF00806:Pumilio-family RNA binding repeat,	SSF48371:ARM repeat,	2.20784611482867	0.000227148329263544	FDR<0.01	3.64369045318918	415692.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	1100	Transcription
P17742	P17742	Ppia	23.271	26.007	293725000	51.6422226812642	33.8845215505557	47.132016778998	42.5966944965071	20.2741059119293	20.4670582697149	99389000	0	Ppia	0	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) (SP18) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]		FUNCTION: Catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (PubMed:24429998). Exerts a strong chemotactic effect on leukocytes partly through activation of one of its membrane receptors BSG/CD147, initiating a signaling cascade that culminates in MAPK/ERK activation (By similarity). Activates endothelial cells (ECs) in a proinflammatory manner by stimulating activation of NF-kappa-B and ERK, JNK and p38 MAP-kinases and by inducing expression of adhesion molecules including SELE and VCAM1 (By similarity). Induces apoptosis in ECs by promoting the FOXO1-dependent expression of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis (By similarity). In response to oxidative stress, initiates proapoptotic and antiapoptotic signaling in ECs via activation of NF-kappa-B and AKT1 and up-regulation of antiapoptotic protein BCL2 (By similarity). Negatively regulates MAP3K5/ASK1 kinase activity, autophosphorylation and oxidative stress-induced apoptosis mediated by MAP3K5/ASK1 (By similarity). Necessary for the assembly of TARDBP in heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and regulates TARDBP binding to RNA UG repeats and TARDBP-dependent expression of HDAC6, ATG7 and VCP which are involved in clearance of protein aggregates (PubMed:25678563). Plays an important role in platelet activation and aggregation (PubMed:24429998). Regulates calcium mobilization and integrin ITGA2B:ITGB3 bidirectional signaling via increased ROS production as well as by facilitating the interaction between integrin and the cell cytoskeleton (PubMed:24429998). Binds heparan sulfate glycosaminoglycans (By similarity). {ECO:0000250|UniProtKB:P62937, ECO:0000269|PubMed:24429998, ECO:0000269|PubMed:25678563}.		activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of viral life cycle [GO:1903901]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P62937}. Secreted {ECO:0000250|UniProtKB:P62937}. Nucleus {ECO:0000250|UniProtKB:P62937}. Note=Secretion occurs in response to oxidative stress in vascular smooth muscle through a vesicular secretory pathway that involves actin remodeling and myosin II activation, and mediates ERK1/2 activation. {ECO:0000250|UniProtKB:P62937}.	268373;		IPR029000;IPR024936;IPR020892;IPR002130;	PF00160;		17971			NA		ACTIVITY REGULATION: Binds cyclosporin A (CsA). CsA mediates some of its effects via an inhibitory action on PPIase. {ECO:0000250|UniProtKB:P62937}.		5.2.1.8			5 out of 5	Beta strand (9); Chain (2); Cross-link (3); Domain (1); Glycosylation (1); Helix (3); Initiator methionine (1); Modified residue (10); Sequence conflict (2); Turn (5)		3D-structure;Acetylation;Apoptosis;Cytoplasm;Direct protein sequencing;Glycoprotein;Isomerase;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Rotamase;Secreted;Ubl conjugation	DOMAIN 7..163;  /note=PPIase cyclophilin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00156					PS00170;PS50072;	268373	GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0030182~neuron differentiation,GO:0034389~lipid particle organization,GO:0045069~regulation of viral genome replication,GO:0045070~positive regulation of viral genome replication,GO:0050714~positive regulation of protein secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005515~protein binding,GO:0016018~cyclosporin A binding,GO:0016853~isomerase activity,GO:0042277~peptide binding,GO:0044822~poly(A) RNA binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,	PF00160:Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD,	SSF50891:Cyclophilin-like,	4.96030330008995	2.08205371715019e-10	FDR<0.01	9.68150806984904	196557000	Present in Nucleus	RBP	Others	Others	Others	Others	8	Transcription
Q8R081	Q8R081	Hnrnpl	11.19	14.883	206833000	20.7005050923243	32.3729362253156	14.5917235743886	10.2219178362244	22.2940586333742	20.5246090061984	35966400	0	Hnrnpl	0	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)		FUNCTION: Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion (PubMed:22523384). Exhibits a binding preference for CA-rich elements. Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts. Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter. {ECO:0000250|UniProtKB:P14866, ECO:0000269|PubMed:22523384}.		cellular response to amino acid starvation [GO:0034198]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P14866}. Cytoplasm {ECO:0000250|UniProtKB:P14866}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. These granules are not identical with P bodies or stress granules. {ECO:0000250|UniProtKB:P14866}.	15388;	cd12780;cd12785;cd12699;cd12704;	IPR006536;IPR034816;IPR035005;IPR035008;IPR034817;IPR012677;IPR021790;IPR035979;IPR000504;	PF00076;PF11835;	SM00360;	63964	COMPBIAS 281..302;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..334;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 358..375;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 281..376;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (11); Chain (1); Compositional bias (3); Cross-link (5); Domain (4); Erroneous initiation (1); Helix (5); Modified residue (9); Region (2); Sequence conflict (1); Turn (2)		3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 99..173;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 190..267;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 379..476;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 492..580;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: RRM domain 2 has moderate RNA-binding affinity. RRM domains 3 and 4 may facilitate RNA looping when binding to two appropriately separated binding sites within the same target pre-mRNA. {ECO:0000250|UniProtKB:P14866}.				PS50102;	15388	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0034198~cellular response to amino acid starvation,GO:0045727~positive regulation of translation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:1902416~positive regulation of mRNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0035770~ribonucleoprotein granule,GO:0045120~pronucleus,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0097157~pre-mRNA intronic binding,GO:1990715~mRNA CDS binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	4.10332307236882	1.68630221994543e-09	FDR<0.01	8.77306458825674	121399700	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	16	Transcription
Q64152	Q64152-2;Q64152	Btf3	34.106	89.888	200051000	24.7206565806388	24.0326844508532	3.47572208126238	NA	7.31154492944359	27.5558004960044	25126660	1	Btf3	0	Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3)		FUNCTION: When associated with NACA, prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. BTF3 is also a general transcription factor that can form a stable complex with RNA polymerase II. Required for the initiation of transcription (By similarity). {ECO:0000250}.		in utero embryonic development [GO:0001701]; protein transport [GO:0015031]	cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]		SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus. Note=The heterodimer with NACA is cytoplasmic. {ECO:0000250}.	218490;		IPR039370;IPR038187;IPR002715;	PF01849;	SM01407;	22031		REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 168..190;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Domain (1); Modified residue (6); Region (2); Sequence conflict (3)		Alternative splicing;Chaperone;Cytoplasm;Methylation;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transcription;Transcription regulation;Transport	DOMAIN 80..145;  /note=NAC-A/B;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00507					PS51151;	218490	GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0015031~protein transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR002715:Nascent polypeptide-associated complex NAC domain,	PF01849:NAC domain,		4.3211934975134	4.79416832346391e-06	FDR<0.01	5.31928672193603	112588830	Present in Nucleus	RBP	Others	Others	Others	Others	18	Transcription
P17225	P17225;B2RU80	Ptbp1	26.7	41.736	172731500	10.6570043160867	20.8441896821261	60.2518527444719	12.8625635089073	52.1730056868576	23.5810125686797	33915700	0	Ptbp1	0	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)		FUNCTION: Plays a role in pre-mRNA splicing and in the regulation of alternative splicing events. Activates exon skipping of its own pre-mRNA during muscle cell differentiation. Binds to the polypyrimidine tract of introns. May promote RNA looping when bound to two separate polypyrimidine tracts in the same pre-mRNA. May promote the binding of U2 snRNP to pre-mRNA. Cooperates with RAVER1 to modulate switching between mutually exclusive exons during maturation of the TPM1 pre-mRNA. Represses the splicing of MAPT/Tau exon 10.		3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; neurogenesis [GO:0022008]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	SUBCELLULAR LOCATION: Nucleus.		cd12777;cd12693;	IPR006536;IPR012677;IPR034798;IPR021790;IPR035000;IPR035979;IPR000504;	PF00076;PF11835;	SM00360;	56478			NA							5 out of 5	Chain (1); Cross-link (2); Domain (4); Modified residue (6)		Acetylation;Activator;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 58..142;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 183..259;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 335..386;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 450..525;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The C-terminal 195 amino acids of PTB are sufficient for specific RNA binding.				PS50102;	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010976~positive regulation of neuron projection development,GO:0032024~positive regulation of insulin secretion,GO:0033119~negative regulation of RNA splicing,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0051148~negative regulation of muscle cell differentiation,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0075522~IRES-dependent viral translational initiation,GO:1904411~positive regulation of secretory granule organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0044306~neuron projection terminus,GO:0070062~extracellular exosome,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0000166~nucleotide binding,GO:0001069~regulatory region RNA binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	4.72251463815009	8.32674194857231e-09	FDR<0.01	8.07952489421616	103323600	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	24	Transcription
Q6DFW4	Q6DFW4	Nop58	3.1825	3.535	95775500	4.98355427090601	3.33600213504137	4.2718612499466	1.73970529392321	10.0712034080952	9.19540229885057	66282800	0	Nop58	0	Nucleolar protein 58 (MSSP) (Nucleolar protein 5) (SIK-similar protein)		FUNCTION: Required for 60S ribosomal subunit biogenesis (By similarity). Core component of box C/D small nucleolar ribonucleoprotein (snoRNP) particles. Required for the biogenesis of box C/D snoRNAs such as U3, U8 and U14 snoRNAs (By similarity). {ECO:0000250}.		ribosome biogenesis [GO:0042254]; snoRNA localization [GO:0048254]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]	ATPase binding [GO:0051117]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}.	55989;		IPR029012;IPR012974;IPR042239;IPR002687;IPR036070;IPR012976;	PF01798;PF08156;	SM00931;	60343	COMPBIAS 414..428;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 471..485;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 414..440;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 470..536;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (15); Domain (1); Frameshift (1); Modified residue (6); Region (2); Sequence conflict (3)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation	DOMAIN 282..400;  /note=Nop;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00690					PS51358;	55989	GO:0000154~rRNA modification,GO:0006608~snRNP protein import into nucleus,GO:0042254~ribosome biogenesis,GO:0048254~snoRNA localization,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0070761~pre-snoRNP complex,	GO:0001094~TFIID-class transcription factor binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,	IPR002687:Nop domain,IPR012974:NOP5, N-terminal,IPR012976:NOSIC,	PF01798:Putative snoRNA binding domain,PF08156:NOP5NT (NUC127) domain,	SSF89124:Nop domain,	2.12174382176606	1.41218917088403e-05	FDR<0.01	4.85010712313677	81029150	Present in Nucleus	RBP	RBD	Others	Others	RBD	29	Transcription
Q60668	Q60668-4;Q60668-3;Q60668-2;Q60668	Hnrnpd	15.277	19.674	133823000	13.2648865188958	19.0103226051746	70.7213578500707	12.5338413717036	24.1254523522316	20.5347242186537	18726200	0	Hnrnpd	0	Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1)		FUNCTION: Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. May play a role in the regulation of the rhythmic expression of circadian clock core genes. Directly binds to the 3'UTR of CRY1 mRNA and induces CRY1 rhythmic translation. May also be involved in the regulation of PER2 translation. {ECO:0000250|UniProtKB:Q14103}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA stabilization [GO:0048255]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of telomere maintenance [GO:0032204]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14103}. Cytoplasm {ECO:0000250|UniProtKB:Q14103}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Cytoplasmic localization oscillates diurnally. {ECO:0000250|UniProtKB:Q14103}.	11991;		IPR012956;IPR012677;IPR035979;IPR000504;	PF08143;PF00076;	SM00360;	38354	COMPBIAS 67..91;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..91;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (3); Domain (2); Frameshift (2); Initiator methionine (1); Modified residue (24); Region (1); Sequence caution (2); Sequence conflict (6)		Acetylation;Alternative splicing;Biological rhythms;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 97..179;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 182..261;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	11991	GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0021549~cerebellum development,GO:0042752~regulation of circadian rhythm,GO:0043488~regulation of mRNA stability,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0048511~rhythmic process,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071230~cellular response to amino acid stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071732~cellular response to nitric oxide,GO:0097167~circadian regulation of translation,GO:1901355~response to rapamycin,GO:1904383~response to sodium phosphate,GO:1904586~cellular response to putrescine,GO:1990828~hepatocyte dedifferentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008134~transcription factor binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042162~telomeric DNA binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012956:CARG-binding factor, N-terminal,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08143:CBFNT (NUC161) domain,	SSF54928:RNA-binding domain, RBD,	4.3692584822801	6.92140997117675e-09	FDR<0.01	8.15980542572723	76274600	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	31	Transcription
Q9Z2X1	Q9Z2X1;Q9Z2X1-2	Hnrnpf	13.445	19.41	94075000	16.4289938884143	25.0972518509223	31.7904374364191	12.114897689689	14.77563202766	13.8287721433214	53448000	0	Hnrnpf	0	Heterogeneous nuclear ribonucleoprotein F (hnRNP F) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]		FUNCTION: Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Plays a role in the regulation of alternative splicing events. Binds G-rich sequences in pre-mRNAs and keeps target RNA in an unfolded state (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	98758;		IPR012677;IPR035979;IPR000504;IPR012996;	PF00076;PF08080;	SM00360;	45730		REGION 81..86;  /note=Interaction with RNA;  /evidence=ECO:0000250; REGION 179..184;  /note=Interaction with RNA;  /evidence=ECO:0000250; REGION 355..360;  /note=Interaction with RNA;  /evidence=ECO:0000250	NA							4 out of 5	Alternative sequence (1); Beta strand (7); Chain (2); Cross-link (6); Domain (3); Erroneous initiation (2); Erroneous termination (1); Helix (5); Initiator methionine (1); Modified residue (12); Region (3); Sequence conflict (1); Site (12); Turn (1)		3D-structure;Acetylation;Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 11..90;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 111..188;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 289..366;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The N-terminal RRM domains are responsible for recognizing the G-tract of BCL-X RNA. {ECO:0000250}.				PS50102;	98758	GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0008134~transcription factor binding,GO:0017025~TBP-class protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012996:Zinc finger, CHHC-type,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08080:RNPHF zinc finger,	SSF54928:RNA-binding domain, RBD,	4.12241702001129	8.47201685494811e-10	FDR<0.01	9.07201318887748	73761500	Present in Nucleus	RBP	DBD	DBD	Others	RBD	34	Transcription
O88569	O88569;O88569-2;O88569-3	Hnrnpa2b1	10.857	15.764	114959000	12.1712247903507	35.8795881023286	56.1955605507165	22.4356097998744	20.9731543624161	44.1169982794371	27192600	0	Hnrnpa2b1	0	Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)		FUNCTION: Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs. Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (By similarity). Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts. Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs. Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (By similarity). Plays also a role in the activation of the innate immune response. Mechanistically, senses the presence of viral DNA in the nucleus, homodimerizes and is demethylated by JMJD6. In turn, translocates to the cytoplasm where it activates the TBK1-IRF3 pathway, leading to interferon alpha/beta production (PubMed:31320558). {ECO:0000250|UniProtKB:A7VJC2, ECO:0000250|UniProtKB:P22626, ECO:0000269|PubMed:31320558}.		G-quadruplex DNA unwinding [GO:0044806]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; primary miRNA processing [GO:0031053]; RNA transport [GO:0050658]; telomere capping [GO:0016233]	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic cytosol [GO:0099524]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA intronic binding [GO:0097157]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; single-stranded telomeric DNA binding [GO:0043047]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:31320558}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P22626}. Cytoplasm {ECO:0000269|PubMed:31320558}. Cytoplasmic granule {ECO:0000250|UniProtKB:P22626}. Secreted, extracellular exosome {ECO:0000250|UniProtKB:P22626}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Not found in the nucleolus. Found in exosomes following sumoylation. {ECO:0000250|UniProtKB:P22626}.	53379;	cd12762;	IPR034489;IPR034486;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	37403	COMPBIAS 191..205;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 193..353;  /note=Disordered;  /evidence=ECO:0000250|UniProtKB:P22626; REGION 308..347;  /note=Nuclear targeting sequence;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (9); Domain (2); Modified residue (36); Motif (1); Region (2); Sequence conflict (3)		Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Secreted;Spliceosome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 21..104;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 112..191;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The disordered region, when incubated at high concentration, is able to polymerize into labile, amyloid-like fibers and form cross-beta polymerization structures, probably driving the formation of hydrogels. In contrast to irreversible, pathogenic amyloids, the fibers polymerized from LC regions disassemble upon dilution. A number of evidence suggests that formation of cross-beta structures by LC regions mediate the formation of RNA granules, liquid-like droplets, and hydrogels. {ECO:0000250|UniProtKB:P22626}.	MOTIF 9..15;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;	53379	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0016233~telomere capping,GO:0031053~primary miRNA processing,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:1990428~miRNA transport,	GO:0000785~chromatin,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:0071598~neuronal ribonucleoprotein granule,	GO:0000166~nucleotide binding,GO:0001069~regulatory region RNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0035198~miRNA binding,GO:0043047~single-stranded telomeric DNA binding,GO:0044822~poly(A) RNA binding,GO:0097157~pre-mRNA intronic binding,GO:1990247~N6-methyladenosine-containing RNA binding,GO:1990715~mRNA CDS binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF11627:Nuclear factor hnRNPA1,	SSF54928:RNA-binding domain, RBD,	4.54293083257835	9.17540504074692e-09	FDR<0.01	8.0373747550782	71075800	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	36	Transcription
Q8K310	Q8K310	Matr3	3.2916	6.0949	81740000	9.40379913485048	5.35704719558579	5.90737240075614	2.21891849912353	26.4641278746659	19.2968237428119	57002666.6666667	0	Matr3	0	Matrin-3		FUNCTION: May play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. In association with the SFPQ-NONO heteromer may play a role in nuclear retention of defective RNAs (By similarity). {ECO:0000250}.; FUNCTION: May play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. In association with the SFPQ-NONO heteromer may play a role in nuclear retention of defective RNAs. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. May bind to specific miRNA hairpins (By similarity). {ECO:0000250|UniProtKB:P43243}.		activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000255|PROSITE-ProRule:PRU00130}.	17184;	cd12714;cd12715;	IPR034928;IPR034930;IPR000690;IPR003604;IPR012677;IPR035979;IPR000504;		SM00360;SM00451;	94630	COMPBIAS 588..646;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 647..663;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 689..734;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 748..776;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 147..174;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 187..213;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 342..394;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 588..779;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (12); Chain (1); Compositional bias (4); Cross-link (18); Domain (2); Helix (5); Initiator methionine (1); Modified residue (42); Motif (1); Region (4); Turn (3); Zinc finger (1)		3D-structure;Acetylation;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 398..473;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 496..571;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 709..717;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 800..831;  /note=Matrin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00130	PS50102;PS50171;	17184	GO:0003170~heart valve development,GO:0003281~ventricular septum development,GO:0010608~posttranscriptional regulation of gene expression,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016363~nuclear matrix,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR012677:Nucleotide-binding, alpha-beta plait,		SSF54928:RNA-binding domain, RBD,	2.83621303109136	1.22758125877926e-05	FDR<0.01	4.91094975047065	69371333.3333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	37	Transcription
P35550	P35550	Fbl	30.828	36.846	121330000	9.41530929291027	36.5884892612784	6.27313217489493	8.28294541538971	19.8929757902485	15.9456572002615	16998900	0	Fbl	0	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase) (Nucleolar protein 1) (U6 snRNA 2'-O-methyltransferase fibrillarin)		FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that has the ability to methylate both RNAs and proteins (PubMed:32017896). Involved in pre-rRNA processing by catalyzing the site-specific 2'-hydroxyl methylation of ribose moieties in pre-ribosomal RNA (By similarity). Site specificity is provided by a guide RNA that base pairs with the substrate (By similarity). Methylation occurs at a characteristic distance from the sequence involved in base pairing with the guide RNA (By similarity). Probably catalyzes 2'-O-methylation of U6 snRNAs in box C/D RNP complexes (PubMed:32017896). U6 snRNA 2'-O-methylation is required for mRNA splicing fidelity (PubMed:32017896). Also acts as a protein methyltransferase by mediating methylation of 'Gln-105' of histone H2A (H2AQ104me), a modification that impairs binding of the FACT complex and is specifically present at 35S ribosomal DNA locus (By similarity). {ECO:0000250|UniProtKB:P15646, ECO:0000250|UniProtKB:P22087, ECO:0000269|PubMed:32017896}.		box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]; sno(s)RNA metabolic process [GO:0016074]; snoRNA localization [GO:0048254]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P22087}. Nucleus, nucleoplasm {ECO:0000305|PubMed:32017896}. Note=Fibrillar region of the nucleolus. {ECO:0000250|UniProtKB:P22087}.	14113;		IPR000692;IPR020813;IPR029063;	PF01269;	SM01206;	34307		REGION 1..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..179;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q9Y9U3; REGION 197..198;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:P22087; REGION 222..223;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:P22087; REGION 242..245;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:P22087	NA				2.1.1.-			5 out of 5	Chain (1); Cross-link (6); Modified residue (13); Region (5); Sequence conflict (4)		Acetylation;Isopeptide bond;Methylation;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;S-adenosyl-L-methionine;Transferase;Ubl conjugation;rRNA processing						PS00566;	14113	GO:0000494~box C/D snoRNA 3'-end processing,GO:0001649~osteoblast differentiation,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0008033~tRNA processing,GO:0016074~snoRNA metabolic process,GO:0016571~histone methylation,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0048254~snoRNA localization,GO:1990258~histone glutamine methylation,	GO:0001651~dense fibrillar component,GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0070062~extracellular exosome,	GO:0001094~TFIID-class transcription factor binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,GO:1990259~histone-glutamine methyltransferase activity,	IPR000692:Fibrillarin,IPR020813:Fibrillarin, conserved site,	PF01269:Fibrillarin,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	4.07331757775419	8.8028725644349e-08	FDR<0.01	7.05537558520078	69164450	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	38	Transcription
Q9JIK5	Q9JIK5	Ddx21	8.7069	10.33	66658000	11.1017363115591	6.77414984419455	6.26684213824654	2.29005885451256	53.0475836825633	48.2183326100583	71017816.6666667	0	Ddx21	0	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)		FUNCTION: RNA helicase that acts as a sensor of the transcriptional status of both RNA polymerase (Pol) I and II: promotes ribosomal RNA (rRNA) processing and transcription from polymerase II (Pol II) (By similarity). Binds various RNAs, such as rRNAs, snoRNAs, 7SK and, at lower extent, mRNAs (By similarity). In the nucleolus, localizes to rDNA locus, where it directly binds rRNAs and snoRNAs, and promotes rRNA transcription, processing and modification (By similarity). Required for rRNA 2'-O-methylation, possibly by promoting the recruitment of late-acting snoRNAs SNORD56 and SNORD58 with pre-ribosomal complexes (By similarity). In the nucleoplasm, binds 7SK RNA and is recruited to the promoters of Pol II-transcribed genes: acts by facilitating the release of P-TEFb from inhibitory 7SK snRNP in a manner that is dependent on its helicase activity, thereby promoting transcription of its target genes (By similarity). Functions as cofactor for JUN-activated transcription: required for phosphorylation of JUN at 'Ser-77' (By similarity). Can unwind double-stranded RNA (helicase) and can fold or introduce a secondary structure to a single-stranded RNA (foldase) (By similarity). Together with SIRT7, required to prevent R-loop-associated DNA damage and transcription-associated genomic instability: deacetylation by SIRT7 activates the helicase activity, thereby overcoming R-loop-mediated stalling of RNA polymerases (By similarity). Involved in rRNA processing. May bind to specific miRNA hairpins (By similarity). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (PubMed:21703541). {ECO:0000250|UniProtKB:Q9NR30, ECO:0000269|PubMed:21703541}.		defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; R-loop disassembly [GO:0062176]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NR30}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9NR30}. Cytoplasm, cytosol {ECO:0000269|PubMed:21703541}. Mitochondrion {ECO:0000303|PubMed:21703541}. Note=Present both in nucleolus and nucleoplasm. Interaction with JUN promotes translocation from the nucleolus to the nucleoplasm. Interaction with WDR46 is required for localization to the nucleolus. Colocalizes in the cytosol with DDX1, DHX36 and TICAM1 (PubMed:21703541). The multi-helicase-TICAM1 complex may translocate to the mitochondria upon poly(I:C) RNA ligand stimulation (PubMed:21703541). {ECO:0000250|UniProtKB:Q9NR30, ECO:0000269|PubMed:21703541}.	56200;		IPR011545;IPR012562;IPR014001;IPR001650;IPR027417;IPR035979;IPR014014;	PF00270;PF08152;PF00271;	SM00487;SM00490;	93551	COMPBIAS 21..112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 119..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 158..179;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 195..220;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 227..241;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..260;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 117..227;  /note=3 X 37 AA tandem repeats; REGION 783..851;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 807..833;  /note=3 X 5 AA repeats	NA		ACTIVITY REGULATION: Acetylation inhibits the helicase activity. {ECO:0000250|UniProtKB:Q9NR30}.		3.6.4.13			5 out of 5	Chain (1); Compositional bias (5); Domain (2); Helix (1); Modified residue (18); Motif (2); Nucleotide binding (1); Region (4); Repeat (6); Sequence conflict (2)		3D-structure;ATP-binding;Acetylation;Antiviral defense;Cytoplasm;Helicase;Hydrolase;Immunity;Innate immunity;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;rRNA processing	DOMAIN 289..468;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 501..645;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The helicase and foldase activities reside in two separate domains, the helicase in the N-terminus and the foldase in the C-terminus. {ECO:0000250|UniProtKB:Q9NR30}.; DOMAIN: The 3 X 5 AA repeats seem to be critical for the RNA folding activity. {ECO:0000250}.	MOTIF 258..286;  /note=Q motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00552; MOTIF 411..414;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541	REPEAT 117..153;  /note=1-1; REPEAT 154..190;  /note=1-2; REPEAT 191..227;  /note=1-3; REPEAT 807..811;  /note=2-1; REPEAT 817..823;  /note=2-2; REPEAT 829..833;  /note=2-3		PS51192;PS51194;PS51195;	56200	GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0043330~response to exogenous dsRNA,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0097322~7SK snRNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012562:GUCT,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08152:GUCT (NUC152) domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54928:RNA-binding domain, RBD,	3.48594114354964	1.08261716314698e-05	FDR<0.01	4.96552509215264	68837908.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	39	Transcription
P63017	P63017;P17156;Q61696;P16627;P17879	Hspa8	15.556	16.495	56270000	35.1345653854262	30.6250574219827	14.9754402779442	27.1392514994436	19.6780668267149	17.551249648975	32235333.3333333	0	Hspa8	0	Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8)		FUNCTION: Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1. Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70. Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1. Interacts with VGF-derived peptide TLQP-21. {ECO:0000250|UniProtKB:P11142}.		ATP metabolic process [GO:0046034]; cellular protein complex disassembly [GO:0043624]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport involved in chaperone-mediated autophagy [GO:0061741]; clathrin coat disassembly [GO:0072318]; late endosomal microautophagy [GO:0061738]; maintenance of postsynaptic specialization structure [GO:0098880]; modulation by host of viral process [GO:0044788]; mRNA processing [GO:0006397]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of supramolecular fiber organization [GO:1902904]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of catalytic activity [GO:0043085]; positive regulation of gene expression [GO:0010628]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein refolding [GO:1904592]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein autophosphorylation [GO:0046777]; protein folding [GO:0006457]; protein import into nucleus [GO:0006606]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of protein complex stability [GO:0061635]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380]; slow axonal transport [GO:1990832]; vesicle-mediated transport [GO:0016192]	asymmetric synapse [GO:0032279]; autophagosome [GO:0005776]; axon [GO:0030424]; cell surface [GO:0009986]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; late endosome lumen [GO:0031906]; lysosomal matrix [GO:1990836]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]	A1 adenosine receptor binding [GO:0031686]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; clathrin-uncoating ATPase activity [GO:1990833]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; prostaglandin binding [GO:1904593]; protein folding chaperone [GO:0044183]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Melanosome {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Translocates rapidly from the cytoplasm to the nuclei, and especially to the nucleoli, upon heat shock (By similarity). {ECO:0000250}.	15481;		IPR043129;IPR018181;IPR029048;IPR029047;IPR013126;	PF00012;		70871		REGION 2..386;  /note=Nucleotide-binding domain (NBD);  /evidence=ECO:0000250|UniProtKB:P11142; REGION 186..377;  /note=Interaction with BAG1;  /evidence=ECO:0000250; REGION 394..509;  /note=Substrate-binding domain (SBD);  /evidence=ECO:0000250|UniProtKB:P11142; REGION 614..646;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 71;  /note=ATP;  /evidence=ECO:0000250	3.6.4.10			5 out of 5	Beta strand (17); Binding site (1); Chain (1); Cross-link (2); Frameshift (1); Helix (15); Initiator methionine (1); Modified residue (20); Nucleotide binding (4); Region (4); Sequence conflict (14); Turn (7)		3D-structure;ATP-binding;Acetylation;Cell membrane;Chaperone;Cytoplasm;Direct protein sequencing;Hydrolase;Isopeptide bond;Membrane;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Spliceosome;Stress response;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing		DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as the ATPase domain) is responsible for binding and hydrolyzing ATP. The C-terminal substrate-binding domain (SBD) (also known as peptide-binding domain) binds to the client/substrate proteins. The two domains are allosterically coupled so that, when ATP is bound to the NBD, the SBD binds relatively weakly to clients. When ADP is bound in the NBD, a conformational change enhances the affinity of the SBD for client proteins. {ECO:0000250|UniProtKB:P11142}.				PS00297;PS00329;PS01036;	15481	GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006457~protein folding,GO:0006606~protein import into nucleus,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0031647~regulation of protein stability,GO:0042026~protein refolding,GO:0043085~positive regulation of catalytic activity,GO:0043624~cellular protein complex disassembly,GO:0044788~modulation by host of viral process,GO:0044829~positive regulation by host of viral genome replication,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046034~ATP metabolic process,GO:0046777~protein autophosphorylation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0050766~positive regulation of phagocytosis,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051726~regulation of cell cycle,GO:0061077~chaperone-mediated protein folding,GO:0061635~regulation of protein complex stability,GO:0061684~chaperone-mediated autophagy,GO:0061738~late endosomal microautophagy,GO:0061740~protein targeting to lysosome involved in chaperone-mediated autophagy,GO:0061741~chaperone-mediated protein transport involved in chaperone-mediated autophagy,GO:0072318~clathrin coat disassembly,GO:0097214~positive regulation of lysosomal membrane permeability,GO:1902904~negative regulation of fibril organization,GO:1904592~positive regulation of protein refolding,GO:1904764~chaperone-mediated autophagy translocation complex disassembly,	GO:0000151~ubiquitin ligase complex,GO:0000974~Prp19 complex,GO:0001917~photoreceptor inner segment,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0005776~autophagosome,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032279~asymmetric synapse,GO:0042470~melanosome,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:1990124~messenger ribonucleoprotein complex,GO:1990836~lysosomal matrix,	GO:0000166~nucleotide binding,GO:0001664~G-protein coupled receptor binding,GO:0001786~phosphatidylserine binding,GO:0003723~RNA binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0016887~ATPase activity,GO:0019899~enzyme binding,GO:0023026~MHC class II protein complex binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0031686~A1 adenosine receptor binding,GO:0042277~peptide binding,GO:0042623~ATPase activity, coupled,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,GO:0055131~C3HC4-type RING finger domain binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1904593~prostaglandin binding,GO:1990833~clathrin-uncoating ATPase activity,	IPR013126:Heat shock protein 70 family,IPR018181:Heat shock protein 70, conserved site,	PF00012:Hsp70 protein,	SSF100920:Heat shock protein 70kD (HSP70), peptide-binding domain,SSF100934:Heat shock protein 70kD (HSP70), C-terminal subdomain,	4.39670873507392	4.04999265480732e-10	FDR<0.01	9.3925457644346	44252666.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	56	Transcription
Q8CI11	Q8CI11;Q8CI11-2;REV__Q8BMK4;Q5SPX1-2;Q5SPX1	Gnl3	21.437	24.123	27587000	16.9190423822012	18.7227350171313	14.1464725770629	15.4657510942019	30.8537225016198	22.1278102318994	48152233.3333333	0	Gnl3	0	Guanine nucleotide-binding protein-like 3 (Nucleolar GTP-binding protein 3) (Nucleostemin)		FUNCTION: May be required to maintain the proliferative capacity of stem cells (By similarity). Stabilizes MDM2 by preventing its ubiquitination, and hence proteasomal degradation. {ECO:0000250, ECO:0000269|PubMed:21132010}.		cell population proliferation [GO:0008283]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell population proliferation [GO:0042127]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]	chromosome [GO:0005694]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA 5'-UTR binding [GO:0048027]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21132010}. Nucleus, nucleolus {ECO:0000269|PubMed:12464630}. Note=Shuttles between the nucleus and nucleolus. {ECO:0000250|UniProtKB:Q811S9}.	30877;		IPR030378;IPR014813;IPR006073;IPR023179;IPR027417;	PF08701;PF01926;		60786	COMPBIAS 1..45;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 69..117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 460..501;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 503..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..46;  /note=Basic;  /evidence=ECO:0000250; REGION 69..126;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..451;  /note=Intermediate;  /evidence=ECO:0000250; REGION 460..538;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 460..532;  /note=Acidic;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (5); Domain (1); Modified residue (6); Mutagenesis (1); Nucleotide binding (3); Region (6); Sequence conflict (2)		Acetylation;Alternative splicing;Coiled coil;GTP-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 129..307;  /note=CP-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01058	DOMAIN: The basic domain (B) allows nucleolar localization in the absence of GTP. The intermediate domain (I) inhibits nucleolar localization by the B domain and is required for exit from the nucleolus. Exit from the nucleolus to the nucleoplasm requires both the I and the acidic (A) domains, and may be triggered by GTP hydrolysis (By similarity). {ECO:0000250}.; DOMAIN: In contrast to other GTP-binding proteins, this family is characterized by a circular permutation of the GTPase motifs described by a G4-G1-G3 pattern.				PS51721;	30877	GO:0008283~cell proliferation,GO:0032206~positive regulation of telomere maintenance,GO:0033235~positive regulation of protein sumoylation,GO:0042127~regulation of cell proliferation,GO:0042254~ribosome biogenesis,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904816~positive regulation of protein localization to chromosome, telomeric region,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR014813:Guanine nucleotide-binding protein-like 3, N-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF01926:50S ribosome-binding GTPase,PF08701:GNL3L/Grn1 putative GTPase,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.31377509274559	1.89304097616583e-10	FDR<0.01	9.72283998533356	37869616.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	64	Transcription
Q9Z130	Q9Z130	Hnrnpdl	12.922	11.98	60600500	7.09521782318717	8.19202097157369	4.10728221136074	5.66989850881669	8.32916874895885	6.77277345072807	5461526.66666667	0	Hnrnpdl	0	Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein)		FUNCTION: Acts as a transcriptional regulator. Promotes transcription repression (By similarity). Promotes transcription activation in differentiated myotubes. Binds to double- and single-stranded DNA sequences (By similarity). Binds to the transcription suppressor CATR sequence of the COX5B promoter. Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs (By similarity). Binds both to nuclear and cytoplasmic poly(A) mRNAs (By similarity). Binds to poly(G) and poly(A), but not to poly(U) or poly(C) RNA homopolymers (By similarity). Binds to the 5'-ACUAGC-3' RNA consensus sequence (By similarity). {ECO:0000250, ECO:0000269|PubMed:15190078}.		mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10717477, ECO:0000269|PubMed:15190078}. Cytoplasm {ECO:0000250|UniProtKB:O14979}. Note=Shuttles between the nucleus and the cytoplasm in a TNPO1-dependent manner. {ECO:0000250|UniProtKB:O14979}.		cd12758;	IPR034847;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	33559		REGION 194..229;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 223..301;  /note=Necessary for interaction with TNPO1;  /evidence=ECO:0000250; REGION 279..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (1); Domain (2); Modified residue (5); Region (3)		Acetylation;Activator;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 29..111;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 114..193;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016071~mRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.93685076401031	5.00278129413337e-08	FDR<0.01	7.30078848269068	33031013.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	73	Transcription
Q61990	Q61990;Q61990-2;Q61990-3;P57722-2;P57722	Pcbp2	10.533	14.108	60246000	NA	12.9620988230414	NA	NA	6.81152510047	42.8063867128976	858713.333333333	3	Pcbp2	0	Poly(rC)-binding protein 2 (Alpha-CP2) (CTBP) (CBP) (Putative heterogeneous nuclear ribonucleoprotein X) (hnRNP X)		FUNCTION: Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. Major cellular poly(rC)-binding protein. Binds also poly(rU). Negatively regulates cellular antiviral responses mediated by MAVS signaling. It acts as an adapter between MAVS and the E3 ubiquitin ligase ITCH, therefore triggering MAVS ubiquitinationa and degradation (By similarity). {ECO:0000250}.		defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	C-rich single-stranded DNA binding [GO:1990829]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.	18521;		IPR004087;IPR004088;IPR036612;	PF00013;	SM00322;	38222			NA							5 out of 5	Alternative sequence (2); Chain (1); Cross-link (3); Domain (3); Modified residue (5)		Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 13..75;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 97..162;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 284..348;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The KH domains mediates poly(C) binding. {ECO:0000250}.				PS50084;	18521	GO:0002376~immune system process,GO:0039694~viral RNA genome replication,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045087~innate immune response,GO:0050687~negative regulation of defense response to virus,GO:0051607~defense response to virus,GO:0075522~IRES-dependent viral translational initiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:1990829~C-rich single-stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.81984910348137	1.14097386624534e-05	FDR<0.01	4.94272430288715	30552356.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	77	Transcription
P17182	P17182;P21550;P17183	Eno1	10.223	11.085	44468500	4.86902327393125	9.89119683481701	16.8310499208941	9.78282136568186	11.1989607364437	8.06451612903226	13085033.3333333	0	Eno1	0	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 1) (Non-neural enolase) (NNE)		FUNCTION: Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. In addition to glycolysis, involved in various processes such as growth control, hypoxia tolerance and allergic responses. May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons. Stimulates immunoglobulin production. {ECO:0000250|UniProtKB:P06733}.	PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5.	canonical glycolysis [GO:0061621]; cellular response to interleukin-7 [GO:0098761]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; positive regulation of binding [GO:0051099]; regulation of vacuole fusion, non-autophagic [GO:0032889]	cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]	DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; GTPase binding [GO:0051020]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form (By similarity). ENO1 is localized to the M-band. {ECO:0000250, ECO:0000269|PubMed:11229603}.	13806;433182;	cd03313;	IPR000941;IPR036849;IPR029017;IPR020810;IPR020809;IPR020811;	PF00113;PF03952;	SM01192;SM01193;	47141		REGION 370..373;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:P00924; REGION 405..434;  /note=Required for interaction with PLG;  /evidence=ECO:0000250	NA	ACT_SITE 210;  /note=Proton donor;  /evidence=ECO:0000250|UniProtKB:P00924; ACT_SITE 343;  /note=Proton acceptor;  /evidence=ECO:0000250|UniProtKB:P00924		BINDING 158;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 167;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 293;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 318;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 394;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924	4.2.1.11	METAL 40;  /note=Magnesium 1;  /evidence=ECO:0000250|UniProtKB:P06733; METAL 245;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P06733; METAL 293;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P06733; METAL 318;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P06733		5 out of 5	Active site (2); Binding site (5); Chain (1); Cross-link (1); Initiator methionine (1); Metal binding (4); Modified residue (30); Region (2); Sequence conflict (1)		Acetylation;Cell membrane;Cytoplasm;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Lyase;Magnesium;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Ubl conjugation						PS00164;	13806	GO:0001701~in utero embryonic development,GO:0006096~glycolytic process,GO:0051099~positive regulation of binding,GO:0071229~cellular response to acid chemical,GO:0098609~cell-cell adhesion,	GO:0000015~phosphopyruvate hydratase complex,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0019897~extrinsic component of plasma membrane,GO:0043005~neuron projection,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0097060~synaptic membrane,	GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004634~phosphopyruvate hydratase activity,GO:0031072~heat shock protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000941:Enolase,IPR020809:Enolase, conserved site,IPR020810:Enolase, C-terminal,IPR020811:Enolase, N-terminal,	PF00113:Enolase, C-terminal TIM barrel domain,PF03952:Enolase, N-terminal domain,	SSF51604:Enolase C-terminal domain-like,SSF54826:Enolase N-terminal domain-like,	3.28428073422894	1.12062195569388e-08	FDR<0.01	7.95054087290603	28776766.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	84	Transcription
Q91VC3	Q91VC3	Eif4a3	23.922	50.186	29753000	24.6530088997362	17.9433349482335	8.20883270398949	25.3787782656143	37.5079704437193	12.9207313133923	19138531.6666667	0	Eif4a3	0	Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]		FUNCTION: ATP-dependent RNA helicase. Involved in pre-mRNA splicing as component of the spliceosome. Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Its RNA-dependent ATPase and RNA-helicase activities are induced by CASC3, but abolished in presence of the MAGOH-RBM8A heterodimer, thereby trapping the ATP-bound EJC core onto spliced mRNA in a stable conformation. The inhibition of ATPase activity by the MAGOH-RBM8A heterodimer increases the RNA-binding affinity of the EJC. Involved in translational enhancement of spliced mRNAs after formation of the 80S ribosome complex. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Shows higher affinity for single-stranded RNA in an ATP-bound core EJC complex than after the ATP is hydrolyzed. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms; the function is different from the established EJC assembly. Involved in craniofacial development. {ECO:0000250|UniProtKB:P38919}.		embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of gene expression [GO:0010629]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA binding [GO:1902415]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; rRNA processing [GO:0006364]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 1 spliceosome [GO:0071006]	ATP binding [GO:0005524]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q3B8Q2}. Nucleus speckle {ECO:0000250|UniProtKB:P38919}. Cytoplasm {ECO:0000250|UniProtKB:Q3B8Q2}. Note=Nucleocytoplasmic shuttling protein. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. Detected in dendritic layer as well as the nuclear and cytoplasmic (somatic) compartments of neurons. Colocalizes with STAU1 and FMR1 in dendrites. {ECO:0000250|UniProtKB:Q3B8Q2}.	192170;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	46840			NA		ACTIVITY REGULATION: The ATPase activity is increased some 4-fold in the presence of RNA. {ECO:0000250|UniProtKB:P38919}.	BINDING 60;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:P38919; BINDING 65;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P38919; BINDING 342;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P38919	3.6.4.13			5 out of 5	Binding site (3); Chain (2); Cross-link (5); Domain (2); Initiator methionine (1); Modified residue (9); Motif (2); Nucleotide binding (2); Sequence conflict (13)		ATP-binding;Acetylation;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;Nonsense-mediated mRNA decay;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Translation regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport;rRNA processing	DOMAIN 69..239;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 250..411;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 38..66;  /note=Q motif; MOTIF 187..190;  /note=DEAD box;  /evidence=ECO:0000305			PS00039;PS51192;PS51194;PS51195;	192170	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0008306~associative learning,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0010629~negative regulation of gene expression,GO:0014070~response to organic cyclic compound,GO:0016259~selenocysteine metabolic process,GO:0017148~negative regulation of translation,GO:0035640~exploration behavior,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0051028~mRNA transport,GO:0072715~cellular response to selenite ion,GO:0090394~negative regulation of excitatory postsynaptic potential,GO:1902415~regulation of mRNA binding,GO:1904570~negative regulation of selenocysteine incorporation,GO:1904574~negative regulation of selenocysteine insertion sequence binding,GO:1990416~cellular response to brain-derived neurotrophic factor stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0035145~exon-exon junction complex,GO:0043025~neuronal cell body,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003729~mRNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,GO:0008143~poly(A) binding,GO:0035368~selenocysteine insertion sequence binding,GO:0035613~RNA stem-loop binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.45525200819987	7.93648941303925e-09	FDR<0.01	8.10037155874342	24445765.8333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	96	Transcription
P14602	P14602;P14602-2;P14602-3	Hspb1	16.066	26.435	30542000	6.72043010752688	6.24570607707201	11.546144165156	5.77000750100975	8.03729303970423	6.63746183459445	13477550	0	Hspb1	0	Heat shock protein beta-1 (HspB1) (Growth-related 25 kDa protein) (Heat shock 25 kDa protein) (HSP 25) (Heat shock 27 kDa protein) (HSP 27) (p25)		FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state. Plays a role in stress resistance and actin organization (PubMed:17661394). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (By similarity). {ECO:0000250|UniProtKB:P04792, ECO:0000269|PubMed:17661394}.		anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of regulatory T cell differentiation [GO:0045590]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cardiac myofibril [GO:0097512]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; I band [GO:0031674]; M band [GO:0031430]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; proteasome complex [GO:0000502]; spindle [GO:0005819]; synapse [GO:0045202]; Z disc [GO:0030018]	identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04792}. Nucleus {ECO:0000250|UniProtKB:P04792}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P04792}. Note=Cytoplasmic in interphase cells. Colocalizes with mitotic spindles in mitotic cells. Translocates to the nucleus during heat shock and resides in sub-nuclear structures known as SC35 speckles or nuclear splicing speckles. {ECO:0000250|UniProtKB:P04792}.	15507;	cd06475;	IPR002068;IPR037876;IPR001436;IPR008978;	PF00011;		23014		REGION 74..209;  /note=Interaction with TGFB1I1;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Domain (1); Modified residue (12); Region (1); Sequence conflict (12)		Acetylation;Alternative splicing;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Stress response	DOMAIN 80..188;  /note=sHSP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00285					PS01031;	15507	GO:0001895~retina homeostasis,GO:0006469~negative regulation of protein kinase activity,GO:0006986~response to unfolded protein,GO:0009615~response to virus,GO:0010976~positive regulation of neuron projection development,GO:0032731~positive regulation of interleukin-1 beta production,GO:0035556~intracellular signal transduction,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0070527~platelet aggregation,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:2001028~positive regulation of endothelial cell chemotaxis,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0000502~proteasome complex,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030018~Z disc,GO:0030424~axon,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0031430~M band,GO:0031674~I band,GO:0043204~perikaryon,GO:0043292~contractile fiber,GO:0045202~synapse,GO:0070062~extracellular exosome,GO:0097512~cardiac myofibril,GO:0098839~postsynaptic density membrane,	GO:0005080~protein kinase C binding,GO:0008426~protein kinase C inhibitor activity,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0044822~poly(A) RNA binding,	IPR001436:Alpha crystallin/Heat shock protein,IPR002068:Alpha crystallin/Hsp20 domain,IPR008978:HSP20-like chaperone,	PF00011:Hsp20/alpha crystallin family,	SSF49764:HSP20-like chaperones,	3.23962354019742	1.49500457016626e-07	FDR<0.01	6.82535747971751	22009775	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	106	Transcription
Q3THK3	Q3THK3	Gtf2f1	1.7976	1.8891	31844000	2.59060646097251	2.14174037823135	3.8677238445175	1.71479525344674	1.78641609203616	1.73774024258854	4813270	0	Gtf2f1	0	General transcription factor IIF subunit 1 (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)		FUNCTION: TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation (By similarity). {ECO:0000250}.		negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to virus [GO:0009615]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	98053;		IPR008851;IPR011039;IPR036388;IPR036390;	PF05793;		57241	COMPBIAS 179..214;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 273..287;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 288..305;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 306..320;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..345;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 380..413;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 429..444;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 177..446;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (7); Initiator methionine (1); Modified residue (19); Region (1); Sequence conflict (4)		Acetylation;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							98053	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0009615~response to virus,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0030054~cell junction,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019211~phosphatase activator activity,GO:0044822~poly(A) RNA binding,	IPR008851:Transcription initiation factor IIF, alpha subunit,IPR011039:Transcription Factor IIF, Rap30/Rap74, interaction,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF05793:Transcription initiation factor IIF, alpha subunit (TFIIF-alpha),	SSF46785:Winged helix DNA-binding domain,SSF50916:Rap30/74 interaction domains,	1.07495578720878	0.000236466073303348	FDR<0.01	3.62623116035568	18328635	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	125	Transcription
Q64213	Q64213-2;Q64213-3;Q64213	Sf1	11.792	20.693	25654500	10.528864883077	12.7378799072682	9.43574259294206	19.4344572927801	8.58369098712446	8.34376303712975	10764073.3333333	0	Sf1	0	Splicing factor 1 (CW17) (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (mZFM) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162)		FUNCTION: Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor (By similarity). {ECO:0000250}.		Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of steroid biosynthetic process [GO:0050810]	cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	mRNA binding [GO:0003729]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus.			IPR031150;IPR004087;IPR004088;IPR036612;IPR032570;IPR001878;	PF00013;PF16275;PF00098;	SM00322;SM00343;	70403	COMPBIAS 346..361;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 415..445;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 472..518;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 519..563;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 564..584;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 65..94;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 325..584;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 611..653;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Domain (1); Initiator methionine (1); Modified residue (7); Motif (1); Region (4); Sequence conflict (6); Zinc finger (1)		Acetylation;Alternative splicing;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Spliceosome;Transcription;Transcription regulation;Zinc;Zinc-finger;mRNA processing;mRNA splicing	DOMAIN 141..222;  /note=KH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117		MOTIF 15..19;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 277..296;  /note=CCHC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00047	PS50084;PS50158;	NA	GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030238~male sex determination,GO:0030575~nuclear body organization,GO:0033327~Leydig cell differentiation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0045131~pre-mRNA branch point binding,GO:0046872~metal ion binding,	IPR001878:Zinc finger, CCHC-type,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,PF00098:Zinc knuckle,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.58488950172499	4.42997672289206e-09	FDR<0.01	8.35359855575122	18209286.6666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	126	Transcription
Q9Z1N5	Q9Z1N5	Ddx39b	25.005	26.195	15726500	27.8691265815729	21.2747851246702	24.3783520234032	15.2732382319699	20.7013621496294	22.6916880346729	19935933.3333333	0	Ddx39b	0	Spliceosome RNA helicase Ddx39b (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)		FUNCTION: Involved in nuclear export of spliced and unspliced mRNA. Assembling component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. May undergo several rounds of ATP hydrolysis during assembly of TREX to drive subsequent loading of components such as ALYREF/THOC and CHTOP onto mRNA. Also associates with pre-mRNA independent of ALYREF/THOC4 and the THO complex. Involved in the nuclear export of intronless mRNA; the ATP-bound form is proposed to recruit export adapter ALYREF/THOC4 to intronless mRNA; its ATPase activity is cooperatively stimulated by RNA and ALYREF/THOC4 and ATP hydrolysis is thought to trigger the dissociation from RNA to allow the association of ALYREF/THOC4 and the NXF1-NXT1 heterodimer. Involved in transcription elongation and genome stability. {ECO:0000250|UniProtKB:Q13838}.; FUNCTION: Splice factor that is required for the first ATP-dependent step in spliceosome assembly and for the interaction of U2 snRNP with the branchpoint. Has both RNA-stimulated ATP binding/hydrolysis activity and ATP-dependent RNA unwinding activity. Even with the stimulation of RNA, the ATPase activity is weak. Can only hydrolyze ATP but not other NTPs. The RNA stimulation of ATPase activity does not have a strong preference for the sequence and length of the RNA. However, ssRNA stimulates the ATPase activity much more strongly than dsRNA. Can unwind 5' or 3' overhangs or blunt end RNA duplexes in vitro. The ATPase and helicase activities are not influenced by U2AF2; the effect of ALYREF/THOC4 is reported conflictingly with [] reporting a stimulatory effect. {ECO:0000250|UniProtKB:Q13838}.		liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]	ATPase activity [GO:0016887]; ATPase activity, acting on RNA [GO:0008186]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Can translocate to the cytoplasm in the presence of MX1. {ECO:0000250}.	53817;		IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	49035	COMPBIAS 1..22;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Domain (2); Initiator methionine (1); Modified residue (5); Motif (2); Nucleotide binding (1); Region (1)		ATP-binding;Acetylation;Cytoplasm;Direct protein sequencing;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 76..249;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 261..422;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The helicase C-terminal domain mediates interaction with ALYREF/THOC4. {ECO:0000250}.	MOTIF 45..73;  /note=Q motif; MOTIF 196..199;  /note=DECD box			PS51192;PS51194;PS51195;	53817	GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001889~liver development,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0045727~positive regulation of translation,GO:0046784~viral mRNA export from host cell nucleus,GO:0051028~mRNA transport,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005687~U4 snRNP,GO:0005688~U6 snRNP,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0043234~protein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008186~RNA-dependent ATPase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017070~U6 snRNA binding,GO:0030621~U4 snRNA binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0043008~ATP-dependent protein binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.49790517363872	5.67465229035157e-11	FDR<0.01	10.2460607443565	17831216.6666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	132	Transcription
P62264	P62264	Rps14	15.659	6.4528	17814500	12.2393028493097	17.6447753820094	5.74085768413801	4.55518607935134	11.9743270428202	15.1904118120642	14715266.6666667	0	Rps14	0	40S ribosomal protein S14				erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]	mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]		20044;		IPR001971;IPR018102;IPR036967;	PF00411;		16273		REGION 131..151;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Cross-link (3); Modified residue (3); Region (1)		Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00054;	20044	GO:0000028~ribosomal small subunit assembly,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,GO:0030218~erythrocyte differentiation,GO:0030490~maturation of SSU-rRNA,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,GO:0070181~small ribosomal subunit rRNA binding,	IPR001971:Ribosomal protein S11,IPR018102:Ribosomal S11, conserved site,	PF00411:Ribosomal protein S11,		3.32865026995319	8.52881593663589e-08	FDR<0.01	7.06911125815009	16264883.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	143	Transcription
Q08288	Q08288	Lyar	6.3161	6.8855	26685150	9.8116169544741	18.0551041779511	42.1407501053519	6.66178136033575	11.3049278180359	8.48752334068919	4905866.66666667	0	Lyar	0	Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264)		FUNCTION: Plays a role in the maintenance of the appropriate processing of 47S/45S pre-rRNA to 32S/30S pre-rRNAs and their subsequent processing to produce 18S and 28S rRNAs (By similarity). Also acts at the level of transcription regulation. Along with PRMT5, binds embryonic globin promoter (By similarity). Represses the expression of embryonic globin Hbb-y gene (PubMed:25092918). In neuroblastoma cells, may also repress the expression of oxidative stress genes, including CHAC1, HMOX1, SLC7A11, ULBP1 and that encoding the small nucleolar RNA SNORD41 (By similarity). Preferentially binds to a DNA motif containing 5'-GGTTAT-3' (By similarity). Negatively regulates the antiviral innate immune response by targeting IRF3 and impairing its DNA-binding activity (By similarity). In addition, inhibits NF-kappa-B-mediated expression of proinflammatory cytokines (By similarity). Stimulates phagocytosis of photoreceptor outer segments by retinal pigment epithelial cells (PubMed:25735755). Prevents NCL self-cleavage, maintaining a normal steady-state level of NCL protein in undifferentiated embryonic stem cells (ESCs), which in turn is essential for ESC self-renewal (PubMed:19489080). {ECO:0000250|UniProtKB:Q9NX58, ECO:0000269|PubMed:19489080, ECO:0000269|PubMed:25092918, ECO:0000269|PubMed:25735755}.		erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]	activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulator inhibitor activity [GO:0140416]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19489080, ECO:0000269|PubMed:23212345, ECO:0000269|PubMed:24990247, ECO:0000269|PubMed:8491376}. Cytoplasm {ECO:0000269|PubMed:24990247}. Cell projection, cilium, photoreceptor outer segment {ECO:0000269|PubMed:25735755}. Note=Component of pre-ribosomal particles, including pre-40S, pre-60S and pre-90S (By similarity). Associated with cytoplasmic ribosomes, but not polysomes, as a component of the 60S subunit (PubMed:24990247). In the retina, predominantly expressed in photoreceptor outer segments (PubMed:25735755). In the nucleolus, colocalizes with nucleolin/NCL, therefore may reside in the dense fibrillar component (DFC) (PubMed:19489080). {ECO:0000250|UniProtKB:Q9NX58, ECO:0000269|PubMed:19489080, ECO:0000269|PubMed:24990247, ECO:0000269|PubMed:25735755}.	17089;		IPR039999;IPR014898;IPR036236;	PF08790;		43736	COMPBIAS 140..154;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 176..213;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 272..316;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 140..318;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 6;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 9;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 21;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 25;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 33;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 36;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 48;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 51;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145		5 out of 5	Beta strand (4); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (2); Helix (2); Metal binding (8); Region (1); Sequence conflict (6); Turn (2); Zinc finger (2)		3D-structure;Cell projection;Coiled coil;Cytoplasm;DNA-binding;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The N-terminal zinc-finger domains are required for the appropriate production of 28S rRNA and the formation of pre-60S particles. {ECO:0000250|UniProtKB:Q9NX58}.			ZN_FING 1..26;  /note=C2HC LYAR-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; ZN_FING 28..52;  /note=C2HC LYAR-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145	PS51804;	17089		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR014898:Zinc finger, C2H2, LYAR-type,	PF08790:LYAR-type C2HC zinc finger ,		3.45358709913093	2.5699017358132e-07	FDR<0.01	6.5900834822757	15795508.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	145	Transcription
Q9DBD5	Q9DBD5	Pelp1	2.2955	2.6496	6240000	2.74529182452095	2.23219268287239	3.95319418089817	1.64690382081686	3.66905155017428	3.05838456127473	20776233.3333333	0	Pelp1	0	Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor)		FUNCTION: Coactivator of estrogen receptor-mediated transcription and a corepressor of other nuclear hormone receptors and sequence-specific transcription factors. Plays a role in estrogen receptor (ER) genomic activity when present in the nuclear compartment by activating the ER target genes in a hormonal stimulation dependent manner. Can facilitate ER non-genomic signaling via SRC and PI3K interaction in the cytosol. Plays a role in E2-mediated cell cycle progression by interacting with RB1. May have important functional implications in ER/growth factor cross-talk. Interacts with several growth factor signaling components including EGFR and HRS. Functions as the key stabilizing component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit. Regulates pre-60S association of the critical remodeling factor MDN1 (By similarity). {ECO:0000250|UniProtKB:Q8IZL8, ECO:0000269|PubMed:22872859}.		cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	chromatin binding [GO:0003682]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8IZL8}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Nucleus {ECO:0000269|PubMed:11481323, ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:11481323, ECO:0000269|PubMed:22872859}. Note=Mainly found in the nucleoplasm, with low levels detected in the cytoplasm. Also found associated with the plasma membrane. {ECO:0000269|PubMed:22872859}.	75273;		IPR016024;IPR012583;IPR012980;	PF08166;PF08167;		118069	COMPBIAS 640..678;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 692..706;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 801..828;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 838..869;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 887..966;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 973..992;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1086..1100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1107..1123;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..80;  /note=Required for modulation of ESR1 transcriptional activity;  /evidence=ECO:0000250|UniProtKB:Q8IZL8; REGION 121..189;  /note=Required for modulation of ESR1 transcriptional activity;  /evidence=ECO:0000250|UniProtKB:Q8IZL8; REGION 639..767;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 779..1123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Initiator methionine (1); Modified residue (8); Motif (11); Region (4); Sequence conflict (3)		Acetylation;Activator;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Ubl conjugation		DOMAIN: The Glu-rich region mediates histones interaction. {ECO:0000250|UniProtKB:Q8IZL8}.; DOMAIN: The Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are required for the association with nuclear receptor ESR1. {ECO:0000250|UniProtKB:Q8IZL8}.	MOTIF 33..37;  /note=LXXLL motif 1; MOTIF 69..73;  /note=LXXLL motif 2; MOTIF 111..115;  /note=LXXLL motif 3; MOTIF 155..159;  /note=LXXLL motif 4; MOTIF 177..181;  /note=LXXLL motif 5; MOTIF 264..268;  /note=LXXLL motif 6; MOTIF 271..275;  /note=LXXLL motif 7; MOTIF 365..369;  /note=LXXLL motif 8; MOTIF 460..464;  /note=LXXLL motif 9; MOTIF 580..584;  /note=LXXLL motif 10; MOTIF 585..589;  /note=LXXLL motif 11				75273	GO:0006351~transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071391~cellular response to estrogen stimulus,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,GO:0071339~MLL1 complex,	GO:0003682~chromatin binding,GO:0008134~transcription factor binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR012980:Uncharacterised domain NUC202,IPR016024:Armadillo-type fold,	PF08166:NUC202 domain,PF08167:rRNA processing/ribosome biogenesis,	SSF48371:ARM repeat,	1.42636952690361	2.06598940995458e-05	FDR<0.01	4.68487190895874	13508116.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	173	Transcription
Q3U0V1	Q3U0V1	Khsrp	10.169	16.573	21076000	13.081300281248	15.7713781030186	16.6672222407414	6.02409638554217	8.97746655893707	15.8815868881619	4716983.33333333	0	Khsrp	0	Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP)		FUNCTION: Binds to the dendritic targeting element and may play a role in mRNA trafficking. Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting degradation machinery to ARE-containing mRNAs (By similarity). {ECO:0000250}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=A small proportion is also found in the cytoplasm of neuronal cell bodies and dendrites. {ECO:0000250}.	16549;		IPR015096;IPR004087;IPR004088;IPR036612;	PF09005;PF00013;	SM00322;	76775	COMPBIAS 503..546;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 588..615;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..78;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 90..148;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 394..422;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 498..570;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 572..685;  /note=4 X 12 AA imperfect repeats; REGION 588..650;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 659..678;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 689..735;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Domain (4); Initiator methionine (1); Modified residue (15); Region (8); Repeat (4); Sequence conflict (1)		Acetylation;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 145..209;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 234..300;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 323..387;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 425..492;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117			REPEAT 572..583;  /note=1; REPEAT 618..629;  /note=2; REPEAT 644..655;  /note=3; REPEAT 674..685;  /note=4		PS00178;PS50084;	16549	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0006810~transport,GO:0008380~RNA splicing,GO:0043488~regulation of mRNA stability,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0051028~mRNA transport,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071345~cellular response to cytokine stimulus,GO:2000628~regulation of miRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,	PF00013:KH domain,PF09005:Domain of unknown function (DUF1897),	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.61135222856753	5.36196608792608e-09	FDR<0.01	8.27067593706577	12896491.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	183	Transcription
P70372	P70372	Elavl1	15.605	26.759	19625000	13.9097535191676	10.8296602735572	16.0942479157949	NA	8.44238075137189	9.96710854181202	5709536.66666667	1	Elavl1	0	ELAV-like protein 1 (Elav-like generic protein) (Hu-antigen R) (HuR) (MelG)		FUNCTION: RNA-binding protein that binds to the 3'-UTR region of mRNAs and increases their stability. Involved in embryonic stem cells (ESCs) differentiation: preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), stabilizing them, promoting ESCs differentiation (PubMed:24394384). Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs. Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element, binds to a core element of 27 nucleotides that contain AUUUA, AUUUUA, and AUUUUUA motifs. Binds preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro (By similarity). With ZNF385A, binds the 3'-UTR of p53/TP53 mRNA to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind with ZNF385A the CCNB1 mRNA (PubMed:21402775). Increases the stability of the leptin mRNA harboring an AU-rich element (ARE) in its 3' UTR (PubMed:27616329). {ECO:0000250|UniProtKB:Q15717, ECO:0000269|PubMed:21402775, ECO:0000269|PubMed:24394384, ECO:0000269|PubMed:27616329}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA stabilization [GO:0048255]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; posttranscriptional gene silencing [GO:0016441]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of stem cell population maintenance [GO:2000036]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]	double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9763509}. Nucleus {ECO:0000269|PubMed:9763509}. Cytoplasm, Stress granule {ECO:0000269|PubMed:27616329}. Note=Translocates into the cytoplasm following phosphorylation by MAPKAPK2. Likewise, phosphorylation by PRKCD promotes translocation from the nucleus into the cytoplasm, where it is associated with free and cytoskeleton-bound polysomes (By similarity). Localizes to the stress granules in the presence of PLEKHN1. {ECO:0000250|UniProtKB:Q15717, ECO:0000269|PubMed:27616329}.	15568;	cd12650;cd12773;	IPR006548;IPR034775;IPR002343;IPR034996;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	36169			NA							5 out of 5	Chain (1); Cross-link (1); Domain (3); Initiator methionine (1); Modified residue (11); Sequence conflict (5)		Acetylation;Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 20..98;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 106..186;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 244..322;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The first RRM (RNA recognition motif) domain is essential for binding to AU-rich elements. {ECO:0000250|UniProtKB:Q15717}.				PS50102;	15568	GO:0006417~regulation of translation,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0060965~negative regulation of gene silencing by miRNA,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:2000036~regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:1990904~ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0017091~AU-rich element binding,GO:0019901~protein kinase binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002343:Paraneoplastic encephalomyelitis antigen,IPR006548:Splicing factor ELAV/HuD,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.76344685331523	2.9997149042652e-08	FDR<0.01	7.52292001907634	12667268.3333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	186	Transcription
Q6NS46	Q6NS46	Pdcd11	19.781	18.468	15027600	11.069416309678	12.9227349676285	11.2813339049209	4.43301711144605	16.3797480794745	11.6615355910066	9915131.66666667	0	Pdcd11	0	Protein RRP5 homolog (Apoptosis-linked gene 4 protein) (Programmed cell death protein 11)		FUNCTION: Essential for the generation of mature 18S rRNA, specifically necessary for cleavages at sites A0, 1 and 2 of the 47S precursor. Directly interacts with U3 snoRNA (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	18572;		IPR003107;IPR012340;IPR022967;IPR003029;IPR008847;IPR013026;IPR011990;	PF00575;PF05843;	SM00386;SM00316;	207779	COMPBIAS 10..24;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1016..1031;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1420..1509;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1546..1577;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..56;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 999..1036;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1406..1520;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1545..1577;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (13); Erroneous initiation (2); Initiator methionine (1); Modified residue (5); Region (4); Repeat (4); Sequence caution (1); Sequence conflict (11)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;rRNA processing	DOMAIN 83..171;  /note=S1 motif 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 187..258;  /note=S1 motif 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 281..346;  /note=S1 motif 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 365..436;  /note=S1 motif 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 453..522;  /note=S1 motif 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 542..611;  /note=S1 motif 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 636..707;  /note=S1 motif 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 729..798;  /note=S1 motif 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 846..911;  /note=S1 motif 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 1047..1120;  /note=S1 motif 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 1160..1233;  /note=S1 motif 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 1241..1309;  /note=S1 motif 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180; DOMAIN 1335..1407;  /note=S1 motif 13;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180			REPEAT 1590..1622;  /note=HAT 1; REPEAT 1696..1728;  /note=HAT 2; REPEAT 1766..1798;  /note=HAT 3; REPEAT 1800..1835;  /note=HAT 4		PS50126;	18572	GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0006397~mRNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0032040~small-subunit processome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0044822~poly(A) RNA binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR003107:RNA-processing protein, HAT helix,IPR008847:Suppressor of forked,IPR011990:Tetratricopeptide-like helical,IPR012340:Nucleic acid-binding, OB-fold,IPR013026:Tetratricopeptide repeat-containing domain,IPR022967:RNA-binding domain, S1,	PF00575:S1 RNA binding domain,PF05843:Suppressor of forked protein (Suf),	SSF48452:TPR-like,SSF50249:Nucleic acid-binding proteins,	3.61187847314953	1.9297583256671e-08	FDR<0.01	7.7144970766923	12471365.8333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	189	Transcription
Q9CXY6	Q9CXY6	Ilf2	24.061	7.2566	18927500	8.02568218298555	12.7882143816259	15.7054906395276	2.87331551877712	5.62872903298435	4.44030016429111	4350400	0	Ilf2	0	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)		FUNCTION: Appears to function predominantly as a heterodimeric complex with ILF3. This complex may regulate transcription of the IL2 gene during T-cell activation. It can also promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA (By similarity). Essential for the efficient reshuttling of ILF3 into the nucleus (By similarity). {ECO:0000250, ECO:0000269|PubMed:10574923}.		positive regulation of transcription, DNA-templated [GO:0045893]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11804788}. Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	67781;		IPR006561;IPR043519;	PF07528;	SM00572;	43062	COMPBIAS 368..390;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 351..390;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Beta strand (11); Chain (1); Compositional bias (1); Cross-link (2); Domain (1); Helix (16); Modified residue (6); Region (2); Sequence caution (1); Turn (3)		3D-structure;Activator;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 24..371;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040					PS51703;	67781	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006955~immune response,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006561:DZF,	PF07528:DZF domain,		3.03358316740843	1.68054693621664e-06	FDR<0.01	5.77454935355735	11638950	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	204	Transcription
Q91VR5	Q91VR5	Ddx1	25.8	8.6305	14392000	8.81911985183879	6.48466377018352	6.11321677466683	5.49661957895894	9.81932443047918	5.50388023556607	6950260	0	Ddx1	0	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)		FUNCTION: Acts as an ATP-dependent RNA helicase, able to unwind both RNA-RNA and RNA-DNA duplexes. Possesses 5' single-stranded RNA overhang nuclease activity. Possesses ATPase activity on various RNA, but not DNA polynucleotides. May play a role in RNA clearance at DNA double-strand breaks (DSBs), thereby facilitating the template-guided repair of transcriptionally active regions of the genome. Together with RELA, acts as a coactivator to enhance NF-kappa-B-mediated transcriptional activation (By similarity). Acts as a positive transcriptional regulator of cyclin CCND2 expression (PubMed:19398953). Binds to the cyclin CCND2 promoter region (PubMed:19398953). Associates with chromatin at the NF-kappa-B promoter region via association with RELA. Binds to poly(A) RNA. May be involved in 3'-end cleavage and polyadenylation of pre-mRNAs. Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB: together with archease (ZBTB8OS), acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation (By similarity). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (PubMed:21703541). Specifically binds (via helicase ATP-binding domain) on both short and long poly(I:C) dsRNA (PubMed:21703541). {ECO:0000250|UniProtKB:Q92499, ECO:0000269|PubMed:19398953, ECO:0000269|PubMed:21703541}.		defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92499}. Cytoplasm, cytosol {ECO:0000269|PubMed:21703541}. Cytoplasm {ECO:0000250|UniProtKB:Q92499}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q92499}. Mitochondrion {ECO:0000269|PubMed:21703541}. Note=Localized with MBNL1, TIAL1 and YBX1 in stress granules upon stress. Localized with CSTF2 in cleavage bodies. Forms large aggregates called DDX1 bodies. Relocalized into multiple foci (IR-induced foci or IRIF) after IR treatment, a process that depends on the presence of chromosomal DNA and/or RNA-DNA duplexes. Relocalized at sites of DNA double-strand breaks (DSBs) in an ATM-dependent manner after IR treatment. Colocalized with RELA in the nucleus upon TNF-alpha induction. Enters into the nucleus in case of active transcription while it accumulates in cytosol when transcription level is low (By similarity). Colocalizes in the cytosol with DDX21, DHX36 and TICAM1 (PubMed:21703541). Colocalizes in the mitochondria with TICAM1 and poly(I:C) RNA ligand (PubMed:21703541). The multi-helicase-TICAM1 complex may translocate to the mitochondria upon poly(I:C) stimulation (PubMed:21703541). {ECO:0000250|UniProtKB:Q92499, ECO:0000269|PubMed:21703541}.	104721;		IPR001870;IPR043136;IPR013320;IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;IPR003877;	PF00270;PF00271;PF00622;	SM00487;SM00490;SM00449;	82500		REGION 1..525;  /note=Necessary for interaction with RELA;  /evidence=ECO:0000250|UniProtKB:Q92499; REGION 1..448;  /note=Interaction with dsRNA;  /evidence=ECO:0000269|PubMed:21703541; REGION 1..295;  /note=Necessary for interaction with HNRNPK;  /evidence=ECO:0000250|UniProtKB:Q92499; REGION 525..740;  /note=Necessary for interaction with HNRNPK;  /evidence=ECO:0000250|UniProtKB:Q92499	NA				3.6.4.13			5 out of 5	Chain (1); Cross-link (1); Domain (3); Modified residue (4); Motif (1); Nucleotide binding (1); Region (4)		ATP-binding;Acetylation;Activator;Antiviral defense;Cytoplasm;DNA-binding;Exonuclease;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Mitochondrion;Nuclease;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;tRNA processing	DOMAIN 2..428;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 70..247;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548; DOMAIN 493..681;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The helicase domain is involved in the stimulation of RELA transcriptional activity. {ECO:0000250|UniProtKB:Q92499}.	MOTIF 370..373;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541			PS50188;PS51192;PS51194;PS51195;	104721	GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,GO:0007275~multicellular organism development,GO:0008033~tRNA processing,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032508~DNA duplex unwinding,GO:0043330~response to exogenous dsRNA,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071920~cleavage body,GO:0072669~tRNA-splicing ligase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008143~poly(A) binding,GO:0016787~hydrolase activity,GO:0033677~DNA/RNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF00622:SPRY domain,	SSF49899:Concanavalin A-like lectins/glucanases,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.0578698707493	1.78347634354423e-07	FDR<0.01	6.74873264687306	10671130	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	215	Transcription
Q6P5F9	Q6P5F9	Xpo1	10.625	7.7566	12152350	8.86053517632465	11.3677700982175	15.7606896877807	5.2653748946925	12.444621434616	5.11665984445354	8653693.33333333	0	Xpo1	0	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)		FUNCTION: Mediates the nuclear export of cellular proteins (cargos) bearing a leucine-rich nuclear export signal (NES) and of RNAs. In the nucleus, in association with RANBP3, binds cooperatively to the NES on its target protein and to the GTPase Ran in its active GTP-bound form. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the cargo from the export receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Involved in U3 snoRNA transport from Cajal bodies to nucleoli. Binds to late precursor U3 snoRNA bearing a TMG cap (By similarity). {ECO:0000250, ECO:0000269|PubMed:20921223}.		mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]	annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Note=Located in the nucleoplasm, Cajal bodies and nucleoli. Shuttles between the nucleus/nucleolus and the cytoplasm (By similarity). {ECO:0000250}.	103573;		IPR011989;IPR016024;IPR041123;IPR041235;IPR013598;IPR001494;IPR014877;IPR040485;	PF08767;PF18777;PF18784;PF18787;PF03810;PF08389;	SM01102;SM00913;	123093		REGION 327..450;  /note=Necessary for interaction with Ran and nuclear export complex formation;  /evidence=ECO:0000250; REGION 411..481;  /note=Necessary for interaction with RANBP3;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (11); Chain (1); Domain (1); Helix (65); Modified residue (7); Region (2); Repeat (10); Turn (10)		3D-structure;Acetylation;Cytoplasm;Nucleus;Phosphoprotein;Protein transport;RNA-binding;Reference proteome;Repeat;Transport;mRNA transport	DOMAIN 46..112;  /note=Importin N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00115			REPEAT 217..240;  /note=HEAT 1; REPEAT 241..277;  /note=HEAT 2; REPEAT 354..472;  /note=HEAT 3; REPEAT 515..553;  /note=HEAT 4; REPEAT 560..597;  /note=HEAT 5; REPEAT 602..639;  /note=HEAT 6; REPEAT 775..813;  /note=HEAT 7; REPEAT 885..916;  /note=HEAT 8; REPEAT 917..954;  /note=HEAT 9; REPEAT 1002..1039;  /note=HEAT 10		PS50166;	103573	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006611~protein export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0010824~regulation of centrosome duplication,GO:0015031~protein transport,GO:0034504~protein localization to nucleus,GO:0042176~regulation of protein catabolic process,GO:0042493~response to drug,GO:0046825~regulation of protein export from nucleus,GO:0051028~mRNA transport,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005642~annulate lamellae,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003723~RNA binding,GO:0005049~nuclear export signal receptor activity,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0019904~protein domain specific binding,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR014877:CRM1 C-terminal domain,IPR016024:Armadillo-type fold,	PF03810:Importin-beta N-terminal domain,PF08389:Exportin 1-like protein,PF08767:CRM1 C terminal,	SSF48371:ARM repeat,	3.17331679285464	3.14871124240274e-08	FDR<0.01	7.50186716520696	10403021.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	220	Transcription
P63101	P63101	Ywhaz	34.394	16.974	16060450	8.42389015247241	7.01705143498702	6.13195977434388	4.4937761200737	6.84181718664477	5.45018530630041	4001348.33333333	0	Ywhaz	0	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) (SEZ-2)		FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Induces ARHGEF7 activity on RAC1 as well as lamellipodia and membrane ruffle formation (By similarity). In neurons, regulates spine maturation through the modulation of ARHGEF7 activity (By similarity). {ECO:0000250|UniProtKB:O55043, ECO:0000250|UniProtKB:P63104}.		angiogenesis [GO:0001525]; ERK1 and ERK2 cascade [GO:0070371]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; histamine secretion by mast cell [GO:0002553]; lung development [GO:0030324]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; protein targeting to mitochondrion [GO:0006626]; regulation of cell death [GO:0010941]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of synapse maturation [GO:0090128]; respiratory system process [GO:0003016]; response to drug [GO:0042493]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]; tube formation [GO:0035148]	cell leading edge [GO:0031252]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Note=Located to stage I to stage IV melanosomes. {ECO:0000250}.	22631;		IPR000308;IPR023409;IPR036815;IPR023410;	PF00244;	SM00101;	27771			NA							5 out of 5	Chain (1); Modified residue (8); Sequence conflict (4); Site (2)		Acetylation;Cytoplasm;Direct protein sequencing;Phosphoprotein;Reference proteome						PS00796;PS00797;	22631	GO:0002553~histamine secretion by mast cell,GO:0006605~protein targeting,GO:0006626~protein targeting to mitochondrion,GO:0010941~regulation of cell death,GO:0042493~response to drug,GO:0051683~establishment of Golgi localization,GO:0090168~Golgi reassembly,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0030659~cytoplasmic vesicle membrane,GO:0031252~cell leading edge,GO:0042470~melanosome,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000308:14-3-3 protein,IPR023409:14-3-3 protein, conserved site,IPR023410:14-3-3 domain,	PF00244:14-3-3 protein,	SSF48445:14-3-3 protein,	3.13495657074604	9.80892432075236e-07	FDR<0.01	6.00837861618538	10030899.1666667	Present in Nucleus	RBP	Others	Others	Others	Others	225	Transcription
Q60749	Q60749;Q9WU01-2;Q9R226;Q9WU01	Khdrbs1	8.4265	13.225	11693850	31.3518936543767	15.5443636137537	NA	10.4729588203259	NA	9.72668028401906	5180443.33333333	2	Khdrbs1	0	KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein) (Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)		FUNCTION: Recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain-containing proteins. Role in G2-M progression in the cell cycle. Represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. Also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export. Positively regulates the association of constitutive transport element (CTE)-containing mRNA with large polyribosomes and translation initiation. May not be involved in the nucleocytoplasmic export of unspliced (CTE)-containing RNA species. RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). In cooperation with HNRNPA1 modulates alternative splicing of BCL2L1 by promoting splicing toward isoform Bcl-X(S), and of SMN1 (By similarity). Can regulate CD44 alternative splicing in a Ras pathway-dependent manner. Can regulate alternative splicing of NRXN1 and NRXN3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners. In a neuronal activity-dependent manner cooperates synergistically with KHDRBS2/SLIM-1 in regulation of NRXN1 exon skipping at AS4. The cooperation with KHDRBS2/SLIM-1 is antagonistic for regulation of NXRN3 alternative splicing at AS4 (PubMed:12478298, PubMed:22196734, PubMed:24469635). {ECO:0000250|UniProtKB:O75525, ECO:0000269|PubMed:12478298, ECO:0000269|PubMed:12496368, ECO:0000269|PubMed:22196734, ECO:0000269|PubMed:24469635, ECO:0000269|PubMed:7512695, ECO:0000269|PubMed:9315629}.		cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]	cytoplasm [GO:0005737]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12496368}. Cytoplasm {ECO:0000250|UniProtKB:Q07666}. Membrane {ECO:0000269|PubMed:12496368}. Note=Predominantly located in the nucleus but also located partially in the cytoplasm. {ECO:0000250|UniProtKB:Q07666}.	20218;		IPR004087;IPR004088;IPR036612;IPR032571;IPR032335;	PF00013;PF16274;PF16568;	SM00322;	48371		REGION 1..94;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 100..260;  /note=Involved in homodimerization;  /evidence=ECO:0000250|UniProtKB:Q07666; REGION 280..317;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 326..345;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 351..443;  /note=Interaction with HNRNPA1;  /evidence=ECO:0000250|UniProtKB:Q07666; REGION 400..420;  /note=Interaction with ZBTB7A;  /evidence=ECO:0000250|UniProtKB:Q07666; REGION 411..443;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Cross-link (5); Domain (1); Modified residue (33); Mutagenesis (4); Region (7); Sequence conflict (6)		Acetylation;Cell cycle;Cytoplasm;Direct protein sequencing;Isopeptide bond;Membrane;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;SH3-binding;Transcription;Transcription regulation;Ubl conjugation;mRNA processing	DOMAIN 171..197;  /note=KH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The KH domain is required for binding to RNA. {ECO:0000269|PubMed:9315629}.; DOMAIN: The Pro-rich domains are flanked by Arg/Gly-rich motifs which can be asymmetric dimethylated on arginine residues to give the DMA/Gly-rich regions. Selective methylation on these motifs can modulate protein-protein interactions (By similarity). {ECO:0000250}.				PS50084;	20218	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007166~cell surface receptor signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045948~positive regulation of translational initiation,GO:0046831~regulation of RNA export from nucleus,GO:0046833~positive regulation of RNA export from nucleus,GO:0048024~regulation of mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0070618~Grb2-Sos complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,GO:0008143~poly(A) binding,GO:0008266~poly(U) RNA binding,GO:0017124~SH3 domain binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.73324572510317	5.25001766093684e-07	FDR<0.01	6.27983923563509	8437146.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	247	Transcription
Q3U821	Q3U821	Wdr75	9.5998	14.185	11096550	8.0450522928399	6.67645880624917	22.1960801722416	9.8755678451511	7.25426187885383	7.82105427811669	4110051.66666667	0	Wdr75	0	WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog)		FUNCTION: Ribosome biogenesis factor. Involved in nucleolar processing of pre-18S ribosomal RNA. Required for optimal pre-ribosomal RNA transcription by RNA polymerase I. {ECO:0000250|UniProtKB:Q8IWA0}.		positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8IWA0}.	73674;		IPR011047;IPR015943;IPR001680;IPR017986;IPR036322;	PF00400;	SM00320;	94037	COMPBIAS 770..787;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 788..807;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 761..807;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Modified residue (6); Region (1); Repeat (13); Sequence conflict (2)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation;WD repeat;rRNA processing				REPEAT 4..42;  /note=WD 1;  /evidence=ECO:0000255; REPEAT 46..85;  /note=WD 2;  /evidence=ECO:0000255; REPEAT 89..130;  /note=WD 3;  /evidence=ECO:0000255; REPEAT 144..183;  /note=WD 4;  /evidence=ECO:0000255; REPEAT 192..230;  /note=WD 5;  /evidence=ECO:0000255; REPEAT 236..275;  /note=WD 6;  /evidence=ECO:0000255; REPEAT 278..317;  /note=WD 7;  /evidence=ECO:0000255; REPEAT 323..361;  /note=WD 8;  /evidence=ECO:0000255; REPEAT 375..422;  /note=WD 9;  /evidence=ECO:0000255; REPEAT 429..473;  /note=WD 10;  /evidence=ECO:0000255; REPEAT 486..524;  /note=WD 11;  /evidence=ECO:0000255; REPEAT 528..568;  /note=WD 12;  /evidence=ECO:0000255; REPEAT 573..610;  /note=WD 13;  /evidence=ECO:0000255		PS50082;PS50294;	73674	GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016573~histone acetylation,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000124~SAGA complex,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016021~integral component of membrane,	GO:0003712~transcription cofactor activity,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,SSF50998:Quinoprotein alcohol dehydrogenase-like,	3.30484651706165	2.07594107161432e-08	FDR<0.01	7.68278497868291	7603300.83333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	266	Transcription
F6ZDS4	F6ZDS4	Tpr	3.1846	3.6869	4125350	4.47327219861329	3.29967663169009	5.21294896522963	2.08685490097873	9.45090256119459	9.63020030816641	10979250	0	Tpr	0	Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein)		FUNCTION: Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Plays a limited role in the regulation of nuclear protein export. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. Plays also a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases (By similarity). {ECO:0000250}.		cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P12270}. Nucleus membrane {ECO:0000250|UniProtKB:P12270}; Peripheral membrane protein {ECO:0000250|UniProtKB:P12270}; Nucleoplasmic side {ECO:0000250|UniProtKB:P12270}. Nucleus envelope {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:12513910}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P12270, ECO:0000269|PubMed:12513910}. Cytoplasm {ECO:0000250|UniProtKB:P12270}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P12270}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P12270}. Nucleus membrane {ECO:0000250|UniProtKB:P12270}; Peripheral membrane protein {ECO:0000250|UniProtKB:P12270}; Cytoplasmic side {ECO:0000250|UniProtKB:P12270}. Note=Detected as discrete intranuclear foci with IFI204 (By similarity). In interphase, localizes to the nucleoplasmic side of the nuclear pore complex (NPC) core structure, forming a fibrous structure called the nuclear basket. Detected exclusively to the cytoplasmic margin of NPC (By similarity). Docking to the inner nucleoplasmic side of the NPC is mediated through binding to nucleoporins. Anchored by NUP153 to the NPC. The assembly of the NPC is a stepwise process in which Trp-containing peripheral structures assemble after other components, including p62. Detected as filaments that emanate from the nuclear basket of the NPC and extend to the nucleolus to delineate a chromatin-free network extending from the nuclear envelope to the perinucleolar region. Detected in diffuse and discrete spheroidal intranuclear foci. Nucleocytoplasmic shuttling protein imported into the nucleus in a XPO1/CRM1- and Importin alpha/Importin beta receptor-dependent manner. Remains localized to the nuclear membrane after poliovirus (PV) infection. During mitosis, remains associated with the nuclear envelope until prometaphase. Associated with the mitotic spindle from late prometaphase until anaphase. Reorganized during mitosis in a viscous and dynamic nuclear-derived spindle matrix that embeds the microtubule spindle apparatus from pole to pole in a microtubule-independent manner. Recruited to the reforming nuclear envelope during telophase and cytokinesis. Detected at kinetochores during prometaphase. Colocalizes with MAD2L1 in the spindle matrix but not at kinetochore. Colocalizes with dynein, dynactin, tubulin at kinetochore during the metaphase-anaphase transition. Colocalizes with DYNLL1 at the mitotic spindle (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P12270}.	108989;		IPR012929;	PF07926;		273990	COMPBIAS 1689..1706;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1707..1744;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1873..1897;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1950..1968;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1975..2007;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2014..2053;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2068..2082;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2096..2138;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2139..2158;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2295..2327;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2364..2393;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 77..87;  /note=Sufficient for interaction with TPR;  /evidence=ECO:0000250; REGION 88..191;  /note=Necessary for interaction with HSF1;  /evidence=ECO:0000250; REGION 511..587;  /note=Necessary for association to the NPC;  /evidence=ECO:0000250; REGION 989..1011;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1292..1394;  /note=Necessary for interaction with HSF1;  /evidence=ECO:0000250; REGION 1689..1744;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1873..2193;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1882..1937;  /note=Sufficient and essential for mediating its nuclear import;  /evidence=ECO:0000250; REGION 2295..2431;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (5); Compositional bias (11); Modified residue (32); Region (10)		Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Kinetochore;Membrane;Methylation;Mitosis;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Proto-oncogene;Reference proteome;Translocation;Transport;mRNA transport		DOMAIN: The N-terminal domain mediates intranuclear attachment to the nuclear pore complex. The C-terminal domain mediates its nuclear import (By similarity). {ECO:0000250}.					108989	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000189~MAPK import into nucleus,GO:0006404~RNA import into nucleus,GO:0006405~RNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0006913~nucleocytoplasmic transport,GO:0006999~nuclear pore organization,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0010965~regulation of mitotic sister chromatid separation,GO:0015031~protein transport,GO:0031453~positive regulation of heterochromatin assembly,GO:0031990~mRNA export from nucleus in response to heat stress,GO:0034605~cellular response to heat,GO:0035457~cellular response to interferon-alpha,GO:0042307~positive regulation of protein import into nucleus,GO:0045947~negative regulation of translational initiation,GO:0046827~positive regulation of protein export from nucleus,GO:0046832~negative regulation of RNA export from nucleus,GO:0051028~mRNA transport,GO:0051301~cell division,GO:0070849~response to epidermal growth factor,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:0090316~positive regulation of intracellular protein transport,GO:1901673~regulation of mitotic spindle assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0042405~nuclear inclusion body,GO:0044615~nuclear pore nuclear basket,GO:0072686~mitotic spindle,	GO:0003682~chromatin binding,GO:0003729~mRNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0015631~tubulin binding,GO:0031072~heat shock protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0051019~mitogen-activated protein kinase binding,GO:0070840~dynein complex binding,	IPR012929:Tetratricopeptide, MLP1/MLP2-like,IPR015866:Serine-tRNA synthetase, type1, N-terminal,	PF07926:TPR/MLP1/MLP2-like protein,		2.17357795087632	6.98096225541556e-06	FDR<0.01	5.15608471012555	7552300	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	267	Transcription
P28659	P28659-2;P28659-3;P28659;P28659-4	Celf1	6.313	14.339	13079640	2.91358312452654	4.99276049727895	4.20168067226891	NA	NA	9.48136910969944	1000505	2	Celf1	0	CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Brain protein F41) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Deadenylation factor EDEN-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2)		FUNCTION: RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing (By similarity). Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition (By similarity). Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs (By similarity). Activates SM exon 5 inclusion by antagonizing the repressive effect of PTB (By similarity). Promotes exclusion of exon 11 of the INSR pre-mRNA (By similarity). Inhibits, together with HNRNPH1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast (By similarity). Increases translation and controls the choice of translation initiation codon of CEBPB mRNA (By similarity). Increases mRNA translation of CEBPB in aging liver. Increases translation of CDKN1A mRNA by antagonizing the repressive effect of CALR3 (By similarity). Mediates rapid cytoplasmic mRNA deadenylation (By similarity). Recruits the deadenylase PARN to the poly(A) tail of EDEN-containing mRNAs to promote their deadenylation (By similarity). Required for completion of spermatogenesis. Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK and to Bruno response elements (BREs) (By similarity). Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA (By similarity). Binds to AU-rich sequences (AREs or EDEN-like) localized in the 3'-UTR of JUN and FOS mRNAs. Binds to the IR RNA (By similarity). Binds to the 5'-region of CDKN1A and CEBPB mRNAs (By similarity). Binds with the 5'-region of CEBPB mRNA in aging liver. May be a specific regulator of miRNA biogenesis. Binds to primary microRNA pri-MIR140 and, with CELF2, negatively regulates the processing to mature miRNA (By similarity). {ECO:0000250|UniProtKB:Q92879, ECO:0000269|PubMed:15082764, ECO:0000269|PubMed:16931514, ECO:0000269|PubMed:17130239}.		cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; mRNA destabilization [GO:0061157]; mRNA splice site selection [GO:0006376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; posttranscriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	BRE binding [GO:0042835]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=RNA-binding activity is detected in both nuclear and cytoplasmic compartments. {ECO:0000250}.	13046;	cd12631;cd12634;cd12638;	IPR034196;IPR034198;IPR034199;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	52107		REGION 277..309;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Cross-link (1); Domain (3); Frameshift (1); Modified residue (5); Mutagenesis (1); Region (1); Sequence conflict (7)		Acetylation;Activator;Alternative splicing;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 16..99;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 108..188;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 401..479;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: RRM1 and RRM2 domains preferentially target UGU(U/G)-rich mRNA elements. {ECO:0000250}.				PS50102;	13046	GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0007286~spermatid development,GO:0008380~RNA splicing,GO:0040018~positive regulation of multicellular organism growth,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0031369~translation initiation factor binding,GO:0042835~BRE binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.61314872574401	2.39241132632097e-05	FDR<0.01	4.62116415018776	7040072.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	281	Transcription
Q6ZWV3	Q6ZWV3	Rpl10	16.264	13.337	6216250	9.28677563150074	6.63437935381145	3.48833153102871	NA	9.46700747893591	10.4082099960449	7684445	1	Rpl10	0	60S ribosomal protein L10 (Protein QM homolog) (Ribosomal protein L10)		FUNCTION: Component of the large ribosomal subunit. Plays a role in the formation of actively translating ribosomes. May play a role in the embryonic brain development. {ECO:0000250|UniProtKB:P27635}.		embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]		110954;	cd01433;	IPR001197;IPR016180;IPR036920;IPR018255;	PF00252;		24604			NA							5 out of 5	Chain (1); Cross-link (2); Modified residue (1); Sequence conflict (1)		3D-structure;Citrullination;Developmental protein;Isopeptide bond;Reference proteome;Ribonucleoprotein;Ribosomal protein;Translation regulation;Ubl conjugation						PS01257;	110954	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001197:Ribosomal protein L10e,IPR016180:Ribosomal protein L10e/L16,IPR018255:Ribosomal protein L10e, conserved site,	PF00252:Ribosomal protein L16p/L10e,	SSF54686:Ribosomal protein L16p/L10e,	3.16160106799161	5.6941553654596e-07	FDR<0.01	6.24457068726963	6950347.5	Present in Nucleus	RBP	Others	Others	Others	Others	286	Transcription
Q91VM5	Q91VM5;Q9WV02;Q9WV02-2	Rbmxl1;Rbmx	8.9481	21.26	9055800	35.5113636363636	83.2778147901399	41.9357544242221	13.7356977047649	23.4203007166612	42.4592391304348	4804025	0	Rbmxl1	0	RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1) (RNA binding motif protein, X chromosome retrogene)		FUNCTION: RNA-binding protein which may be involved in pre-mRNA splicing. {ECO:0000250}.		cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splice site selection [GO:0006376]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]	catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]	chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	19656;		IPR012677;IPR035979;IPR012604;IPR000504;IPR003954;	PF08081;PF00076;	SM00360;SM00361;	42162	COMPBIAS 61..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 145..164;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 194..208;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 220..274;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 305..333;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 59..388;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Cross-link (1); Domain (1); Modified residue (1); Region (1); Sequence conflict (5)		Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 8..86;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	19656	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0006509~membrane protein ectodomain proteolysis,GO:0008380~RNA splicing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0051260~protein homooligomerization,GO:0071347~cellular response to interleukin-1,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0044530~supraspliceosomal complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012604:RBM1CTR,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08081:RBM1CTR (NUC064) family,	SSF54928:RNA-binding domain, RBD,	4.77867271713871	1.8074108945545e-08	FDR<0.01	7.74294310424487	6929912.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	287	Transcription
P08775	P08775	Polr2a	0.7924	1.1095	8356050	7.02493853178785	5.62239964016642	8.83314194859111	3.6187305493233	5.64907920009038	5.89275191514437	5451601.66666667	0	Polr2a	0	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates (By similarity). Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1), which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing (By similarity). Regulation of gene expression levels depends on the balance between methylation and acetylation levels of tha CTD-lysines (PubMed:26687004). Initiation or early elongation steps of transcription of growth-factors-induced immediate early genes are regulated by the acetylation status of the CTD (PubMed:24207025). Methylation and dimethylation have a repressive effect on target genes expression (PubMed:26687004). {ECO:0000250|UniProtKB:P24928, ECO:0000269|PubMed:24207025, ECO:0000269|PubMed:26687004}.		cellular response to oxygen levels [GO:0071453]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]	core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24207025, ECO:0000269|PubMed:26687004}. Cytoplasm {ECO:0000250|UniProtKB:P24928}. Chromosome {ECO:0000250|UniProtKB:P24928}. Note=Hypophosphorylated form is mainly found in the cytoplasm, while the hyperphosphorylated and active form is nuclear (By similarity). Co-localizes with kinase SRPK2 and helicase DDX23 at chromatin loci where unscheduled R-loops form (By similarity). {ECO:0000250|UniProtKB:P24928}.	20020;		IPR000722;IPR000684;IPR006592;IPR007080;IPR007066;IPR042102;IPR007083;IPR007081;IPR007075;IPR007073;IPR038593;IPR038120;	PF04997;PF00623;PF04983;PF05000;PF04998;PF04992;PF04990;PF05001;	SM00663;	217176	COMPBIAS 1565..1584;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1607..1963;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 833..845;  /note=Bridging helix; REGION 1546..1970;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1593..1960;  /note=C-terminal domain (CTD); 52 X 7 AA approximate tandem repeats of Y-[ST]-P-[STQ]-[ST]-P-[SRNTEVKGN]	NA				2.7.7.6	METAL 71;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 74;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 81;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 84;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 111;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 114;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 154;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 184;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 495;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250; METAL 495;  /note=Magnesium 2; shared with RPB2;  /evidence=ECO:0000250; METAL 497;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250; METAL 497;  /note=Magnesium 2; shared with RPB2;  /evidence=ECO:0000250; METAL 499;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (2); Metal binding (13); Modified residue (69); Mutagenesis (16); Region (3); Repeat (52); Sequence conflict (2)	MISCELLANEOUS: The binding of ribonucleoside triphosphate to the RNA polymerase II transcribing complex probably involves a two-step mechanism. The initial binding seems to occur at the entry (E) site and involves a magnesium ion temporarily coordinated by three conserved aspartate residues of the two largest RNA Pol II subunits. The ribonucleoside triphosphate is transferred by a rotation to the nucleotide addition (A) site for pairing with the template DNA. The catalytic A site involves three conserved aspartate residues of the RNA Pol II largest subunit which permanently coordinate a second magnesium ion.	Acetylation;Chromosome;Cytoplasm;DNA-binding;DNA-directed RNA polymerase;Magnesium;Metal-binding;Methylation;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transferase;Ubl conjugation;Zinc		DOMAIN: The C-terminal domain (CTD) serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. {ECO:0000305}.		REPEAT 1593..1599;  /note=1; REPEAT 1600..1606;  /note=2; approximate; REPEAT 1608..1614;  /note=3; REPEAT 1615..1621;  /note=4; REPEAT 1622..1628;  /note=5; REPEAT 1629..1635;  /note=6; REPEAT 1636..1642;  /note=7; REPEAT 1643..1649;  /note=8; REPEAT 1650..1656;  /note=9; REPEAT 1657..1663;  /note=10; REPEAT 1664..1670;  /note=11; REPEAT 1671..1677;  /note=12; REPEAT 1678..1684;  /note=13; REPEAT 1685..1691;  /note=14; REPEAT 1692..1698;  /note=15; REPEAT 1699..1705;  /note=16; REPEAT 1706..1712;  /note=17; REPEAT 1713..1719;  /note=18; REPEAT 1720..1726;  /note=19; REPEAT 1727..1733;  /note=20; REPEAT 1734..1740;  /note=21; REPEAT 1741..1747;  /note=22; REPEAT 1748..1754;  /note=23; REPEAT 1755..1761;  /note=24; REPEAT 1762..1768;  /note=25; REPEAT 1769..1775;  /note=26; REPEAT 1776..1782;  /note=27; REPEAT 1783..1789;  /note=28; REPEAT 1790..1796;  /note=29; REPEAT 1797..1803;  /note=30; REPEAT 1804..1810;  /note=31; REPEAT 1811..1817;  /note=32; REPEAT 1818..1824;  /note=33; REPEAT 1825..1831;  /note=34; REPEAT 1832..1838;  /note=35; REPEAT 1839..1845;  /note=36; REPEAT 1846..1852;  /note=37; REPEAT 1853..1859;  /note=38; REPEAT 1860..1866;  /note=39; REPEAT 1867..1873;  /note=40; REPEAT 1874..1880;  /note=41; REPEAT 1881..1887;  /note=42; REPEAT 1888..1894;  /note=43; REPEAT 1895..1901;  /note=44; REPEAT 1902..1908;  /note=45; REPEAT 1909..1915;  /note=46; REPEAT 1916..1922;  /note=47; REPEAT 1923..1929;  /note=48; REPEAT 1930..1936;  /note=49; REPEAT 1940..1946;  /note=50; REPEAT 1947..1953;  /note=51; approximate; REPEAT 1954..1960;  /note=52; approximate		PS00115;	20020	GO:0006351~transcription, DNA-templated,GO:0006353~DNA-templated transcription, termination,GO:0006366~transcription from RNA polymerase II promoter,GO:0014070~response to organic cyclic compound,GO:0033120~positive regulation of RNA splicing,GO:0034587~piRNA metabolic process,GO:0071453~cellular response to oxygen levels,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0005719~nuclear euchromatin,GO:0005730~nucleolus,	GO:0001047~core promoter binding,GO:0001055~RNA polymerase II activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000684:RNA polymerase II, heptapeptide repeat, eukaryotic,IPR000722:RNA polymerase, alpha subunit,IPR006592:RNA polymerase, N-terminal,IPR007066:RNA polymerase Rpb1, domain 3,IPR007073:RNA polymerase Rpb1, domain 7,IPR007075:RNA polymerase Rpb1, domain 6,IPR007080:RNA polymerase Rpb1, domain 1,IPR007081:RNA polymerase Rpb1, domain 5,IPR007083:RNA polymerase Rpb1, domain 4,	PF00623:RNA polymerase Rpb1, domain 2,PF04983:RNA polymerase Rpb1, domain 3,PF04990:RNA polymerase Rpb1, domain 7,PF04992:RNA polymerase Rpb1, domain 6,PF04997:RNA polymerase Rpb1, domain 1,PF04998:RNA polymerase Rpb1, domain 5,PF05000:RNA polymerase Rpb1, domain 4,PF05001:RNA polymerase Rpb1 C-terminal repeat ,		1.89665621257999	0.000601083839186507	FDR<0.01	3.22106494836889	6903825.83333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	289	Transcription
D3YXK2	D3YXK2	Safb	1.8406	1.888	7270600	3.11837345640514	2.04281745383233	3.64630811303555	1.56857824068265	9.1399323645005	9.59877135726627	5381796.66666667	0	Safb	0	Scaffold attachment factor B1 (SAF-B1)		FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (By similarity). Functions as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription (By similarity). Thereby acts as a negative regulator of cell proliferation (By similarity). When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (PubMed:19403048). {ECO:0000250|UniProtKB:Q15424, ECO:0000269|PubMed:19403048}.		hormone metabolic process [GO:0042445]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15424}.	224903;		IPR012677;IPR035979;IPR000504;IPR034781;IPR003034;IPR036361;	PF00076;PF02037;	SM00360;SM00513;	105104	COMPBIAS 77..100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 101..117;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 262..287;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 289..305;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 403..425;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 499..570;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 606..661;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 771..821;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 833..855;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 64..117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 222..429;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 499..661;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 550..814;  /note=Interaction with POLR2A; SFRS1; SFRS9 and SFRS10;  /evidence=ECO:0000250|UniProtKB:O88453; REGION 621..937;  /note=Interaction with SAFB2;  /evidence=ECO:0000250; REGION 684..738;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 771..937;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (9); Cross-link (13); Domain (2); Initiator methionine (1); Modified residue (21); Motif (1); Region (8)		Acetylation;Coiled coil;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 31..65;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 428..506;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 621..638;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;PS50800;	224903	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0040007~growth,GO:0042445~hormone metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02037:SAP domain,	SSF54928:RNA-binding domain, RBD,	1.67991451417538	0.000408711732803032	FDR<0.01	3.38858289490775	6326198.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	307	Transcription
P10639	P10639	Txn	3.8451	18.265	8639100	9.31358852565894	7.72558714462299	10.6131199388684	6.9536193588763	5.19642485969653	4.17658605855574	3441850	0	Txn	0	Thioredoxin (Trx) (ATL-derived factor) (ADF)		FUNCTION: Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions (By similarity). Plays a role in the reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to the response to intracellular nitric oxide. Nitrosylates the active site Cys of CASP3 in response to nitric oxide (NO), and thereby inhibits caspase-3 activity. Induces the FOS/JUN AP-1 DNA binding activity in ionizing radiation (IR) cells through its oxidation/reduction status and stimulates AP-1 transcriptional activity (By similarity). {ECO:0000250}.; FUNCTION: ADF augments the expression of the interleukin-2 receptor TAC (IL2R/P55).		cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA binding [GO:0043388]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to nitric oxide [GO:0071731]; response to radiation [GO:0009314]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; protein homodimerization activity [GO:0042803]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P10599}. Cytoplasm {ECO:0000250|UniProtKB:P10599}. Secreted {ECO:0000250|UniProtKB:P10599}. Note=Translocates from the cytoplasm into the nucleus after phorbol 12-myristate 13-acetate induction (PMA). Predominantly in the cytoplasm in non irradiated cells. Radiation induces translocation of TRX from the cytoplasm to the nucleus. Secreted by a leaderless secretory pathway. {ECO:0000250|UniProtKB:P10599}.	22166;		IPR005746;IPR036249;IPR017937;IPR013766;	PF00085;		11675			NA	ACT_SITE 32;  /note=Nucleophile;  /evidence=ECO:0000250; ACT_SITE 35;  /note=Nucleophile;  /evidence=ECO:0000250						5 out of 5	Active site (2); Chain (1); Disulfide bond (2); Domain (1); Modified residue (8); Sequence conflict (1); Site (3)		Acetylation;Activator;Cytoplasm;Disulfide bond;Electron transport;Nucleus;Redox-active center;Reference proteome;S-nitrosylation;Secreted;Transcription;Transcription regulation;Transport	DOMAIN 2..105;  /note=Thioredoxin;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00691					PS00194;PS51352;	22166	GO:0000103~sulfate assimilation,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006457~protein folding,GO:0006662~glycerol ether metabolic process,GO:0006810~transport,GO:0009314~response to radiation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033158~regulation of protein import into nucleus, translocation,GO:0034599~cellular response to oxidative stress,GO:0043388~positive regulation of DNA binding,GO:0045454~cell redox homeostasis,GO:0046826~negative regulation of protein export from nucleus,GO:0055114~oxidation-reduction process,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0015037~peptide disulfide oxidoreductase activity,GO:0016671~oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR005746:Thioredoxin,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR017937:Thioredoxin, conserved site,	PF00085:Thioredoxin,	SSF52833:Thioredoxin-like,	2.86854965862582	3.85001591385908e-07	FDR<0.01	6.41453747535204	6040475	Present in Nucleus	RBP	Others	Others	Others	Others	319	Transcription
Q05CL8	Q05CL8;Q05CL8-2	Larp7	23.122	28.084	9024850	9.17852225791647	6.40245854408093	9.86485153398441	3.79506641366224	9.16590284142988	10.8007690147539	2553360	0	Larp7	0	La-related protein 7 (La ribonucleoprotein domain family member 7)		FUNCTION: RNA-binding protein that specifically binds distinct small nuclear RNA (snRNAs) and regulates their processing and function (PubMed:32017896). Specifically binds the 7SK snRNA (7SK RNA) and acts as a core component of the 7SK ribonucleoprotein (RNP) complex, thereby acting as a negative regulator of transcription elongation by RNA polymerase II (By similarity). The 7SK RNP complex sequesters the positive transcription elongation factor b (P-TEFb) in a large inactive 7SK RNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (By similarity). The 7SK RNP complex also promotes snRNA gene transcription by RNA polymerase II via interaction with the little elongation complex (LEC) (By similarity). LARP7 specifically binds to the highly conserved 3'-terminal U-rich stretch of 7SK RNA; on stimulation, remains associated with 7SK RNA, whereas P-TEFb is released from the complex (By similarity). LARP7 also acts as a regulator of mRNA splicing fidelity by promoting U6 snRNA processing (PubMed:32017896). Specifically binds U6 snRNAs and associates with a subset of box C/D RNP complexes: promotes U6 snRNA 2'-O-methylation by facilitating U6 snRNA loading into box C/D RNP complexes (PubMed:32017896). U6 snRNA 2'-O-methylation is required for mRNA splicing fidelity (PubMed:32017896). Binds U6 snRNAs with a 5'-CAGGG-3' sequence motif (By similarity). U6 snRNA processing is required for spermatogenesis (PubMed:32017896). {ECO:0000250|UniProtKB:Q4G0J3, ECO:0000269|PubMed:32017896}.		box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; germ cell proliferation [GO:0036093]; mRNA processing [GO:0006397]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]	7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	7SK snRNA binding [GO:0097322]; U6 snRNA binding [GO:0017070]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:32017896}.	28036;	cd08032;cd12290;cd12542;	IPR006630;IPR014886;IPR034946;IPR034887;IPR034910;IPR002344;IPR012677;IPR035979;IPR000504;IPR036388;IPR036390;	PF05383;PF00076;PF08777;	SM00715;SM00360;	64802	COMPBIAS 232..246;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 263..315;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 324..348;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 180..364;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (3); Cross-link (2); Domain (3); Erroneous termination (1); Modified residue (9); Mutagenesis (1); Region (2); Sequence conflict (3)		Acetylation;Alternative splicing;Differentiation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spermatogenesis;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 22..116;  /note=HTH La-type RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00332; DOMAIN 119..197;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 438..551;  /note=xRRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01288	DOMAIN: The xRRM domain binds the 3' end of 7SK snRNA (7SK RNA) at the top of stem-loop 4. {ECO:0000250|UniProtKB:Q4G0J3}.				PS50961;PS50102;PS51939;	28036	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0035562~negative regulation of chromatin binding,GO:0036093~germ cell proliferation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002344:Lupus La protein,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014886:RNA-binding motif,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF05383:La domain,PF08777:RNA binding motif,	SSF46785:Winged helix DNA-binding domain,SSF54928:RNA-binding domain, RBD,	3.38444003955048	3.16694263928796e-07	FDR<0.01	6.49935980264208	5789105	Present in Nucleus	RBP	DBD	DBD	Others	RBD	331	Transcription
Q9CPN8	Q9CPN8	Igf2bp3	15.114	15.173	9151500	21.4123592137382	8.07037365830038	5.5869042963294	15.2893509670514	6.4762644906418	9.7323600973236	2402593.33333333	0	Igf2bp3	0	Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (mIMP-3) (IGF-II mRNA-binding protein 3) (VICKZ family member 3)		FUNCTION: RNA-binding factor that may recruit target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation (By similarity). Binds to beta-actin/ACTB and MYC transcripts (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. {ECO:0000250, ECO:0000269|PubMed:15753088}.		mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11288142, ECO:0000269|PubMed:12921532}. Cytoplasm {ECO:0000250}. Note=Found in lamellipodia of the leading edge, in the perinuclear region, and beneath the plasma membrane. The subcytoplasmic localization is cell specific and regulated by cell contact and growth. Localized at the connecting piece and the tail of the spermatozoa. In response to cellular stress, such as oxidative stress, recruited to stress granules. {ECO:0000250}.	140488;	cd12630;	IPR034844;IPR004087;IPR004088;IPR036612;IPR012677;IPR035979;IPR000504;	PF00013;PF00076;	SM00322;SM00360;	63575		REGION 158..192;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (2); Domain (6); Modified residue (3); Region (1); Sequence conflict (3)		Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Translation regulation;Transport;Ubl conjugation;mRNA transport	DOMAIN 2..75;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 81..156;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 195..260;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 276..343;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 405..470;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 487..553;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: All KH domains contribute binding to target mRNA. They are also required for RNA-dependent homo- and heterooligomerization. The integrity of KH domains seems not to be required for localization to stress granules (By similarity). {ECO:0000250}.				PS50084;PS50102;	140488	GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0006810~transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR002059:Cold-shock protein, DNA-binding,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR012677:Nucleotide-binding, alpha-beta plait,IPR019844:Cold-shock conserved site,	PF00013:KH domain,PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00313:'Cold-shock' DNA-binding domain,	SSF50249:Nucleic acid-binding proteins,SSF54791:Eukaryotic type KH-domain (KH-domain type I),SSF54928:RNA-binding domain, RBD,	3.45858892288126	3.46132483567061e-08	FDR<0.01	7.46075764146885	5777046.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	333	Transcription
Q8C7V3	Q8C7V3	Utp15	10.235	11.081	6969650	10.7828337287039	7.5013127297277	12.7283141347928	3.30218274279299	11.0615798148292	15.846102651053	4338300	0	Utp15	0	U3 small nucleolar RNA-associated protein 15 homolog (Src-associated protein SAW)		FUNCTION: Ribosome biogenesis factor. Involved in nucleolar processing of pre-18S ribosomal RNA. Required for optimal pre-ribosomal RNA transcription by RNA polymerase I. {ECO:0000250|UniProtKB:Q8TED0}.		positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8TED0}. Note=Found predominantly at the fibrillar center. {ECO:0000250|UniProtKB:Q8TED0}.	105372;		IPR020472;IPR018983;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF09384;PF00400;	SM00320;	59375	COMPBIAS 502..528;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 496..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (1); Region (1); Repeat (7); Sequence conflict (1)		Acetylation;Isopeptide bond;Nucleus;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation;WD repeat;rRNA processing				REPEAT 36..75;  /note=WD 1; REPEAT 78..117;  /note=WD 2; REPEAT 120..159;  /note=WD 3; REPEAT 162..202;  /note=WD 4; REPEAT 204..242;  /note=WD 5; REPEAT 246..285;  /note=WD 6; REPEAT 287..326;  /note=WD 7		PS00678;PS50082;PS50294;	105372	GO:0006364~rRNA processing,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030054~cell junction,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR018983:U3 small nucleolar RNA-associated protein 15, C-terminal,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,PF09384:UTP15 C terminal,	SSF50978:WD40 repeat-like,	3.25127425238998	6.3393210290019e-08	FDR<0.01	7.19795725460225	5653975	Present in Nucleus	RBP	ChD	Others	ChD	RBD	338	Transcription
Q9Z1X4	Q9Z1X4-2;Q9Z1X4-3;Q9Z1X4	Ilf3	7.6664	10.609	7167900	8.25900231252065	8.05477245267821	2.78971154382637	6.11957652530445	9.6237128284092	5.53648543904329	3911805	0	Ilf3	0	Interleukin enhancer-binding factor 3		FUNCTION: RNA-binding protein that plays an essential role in the biogenesis of circular RNAs (circRNAs) which are produced by back-splicing circularization of pre-mRNAs. Within the nucleus, promotes circRNAs processing by stabilizing the regulatory elements residing in the flanking introns of the circularized exons. Plays thereby a role in the back-splicing of a subset of circRNAs. As a consequence, participates in a wide range of transcriptional and post-transcriptional processes. Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Upon viral infection, ILF3 accumulates in the cytoplasm and participates in the innate antiviral response. Mechanistically, ILF3 becomes phosphorylated and activated by the double-stranded RNA-activated protein kinase/PKR which releases ILF3 from cellular mature circRNAs. In turn, unbound ILF3 molecules are able to interact with and thus inhibit viral mRNAs. {ECO:0000250|UniProtKB:Q12906, ECO:0000269|PubMed:21123651}.		defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q12906}. Cytoplasm {ECO:0000269|PubMed:21123651}. Nucleus {ECO:0000269|PubMed:21123651}. Note=Localizes in the cytoplasm in response to viral infection. The unphosphorylated form is retained in the nucleus by ILF2. Phosphorylation at Thr-188 and Thr-315 causes the dissociation of ILF2 from the ILF2-ILF3 complex resulting in a cytoplasmic sequestration of ILF3. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000269|PubMed:21123651}.	16201;		IPR014720;IPR006561;IPR033099;IPR043519;	PF00035;PF07528;	SM00358;SM00572;	96021	COMPBIAS 67..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 372..399;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 505..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 741..898;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 52..85;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 363..402;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 466..495;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 505..524;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 609..898;  /note=Interaction with PRMT1;  /evidence=ECO:0000250; REGION 631..661;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 719..898;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Beta strand (17); Chain (1); Compositional bias (4); Cross-link (3); Domain (3); Frameshift (2); Helix (16); Modified residue (17); Motif (1); Region (7); Sequence conflict (1); Turn (6)		3D-structure;Acetylation;Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 5..378;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040; DOMAIN 398..467;  /note=DRBM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 524..590;  /note=DRBM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266		MOTIF 371..389;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255			PS50137;PS51703;	16201	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006479~protein methylation,GO:0017148~negative regulation of translation,GO:0045071~negative regulation of viral genome replication,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR006561:DZF,IPR014720:Double-stranded RNA-binding-like domain,	PF00035:Double-stranded RNA binding motif,PF07528:DZF domain,		2.77883615069807	1.60026291379534e-07	FDR<0.01	6.79580865945014	5539852.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	344	Transcription
Q8CFI7	Q8CFI7	Polr2b	5.6561	7.7638	6361350	15.4109325155265	18.9735319229675	1.95308685377239	8.38293234973594	12.3293920376786	8.87862913966084	4257583.33333333	0	Polr2b	0	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Second largest component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Proposed to contribute to the polymerase catalytic activity and forms the polymerase active center together with the largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB2 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template (By similarity). {ECO:0000250}.		transcription by RNA polymerase II [GO:0006366]	chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	231329;	cd00653;	IPR015712;IPR007120;IPR037033;IPR007121;IPR007644;IPR007642;IPR037034;IPR007645;IPR007646;IPR007647;IPR007641;IPR014724;	PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;		133911			NA				2.7.7.6	METAL 792;  /note=Magnesium; shared with RPB1;  /evidence=ECO:0000250; METAL 1119;  /note=Zinc;  /evidence=ECO:0000250; METAL 1122;  /note=Zinc;  /evidence=ECO:0000250; METAL 1137;  /note=Zinc;  /evidence=ECO:0000250; METAL 1140;  /note=Zinc;  /evidence=ECO:0000250		4 out of 5	Chain (1); Erroneous initiation (1); Metal binding (5); Modified residue (2); Zinc finger (1)	MISCELLANEOUS: The binding of ribonucleoside triphosphate to the RNA polymerase II transcribing complex probably involves a two-step mechanism. The initial binding seems to occur at the entry (E) site and involves a magnesium ion coordinated by three conserved aspartate residues of the two largest RNA Pol II subunits (By similarity). {ECO:0000250}.	DNA-directed RNA polymerase;Magnesium;Metal-binding;Methylation;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transferase;Zinc;Zinc-finger					ZN_FING 1119..1140;  /note=C4-type	PS01166;	231329	GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0034587~piRNA metabolic process,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0016020~membrane,	GO:0001055~RNA polymerase II activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0032549~ribonucleoside binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6,IPR007121:RNA polymerase, beta subunit, conserved site,IPR007641:RNA polymerase Rpb2, domain 7,IPR007642:RNA polymerase Rpb2, domain 2,IPR007644:RNA polymerase, beta subunit, protrusion,IPR007645:RNA polymerase Rpb2, domain 3,IPR007646:RNA polymerase Rpb2, domain 4,IPR007647:RNA polymerase Rpb2, domain 5,IPR014724:RNA polymerase Rpb2, OB-fold,IPR015712:DNA-directed RNA polymerase, subunit 2,	PF00562:RNA polymerase Rpb2, domain 6,PF04560:RNA polymerase Rpb2, domain 7,PF04561:RNA polymerase Rpb2, domain 2,PF04563:RNA polymerase beta subunit,PF04565:RNA polymerase Rpb2, domain 3,PF04566:RNA polymerase Rpb2, domain 4,PF04567:RNA polymerase Rpb2, domain 5,		3.05699337341039	1.66366044430172e-06	FDR<0.01	5.77893530918362	5309466.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	356	Transcription
P52293	P52293	Kpna2	7.6927	7.8824	6575250	9.15248032216731	8.73438728273212	13.4687390566495	7.36377025036819	7.63242253091131	6.67467627820051	3662128.33333333	0	Kpna2	0	Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha)		FUNCTION: Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus.		entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; host cell [GO:0043657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; repressing transcription factor binding [GO:0070491]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P52292}. Nucleus {ECO:0000250|UniProtKB:P52292}.	16647;		IPR011989;IPR016024;IPR032413;IPR000225;IPR002652;IPR036975;IPR024931;	PF00514;PF16186;PF01749;	SM00185;	57928	COMPBIAS 55..70;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 45..70;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 142..238;  /note=NLS binding site (major); REGION 315..403;  /note=NLS binding site (minor)	NA							5 out of 5	Beta strand (4); Chain (1); Compositional bias (1); Domain (1); Helix (33); Initiator methionine (1); Modified residue (2); Motif (1); Region (3); Repeat (10); Sequence conflict (3); Turn (1)		3D-structure;Acetylation;Cytoplasm;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	DOMAIN 2..60;  /note=IBB;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00561	DOMAIN: Consists of an N-terminal hydrophilic region, a hydrophobic central region composed of 10 repeats, and a short hydrophilic C-terminus. The N-terminal hydrophilic region contains the importin beta binding domain (IBB domain), which is sufficient for binding importin beta and essential for nuclear protein import.; DOMAIN: The IBB domain is thought to act as an intrasteric autoregulatory sequence by interacting with the internal autoinhibitory NLS. Binding of KPNB1 probably overlaps the internal NLS and contributes to a high affinity for cytoplasmic NLS-containing cargo substrates. After dissociation of the importin/substrate complex in the nucleus the internal autohibitory NLS contributes to a low affinity for nuclear NLS-containing proteins.; DOMAIN: The major and minor NLS binding sites are mainly involved in recognition of simple or bipartite NLS motifs. Structurally located within in a helical surface groove they contain several conserved Trp and Asn residues of the corresponding third helices (H3) of ARM repeats which mainly contribute to binding.	MOTIF 45..54;  /note=Nuclear localization signal;  /evidence=ECO:0000269|PubMed:10201409, ECO:0000269|PubMed:10764582	REPEAT 71..111;  /note=ARM 1; truncated; REPEAT 112..151;  /note=ARM 2; REPEAT 152..193;  /note=ARM 3; REPEAT 200..244;  /note=ARM 4; REPEAT 246..282;  /note=ARM 5; REPEAT 283..322;  /note=ARM 6; REPEAT 325..364;  /note=ARM 7; REPEAT 367..409;  /note=ARM 8; REPEAT 410..456;  /note=ARM 9; REPEAT 457..496;  /note=ARM 10; atypical		PS50176;PS51214;	16647	GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing protein import into nucleus,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008565~protein transporter activity,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000225:Armadillo,IPR002652:Importin-alpha, importin-beta-binding domain,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024931:Importin subunit alpha,	PF00514:Armadillo/beta-catenin-like repeat,PF01749:Importin beta binding domain,	SSF48371:ARM repeat,	3.06822758612601	4.51369146998126e-09	FDR<0.01	8.34546813011958	5118689.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	366	Transcription
P97801	P97801	Smn1	5.0907	4.54	7994850	2.30968218773097	2.61103423065876	NA	2.067055273058	2.71901680352385	2.63907948907421	2195453.33333333	1	Smn1	0	Survival motor neuron protein		FUNCTION: The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. Ensures the correct splicing of U12 intron-containing genes that may be important for normal motor and proprioceptive neurons development. Also required for resolving RNA-DNA hybrids created by RNA polymerase II, that form R-loop in transcription terminal regions, an important step in proper transcription termination. May also play a role in the metabolism of small nucleolar ribonucleoprotein (snoRNPs). {ECO:0000250|UniProtKB:Q16637, ECO:0000269|PubMed:23063131}.		axonogenesis [GO:0007409]; DNA-templated transcription, termination [GO:0006353]; microtubule depolymerization [GO:0007019]; positive regulation of RNA splicing [GO:0033120]; regulation of neuron projection development [GO:0010975]; spliceosomal snRNP assembly [GO:0000387]	Cajal body [GO:0015030]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018]	fibroblast growth factor binding [GO:0017134]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, gem {ECO:0000250|UniProtKB:Q16637}. Nucleus, Cajal body {ECO:0000250|UniProtKB:Q16637}. Cytoplasm {ECO:0000269|PubMed:21389246}. Cell projection, axon {ECO:0000269|PubMed:21389246}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q16637}. Perikaryon {ECO:0000250|UniProtKB:Q16637}. Cell projection, neuron projection {ECO:0000250|UniProtKB:Q16637}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:17353360}. Note=Colocalizes with actin and at the Z-line of skeletal muscle (PubMed:17353360). Under stress conditions colocalizes with RPP20/POP7 in punctuated cytoplasmic granules. Colocalized and redistributed with ZPR1 from the cytoplasm to nuclear gems (Gemini of coiled bodies) and Cajal bodies. Colocalizes with FMR1 in cytoplasmic granules in the soma and neurite cell processes (By similarity). {ECO:0000250|UniProtKB:Q16637}.	20595;	cd04508;	IPR010304;IPR002999;	PF06003;	SM00333;	31254	COMPBIAS 186..200;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 10..41;  /note=P1 (binding site for GEMIN2);  /evidence=ECO:0000250; REGION 54..85;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 94..204;  /note=Required for interaction with RPP20/POP7;  /evidence=ECO:0000250; REGION 146..216;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..262;  /note=P2 (binding site for SNRPB);  /evidence=ECO:0000250; REGION 274..288;  /note=Required for interaction with SYNCRIP;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Domain (1); Modified residue (5); Mutagenesis (5); Region (7)		Cell projection;Cytoplasm;Isopeptide bond;Neurogenesis;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 88..148;  /note=Tudor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00211	DOMAIN: The Tudor domain mediates association with dimethylarginines, which are common in snRNP proteins. {ECO:0000250}.				PS50304;	20595	GO:0000387~spliceosomal snRNP assembly,GO:0006353~DNA-templated transcription, termination,GO:0006397~mRNA processing,GO:0007019~microtubule depolymerization,GO:0007399~nervous system development,GO:0007409~axonogenesis,GO:0008380~RNA splicing,GO:0010975~regulation of neuron projection development,GO:0033120~positive regulation of RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0030018~Z disc,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043204~perikaryon,GO:0097504~Gemini of coiled bodies,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0017134~fibroblast growth factor binding,GO:0042802~identical protein binding,	IPR002999:Tudor domain,IPR010304:Survival motor neuron,	PF06003:Survival motor neuron protein (SMN),		1.57336698680338	5.46417967281958e-05	FDR<0.01	4.26247502864732	5095151.66666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	368	Transcription
Q9D945	Q9D945-2;Q9D945	Llph	22.481	10.561	6220200	9.95321986662685	5.88235294117647	NA	NA	17.7311252172063	10.8498703440494	2972653.33333333	2	Llph	0	Protein LLP homolog (Protein LAPS18-like)		FUNCTION: In hippocampal neurons, regulates dendritic and spine growth and synaptic transmission. {ECO:0000269|PubMed:26961175}.		dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999]	chromosome [GO:0005694]; nucleolus [GO:0005730]	basal RNA polymerase II transcription machinery binding [GO:0001099]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:26961175}. Chromosome {ECO:0000250|UniProtKB:Q9BRT6}. Note=Cell-permeable protein. 22 hours after injection in the hippocampal area CA1, internalized by most cells at the injection site (PubMed:26961175). Localizes at the chromosome periphery during mitosis (By similarity). {ECO:0000250|UniProtKB:Q9BRT6, ECO:0000269|PubMed:26961175}.	66225;		IPR018784;	PF10169;		15391	COMPBIAS 1..18;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 105..123;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 57..76;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 104..130;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (1); Region (3)		Alternative splicing;Chromosome;Coiled coil;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation							66225	GO:0060999~positive regulation of dendritic spine development,GO:0097484~dendrite extension,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0001099~basal RNA polymerase II transcription machinery binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR018784:Learning associated protein 18-like,	PF10169:Learning-associated protein,		3.55844726570876	7.76789771601059e-07	FDR<0.01	6.10969650164596	4596426.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	391	Transcription
Q61464	Q61464-4;Q61464;Q61464-7;Q61464-2;Q61464-5;Q61464-3	Znf638	2.394	3.3949	3524550	6.64982045484772	9.04649900488511	7.71724031486341	3.10424039237599	10.3385887826312	10.8773685470011	4481820	0	Znf638	0	Zinc finger protein 638 (Nuclear protein 220) (Zinc finger matrin-like protein)		FUNCTION: Transcription factor that binds to cytidine clusters in double-stranded DNA (By similarity). Plays a key role in the silencing of unintegrated retroviral DNA: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). Mediates transcriptional repression of unintegrated viral DNA by specifically binding to the cytidine clusters of retroviral DNA and mediating the recruitment of chromatin silencers, such as the HUSH complex, SETDB1 and the histone deacetylases HDAC1 and HDAC4 (PubMed:30487602). Acts as an early regulator of adipogenesis by acting as a transcription cofactor of CEBPs (CEBPA, CEBPD and/or CEBPG), controlling the expression of PPARG and probably of other proadipogenic genes, such as SREBF1 (PubMed:21602272). May also regulate alternative splicing of target genes during adipogenesis (PubMed:25024404). {ECO:0000250|UniProtKB:Q14966, ECO:0000269|PubMed:21602272, ECO:0000269|PubMed:25024404, ECO:0000269|PubMed:30487602}.		RNA splicing [GO:0008380]	intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00130, ECO:0000269|PubMed:21602272, ECO:0000269|PubMed:25024404}.	18139;		IPR000690;IPR003604;IPR012677;IPR035979;IPR000504;IPR033096;IPR036236;IPR013087;		SM00360;SM00355;SM00451;	218134	COMPBIAS 15..34;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 63..77;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 78..112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 113..138;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 470..487;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 488..553;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 558..584;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 616..632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 639..653;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 751..782;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 783..804;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 834..850;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 851..868;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1098..1140;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1396..1417;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1443..1462;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1484..1500;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1504..1518;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1557..1583;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1862..1887;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..138;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 352..373;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 463..673;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 470..573;  /note=Involved in localization to nuclear speckles;  /evidence=ECO:0000269|PubMed:25024404; REGION 749..804;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 827..899;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1082..1151;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1396..1420;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1442..1462;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1484..1527;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1550..1583;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1763..1898;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1930..1960;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (8); Chain (1); Compositional bias (20); Cross-link (3); Domain (2); Modified residue (18); Region (13); Sequence conflict (1); Zinc finger (1)	MISCELLANEOUS: [Isoform 3]: Due to intron retention. {ECO:0000305}.	Activator;Alternative splicing;DNA-binding;Direct protein sequencing;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 676..751;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 902..976;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The matrin-type zinc finger domain is required for localization to nuclear speckles. {ECO:0000269|PubMed:25024404}.			ZN_FING 1876..1906;  /note=Matrin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00130	PS50102;PS50171;	18139	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015880:Zinc finger, C2H2-like,IPR022755:Zinc finger, double-stranded RNA binding,	PF12171:Zinc-finger double-stranded RNA-binding,	SSF54928:RNA-binding domain, RBD,	2.54112719451931	3.13273739202463e-06	FDR<0.01	5.50407600919575	4003185	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	424	Transcription
P10922	P10922	H1f0	10.332	4.8703	2296800	24.9893795137067	16.6741700431861	17.2223753100028	13.4889053753288	1.97153109104531	8.93335715561908	5631816.66666667	0	H1f0	0	Histone H1.0 (Histone H1') (Histone H1(0)) (MyD196) [Cleaved into: Histone H1.0, N-terminally processed]		FUNCTION: Histones H1 are necessary for the condensation of nucleosome chains into higher-order structures. The histones H1.0 are found in cells that are in terminal stages of differentiation or that have low rates of cell division.		chromatin silencing [GO:0006342]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription regulatory region DNA binding [GO:2000679]	actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	14958;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	20861	COMPBIAS 96..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 121..194;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..28;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 86..194;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (2); Compositional bias (2); Domain (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (2)		ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Nucleus;Reference proteome	DOMAIN 24..97;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837					PS51504;	14958	GO:0006334~nucleosome assembly,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0015629~actin cytoskeleton,	GO:0003677~DNA binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR007110:Immunoglobulin-like domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013768:Intercellular adhesion molecule, N-terminal,IPR013783:Immunoglobulin-like fold,	PF00538:linker histone H1 and H5 family,PF03921:Intercellular adhesion molecule (ICAM), N-terminal domain,	SSF46785:Winged helix DNA-binding domain,SSF48726:Immunoglobulin,	3.29428462662765	2.43071313859592e-06	FDR<0.01	5.61426629153753	3964308.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	428	Transcription
Q8BGC0	Q8BGC0;Q8BGC0-2	Htatsf1	5.6953	6.3531	6154550	2.21057983509074	1.8311999853504	2.49463653145737	1.57860672170742	1.51825704091703	1.50197509725289	911994.333333333	0	Htatsf1	0	HIV Tat-specific factor 1 homolog		FUNCTION: Functions as a general transcription factor playing a role in the process of transcriptional elongation. May mediate the reciprocal stimulatory effect of splicing on transcriptional elongation (By similarity). {ECO:0000250}.		mRNA splicing, via spliceosome [GO:0000398]	nucleoplasm [GO:0005654]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	72459;	cd12281;	IPR012677;IPR035979;IPR000504;IPR003954;IPR034393;IPR034392;	PF00076;	SM00360;SM00361;	86240	COMPBIAS 80..96;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 98..123;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 432..486;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 496..533;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 534..552;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 553..584;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 612..691;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 692..732;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 733..747;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 382..757;  /note=Mediates interaction with the P-TEFb complex;  /evidence=ECO:0000250; REGION 383..417;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 432..757;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (9); Cross-link (1); Domain (2); Erroneous initiation (2); Initiator methionine (1); Modified residue (21); Region (5)		Acetylation;Activator;Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 134..219;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 265..350;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domains mediate interaction with U snRNPs. {ECO:0000250}.				PS50102;	72459	GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005684~U2-type spliceosomal complex,GO:0005686~U2 snRNP,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.2951506426004	0.000938236111777496	FDR<0.01	3.02768785550325	3533272.16666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	465	Transcription
Q78PY7	Q78PY7	Snd1	3.9324	3.8136	3005500	9.44465432565168	6.02990834539315	5.60035842293907	3.06288094581764	10.6613217906756	8.04117079446767	3809581.66666667	0	Snd1	0	Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (p100 co-activator)		FUNCTION: Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs (By similarity). As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition (By similarity). Functions as a bridging factor between STAT6 and the basal transcription factor (By similarity). Plays a role in PIM1 regulation of MYB activity (By similarity). Functions as a transcriptional coactivator for STAT5 (PubMed:12819296). {ECO:0000250|UniProtKB:Q7KZF4, ECO:0000269|PubMed:12819296}.		gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]	endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q7KZF4}. Nucleus {ECO:0000250|UniProtKB:Q7KZF4}. Melanosome {ECO:0000250|UniProtKB:Q7KZF4}. Note=In IL-4 stimulated cells colocalizes with STAT6 in the nucleus. {ECO:0000250|UniProtKB:Q7KZF4}.	56463;	cd04508;	IPR016685;IPR035437;IPR016071;IPR002071;IPR002999;	PF00565;PF00567;	SM00318;SM00333;	102088			NA				3.1.31.1			5 out of 5	Chain (1); Cross-link (1); Domain (5); Erroneous initiation (1); Initiator methionine (1); Modified residue (11); Motif (2); Sequence conflict (2)		Acetylation;Cytoplasm;Endonuclease;Hydrolase;Isopeptide bond;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 18..166;  /note=TNase-like 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00272; DOMAIN 193..328;  /note=TNase-like 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00272; DOMAIN 341..496;  /note=TNase-like 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00272; DOMAIN 525..660;  /note=TNase-like 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00272; DOMAIN 729..787;  /note=Tudor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00211		MOTIF 321..325;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 388..392;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS01284;PS50830;PS50304;	56463	GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006401~RNA catabolic process,GO:0031047~gene silencing by RNA,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016442~RISC complex,GO:0042470~melanosome,GO:0070062~extracellular exosome,GO:0097433~dense body,	GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002071:Thermonuclease active site,IPR002999:Tudor domain,IPR016071:Staphylococcal nuclease (SNase-like), OB-fold,IPR016685:RNA-induced silencing complex, nuclease component Tudor-SN,	PF00565:Staphylococcal nuclease homologue,PF00567:Tudor domain,	SSF50199:Staphylococcal nuclease,	2.53254076413522	6.21485452667832e-07	FDR<0.01	6.20656903258956	3407540.83333333	Present in Nucleus	RBP	DBD	DBD	ChD	RBD	472	Transcription
P23249	P23249	Mov10	15.575	19.987	5898200	0.486570650058388	8.67227473766369	11.599716966906	NA	2.87339808057008	4.48772606920074	887185	1	Mov10	0	Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein)		FUNCTION: Probable RNA helicase. Required for miRNA-mediated gene silencing by the RNA-induced silencing complex (RISC). Required for both miRNA-mediated translational repression and miRNA-mediated cleavage of complementary mRNAs by RISC (By similarity). In cooperation with FMR1, regulates miRNA-mediated translational repression by AGO2 (By similarity). Restricts retrotransposition of long interspersed element-1 (LINE-1) in cooperation with TUT4 and TUT7 counteracting the RNA chaperonne activity of L1RE1. Facilitates LINE-1 uridylation by TUT4 and TUT7 (By similarity). Required for embryonic viability and for normal central nervous system development and function. Plays two critical roles in early brain development: suppresses retroelements in the nucleus by directly inhibiting cDNA synthesis, while regulates cytoskeletal mRNAs to influence neurite outgrowth in the cytosol (PubMed:28662698). May function as a messenger ribonucleoprotein (mRNP) clearance factor (By similarity). {ECO:0000250|UniProtKB:Q9HCE1, ECO:0000269|PubMed:28662698}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; P granule [GO:0043186]	5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000250|UniProtKB:Q9HCE1}. Nucleus {ECO:0000269|PubMed:28662698}. Cytoplasm {ECO:0000269|PubMed:28662698}. Cytoplasm, Cytoplasmic ribonucleoprotein granule {ECO:0000250|UniProtKB:Q9HCE1}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9HCE1}. Note=In young mouse (P2) neurons, localizes both in nucleus and cytoplasm, but in the adulthood it is only cytoplasmic (PubMed:28662698). Co-enriched in cytoplasmic foci with TUT4 (By similarity). {ECO:0000250|UniProtKB:Q9HCE1, ECO:0000269|PubMed:28662698}.	17454;	cd18808;	IPR041679;IPR041677;IPR026122;IPR027417;	PF13086;PF13087;		113583		REGION 922..966;  /note=Interaction with AGO2 and APOBEC3G;  /evidence=ECO:0000250; REGION 966..1004;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Modified residue (4); Motif (1); Mutagenesis (1); Nucleotide binding (1); Region (2); Sequence conflict (1)		ATP-binding;Acetylation;Cytoplasm;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;RNA-mediated gene silencing;Reference proteome			MOTIF 646..649;  /note=DEAG box				17454	GO:0031047~gene silencing by RNA,GO:0035195~gene silencing by miRNA,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR026122:Putative helicase MOV-10/Armitage,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.51200602230237	0.00137408343297087	FDR<0.01	2.86198689654956	3392692.5	Present in Nucleus	RBP	Others	Others	Others	Others	473	Transcription
Q3UHX9	Q3UHX9-2;Q3UHX9	D2Wsu81e	1.8789	6.2587	3492420	5.68117259402341	NA	NA	NA	11.1263170777841	4.70366886171213	2687616.66666667	3	D2Wsu81e	0	Putative methyltransferase C9orf114 homolog (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)		FUNCTION: Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase. Also involved in chromosome alignment. May promote centrosome maturation probably by recruiting A-kinase anchor protein AKAP9 to centrosomes in early mitosis. Binds specifically to miRNA MIR145 hairpin, regulates MIR145 expression at a postranscriptional level (By similarity). {ECO:0000250|UniProtKB:Q5T280}.		cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]	methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q5T280}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q5T280}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q5T280}. Note=Associated with the outer kinetochore. {ECO:0000250|UniProtKB:Q5T280}.	227695;	cd18086;	IPR029028;IPR012340;IPR003750;IPR029026;	PF02598;		42958	COMPBIAS 47..66;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 47..72;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.-			4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Region (2); Sequence conflict (1)	MISCELLANEOUS: [Isoform 1]: May be due to intron retention.	Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinetochore;Methyltransferase;Mitosis;Reference proteome;Transferase							227695	GO:0007049~cell cycle,GO:0032259~methylation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005694~chromosome,	GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR003750:Putative RNA methyltransferase,IPR012340:Nucleic acid-binding, OB-fold,	PF02598:Putative RNA methyltransferase,	SSF50249:Nucleic acid-binding proteins,SSF75217:alpha/beta knot,	2.35432615209089	0.000280938464026598	FDR<0.01	3.55138879632385	3090018.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	495	Transcription
Q9D902	Q9D902	Gtf2e2	8.8003	13.379	4775650	0.373106484590702	5.00400320256205	NA	NA	2.51724311534008	3.93995508451204	1011514.16666667	2	Gtf2e2	0	General transcription factor IIE subunit 2 (Transcription initiation factor IIE subunit beta) (TFIIE-beta)	DNA_BIND 67..147;  /note=TFIIE beta;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00682	FUNCTION: Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase (By similarity). {ECO:0000250|UniProtKB:P29084}.		transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00682}.	68153;	cd07977;	IPR040501;IPR016656;IPR003166;IPR036388;IPR036390;	PF18121;PF02186;		33047	COMPBIAS 48..64;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 256..274;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 17..64;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 242..277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); DNA binding (1); Modified residue (3); Region (2); Sequence conflict (2)		Acetylation;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation						PS51351;	68153	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005673~transcription factor TFIIE complex,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR003166:Transcription factor TFIIE beta subunit, DNA-binding domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016656:Transcription initiation factor TFIIE, beta subunit,	PF02186:TFIIE beta subunit core domain,	SSF46785:Winged helix DNA-binding domain,	1.84836948031892	0.0122995323720587	FDR<0.1	1.91011140011305	2893582.08333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	514	Transcription
Q0VBL3	Q0VBL3-2;Q0VBL3	Rbm15	4.0834	4.2199	3561050	7.47384155455904	5.98336624184766	9.02445627650934	4.93754011751346	7.00182047332306	6.15384615384615	2186923.5	0	Rbm15	0	RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15)		FUNCTION: RNA-binding protein that acts as a key regulator of N6-methyladenosine (m6A) methylation of RNAs, thereby regulating different processes, such as hematopoietic cell homeostasis, alternative splicing of mRNAs and X chromosome inactivation mediated by Xist RNA (PubMed:29535189). Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (PubMed:29535189). Plays a key role in m6A methylation, possibly by binding target RNAs and recruiting the WMM complex (PubMed:29535189). Involved in random X inactivation mediated by Xist RNA: acts by binding Xist RNA and recruiting the WMM complex, which mediates m6A methylation, leading to target YTHDC1 reader on Xist RNA and promoting transcription repression activity of Xist (By similarity). Required for the development of multiple tissues, such as the maintenance of the homeostasis of long-term hematopoietic stem cells and for megakaryocyte (MK) and B-cell differentiation (PubMed:17283045, PubMed:17376872, PubMed:18981216, PubMed:25468569). Regulates megakaryocyte differentiation by regulating alternative splicing of genes important for megakaryocyte differentiation; probably regulates alternative splicing via m6A regulation (By similarity). Required for placental vascular branching morphogenesis and embryonic development of the heart and spleen (PubMed:18981216). Acts as a regulator of thrombopoietin response in hematopoietic stem cells by regulating alternative splicing of MPL (PubMed:25468569). May also function as an mRNA export factor, stimulating export and expression of RTE-containing mRNAs which are present in many retrotransposons that require to be exported prior to splicing (By similarity). High affinity binding of pre-mRNA to RBM15 may allow targeting of the mRNP to the export helicase DBP5 in a manner that is independent of splicing-mediated NXF1 deposition, resulting in export prior to splicing (By similarity). May be implicated in HOX gene regulation (By similarity). {ECO:0000250|UniProtKB:Q96T37, ECO:0000269|PubMed:17283045, ECO:0000269|PubMed:17376872, ECO:0000269|PubMed:18981216, ECO:0000269|PubMed:25468569, ECO:0000269|PubMed:29535189}.		branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]	nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]	mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:Q96T37}. Nucleus, nucleoplasm {ECO:0000269|PubMed:17283045}. Nucleus envelope {ECO:0000250|UniProtKB:Q96T37}. Nucleus membrane {ECO:0000250|UniProtKB:Q96T37}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q96T37}. Note=Colocalizes at the nuclear pore with DBP5 and NXF1. {ECO:0000250|UniProtKB:Q96T37}.	229700;	cd12553;cd12555;cd12557;	IPR012677;IPR035979;IPR034470;IPR034472;IPR034473;IPR000504;IPR016194;IPR012921;IPR010912;	PF00076;PF07744;	SM00360;	105722	COMPBIAS 1..18;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 31..70;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 76..92;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 93..107;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 108..157;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 557..582;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 610..752;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 753..776;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..167;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 257..297;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 553..779;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 866..885;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (8); Cross-link (5); Domain (4); Erroneous initiation (1); Modified residue (23); Region (4); Sequence caution (1); Sequence conflict (4)		Acetylation;Alternative splicing;Isopeptide bond;Membrane;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 169..251;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 373..450;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 454..528;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 778..957;  /note=SPOC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00249					PS50102;PS50917;	229700	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0001569~patterning of blood vessels,GO:0007221~positive regulation of transcription of Notch receptor target,GO:0045638~negative regulation of myeloid cell differentiation,GO:0048536~spleen development,GO:0060412~ventricular septum morphogenesis,GO:0060674~placenta blood vessel development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR010912:Spen paralogue/orthologue C-terminal, metazoa,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,IPR016194:SPOC like C-terminal domain,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF07744:SPOC domain,	SSF100939:SPOC domain-like,SSF54928:RNA-binding domain, RBD,	2.56207974893309	6.25557237854917e-08	FDR<0.01	7.20373294664639	2873986.75	Present in Nucleus	RBP	RBD	Others	Others	RBD	516	Transcription
Q62167	Q62167	Ddx3x	5.3903	6.9164	2573400	7.27749072119933	13.1249097662454	NA	4.46468434681668	14.2547610902041	4.212299915754	2843503.33333333	1	Ddx3x	0	ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (D1Pas1-related sequence 2) (DEAD box RNA helicase DEAD3) (mDEAD3) (DEAD box protein 3, X-chromosomal) (Embryonic RNA helicase)		FUNCTION: Multifunctional ATP-dependent RNA helicase. The ATPase activity can be stimulated by various ribo-and deoxynucleic acids indicative for a relaxed substrate specificity. In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs. Binds RNA G-quadruplex (rG4s) structures, including those located in the 5'-UTR of NRAS mRNA. Involved in many cellular processes, which do not necessarily require its ATPase/helicase catalytic activities. Involved in transcription regulation. Positively regulates CDKN1A/WAF1/CIP1 transcription in an SP1-dependent manner, hence inhibits cell growth. This function requires its ATPase, but not helicase activity. CDKN1A up-regulation may be cell-type specific. Binds CDH1/E-cadherin promoter and represses its transcription. Potentiates HNF4A-mediated MTTP transcriptional activation; this function requires ATPase, but not helicase activity. Facilitates HNF4A acetylation, possibly catalyzed by CREBBP/EP300, thereby increasing the DNA-binding affinity of HNF4 to its response element. In addition, disrupts the interaction between HNF4 and SHP that forms inactive heterodimers and enhances the formation of active HNF4 homodimers. By promoting HNF4A-induced MTTP expression, may play a role in lipid homeostasis. May positively regulate TP53 transcription. Associates with mRNPs, predominantly with spliced mRNAs carrying an exon junction complex (EJC). Involved in the regulation of translation initiation. Not involved in the general process of translation, but promotes efficient translation of selected complex mRNAs, containing highly structured 5'-untranslated regions (UTR). This function depends on helicase activity. Might facilitate translation by resolving secondary structures of 5'-UTRs during ribosome scanning. Alternatively, may act prior to 43S ribosomal scanning and promote 43S pre-initiation complex entry to mRNAs exhibiting specific RNA motifs, by performing local remodeling of transcript structures located close to the cap moiety. Independently of its ATPase activity, promotes the assembly of functional 80S ribosomes and disassembles from ribosomes prior to the translation elongation process. Positively regulates the translation of cyclin E1/CCNE1 mRNA and consequently promotes G1/S-phase transition during the cell cycle. May activate TP53 translation. Required for endoplasmic reticulum stress-induced ATF4 mRNA translation. Independently of its ATPase/helicase activity, enhances IRES-mediated translation; this activity requires interaction with EIF4E. Independently of its ATPase/helicase activity, has also been shown specifically repress cap-dependent translation, possibly by acting on translation initiation factor EIF4E. Involved in innate immunity, acting as a viral RNA sensor. Binds viral RNAs and promotes the production of type I interferon (IFN-alpha and IFN-beta). Potentiate MAVS/DDX58-mediated induction of IFNB in early stages of infection (By similarity). Enhances IFNB1 expression via IRF3/IRF7 pathway and participates in NFKB activation in the presence of MAVS and TBK1 (PubMed:30475900). Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, acts as a scaffolding adapter that links IKBKE and IRF3 and coordinates their activation. Involved in the TLR7/TLR8 signaling pathway leading to type I interferon induction, including IFNA4 production. In this context, acts as an upstream regulator of IRF7 activation by MAP3K14/NIK and CHUK/IKKA. Stimulates CHUK autophosphorylation and activation following physiological activation of the TLR7 and TLR8 pathways, leading to MAP3K14/CHUK-mediated activatory phosphorylation of IRF7. Also stimulates MAP3K14/CHUK-dependent NF-kappa-B signaling. Negatively regulates TNF-induced IL6 and IL8 expression, via the NF-kappa-B pathway. May act by interacting with RELA/p65 and trapping it in the cytoplasm. May also bind IFNB promoter; the function is independent of IRF3 (By similarity). Involved in both stress and inflammatory responses (PubMed:31511697). Independently of its ATPase/helicase activity, required for efficient stress granule assembly through its interaction with EIF4E, hence promotes survival in stressed cells (By similarity). Independently of its helicase activity, regulates NLRP3 inflammasome assembly through interaction with NLRP3 and hence promotes cell death by pyroptosis during inflammation. This function is independent of helicase activity. Therefore DDX3X availability may be used to interpret stress signals and choose between pro-survival stress granules and pyroptotic NLRP3 inflammasomes and serve as a live-or-die checkpoint in stressed cells (PubMed:31511697). In association with GSK3A/B, negatively regulates extrinsic apoptotic signaling pathway via death domain receptors, including TNFRSF10B, slowing down the rate of CASP3 activation following death receptor stimulation. Cleavage by caspases may inactivate DDX3X and relieve the inhibition. Independently of its ATPase/helicase activity, allosteric activator of CSNK1E. Stimulates CSNK1E-mediated phosphorylation of DVL2, thereby involved in the positive regulation of Wnt/beta-catenin signaling pathway. Also activates CSNK1A1 and CSNK1D in vitro, but it is uncertain if these targets are physiologically relevant. ATPase and casein kinase-activating functions are mutually exclusive. May be involved in mitotic chromosome segregation (By similarity). {ECO:0000250|UniProtKB:O00571, ECO:0000269|PubMed:30475900, ECO:0000269|PubMed:31511697}.		cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055]	cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O00571}. Nucleus {ECO:0000269|PubMed:25050112}. Cytoplasm {ECO:0000269|PubMed:25050112}. Cytoplasm, Stress granule {ECO:0000269|PubMed:31511697}. Inflammasome {ECO:0000269|PubMed:31511697}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:O00571}. Note=Shuttles between the nucleus and the cytosol. Exported from the nucleus partly through the XPO1/CRM1 system and partly through NXF1/TAP. Localizes to nuclear pores on the outer side of the nuclear membrane. In the cytosol, partly colocalizes with mitochondria. At G0, predominantly located in nucleus. In G1/S phase, predominantly cytoplasmic. During prophase/prometaphase, localizes in close proximity to the condensing chromosomes. During telophase, localizes around the newly synthesized nuclear membrane and in the cytoplasm. Colocalizes with TRPV4 at the plasma membrane. When TRPV4 channel is activated, intracellular Ca(2+) levels increase and the calmodulin/CAMKII pathway is activated, relocalizes to the nucleus. WNT3A stimulation promotes DDX3 recruitment to the plasma membrane. {ECO:0000250|UniProtKB:O00571}.	13205;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	73101	COMPBIAS 19..34;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 55..69;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 91..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 603..626;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..139;  /note=Required for TBK1 and IKBKE-dependent IFNB1 activation;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 19..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 38..44;  /note=Interaction with EIF4E;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 100..662;  /note=Interaction with GSK3B;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 100..110;  /note=Interaction with IKBKE;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 139..172;  /note=Interaction with CHUK;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 250..259;  /note=Involved in stimulation of ATPase activity by DNA and RNA, nucleic acid binding and unwinding;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 536..661;  /note=Interaction with NXF1;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 601..633;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Initiator methionine (1); Modified residue (17); Motif (3); Nucleotide binding (2); Region (9)	MISCELLANEOUS: Encoded by an chromosome X-linked gene which escapes X chromosome inactivation (XCI) in females, but exhibits developmental- and tissue-specific differences in escape from XCI. DDX3Y, its homolog on chromosome Y, is located in the Y non-recombinant portion (By similarity). In 8 to 16 cell stage embryos, expression from paternal and maternal copies of DDX3X is detected. Paternally derived DDX3X is preferentially inactivated in extraembryonic tissues of embryos from 6.5 dpc (PubMed:27179789). {ECO:0000250|UniProtKB:O00571, ECO:0000269|PubMed:27179789}.	ATP-binding;Acetylation;Apoptosis;Cell membrane;Cell projection;Chromosome partition;Cytoplasm;DNA-binding;Direct protein sequencing;Helicase;Hydrolase;Immunity;Inflammasome;Inflammatory response;Innate immunity;Isopeptide bond;Membrane;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	DOMAIN 211..403;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 414..575;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The C-terminus (residues 536-662) is dispensable for DDX3X trafficking. {ECO:0000250|UniProtKB:O00571}.	MOTIF 12..21;  /note=Nuclear export signal;  /evidence=ECO:0000250|UniProtKB:O00571; MOTIF 180..208;  /note=Q motif; MOTIF 347..350;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	13205	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0007059~chromosome segregation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009615~response to virus,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0017148~negative regulation of translation,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0031333~negative regulation of protein complex assembly,GO:0034063~stress granule assembly,GO:0035556~intracellular signal transduction,GO:0042254~ribosome biogenesis,GO:0042256~mature ribosome assembly,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045070~positive regulation of viral genome replication,GO:0045087~innate immune response,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0071243~cellular response to arsenic-containing substance,GO:0071470~cellular response to osmotic stress,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1903608~protein localization to cytoplasmic stress granule,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0022627~cytosolic small ribosomal subunit,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008143~poly(A) binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0031369~translation initiation factor binding,GO:0035613~RNA stem-loop binding,GO:0043024~ribosomal small subunit binding,GO:0043273~CTPase activity,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.83780026656378	1.31197640437789e-06	FDR<0.01	5.88207397558584	2708451.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	534	Transcription
Q9CXW4	Q9CXW4	Rpl11	9.6711	3.2716	1542700	8.62366333218351	4.33764205777739	7.19114051488566	4.65116279069767	4.05071495118889	7.53012048192771	3640323.33333333	0	Rpl11	0	60S ribosomal protein L11		FUNCTION: Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polypeptide chain. The nascent polypeptides leave the ribosome through a tunnel in the LSU and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel. As part of the 5S RNP/5S ribonucleoprotein particle it is an essential component of the LSU, required for its formation and the maturation of rRNAs. It also couples ribosome biogenesis to p53/TP53 activation. As part of the 5S RNP it accumulates in the nucleoplasm and inhibits MDM2, when ribosome biogenesis is perturbed, mediating the stabilization and the activation of TP53 (PubMed:21804542). Promotes nucleolar location of PML (PubMed:15195100). {ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:21804542}.		cytoplasmic translation [GO:0002181]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of protein binding [GO:0032092]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:21804542}. Cytoplasm {ECO:0000269|PubMed:21804542}.	67025;		IPR002132;IPR031309;IPR020929;IPR022803;IPR031310;	PF00281;PF00673;		20252			NA							5 out of 5	Chain (1); Cross-link (3); Initiator methionine (1); Modified residue (5); Sequence conflict (1)		3D-structure;Acetylation;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding						PS00358;	67025	GO:0000027~ribosomal large subunit assembly,GO:0006364~rRNA processing,GO:0006412~translation,GO:0006605~protein targeting,GO:0034504~protein localization to nucleus,GO:0042273~ribosomal large subunit biogenesis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0044822~poly(A) RNA binding,	IPR002132:Ribosomal protein L5,IPR020929:Ribosomal protein L5, conserved site,IPR022803:Ribosomal protein L5 domain,	PF00281:Ribosomal protein L5,PF00673:ribosomal L5P family C-terminus,	SSF55282:RL5-like,	2.52544372177555	3.23134393161077e-07	FDR<0.01	6.49061681491601	2591511.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	543	Transcription
P56960	P56960	Exosc10	5.6086	4.8362	3259550	6.62866233594061	5.90981620471603	NA	3.38615738859542	4.68033323972667	7.07363655655372	1902705.33333333	1	Exosc10	0	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog)		FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. EXOSC10 has 3'-5' exonuclease activity (By similarity). EXOSC10 is required for nucleolar localization of C1D and probably mediates the association of MTREX, C1D and MPHOSPH6 with the RNA exosome involved in the maturation of 5.8S rRNA (By similarity). {ECO:0000250|UniProtKB:Q01780}.		CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q01780}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q01780}. Nucleus {ECO:0000250|UniProtKB:Q01780}.	50912;		IPR002562;IPR012588;IPR010997;IPR002121;IPR012337;	PF01612;PF00570;PF08066;	SM00474;SM00341;	100942	COMPBIAS 735..757;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 777..815;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 734..757;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 777..887;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.13.-			5 out of 5	Chain (1); Compositional bias (2); Cross-link (7); Domain (1); Modified residue (1); Region (3); Sequence conflict (3)		Cytoplasm;Direct protein sequencing;Exonuclease;Exosome;Hydrolase;Isopeptide bond;Nonsense-mediated mRNA decay;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing	DOMAIN 503..583;  /note=HRDC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00328					PS50967;	50912	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000460~maturation of 5.8S rRNA,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006139~nucleobase-containing compound metabolic process,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0044237~cellular metabolic process,GO:0071028~nuclear mRNA surveillance,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071044~histone mRNA catabolic process,GO:0071048~nuclear retention of unspliced pre-mRNA at the site of transcription,	GO:0000176~nuclear exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0035327~transcriptionally active chromatin,	GO:0000166~nucleotide binding,GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004532~exoribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR002121:HRDC domain,IPR002562:3'-5' exonuclease domain,IPR010997:HRDC-like,IPR012337:Ribonuclease H-like domain,IPR012588:Exosome-associated factor Rrp6, N-terminal,	PF00570:HRDC domain,PF01612:3'-5' exonuclease,PF08066:PMC2NT (NUC016) domain,	SSF47819:HRDC-like,SSF53098:Ribonuclease H-like,	2.40886543003322	5.21837104246989e-07	FDR<0.01	6.28246504444464	2581127.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	545	Transcription
Q9JJY4	Q9JJY4	Ddx20	5.1251	5.3158	1700000	3.23886639676113	2.94724432655467	3.59053534882051	2.10327058576086	2.4083038316114	2.81777452168278	3283961.66666667	0	Ddx20	0	Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3) (Regulator of steroidogenic factor 1) (ROSF-1)		FUNCTION: The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. May also play a role in the metabolism of small nucleolar ribonucleoprotein (snoRNPs) (By similarity). {ECO:0000250}.		negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; transcription repressor complex [GO:0017053]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus, gem. Note=Localized in subnuclear structures next to coiled bodies, called Gemini of Cajal bodies (Gems).	53975;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	91710	COMPBIAS 465..507;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 541..569;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 642..686;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 695..715;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 717..732;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 27..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 465..573;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 642..753;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 85;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000250; BINDING 90;  /note=ATP;  /evidence=ECO:0000250	3.6.4.13			5 out of 5	Binding site (2); Chain (1); Compositional bias (5); Domain (2); Modified residue (15); Motif (2); Nucleotide binding (2); Region (3); Sequence conflict (4)		ATP-binding;Cytoplasm;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;mRNA processing;mRNA splicing	DOMAIN 94..265;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 300..449;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 63..91;  /note=Q motif; MOTIF 212..215;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	53975	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000387~spliceosomal snRNP assembly,GO:0006397~mRNA processing,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0043065~positive regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048477~oogenesis,GO:0050810~regulation of steroid biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0017053~transcriptional repressor complex,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0090571~RNA polymerase II transcription repressor complex,GO:0097504~Gemini of coiled bodies,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0030674~protein binding, bridging,GO:0042826~histone deacetylase binding,GO:0070491~repressing transcription factor binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.71276620251061	6.36982065182296e-06	FDR<0.01	5.19587279545431	2491980.83333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	557	Transcription
Q9QZH3	Q9QZH3	Ppie	6.9114	12.266	4792050	NA	NA	NA	NA	NA	4.33519746824468	89757.3333333333	5	Ppie	0	Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E)		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Combines RNA-binding and PPIase activities. Binds mRNA and has a preference for single-stranded RNA molecules with poly-A and poly-U stretches, suggesting it binds to the poly(A)-region in the 3'-UTR of mRNA molecules. Catalyzes the cis-trans isomerization of proline imidic peptide bonds in proteins. Inhibits KMT2A activity; this requires proline isomerase activity. {ECO:0000250|UniProtKB:Q9UNP9}.		mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]	cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UNP9}.	56031;	cd12347;	IPR029000;IPR020892;IPR002130;IPR012677;IPR016304;IPR034168;IPR035979;IPR000504;	PF00160;PF00076;	SM00360;	33449	COMPBIAS 110..132;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 110..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				5.2.1.8			4 out of 5	Chain (1); Compositional bias (1); Domain (2); Modified residue (2); Region (1); Sequence conflict (2)		Isomerase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Rotamase;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 5..83;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 143..299;  /note=PPIase cyclophilin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00156	DOMAIN: The RRM domain mediates both interaction with RNA and with KMT2A (via the third PHD-type zinc-finger), but has much higher affinity for the KMT2A PHD-type zinc-finger. {ECO:0000250|UniProtKB:Q9UNP9}.				PS00170;PS50072;PS50102;	56031	GO:0000413~protein peptidyl-prolyl isomerization,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006457~protein folding,GO:0008380~RNA splicing,GO:0045070~positive regulation of viral genome replication,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016853~isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR016304:Cyclophilin-type peptidyl-prolyl cis-trans isomerase E,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00160:Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD,	SSF50891:Cyclophilin-like,SSF54928:RNA-binding domain, RBD,	2.84055621293419	0.000694837174939166	FDR<0.01	3.15811695412959	2440903.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	566	Transcription
Q8BJW5	Q8BJW5;Q8BJW5-2	Nol11	4.0367	4.6071	3840885	NA	NA	20.3873598369011	NA	4.91787154519524	NA	1003682.16666667	4	Nol11	0	Nucleolar protein 11		FUNCTION: Ribosome biogenesis factor. May be required for both optimal rDNA transcription and small subunit (SSU) pre-rRNA processing at sites A', A0, 1 and 2b (By similarity). {ECO:0000250|UniProtKB:Q9H8H0}.		maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]	nucleolus [GO:0005730]; t-UTP complex [GO:0034455]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H8H0}.	68979;		IPR042859;IPR012584;	PF08168;		80818		REGION 549..572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Alternative sequence (1); Chain (1); Modified residue (1); Region (1); Sequence conflict (7)	MISCELLANEOUS: [Isoform 2]: May be due to a competing acceptor splice site. {ECO:0000305}.	Activator;Alternative splicing;Methylation;Nucleus;Reference proteome;Ribosome biogenesis;Transcription;Transcription regulation;rRNA processing							68979	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0030490~maturation of SSU-rRNA,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0034455~t-UTP complex,	GO:0044822~poly(A) RNA binding,	IPR012584:NUC205,	PF08168:NUC205 domain,		2.71616809771231	0.000634379003215043	FDR<0.01	3.19765119980576	2422283.58333333	Present in Nucleus	RBP	Others	Others	Others	Others	569	Transcription
Q6Y7W8	Q6Y7W8;Q6Y7W8-2	Gigyf2	6.0302	5.8857	1192215	12.2762650691154	10.5450749227573	4.96204039100878	2.78466208125644	67.7323218639935	8.61400637436472	3538660	0	Gigyf2	0	GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein)		FUNCTION: Key component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation (PubMed:26763119). In the 4EHP-GYF2 complex, acts as a factor that bridges EIF4E2 to ZFP36/TTP, linking translation repression with mRNA decay (PubMed:26763119). Also recruits and bridges the association of the 4EHP complex with the decapping effector protein DDX6, which is required for the ZFP36/TTP-mediated down-regulation of AU-rich mRNA (By similarity). May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling, including IGF1 and insulin receptors (PubMed:12771153). {ECO:0000250|UniProtKB:Q6Y7W6, ECO:0000269|PubMed:12771153, ECO:0000269|PubMed:26763119}.		adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982]	proline-rich region binding [GO:0070064]		227331;	cd00072;	IPR003169;IPR035445;	PF02213;	SM00444;	149193	COMPBIAS 148..182;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 267..285;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..366;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 370..390;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 391..417;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 418..435;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..461;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 846..902;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 903..937;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 972..998;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1094..1115;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1207..1223;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 112..132;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 148..196;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 209..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 267..484;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 548..564;  /note=Required for GRB10-binding;  /evidence=ECO:0000269|PubMed:12771153; REGION 732..794;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 846..937;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 958..998;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1011..1053;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1090..1118;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1202..1223;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1239..1263;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (12); Cross-link (1); Domain (1); Initiator methionine (1); Modified residue (16); Motif (1); Region (12); Sequence conflict (2)		Acetylation;Alternative splicing;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 534..582;  /note=GYF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00101		MOTIF 281..311;  /note=DDX6 binding motif;  /evidence=ECO:0000250|UniProtKB:Q6Y7W6			PS50829;	227331	GO:0007631~feeding behavior,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0017148~negative regulation of translation,GO:0021522~spinal cord motor neuron differentiation,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0035264~multicellular organism growth,GO:0044267~cellular protein metabolic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048873~homeostasis of number of cells within a tissue,GO:0050881~musculoskeletal movement,GO:0050885~neuromuscular process controlling balance,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003169:GYF,	PF02213:GYF domain,	SSF55277:GYF domain,	3.1428262227361	1.22791247839871e-05	FDR<0.01	4.91083258718758	2365437.5	Unexpected	RBP	Others	Others	Others	Others	572	Transcription
Q9QWV9	Q9QWV9	Ccnt1	17.744	6.915	3695000	20.2146799005438	5.67086310536464	NA	NA	2.99958005879177	0.191029265683503	1010095	2	Ccnt1	0	Cyclin-T1 (CycT1) (Cyclin-T)		FUNCTION: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II).		cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; snRNA binding [GO:0017069]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	12455;	cd00043;	IPR028863;IPR013763;IPR036915;IPR043198;IPR006671;	PF00134;	SM00385;	80598	COMPBIAS 483..509;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 510..529;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..574;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 705..724;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 483..586;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 691..724;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (3); Modified residue (5); Motif (1); Mutagenesis (5); Region (2); Sequence conflict (2)		Acetylation;Cell cycle;Cell division;Coiled coil;Cyclin;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 253..270;  /note=Nuclear localization signal;  /evidence=ECO:0000255				12455	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051301~cell division,GO:1900364~negative regulation of mRNA polyadenylation,GO:1901409~positive regulation of phosphorylation of RNA polymerase II C-terminal domain,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0008024~cyclin/CDK positive transcription elongation factor complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0017069~snRNA binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,GO:0070063~RNA polymerase binding,GO:0097322~7SK snRNA binding,	IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,	PF00134:Cyclin, N-terminal domain,	SSF47954:Cyclin-like,	2.16275241988	0.021546093753845	FDR<0.1	1.666631454734	2352547.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	573	Transcription
Q9JIF0	Q9JIF0-3;Q9JIF0-2;Q9JIF0;Q6PAK3	Prmt1	12.277	7.5534	2965150	3.55884551051639	3.83906633906634	10.6040040719376	5.77867668303958	4.41189446748434	4.50694068866054	1644066.66666667	0	Prmt1	0	Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1)		FUNCTION: Arginine methyltransferase that methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues present in proteins such as ESR1, histone H2, H3 and H4, ILF3, HNRNPA1, HNRNPD, NFATC2IP, SUPT5H, TAF15, EWS, HABP4 and SERBP1 (PubMed:15327772, PubMed:19858291). Constitutes the main enzyme that mediates monomethylation and asymmetric dimethylation of histone H4 'Arg-4' (H4R3me1 and H4R3me2a, respectively), a specific tag for epigenetic transcriptional activation (By similarity). Methylates H4R3 in genes involved in glioblastomagenesis in a CHTOP- and/or TET1-dependent manner (By similarity). May be involved in the regulation of TAF15 transcriptional activity, act as an activator of estrogen receptor (ER)-mediated transactivation, play a key role in neurite outgrowth and act as a negative regulator of megakaryocytic differentiation, by modulating p38 MAPK pathway (By similarity). Methylates RBM15, promoting ubiquitination and degradation of RBM15 (By similarity). Methylates CHTOP and this methylation is critical for its 5-hydroxymethylcytosine (5hmC)-binding activity (PubMed:19858291). {ECO:0000250|UniProtKB:Q99873, ECO:0000269|PubMed:15327772, ECO:0000269|PubMed:19858291}.		histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine omega-N-methylation [GO:0035247]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	[cytochrome c]-arginine N-methyltransferase activity [GO:0016275]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; S-adenosyl-L-methionine binding [GO:1904047]; snoRNP binding [GO:0030519]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19858291}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm, cytosol {ECO:0000269|PubMed:19858291}. Cytoplasm {ECO:0000269|PubMed:19858291}. Note=Mostly found in the cytoplasm (PubMed:19858291). Colocalizes with CHTOP within the nucleus (PubMed:19858291). Low levels detected also in the chromatin fraction (PubMed:22872859). {ECO:0000269|PubMed:19858291, ECO:0000269|PubMed:22872859}.	15469;		IPR025799;IPR041698;IPR029063;	PF13649;		42436			NA	ACT_SITE 162;  /evidence=ECO:0000250; ACT_SITE 171;  /evidence=ECO:0000250		BINDING 63;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250; BINDING 72;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250; BINDING 96;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250; BINDING 118;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250; BINDING 147;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250	2.1.1.319			5 out of 5	Active site (2); Alternative sequence (2); Binding site (5); Chain (1); Cross-link (1); Domain (1); Modified residue (5); Mutagenesis (9)		Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;S-adenosyl-L-methionine;Transferase;Ubl conjugation	DOMAIN 50..371;  /note=SAM-dependent MTase PRMT-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01015					PS51678;	15469	GO:0001701~in utero embryonic development,GO:0006355~regulation of transcription, DNA-templated,GO:0006479~protein methylation,GO:0016571~histone methylation,GO:0018216~peptidyl-arginine methylation,GO:0019919~peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,GO:0031175~neuron projection development,GO:0032259~methylation,GO:0035247~peptidyl-arginine omega-N-methylation,GO:0043985~histone H4-R3 methylation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0046985~positive regulation of hemoglobin biosynthetic process,GO:1900745~positive regulation of p38MAPK cascade,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0034709~methylosome,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0008327~methyl-CpG binding,GO:0008469~histone-arginine N-methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0016275~[cytochrome c]-arginine N-methyltransferase activity,GO:0016740~transferase activity,GO:0019899~enzyme binding,GO:0030519~snoRNP binding,GO:0035241~protein-arginine omega-N monomethyltransferase activity,GO:0035242~protein-arginine omega-N asymmetric methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042802~identical protein binding,GO:0044020~histone methyltransferase activity (H4-R3 specific),GO:0044822~poly(A) RNA binding,GO:0048273~mitogen-activated protein kinase p38 binding,	IPR025799:Protein arginine N-methyltransferase,		SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.56975003403025	6.33014598169661e-07	FDR<0.01	6.19858627445117	2304608.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	578	Transcription
Q6ZQ58	Q6ZQ58;Q6ZQ58-2	Larp1	13.068	3.8896	1793500	6.25547353934693	12.1422587029639	7.65403750478377	5.94883997620464	4.79823424979607	8.89046941678521	2796798.33333333	0	Larp1	0	La-related protein 1 (La ribonucleoprotein domain family member 1)		FUNCTION: RNA-binding protein that regulates the translation of specific target mRNA species downstream of the mTORC1 complex, in function of growth signals and nutrient availability. Interacts on the one hand with the 3' poly-A tails that are present in all mRNA molecules, and on the other hand with the 7-methylguanosine cap structure of mRNAs containing a 5' terminal oligopyrimidine (5'TOP) motif, which is present in mRNAs encoding ribosomal proteins and several components of the translation machinery. The interaction with the 5' end of mRNAs containing a 5'TOP motif leads to translational repression by preventing the binding of EIF4G1. When mTORC1 is activated, LARP1 is phosphorylated and dissociates from the 5' untranslated region (UTR) of mRNA. Does not prevent binding of EIF4G1 to mRNAs that lack a 5'TOP motif. Interacts with the free 40S ribosome subunit and with ribosomes, both monosomes and polysomes. Under normal nutrient availability, interacts primarily with the 3' untranslated region (UTR) of mRNAs encoding ribosomal proteins and increases protein synthesis. Associates with actively translating ribosomes and stimulates translation of mRNAs containing a 5'TOP motif, thereby regulating protein synthesis, and as a consequence, cell growth and proliferation. Stabilizes mRNAs species with a 5'TOP motif, which is required to prevent apoptosis. {ECO:0000250|UniProtKB:Q6PKG0}.		cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; posttranscriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TORC1 signaling [GO:0038202]; TOR signaling [GO:0031929]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]	eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10878606}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q6PKG0}. Note=Colocalizes with RPTOR and PABPC1 in cytoplasmic granules that resemble stress granules. {ECO:0000250|UniProtKB:Q6PKG0}.	73158;		IPR006607;IPR006630;IPR036388;IPR036390;	PF05383;	SM00684;SM00715;	121125	COMPBIAS 55..69;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 100..123;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 171..216;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 224..259;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 532..556;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 740..773;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 822..837;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1003..1022;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1028..1072;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..268;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 70..550;  /note=Required for interaction with PABPC1;  /evidence=ECO:0000250|UniProtKB:Q6PKG0; REGION 289..331;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 488..578;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 551..1072;  /note=Required for interaction with RPTOR and for repression of mRNAs with a 5'TOP motif;  /evidence=ECO:0000250|UniProtKB:Q6PKG0; REGION 737..773;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 790..837;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 850..1000;  /note=Interaction with mRNA;  /evidence=ECO:0000250|UniProtKB:Q6PKG0; REGION 933..976;  /note=Interaction with 7-methylguanosine mRNA cap structure;  /evidence=ECO:0000250|UniProtKB:Q6PKG0; REGION 1003..1072;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (9); Cross-link (4); Domain (1); Initiator methionine (1); Modified residue (43); Region (10)		Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Methylation;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Translation regulation;Ubl conjugation	DOMAIN 372..462;  /note=HTH La-type RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00332	DOMAIN: The C-terminal region mediates interaction with the mRNA and polysomes. It is required for translational repression of mRNAs with a 5'TOP motif. {ECO:0000250|UniProtKB:Q6PKG0}.; DOMAIN: The N-terminal region mediates interaction with PABPC1. {ECO:0000250|UniProtKB:Q6PKG0}.				PS50961;	73158	GO:0006413~translational initiation,GO:0008283~cell proliferation,GO:0016239~positive regulation of macroautophagy,GO:0031929~TOR signaling,GO:0045070~positive regulation of viral genome replication,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0031931~TORC1 complex,	GO:0000339~RNA cap binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0008494~translation activator activity,GO:0031369~translation initiation factor binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR006607:Protein of unknown function DM15,IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF05383:La domain,	SSF46785:Winged helix DNA-binding domain,	2.85478309912513	1.29652959795547e-07	FDR<0.01	6.88721756444649	2295149.16666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	579	Transcription
Q9CQF3	Q9CQF3	Nudt21	6.8887	6.6155	3653900	9.01063254640476	126.781276941021	23.9263069745185	NA	12.8551227664224	5.98479861152672	536046.666666667	1	Nudt21	0	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Nudix hydrolase 21)		FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation. The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs. NUDT21/CPSF5 activates indirectly the mRNA 3'-processing machinery by recruiting CPSF6 and/or CPSF7. Binds to 5'-UGUA-3' elements localized upstream of pA signals that act as enhancers of pre-mRNA 3'-end processing. The homodimer mediates simultaneous sequence-specific recognition of two 5'-UGUA-3' elements within the pre-mRNA (By similarity). Plays a role in somatic cell fate transitions and pluripotency by regulating widespread changes in gene expression through an APA-dependent function(PubMed:29249356). Binds to chromatin (PubMed:18032416). Binds to, but does not hydrolyze mono- and di-adenosine nucleotides (By similarity). {ECO:0000250|UniProtKB:O43809, ECO:0000269|PubMed:18032416, ECO:0000269|PubMed:29249356}.		cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear body [GO:0016604]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18032416}. Cytoplasm {ECO:0000250|UniProtKB:O43809}. Note=Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm). In punctate subnuclear structures localized adjacent to nuclear speckles, called paraspeckles. {ECO:0000250|UniProtKB:O43809}.	68219;		IPR016706;IPR015797;IPR000086;	PF13869;		26240		REGION 2..147;  /note=Necessary for RNA-binding;  /evidence=ECO:0000250|UniProtKB:O43809; REGION 81..160;  /note=Necessary for interactions with PAPOLA and PABPN1;  /evidence=ECO:0000250|UniProtKB:O43809; REGION 102..104;  /note=Interaction with RNA;  /evidence=ECO:0000250|UniProtKB:O43809	NA							5 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (6); Motif (1); Region (3); Sequence conflict (1); Site (2)		Acetylation;Cytoplasm;Differentiation;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	DOMAIN 76..201;  /note=Nudix hydrolase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00794		MOTIF 109..130;  /note=Nudix box			PS51462;	68219	GO:0006378~mRNA polyadenylation,GO:0006379~mRNA cleavage,GO:0006397~mRNA processing,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005849~mRNA cleavage factor complex,GO:0042382~paraspeckles,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0016787~hydrolase activity,GO:0017091~AU-rich element binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000086:NUDIX hydrolase domain,IPR015797:NUDIX hydrolase domain-like,IPR016706:Cleavage/polyadenylation specificity factor subunit 5,	PF13869:Nucleotide hydrolase,	SSF55811:Nudix,	3.78771546342205	1.82544936681244e-05	FDR<0.01	4.73863020873941	2094973.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	607	Transcription
Q6PB66	Q6PB66	Lrpprc	11.498	2.4718	884265	12.7258844489692	5.39956803455724	10.5138098892896	16.3869952805454	11.4964993159583	7.12098554439935	3205071.66666667	0	Lrpprc	0	Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (mLRP130)		FUNCTION: May play a role in RNA metabolism in both nuclei and mitochondria. In the nucleus binds to HNRPA1-associated poly(A) mRNAs and is part of nmRNP complexes at late stages of mRNA maturation which are possibly associated with nuclear mRNA export. May bind mature mRNA in the nucleus outer membrane. In mitochondria binds to poly(A) mRNA. Plays a role in translation or stability of mitochondrially encoded cytochrome c oxidase (COX) subunits. May be involved in transcription regulation. Cooperates with PPARGC1A to regulate certain mitochondrially encoded genes and gluconeogenic genes and may regulate docking of PPARGC1A to transcription factors. Seems to be involved in the transcription regulation of the multidrug-related genes MDR1 and MVP. Part of a nuclear factor that binds to the invMED1 element of MDR1 and MVP gene promoters (By similarity). Binds single-stranded DNA. {ECO:0000250}.		mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]	beta-tubulin binding [GO:0048487]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}. Nucleus {ECO:0000269|PubMed:12071956}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus inner membrane {ECO:0000250}. Nucleus outer membrane {ECO:0000250}.	72416;		IPR033490;IPR002885;IPR033443;IPR011990;	PF01535;PF17177;		156615		REGION 931..1050;  /note=RNA-binding	NA							5 out of 5	Chain (1); Erroneous initiation (1); Erroneous translation (1); Modified residue (10); Region (1); Repeat (20); Sequence conflict (4); Transit peptide (1)		Acetylation;DNA-binding;Membrane;Mitochondrion;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Transit peptide;Transport;mRNA transport				REPEAT 125..159;  /note=PPR 1; REPEAT 160..194;  /note=PPR 2; REPEAT 195..229;  /note=PPR 3; REPEAT 230..264;  /note=PPR 4; REPEAT 265..299;  /note=PPR 5; REPEAT 300..334;  /note=PPR 6; REPEAT 402..436;  /note=PPR 7; REPEAT 437..471;  /note=PPR 8; REPEAT 677..708;  /note=PPR 9; REPEAT 709..745;  /note=PPR 10; REPEAT 746..783;  /note=PPR 11; REPEAT 784..820;  /note=PPR 12; REPEAT 821..856;  /note=PPR 13; REPEAT 953..987;  /note=PPR 14; REPEAT 1030..1064;  /note=PPR 15; REPEAT 1065..1101;  /note=PPR 16; REPEAT 1102..1136;  /note=PPR 17; REPEAT 1137..1175;  /note=PPR 18; REPEAT 1176..1210;  /note=PPR 19; REPEAT 1315..1349;  /note=PPR 20		PS51375;	72416	GO:0000961~negative regulation of mitochondrial RNA catabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0051028~mRNA transport,GO:0070129~regulation of mitochondrial translation,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0042645~mitochondrial nucleoid,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0048487~beta-tubulin binding,	IPR002885:Pentatricopeptide repeat,	PF01535:PPR repeat,PF13812:Pentatricopeptide repeat domain,		3.08941297503441	5.18988593684572e-07	FDR<0.01	6.28484218695749	2044668.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	609	Transcription
Q8R2N2	Q8R2N2	Cirh1a	6.5468	5.0502	2146350	2.83270069684437	5.49148819330038	7.75975789555366	NA	5.90179414542021	3.06908510572998	1701123.33333333	1	Cirh1a	0	U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (Testis-expressed gene 292 protein)		FUNCTION: Ribosome biogenesis factor. Involved in nucleolar processing of pre-18S ribosomal RNA. Involved in small subunit (SSU) pre-rRNA processing at sites A', A0, 1 and 2b. Required for optimal pre-ribosomal RNA transcription by RNA polymerase. May be a transcriptional regulator. Acts as a positive regulator of HIVEP1. {ECO:0000250|UniProtKB:Q969X6}.		maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]	90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q969X6}. Chromosome {ECO:0000250|UniProtKB:Q969X6}. Note=Found predominantly at the fibrillar center. {ECO:0000250|UniProtKB:Q969X6}.	21771;		IPR015943;IPR001680;IPR017986;IPR036322;	PF00400;	SM00320;	76909			NA							4 out of 5	Chain (1); Cross-link (1); Erroneous initiation (3); Frameshift (2); Repeat (11)		Chromosome;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation;WD repeat;rRNA processing				REPEAT 14..53;  /note=WD 1; REPEAT 57..96;  /note=WD 2; REPEAT 99..138;  /note=WD 3; REPEAT 143..181;  /note=WD 4; REPEAT 193..231;  /note=WD 5; REPEAT 234..273;  /note=WD 6; REPEAT 285..322;  /note=WD 7; REPEAT 324..359;  /note=WD 8; REPEAT 435..474;  /note=WD 9; REPEAT 482..521;  /note=WD 10; REPEAT 524..563;  /note=WD 11		PS50294;	21771	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0030490~maturation of SSU-rRNA,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0034455~t-UTP complex,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.30592566720436	2.80822473863147e-06	FDR<0.01	5.5515681391199	1923736.66666667	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	631	Transcription
Q8K3A9	Q8K3A9	Mepce	11.991	13.959	2877600	NA	NA	NA	NA	10.845516463494	5.18645298480369	475265	4	Mepce	0	7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-)		FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that adds a methylphosphate cap at the 5'-end of 7SK snRNA (7SK RNA), leading to stabilize it (By similarity). Also has a non-enzymatic function as part of the 7SK RNP complex: the 7SK RNP complex sequesters the positive transcription elongation factor b (P-TEFb) in a large inactive 7SK RNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:23154982). The 7SK RNP complex also promotes snRNA gene transcription by RNA polymerase II via interaction with the little elongation complex (LEC) (By similarity). In the 7SK RNP complex, MEPCE is required to stabilize 7SK RNA and facilitate the assembly of 7SK RNP complex (By similarity). MEPCE has a non-enzymatic function in the 7SK RNP complex; it has a non-enzymatic function; interaction with LARP7 within the 7SK RNP complex occluding its catalytic center (By similarity). {ECO:0000250|UniProtKB:Q7L2J0, ECO:0000269|PubMed:23154982}.		negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031]	7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7L2J0}.	231803;		IPR039772;IPR010675;IPR024160;IPR025714;IPR029063;	PF06859;PF13847;		72050	COMPBIAS 246..264;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 271..291;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 310..336;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..291;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 309..383;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 428..430;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q7L2J0; REGION 451..452;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q7L2J0; REGION 536..537;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q7L2J0	NA			BINDING 399;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q7L2J0; BINDING 410;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q7L2J0; BINDING 558;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q7L2J0	2.1.1.-			5 out of 5	Binding site (3); Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Erroneous initiation (1); Frameshift (1); Modified residue (14); Region (6); Sequence conflict (3)		Acetylation;Isopeptide bond;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;S-adenosyl-L-methionine;Transferase;Ubl conjugation	DOMAIN 408..663;  /note=Bin3-type SAM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00848					PS51515;	231803	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001510~RNA methylation,GO:0016073~snRNA metabolic process,GO:0032259~methylation,GO:0035562~negative regulation of chromatin binding,GO:0040031~snRNA modification,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,		GO:0008168~methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR010675:Bicoid-interacting 3,IPR024160:Bin3-type S-adenosyl-L-methionine binding domain,IPR025714:Methyltransferase domain,	PF06859:Bicoid-interacting protein 3 (Bin3),PF13847:Methyltransferase domain,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	3.30019470716152	3.83555532042194e-05	FDR<0.01	4.41617174902	1676432.5	Present in Nucleus	RBP	Others	Others	Others	Others	673	Transcription
Q7TQK4	Q7TQK4	Exosc3	8.4308	NA	1189685	4.55456367280015	17.061352624036	NA	NA	5.04795557799091	NA	1970188.33333333	3	Exosc3	1	Exosome complex component RRP40 (EC 3.1.13.-) (Exosome component 3) (Ribosomal RNA-processing protein 40)		FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC3 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC9 and EXOSC5 (By similarity). {ECO:0000250, ECO:0000269|PubMed:21255825}.		CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Nucleus {ECO:0000250}.	66362;	cd05790;	IPR026699;IPR004088;IPR036612;IPR012340;IPR037319;	PF15985;		29546			NA				3.1.13.-			5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (1); Sequence conflict (1)		Acetylation;Cytoplasm;Exonuclease;Exosome;Hydrolase;Isopeptide bond;Nuclease;Nucleus;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing							66362	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045006~DNA deamination,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071049~nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,	IPR004088:K Homology domain, type 1,IPR012340:Nucleic acid-binding, OB-fold,IPR026699:Exosome complex RNA-binding protein 1/RRP40/RRP4,		SSF50249:Nucleic acid-binding proteins,SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.9228354308239	0.000190280464074085	FDR<0.01	3.72060579805218	1579936.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	686	Transcription
Q8VDM6	Q8VDM6-2;Q8VDM6;Q8VDM6-3	Hnrnpul1	4.6089	7.374	2120285	1.06416941577099	9.40468353239913	2.82111321127317	NA	6.21040864488883	3.68541313481241	986723.333333333	1	Hnrnpul1	0	Heterogeneous nuclear ribonucleoprotein U-like protein 1		FUNCTION: Acts as a basic transcriptional regulator. Represses basic transcription driven by several virus and cellular promoters. When associated with BRD7, activates transcription of glucocorticoid-responsive promoter in the absence of ligand-stimulation. Plays also a role in mRNA processing and transport. Binds avidly to poly(G) and poly(C) RNA homopolymers in vitro (By similarity). {ECO:0000250}.		response to virus [GO:0009615]; RNA processing [GO:0006396]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	232989;	cd12884;	IPR001870;IPR043136;IPR013320;IPR027025;IPR027417;IPR003034;IPR036361;IPR003877;IPR035778;	PF02037;PF00622;	SM00513;SM00449;	96002	COMPBIAS 52..66;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 102..118;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 167..200;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 595..615;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 666..696;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 697..724;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 725..756;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 774..811;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..103;  /note=Necessary for interaction with HRMT1L1;  /evidence=ECO:0000250; REGION 36..131;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 146..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 214..859;  /note=Necessary for interaction with TP53;  /evidence=ECO:0000250; REGION 457..595;  /note=Necessary for interaction with BRD7 and transcriptional activation;  /evidence=ECO:0000250; REGION 595..814;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 613..661;  /note=5 X 3 AA repeats of R-G-G; REGION 613..661;  /note=Necessary for transcription repression;  /evidence=ECO:0000250	NA							4 out of 5	Alternative sequence (3); Chain (1); Compositional bias (8); Cross-link (9); Domain (2); Erroneous initiation (1); Modified residue (11); Region (8); Repeat (5); Sequence conflict (4)		Activator;Alternative splicing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ribonucleoprotein;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 3..37;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 192..389;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548	DOMAIN: The RGG-box domain is methylated. {ECO:0000250}.		REPEAT 613..615;  /note=1-1; REPEAT 620..622;  /note=1-2; REPEAT 639..641;  /note=1-3; REPEAT 645..647;  /note=1-4; REPEAT 659..661;  /note=1-5		PS50188;PS50800;	232989	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0009615~response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR027025:Heterogeneous nuclear ribonucleoprotein U-like protein 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00622:SPRY domain,PF02037:SAP domain,	SSF49899:Concanavalin A-like lectins/glucanases,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.06039374913775	0.000192710221323079	FDR<0.01	3.7150952498153	1553504.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	692	Transcription
Q9CQC6	Q9CQC6	Bzw1	11.291	6.1192	1428390	4.53741095331004	4.53638178189076	1.8690540717343	3.06993307545896	4.28798078984606	2.42201123813214	1469805	0	Bzw1	0	Basic leucine zipper and W2 domain-containing protein 1		FUNCTION: Enhances histone H4 gene transcription but does not seem to bind DNA directly. {ECO:0000250}.			cytoplasm [GO:0005737]			66882;	cd11560;	IPR016024;IPR016021;IPR043510;IPR003307;	PF02020;	SM00515;	48043		REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Cross-link (1); Domain (1); Modified residue (4); Region (1); Sequence conflict (1)		Acetylation;Activator;Isopeptide bond;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 247..414;  /note=W2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00695					PS51363;	66882	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003307:W2 domain,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	PF02020:eIF4-gamma/eIF5/eIF2-epsilon,	SSF48371:ARM repeat,	2.04635941504815	1.61333003409127e-05	FDR<0.01	4.79227678120175	1449097.5	Unexpected	RBP	Others	Others	Others	Others	714	Transcription
Q9QYL7	Q9QYL7	Abt1	8.8006	6.1641	2633285	NA	NA	NA	NA	7.4889537931551	9.90687537150783	35636.5	4	Abt1	0	Activator of basal transcription 1		FUNCTION: Could be a novel TATA-binding protein (TBP) which can function as a basal transcription activator. Can act as a regulator of basal transcription for class II genes.		endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]	nucleolus [GO:0005730]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10648625}. Nucleus, nucleolus {ECO:0000269|PubMed:10648625}.	30946;	cd12263;	IPR039119;IPR034353;IPR012677;IPR035979;			30659	COMPBIAS 220..243;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 220..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (2); Compositional bias (1); Domain (1); Region (2); Sequence conflict (2)		Coiled coil;DNA-binding;Nucleus;RNA-binding;Reference proteome;Transcription;Transcription regulation	DOMAIN 48..145;  /note=RRM						30946	GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000472~endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0021522~spinal cord motor neuron differentiation,GO:0034462~small-subunit processome assembly,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR012677:Nucleotide-binding, alpha-beta plait,		SSF54928:RNA-binding domain, RBD,	2.99367161105204	2.68130050076197e-05	FDR<0.01	4.5716545107059	1334460.75	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	733	Transcription
Q8R409	Q8R409	Hexim1	3.5506	4.4408	2105300	NA	4.34291670285764	NA	2.82438004857934	NA	4.86050354816759	336727.166666667	3	Hexim1	0	Protein HEXIM1 (Cardiac lineage protein 1)		FUNCTION: Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor. Core component of the 7SK RNP complex: in cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation. May also regulate NF-kappa-B, ESR1, NR3C1 and CIITA-dependent transcriptional activity. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:O94992}.		activation of innate immune response [GO:0002218]; heart development [GO:0007507]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; positive regulation of signal transduction by p53 class mediator [GO:1901798]	7SK snRNP [GO:0120259]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860]; P-TEFb complex binding [GO:0106140]; snRNA binding [GO:0017069]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O94992}. Cytoplasm {ECO:0000250|UniProtKB:O94992}. Note=Binds alpha-importin and is mostly nuclear. {ECO:0000250|UniProtKB:O94992}.	192231;		IPR024872;	PF15313;		40243	COMPBIAS 8..23;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 25..46;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 144..162;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 234..248;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..162;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 147..174;  /note=Basic region; mediates nuclear localization and interaction with 7SK snRNA and NR3C1;  /evidence=ECO:0000250; REGION 199..202;  /note=Interaction with P-TEFb;  /evidence=ECO:0000250; REGION 207..247;  /note=Autoinhibitory acidic region; in absence of 7SK snRNA interacts with the basic region preventing interaction with P-TEFb and modulating subcellular localization;  /evidence=ECO:0000250; REGION 210..259;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 283..311;  /note=Mediates interaction with CCNT1;  /evidence=ECO:0000250; REGION 307..352;  /note=Required for inhibition of ESR1-dependent transcription;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Modified residue (7); Region (7)		Coiled coil;Cytoplasm;Immunity;Innate immunity;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation		DOMAIN: The coiled-coil domain mediates oligomerization. {ECO:0000250}.					192231	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007507~heart development,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:1901798~positive regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0017069~snRNA binding,GO:0097322~7SK snRNA binding,	IPR024872:HEXIM,	PF15313:Hexamethylene bis-acetamide-inducible protein,		1.97531734713395	7.23473327718549e-05	FDR<0.01	4.14057747537864	1221013.58333333	Present in Nucleus	RBP	Others	Others	Others	Others	766	Transcription
Q99KG3	Q99KG3-3;Q99KG3;Q99KG3-2	Rbm10	5.2388	1.0228	1333850	5.80416739218759	8.16126662858075	6.7150147730325	1.90967249116776	7.82350179940541	6.18199802176063	1090761.66666667	0	Rbm10	0	RNA-binding protein 10 (RNA-binding motif protein 10)		FUNCTION: Not known. Binds to RNA homopolymers, with a preference for poly(G) and poly(U) and little for poly(A) (By similarity). May bind to specific miRNA hairpins (By similarity). {ECO:0000250|UniProtKB:P70501, ECO:0000250|UniProtKB:P98175}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of smooth muscle cell apoptotic process [GO:0034391]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	236732;	cd16167;cd12754;	IPR000467;IPR012677;IPR041591;IPR035979;IPR033095;IPR035618;IPR034992;IPR000504;IPR013087;IPR001876;IPR036443;	PF01585;PF17780;PF00076;PF00641;	SM00443;SM00360;SM00547;	103494	COMPBIAS 1..61;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 110..126;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 508..522;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..646;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 737..753;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 818..836;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..127;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 464..487;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 503..522;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 537..566;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 620..646;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 712..753;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 818..861;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (6); Domain (3); Erroneous initiation (1); Modified residue (12); Region (7); Sequence conflict (3); Zinc finger (2)		Acetylation;Alternative splicing;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Zinc;Zinc-finger	DOMAIN 129..209;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 300..384;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 858..904;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092				ZN_FING 212..242;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322; ZN_FING 759..784;  /note=C2H2-type; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50174;PS50102;PS01358;PS50199;PS50157;	236732	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0034391~regulation of smooth muscle cell apoptotic process,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0042981~regulation of apoptotic process,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000467:G-patch domain,IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00641:Zn-finger in Ran binding protein and others,PF01585:G-patch domain,	SSF54928:RNA-binding domain, RBD,SSF90209:Ran binding protein zinc finger-like,	2.15803077005055	6.6732129251561e-05	FDR<0.01	4.17566501770204	1212305.83333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	769	Transcription
Q91VN6	Q91VN6	Ddx41	8.9548	9.9105	1847900	1.70227253383267	6.29049506196138	32.6946969201596	NA	2.59228535877229	8.15793767335618	463918.166666667	1	Ddx41	0	Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41)		FUNCTION: Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing. {ECO:0000250|UniProtKB:Q9UJV9}.		cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]	catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UJV9}.	72935;	cd17951;	IPR011545;IPR044113;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	69820	COMPBIAS 1..20;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 53..76;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 51..84;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Domain (2); Modified residue (4); Motif (2); Nucleotide binding (1); Region (2); Sequence conflict (1); Zinc finger (1)		ATP-binding;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing	DOMAIN 212..396;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 407..567;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 181..209;  /note=Q motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00552; MOTIF 344..347;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541		ZN_FING 580..597;  /note=CCHC-type	PS51192;PS51194;PS51195;	72935	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008283~cell proliferation,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0030154~cell differentiation,GO:0035458~cellular response to interferon-beta,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.7608097738892	0.000107321152754114	FDR<0.01	3.96931467114675	1155909.08333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	785	Transcription
Q80W00	Q80W00-2;Q80W00	Ppp1r10	7.3749	14.221	1811100	9.92457324335053	8.04764204088202	NA	NA	13.2671743572054	NA	482976.166666667	3	Ppp1r10	0	Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53)		FUNCTION: Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers. {ECO:0000269|PubMed:20516061}.		negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; PTW/PP1 phosphatase complex [GO:0072357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00649}. Note=Found in discrete nucleoplasmic bodies and within nucleoli (By similarity). Associates with chromatin during interphase, excluded from condensed chromosomes during early mitosis and is reloaded onto chromosomes at the late telophase. {ECO:0000250, ECO:0000269|PubMed:20516061}.	52040;		IPR003617;IPR035441;IPR017923;IPR000571;IPR036855;	PF08711;PF00642;	SM00509;SM00356;	94372	COMPBIAS 151..200;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..335;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 336..359;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 584..600;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..677;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 800..851;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..348;  /note=Interaction with TOX4;  /evidence=ECO:0000269|PubMed:20516061; REGION 147..213;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 247..270;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 306..400;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 382..450;  /note=Essential for PPP1CA inhibition;  /evidence=ECO:0000250; REGION 388..417;  /note=Necessary for interaction with PPP1CA;  /evidence=ECO:0000269|PubMed:20516061; REGION 393..408;  /note=Necessary for interaction with PPP1CC;  /evidence=ECO:0000250; REGION 418..619;  /note=Interaction with WDR82;  /evidence=ECO:0000269|PubMed:20516061; REGION 534..853;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Cross-link (2); Domain (1); Modified residue (8); Motif (1); Mutagenesis (1); Region (9); Sequence conflict (4); Zinc finger (1)		Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein phosphatase inhibitor;RNA-binding;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 73..147;  /note=TFIIS N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00649		MOTIF 420..423;  /note=PP1-binding motif		ZN_FING 854..882;  /note=C3H1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS51319;PS50103;	52040	GO:0006351~transcription, DNA-templated,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0072357~PTW/PP1 phosphatase complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR017923:Transcription factor IIS, N-terminal,	PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),PF08711:TFIIS helical bundle-like domain,	SSF47676:Conserved domain common to transcription factors TFIIS, elongin A, CRSP70,SSF90229:CCCH zinc finger,	3.35238698704139	2.18656313497371e-06	FDR<0.01	5.66023797828947	1147038.08333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	786	Transcription
P26040	P26040	Ezr	5.5539	5.9725	1315050	7.97257434425576	1.99282582702272	3.67985280588776	5.16822574810068	3.8442317302887	6.1038881767686	898940	0	Ezr	0	Ezrin (Cytovillin) (Villin-2) (p81)		FUNCTION: Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis (By similarity). {ECO:0000250}.		actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular protein-containing complex localization [GO:0034629]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell tip [GO:0051286]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schwann cell microvillus [GO:0097454]; T-tubule [GO:0030315]; uropod [GO:0001931]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; S100 protein binding [GO:0044548]	SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000250|UniProtKB:P15311}; Peripheral membrane protein {ECO:0000250|UniProtKB:P15311}; Cytoplasmic side {ECO:0000250|UniProtKB:P15311}. Cell projection {ECO:0000250|UniProtKB:P15311}. Cell projection, microvillus membrane {ECO:0000250|UniProtKB:P15311}; Peripheral membrane protein {ECO:0000250|UniProtKB:P15311}; Cytoplasmic side {ECO:0000250|UniProtKB:P15311}. Cell projection, ruffle membrane {ECO:0000250|UniProtKB:P15311}; Peripheral membrane protein {ECO:0000250|UniProtKB:P15311}; Cytoplasmic side {ECO:0000250|UniProtKB:P15311}. Cytoplasm, cell cortex {ECO:0000250|UniProtKB:P15311}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P15311}. Cell projection, microvillus {ECO:0000269|PubMed:9472040}. Note=Localization to the apical membrane of parietal cells depends on the interaction with PALS1. Microvillar peripheral membrane protein (cytoplasmic side). Localizes to cell extensions and peripheral processes of astrocytes (By similarity). {ECO:0000250|UniProtKB:P15311, ECO:0000250|UniProtKB:P31977}.	22350;	cd14473;cd13194;	IPR019749;IPR011174;IPR011259;IPR041789;IPR000798;IPR014352;IPR035963;IPR019748;IPR019747;IPR000299;IPR018979;IPR018980;IPR008954;IPR011993;IPR029071;	PF00769;PF09380;PF00373;PF09379;	SM00295;SM01196;	69407	COMPBIAS 540..565;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 244..586;  /note=Interaction with SCYL3;  /evidence=ECO:0000250; REGION 306..338;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..565;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: A head-to-tail association, of the N-terminal and C-terminal halves results in a closed conformation (inactive form) which is incapable of actin or membrane-binding. {ECO:0000269|PubMed:9456324}.					5 out of 5	Chain (1); Compositional bias (1); Domain (1); Modified residue (7); Motif (1); Region (3); Sequence conflict (3)		Acetylation;Cell membrane;Cell projection;Cell shape;Cytoplasm;Cytoskeleton;Direct protein sequencing;Membrane;Phosphoprotein;Reference proteome;S-nitrosylation	DOMAIN 2..295;  /note=FERM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00084	DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex. {ECO:0000250|UniProtKB:P15311}.	MOTIF 115..120;  /note=[IL]-x-C-x-x-[DE] motif;  /evidence=ECO:0000250|UniProtKB:P15311			PS00660;PS00661;PS50057;	22350	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001951~intestinal D-glucose absorption,GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0007159~leukocyte cell-cell adhesion,GO:0008360~regulation of cell shape,GO:0010628~positive regulation of gene expression,GO:0010737~protein kinase A signaling,GO:0022614~membrane to membrane docking,GO:0030033~microvillus assembly,GO:0030953~astral microtubule organization,GO:0031532~actin cytoskeleton reorganization,GO:0031623~receptor internalization,GO:0032532~regulation of microvillus length,GO:0034629~cellular protein complex localization,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0040018~positive regulation of multicellular organism growth,GO:0043622~cortical microtubule organization,GO:0046847~filopodium assembly,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050714~positive regulation of protein secretion,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0051017~actin filament bundle assembly,GO:0051660~establishment of centrosome localization,GO:0061028~establishment of endothelial barrier,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071320~cellular response to cAMP,GO:0072697~protein localization to cell cortex,GO:0090002~establishment of protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:1900041~negative regulation of interleukin-2 secretion,GO:1902115~regulation of organelle assembly,GO:1902896~terminal web assembly,GO:1902966~positive regulation of protein localization to early endosome,GO:1903364~positive regulation of cellular protein catabolic process,GO:1903753~negative regulation of p38MAPK cascade,GO:2000643~positive regulation of early endosome to late endosome transport,	GO:0001726~ruffle,GO:0001772~immunological synapse,GO:0001931~uropod,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005903~brush border,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0019898~extrinsic component of membrane,GO:0030175~filopodium,GO:0030315~T-tubule,GO:0031528~microvillus membrane,GO:0031982~vesicle,GO:0032587~ruffle membrane,GO:0036064~ciliary basal body,GO:0036398~TCR signalosome,GO:0042995~cell projection,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0044393~microspike,GO:0044853~plasma membrane raft,GO:0045121~membrane raft,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0051286~cell tip,GO:0070062~extracellular exosome,GO:0071944~cell periphery,GO:0097449~astrocyte projection,GO:0097454~Schwann cell microvillus,GO:0098592~cytoplasmic side of apical plasma membrane,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0034236~protein kinase A catalytic subunit binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0044548~S100 protein binding,GO:0044822~poly(A) RNA binding,GO:0050839~cell adhesion molecule binding,GO:0051015~actin filament binding,GO:0051117~ATPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR008954:Moesin,IPR011174:Ezrin/radixin/moesin,IPR011259:Ezrin/radixin/moesin, C-terminal,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,	PF00373:FERM central domain,PF00769:Ezrin/radixin/moesin family,PF09379:FERM N-terminal domain ,PF09380:FERM C-terminal PH-like domain,	SSF47031:Second domain of FERM,SSF48678:Moesin tail domain,SSF50729:PH domain-like,SSF54236:Ubiquitin-like,	2.23042980052826	1.55343991734355e-06	FDR<0.01	5.80870553936476	1106995	Present in Nucleus	RBP	Others	Others	Others	Others	794	Transcription
P19426	P19426-2;P19426	Nelfe	5.2563	12.028	1850325	NA	8.02310654685494	0.342067455702264	NA	NA	NA	161098.5	4	Nelfe	0	Negative elongation factor E (NELF-E) (RNA-binding protein RD)		FUNCTION: Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II (By similarity). The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex (By similarity). Provides the strongest RNA binding activity of the NELF complex and may initially recruit the NELF complex to RNA (By similarity). {ECO:0000250|UniProtKB:P18615}.		negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]	NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P18615}.	27632;	cd12305;	IPR033102;IPR034637;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	42554	COMPBIAS 35..58;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 83..100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 183..261;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 30..58;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 79..262;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 184..247;  /note=32 X 2 AA approximate tandem repeats of R-[DSE]	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (3); Domain (1); Modified residue (14); Natural variant (2); Region (3); Repeat (32); Sequence conflict (1)		Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 266..336;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domain interacts with RNA, and is essential for NELF complex function. It is however not required for the NELF complex formation (By similarity). {ECO:0000250|UniProtKB:P18615}.		REPEAT 184..185;  /note=1; REPEAT 186..187;  /note=2; REPEAT 188..189;  /note=3; REPEAT 190..191;  /note=4; REPEAT 192..193;  /note=5; approximate; REPEAT 194..195;  /note=6; REPEAT 196..197;  /note=7; REPEAT 198..199;  /note=8; REPEAT 200..201;  /note=9; REPEAT 202..203;  /note=10; approximate; REPEAT 204..205;  /note=11; REPEAT 206..207;  /note=12; REPEAT 208..209;  /note=13; REPEAT 210..211;  /note=14; REPEAT 212..213;  /note=15; REPEAT 214..215;  /note=16; REPEAT 216..217;  /note=17; REPEAT 218..219;  /note=18; approximate; REPEAT 220..221;  /note=19; approximate; REPEAT 222..223;  /note=20; REPEAT 224..225;  /note=21; REPEAT 226..227;  /note=22; REPEAT 228..229;  /note=23; REPEAT 230..231;  /note=24; approximate; REPEAT 232..233;  /note=25; REPEAT 234..235;  /note=26; REPEAT 236..237;  /note=27; REPEAT 238..239;  /note=28; REPEAT 240..241;  /note=29; REPEAT 242..243;  /note=30; REPEAT 244..245;  /note=31; REPEAT 246..247;  /note=32		PS50102;	27632	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1900364~negative regulation of mRNA polyadenylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032021~NELF complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.85972155023648	0.0569953131375243	FDR<0.1	1.24416085594504	1005711.75	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	818	Transcription
Q1PSW8	Q1PSW8	Trim71	2.6568	5.0008	712155	4.67945718296678	7.03630734590487	6.57246138678935	3.83818223689261	3.28342526924087	5.11927920548787	1251801.66666667	0	Trim71	0	E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)		FUNCTION: E3 ubiquitin-protein ligase that cooperates with the microRNAs (miRNAs) machinery and promotes embryonic stem cells proliferation and maintenance (PubMed:19898466). Binds to miRNAs and associates with AGO2, participating in post-transcriptional repression of transcripts such as CDKN1A. Facilitates the G1-S transition to promote rapid embryonic stem cell self-renewal by repressing CDKN1A expression (PubMed:22735451). In addition, participates in post-transcriptional mRNA repression in a miRNA independent mechanism (PubMed:23125361). Required to maintain proliferation and prevent premature differentiation of neural progenitor cells during early neural development: positively regulates FGF signaling by controlling the stability of SHCBP1 (PubMed:22735451). Specific regulator of miRNA biogenesis. miRNA Binds MIR29A hairpin and postranscriptionally modulates MIR29A levels, which indirectly regulates TET proteins expression (By similarity). {ECO:0000250|UniProtKB:Q2Q1W2, ECO:0000269|PubMed:19898466, ECO:0000269|PubMed:22735451, ECO:0000269|PubMed:23125361}.	PATHWAY: Protein modification; protein ubiquitination.	3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]	P-body [GO:0000932]	miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:19898466, ECO:0000269|PubMed:22508726, ECO:0000269|PubMed:22735451}.	636931;		IPR011042;IPR017868;IPR001298;IPR013783;IPR014756;IPR001258;IPR013017;IPR000315;IPR001841;IPR013083;IPR017907;	PF00630;PF01436;PF00643;	SM00336;SM00557;SM00184;	92054	COMPBIAS 26..45;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 26..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 127..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27	METAL 265;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 268;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 288;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 293;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024		5 out of 5	Chain (1); Coiled coil (2); Compositional bias (1); Initiator methionine (1); Metal binding (4); Modified residue (1); Mutagenesis (2); Region (2); Repeat (7); Zinc finger (3)		Acetylation;Coiled coil;Cytoplasm;Developmental protein;Metal-binding;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger		DOMAIN: The NHL domain, containing the 6 NHL repeats, is necessary and sufficient to target RNA but not to repress mRNA. The minimal region needed to execute repression consists of the coiled coil domain and the Filamin repeat. The RING-type domain is dispensable for mRNA repression. {ECO:0000250|UniProtKB:Q2Q1W2}.		REPEAT 466..567;  /note=Filamin; REPEAT 580..623;  /note=NHL 1; REPEAT 627..670;  /note=NHL 2; REPEAT 674..717;  /note=NHL 3; REPEAT 721..764;  /note=NHL 4; REPEAT 768..811;  /note=NHL 5; REPEAT 815..855;  /note=NHL 6	ZN_FING 12..94;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 181..228;  /note=B box-type 1; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 260..301;  /note=B box-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024	PS50194;PS51125;PS50119;PS00518;PS50089;	636931	GO:0000082~G1/S transition of mitotic cell cycle,GO:0001843~neural tube closure,GO:0007275~multicellular organism development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010586~miRNA metabolic process,GO:0017148~negative regulation of translation,GO:0021915~neural tube development,GO:0031047~gene silencing by RNA,GO:0035278~miRNA mediated inhibition of translation,GO:0051246~regulation of protein metabolic process,GO:0051865~protein autoubiquitination,GO:0060964~regulation of gene silencing by miRNA,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071310~cellular response to organic substance,GO:0072089~stem cell proliferation,GO:2000177~regulation of neural precursor cell proliferation,GO:2000637~positive regulation of gene silencing by miRNA,	GO:0000932~cytoplasmic mRNA processing body,GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0030371~translation repressor activity,GO:0035198~miRNA binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Zinc finger, B-box,IPR001258:NHL repeat,IPR001298:Filamin/ABP280 repeat,IPR001841:Zinc finger, RING-type,IPR011042:Six-bladed beta-propeller, TolB-like,IPR013017:NHL repeat, subgroup,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,IPR017907:Zinc finger, RING-type, conserved site,	PF00630:Filamin/ABP280 repeat,PF00643:B-box zinc finger,PF01436:NHL repeat,	SSF81296:E set domains,	2.18762593873374	5.91843693468151e-07	FDR<0.01	6.22779297575592	981978.333333333	Unexpected	RBP	DBD	DBD	ChD	Others	823	Transcription
Q8BIZ6	Q8BIZ6	Snip1	3.2674	4.202	1119685	3.76676209130631	3.45805380731724	NA	NA	2.14458813184928	6.72178530617732	811363.333333333	2	Snip1	0	Smad nuclear-interacting protein 1		FUNCTION: Required for pre-mRNA splicing as component of the spliceosome. Down-regulates NF-kappa-B signaling by competing with RELA for CREBBP/EP300 binding. Involved in the microRNA (miRNA) biogenesis. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. {ECO:0000250|UniProtKB:Q8TAD8}.		I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mRNA splicing, via spliceosome [GO:0000398]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8TAD8}.	76793;	cd00060;	IPR000253;IPR008984;	PF00498;	SM00240;	44415	COMPBIAS 1..21;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 64..87;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 97..185;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 366..383;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..209;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 359..383;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (5); Domain (1); Modified residue (7); Region (2); Sequence conflict (1)		Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;RNA-mediated gene silencing;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 268..331;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086					PS50006;	76793	GO:0006355~regulation of transcription, DNA-templated,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0031047~gene silencing by RNA,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,	PF00498:FHA domain,	SSF49879:SMAD/FHA domain,	1.88867492432765	5.86544113345389e-05	FDR<0.01	4.23169931950407	965524.166666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	829	Transcription
Q62176	Q62176;D3Z4I3	Rbm38;Rbm24	3.574	7.2346	1473030	NA	NA	NA	NA	NA	6.80457267283615	377815	5	Rbm38	0	RNA-binding protein 38 (RNA-binding motif protein 38) (RNA-binding region-containing protein 1) (ssDNA-binding protein SEB4)		FUNCTION: RNA-binding protein that specifically bind the 3'-UTR of CDKN1A transcripts, leading to maintain the stability of CDKN1A transcripts, thereby acting as a mediator of the p53/TP53 family to regulate CDKN1A. CDKN1A is a cyclin-dependent kinase inhibitor transcriptionally regulated by the p53/TP53 family to induce cell cycle arrest. Has the ability to induce cell cycle arrest in G1 and maintain the stability of CDKN1A transcripts induced by p53/TP53. Also acts as a mRNA splicing factor. Specifically regulates the expression of FGFR2-IIIb, an epithelial cell-specific isoform of FGFR2 (By similarity). Plays a role in myogenic differentiation. {ECO:0000250, ECO:0000269|PubMed:19817877}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; mRNA processing [GO:0006397]; negative regulation of cell population proliferation [GO:0008285]; regulation of myotube differentiation [GO:0010830]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Nucleus {ECO:0000250}.	56190;		IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	25364		REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Domain (1); Region (1); Sequence conflict (2)		Cell cycle;Cytoplasm;Differentiation;Nucleus;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	DOMAIN 32..109;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	56190	GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0010830~regulation of myotube differentiation,GO:0030154~cell differentiation,GO:0043484~regulation of RNA splicing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.4863191500881	0.000940356339135384	FDR<0.01	3.02670754342711	925422.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	852	Transcription
Q8C570	Q8C570	Rae1	1.7837	2.6843	1318550	NA	7.1093416749609	NA	NA	5.51055270843666	3.05203723485427	462018.833333333	3	Rae1	0	mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)		FUNCTION: Plays a role in mitotic bipolar spindle formation. Binds mRNA. May function in nucleocytoplasmic transport and in directly or indirectly attaching cytoplasmic mRNPs to the cytoskeleton. {ECO:0000250|UniProtKB:P78406}.		cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P78406}. Nucleus {ECO:0000250|UniProtKB:P78406}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:P78406}. Note=Recruited from interphase nuclei to spindle MTs during mitosis. {ECO:0000250|UniProtKB:P78406}.	66679;		IPR020472;IPR037631;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	40965		REGION 15..34;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (1); Region (1); Repeat (7); Sequence conflict (1)		Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transport;WD repeat				REPEAT 37..79;  /note=WD 1; REPEAT 84..114;  /note=WD 2; REPEAT 125..157;  /note=WD 3; REPEAT 168..206;  /note=WD 4; REPEAT 215..255;  /note=WD 5; REPEAT 271..301;  /note=WD 6; REPEAT 310..346;  /note=WD 7		PS00678;PS50082;PS50294;	66679	GO:0000972~transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0006405~RNA export from nucleus,GO:0006606~protein import into nucleus,GO:0071407~cellular response to organic cyclic compound,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0043130~ubiquitin binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	1.83222089414897	0.000855969905182978	FDR<0.01	3.06754150429799	890284.416666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	865	Transcription
Q69ZR9	Q69ZR9-2;Q69ZR9	Fam208a	4.0965	5.1563	852610	2.01251786109602	8.30426839395449	NA	NA	7.05716302046577	3.67755222124154	908682	2	Fam208a	0	Protein TASOR (Transgene activation suppressor protein)		FUNCTION: Component of the HUSH complex, a multiprotein complex that mediates epigenetic repression. The HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2. Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression. The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (By similarity). Plays a crucial role in early embryonic development (PubMed:31112734, PubMed:24781204, PubMed:28839193). Involved in the organization of spindle poles and spindle apparatus assembly during zygotic division (PubMed:31112734). Plays an important role in maintaining epiblast fitness or potency (PubMed:28839193). {ECO:0000250|UniProtKB:Q9UK61, ECO:0000269|PubMed:24781204, ECO:0000269|PubMed:28839193, ECO:0000269|PubMed:31112734}.		anterior/posterior axis specification, embryo [GO:0008595]; in utero embryonic development [GO:0001701]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; mitotic spindle assembly [GO:0090307]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]	heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24781204}. Chromosome {ECO:0000250|UniProtKB:Q9UK61}. Note=Localizes to chromatin. {ECO:0000250|UniProtKB:Q9UK61}.	218850;		IPR022188;	PF12509;		181396	COMPBIAS 637..671;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 691..710;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 924..939;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..96;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 631..671;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 687..710;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 915..941;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (3); Cross-link (4); Initiator methionine (1); Modified residue (12); Mutagenesis (1); Region (4)		Acetylation;Alternative splicing;Chromosome;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation							218850	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0044822~poly(A) RNA binding,	IPR022188:Protein of unknown function DUF3715,	PF12509:Protein of unknown function (DUF3715),		2.1935694738091	5.51162933839213e-05	FDR<0.01	4.25871999677963	880646	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	871	Transcription
Q8BWW4	Q8BWW4	Larp4	9.6229	4.9018	1029700	3.98453998485875	7.7857365306758	2.86820593718629	6.57591898467811	3.86309201885189	7.7000077000077	603427.333333333	0	Larp4	0	La-related protein 4 (La ribonucleoprotein domain family member 4)		FUNCTION: RNA binding protein that binds to the poly-A tract of mRNA molecules. Associates with the 40S ribosomal subunit and with polysomes. Plays a role in the regulation of mRNA translation. Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000250|UniProtKB:Q71RC2}.		cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412]	cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]	mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]	SUBCELLULAR LOCATION: Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q71RC2}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q71RC2}. Note=Localized throughout the cytosol. Partially localized in stress granules in response to arsenite treatment. {ECO:0000250|UniProtKB:Q71RC2}.	207214;	cd12707;	IPR006630;IPR034903;IPR035979;IPR036388;IPR036390;	PF05383;	SM00715;	79763	COMPBIAS 21..51;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 377..398;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..459;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 650..671;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 12..21;  /note=Interaction with PABPC1;  /evidence=ECO:0000250|UniProtKB:Q71RC2; REGION 21..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 107..299;  /note=Interaction with the poly-A tract of mRNA;  /evidence=ECO:0000250|UniProtKB:Q71RC2; REGION 363..398;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 437..470;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 529..562;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 576..601;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 615..719;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (4); Domain (2); Modified residue (11); Region (8)		Acetylation;Cytoplasm;Methylation;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome	DOMAIN 109..198;  /note=HTH La-type RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00332; DOMAIN 199..277;  /note=RRM					PS50961;	207214	GO:0007010~cytoskeleton organization,GO:0022604~regulation of cell morphogenesis,	GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR006630:RNA-binding protein Lupus La,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF05383:La domain,	SSF46785:Winged helix DNA-binding domain,SSF54928:RNA-binding domain, RBD,	2.45587339091335	5.57282314194127e-07	FDR<0.01	6.25392473941245	816563.666666667	Unexpected	RBP	DBD	DBD	Others	RBD	887	Transcription
Q9JHI7	Q9JHI7	Exosc9	0.28046	NA	793400	NA	7.10631040363843	NA	NA	10.7242056044698	10.8571738776396	638121.666666667	3	Exosc9	1	Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75)		FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs (By similarity). {ECO:0000250}.		exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA polymerase II activating transcription factor binding [GO:0001102]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q06265}. Nucleus {ECO:0000250|UniProtKB:Q06265}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q06265}. Note=Colocalizes with SETX in nuclear foci upon induction of transcription-related DNA damage at the S phase (By similarity). {ECO:0000250|UniProtKB:Q06265}.	50911;	cd11368;	IPR001247;IPR015847;IPR036345;IPR027408;IPR020568;IPR033100;	PF01138;PF03725;		48937	COMPBIAS 350..365;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 337..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 377..438;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Modified residue (6); Region (2)		Acetylation;Cytoplasm;Exosome;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing							50911	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0030307~positive regulation of cell growth,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034473~U1 snRNA 3'-end processing,GO:0034475~U4 snRNA 3'-end processing,GO:0034476~U5 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071028~nuclear mRNA surveillance,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071042~nuclear polyadenylation-dependent mRNA catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0000228~nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,GO:0017091~AU-rich element binding,GO:0044822~poly(A) RNA binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,	PF01138:3' exoribonuclease family, domain 1,PF03725:3' exoribonuclease family, domain 2,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55666:Ribonuclease PH domain 2-like,	1.96458580716018	0.0622474160924387	FDR<0.1	1.20587867154285	715760.833333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	926	Transcription
O54879	O54879	Hmgb3	3.7234	4.9113	1248900	NA	1.60456981483264	NA	NA	NA	5.50085263215798	177840	4	Hmgb3	0	High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4)	DNA_BIND 9..79;  /note=HMG box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267; DNA_BIND 93..161;  /note=HMG box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor (PubMed:19890330). Negatively regulates B-cell and myeloid cell differentiation. In hematopoietic stem cells may regulate the balance between self-renewal and differentiation. Involved in negative regulation of canonical Wnt signaling (PubMed:12714519, PubMed:15358624, PubMed:16945912). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P40618, ECO:0000269|PubMed:12714519, ECO:0000269|PubMed:15358624, ECO:0000269|PubMed:16945912, ECO:0000269|PubMed:19890330}.		DNA geometric change [GO:0032392]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P40618, ECO:0000255|PROSITE-ProRule:PRU00267}. Chromosome {ECO:0000305}. Cytoplasm {ECO:0000269|PubMed:19890330}.	15354;		IPR009071;IPR036910;IPR017967;IPR031077;	PF00505;PF09011;	SM00398;	23010	COMPBIAS 71..93;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..181;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 182..200;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 71..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 161..200;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); DNA binding (2); Disulfide bond (1); Modified residue (9); Region (2)		Acetylation;Chromosome;Cytoplasm;DNA-binding;Disulfide bond;Immunity;Innate immunity;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation						PS00353;PS50118;	15354	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032392~DNA geometric change,GO:0045087~innate immune response,GO:0045578~negative regulation of B cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008301~DNA binding, bending,	IPR009071:High mobility group (HMG) box domain,IPR017967:HMG box A DNA-binding domain, conserved site,	PF00505:HMG (high mobility group) box,PF09011:HMG-box domain,	SSF47095:HMG-box,	1.83364184449308	0.0023528834483152	FDR<0.01	2.62839958536424	713370	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	927	Transcription
Q8R3N6	Q8R3N6	Thoc1	2.9621	2.7704	959695	3.52199485788751	2.70124257158293	9.20725531718995	NA	7.11541198235378	3.82657942065588	427503.166666667	1	Thoc1	0	THO complex subunit 1 (Tho1) (Nuclear matrix protein p84)		FUNCTION: Required for efficient export of polyadenylated RNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. Regulates transcriptional elongation of a subset of genes. Involved in genome stability by preventing co-transcriptional R-loop formation (By similarity). {ECO:0000250}.; FUNCTION: Participates in an apoptotic pathway which is characterized by activation of caspase-6, increases in the expression of BAK1 and BCL2L1 and activation of NF-kappa-B. This pathway does not require p53/TP53, nor does the presence of p53/TP53 affect the efficiency of cell killing. Activates a G2/M cell cycle checkpoint prior to the onset of apoptosis. Apoptosis is inhibited by association with RB1 (By similarity). Essential for early embryonic development. Required for normal gene expression during postnatal testis development. {ECO:0000250, ECO:0000269|PubMed:16705185, ECO:0000269|PubMed:19307311}.		apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]	chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000269|PubMed:16705185}. Nucleus matrix {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Can shuttle between the nucleus and cytoplasm. Nuclear localization is required for induction of apoptotic cell death. Translocates to the cytoplasm during the early phase of apoptosis execution (By similarity). {ECO:0000250}.	225160;		IPR011029;IPR000488;IPR021861;	PF00531;PF11957;	SM00005;	75436	COMPBIAS 541..555;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 194..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 533..569;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (5); Domain (1); Modified residue (8); Motif (1); Region (2)		Acetylation;Apoptosis;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 570..653;  /note=Death;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00064	DOMAIN: An intact death domain is needed for apoptosis. {ECO:0000250}.	MOTIF 414..430;  /note=Nuclear localization signal;  /evidence=ECO:0000250			PS50017;	225160	GO:0000018~regulation of DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0008380~RNA splicing,GO:0031297~replication fork processing,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0042981~regulation of apoptotic process,GO:0046784~viral mRNA export from host cell nucleus,GO:0048297~negative regulation of isotype switching to IgA isotypes,GO:0051028~mRNA transport,GO:2000002~negative regulation of DNA damage checkpoint,	GO:0000346~transcription export complex,GO:0000347~THO complex,GO:0000445~THO complex part of transcription export complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0045171~intercellular bridge,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR000488:Death domain,IPR011029:Death-like domain,IPR021861:THO complex, subunit THOC1,	PF00531:Death domain,PF11957:THO complex subunit 1 transcription elongation factor,	SSF47986:DEATH domain,	2.03664348986986	2.46566259703385e-05	FDR<0.01	4.60806635283019	693599.083333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	936	Transcription
Q8VHK9	Q8VHK9	Dhx36	4.9133	3.1609	715615	6.45452785128768	4.73529690311583	4.32825484764543	NA	4.49883030412093	5.16608978664049	651541.833333333	1	Dhx36	0	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)		FUNCTION: Multifunctional ATP-dependent helicase that unwinds G-quadruplex (G4) structures (PubMed:25611385). Plays a role in many biological processes such as genomic integrity, gene expression regulations and as a sensor to initiate antiviral responses (PubMed:21703541, PubMed:21590736). G4 structures correspond to helical structures containing guanine tetrads (By similarity). Binds with high affinity to and unwinds G4 structures that are formed in nucleic acids (G4-ADN and G4-RNA) (By similarity). Plays a role in genomic integrity (By similarity). Converts the G4-RNA structure present in telomerase RNA template component (TREC) into a double-stranded RNA to promote P1 helix formation that acts as a template boundary ensuring accurate reverse transcription (By similarity). Plays a role in transcriptional regulation. Resolves G4-DNA structures in promoters of genes, such as YY1, KIT/c-kit and ALPL and positively regulates their expression (PubMed:25611385) (By similarity). Plays a role in post-transcriptional regulation (By similarity). Unwinds a G4-RNA structure located in the 3'-UTR polyadenylation site of the pre-mRNA TP53 and stimulates TP53 pre-mRNA 3'-end processing in response to ultraviolet (UV)-induced DNA damage (By similarity). Binds to the precursor-microRNA-134 (pre-miR-134) terminal loop and regulates its transport into the synapto-dendritic compartment (By similarity). Involved in the pre-miR-134-dependent inhibition of target gene expression and the control of dendritic spine size (By similarity). Plays a role in the regulation of cytoplasmic mRNA translation and mRNA stability (By similarity). Binds to both G4-RNA structures and alternative non-quadruplex-forming sequence within the 3'-UTR of the PITX1 mRNA regulating negatively PITX1 protein expression (By similarity). Binds to both G4-RNA structure in the 5'-UTR and AU-rich elements (AREs) localized in the 3'-UTR of NKX2-5 mRNA to either stimulate protein translation or induce mRNA decay in an ELAVL1-dependent manner, respectively (By similarity). Binds also to ARE sequences present in several mRNAs mediating exosome-mediated 3'-5' mRNA degradation (By similarity). Involved in cytoplasmic urokinase-type plasminogen activator (uPA) mRNA decay (By similarity). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (PubMed:21703541). Required for the early embryonic development and hematopoiesis (PubMed:22422825). Involved in the regulation of cardioblast differentiation and proliferation during heart development (PubMed:26489465). Involved in spermatogonia differentiation (PubMed:25611385). May play a role in ossification (PubMed:21590736). {ECO:0000250|UniProtKB:D4A2Z8, ECO:0000250|UniProtKB:Q05B79, ECO:0000250|UniProtKB:Q9H2U1, ECO:0000269|PubMed:21590736, ECO:0000269|PubMed:21703541, ECO:0000269|PubMed:22422825, ECO:0000269|PubMed:25611385, ECO:0000269|PubMed:26489465}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]	axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H2U1}. Cytoplasm {ECO:0000250|UniProtKB:Q9H2U1}. Cytoplasm, cytosol {ECO:0000269|PubMed:21703541}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9H2U1}. Nucleus speckle {ECO:0000250|UniProtKB:Q9H2U1}. Chromosome, telomere {ECO:0000250|UniProtKB:Q9H2U1}. Mitochondrion {ECO:0000269|PubMed:21703541}. Perikaryon {ECO:0000250|UniProtKB:D4A2Z8}. Cell projection, dendrite {ECO:0000250|UniProtKB:D4A2Z8}. Cell projection, axon {ECO:0000250|UniProtKB:D4A2Z8}. Note=Predominantly localized in the nucleus. Colocalizes with SRSF2 in nuclear speckles. Colocalizes with DDX5 in nucleolar caps upon transcription inhibition. Accumulates and colocalized with TIA1 in cytoplasmic stress granules (SGs) in an arsenite-, heat shock- and RNA-binding-dependent manner. Shuttles into and out of SGs in an ATPase-dependent manner (By similarity). Colocalizes in the cytosol with the multi-helicase-TICAM1 complex that translocates to the mitochondria upon poly(I:C) stimulation (PubMed:21703541). {ECO:0000250|UniProtKB:Q9H2U1, ECO:0000269|PubMed:21703541}.	72162;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	113883	COMPBIAS 1..27;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..193;  /note=Necessary for nuclear and nucleolar caps localizations;  /evidence=ECO:0000250|UniProtKB:Q9H2U1; REGION 1..97;  /note=Required for the pre-miR-134 transport;  /evidence=ECO:0000250|UniProtKB:D4A2Z8; REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..44;  /note=Required for recruitment to cytoplasmic stress granules;  /evidence=ECO:0000250|UniProtKB:Q9H2U1; REGION 46..98;  /note=Required for G4-DNA- and G4-RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q9H2U1; REGION 46..68;  /note=DSM (DHX36-specific motif);  /evidence=ECO:0000250|UniProtKB:Q05B79, ECO:0000250|UniProtKB:Q9H2U1; REGION 99..379;  /note=RecA-like domain 1;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 258..310;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 380..621;  /note=RecA-like domain 2;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 491..550;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 622..691;  /note=WH domain;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 631..690;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 834..898;  /note=OB-fold-like subdomains;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 842..853;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 863..893;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79	NA		ACTIVITY REGULATION: ATPase activity is enhanced in the presence of homomeric poly(U) RNAs, but not by double-stranded DNA (dsDNA), double-stranded RNA (dsRNA) and tRNA. {ECO:0000250|UniProtKB:Q9H2U1}.	BINDING 550;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:Q05B79	3.6.4.13	METAL 328;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q05B79; METAL 330;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q05B79		5 out of 5	Beta strand (30); Binding site (1); Chain (1); Coiled coil (1); Compositional bias (1); Domain (2); Helix (40); Metal binding (2); Modified residue (3); Motif (2); Nucleotide binding (2); Region (15); Sequence conflict (3); Turn (7)		3D-structure;ATP-binding;Acetylation;Activator;Antiviral defense;Cell projection;Chromosome;Coiled coil;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Helicase;Hydrolase;Immunity;Innate immunity;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Telomere;Transcription;Transcription regulation;Translation regulation;Transport	DOMAIN 210..380;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 470..640;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The DHX36-specific motif (DSM) form folds into a DNA-binding-induced alpha-helix that together with the oligonucleotide and oligosaccharide-binding-fold-like (OB-fold-like) subdomain bind to Myc-promoter G4-DNA-containing structure in an ATP-dependent manner. Upon G4-DNA-binding, DHX36 pulls on DSM in the 3'-direction, inducing rearrangement of the RecA-like 1 and 2 and the degenerate-winged-helix (WH) regions; these rearrangements are propbably responsible for the ATP-independent repetitive G4-DNA unfolding activity, one residue at a time. Upon resolving of G4-DNA into separate nucleotide strands, and ATP hydrolysis, the apoprotein of DHX36 seems incompatible with G4-DNA-binding (By similarity). The N-terminus is necessary for its recruitment to cytoplasmic stress granules (SGs) upon arsenite-induced treatment (By similarity). {ECO:0000250|UniProtKB:Q05B79, ECO:0000250|UniProtKB:Q9H2U1}.	MOTIF 327..330;  /note=DEAH box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; MOTIF 510..521;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q9H2U1			PS00690;PS51192;PS51194;	72162	GO:0001503~ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032206~positive regulation of telomere maintenance,GO:0043330~response to exogenous dsRNA,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0016787~hydrolase activity,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.22045747021606	8.21260301941364e-07	FDR<0.01	6.08551916958044	683578.416666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	942	Transcription
Q9CZ91	Q9CZ91	Srfbp1	2.8571	4.3083	1136340	3.64126278993555	2.77400205276152	3.7314825180044	NA	6.83667190811513	5.21457996558377	188914.4	1	Srfbp1	0	Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP)		FUNCTION: May be involved in regulating transcriptional activation of cardiac genes during the aging process. May play a role in biosynthesis and/or processing of SLC2A4 in adipose cells. {ECO:0000269|PubMed:15492011, ECO:0000269|PubMed:16647043}.		maturation of SSU-rRNA [GO:0030490]	90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]		SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:16647043}.	67222;		IPR037393;IPR015158;	PF09073;		48746	COMPBIAS 150..184;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 207..221;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 232..254;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 273..315;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 364..385;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 137..342;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 357..389;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 406..441;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (2); Compositional bias (5); Cross-link (2); Modified residue (4); Region (3); Sequence conflict (14)		Coiled coil;Cytoplasm;Isopeptide bond;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							67222	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030490~maturation of SSU-rRNA,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030686~90S preribosome,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR015158:Bud-site selection protein, BUD22,	PF09073:BUD22,		2.00195316163641	5.6652967060555e-06	FDR<0.01	5.24677734009391	662627.2	Present in Nucleus	RBP	Others	Others	Others	Others	950	Transcription
P63280	P63280	Ube2i	6.648	4.4537	768935	13.6901909781641	NA	4.33294336843017	NA	NA	6.31074088097943	546811.666666667	3	Ube2i	0	SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (mUBC9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I)		FUNCTION: Accepts the ubiquitin-like proteins SUMO1, SUMO2 and SUMO3 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2, CBX4 and ZNF451. Can catalyze the formation of poly-SUMO chains. Essential for nuclear architecture, chromosome segregation and embryonic viability. Necessary for sumoylation of FOXL2 and KAT5 (By similarity). Sumoylates p53/TP53 at 'Lys-386'. Mediates sumoylation of ERCC6 which is essential for its transcription-coupled nucleotide excision repair activity (By similarity). {ECO:0000250|UniProtKB:P63279, ECO:0000269|PubMed:16326389, ECO:0000269|PubMed:17187077, ECO:0000269|PubMed:22214662}.	PATHWAY: Protein modification; protein sumoylation.	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein modification process [GO:0006464]; chromosome segregation [GO:0007059]; multicellular organism development [GO:0007275]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular steroid hormone receptor signaling pathway [GO:0033145]; positive regulation of SUMO transferase activity [GO:1903755]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein sumoylation [GO:0016925]; regulation of signaling receptor activity [GO:0010469]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sumoylated E2 ligase complex [GO:1990356]; synapse [GO:0045202]; transferase complex [GO:1990234]	ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; enzyme binding [GO:0019899]; HLH domain binding [GO:0043398]; protein C-terminus binding [GO:0008022]; RING-like zinc finger domain binding [GO:0071535]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18681895, ECO:0000269|PubMed:8610150, ECO:0000269|PubMed:9223278}. Cytoplasm {ECO:0000269|PubMed:18681895, ECO:0000269|PubMed:9223278}. Note=Mainly nuclear (PubMed:18681895). In spermatocytes, localizes in synaptonemal complexes (By similarity). Recruited by BCL11A into the nuclear body (PubMed:18681895). {ECO:0000250|UniProtKB:P63279, ECO:0000269|PubMed:18681895}.	22196;	cd00195;	IPR000608;IPR023313;IPR016135;	PF00179;		18007		REGION 13..18;  /note=Interaction with SUMO1;  /evidence=ECO:0000250	NA	ACT_SITE 93;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00388			2.3.2.-			5 out of 5	Active site (1); Beta strand (5); Chain (1); Cross-link (6); Domain (1); Helix (5); Initiator methionine (1); Modified residue (3); Region (1); Site (4); Turn (3)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Chromosome partition;Cytoplasm;Developmental protein;Host-virus interaction;Isopeptide bond;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	DOMAIN 4..157;  /note=UBC core;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00388					PS00183;PS50127;	22196	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006464~cellular protein modification process,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007275~multicellular organism development,GO:0010469~regulation of receptor activity,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0033145~positive regulation of intracellular steroid hormone receptor signaling pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051301~cell division,GO:1903755~positive regulation of SUMO transferase activity,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0016605~PML body,GO:0030425~dendrite,GO:0045202~synapse,GO:1990234~transferase complex,	GO:0000166~nucleotide binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0019899~enzyme binding,GO:0043398~HLH domain binding,GO:0043425~bHLH transcription factor binding,GO:0044822~poly(A) RNA binding,GO:0061656~SUMO conjugating enzyme activity,GO:0071535~RING-like zinc finger domain binding,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,IPR027230:SUMO-conjugating enzyme Ubc9,	PF00179:Ubiquitin-conjugating enzyme,	SSF54495:UBC-like,	2.68723043988894	3.44861567695185e-05	FDR<0.01	4.46235520188635	657873.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	955	Transcription
O88291	O88291;O88291-2;O88291-3	Znf326	4.5955	6.6758	975840	21.8373987290634	3.46656498076056	NA	NA	NA	NA	296343	4	Znf326	0	DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs) (Zinc finger protein-associated with nuclear matrix of 75 kDa)		FUNCTION: Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (By similarity). May also play a role in neuronal differentiation. Able to bind DNA and activate expression in vitro. {ECO:0000250, ECO:0000269|PubMed:10798446}.		mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:10798446, ECO:0000269|PubMed:9809746}.	54367;		IPR007071;IPR034736;	PF04988;		65225	COMPBIAS 273..302;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 482..527;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 544..563;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..124;  /note=Mediates transcriptional activation; REGION 156..196;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 256..302;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 470..580;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (3); Cross-link (8); Modified residue (17); Motif (1); Region (4); Sequence caution (1); Sequence conflict (3); Zinc finger (2)		Acetylation;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing			MOTIF 238..260;  /note=Bipartite nuclear localization signal		ZN_FING 314..336;  /note=C2H2 AKAP95-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140; ZN_FING 407..430;  /note=C2H2 AKAP95-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140	PS51799;	54367	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0043484~regulation of RNA splicing,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,GO:0044609~DBIRD complex,	GO:0000993~RNA polymerase II core binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),	PF04988:A-kinase anchoring protein 95 (AKAP95),		2.79534962091103	0.000676983500375358	FDR<0.01	3.16942191592823	636091.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	962	Transcription
Q91W50	Q91W50	Csde1	4.8182	4.6236	664920	3.22435029341588	8.14332247557003	NA	5.40365286933967	5.88546877758813	6.26684213824654	561733.333333333	1	Csde1	0	Cold shock domain-containing protein E1		FUNCTION: RNA-binding protein involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Required for efficient formation of stress granules. {ECO:0000250|UniProtKB:O75534}.		IRES-dependent viral translational initiation [GO:0075522]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; stress granule assembly [GO:0034063]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; P-body [GO:0000932]; plasma membrane [GO:0005886]	RNA stem-loop binding [GO:0035613]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O75534}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:O75534}. Cytoplasm, P-body {ECO:0000250|UniProtKB:O75534}.	229663;	cd04458;	IPR011129;IPR019844;IPR002059;IPR012340;IPR024642;	PF00313;PF12901;	SM00357;	88791			NA							3 out of 5	Chain (1); Cross-link (1); Domain (10); Modified residue (6)		Acetylation;Cytoplasm;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 26..87;  /note=CSD 1; DOMAIN 136..179;  /note=CSD 2; truncated; DOMAIN 186..245;  /note=CSD 3; DOMAIN 297..337;  /note=CSD 4; truncated; DOMAIN 349..410;  /note=CSD 5; DOMAIN 447..507;  /note=CSD 6; DOMAIN 519..579;  /note=CSD 7; DOMAIN 610..670;  /note=CSD 8; DOMAIN 674..735;  /note=CSD 9; DOMAIN 748..789;  /note=SUZ-C;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01287					PS00352;PS51857;PS51938;	229663	GO:0006355~regulation of transcription, DNA-templated,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070937~CRD-mediated mRNA stability complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,IPR024642:SUZ-C domain,	PF00313:'Cold-shock' DNA-binding domain,PF12901:SUZ-C motif,	SSF50249:Nucleic acid-binding proteins,	2.40442398204785	7.67476819058379e-07	FDR<0.01	6.11493473312383	613326.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	971	Transcription
Q7TSH6	Q7TSH6-3;Q7TSH6;Q7TSH6-2	Scaf4	1.545	1.5111	583985	3.98914951332376	2.95412247791793	4.82998454404946	1.98176773682124	6.6203243958954	3.31829041677728	618365.666666667	0	Scaf4	0	SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15)		FUNCTION: Anti-terminator protein required to prevent early mRNA termination during transcription. Together with SCAF8, acts by suppressing the use of early, alternative poly(A) sites, thereby preventing the accumulation of non-functional truncated proteins. Mechanistically, associates with the phosphorylated C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit (POLR2A), and subsequently binds nascent RNA upstream of early polyadenylation sites to prevent premature mRNA transcript cleavage and polyadenylation. Independently of SCAF8, also acts as a suppressor of transcriptional readthrough. {ECO:0000250|UniProtKB:O95104}.		mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O95104}.	224432;	cd12461;	IPR006569;IPR008942;IPR012677;IPR035979;IPR000504;IPR034369;	PF04818;PF00076;	SM00582;SM00360;	129056	COMPBIAS 365..382;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 398..412;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 428..454;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 455..472;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 496..538;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 539..557;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 800..823;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 920..956;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 977..1003;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1029..1125;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 299..324;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 348..561;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 691..722;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 800..859;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 920..1183;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (3); Chain (1); Compositional bias (10); Domain (2); Erroneous initiation (2); Modified residue (4); Region (5); Sequence conflict (4)		Acetylation;Alternative splicing;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation	DOMAIN 1..139;  /note=CID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00724; DOMAIN 569..643;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS51391;PS50102;	224432	GO:0006397~mRNA processing,	GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006569:CID domain,IPR006903:RNA polymerase II-binding domain,IPR008942:ENTH/VHS,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF04818:RNA polymerase II-binding domain.,	SSF48464:ENTH/VHS domain,SSF54928:RNA-binding domain, RBD,	1.56227066767694	0.000140722259597084	FDR<0.01	3.85163719996712	601175.333333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	977	Transcription
Q80YR5	Q80YR5	Safb2	1.7774	2.8711	319185	5.85857402308278	4.5407074422195	8.29324929507381	NA	13.3239177647796	16.1170744286497	751843.333333333	1	Safb2	0	Scaffold attachment factor B2 (SAF-B2)		FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA. Can function as an estrogen receptor corepressor and can also inhibit cell proliferation (By similarity). {ECO:0000250}.		regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	224902;		IPR012677;IPR035979;IPR000504;IPR034782;IPR003034;IPR036361;	PF00076;PF02037;	SM00360;SM00513;	111838	COMPBIAS 84..104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 200..229;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 256..281;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 283..299;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 424..444;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 520..594;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 632..696;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 60..134;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 200..444;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 520..696;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 963..991;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (7); Cross-link (20); Domain (2); Erroneous initiation (1); Initiator methionine (1); Modified residue (8); Motif (1); Region (5); Sequence conflict (1)		Acetylation;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 25..59;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 451..529;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 755..772;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;PS50800;	224902	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0050684~regulation of mRNA processing,GO:0060008~Sertoli cell differentiation,GO:0060765~regulation of androgen receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02037:SAP domain,	SSF54928:RNA-binding domain, RBD,	2.55474864436029	5.87127868859551e-05	FDR<0.01	4.23126730472766	535514.166666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1016	Transcription
Q8CJG0	Q8CJG0;Q8CJF8-2;Q8CJG1;Q8CJF9;Q8CJF8	Ago2	6.8569	4.2432	687475	11.6122439500209	4.6604837582141	1.92722787542399	3.84113082891603	NA	2.32201736868992	314820	1	Ago2	0	Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer)		FUNCTION: Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-alpha) mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions. Regulates lymphoid and erythroid development and function, and this is independent of endonuclease activity. {ECO:0000255|HAMAP-Rule:MF_03031, ECO:0000269|PubMed:15284456, ECO:0000269|PubMed:17626790, ECO:0000269|PubMed:19174539}.		cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-Rule:MF_03031}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03031}. Note=Translational repression of mRNAs results in their recruitment to P-bodies. Translocation to the nucleus requires IMP8. {ECO:0000255|HAMAP-Rule:MF_03031}.	239528;		IPR028602;IPR014811;IPR032472;IPR032473;IPR032474;IPR003100;IPR036085;IPR003165;IPR012337;IPR036397;	PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;	SM01163;SM00949;SM00950;	97304		REGION 312..317;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 525..567;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 588..591;  /note=Interaction with GW182 family members;  /evidence=ECO:0000255; REGION 651..661;  /note=Interaction with GW182 family members;  /evidence=ECO:0000255; REGION 710..711;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 754..762;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 791..813;  /note=Interaction with guide RNA;  /evidence=ECO:0000250	NA				3.1.26.n2	METAL 598;  /note=Divalent metal cation;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031; METAL 670;  /note=Divalent metal cation;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031; METAL 808;  /note=Divalent metal cation;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031		5 out of 5	Chain (1); Domain (2); Erroneous initiation (1); Metal binding (3); Modified residue (4); Region (7); Sequence conflict (7)		Cytoplasm;Developmental protein;Differentiation;Endonuclease;Hydrolase;Hydroxylation;Magnesium;Manganese;Metal-binding;Nitration;Nuclease;Nucleus;Phosphoprotein;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repressor;Ribonucleoprotein;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	DOMAIN 236..349;  /note=PAZ;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031; DOMAIN 518..819;  /note=Piwi;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031	DOMAIN: The Piwi domain may perform RNA cleavage by a mechanism similar to that of RNase H. However, while RNase H utilizes a triad of Asp-Asp-Glu (DDE) for metal ion coordination, this protein appears to utilize a triad of Asp-Asp-His (DDH). {ECO:0000255|HAMAP-Rule:MF_03031}.				PS50821;PS50822;	239528	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0009791~post-embryonic development,GO:0010501~RNA secondary structure unwinding,GO:0010586~miRNA metabolic process,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0035087~siRNA loading onto RISC involved in RNA interference,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035278~miRNA mediated inhibition of translation,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045947~negative regulation of translational initiation,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0090625~mRNA cleavage involved in gene silencing by siRNA,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005844~polysome,GO:0005845~mRNA cap binding complex,GO:0016020~membrane,GO:0016442~RISC complex,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0035068~micro-ribonucleoprotein complex,GO:0070578~RISC-loading complex,	GO:0000340~RNA 7-methylguanosine cap binding,GO:0000993~RNA polymerase II core binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0035197~siRNA binding,GO:0035198~miRNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070551~endoribonuclease activity, cleaving siRNA-paired mRNA,GO:0090624~endoribonuclease activity, cleaving miRNA-paired mRNA,	IPR003100:Argonaute/Dicer protein, PAZ,IPR003165:Stem cell self-renewal protein Piwi,IPR012337:Ribonuclease H-like domain,IPR014811:Domain of unknown function DUF1785,	PF02170:PAZ domain,PF02171:Piwi domain,PF08699:Domain of unknown function (DUF1785),	SSF101690:PAZ domain,SSF53098:Ribonuclease H-like,	2.10345725573899	6.09157572330233e-05	FDR<0.01	4.2152703527827	501147.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1040	Transcription
Q91W39	Q91W39	Ncoa5	3.0948	2.9596	133015	NA	1.48924763209627	NA	NA	8.02568218298555	11.9760479041916	848832.666666667	3	Ncoa5	0	Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA)		FUNCTION: Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2) (By similarity). {ECO:0000250}.		glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]	actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24268775}.	228869;		IPR036621;			65319	COMPBIAS 16..77;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 391..428;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 446..490;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 507..529;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..158;  /note=Transcription repression; REGION 1..77;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 148..172;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 378..428;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 446..529;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..579;  /note=Transcription activation	NA							4 out of 5	Chain (1); Compositional bias (4); Modified residue (14); Motif (1); Region (6)		Acetylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation		DOMAIN: Contains one Leu-Xaa-Xaa-Leu-Leu (LxxLL) motif that is essential for the association with nuclear receptors. {ECO:0000250}.	MOTIF 345..349;  /note=LXXLL motif				228869	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0042593~glucose homeostasis,GO:0046627~negative regulation of insulin receptor signaling pathway,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0015629~actin cytoskeleton,	GO:0003682~chromatin binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,		SSF52954:Class II aaRS ABD-related,	2.07130721335269	0.00187671024075068	FDR<0.01	2.72660277615719	490923.833333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1049	Transcription
Q9CY57	Q9CY57-5;Q9CY57-4;Q9CY57-3;Q9CY57-2;Q9CY57	Chtop	1.9683	8.3244	489575	NA	3.89120199229542	15.8904196659834	5.67150635208711	1.18989540819362	6.26841346455212	452100	1	Chtop	0	Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG)		FUNCTION: Plays an important role in the ligand-dependent activation of estrogen receptor target genes (By similarity). May play a role in the silencing of fetal globin genes (PubMed:20688955). Recruits the 5FMC complex to ZNF148, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Required for the tumorigenicity of glioblastoma cells. Binds to 5-hydroxymethylcytosine (5hmC) and associates with the methylosome complex containing PRMT1, PRMT5, MEP50 and ERH. The CHTOP-methylosome complex associated with 5hmC methylates H4R3 and transactivates genes involved in glioblastomagenesis (PubMed:25284789). {ECO:0000250|UniProtKB:Q9Y3Y2, ECO:0000269|PubMed:20688955, ECO:0000269|PubMed:22872859, ECO:0000269|PubMed:25284789}.		in utero embryonic development [GO:0001701]; mRNA export from nucleus [GO:0006406]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; transcription export complex [GO:0000346]	methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19254951}. Nucleus, nucleolus {ECO:0000269|PubMed:19254951}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19858291, ECO:0000269|PubMed:22872859}. Nucleus speckle {ECO:0000269|PubMed:19858291}. Note=Mostly associated with facultative heterochromatin. Localizes to regions surrounding nuclear speckles known as perispeckles in which TREX complex assembly seems to occur (By similarity). {ECO:0000250|UniProtKB:Q9Y3Y2, ECO:0000269|PubMed:19858291}.	66511;		IPR025715;	PF13865;	SM01218;	26585		REGION 152..205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 154..207;  /note=Interaction with PRMT1	NA							5 out of 5	Alternative sequence (3); Chain (1); Cross-link (1); Erroneous initiation (3); Initiator methionine (1); Modified residue (5); Motif (1); Region (2); Sequence conflict (1)	MISCELLANEOUS: [Isoform 2]: May be due to an intron retention. {ECO:0000305}.	Acetylation;Alternative splicing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 195..204;  /note=GAR motif; involved in 5hmC binding;  /evidence=ECO:0000250|UniProtKB:Q9Y3Y2				66511	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0008284~positive regulation of cell proliferation,GO:0031062~positive regulation of histone methylation,GO:0032781~positive regulation of ATPase activity,GO:0051096~positive regulation of helicase activity,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0044822~poly(A) RNA binding,	IPR025715:Friend of PRMT1 duplication,	PF13865:C-terminal duplication domain of Friend of PRMT1,		2.19818066953653	0.000347895145097511	FDR<0.01	3.45855163182175	470837.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1060	Transcription
Q8CH25	Q8CH25;Q8CH25-2	Sltm	2.2495	2.9492	553700	3.64990145266078	2.61889796773518	3.30109266167101	1.94605534581404	7.21552781585973	9.77135040062537	364175	0	Sltm	0	SAFB-like transcription modulator (Modulator of estrogen-induced transcription) (SAF-like transcription modulator)		FUNCTION: When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. {ECO:0000269|PubMed:17630952}.		apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17630952}. Note=Detected in punctate structures.	66660;		IPR012677;IPR035979;IPR000504;IPR003034;IPR036361;IPR034780;	PF00076;PF02037;	SM00360;SM00513;	116919	COMPBIAS 78..122;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 151..170;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 171..197;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 220..237;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 269..340;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 368..387;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 455..531;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 565..598;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 791..870;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 885..906;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 941..963;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 990..1018;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 57..245;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 269..387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 455..598;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 712..739;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 778..1031;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (12); Cross-link (4); Domain (2); Erroneous initiation (3); Initiator methionine (1); Modified residue (24); Region (6); Sequence conflict (2)		Acetylation;Alternative splicing;Apoptosis;Coiled coil;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 22..56;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 384..462;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;PS50800;	66660	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02037:SAP domain,	SSF54928:RNA-binding domain, RBD,	1.85123808235124	4.23664263808864e-05	FDR<0.01	4.37297816730691	458937.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1067	Transcription
Q9CQG2	Q9CQG2-2;Q9CQG2	Mettl16	2.2324	3.0302	866380	NA	3.39847068819031	NA	NA	NA	9.16002564807181	34580.5	4	Mettl16	0	RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16) (EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346)		FUNCTION: RNA N6-methyltransferase that methylates adenosine residues at the N(6) position of a subset of RNAs and is involved in S-adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts (PubMed:29262316, PubMed:30197299). Able to N6-methylate a subset of mRNAs and U6 small nuclear RNAs (U6 snRNAs) (By similarity). In contrast to the METTL3-METTL14 heterodimer, only able to methylate a limited number of RNAs: requires both a 5'UACAGAGAA-3' nonamer sequence and a specific RNA structure (By similarity). Plays a key role in S-adenosyl-L-methionine homeostasis by mediating N6-methylation of MAT2A mRNAs, altering splicing and/or stability of MAT2A transcripts: in presence of S-adenosyl-L-methionine, binds the 3'-UTR region of MAT2A mRNA and specifically N6-methylates the first hairpin of MAT2A mRNA, impairing MAT2A expression (PubMed:29262316, PubMed:30197299). In S-adenosyl-L-methionine-limiting conditions, binds the 3'-UTR region of MAT2A mRNA but stalls due to the lack of a methyl donor, preventing N6-methylation and promoting expression of MAT2A (PubMed:29262316). In addition to mRNAs, also able to mediate N6-methylation of U6 small nuclear RNA (U6 snRNA): specifically N6-methylates adenine in position 43 of U6 snRNAs (By similarity). Also able to bind various lncRNAs, such as 7SK snRNA (7SK RNA) or 7SL RNA (By similarity). Specifically binds the 3'-end of the MALAT1 long non-coding RNA (By similarity) (PubMed:29262316, PubMed:30197299). {ECO:0000250|UniProtKB:Q86W50, ECO:0000269|PubMed:29262316, ECO:0000269|PubMed:30197299}.		mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q86W50}. Cytoplasm {ECO:0000250|UniProtKB:Q86W50}.	67493;		IPR017182;IPR010286;IPR029063;	PF05971;		62341		REGION 17..20;  /note=RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q86W50; REGION 163..167;  /note=K-loop;  /evidence=ECO:0000250|UniProtKB:Q86W50; REGION 199..211;  /note=RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q86W50; REGION 250..254;  /note=RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q86W50; REGION 277..283;  /note=RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q86W50; REGION 289..400;  /note=VCR 1;  /evidence=ECO:0000250|UniProtKB:Q86W50; REGION 457..496;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 506..553;  /note=VCR 2;  /evidence=ECO:0000250|UniProtKB:Q86W50	NA		ACTIVITY REGULATION: Methyltransferase activity is autoinhibited by the K-loop region that blocks S-adenosyl-L-methionine-binding. Upon activation, K-loop changes conformation, allowing S-adenosyl-L-methionine-binding and subsequent methyltransferase activity. {ECO:0000250|UniProtKB:Q86W50}.	BINDING 82;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:Q86W50; BINDING 110;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q86W50; BINDING 114;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:Q86W50; BINDING 133;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:Q86W50; BINDING 164;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:Q86W50; BINDING 184;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:Q86W50	2.1.1.348; 2.1.1.346			5 out of 5	Alternative sequence (1); Binding site (6); Chain (1); Modified residue (4); Region (8); Sequence conflict (2)		Alternative splicing;Cytoplasm;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase		DOMAIN: The VCR (vertebrate conserved) regions bind the first hairpin of MAT2A mRNAs. The VCR regions interact with the internal stem-loop within U6 snRNAs, inducing the conformational rearrangement of the A43-containing region of U6 snRNA, thereby modifying the RNA structure to become suitable for productive catalysis by the methyltransferase region. {ECO:0000250|UniProtKB:Q86W50}.; DOMAIN: The K-loop region occludes the S-adenosyl-L-methionine-binding pocket. Upon activation, conformation of the K-loop changes, allowing S-adenosyl-L-methionine-binding. {ECO:0000250|UniProtKB:Q86W50}.					67493	GO:0032259~methylation,GO:0070475~rRNA base methylation,	GO:0005634~nucleus,	GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0052907~23S rRNA (adenine(1618)-N(6))-methyltransferase activity,	IPR010286:Ribosomal RNA large subunit methyltransferase F-like,IPR017182:S-adenosyl-L-methionine dependent methyltransferase, Mett10D, predicted,	PF05971:Protein of unknown function (DUF890),	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	1.92956147173738	0.00226420401369728	FDR<0.01	2.64508444407778	450480.25	Present in Nucleus	RBP	RBD	Others	Others	RBD	1071	Transcription
P62192	P62192	Psmc1	3.9753	2.6142	585660	5.14668039114771	3.68595650571323	NA	NA	1.92592877915375	3.29793549238177	297759.166666667	2	Psmc1	0	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)		FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC1 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. {ECO:0000250|UniProtKB:P62191}.		negative regulation of neuron death [GO:1901215]; protein catabolic process [GO:0030163]	cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]	ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Membrane {ECO:0000250|UniProtKB:P62191}; Lipid-anchor {ECO:0000250|UniProtKB:P62191}.	19179;		IPR005937;IPR035244;IPR003593;IPR041569;IPR003959;IPR003960;IPR027417;IPR032501;	PF00004;PF17862;PF16450;	SM00382;	49185	COMPBIAS 12..33;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 84..102;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..49;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 84..104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Initiator methionine (1); Lipidation (1); Modified residue (5); Nucleotide binding (1); Region (2)		ATP-binding;Acetylation;Cytoplasm;Isopeptide bond;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Nucleus;Phosphoprotein;Proteasome;Reference proteome;Ubl conjugation						PS00674;	19179	GO:0030163~protein catabolic process,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0045899~positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,GO:1901215~negative regulation of neuron death,	GO:0000502~proteasome complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005838~proteasome regulatory particle,GO:0008540~proteasome regulatory particle, base subcomplex,GO:0016020~membrane,GO:0022624~proteasome accessory complex,GO:0031595~nuclear proteasome complex,GO:0031597~cytosolic proteasome complex,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017025~TBP-class protein binding,GO:0036402~proteasome-activating ATPase activity,GO:0044822~poly(A) RNA binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR005937:26S proteasome subunit P45,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.71503867208219	9.86474467792348e-05	FDR<0.01	4.00591415079739	441709.583333333	Present in Nucleus	RBP	Others	Others	Others	Others	1080	Transcription
Q68FL6	Q68FL6	Mars	2.2952	6.1231	427510	3.55973230813043	5.98874116660678	3.6200405444541	NA	4.4499822000712	4.23495532122136	447490	1	Mars	0	Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)		FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Plays a role in the synthesis of ribosomal RNA in the nucleolus. {ECO:0000250|UniProtKB:P56192}.		cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P56192}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P56192}. Note=Localizes to the nucleolus in proliferative cells but disappears in quiescent cells. {ECO:0000250|UniProtKB:P56192}.	216443;	cd07957;cd00814;	IPR001412;IPR041872;IPR010987;IPR036282;IPR004046;IPR041598;IPR023458;IPR014758;IPR015413;IPR033911;IPR029038;IPR014729;IPR009068;IPR036249;IPR009080;IPR000738;	PF00043;PF18485;PF09334;PF00458;	SM00991;	101431			NA			BINDING 598;  /note=ATP;  /evidence=ECO:0000250	6.1.1.10			5 out of 5	Binding site (1); Chain (1); Domain (2); Modified residue (2); Motif (2)		ATP-binding;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;tRNA-binding	DOMAIN 74..212;  /note=GST C-terminal; DOMAIN 843..899;  /note=WHEP-TRS		MOTIF 275..285;  /note='HIGH' region; MOTIF 595..599;  /note='KMSKS' region			PS00178;PS50405;PS00762;PS51185;	216443	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006431~methionyl-tRNA aminoacylation,GO:0009303~rRNA transcription,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004825~methionine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR000738:WHEP-TRS,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR004046:Glutathione S-transferase, C-terminal,IPR009068:S15/NS1, RNA-binding,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR010987:Glutathione S-transferase, C-terminal-like,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR014758:Methionyl-tRNA synthetase,IPR015413:Methionyl/Leucyl tRNA synthetase,IPR023458:Methionine-tRNA ligase, type 1,	PF00043:Glutathione S-transferase, C-terminal domain,PF00458:WHEP-TRS domain,PF09334:tRNA synthetases class I (M),	SSF47060:S15/NS1 RNA-binding domain,SSF47323:Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases,SSF47616:GST C-terminal domain-like,SSF57770:Methionyl-tRNA synthetase (MetRS), Zn-domain,	2.04557940330052	5.42296625694747e-06	FDR<0.01	5.26576309784504	437500	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1084	Transcription
Q8BTM8	Q8BTM8;Q8BTM8-2	Flna	6.1757	7.0099	756275	7.48446972531996	2.58444679916264	1.10852455381887	NA	NA	3.21326435525851	91892.5	2	Flna	0	Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)		FUNCTION: Actin binding protein that promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins (By similarity). Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking. Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs (PubMed:17172441). Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (PubMed:20713593). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863). {ECO:0000250, ECO:0000269|PubMed:17172441, ECO:0000269|PubMed:20713593, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:25358863, ECO:0000269|PubMed:9412467}.		actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]	actin binding [GO:0003779]; actin filament binding [GO:0051015]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:25358863}. Perikaryon {ECO:0000269|PubMed:25358863}. Cell projection, growth cone {ECO:0000269|PubMed:25358863}. Note=Colocalizes with CPMR1 in the central region of DRG neuron growth cone (PubMed:25358863). Following SEMA3A stimulation of DRG neurons, colocalizes with F-actin (PubMed:25358863). {ECO:0000269|PubMed:25358863}.	192176;	cd00014;	IPR001589;IPR001715;IPR036872;IPR017868;IPR001298;IPR013783;IPR014756;	PF00307;PF00630;	SM00033;SM00557;	281222	COMPBIAS 1..17;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..37;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..274;  /note=Actin-binding; REGION 271..294;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1490..1607;  /note=Interaction with furin; REGION 1741..1778;  /note=Hinge 1;  /evidence=ECO:0000250; REGION 2517..2647;  /note=Self-association site, tail;  /evidence=ECO:0000250; REGION 2517..2553;  /note=Hinge 2;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (5); Domain (2); Erroneous initiation (2); Frameshift (1); Initiator methionine (1); Modified residue (50); Region (7); Repeat (24); Sequence conflict (4)	MISCELLANEOUS: [Isoform 2]: May be due to an intron retention. {ECO:0000305}.	Acetylation;Actin-binding;Alternative splicing;Cell projection;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Isopeptide bond;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 43..149;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 166..269;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044	DOMAIN: Comprised of a NH2-terminal actin-binding domain, 24 immunoglobulin-like internally homologous repeats and two hinge regions. Repeat 24 and the second hinge domain are important for dimer formation. Filamin repeat 20 interacts with filamin repeat 21 masking the ligand binding site on filamin repeat 21, resulting in an autoinhibited conformation. The autoinhibition can be relieved by ligands like ITGB7 or FBLIM1. Filamin repeats 19 and 21 can simultaneously engage ligands. {ECO:0000250|UniProtKB:P21333}.		REPEAT 276..374;  /note=Filamin 1; REPEAT 376..474;  /note=Filamin 2; REPEAT 475..570;  /note=Filamin 3; REPEAT 571..663;  /note=Filamin 4; REPEAT 667..763;  /note=Filamin 5; REPEAT 764..866;  /note=Filamin 6; REPEAT 867..965;  /note=Filamin 7; REPEAT 966..1061;  /note=Filamin 8; REPEAT 1062..1154;  /note=Filamin 9; REPEAT 1155..1249;  /note=Filamin 10; REPEAT 1250..1349;  /note=Filamin 11; REPEAT 1350..1442;  /note=Filamin 12; REPEAT 1443..1539;  /note=Filamin 13; REPEAT 1540..1636;  /note=Filamin 14; REPEAT 1641..1740;  /note=Filamin 15; REPEAT 1765..1860;  /note=Filamin 16; REPEAT 1861..1952;  /note=Filamin 17; REPEAT 1953..2039;  /note=Filamin 18; REPEAT 2042..2134;  /note=Filamin 19; REPEAT 2135..2230;  /note=Filamin 20; REPEAT 2233..2325;  /note=Filamin 21; REPEAT 2327..2420;  /note=Filamin 22; REPEAT 2424..2516;  /note=Filamin 23; REPEAT 2552..2646;  /note=Filamin 24		PS00019;PS00020;PS50021;PS50194;	192176	GO:0001525~angiogenesis,GO:0001837~epithelial to mesenchymal transition,GO:0001974~blood vessel remodeling,GO:0003007~heart morphogenesis,GO:0007195~adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0010977~negative regulation of neuron projection development,GO:0016479~negative regulation of transcription from RNA polymerase I promoter,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030334~regulation of cell migration,GO:0031532~actin cytoskeleton reorganization,GO:0032231~regulation of actin filament bundle assembly,GO:0034394~protein localization to cell surface,GO:0042177~negative regulation of protein catabolic process,GO:0042384~cilium assembly,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043113~receptor clustering,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0044319~wound healing, spreading of cells,GO:0045022~early endosome to late endosome transport,GO:0045184~establishment of protein localization,GO:0045216~cell-cell junction organization,GO:0050821~protein stabilization,GO:0051220~cytoplasmic sequestering of protein,GO:0051764~actin crosslink formation,GO:0060271~cilium morphogenesis,GO:0070527~platelet aggregation,GO:0071526~semaphorin-plexin signaling pathway,GO:0090307~mitotic spindle assembly,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0030426~growth cone,GO:0030863~cortical cytoskeleton,GO:0031012~extracellular matrix,GO:0031523~Myb complex,GO:0031941~filamentous actin,GO:0032432~actin filament bundle,GO:0043025~neuronal cell body,GO:0043198~dendritic shaft,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097440~apical dendrite,	GO:0001664~G-protein coupled receptor binding,GO:0001948~glycoprotein binding,GO:0003779~actin binding,GO:0004871~signal transducer activity,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0017048~Rho GTPase binding,GO:0017160~Ral GTPase binding,GO:0019900~kinase binding,GO:0031267~small GTPase binding,GO:0031852~mu-type opioid receptor binding,GO:0032403~protein complex binding,GO:0034988~Fc-gamma receptor I complex binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,GO:0048365~Rac GTPase binding,GO:0051015~actin filament binding,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001298:Filamin/ABP280 repeat,IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR017868:Filamin/ABP280 repeat-like,	PF00307:Calponin homology (CH) domain,PF00630:Filamin/ABP280 repeat,	SSF47576:Calponin-homology domain, CH-domain,SSF81296:E set domains,	1.92373875791774	0.000804441856020845	FDR<0.01	3.09450534065365	424083.75	Present in Nucleus	RBP	Others	Others	Others	Others	1091	Transcription
Q8BML9	Q8BML9	Qars	12.998	6.922	438885	3.65123411713159	NA	21.3972397560715	NA	4.57707799340901	1.57746123389018	351629.5	2	Qars	0	Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)		FUNCTION: Glutamine--tRNA ligase. Plays a critical role in brain development. {ECO:0000250|UniProtKB:P47897}.		brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]	ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P47897}. Cytoplasm {ECO:0000250|UniProtKB:P47897}.	97541;		IPR001412;IPR004514;IPR007638;IPR007639;IPR042558;IPR042559;IPR000924;IPR020058;IPR020059;IPR020056;IPR011035;IPR014729;	PF00749;PF03950;PF04558;PF04557;		87677			NA			BINDING 303;  /note=L-glutamine;  /evidence=ECO:0000250|UniProtKB:P00962; BINDING 438;  /note=L-glutamine;  /evidence=ECO:0000250|UniProtKB:P00962; BINDING 457;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P00962	6.1.1.18			5 out of 5	Binding site (3); Chain (1); Initiator methionine (1); Modified residue (4); Nucleotide binding (4); Sequence conflict (4)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome						PS00178;	97541	GO:0006418~tRNA aminoacylation for protein translation,GO:0006425~glutaminyl-tRNA aminoacylation,GO:0007420~brain development,GO:0043066~negative regulation of apoptotic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,	GO:0003723~RNA binding,GO:0004819~glutamine-tRNA ligase activity,GO:0005524~ATP binding,GO:0019901~protein kinase binding,	IPR000924:Glutamyl/glutaminyl-tRNA synthetase, class Ib,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR004514:Glutamine-tRNA synthetase, class Ib,IPR007638:Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain 2,IPR007639:Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain, N-terminal,IPR011035:Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR020056:Ribosomal protein L25/Gln-tRNA synthetase, beta-barrel domain,IPR020058:Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain,IPR020059:Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain,IPR020061:Glutamyl/glutaminyl-tRNA synthetase, class Ib, alpha-bundle domain,	PF00749:tRNA synthetases class I (E and Q), catalytic domain,PF03950:tRNA synthetases class I (E and Q), anti-codon binding domain,PF04557:Glutaminyl-tRNA synthetase, non-specific RNA binding region part 2    ,PF04558:Glutaminyl-tRNA synthetase, non-specific RNA binding region part 1    ,	SSF50715:Ribosomal protein L25-like,	2.60519584829527	0.00031538371242677	FDR<0.01	3.50116073899008	395257.25	Unexpected	RBP	DBD	DBD	Others	RBD	1110	Transcription
P61255	P61255	Rpl26	NA	40.283	281815	NA	21.0961562803257	6.02010715790741	NA	26.9034167339252	NA	437921.666666667	3	Rpl26	1	60S ribosomal protein L26 (Silica-induced gene 20 protein) (SIG-20)		FUNCTION: Component of the large ribosomal subunit. {ECO:0000305|PubMed:26100019}.		cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of translation [GO:0045727]; regulation of translation involved in cellular response to UV [GO:1904803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; terminal bouton [GO:0043195]	mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		19941;	cd06089;	IPR005824;IPR041988;IPR014722;IPR005825;IPR005756;IPR008991;	PF00467;PF16906;	SM00739;	17258		REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 122..145;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Cross-link (1); Modified residue (1); Region (2)		3D-structure;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01108;	19941	GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0042273~ribosomal large subunit biogenesis,	GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0043195~terminal bouton,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR005756:Ribosomal protein L26/L24P, eukaryotic/archaeal,IPR005824:KOW,IPR005825:Ribosomal protein L24/L26, conserved site,IPR008991:Translation protein SH3-like domain,IPR014722:Ribosomal protein L2 domain 2,	PF00467:KOW motif,	SSF50104:Translation proteins SH3-like domain,	4.26762853792409	5.14661660623706e-05	FDR<0.01	4.2884781830219	359868.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	1127	Transcription
Q80UM3	Q80UM3	Naa15	7.335	7.4342	334220	4.28816466552316	9.11909538573773	9.9403578528827	5.81970552290054	8.93415527561869	8.68432479374729	361765	0	Naa15	0	N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)		FUNCTION: Auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Required to control retinal neovascularization in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter. {ECO:0000269|PubMed:10842358, ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:12888564, ECO:0000269|PubMed:15452080}.		angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]	N-acetyltransferase activity [GO:0008080]; ribosome binding [GO:0043022]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}. Note=Mainly cytoplasmic, nuclear in some cases. Present in the free cytosolic and cytoskeleton-bound polysomes, but not in the membrane-bound polysomes. {ECO:0000250}.			IPR021183;IPR013026;IPR011990;IPR019734;	PF12569;PF13181;	SM00028;	100961		REGION 500..865;  /note=Interaction with HYPK;  /evidence=ECO:0000250; REGION 575..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Frameshift (1); Modified residue (8); Motif (1); Region (2); Repeat (9); Sequence caution (1); Sequence conflict (11)		Acetylation;Angiogenesis;Cytoplasm;Developmental protein;Differentiation;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Transcription;Transcription regulation			MOTIF 612..629;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255	REPEAT 46..79;  /note=TPR 1; REPEAT 80..113;  /note=TPR 2; REPEAT 148..184;  /note=TPR 3; REPEAT 224..257;  /note=TPR 4; REPEAT 374..407;  /note=TPR 5; REPEAT 409..441;  /note=TPR 6; REPEAT 485..518;  /note=TPR 7; REPEAT 672..705;  /note=TPR 8; REPEAT 799..834;  /note=TPR 9		PS50005;PS50293;	NA	GO:0001525~angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006474~N-terminal protein amino acid acetylation,GO:0007275~multicellular organism development,GO:0017196~N-terminal peptidyl-methionine acetylation,GO:0030154~cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050821~protein stabilization,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031415~NatA complex,GO:0048471~perinuclear region of cytoplasm,	GO:0004596~peptide alpha-N-acetyltransferase activity,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR021183:N-terminal acetyltransferase A, auxiliary subunit,	PF12569:NMDA receptor-regulated protein 1 ,PF13181:Tetratricopeptide repeat,	SSF48452:TPR-like,	2.89877680581273	1.73014163998056e-08	FDR<0.01	7.76191834141226	347992.5	Present in Nucleus	RBP	Others	Others	Others	Others	1137	Transcription
Q8C9B9	Q8C9B9;Q8C9B9-3;Q8C9B9-2	Dido1	2.1105	2.6871	257380	2.34345706786652	4.25985090521832	3.9677816133	2.27806000410051	9.69743987587277	6.94589150517469	409047.5	0	Dido1	0	Death-inducer obliterator 1 (DIO-1) (Death-associated transcription factor 1) (DATF-1)		FUNCTION: Required for early embryonic stem cell development (By similarity). Putative transcription factor, weakly pro-apoptotic when overexpressed. {ECO:0000250}.		apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Note=Translocates to the mitotic spindle upon loss of interaction with H3K4me3 during early mitosis (By similarity). Translocates to the nucleus after pro-apoptotic stimuli. {ECO:0000250}.	23856;		IPR033082;IPR012921;IPR003618;IPR036575;IPR019786;IPR011011;IPR001965;IPR019787;IPR013083;	PF00628;PF07744;PF07500;	SM00249;SM00510;	247176	COMPBIAS 1..44;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 46..60;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 63..89;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 91..123;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 131..145;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 152..196;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 218..247;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 489..505;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 601..616;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 778..795;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 863..885;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 909..924;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 939..970;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1198..1216;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1252..1268;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1274..1288;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1521..1548;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1549..1563;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1569..1585;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1662..1677;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1678..1717;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1740..1754;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1853..1871;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2027..2041;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2077..2245;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..256;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 481..535;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 598..624;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 641..668;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 778..822;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 856..970;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1011..1039;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1197..1218;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1245..1288;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1320..1347;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1362..1421;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1509..1609;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1630..2256;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Beta strand (3); Chain (1); Compositional bias (25); Cross-link (1); Domain (1); Erroneous initiation (3); Helix (3); Modified residue (27); Motif (2); Region (13); Sequence conflict (14); Zinc finger (1)		3D-structure;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 667..787;  /note=TFIIS central;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00651	DOMAIN: The PHD-type zinc finger forms an aromatic cage around H3K4me3. {ECO:0000250}.	MOTIF 162..170;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 182..190;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 265..319;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51321;PS01359;PS50016;	23856	GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,	GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR003618:Transcription elongation factor S-II, central domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR012921:Spen paralogue and orthologue SPOC, C-terminal,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF07500:Transcription factor S-II (TFIIS), central domain,PF07744:SPOC domain,	SSF46942:Elongation factor TFIIS domain 2,SSF57903:FYVE/PHD zinc finger,	1.88412228942379	3.53666694294045e-05	FDR<0.01	4.45140583689254	333213.75	Present in Nucleus	RBP	DBD	DBD	ChD	Others	1149	Transcription
Q69ZA1	Q69ZA1-2;Q69ZA1	Cdk13	2.5574	4.4189	71423	3.59247018249749	3.10327706057597	3.28267078094738	4.12235138923242	2.41103288648857	8.09192425958893	570363.333333333	0	Cdk13	0	Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13)		FUNCTION: Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. {ECO:0000269|PubMed:17261272}.		alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; transcription elongation from RNA polymerase II promoter [GO:0006368]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin K-CDK13 complex [GO:0002945]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}.	69562;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	164553	COMPBIAS 39..59;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 190..205;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 218..244;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 245..269;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 270..319;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 328..348;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 363..411;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 412..434;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 435..452;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 490..512;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 560..592;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1052..1074;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1140..1168;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1197..1211;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1233..1256;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1465..1497;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 30..59;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 74..599;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 653..678;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1048..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1138..1168;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1197..1272;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1465..1511;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 837;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027		BINDING 734;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.22; 2.7.11.23			5 out of 5	Active site (1); Alternative sequence (1); Binding site (1); Chain (1); Compositional bias (16); Cross-link (2); Domain (1); Erroneous initiation (3); Frameshift (1); Modified residue (20); Nucleotide binding (1); Region (8); Sequence conflict (7)		ATP-binding;Acetylation;Alternative splicing;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 705..998;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	69562	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006468~protein phosphorylation,GO:0008380~RNA splicing,GO:0016310~phosphorylation,GO:0030097~hemopoiesis,GO:0070816~phosphorylation of RNA polymerase II C-terminal domain,GO:2000737~negative regulation of stem cell differentiation,	GO:0002945~cyclin K-CDK13 complex,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0016607~nuclear speck,GO:0019908~nuclear cyclin-dependent protein kinase holoenzyme complex,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0030332~cyclin binding,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	1.87770068762134	4.79176430326637e-06	FDR<0.01	5.3195045521188	320893.166666667	Present in Nucleus	RBP	Others	Others	Others	Others	1163	Transcription
Q9Z1Z2	Q9Z1Z2	Strap	3.0129	3.119	246570	5.84385226741468	NA	NA	0.730140186915888	2.71938650640416	3.40460302328749	235809.5	2	Strap	0	Serine-threonine kinase receptor-associated protein (UNR-interacting protein)		FUNCTION: The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. STRAP plays a role in the cellular distribution of the SMN complex. Negatively regulates TGF-beta signaling but positively regulates the PDPK1 kinase activity by enhancing its autophosphorylation and by significantly reducing the association of PDPK1 with 14-3-3 protein (By similarity). {ECO:0000250}.		alternative mRNA splicing, via spliceosome [GO:0000380]; anatomical structure development [GO:0048856]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; ribonucleoprotein complex assembly [GO:0022618]; spliceosomal snRNP assembly [GO:0000387]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]	mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Localized predominantly in the cytoplasm but also found in the nucleus. {ECO:0000250}.	20901;		IPR020472;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	38442	COMPBIAS 336..350;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 326..350;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (1); Repeat (7); Sequence conflict (2)		Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat;mRNA processing;mRNA splicing				REPEAT 12..56;  /note=WD 1; REPEAT 57..96;  /note=WD 2; REPEAT 98..137;  /note=WD 3; REPEAT 141..179;  /note=WD 4; REPEAT 180..212;  /note=WD 5; REPEAT 221..262;  /note=WD 6; REPEAT 263..302;  /note=WD 7		PS00678;PS50082;PS50294;	20901	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000387~spliceosomal snRNP assembly,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010633~negative regulation of epithelial cell migration,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0030277~maintenance of gastrointestinal epithelium,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0050680~negative regulation of epithelial cell proliferation,GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	1.42269487481824	0.00396302971300261	FDR<0.01	2.4019726715102	241189.75	Present in Nucleus	RBP	ChD	Others	ChD	Others	1240	Transcription
Q80VY9	Q80VY9	Dhx33	0.37379	1.5871	159059	NA	2.15294522907337	112.157918349035	NA	4.0766408479413	3.55935219789998	259509.5	2	Dhx33	0	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)		FUNCTION: Implicated in nucleolar organization, ribosome biogenesis, protein synthesis and cytoplasmic dsRNA sensing (By similarity) (PubMed:21930779). Stimulates RNA polymerase I transcription of the 47S precursor rRNA. Associates with ribosomal DNA (rDNA) loci where it is involved in POLR1A recruitment (PubMed:21930779). In the cytoplasm, promotes elongation-competent 80S ribosome assembly at the late stage of mRNA translation initiation (PubMed:26100019). Senses cytosolic dsRNA mediating NLRP3 inflammasome formation in macrophages and type I interferon production in myeloid dendritic cells (By similarity). Required for NLRP3 activation induced by viral dsRNA and bacterial RNA (By similarity). In dendritic cells, required for induction of type I interferon production induced by cytoplasmic dsRNA via the activation of MAPK and NF-kappa-B signaling pathways (PubMed:24037184). {ECO:0000250|UniProtKB:Q9H6R0, ECO:0000269|PubMed:21930779, ECO:0000269|PubMed:24037184, ECO:0000269|PubMed:26100019}.		positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21930779}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9H6R0}. Cytoplasm {ECO:0000250|UniProtKB:Q9H6R0}. Nucleus {ECO:0000250|UniProtKB:Q9H6R0}. Inflammasome {ECO:0000250|UniProtKB:Q9H6R0}. Note=Predominantly in the nucleolus. During mitosis, localizes with the nucleolar organizing regions. Upon dsRNA-binding, localizes in the inflammasome. {ECO:0000250|UniProtKB:Q9H6R0}.	216877;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	78347		REGION 1..71;  /note=Required for nucleolar location;  /evidence=ECO:0000250|UniProtKB:Q9H6R0; REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 29..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 462..553;  /note=HA2; required for interaction with EIF3G and RPL26;  /evidence=ECO:0000250|UniProtKB:Q9H6R0	NA				3.6.4.13			5 out of 5	Chain (1); Domain (2); Motif (2); Mutagenesis (1); Nucleotide binding (1); Region (4); Sequence conflict (1)		ATP-binding;Cytoplasm;Helicase;Hydrolase;Inflammasome;Nucleotide-binding;Nucleus;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 75..243;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 271..441;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 185..188;  /note=DEAH box; MOTIF 536..550;  /note=Critical for rDNA-binding			PS00690;PS51192;PS51194;	216877	GO:0006396~RNA processing,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000182~rDNA binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0033613~activating transcription factor binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.83689795868786	0.0611647258368543	FDR<0.1	1.2134989665956	209284.25	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1272	Transcription
Q99MN1	Q99MN1	Kars	3.4276	3.2682	311185	NA	NA	NA	NA	NA	3.247596778384	79305	5	Kars	0	Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)		FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. When secreted, acts as a signaling molecule that induces immune response through the activation of monocyte/macrophages. Catalyzes the synthesis of the signaling molecule diadenosine tetraphosphate (Ap4A), and thereby mediates disruption of the complex between HINT1 and MITF and the concomitant activation of MITF transcriptional activity. {ECO:0000250|UniProtKB:Q15046}.		basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q15046}. Cytoplasm {ECO:0000250|UniProtKB:Q15046}. Nucleus {ECO:0000250|UniProtKB:Q15046}. Cell membrane {ECO:0000250|UniProtKB:Q15046}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q15046}. Secreted {ECO:0000250|UniProtKB:Q15046}. Note=Secretion is induced by TNF-alpha. Cytosolic in quiescent mast cells. Translocates into the nucleus in response to mast cell activation by immunoglobulin E. {ECO:0000250|UniProtKB:Q15046}.	85305;	cd00775;cd04322;	IPR004364;IPR006195;IPR002313;IPR034762;IPR044136;IPR018149;IPR012340;IPR004365;	PF00152;PF01336;		67840	COMPBIAS 9..43;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..66;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 573..595;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 275;  /note=Substrate; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q15046; BINDING 299;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q15046; BINDING 337;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q15046; BINDING 339;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q15046; BINDING 495;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q15046; BINDING 499;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q15046	2.7.7.-; 6.1.1.6			5 out of 5	Binding site (6); Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (9); Nucleotide binding (4); Region (2)	MISCELLANEOUS: It is likely that the same gene provides both this cytoplasmic isoform and an additional mitochondrial isoform. {ECO:0000305}.; MISCELLANEOUS: Shares a bidirectional promoter with Terf2ip/Rap1. {ECO:0000305|PubMed:14659874}.	ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cell membrane;Cytoplasm;Ligase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome;Secreted;Transferase		DOMAIN: The N-terminal domain (1-65) is a functional tRNA-binding domain and is involved in the interaction with DARS, but has a repulsive role in the binding to EEF1A1. A central domain (208-259) is involved in homodimerization. The C-terminal domain (452-597) is not required for interaction with AIMP2 (By similarity). {ECO:0000250|UniProtKB:Q15046}.				PS50862;	85305	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006430~lysyl-tRNA aminoacylation,GO:0015966~diadenosine tetraphosphate biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0015630~microtubule cytoskeleton,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004824~lysine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016597~amino acid binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR002313:Lysine-tRNA ligase, class II,IPR004364:Aminoacyl-tRNA synthetase, class II (D/K/N),IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR012340:Nucleic acid-binding, OB-fold,IPR018149:Lysyl-tRNA synthetase, class II, C-terminal,IPR018150:Aminoacyl-tRNA synthetase, class II (D/K/N)-like,	PF00152:tRNA synthetases class II (D, K and N) ,PF01336:OB-fold nucleic acid binding domain,	SSF50249:Nucleic acid-binding proteins,	1.72835584959588	0.00326981115225299	FDR<0.01	2.48547732926718	195245	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1288	Transcription
Q91WT4	Q91WT4	Dnajc17	7.3215	4.431	311985	1.08692107866048	NA	NA	NA	NA	NA	51040	5	Dnajc17	0	DnaJ homolog subfamily C member 17		FUNCTION: May negatively affect PAX8-induced thyroglobulin/TG transcription. {ECO:0000269|PubMed:20160132}.		negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998]	cytoplasm [GO:0005737]; nucleus [GO:0005634]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:D3ZSC8}. Nucleus {ECO:0000250|UniProtKB:D3ZSC8}. Note=Predominantly nuclear. {ECO:0000250|UniProtKB:D3ZSC8}.	69408;	cd06257;cd12429;	IPR001623;IPR034254;IPR036869;IPR012677;IPR035979;IPR000504;	PF00226;PF00076;	SM00271;	34465		REGION 104..123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 150..170;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Domain (2); Modified residue (2); Region (2); Sequence conflict (5)		Chaperone;Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation	DOMAIN 11..76;  /note=J;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00286; DOMAIN 178..249;  /note=RRM					PS50076;	69408	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:1901998~toxin transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR001623:DnaJ domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00226:DnaJ domain,	SSF46565:Chaperone J-domain,SSF54928:RNA-binding domain, RBD,	1.71333958978594	0.0292325946486358	FDR<0.1	1.53413263549528	181512.5	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1303	Transcription
Q8BKT7	Q8BKT7	Thoc5	NA	2.4222	153835	7.20668780628423	7.94028902652057	NA	NA	NA	0.751936235807203	185239.5	3	Thoc5	1	THO complex subunit 5 homolog (Fms-interacting protein) (FMIP)		FUNCTION: Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. THOC5 in conjunction with ALYREF/THOC4 functions in NXF1-NXT1 mediated nuclear export of HSP70 mRNA; both proteins enhance the RNA binding activity of NXF1 and are required for NXF1 localization to the nuclear rim. Involved in transcription elongation and genome stability. Involved in alternative polyadenylation site choice by recruiting CPSF6 to 5' region of target genes; probably mediates association of the TREX and CFIm complexes.; FUNCTION: Regulates the expression of myeloid transcription factors CEBPA, CEBPB and GAB2 by enhancing the levels of phosphatidylinositol 3,4,5-trisphosphate. May be involved in the differentiation of granulocytes and adipocytes. Essential for hematopoietic primitive cell survival and plays an integral role in monocytic development.		blastocyst development [GO:0001824]; cell morphogenesis [GO:0000902]; monocyte differentiation [GO:0030224]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of macrophage differentiation [GO:0045650]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; primitive hemopoiesis [GO:0060215]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell division [GO:2000035]; RNA splicing [GO:0008380]; stem cell division [GO:0017145]; viral mRNA export from host cell nucleus [GO:0046784]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15221008}. Cytoplasm {ECO:0000269|PubMed:15221008}. Note=Shuttles between nucleus and cytoplasm. {ECO:0000250|UniProtKB:Q13769}.	107829;		IPR019163;	PF09766;		78686	COMPBIAS 317..336;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..199;  /note=Interaction with THOC7;  /evidence=ECO:0000250|UniProtKB:Q13769; REGION 2..144;  /note=Interaction with CSF1R;  /evidence=ECO:0000269|PubMed:10597251; REGION 299..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Initiator methionine (1); Modified residue (8); Motif (1); Mutagenesis (3); Region (4); Sequence conflict (2)		Acetylation;Cytoplasm;Differentiation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport			MOTIF 7..10;  /note=Nuclear localization signal				107829	GO:0000902~cell morphogenesis,GO:0001824~blastocyst development,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0010468~regulation of gene expression,GO:0010793~regulation of mRNA export from nucleus,GO:0017145~stem cell division,GO:0030154~cell differentiation,GO:0030224~monocyte differentiation,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0045650~negative regulation of macrophage differentiation,GO:0046784~viral mRNA export from host cell nucleus,GO:0051028~mRNA transport,GO:0060215~primitive hemopoiesis,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000035~regulation of stem cell division,	GO:0000228~nuclear chromosome,GO:0000346~transcription export complex,GO:0000347~THO complex,GO:0000445~THO complex part of transcription export complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR019163:THO complex, subunit 5,	PF09766:Fms-interacting protein,		1.67588202397229	0.0267559525019589	FDR<0.1	1.57257958369247	169537.25	Present in Nucleus	RBP	Others	Others	Others	Others	1309	Transcription
P26638	P26638	Sars	7.2815	NA	71175	NA	3.02206104563312	2.1596406357982	NA	NA	NA	205509	4	Sars	1	Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)		FUNCTION: Catalyzes the attachment of serine to tRNA(Ser) in a two-step reaction: serine is first activated by ATP to form Ser-AMP and then transferred to the acceptor end of tRNA(Ser). Is probably also able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec). In the nucleus, binds to the VEGFA core promoter and prevents MYC binding and transcriptional activation by MYC. Recruits SIRT2 to the VEGFA promoter, promoting deacetylation of histone H4 at 'Lys-16' (H4K16). Thereby, inhibits the production of VEGFA and sprouting angiogenesis mediated by VEGFA. {ECO:0000250|UniProtKB:P49591}.	PATHWAY: Aminoacyl-tRNA biosynthesis; selenocysteinyl-tRNA(Sec) biosynthesis; L-seryl-tRNA(Sec) from L-serine and tRNA(Sec): step 1/1.	negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P49591}. Nucleus {ECO:0000250|UniProtKB:P49591}. Note=Predominantly cytoplasmic, but a minor proportion is also found in the nucleus. {ECO:0000250|UniProtKB:P49591}.	20226;	cd00770;	IPR002314;IPR006195;IPR002317;IPR015866;IPR042103;IPR033729;IPR010978;	PF02403;PF00587;		58389	COMPBIAS 478..499;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 9..61;  /note=Interaction with tRNA;  /evidence=ECO:0000250|UniProtKB:P49591; REGION 470..512;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 271;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591; BINDING 302;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591; BINDING 325;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591; BINDING 427;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591	6.1.1.11			5 out of 5	Binding site (4); Chain (1); Compositional bias (1); Modified residue (4); Motif (1); Nucleotide binding (3); Region (2); Sequence conflict (3); Site (1)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;DNA-binding;Ligase;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome		DOMAIN: Consists of two distinct domains, a catalytic core and a N-terminal extension that is involved in tRNA binding. {ECO:0000250|UniProtKB:P49591}.	MOTIF 482..494;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P49591			PS50862;	20226	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006434~seryl-tRNA aminoacylation,GO:0097056~selenocysteinyl-tRNA(Sec) biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004828~serine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR002317:Serine-tRNA ligase, type1,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR010978:tRNA-binding arm,IPR015866:Serine-tRNA synthetase, type1, N-terminal,	PF00587:tRNA synthetase class II core domain (G, H, P, S and T),PF02403:Seryl-tRNA synthetase N-terminal domain,	SSF46589:tRNA-binding arm,	1.85685324984653	0.00792556171140818	FDR<0.01	2.10096994809821	138342	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1344	Transcription
Q99MU3	Q99MU3-5;Q99MU3;Q99MU3-2	Adar	1.605	NA	78106.5	NA	NA	NA	NA	5.77700751010976	4.18532624618089	100711.333333333	4	Adar	1	Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (RNA adenosine deaminase 1)		FUNCTION: Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Does not affect polyomavirus replication but provides protection against virus-induced cytopathic effects. Essential for embryonic development and cell survival and plays a critical role in the maintenance of hematopoietic stem cells. {ECO:0000269|PubMed:15556947, ECO:0000269|PubMed:17079286, ECO:0000269|PubMed:17369310}.		adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; innate immune response [GO:0045087]; in utero embryonic development [GO:0001701]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]	SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm. Nucleus, nucleolus. Note=Long forms starting at Met-1 are found predominantly in cytoplasm. Shuttles between the cytoplasm and nucleus.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm. Nucleus, nucleolus. Note=Long forms starting at Met-1 are found predominantly in cytoplasm.; SUBCELLULAR LOCATION: [Isoform 3]: Nucleus, nucleolus. Note=Short forms starting at Met-519 are found exclusively in the nucleolus.; SUBCELLULAR LOCATION: [Isoform 4]: Nucleus, nucleolus. Note=Short forms starting at Met-519 are found exclusively in the nucleolus.	56417;	cd19913;cd19915;	IPR002466;IPR044456;IPR044457;IPR014720;IPR000607;IPR036388;IPR036390;IPR042371;	PF02137;PF00035;PF02295;	SM00552;SM00358;SM00550;	130447	COMPBIAS 1..20;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 365..383;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 528..550;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 638..656;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 135..204;  /note=Interaction with Z-DNA;  /evidence=ECO:0000250|UniProtKB:P55265; REGION 221..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..383;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 527..564;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 631..657;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 665..674;  /note=N-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P55265; REGION 744..750;  /note=C-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P55265	NA	ACT_SITE 861;  /note=Proton donor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240			3.5.4.37	METAL 859;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240; METAL 915;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240; METAL 985;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240		5 out of 5	Active site (1); Alternative sequence (3); Chain (1); Compositional bias (4); Cross-link (4); Domain (6); Metal binding (3); Modified residue (12); Natural variant (4); Region (8); Sequence conflict (8)		Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;mRNA processing	DOMAIN 135..201;  /note=Z-binding 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00073; DOMAIN 246..310;  /note=Z-binding 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00073; DOMAIN 456..524;  /note=DRBM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 567..635;  /note=DRBM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 675..743;  /note=DRBM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 835..1170;  /note=A to I editase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240	DOMAIN: The third dsRNA-binding domain (DRBM 3) contains an additional N-terminal alpha-helix that is part of a bi-partite nuclear localization signal, together with the sequence immediately C-terminal to DRBM 3. The presence of DRBM 3 is important to bring together the N-terminal and the C-terminal part of the bi-partite nuclear localization signal for import mediated by TNPO1. RNA binding interferes with nuclear import. {ECO:0000250|UniProtKB:P55265}.; DOMAIN: The first Z-binding domain binds Z-DNA. {ECO:0000255|PROSITE-ProRule:PRU00073}.				PS50141;PS50137;PS50139;	56417	GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002376~immune system process,GO:0002566~somatic diversification of immune receptors via somatic mutation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006382~adenosine to inosine editing,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0009615~response to virus,GO:0016553~base conversion or substitution editing,GO:0030218~erythrocyte differentiation,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0035455~response to interferon-alpha,GO:0043066~negative regulation of apoptotic process,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0051607~defense response to virus,GO:0060216~definitive hemopoiesis,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0061484~hematopoietic stem cell homeostasis,GO:0098586~cellular response to virus,GO:1900369~negative regulation of RNA interference,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0044530~supraspliceosomal complex,	GO:0003677~DNA binding,GO:0003692~left-handed Z-DNA binding,GO:0003723~RNA binding,GO:0003726~double-stranded RNA adenosine deaminase activity,GO:0004000~adenosine deaminase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000607:Double-stranded RNA-specific adenosine deaminase (DRADA),IPR002466:Adenosine deaminase/editase,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014720:Double-stranded RNA-binding-like domain,	PF00035:Double-stranded RNA binding motif,PF02137:Adenosine-deaminase (editase) domain,PF02295:Adenosine deaminase z-alpha domain,	SSF46785:Winged helix DNA-binding domain,	1.75941191758924	0.0112284591968132	FDR<0.1	1.94967983485447	89408.9166666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1393	Transcription
Q8BY02	Q8BY02	Nkrf	NA	12.626	84203	NA	NA	NA	NA	3.07257420266699	NA	13690.6666666667	5	Nkrf	1	NF-kappa-B-repressing factor (NFkB-repressing factor) (Transcription factor NRF)	DNA_BIND 296..388;  /evidence=ECO:0000250	FUNCTION: Interacts with a specific negative regulatory element (NRE) 5'-AATTCCTCTGA-3' to mediate transcriptional repression of certain NK-kappa-B responsive genes. Involved in the constitutive silencing of the interferon beta promoter, independently of the virus-induced signals, and in the inhibition of the basal and cytokine-induced iNOS promoter activity. Also involved in the regulation of IL-8 transcription (By similarity). {ECO:0000250}.		negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	77286;	cd02640;	IPR000467;IPR001374;IPR036867;IPR034071;	PF01585;PF01424;	SM00443;SM00393;	77739	COMPBIAS 133..150;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 414..430;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..296;  /note=Active repression domain;  /evidence=ECO:0000250; REGION 27..49;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 65..85;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 133..160;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 414..436;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (4); DNA binding (1); Domain (2); Modified residue (1); Motif (1); Region (5); Sequence conflict (1)		DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 551..596;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092; DOMAIN 600..664;  /note=R3H;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00382		MOTIF 25..45;  /note=Nuclear localization signal;  /evidence=ECO:0000250			PS50174;PS51061;	77286	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR001374:Single-stranded nucleic acid binding R3H,IPR014720:Double-stranded RNA-binding-like domain,	PF01424:R3H domain,PF01585:G-patch domain,	SSF82708:R3H domain,	2.63888680160239	0.011139948273836	FDR<0.1	1.95311682571882	48946.8333333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1428	Transcription
Q8R326	Q8R326;Q8R326-2	Pspc1	13.129	5.7392	5520350	14.6177459435755	11.5460108532502	10.9508634755851	6.17817867292722	6.08902149424588	5.77934462231983	6760650	0	Pspc1	0	Paraspeckle component 1 (Paraspeckle protein 1) (mPSP1)		FUNCTION: Together with NONO, required for the formation of nuclear paraspeckles. Regulates, cooperatively with NONO and SFPQ, androgen receptor-mediated gene transcription activity in Sertoli cell line. Binds to poly(A), poly(G) and poly(U) RNA homopolymers. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:Q8WXF1, ECO:0000269|PubMed:16641145, ECO:0000269|PubMed:22966205}.		activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=In punctate subnuclear structures localized adjacent to nuclear splicing speckles, called paraspeckles. Colocalizes with NONO and SFPQ in paraspeckles and perinucleolar caps in an RNA-dependent manner. May cycle between paraspeckles and nucleolus. In telophase, when daughter nuclei form, localizes to perinucleolar caps. {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 1]: Nucleus matrix. Cytoplasm. Nucleus speckle {ECO:0000250}.	66645;	cd12586;cd12589;	IPR012975;IPR012677;IPR034522;IPR034523;IPR035979;IPR000504;	PF08075;PF00076;	SM00360;	58758	COMPBIAS 470..492;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 124..357;  /note=Sufficient for paraspeckles localization;  /evidence=ECO:0000250; REGION 230..357;  /note=Sufficient for perinucleolar caps localization and interaction with NONO;  /evidence=ECO:0000250; REGION 460..523;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (1); Domain (2); Modified residue (6); Mutagenesis (4); Region (3); Sequence conflict (1)		Acetylation;Activator;Alternative splicing;Biological rhythms;Coiled coil;Cytoplasm;Immunity;Innate immunity;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 81..153;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 155..236;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	66645	GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0042382~paraspeckles,	GO:0000166~nucleotide binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006077:Vinculin/alpha-catenin,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF01044:Vinculin family,PF08075:NOPS (NUC059) domain,	SSF47220:alpha-catenin/vinculin-like,SSF54928:RNA-binding domain, RBD,	3.1064721183589	4.16765701477199e-08	FDR<0.01	7.38010802932491	6140500	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	315	Transcription
Q8R3G1	Q8R3G1	Ppp1r8	8.6534	13.832	3250115	NA	NA	NA	83.6960160696351	30.0291282544068	7.49007564976406	352974.5	3	Ppp1r8	0	Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8)		FUNCTION: Inhibitor subunit of the major nuclear protein phosphatase-1 (PP-1). It has RNA-binding activity but does not cleave RNA and may target PP-1 to RNA-associated substrates. May also be involved in pre-mRNA splicing. Binds DNA and might act as a transcriptional repressor. Essential for cell proliferation and early embryonic development. {ECO:0000269|PubMed:15199142, ECO:0000269|PubMed:15501817}.		cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Mainly, but not exclusively, nuclear.	100336;	cd00060;	IPR000253;IPR008984;	PF00498;	SM00240;	38528		REGION 1..142;  /note=Interaction with CDC5L, SF3B1 and MELK;  /evidence=ECO:0000250; REGION 143..224;  /note=Interaction with EED;  /evidence=ECO:0000250; REGION 191..200;  /note=Involved in PP-1 inhibition;  /evidence=ECO:0000250; REGION 200..203;  /note=Involved in PP-1 binding;  /evidence=ECO:0000250; REGION 310..329;  /note=Interaction with EED;  /evidence=ECO:0000250; REGION 314..351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 330..351;  /note=RNA-binding;  /evidence=ECO:0000250; REGION 331..337;  /note=Involved in PP-1 inhibition;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (10); Chain (1); Domain (1); Modified residue (7); Motif (2); Region (8); Turn (1)		3D-structure;DNA-binding;Developmental protein;Nucleus;Phosphoprotein;Protein phosphatase inhibitor;RNA-binding;Reference proteome;Repressor;Spliceosome;Transcription;Transcription regulation;mRNA processing;mRNA splicing	DOMAIN 49..101;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086	DOMAIN: Has a basic N- and C-terminal and an acidic central domain. {ECO:0000269|PubMed:18253837}.; DOMAIN: The FHA domain mediates interactions with threonine-phosphorylated MELK. {ECO:0000269|PubMed:18253837}.	MOTIF 185..209;  /note=Nuclear localization signal 1;  /evidence=ECO:0000250; MOTIF 210..240;  /note=Nuclear localization signal 2;  /evidence=ECO:0000250			PS50006;	100336	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0008599~protein phosphatase type 1 regulator activity,GO:0019888~protein phosphatase regulator activity,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,	PF00498:FHA domain,	SSF49879:SMAD/FHA domain,	4.22071259742772	3.923349851912e-05	FDR<0.01	4.40634296335139	1801544.75	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	655	Transcription
Q61545	Q61545	Ewsr1	19.145	43.452	2217400	19.4295484572939	12.8954053670677	15.8793171893609	6.96864111498258	10.4962633302544	13.271576265113	1047586.66666667	0	Ewsr1	0	RNA-binding protein EWS		FUNCTION: Might function as a transcriptional repressor. {ECO:0000250}.		regulation of transcription, DNA-templated [GO:0006355]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Relocates from cytoplasm to ribosomes upon PTK2B/FAK2 activation. {ECO:0000250}.	14030;	cd12533;	IPR034869;IPR033109;IPR012677;IPR035979;IPR000504;IPR034870;IPR001876;IPR036443;	PF00076;PF00641;	SM00360;SM00547;	68462	COMPBIAS 121..178;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 180..194;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 195..293;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..475;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 547..561;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 636..655;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..285;  /note=EAD (Gln/Pro/Thr-rich); REGION 8..285;  /note=31 X approximate tandem repeats; REGION 121..350;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 447..524;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 544..655;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (6); Domain (2); Modified residue (38); Motif (1); Region (5); Repeat (31); Sequence conflict (2); Zinc finger (1)	MISCELLANEOUS: Binds calmodulin in the presence, but not in the absence, of calcium ion. {ECO:0000250}.	Acetylation;Calmodulin-binding;Cell membrane;Cytoplasm;Membrane;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 256..285;  /note=IQ; DOMAIN 360..446;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 638..655;  /note=Nuclear localization signal;  /evidence=ECO:0000250	REPEAT 8..16;  /note=1; REPEAT 17..27;  /note=2; REPEAT 28..34;  /note=3; REPEAT 35..42;  /note=4; REPEAT 43..50;  /note=5; REPEAT 51..59;  /note=6; REPEAT 60..68;  /note=7; REPEAT 69..75;  /note=8; REPEAT 76..84;  /note=9; REPEAT 85..91;  /note=10; REPEAT 92..110;  /note=11; REPEAT 111..116;  /note=12; REPEAT 117..125;  /note=13; REPEAT 126..156;  /note=14; REPEAT 157..163;  /note=15; REPEAT 164..170;  /note=16; REPEAT 171..177;  /note=17; REPEAT 178..188;  /note=18; REPEAT 189..193;  /note=19; REPEAT 194..201;  /note=20; REPEAT 202..206;  /note=21; REPEAT 207..212;  /note=22; REPEAT 213..218;  /note=23; REPEAT 219..224;  /note=24; REPEAT 225..230;  /note=25; REPEAT 231..238;  /note=26; REPEAT 239..245;  /note=27; REPEAT 246..252;  /note=28; REPEAT 253..259;  /note=29; REPEAT 260..276;  /note=30; REPEAT 277..285;  /note=31	ZN_FING 517..548;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS50102;PS01358;PS50199;	14030	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00641:Zn-finger in Ran binding protein and others,	SSF54928:RNA-binding domain, RBD,SSF90209:Ran binding protein zinc finger-like,	3.94765477382884	1.76950011325785e-08	FDR<0.01	7.7521494052292	1632493.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	680	Transcription
E9PVA8	E9PVA8	Gcn1l1	6.7997	11.291	781060	4.38615728760033	4.25803704492229	2.1846463057631	6.34799720688123	4.82346131584025	9.16422287390029	1147150.66666667	0	Gcn1l1	0	eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)		FUNCTION: Acts as a positive activator of the GCN2 protein kinase activity in response to amino acid starvation (PubMed:15937339). Forms a complex with EIF2AK4/GCN2 on translating ribosomes; during this process, GCN1 seems to act as a chaperone to facilitate delivery of uncharged tRNAs that enter the A site of ribosomes to the tRNA-binding domain of EIF2AK4/GCN2, and hence stimulating EIF2AK4/GCN2 kinase activity (By similarity). Participates in the repression of global protein synthesis and in gene-specific mRNA translation activation, such as the transcriptional activator ATF4, by promoting the EIF2AK4/GCN2-mediated phosphorylation of eukaryotic translation initiation factor 2 (eIF-2-alpha/EIF2S1) on 'Ser-52', and hence allowing ATF4-mediated reprogramming of amino acid biosynthetic gene expression to alleviate nutrient depletion (PubMed:24333428). {ECO:0000250|UniProtKB:P33892, ECO:0000269|PubMed:15937339, ECO:0000269|PubMed:24333428}.		cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]	cytosol [GO:0005829]; polysome [GO:0005844]	protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:23447528}. Note=Associates with ribosomes in undifferentiated neuroblastoma cells and increases after neuronal differentiation (PubMed:23447528).	231659;		IPR011989;IPR016024;IPR000225;IPR033173;IPR021133;IPR034085;		SM00185;SM01349;	293021			NA							5 out of 5	Chain (1); Coiled coil (1); Initiator methionine (1); Modified residue (4); Repeat (47); Sequence conflict (5)		Acetylation;Activator;Coiled coil;Cytoplasm;Phosphoprotein;Reference proteome;Repeat;Stress response;Translation regulation				REPEAT 140..178;  /note=HEAT 1;  /evidence=ECO:0000255; REPEAT 257..293;  /note=HEAT 2;  /evidence=ECO:0000255; REPEAT 294..331;  /note=HEAT 3;  /evidence=ECO:0000255; REPEAT 385..423;  /note=HEAT 4;  /evidence=ECO:0000255; REPEAT 425..459;  /note=HEAT 5;  /evidence=ECO:0000255; REPEAT 460..500;  /note=HEAT 6;  /evidence=ECO:0000255; REPEAT 560..597;  /note=HEAT 7;  /evidence=ECO:0000255; REPEAT 599..636;  /note=HEAT 8;  /evidence=ECO:0000255; REPEAT 700..732;  /note=HEAT 9;  /evidence=ECO:0000255; REPEAT 733..772;  /note=HEAT 10;  /evidence=ECO:0000255; REPEAT 879..918;  /note=HEAT 11;  /evidence=ECO:0000255; REPEAT 979..1016;  /note=HEAT 12;  /evidence=ECO:0000255; REPEAT 1035..1072;  /note=HEAT 13;  /evidence=ECO:0000255; REPEAT 1078..1115;  /note=HEAT 14;  /evidence=ECO:0000255; REPEAT 1155..1192;  /note=HEAT 15;  /evidence=ECO:0000255; REPEAT 1210..1250;  /note=HEAT 16;  /evidence=ECO:0000255; REPEAT 1251..1289;  /note=HEAT 17;  /evidence=ECO:0000255; REPEAT 1290..1332;  /note=HEAT 18;  /evidence=ECO:0000255; REPEAT 1335..1372;  /note=HEAT 19;  /evidence=ECO:0000255; REPEAT 1374..1410;  /note=HEAT 20;  /evidence=ECO:0000255; REPEAT 1413..1451;  /note=HEAT 21;  /evidence=ECO:0000255; REPEAT 1455..1492;  /note=HEAT 22;  /evidence=ECO:0000255; REPEAT 1493..1530;  /note=HEAT 23;  /evidence=ECO:0000255; REPEAT 1534..1571;  /note=HEAT 24;  /evidence=ECO:0000255; REPEAT 1573..1609;  /note=HEAT 25;  /evidence=ECO:0000255; REPEAT 1611..1648;  /note=HEAT 26;  /evidence=ECO:0000255; REPEAT 1653..1690;  /note=HEAT 27;  /evidence=ECO:0000255; REPEAT 1692..1729;  /note=HEAT 28;  /evidence=ECO:0000255; REPEAT 1731..1769;  /note=HEAT 29;  /evidence=ECO:0000255; REPEAT 1773..1810;  /note=HEAT 30;  /evidence=ECO:0000255; REPEAT 1812..1848;  /note=HEAT 31;  /evidence=ECO:0000255; REPEAT 1921..1958;  /note=HEAT 32;  /evidence=ECO:0000255; REPEAT 1959..1996;  /note=HEAT 33;  /evidence=ECO:0000255; REPEAT 2001..2038;  /note=HEAT 34;  /evidence=ECO:0000255; REPEAT 2039..2074;  /note=HEAT 35;  /evidence=ECO:0000255; REPEAT 2076..2108;  /note=HEAT 36;  /evidence=ECO:0000255; REPEAT 2111..2146;  /note=HEAT 37;  /evidence=ECO:0000255; REPEAT 2147..2184;  /note=HEAT 38;  /evidence=ECO:0000255; REPEAT 2188..2225;  /note=HEAT 39;  /evidence=ECO:0000255; REPEAT 2259..2296;  /note=HEAT 40;  /evidence=ECO:0000255; REPEAT 2301..2338;  /note=HEAT 41;  /evidence=ECO:0000255; REPEAT 2339..2380;  /note=HEAT 42;  /evidence=ECO:0000255; REPEAT 2382..2417;  /note=HEAT 43;  /evidence=ECO:0000255; REPEAT 2422..2459;  /note=HEAT 44;  /evidence=ECO:0000255; REPEAT 2546..2583;  /note=HEAT 45;  /evidence=ECO:0000255; REPEAT 2588..2625;  /note=HEAT 46;  /evidence=ECO:0000255; REPEAT 2627..2661;  /note=HEAT 47;  /evidence=ECO:0000255		PS50077;	231659	GO:0006417~regulation of translation,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0034198~cellular response to amino acid starvation,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:1990253~cellular response to leucine starvation,	GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0005515~protein binding,GO:0019887~protein kinase regulator activity,GO:0019901~protein kinase binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,IPR026827:Proteasome component ECM29/Translational activator GCN1,		SSF48371:ARM repeat,	2.46818763345387	1.57115614661995e-06	FDR<0.01	5.80378065121367	964105.333333333	Unexpected	RBP	Others	Others	Others	Others	830	Transcription
Q6ZQ08	Q6ZQ08-2;Q6ZQ08;Q6ZQ08-4;Q6ZQ08-3	Cnot1	1.1715	7.6076	100428	5.45970735968552	6.60676532769556	7.35889322245934	NA	2.65893802015475	5.37374388736633	518482.133333333	1	Cnot1	0	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1)		FUNCTION: Scaffolding component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Its scaffolding function implies its interaction with the catalytic complex module and diverse RNA-binding proteins mediating the complex recruitment to selected mRNA 3'UTRs. Involved in degradation of AU-rich element (ARE)-containing mRNAs probably via association with ZFP36. Mediates the recruitment of the CCR4-NOT complex to miRNA targets and to the RISC complex via association with TNRC6A, TNRC6B or TNRC6C. Acts as a transcriptional repressor. Represses the ligand-dependent transcriptional activation by nuclear receptors. Involved in the maintenance of embryonic stem (ES) cell identity; prevents their differentiation towards extraembryonic trophectoderm lineages. {ECO:0000269|PubMed:22367759}.		gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; trophectodermal cell differentiation [GO:0001829]	CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]	armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; molecular adaptor activity [GO:0060090]; poly(A)-specific ribonuclease activity [GO:0004535]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:20133598}. Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=NANOS2 promotes its localization to P-body.	234594;		IPR007196;IPR024557;IPR040398;IPR032191;IPR032194;IPR032193;IPR038535;IPR016021;	PF16415;PF16418;PF16417;PF12842;PF04054;		266808	COMPBIAS 1328..1351;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 725..770;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 799..1014;  /note=Interaction with ZFP36;  /evidence=ECO:0000250; REGION 1089..1604;  /note=Interaction with CNOT6, CNOT6L, CNOT7 and CNOT8;  /evidence=ECO:0000250; REGION 1314..1351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (1); Erroneous initiation (3); Modified residue (2); Motif (7); Mutagenesis (1); Region (4); Sequence conflict (3)		Alternative splicing;Cytoplasm;Developmental protein;Nucleus;Phosphoprotein;RNA-mediated gene silencing;Reference proteome;Repressor;Transcription;Transcription regulation;Translation regulation		DOMAIN: Contains Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs, a motif known to be important for the association with nuclear receptors. {ECO:0000250}.	MOTIF 153..157;  /note=LXXLL; MOTIF 181..185;  /note=LXXLL; MOTIF 223..227;  /note=LXXLL; MOTIF 570..574;  /note=LXXLL; MOTIF 1638..1642;  /note=LXXLL; MOTIF 1941..1945;  /note=LXXLL; MOTIF 2095..2099;  /note=LXXLL				234594	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0010606~positive regulation of cytoplasmic mRNA processing body assembly,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0035195~gene silencing by miRNA,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0061014~positive regulation of mRNA catabolic process,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:2000036~regulation of stem cell population maintenance,	GO:0000932~cytoplasmic mRNA processing body,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030014~CCR4-NOT complex,GO:0030015~CCR4-NOT core complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004535~poly(A)-specific ribonuclease activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0030331~estrogen receptor binding,GO:0032947~protein complex scaffold,GO:0042974~retinoic acid receptor binding,GO:0044822~poly(A) RNA binding,GO:0070016~armadillo repeat domain binding,	IPR007196:CCR4-Not complex component, Not1, C-terminal,IPR024557:CCR4-Not complex, Not1 subunit, domain of unknown function DUF3819,	PF04054:CCR4-Not complex component, Not1,PF12842:Domain of unknown function (DUF3819),		2.14926179808077	9.66673253052538e-05	FDR<0.01	4.01472029776419	309455.066666667	Present in Nucleus	RBP	Others	Others	Others	Others	1177	Transcription
Q8VDP4	Q8VDP4	Ccar2	10.512	15.73	156281.5	1.59775036748258	1.44835177567928	3.1207090250905	NA	3.09770150548293	11.9284768527907	239717.666666667	1	Ccar2	0	Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2)		FUNCTION: Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (By similarity). Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis (By similarity). Inhibits SUV39H1 methyltransferase activity (PubMed:19218236). Mediates ligand-dependent transcriptional activation by nuclear hormone receptors (By similarity). Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress (By similarity). Regulates the circadian expression of the core clock components NR1D1 and ARNTL/BMAL1 (PubMed:23398316). Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (By similarity). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (By similarity). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (By similarity). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (By similarity). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (By similarity). {ECO:0000250|UniProtKB:Q8N163, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:23398316, ECO:0000269|PubMed:24415752, ECO:0000269|PubMed:25732823}.		cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA polymerase II complex binding [GO:0000993]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8N163}. Cytoplasm {ECO:0000250|UniProtKB:Q8N163}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q8N163}. Note=Recruited to chromatin, post-UV irradiation. Sequestered to the cytoplasm in the presence of MCC. Translocated to the cytoplasm during UV-induced apoptosis. {ECO:0000250|UniProtKB:Q8N163}.	219158;		IPR025224;IPR028811;IPR025954;IPR011992;IPR025223;	PF14443;PF14444;	SM01122;	103002	COMPBIAS 187..219;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 469..494;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 568..605;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 615..638;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..219;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 280..307;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 446..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 567..638;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 609..669;  /note=Interaction with MCC;  /evidence=ECO:0000250|UniProtKB:Q8N163; REGION 703..922;  /note=Interaction with NR1D1;  /evidence=ECO:0000250|UniProtKB:Q8N163	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (4); Cross-link (2); Erroneous initiation (2); Modified residue (17); Region (7); Sequence conflict (3)		Acetylation;Activator;Apoptosis;Biological rhythms;Cell cycle;Coiled coil;Cytoplasm;Cytoskeleton;DNA damage;Direct protein sequencing;Isopeptide bond;Metalloenzyme inhibitor;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Wnt signaling pathway;mRNA processing;mRNA splicing							219158	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0009411~response to UV,GO:0016055~Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0031647~regulation of protein stability,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0042752~regulation of circadian rhythm,GO:0043065~positive regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090311~regulation of protein deacetylation,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:2000003~positive regulation of DNA damage checkpoint,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0044609~DBIRD complex,	GO:0000993~RNA polymerase II core binding,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR011992:EF-hand-like domain,IPR025223:S1-like RNA binding domain,IPR025224:DBC1/CARP1,IPR025954:DBC1/CARP1 catalytically inactive NUDIX hydrolase domain,	PF14443:DBC1,PF14444:S1-like,	SSF47473:EF-hand,	2.2041822883682	0.000708446093187168	FDR<0.01	3.14969319033118	197999.583333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1283	Transcription
P30681	P30681	Hmgb2	1.8989	2.1843	59531000	7.49793806703157	4.73911189043173	5.24548887956357	2.23398789178563	23.9498012166499	12.4646316078128	13073805	0	Hmgb2	0	High mobility group protein B2 (High mobility group protein 2) (HMG-2)	DNA_BIND 9..79;  /note=HMG box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267; DNA_BIND 95..163;  /note=HMG box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. In the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and V(D)J recombination and probably other processes. Binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (By similarity). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (PubMed:9184213). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (PubMed:19890330). In the extracellular compartment acts as a chemokine. Promotes proliferation and migration of endothelial cells implicating AGER/RAGE (By similarity). Has antimicrobial activity in gastrointestinal epithelial tissues (By similarity). Involved in inflammatory response to antigenic stimulus coupled with proinflammatory activity (PubMed:25306442). May play a role in germ cell differentiation (PubMed:11262228). Involved in modulation of neurogenesis probably by regulation of neural stem proliferation (PubMed:24391977). Involved in articular cartilage surface maintenance implicating LEF1 and the Wnt/beta-catenin pathway (PubMed:19805379). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P26583, ECO:0000269|PubMed:19805379, ECO:0000269|PubMed:19890330, ECO:0000269|PubMed:23495099, ECO:0000269|PubMed:24391977, ECO:0000269|PubMed:25306442, ECO:0000269|PubMed:9184213, ECO:0000305|PubMed:11262228}.		cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	chemoattractant activity [GO:0042056]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; non-sequence-specific DNA binding, bending [GO:0044378]; protein domain specific binding [GO:0019904]; RAGE receptor binding [GO:0050786]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09429}. Chromosome {ECO:0000250|UniProtKB:P26583}. Cytoplasm {ECO:0000269|PubMed:19890330}. Secreted {ECO:0000250|UniProtKB:P26583}.	97165;		IPR009071;IPR036910;IPR017967;	PF00505;PF09011;	SM00398;	24162	COMPBIAS 71..95;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 188..210;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 71..102;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 162..210;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 165..180;  /note=Required for chemotactic activity;  /evidence=ECO:0000250|UniProtKB:P26583	NA							5 out of 5	Chain (1); Compositional bias (2); DNA binding (2); Disulfide bond (1); Modified residue (11); Region (3); Sequence conflict (19)		Acetylation;Chemotaxis;Chromosome;Cytoplasm;DNA recombination;DNA-binding;Disulfide bond;Immunity;Inflammatory response;Innate immunity;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Secreted;Transcription;Transcription regulation		DOMAIN: Both, HMG box 1 and HMG box 2, show antimicrobial activity. {ECO:0000250|UniProtKB:P26583}.				PS00353;PS50118;	97165	GO:0001938~positive regulation of endothelial cell proliferation,GO:0002376~immune system process,GO:0002437~inflammatory response to antigenic stimulus,GO:0006265~DNA topological change,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007283~spermatogenesis,GO:0007289~spermatid nucleus differentiation,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0032075~positive regulation of nuclease activity,GO:0032496~response to lipopolysaccharide,GO:0032728~positive regulation of interferon-beta production,GO:0042493~response to drug,GO:0043388~positive regulation of DNA binding,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045595~regulation of cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048545~response to steroid hormone,GO:0050767~regulation of neurogenesis,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0060326~cell chemotaxis,GO:0071222~cellular response to lipopolysaccharide,GO:0072091~regulation of stem cell proliferation,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001158~enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0008144~drug binding,GO:0008301~DNA binding, bending,GO:0019904~protein domain specific binding,GO:0042056~chemoattractant activity,GO:0044212~transcription regulatory region DNA binding,GO:0044378~non-sequence-specific DNA binding, bending,GO:0044822~poly(A) RNA binding,GO:0050786~RAGE receptor binding,GO:0097100~supercoiled DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR017967:HMG box A DNA-binding domain, conserved site,	PF00505:HMG (high mobility group) box,PF09011:HMG-box domain,	SSF47095:HMG-box,	2.37198178754392	0.00010786622873488	FDR<0.01	3.9671145049909	36302402.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	65	Transcription factor activity
Q501J6	Q501J6;Q501J6-2	Ddx17	11.244	14.841	12030750	23.9721922569819	10.7188029240894	18.6703011519576	9.12325517744731	11.5810441469403	14.1171155909425	6599783.33333333	0	Ddx17	0	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17)		FUNCTION: As an RNA helicase, unwinds RNA and alters RNA structures through ATP binding and hydrolysis. Involved in multiple cellular processes, including pre-mRNA splicing, alternative splicing, ribosomal RNA processing and miRNA processing, as well as transcription regulation. Regulates the alternative splicing of exons exhibiting specific features. This function requires the RNA helicase activity. Affects NFAT5 and histone macro-H2A.1/MACROH2A1 alternative splicing in a CDK9-dependent manner. Affects splicing of mediators of steroid hormone signaling pathway, including kinases that phosphorylates ESR1 and transcriptional regulators. By acting splicing of regulatory factors, participates in ESR1 and AR stabilization. Promotes the inclusion of specific AC-rich alternative exons in CD44 transcripts. In myoblasts and epithelial cells, cooperates with HNRNPH1 to control the splicing of specific subsets of exons. In addition to binding mature mRNAs, also interacts with certain pri-microRNAs, including MIR132/miR-132, and stabilizes the primary transcript. Also participates in the MIR132 processing, resulting in significantly higher levels of mature MIR132 than MIR212 despite the fact that both are cotranscribed and co-regulated (PubMed:26947125). Binding of pri-microRNAs may occur on the 3' segment flanking the stem loop via the 5'-[ACG]CAUC[ACU]-3' consensus sequence (By similarity). Participates in MYC down-regulation at high cell density through the production of MYC-targeting microRNAs. Along with DDX5, may be involved in the processing of the 32S intermediate into the mature 28S rRNA. Promoter-specific transcription regulator, functioning as a coactivator or corepressor depending on the context of the promoter and the transcriptional complex in which it exists. Enhances NFAT5 transcriptional activity. Synergizes with TP53 in the activation of the MDM2 promoter; this activity requires acetylation on lysine residues. May also coactivate MDM2 transcription through a TP53-independent pathway. Coactivates MMP7 transcription. Along with CTNNB1, coactivates MYC, JUN, FOSL1 and cyclin D1/CCND1 transcription. Alone or in combination with DDX5 and/or SRA1 non-coding RNA, plays a critical role in promoting the assembly of proteins required for the formation of the transcription initiation complex and chromatin remodeling leading to coactivation of MYOD1-dependent transcription. This helicase-independent activity is required for skeletal muscle cells to properly differentiate into myotubes (PubMed:17011493). During epithelial-to-mesenchymal transition, coregulates SMAD-dependent transcriptional activity, directly controlling key effectors of differentiation, including miRNAs which in turn directly repress its expression. Plays a role in estrogen and testosterone signaling pathway at several levels. Mediates the use of alternative promoters in estrogen-responsive genes and regulates transcription and splicing of a large number of steroid hormone target genes. Contrary to the splicing regulation activity, transcriptional coregulation of the estrogen receptor ESR1 is helicase activity-independent. Plays a role in innate immunity. Specifically restricts bunyavirus infection, including Rift Valley fever virus (RVFV) or La Crosse virus (LACV), but not vesicular stomatitis virus (VSV), in an interferon- and DROSHA-independent manner. Binds to RVFV RNA, likely via structured viral RNA elements (By similarity). Promotes mRNA degradation mediated by the antiviral zinc-finger protein ZC3HAV1, in an ATPase-dependent manner (By similarity). {ECO:0000250|UniProtKB:Q92841, ECO:0000269|PubMed:17011493, ECO:0000269|PubMed:26947125}.		alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92841}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q92841}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q92841}. Note=In the course of bunyavirus infection, relocalizes from the nucleus to the cytosol where it binds viral RNA to antagonize replication. {ECO:0000250|UniProtKB:Q92841}.	67040;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	72399	COMPBIAS 1..18;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 486..500;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 503..531;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 583..623;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 636..650;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..38;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 468..650;  /note=Transactivation domain;  /evidence=ECO:0000250; REGION 472..543;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 583..650;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 639..647;  /note=Interaction with YAP1;  /evidence=ECO:0000250|UniProtKB:Q92841	NA				3.6.4.13			5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Cross-link (4); Domain (2); Modified residue (5); Motif (2); Nucleotide binding (1); Region (5); Sequence conflict (2)		ATP-binding;Acetylation;Alternative splicing;Antiviral defense;Cytoplasm;Helicase;Hydrolase;Immunity;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;RNA-mediated gene silencing;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing;rRNA processing	DOMAIN 123..298;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 326..473;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 92..120;  /note=Q motif; MOTIF 246..249;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	67040	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009791~post-embryonic development,GO:0010501~RNA secondary structure unwinding,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0072358~cardiovascular system development,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0030331~estrogen receptor binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.76915631507071	1.75290727913838e-09	FDR<0.01	8.75624105551119	9315266.66666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	233	Transcription factor activity
P56959	P56959	Fus	24.521	28.286	47650000	39.96003996004	19.9944015675611	54.3183052688756	16.3937113723176	44.9317038102085	6.88183882733466	13352450	0	Fus	0	RNA-binding protein FUS (Protein pigpen)		FUNCTION: DNA/RNA-binding protein that plays a role in various cellular processes such as transcription regulation, RNA splicing, RNA transport, DNA repair and damage response. Binds to nascent pre-mRNAs and acts as a molecular mediator between RNA polymerase II and U1 small nuclear ribonucleoprotein thereby coupling transcription and splicing. Binds also its own pre-mRNA and autoregulates its expression; this autoregulation mechanism is mediated by non-sense-mediated decay. Plays a role in DNA repair mechanisms by promoting D-loop formation and homologous recombination during DNA double-strand break repair (By similarity). In neuronal cells, plays crucial roles in dendritic spine formation and stability, RNA transport, mRNA stability and synaptic homeostasis (PubMed:16317045, PubMed:25968143). {ECO:0000250|UniProtKB:P35637, ECO:0000269|PubMed:16317045, ECO:0000269|PubMed:25968143}.		cellular response to calcium ion [GO:0071277]; gene expression [GO:0010467]; mRNA stabilization [GO:0048255]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]	DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; myosin V binding [GO:0031489]; retinoid X receptor binding [GO:0046965]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P35637}. Note=Displays a punctate pattern inside the nucleus and is excluded from nucleoli. {ECO:0000250|UniProtKB:P35637}.	233908;		IPR034459;IPR012677;IPR035979;IPR000504;IPR034870;IPR001876;IPR036443;	PF00076;PF00641;	SM00360;SM00547;	52673	COMPBIAS 1..190;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..484;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..518;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..279;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 368..417;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 437..518;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Modified residue (29); Region (3); Zinc finger (1)		DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 278..364;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176				ZN_FING 415..446;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS50102;PS01358;PS50199;	233908	GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0044327~dendritic spine head,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0030331~estrogen receptor binding,GO:0031489~myosin V binding,GO:0035255~ionotropic glutamate receptor binding,GO:0044822~poly(A) RNA binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00641:Zn-finger in Ran binding protein and others,	SSF54928:RNA-binding domain, RBD,SSF90209:Ran binding protein zinc finger-like,	4.64385820360107	1.48307653745271e-08	FDR<0.01	7.82883643566369	30501225	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	78	Transcription factor activity
P62960	P62960;Q9Z2C8-2;Q9Z2C8	Ybx1	12.861	NA	246020	NA	10.3417963700295	5.75871004894904	NA	0.879352796341892	NA	345411.666666667	3	Ybx1	1	Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor)		FUNCTION: DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation (PubMed:8505341, PubMed:29712925). Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) (By similarity). Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay (By similarity). Component of the CRD-mediated complex that promotes MYC mRNA stability (By similarity). Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs (By similarity). Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs (By similarity). Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs (PubMed:29712925). Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' (By similarity). Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes (By similarity). Promotes separation of DNA strands that contain mismatches or are modified by cisplatin (By similarity). Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair (By similarity). The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (By similarity). {ECO:0000250|UniProtKB:P67809, ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:29712925, ECO:0000269|PubMed:8505341}.		cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; histone pre-mRNA 3'end processing complex [GO:0071204]; intracellular membrane-bounded organelle [GO:0043231]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]	C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P67809}. Nucleus {ECO:0000250|UniProtKB:P67809}. Cytoplasmic granule {ECO:0000250|UniProtKB:P67809}. Secreted {ECO:0000250|UniProtKB:P67809}. Secreted, extracellular exosome {ECO:0000250|UniProtKB:P67809}. Note=Predominantly cytoplasmic in proliferating cells. Cytotoxic stress and DNA damage enhance translocation to the nucleus. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles between nucleus and cytoplasm. Localized with DDX1, MBNL1 and TIAL1 in stress granules upon stress. Secreted by mesangial and monocytic cells after inflammatory challenges. {ECO:0000250|UniProtKB:P67809}.	22608;	cd04458;	IPR011129;IPR019844;IPR002059;IPR012340;	PF00313;	SM00357;	35730	COMPBIAS 154..179;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 248..267;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 286..304;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..47;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 16..69;  /note=Interaction with ss-DNA;  /evidence=ECO:0000250|UniProtKB:P67809; REGION 63..68;  /note=C5-methylcytosine binding;  /evidence=ECO:0000250|UniProtKB:P67809; REGION 118..322;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Domain (1); Initiator methionine (1); Modified residue (10); Region (4); Sequence conflict (3); Site (2)		Acetylation;Activator;Cytoplasm;DNA-binding;Isopeptide bond;Mitogen;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Secreted;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 59..123;  /note=CSD	DOMAIN: In the CSD domain, Trp-63 specifically recognizes C5-methylcytosine (m5C) modification through its indole ring. {ECO:0000250|UniProtKB:P67809}.				PS00352;PS51857;	22608	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008284~positive regulation of cell proliferation,GO:0008380~RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0051781~positive regulation of cell division,GO:0070934~CRD-mediated mRNA stabilization,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0070937~CRD-mediated mRNA stability complex,GO:0071204~histone pre-mRNA 3'end processing complex,GO:1990124~messenger ribonucleoprotein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051020~GTPase binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,	PF00313:'Cold-shock' DNA-binding domain,	SSF50249:Nucleic acid-binding proteins,	2.34890137408773	0.00846347715181901	FDR<0.01	2.072451173888	295715.833333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1188	Transcription factor activity
Q7TPV4	Q7TPV4	Mybbp1a	10.13	15.848	221440000	11.8097217629553	6.47291086801735	6.53509345183636	2.23274091274449	37.7800445804526	34.0773555972057	108045666.666667	0	Mybbp1a	0	Myb-binding protein 1A (Myb-binding protein of 160 kDa)		FUNCTION: May activate or repress transcription via interactions with sequence specific DNA-binding proteins (PubMed:9447996, PubMed:11956195, PubMed:14744933). Repression may be mediated at least in part by histone deacetylase activity (HDAC activity) (PubMed:14744933). Acts as a corepressor and in concert with CRY1, represses the transcription of the core circadian clock component PER2 (PubMed:19129230). Preferentially binds to dimethylated histone H3 'Lys-9' (H3K9me2) on the PER2 promoter (PubMed:19129230). Has a role in rRNA biogenesis together with PWP1 (By similarity). {ECO:0000250|UniProtKB:Q9BQG0, ECO:0000269|PubMed:11956195, ECO:0000269|PubMed:14744933, ECO:0000269|PubMed:19129230, ECO:0000269|PubMed:9447996}.		cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleus [GO:0005634]	E-box binding [GO:0070888]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12941609}. Nucleus, nucleolus {ECO:0000269|PubMed:12941609, ECO:0000269|PubMed:19129230}. Cytoplasm {ECO:0000269|PubMed:12941609}. Note=Predominantly nucleolar. Also shuttles between the nucleus and cytoplasm. Nuclear import may be mediated by KPNA2, while export appears to depend partially on XPO1/CRM1. {ECO:0000269|PubMed:12941609}.	18432;		IPR016024;IPR007015;	PF04931;		152037	COMPBIAS 724..748;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1231..1260;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1283..1299;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..580;  /note=Interaction with MYB;  /evidence=ECO:0000269|PubMed:9447996; REGION 710..751;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1146..1344;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1152..1344;  /note=Required for nuclear and nucleolar localization;  /evidence=ECO:0000269|PubMed:12941609	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Initiator methionine (1); Modified residue (20); Motif (2); Mutagenesis (4); Region (5); Sequence conflict (5)		Acetylation;Activator;Biological rhythms;Citrullination;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation			MOTIF 238..256;  /note=Nuclear export signal 1;  /evidence=ECO:0000269|PubMed:12941609; MOTIF 261..279;  /note=Nuclear export signal 2;  /evidence=ECO:0000269|PubMed:12941609				18432	GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006913~nucleocytoplasmic transport,GO:0022904~respiratory electron transport chain,GO:0032922~circadian regulation of gene expression,GO:0042149~cellular response to glucose starvation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0071158~positive regulation of cell cycle arrest,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:2000210~positive regulation of anoikis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042564~NLS-dependent protein nuclear import complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR007015:DNA polymerase V,IPR016024:Armadillo-type fold,	PF04931:DNA polymerase phi,	SSF48371:ARM repeat,	3.47255331942286	4.12907690637902e-06	FDR<0.01	5.38414702807105	164742833.333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	12	Transcription factor activity
P11031	P11031	Sub1	2.2688	2.5881	165105000	2.0701790704896	1.86640288172605	2.66134397870925	1.41520782326885	2.06015657189946	2.03965081178102	58964833.3333333	0	Sub1	0	Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14)		FUNCTION: General coactivator that functions cooperatively with TAFs and mediates functional interactions between upstream activators and the general transcriptional machinery. May be involved in stabilizing the multiprotein transcription complex. Binds single-stranded DNA. Also binds, in vitro, non-specifically to double-stranded DNA (ds DNA).		negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus.	20024;		IPR003173;IPR009044;	PF02229;		14427	COMPBIAS 1..16;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 17..42;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 45..63;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..50;  /note=Regulatory; REGION 77..101;  /note=Interaction with ssDNA;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Modified residue (16); Region (3); Sequence conflict (1); Site (1)		Acetylation;Activator;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							20024	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0060395~SMAD protein signal transduction,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0070062~extracellular exosome,	GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003713~transcription coactivator activity,GO:0044822~poly(A) RNA binding,	IPR003173:Transcriptional coactivator p15,IPR009044:ssDNA-binding transcriptional regulator,	PF02229:Transcriptional Coactivator p15 (PC4),	SSF54447:ssDNA-binding transcriptional regulator domain,	1.06101048689666	0.000125216560198264	FDR<0.01	3.9023382308131	112034916.666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	19	Transcription factor activity
Q99020	Q99020	Hnrnpab	15.213	22.885	185836500	32.2841000807103	25.8431321876211	69.5216907675195	3.83715129887571	31.9386777387416	48.344210780759	29107233.3333333	0	Hnrnpab	0	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A)		FUNCTION: Transcriptional repressor. Binds to CArG box motifs, single-stranded and double-stranded DNA, and RNA. It may be that repression by CBF-A is a result of competitive binding of CBF, a putative positive factor, and CBF-A to the same or overlapping motifs around the CArG boxes.		epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	15384;	cd12757;	IPR012956;IPR034846;IPR012677;IPR035979;IPR000504;	PF08143;PF00076;	SM00360;	30831	COMPBIAS 1..15;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 44..65;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..65;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 239..285;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Domain (2); Modified residue (11); Region (2); Sequence conflict (2)		Acetylation;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 75..158;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 159..238;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	15384	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001837~epithelial to mesenchymal transition,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012956:CARG-binding factor, N-terminal,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08143:CBFNT (NUC161) domain,	SSF54928:RNA-binding domain, RBD,	4.59999436604412	1.54825561760371e-07	FDR<0.01	6.81015733554583	107471866.666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	21	Transcription factor activity
P60335	P60335	Pcbp1	5.8845	7.7325	130554500	17.186855492919	20.2556260001215	6.92712662787476	16.0627088152146	11.2757368694044	13.9407795683935	34663133.3333333	0	Pcbp1	0	Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1)		FUNCTION: Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. {ECO:0000250}.		mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]; translation activator activity [GO:0008494]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	23983;		IPR004087;IPR004088;IPR036612;	PF00013;	SM00322;	37498			NA							5 out of 5	Chain (1); Cross-link (1); Domain (3); Modified residue (7)		Acetylation;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 13..75;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 97..162;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 279..343;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117					PS50084;	23983	GO:0006397~mRNA processing,GO:0039694~viral RNA genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008494~translation activator activity,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:0098847~sequence-specific single stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.50570359202759	2.41338698140416e-08	FDR<0.01	7.61737303432273	82608816.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	28	Transcription factor activity
Q8VEK3	Q8VEK3;Q8VEK3-2	Hnrnpu	6.6724	9.3078	91485000	38.5401009750646	26.992010364932	24.8855265777424	14.0339059166947	18.4822385687354	18.3294535989882	56070833.3333333	0	Hnrnpu	0	Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (Scaffold-attachment factor A) (SAF-A)		FUNCTION: DNA- and RNA-binding protein involved in several cellular processes such as nuclear chromatin organization, telomere-length regulation, transcription, mRNA alternative splicing and stability, Xist-mediated transcriptional silencing and mitotic cell progression (PubMed:20833368, PubMed:21235343, PubMed:22162999, PubMed:26244333). Plays a role in the regulation of interphase large-scale gene-rich chromatin organization through chromatin-associated RNAs (caRNAs) in a transcription-dependent manner, and thereby maintains genomic stability (By similarity). Required for the localization of the long non-coding Xist RNA on the inactive chromosome X (Xi) and the subsequent initiation and maintenance of X-linked transcriptional gene silencing during X-inactivation (PubMed:20833368, PubMed:26244333). Plays a role as a RNA polymerase II (Pol II) holoenzyme transcription regulator (PubMed:21235343, PubMed:22162999). Promotes transcription initiation by direct association with the core-TFIIH basal transcription factor complex for the assembly of a functional pre-initiation complex with Pol II in a actin-dependent manner. Blocks Pol II transcription elongation activity by inhibiting the C-terminal domain (CTD) phosphorylation of Pol II and dissociates from Pol II pre-initiation complex prior to productive transcription elongation. Positively regulates CBX5-induced transcriptional gene silencing and retention of CBX5 in the nucleus. Negatively regulates glucocorticoid-mediated transcriptional activation (By similarity). Key regulator of transcription initiation and elongation in embryonic stem cells upon leukemia inhibitory factor (LIF) signaling (PubMed:21235343). Involved in the long non-coding RNA H19-mediated Pol II transcriptional repression (By similarity). Participates in the circadian regulation of the core clock component ARNTL/BMAL1 transcription (PubMed:18332112). Plays a role in the regulation of telomere length. Plays a role as a global pre-mRNA alternative splicing modulator by regulating U2 small nuclear ribonucleoprotein (snRNP) biogenesis. Plays a role in mRNA stability. Component of the CRD-mediated complex that promotes MYC mRNA stabilization. Enhances the expression of specific genes, such as tumor necrosis factor TNFA, by regulating mRNA stability, possibly through binding to the 3'-untranslated region (UTR). Plays a role in mitotic cell cycle regulation. Involved in the formation of stable mitotic spindle microtubules (MTs) attachment to kinetochore, spindle organization and chromosome congression. Phosphorylation at Ser-58 by PLK1 is required for chromosome alignement and segregation and progression through mitosis. Contributes also to the targeting of AURKA to mitotic spindle MTs. Binds to double- and single-stranded DNA and RNA, poly(A), poly(C) and poly(G) oligoribonucleotides. Binds to chromatin-associated RNAs (caRNAs). Associates with chromatin to scaffold/matrix attachment region (S/MAR) elements in a chromatin-associated RNAs (caRNAs)-dependent manner (By similarity). Binds (via RNA-binding RGG-box region) to the long non-coding Xist RNA; this binding is direct and bridges the Xist RNA and the inactive chromosome X (Xi) (PubMed:20833368, PubMed:26244333). Binds the long non-coding H19 RNA. Binds to SMN1/2 pre-mRNAs at G/U-rich regions. Binds to small nuclear RNAs (snRNAs). Binds to the 3'-UTR of TNFA mRNA (By similarity). Also negatively regulates embryonic stem cell differentiation upon LIF signaling (PubMed:21235343). Required for embryonic development (PubMed:16022389). Binds to brown fat long non-coding RNA 1 (Blnc1); facilitates the recruitment of Blnc1 by ZBTB7B required to drive brown and beige fat development and thermogenesis (PubMed:28784777). {ECO:0000250|UniProtKB:Q00839, ECO:0000269|PubMed:16022389, ECO:0000269|PubMed:18332112, ECO:0000269|PubMed:20833368, ECO:0000269|PubMed:21235343, ECO:0000269|PubMed:22162999, ECO:0000269|PubMed:26244333, ECO:0000269|PubMed:28784777}.		adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA metabolic process [GO:0016071]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]	actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II C-terminal domain binding [GO:0099122]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18332112, ECO:0000269|PubMed:22162999}. Nucleus matrix {ECO:0000250|UniProtKB:Q00839}. Chromosome {ECO:0000269|PubMed:20833368}. Nucleus speckle {ECO:0000250|UniProtKB:Q00839}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q00839}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q00839}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q00839}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:Q00839}. Midbody {ECO:0000250|UniProtKB:Q00839}. Cytoplasm {ECO:0000250|UniProtKB:Q00839}. Cell surface {ECO:0000250|UniProtKB:Q00839}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q00839}. Note=Localizes at inactive X chromosome (Xi) regions (PubMed:20833368). Localizes in the nucleus during interphase. At metaphase, localizes with mitotic spindle microtubules (MTs). At anaphase, localizes in the mitotic spindle midzone. Localizes in spindle MTs proximal to spindle poles in a TPX2- and AURKA-dependent manner. The Ser-58 phosphorylated form localizes to centrosomes during prophase and metaphase, to mitotic spindles in anaphase and to the midbody during cytokinesis (By similarity). Colocalizes with SMARCA4 in the nucleus (PubMed:22162999). Colocalizes with CBX5 in the nucleus. Colocalizes with NR3C1 in nuclear speckles. Localized in cytoplasmic ribonucleoprotein (RNP) granules containing untranslated mRNAs (By similarity). {ECO:0000250|UniProtKB:Q00839, ECO:0000269|PubMed:20833368, ECO:0000269|PubMed:22162999}.	51810;	cd12884;	IPR001870;IPR043136;IPR013320;IPR026745;IPR027417;IPR003034;IPR036361;IPR003877;IPR035778;	PF02037;PF00622;	SM00513;SM00449;	87918	COMPBIAS 78..93;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 116..148;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 151..173;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 211..253;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 647..663;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 746..774;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 41..257;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 464..648;  /note=ATPase domain;  /evidence=ECO:0000250|UniProtKB:Q00839; REGION 587..602;  /note=Actin-binding;  /evidence=ECO:0000250|UniProtKB:Q00839; REGION 647..729;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 690..715;  /note=RNA-binding RGG-box;  /evidence=ECO:0000269|PubMed:20833368, ECO:0000269|PubMed:28784777; REGION 745..774;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (6); Cross-link (14); Domain (2); Initiator methionine (1); Modified residue (32); Nucleotide binding (1); Region (6); Site (1)		ADP-ribosylation;ATP-binding;Acetylation;Activator;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Centromere;Chromatin regulator;Chromosome;Citrullination;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Developmental protein;Differentiation;Isopeptide bond;Kinetochore;Methylation;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Ribonucleoprotein;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 8..42;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186, ECO:0000269|PubMed:20833368; DOMAIN 244..440;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548	DOMAIN: The SAP domain is necessary for specific binding to nuclear scaffold/matrix attachment region (S/MAR) elements in DNA. The RNA-binding RGG-box region is necessary for its association with inactive X chromosome (Xi) regions and to chromatin-associated RNAs (caRNAs) (By similarity). Both the DNA-binding domain SAP and the RNA-binding RGG-box region are necessary for the localization of Xist RNA on the Xi (PubMed:20833368). The ATPase and RNA-binding RGG-box regions are necessary for oligomerization (By similarity). {ECO:0000250|UniProtKB:Q00839, ECO:0000269|PubMed:20833368}.				PS50188;PS50800;	51810	GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032922~circadian regulation of gene expression,GO:0048511~rhythmic process,GO:0055013~cardiac muscle cell development,GO:0070934~CRD-mediated mRNA stabilization,GO:0071549~cellular response to dexamethasone stimulus,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070937~CRD-mediated mRNA stability complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0034046~poly(G) binding,GO:0035326~enhancer binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR026745:Heterogeneous nuclear ribonucleoprotein U,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00622:SPRY domain,PF02037:SAP domain,	SSF49899:Concanavalin A-like lectins/glucanases,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.1039542675582	1.91644320691815e-08	FDR<0.01	7.71750404637442	73777916.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	33	Transcription factor activity
Q921F2	Q921F2	Tardbp	14.045	19.14	89423500	8.81911985183879	14.3787654391994	21.1505922165821	13.8253307710387	11.7401206884407	9.89805008413343	15282116.6666667	0	Tardbp	0	TAR DNA-binding protein 43 (TDP-43)		FUNCTION: RNA-binding protein that is involved in various steps of RNA biogenesis and processing. Preferentially binds, via its two RNA recognition motifs RRM1 and RRM2, to GU-repeats on RNA molecules predominantly localized within long introns and in the 3'UTR of mRNAs. In turn, regulates the splicing of many non-coding and protein-coding RNAs including proteins involved in neuronal survival, as well as mRNAs that encode proteins relevant for neurodegenerative diseases. Plays a role in maintaining mitochondrial homeostasis by regulating the processing of mitochondrial transcripts. Regulates also mRNA stability by recruiting CNOT7/CAF1 deadenylase on mRNA 3'UTR leading to poly(A) tail deadenylation and thus shortening. In response to oxidative insult, associates with stalled ribosomes localized to stress granules (SGs) and contributes to cell survival (By similarity). Participates also in the normal skeletal muscle formation and regeneration, forming cytoplasmic myo-granules and binding mRNAs that encode sarcomeric proteins (PubMed:30464263). Plays a role in the maintenance of the circadian clock periodicity via stabilization of the CRY1 and CRY2 proteins in a FBXL3-dependent manner (PubMed:27123980). Negatively regulates the expression of CDK6 (By similarity). Regulates the expression of HDAC6, ATG7 and VCP in a PPIA/CYPA-dependent manner (PubMed:25678563). {ECO:0000250|UniProtKB:Q13148, ECO:0000269|PubMed:25678563, ECO:0000269|PubMed:27123980, ECO:0000269|PubMed:30464263}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13148}. Cytoplasm {ECO:0000250|UniProtKB:Q13148, ECO:0000269|PubMed:30464263}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q13148}. Note=Continuously travels in and out of the nucleus. Localizes to stress granules in response to oxidative stress. {ECO:0000250|UniProtKB:Q13148}.	230908;		IPR012677;IPR035979;IPR000504;IPR041105;	PF00076;PF18694;	SM00360;	44548		REGION 216..414;  /note=Interaction with UBQLN2;  /evidence=ECO:0000250|UniProtKB:Q13148; REGION 261..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 341..414;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (5); Chain (1); Cross-link (6); Domain (2); Helix (2); Modified residue (3); Region (3); Sequence conflict (3); Turn (1)		3D-structure;Biological rhythms;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 104..200;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 191..262;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domains can bind to both DNA and RNA.				PS50102;	230908	GO:0001933~negative regulation of protein phosphorylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0030264~nuclear fragmentation involved in apoptotic nuclear change,GO:0032024~positive regulation of insulin secretion,GO:0034976~response to endoplasmic reticulum stress,GO:0043922~negative regulation by host of viral transcription,GO:0051726~regulation of cell cycle,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0071765~nuclear inner membrane organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005726~perichromatin fibrils,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,	GO:0000166~nucleotide binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.76367426941574	1.39807823919386e-09	FDR<0.01	8.85446852394128	52352808.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	48	Transcription factor activity
Q61656	Q61656	Ddx5	15.588	21.254	71206500	15.4954675757341	18.7733493532581	37.2120715960258	15.7366317313442	30.269092229924	21.5090768304224	31968933.3333333	0	Ddx5	0	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68)		FUNCTION: Involved in the alternative regulation of pre-mRNA splicing; its RNA helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a RBM4-dependent manner. Binds to the tau pre-mRNA in the stem-loop region downstream of exon 10. The rate of ATP hydrolysis is highly stimulated by single-stranded RNA. Involved in transcriptional regulation; the function is independent of the RNA helicase activity. Transcriptional coactivator for androgen receptor AR but probably not ESR1. Synergizes with DDX17 and SRA1 RNA to activate MYOD1 transcriptional activity and involved in skeletal muscle differentiation. Transcriptional coactivator for p53/TP53 and involved in p53/TP53 transcriptional response to DNA damage and p53/TP53-dependent apoptosis. Transcriptional coactivator for RUNX2 and involved in regulation of osteoblast differentiation. Acts as transcriptional repressor in a promoter-specific manner; the function probably involves association with histone deacetylases, such as HDAC1. As component of a large PER complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as PER1 and NR1D1 and the control of the circadian rhythms. {ECO:0000269|PubMed:17011493, ECO:0000269|PubMed:17960593, ECO:0000269|PubMed:22767893}.		alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of transcription, DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein import into nucleus [GO:0006606]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P17844}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P17844}. Cytoplasm {ECO:0000250|UniProtKB:P17844}. Note=During the G0 phase, predominantly located in the nucleus. Cytoplasmic levels increase during the G1/S phase. During the M phase, located at the vicinity of the condensed chromosomes. At G1, localizes in the cytoplasm. {ECO:0000250|UniProtKB:P17844}.			IPR011545;IPR014001;IPR001650;IPR027417;IPR012587;IPR000629;IPR014014;	PF00270;PF00271;PF08061;	SM00487;SM00490;SM01414;	69290	COMPBIAS 1..16;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 477..614;  /note=Transactivation domain;  /evidence=ECO:0000250; REGION 477..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 121;  /note=ATP;  /evidence=ECO:0000250	3.6.4.13			5 out of 5	Binding site (1); Chain (1); Compositional bias (1); Cross-link (14); Domain (2); Modified residue (7); Motif (2); Nucleotide binding (2); Region (3); Sequence conflict (4)		ATP-binding;Acetylation;Biological rhythms;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 125..300;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 328..475;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 94..122;  /note=Q motif; MOTIF 248..251;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0009299~mRNA transcription,GO:0010501~RNA secondary structure unwinding,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045069~regulation of viral genome replication,GO:0045667~regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0060765~regulation of androgen receptor signaling pathway,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0030331~estrogen receptor binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,GO:0048306~calcium-dependent protein binding,GO:0050681~androgen receptor binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012587:P68HR,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08061:P68HR (NUC004) repeat,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.38710197909731	3.77389534728316e-10	FDR<0.01	9.42321014728916	51587716.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	50	Transcription factor activity
P51859	P51859	Hdgf	13.899	18.493	82799000	13.2086437364611	7.92895654931811	6.5772165219679	2.56891103861073	35.4572208630288	40.0016000640026	19514150	0	Hdgf	0	Hepatoma-derived growth factor (HDGF)		FUNCTION: Acts as a transcriptional repressor (By similarity). Has mitogenic activity for fibroblasts (By similarity). Heparin-binding protein (By similarity). {ECO:0000250|UniProtKB:P51858}.		cellular process [GO:0009987]; cellular response to interleukin-7 [GO:0098761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P51858}. Cytoplasm {ECO:0000250|UniProtKB:P51858}. Secreted, extracellular exosome {ECO:0000269|PubMed:21087088}. Note=Secreted by exosomes and is located inside the exosome (By similarity). May also be secreted as free protein via an as yet unknown pathway (By similarity). {ECO:0000250|UniProtKB:P51858}.	15191;	cd05834;	IPR035496;IPR000313;	PF00855;	SM00293;	26269	COMPBIAS 69..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 94..108;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 110..193;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 209..223;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 69..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 19;  /note=Heparin;  /evidence=ECO:0000250; BINDING 21;  /note=Heparin;  /evidence=ECO:0000250; BINDING 72;  /note=Heparin;  /evidence=ECO:0000250; BINDING 75;  /note=Heparin;  /evidence=ECO:0000250; BINDING 79;  /note=Heparin;  /evidence=ECO:0000250; BINDING 80;  /note=Heparin;  /evidence=ECO:0000250				5 out of 5	Binding site (6); Chain (1); Compositional bias (4); Cross-link (2); Disulfide bond (1); Domain (1); Modified residue (10); Motif (2); Mutagenesis (10); Region (1); Sequence conflict (4)		Acetylation;Cytoplasm;DNA-binding;Disulfide bond;Growth factor;Heparin-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Secreted;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 12..69;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162	DOMAIN: The PWWP domain harbors the heparin-binding sites and is responsible for DNA-binding, while the C-terminal region is essentially unstructured. {ECO:0000250|UniProtKB:P51858}.; DOMAIN: The N-terminal region does not contain a typical signal sequence but is required for secretion (PubMed:21087088). It also determines exosomal location (By similarity). {ECO:0000250|UniProtKB:P51858, ECO:0000269|PubMed:21087088}.	MOTIF 75..80;  /note=Nuclear localization signal;  /evidence=ECO:0000250; MOTIF 155..170;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250			PS50812;	15191	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009987~cellular process,GO:0034504~protein localization to nucleus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,	IPR000313:PWWP,	PF00855:PWWP domain,		3.65812318372797	2.01231712068634e-06	FDR<0.01	5.69630357783496	51156575	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	51	Transcription factor activity
Q99JF8	Q99JF8;Q99JF8-2	Psip1	1.058	1.4827	41046000	3.70342937560181	2.57898130238556	4.3624307464119	1.85825249934961	9.53925403033483	9.37294966726029	24209566.6666667	0	Psip1	0	PC4 and SFRS1-interacting protein (Lens epithelium-derived growth factor) (mLEDGF)		FUNCTION: Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis (By similarity). {ECO:0000250|UniProtKB:O75475}.		mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]	heterochromatin [GO:0000792]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75475}.	101739;	cd05834;	IPR035496;IPR036218;IPR021567;IPR000313;IPR035441;	PF11467;PF00855;	SM00293;	59697	COMPBIAS 61..80;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 88..105;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 106..133;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 207..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 299..348;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 444..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 473..489;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 490..528;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 61..348;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 338..415;  /note=Integrase-binding domain (IBD);  /evidence=ECO:0000250|UniProtKB:O75475; REGION 444..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (2); Compositional bias (8); Cross-link (1); Domain (1); Modified residue (19); Motif (1); Region (3); Sequence conflict (1)		Alternative splicing;Citrullination;Coiled coil;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 7..64;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162		MOTIF 146..156;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:O75475			PS50812;	101739	GO:0000395~mRNA 5'-splice site recognition,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006979~response to oxidative stress,GO:0009408~response to heat,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0034399~nuclear periphery,GO:0035327~transcriptionally active chromatin,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0033613~activating transcription factor binding,GO:0044822~poly(A) RNA binding,GO:0097100~supercoiled DNA binding,	IPR000313:PWWP,IPR017859:Treacle-like, Treacher Collins Syndrome,IPR021567:Lens epithelium-derived growth factor (LEDGF),	PF00855:PWWP domain,PF11467:Lens epithelium-derived growth factor (LEDGF) ,		1.67583598156682	0.000864888900414961	FDR<0.01	3.06303967639134	32627783.3333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	75	Transcription factor activity
P62830	P62830	Rpl23	6.1271	4.3984	42032000	6.88610384244594	9.00738605656639	1.15366866635902	15.3902979561684	9.80296049406921	9.30752047654505	6164000	0	Rpl23	0	60S ribosomal protein L23				cellular response to actinomycin D [GO:0072717]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein-DNA complex disassembly [GO:0032986]; protein stabilization [GO:0050821]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]		65019;		IPR036853;IPR000218;IPR019972;	PF00238;	SM01374;	14865			NA							5 out of 5	Chain (1); Modified residue (2); Sequence conflict (2)		3D-structure;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00049;	65019	GO:0006412~translation,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR000218:Ribosomal protein L14b/L23e,IPR019972:Ribosomal protein L14 conserved site,	PF00238:Ribosomal protein L14p/L23e,	SSF50193:Ribosomal protein L14,	2.67109652949865	1.32071161967337e-05	FDR<0.01	4.87919200120226	24098000	Present in Nucleus	RBP	Others	Others	Others	Others	99	Transcription factor activity
O55128	O55128	Sap18	20.02	21.093	30903000	18.6528883997687	32.6968349463772	46.5354367350738	31.3568091311028	28.165047176454	14.4583887571569	10443683.3333333	0	Sap18	0	Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p18)		FUNCTION: Component of the SIN3-repressing complex. Enhances the ability of SIN3-HDAC1-mediated transcriptional repression. When tethered to the promoter, it can direct the formation of a repressive complex to core histone proteins. Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP and PSAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. The ASAP complex can inhibit mRNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits the formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function (By similarity). {ECO:0000250, ECO:0000269|PubMed:22388736}.		mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]	ASAP complex [GO:0061574]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O00422}. Cytoplasm {ECO:0000250|UniProtKB:O00422}. Nucleus speckle {ECO:0000250|UniProtKB:O00422}. Note=Shuttles between the nucleus and the cytoplasm (By similarity). Colocalizes with ACIN1 and SRSF2 in nuclear speckles (By similarity). {ECO:0000250|UniProtKB:O00422}.	20220;		IPR017250;IPR010516;IPR042534;	PF06487;		17595		REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 93..153;  /note=Involved in splicing regulation activity;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (5); Chain (1); Cross-link (1); Helix (8); Initiator methionine (1); Modified residue (1); Mutagenesis (1); Region (2); Turn (1)		3D-structure;Acetylation;Cytoplasm;Isopeptide bond;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing							20220	GO:0000183~chromatin silencing at rDNA,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043065~positive regulation of apoptotic process,GO:0048025~negative regulation of mRNA splicing, via spliceosome,	GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035145~exon-exon junction complex,GO:0061574~ASAP complex,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR010516:Sin3 associated polypeptide p18,IPR017250:Histone deacetylase complex, SAP18 subunit,	PF06487:Sin3 associated polypeptide p18 (SAP18),		4.64438778162246	3.98203103417557e-10	FDR<0.01	9.39989535959774	20673341.6666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	113	Transcription factor activity
Q9JJ80	Q9JJ80	Rpf2	10.021	12.421	17604300	32.2414237812742	27.8691265815729	10.6241699867198	11.4710470771772	30.9827735778907	29.1953754525283	12504563.3333333	0	Rpf2	0	Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog)		FUNCTION: Involved in ribosomal large subunit assembly. May regulate the localization of the 5S RNP/5S ribonucleoprotein particle to the nucleolus. {ECO:0000250|UniProtKB:Q9H7B2}.		maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H7B2}. Note=Associated with the nucleolus in an RNA-dependent manner. {ECO:0000250|UniProtKB:Q9H7B2}.	67239;		IPR007109;IPR039770;	PF04427;	SM00879;	35364	COMPBIAS 272..300;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 270..306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Domain (1); Region (1); Sequence conflict (2)		Nucleus;Reference proteome;Ribosome biogenesis	DOMAIN 31..234;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	67239	GO:0000027~ribosomal large subunit assembly,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR007109:Brix domain,	PF04427:Brix domain,		4.19017114995156	9.66054832696666e-09	FDR<0.01	8.0149982225889	15054431.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	154	Transcription factor activity
P61979	P61979;P61979-2	Hnrnpk	17.005	38.11	27113500	NA	6.28575020428688	4.24700586086809	NA	NA	7.88146279949559	67796.8333333333	3	Hnrnpk	0	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)		FUNCTION: One of the major pre-mRNA-binding proteins. Binds tenaciously to poly(C) sequences. Likely to play a role in the nuclear metabolism of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich sequences. Can also bind poly(C) single-stranded DNA. Plays an important role in p53/TP53 response to DNA damage, acting at the level of both transcription activation and repression. When sumoylated, acts as a transcriptional coactivator of p53/TP53, playing a role in p21/CDKN1A and 14-3-3 sigma/SFN induction (By similarity). As far as transcription repression is concerned, acts by interacting with long intergenic RNA p21 (lincRNA-p21), a non-coding RNA induced by p53/TP53. This interaction is necessary for the induction of apoptosis, but not cell cycle arrest. {ECO:0000250, ECO:0000269|PubMed:20673990}.		cellular response to forskolin [GO:1904322]; cellular response to insulin stimulus [GO:0032869]; cerebral cortex development [GO:0021987]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of gene expression [GO:0010629]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle development [GO:0001541]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of RNA splicing [GO:0033120]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of postsynapse organization [GO:0099175]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]	axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-DNA complex [GO:0032993]	actinin binding [GO:0042805]; ATPase binding [GO:0051117]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; C-rich single-stranded DNA binding [GO:1990829]; double-stranded DNA binding [GO:0003690]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA 3'-splice site binding [GO:0030628]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61978}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P61978}. Cell projection, podosome {ECO:0000250|UniProtKB:P61978}.	15387;		IPR033090;IPR004087;IPR004088;IPR036612;IPR012987;	PF00013;PF08067;	SM00322;	50976	COMPBIAS 19..37;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..276;  /note=Necessary for interaction with DDX1;  /evidence=ECO:0000250; REGION 1..37;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 54..421;  /note=2 X 22 AA approximate repeats; REGION 59..407;  /note=5 X 4 AA repeats of G-X-G-G; REGION 209..337;  /note=Interaction with ZIK1;  /evidence=ECO:0000269|PubMed:8910362; REGION 236..273;  /note=RNA-binding RGG-box; REGION 245..329;  /note=2 X 6 AA approximate repeats; REGION 250..329;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (11); Domain (3); Modified residue (17); Region (8); Repeat (9); Sequence conflict (5)		Acetylation;Activator;Alternative splicing;Cell junction;Cell projection;Cytoplasm;DNA-binding;Direct protein sequencing;Glycoprotein;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ribonucleoprotein;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 42..104;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 144..209;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 387..451;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117			REPEAT 54..76;  /note=1-1; REPEAT 59..62;  /note=3-1; REPEAT 245..250;  /note=2-1; REPEAT 257..260;  /note=3-2; REPEAT 267..270;  /note=3-3; REPEAT 295..298;  /note=3-4; REPEAT 324..329;  /note=2-2; REPEAT 399..421;  /note=1-2; REPEAT 404..407;  /note=3-5		PS50084;	15387	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001541~ovarian follicle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0010988~regulation of low-density lipoprotein particle clearance,GO:0021987~cerebral cortex development,GO:0032091~negative regulation of protein binding,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0045716~positive regulation of low-density lipoprotein particle receptor biosynthetic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050806~positive regulation of synaptic transmission,GO:0060999~positive regulation of dendritic spine development,GO:0072369~regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,GO:0090129~positive regulation of synapse maturation,GO:1900273~positive regulation of long-term synaptic potentiation,GO:1902165~regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1903861~positive regulation of dendrite extension,GO:1904322~cellular response to forskolin,GO:2000010~positive regulation of protein localization to cell surface,GO:2000173~negative regulation of branching morphogenesis of a nerve,	GO:0000790~nuclear chromatin,GO:0002102~podosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032993~protein-DNA complex,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0043679~axon terminus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0031072~heat shock protein binding,GO:0042805~actinin binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990715~mRNA CDS binding,GO:1990829~C-rich single-stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR009019:K homology domain, prokaryotic type,IPR012987:ROK, N-terminal,	PF00013:KH domain,PF08067:ROKNT (NUC014) domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),SSF54814:Prokaryotic type KH domain (KH-domain type II),	3.41139585257683	8.74190584299064e-05	FDR<0.01	4.05839387550478	13590648.4166667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	172	Transcription factor activity
P53569	P53569;P53569-2	Cebpz	6.8626	10.042	15981500	4.49337227589306	2.47628952777159	4.04776361060514	1.6095284081764	26.335887914461	8.19269211863018	9163850	0	Cebpz	0	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)		FUNCTION: Stimulates transcription from the HSP70 promoter.		positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus.	12607;		IPR016024;IPR005612;IPR040155;	PF03914;		120262	COMPBIAS 122..146;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 629..643;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 644..677;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 887..931;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 939..969;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 122..158;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 621..677;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 876..969;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1032..1052;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Frameshift (2); Modified residue (6); Region (5); Sequence conflict (15)		Activator;Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							12607	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR016024:Armadillo-type fold,	PF03914:CBF/Mak21 family,	SSF48371:ARM repeat,	2.504970933125	5.09751645727196e-05	FDR<0.01	4.29264136343293	12572675	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	188	Transcription factor activity
P48432	P48432;Q04892;Q811W0;P53784;P53783;Q05738	Sox2	3.3563	3.2876	13448500	9.14662032379036	8.60141063134354	NA	NA	NA	9.94826900119379	4929766.66666667	3	Sox2	0	Transcription factor SOX-2	DNA_BIND 43..111;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Transcription factor that forms a trimeric complex with POU5F1 (OCT3/4) on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (PubMed:15863505, PubMed:17097055, PubMed:19740739). Binds to the proximal enhancer region of NANOG (PubMed:15863505). Critical for early embryogenesis and for embryonic stem cell pluripotency (By similarity). Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (PubMed:22198669). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). May function as a switch in neuronal development (By similarity). {ECO:0000250|UniProtKB:P48430, ECO:0000250|UniProtKB:P48431, ECO:0000269|PubMed:15863505, ECO:0000269|PubMed:17097055, ECO:0000269|PubMed:19740739, ECO:0000269|PubMed:22198669}.		adenohypophysis development [GO:0021984]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cellular response to cadmium ion [GO:0071276]; cerebral cortex development [GO:0021987]; detection of mechanical stimulus involved in equilibrioception [GO:0050973]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; diencephalon morphogenesis [GO:0048852]; embryonic organ development [GO:0048568]; endodermal cell fate specification [GO:0001714]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; male genitalia development [GO:0030539]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuronal stem cell population maintenance [GO:0097150]; neuron fate commitment [GO:0048663]; olfactory placode formation [GO:0030910]; osteoblast differentiation [GO:0001649]; pigment biosynthetic process [GO:0046148]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell differentiation [GO:0045597]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to growth factor [GO:0070848]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]; retina morphogenesis in camera-type eye [GO:0060042]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267, ECO:0000269|PubMed:17097055, ECO:0000269|PubMed:32127020}.	20674;		IPR009071;IPR036910;IPR032643;IPR022097;	PF00505;PF12336;	SM00398;	34454	COMPBIAS 247..266;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 247..267;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 299..319;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); DNA binding (1); Helix (3); Modified residue (1); Mutagenesis (1); Region (3); Sequence conflict (3)		3D-structure;Activator;DNA-binding;Developmental protein;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation						PS50118;	20674	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001649~osteoblast differentiation,GO:0001654~eye development,GO:0001708~cell fate specification,GO:0001714~endodermal cell fate specification,GO:0002052~positive regulation of neuroblast proliferation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0007275~multicellular organism development,GO:0007605~sensory perception of sound,GO:0010033~response to organic substance,GO:0010468~regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0021879~forebrain neuron differentiation,GO:0021984~adenohypophysis development,GO:0021987~cerebral cortex development,GO:0022409~positive regulation of cell-cell adhesion,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030539~male genitalia development,GO:0030858~positive regulation of epithelial cell differentiation,GO:0030910~olfactory placode formation,GO:0032526~response to retinoic acid,GO:0035019~somatic stem cell population maintenance,GO:0042246~tissue regeneration,GO:0042472~inner ear morphogenesis,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043586~tongue development,GO:0045165~cell fate commitment,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046148~pigment biosynthetic process,GO:0048286~lung alveolus development,GO:0048568~embryonic organ development,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048663~neuron fate commitment,GO:0048839~inner ear development,GO:0048852~diencephalon morphogenesis,GO:0048863~stem cell differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0050973~detection of mechanical stimulus involved in equilibrioception,GO:0060042~retina morphogenesis in camera-type eye,GO:0060235~lens induction in camera-type eye,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0070848~response to growth factor,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0044798~nuclear transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0031490~chromatin DNA binding,GO:0035198~miRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR009071:High mobility group (HMG) box domain,IPR022097:Transcription factor SOX,	PF00505:HMG (high mobility group) box,PF12336:SOX transcription factor,	SSF47095:HMG-box,	2.6152328038801	7.96808483546751e-05	FDR<0.01	4.09864605066628	9189133.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	235	Transcription factor activity
P68037	P68037	Ube2l3	6.3857	8.4776	10616150	24.1645119976802	1.17076825813099	NA	NA	10.2117925780692	8.19873739444126	7469671.66666667	2	Ube2l3	0	Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (UbcM4) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3)		FUNCTION: Ubiquitin-conjugating enzyme E2 that specifically acts with HECT-type and RBR family E3 ubiquitin-protein ligases. Does not function with most RING-containing E3 ubiquitin-protein ligases because it lacks intrinsic E3-independent reactivity with lysine: in contrast, it has activity with the RBR family E3 enzymes, such as PRKN and ARIH1, that function like RING-HECT hybrids. Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-linked polyubiquitination. Involved in the selective degradation of short-lived and abnormal proteins. Down-regulated during the S-phase it is involved in progression through the cell cycle. Regulates nuclear hormone receptors transcriptional activity. May play a role in myelopoiesis. {ECO:0000250|UniProtKB:P68036}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.	cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P68036}. Cytoplasm {ECO:0000250|UniProtKB:P68036}.	22195;	cd00195;	IPR000608;IPR023313;IPR016135;	PF00179;		17862			NA	ACT_SITE 86;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133			2.3.2.23			5 out of 5	Active site (1); Chain (1); Domain (1); Modified residue (1); Sequence conflict (1)		ATP-binding;Acetylation;Cytoplasm;Nucleotide-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway	DOMAIN 2..149;  /note=UBC core;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00388	DOMAIN: In contrast to other ubiquitin-conjugating enzymes E2, residues essential for lysine reactivity are absent: Pro and a His residues are present instead of an Asp and an Asp residues in positions 88 and 119, respectively. {ECO:0000250|UniProtKB:P68036}.				PS00183;PS50127;	22195	GO:0000209~protein polyubiquitination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008283~cell proliferation,GO:0016567~protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0044770~cell cycle phase transition,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0070979~protein K11-linked ubiquitination,GO:0071383~cellular response to steroid hormone stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003713~transcription coactivator activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0061631~ubiquitin conjugating enzyme activity,GO:0097027~ubiquitin-protein transferase activator activity,	IPR000608:Ubiquitin-conjugating enzyme, E2,IPR016135:Ubiquitin-conjugating enzyme/RWD-like,IPR023313:Ubiquitin-conjugating enzyme, active site,	PF00179:Ubiquitin-conjugating enzyme,	SSF54495:UBC-like,	2.82805669189887	0.000254572747112378	FDR<0.01	3.59418809091103	9042910.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	237	Transcription factor activity
Q8K4L0	Q8K4L0	Ddx54	6.6069	6.0712	5483400	22.1985437755283	13.366660874447	11.7387425458985	3.68351259761308	11.6889340861007	17.2968485142007	10682426.6666667	0	Ddx54	0	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54)		FUNCTION: Has RNA-dependent ATPase activity. Represses the transcriptional activity of nuclear receptors (By similarity). {ECO:0000250}.		RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]	Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	71990;		IPR012541;IPR033517;IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF08147;PF00270;PF00271;	SM01123;SM00487;SM00490;	97748	COMPBIAS 590..627;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 657..684;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 721..747;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 759..779;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 813..827;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..76;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 581..687;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 712..874;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (5); Domain (2); Modified residue (9); Motif (2); Nucleotide binding (1); Region (3)		ATP-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation	DOMAIN 126..298;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 328..472;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 95..123;  /note=Q motif; MOTIF 246..249;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	71990	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0010501~RNA secondary structure unwinding,GO:0016070~RNA metabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005102~receptor binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0030331~estrogen receptor binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012541:DBP10CT,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08147:DBP10CT (NUC160) domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.32908905797461	2.13940887668119e-07	FDR<0.01	6.66970620658473	8082913.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	254	Transcription factor activity
Q91WJ8	Q91WJ8;Q91WJ8-2	Fubp1	8.9577	24.513	12419650	12.9132231404959	5.67794685441744	9.87459267305224	NA	5.72704885172671	7.6499388004896	1518235	1	Fubp1	0	Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1)		FUNCTION: Regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter. May act both as activator and repressor of transcription (By similarity). {ECO:0000250}.		developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of gene expression [GO:0010628]; positive regulation of Schwann cell migration [GO:1900149]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.			IPR015096;IPR004087;IPR004088;IPR036612;	PF09005;PF00013;	SM00322;	68540	COMPBIAS 448..501;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 555..569;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 40..92;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 443..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 545..574;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..651;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (8); Chain (1); Compositional bias (2); Domain (4); Helix (6); Initiator methionine (1); Modified residue (12); Region (5); Sequence conflict (1); Turn (1)		3D-structure;Acetylation;Alternative splicing;DNA-binding;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 96..160;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 181..247;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 271..335;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 372..439;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117					PS50084;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0017145~stem cell division,GO:0071425~hematopoietic stem cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,	GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,	PF00013:KH domain,PF09005:Domain of unknown function (DUF1897),	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.24738734853091	4.79813428516071e-07	FDR<0.01	6.31892760161867	6968942.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	285	Transcription factor activity
Q9WV70	Q9WV70	Noc2l	2.5351	3.2375	7702850	2.81317692069654	2.15559052402406	3.92726701488434	1.7580562929625	8.56091088091773	7.11136395960745	6138150	0	Noc2l	0	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)		FUNCTION: Acts as an inhibitor of histone acetyltransferase activity; prevents acetylation of all core histones by the EP300/p300 histone acetyltransferase at p53/TP53-regulated target promoters in a histone deacetylases (HDAC)-independent manner. Acts as a transcription corepressor of p53/TP53- and TP63-mediated transactivation of the p21/CDKN1A promoter. Involved in the regulation of p53/TP53-dependent apoptosis (By similarity). {ECO:0000250}.		apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	chromosome [GO:0005694]; cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Note=Translocates from the nucleoli to the nucleoplasm in presence of several stressors like ultraviolet irradiation and actinomycin-D. Predominantly detected in the nucleoli in non-mitotic cells. Predominantly detected in nucleoplasma in cells undergoing mitosis (By similarity). {ECO:0000250}.			IPR016024;IPR005343;	PF03715;		85424	COMPBIAS 32..49;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 64..84;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 98..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 669..701;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 702..721;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 23..84;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 98..145;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 669..747;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Modified residue (4); Region (3); Sequence conflict (3)		Apoptosis;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation							NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002903~negative regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0031497~chromatin assembly,GO:0032066~nucleolus to nucleoplasm transport,GO:0034644~cellular response to UV,GO:0035067~negative regulation of histone acetylation,GO:0042273~ribosomal large subunit biogenesis,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030690~Noc1p-Noc2p complex,GO:0030691~Noc2p-Noc3p complex,	GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0031491~nucleosome binding,GO:0031493~nucleosomal histone binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,GO:0070491~repressing transcription factor binding,	IPR005343:Nucleolar complex protein 2,IPR016024:Armadillo-type fold,	PF03715:Noc2p family,	SSF48371:ARM repeat,	1.79407548070575	5.25949368029321e-05	FDR<0.01	4.27905606239353	6920500	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	288	Transcription factor activity
Q9CSN1	Q9CSN1	Snw1	116	17.328	8740500	5.7332874670336	6.78932717767669	3.34224598930481	3.84083576586265	7.42390497401633	10.9723715683908	3596443.33333333	0	Snw1	0	SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Is required in the specific splicing of CDKN1A pre-mRNA; the function probably involves the recruitment of U2AF2 to the mRNA. Is proposed to recruit PPIL1 to the spliceosome. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in transcriptional regulation. Modulates TGF-beta-mediated transcription via association with SMAD proteins, MYOD1-mediated transcription via association with PABPN1, RB1-mediated transcriptional repression, and retinoid-X receptor (RXR)- and vitamin D receptor (VDR)-dependent gene transcription in a cell line-specific manner probably involving coactivators NCOA1 and GRIP1. Is involved in NOTCH1-mediated transcriptional activation. Binds to multimerized forms of Notch intracellular domain (NICD) and is proposed to recruit transcriptional coactivators such as MAML1 to form an intermediate preactivation complex which associates with DNA-bound CBF-1/RBPJ to form a transcriptional activation complex by releasing SNW1 and redundant NOTCH1 NICD. {ECO:0000250|UniProtKB:Q13573}.		cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; Notch binding [GO:0005112]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13573}.	66354;		IPR017862;IPR004015;	PF02731;		61475	COMPBIAS 1..17;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 467..530;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 59..79;  /note=Interaction with PPIL1;  /evidence=ECO:0000250; REGION 174..339;  /note=SNW; REGION 212..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 311..386;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 467..536;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (17); Initiator methionine (1); Modified residue (10); Region (6)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing							66354	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007219~Notch signaling pathway,GO:0008380~RNA splicing,GO:0014010~Schwann cell proliferation,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0035914~skeletal muscle cell differentiation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043923~positive regulation by host of viral transcription,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048384~retinoic acid receptor signaling pathway,GO:0048385~regulation of retinoic acid receptor signaling pathway,GO:0050769~positive regulation of neurogenesis,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0070562~regulation of vitamin D receptor signaling pathway,GO:0070564~positive regulation of vitamin D receptor signaling pathway,GO:0071300~cellular response to retinoic acid,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016363~nuclear matrix,GO:0071013~catalytic step 2 spliceosome,GO:0071141~SMAD protein complex,GO:0071146~SMAD3-SMAD4 protein complex,	GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0035257~nuclear hormone receptor binding,GO:0042809~vitamin D receptor binding,GO:0042974~retinoic acid receptor binding,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,	IPR004015:SKI-interacting protein SKIP, SNW domain,IPR017862:SKI-interacting protein, SKIP,	PF02731:SKIP/SNW domain,		3.28573317298295	3.40400721357605e-05	FDR<0.01	4.46800952825462	6168471.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	314	Transcription factor activity
Q80WJ7	Q80WJ7	Mtdh	13.027	6.2583	1613000	17.3882802990784	11.4311842706904	9.23275782476226	4.02463074012959	24.9413877388138	12.1270919233568	6487850	0	Mtdh	0	Protein LYRIC (3D3/LYRIC) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein)		FUNCTION: Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF-kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance (By similarity). {ECO:0000250}.		bicellular tight junction assembly [GO:0070830]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA polymerase II transcription factor binding [GO:0001085]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Nucleus membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}. Cell junction, tight junction {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}. Note=In epithelial cells, recruited to tight junctions (TJ) during the maturation of the TJ complexes. A nucleolar staining may be due to nuclear targeting of an isoform lacking the transmembrane domain. TNF-alpha causes translocation from the cytoplasm to the nucleus (By similarity). {ECO:0000250}.	67154;		IPR031402;	PF15686;		63846	COMPBIAS 105..143;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 170..198;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 277..302;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..334;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 341..366;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 418..437;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 450..476;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 485..499;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 519..563;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..71;  /note=Activation of NF-kappa-B;  /evidence=ECO:0000250; REGION 72..168;  /note=Interaction with BCCIP;  /evidence=ECO:0000250; REGION 78..222;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 100..204;  /note=Interaction with RELA;  /evidence=ECO:0000250; REGION 277..579;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 378..440;  /note=Lung-homing for mammary tumors	NA							5 out of 5	Chain (1); Compositional bias (9); Modified residue (16); Region (6); Sequence conflict (4); Topological domain (2); Transmembrane (1)		Acetylation;Cell junction;Cytoplasm;Endoplasmic reticulum;Membrane;Nucleus;Phosphoprotein;Reference proteome;Tight junction;Transmembrane;Transmembrane helix							67154	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0010508~positive regulation of autophagy,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0043066~negative regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045766~positive regulation of angiogenesis,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051897~positive regulation of protein kinase B signaling,GO:0070830~bicellular tight junction assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005923~bicellular tight junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0016604~nuclear body,GO:0030054~cell junction,GO:0031965~nuclear membrane,GO:0046581~intercellular canaliculus,GO:0048471~perinuclear region of cytoplasm,	GO:0001085~RNA polymerase II transcription factor binding,GO:0003713~transcription coactivator activity,GO:0003725~double-stranded RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,				3.43004996828985	1.1589795703688e-07	FDR<0.01	6.93592421938955	4050425	Present in Nucleus	RBP	Others	Others	Others	Others	422	Transcription factor activity
P20263	P20263	Pou5f1	7.0452	8.4848	3930800	6.8865780593623	6.80642526545059	17.8897277183441	NA	6.43086816720257	6.25273557181267	4028025	1	Pou5f1	0	POU domain, class 5, transcription factor 1 (NF-A3) (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3)	DNA_BIND 223..282;  /note=Homeobox;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000269|PubMed:23376973	FUNCTION: Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') (PubMed:1972777, PubMed:1690859, PubMed:1967980, PubMed:17525163, PubMed:23376973). Forms a trimeric complex with SOX2 or SOX15 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (PubMed:15863505, PubMed:17097055, PubMed:17496161, PubMed:19740739). Critical for early embryogenesis and for embryonic stem cell pluripotency (PubMed:1972777, PubMed:1690859, PubMed:17496161, PubMed:18662995, PubMed:19740739, PubMed:29153991, PubMed:23376973). {ECO:0000269|PubMed:15863505, ECO:0000269|PubMed:1690859, ECO:0000269|PubMed:17097055, ECO:0000269|PubMed:17496161, ECO:0000269|PubMed:17525163, ECO:0000269|PubMed:18662995, ECO:0000269|PubMed:1967980, ECO:0000269|PubMed:1972777, ECO:0000269|PubMed:19740739, ECO:0000269|PubMed:23376973, ECO:0000269|PubMed:29153991}.		blastocyst development [GO:0001824]; blastocyst growth [GO:0001832]; BMP signaling pathway involved in heart induction [GO:0003130]; cardiac cell fate determination [GO:0060913]; cell fate commitment [GO:0045165]; cell fate commitment involved in formation of primary germ layer [GO:0060795]; cellular response to leukemia inhibitory factor [GO:1990830]; ectodermal cell fate commitment [GO:0001712]; endodermal cell fate commitment [GO:0001711]; endodermal cell fate specification [GO:0001714]; germ-line stem cell population maintenance [GO:0030718]; mesodermal cell fate commitment [GO:0001710]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell differentiation [GO:0045596]; negative regulation of gene expression [GO:0010629]; negative regulation of gene silencing by miRNA [GO:0060965]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of asymmetric cell division [GO:0009786]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]; regulation of gene expression [GO:0010468]; regulation of heart induction by regulation of canonical Wnt signaling pathway [GO:0090081]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; cytokine binding [GO:0019955]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; miRNA binding [GO:0035198]; POU domain binding [GO:0070974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q01860}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00530, ECO:0000269|PubMed:17496161, ECO:0000269|PubMed:17525163, ECO:0000269|PubMed:29153991}. Note=Expressed in a diffuse and slightly punctuate pattern (By similarity). Colocalizes with MAPK8 and MAPK9 in the nucleus (PubMed:29153991). {ECO:0000250|UniProtKB:Q01860, ECO:0000269|PubMed:29153991}.	18999;	cd00086;	IPR009057;IPR017970;IPR001356;IPR010982;IPR013847;IPR000327;IPR015585;	PF00046;PF00157;	SM00389;SM00352;	38216	COMPBIAS 94..109;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 91..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 173..179;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P; REGION 186..189;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P	NA			BINDING 150;  /note=DNA;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P; BINDING 157;  /note=DNA;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P				5 out of 5	Beta strand (1); Binding site (2); Chain (1); Compositional bias (1); Cross-link (1); DNA binding (1); Domain (1); Helix (8); Modified residue (5); Mutagenesis (17); Region (4); Sequence conflict (4); Turn (1)		3D-structure;Cytoplasm;DNA-binding;Developmental protein;Homeobox;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 131..205;  /note=POU-specific;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00530	DOMAIN: The POU-specific domain mediates interaction with PKM. {ECO:0000250|UniProtKB:Q01860}.				PS00027;PS50071;PS00035;PS00465;PS51179;	18999	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001710~mesodermal cell fate commitment,GO:0001711~endodermal cell fate commitment,GO:0001712~ectodermal cell fate commitment,GO:0001714~endodermal cell fate specification,GO:0001824~blastocyst development,GO:0001827~inner cell mass cell fate commitment,GO:0001829~trophectodermal cell differentiation,GO:0001832~blastocyst growth,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0009786~regulation of asymmetric cell division,GO:0010033~response to organic substance,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0030718~germ-line stem cell population maintenance,GO:0032526~response to retinoic acid,GO:0034097~response to cytokine,GO:0035019~somatic stem cell population maintenance,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0045165~cell fate commitment,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0048863~stem cell differentiation,GO:0051897~positive regulation of protein kinase B signaling,GO:0051898~negative regulation of protein kinase B signaling,GO:0060965~negative regulation of gene silencing by miRNA,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,GO:0044798~nuclear transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001158~enhancer sequence-specific DNA binding,GO:0001162~RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019955~cytokine binding,GO:0031490~chromatin DNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0035198~miRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0070974~POU domain binding,GO:0071837~HMG box domain binding,	IPR000327:POU-specific,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013847:POU domain,IPR015585:POU domain-containing protein, class 5,IPR017970:Homeobox, conserved site,	PF00046:Homeobox domain,PF00157:Pou domain - N-terminal to homeobox domain,	SSF46689:Homeodomain-like,SSF47413:lambda repressor-like DNA-binding domains,	2.99182377739308	2.31694899245536e-07	FDR<0.01	6.63508352708141	3979412.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	426	Transcription factor activity
A2AQ19	A2AQ19	Rtf1	10.292	12.042	6316600	1.9300548135567	1.80956172415041	2.52652854977261	1.31304245066243	1.49164677804296	1.54731695240453	1144628.33333333	0	Rtf1	0	RNA polymerase-associated protein RTF1 homolog		FUNCTION: Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. Binds single-stranded DNA (By similarity). Required for maximal induction of heat-shock genes. Required for the trimethylation of histone H3 'Lys-4' (H3K4me3) on genes involved in stem cell pluripotency; this function is synergistic with CXXC1 indicative for an involvement of a SET1 complex. {ECO:0000250, ECO:0000269|PubMed:19345177}.		blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]	RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	76246;		IPR004343;IPR036128;	PF03126;	SM00719;	80797	COMPBIAS 72..88;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 116..130;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 136..174;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 175..190;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 191..218;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 243..258;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 266..305;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 329..353;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 700..715;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 28..218;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 233..362;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 632..654;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 679..715;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (9); Domain (1); Erroneous initiation (2); Modified residue (5); Region (4)		Activator;Coiled coil;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Wnt signaling pathway	DOMAIN 358..489;  /note=Plus3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00693	DOMAIN: The Plus3 domain mediates single-stranded DNA-binding. {ECO:0000250}.				PS51360;	76246	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0001832~blastocyst growth,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0019827~stem cell population maintenance,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016593~Cdc73/Paf1 complex,	GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0044822~poly(A) RNA binding,GO:1990269~RNA polymerase II C-terminal domain phosphoserine binding,	IPR004343:Plus-3,	PF03126:Plus-3 domain,	SSF159042:Plus3-like,	1.46181018129543	0.00360214706094982	FDR<0.01	2.44343856068493	3730614.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	444	Transcription factor activity
P50580	P50580	Pa2g4	15.025	18.507	1302350	10.9967449634908	10.3225806451613	3.2147105153181	3.13440320962889	12.6903553299492	8.781944322473	6021125	0	Pa2g4	0	Proliferation-associated protein 2G4 (IRES-specific cellular trans-acting factor 45 kDa) (ITAF45) (Mpp1) (Proliferation-associated protein 1) (Protein p38-2G4)		FUNCTION: May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly (By similarity). Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site). Together with PTBP1 is required for the translation initiation on the foot-and-mouth disease virus (FMDV) IRES. Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity). {ECO:0000250|UniProtKB:Q6AYD3, ECO:0000250|UniProtKB:Q9UQ80, ECO:0000269|PubMed:10950867, ECO:0000269|PubMed:17690690}.		negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm {ECO:0000250|UniProtKB:Q9UQ80}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9UQ80}. Note=Phosphorylation at Ser-361 by PKC/PRKCD regulates its nucleolar localization. {ECO:0000250|UniProtKB:Q9UQ80}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:7556453}.	18813;		IPR036005;IPR004545;IPR000994;IPR018349;IPR036388;IPR036390;	PF00557;		43699		REGION 2..48;  /note=Necessary for nucleolar localization;  /evidence=ECO:0000250|UniProtKB:Q9UQ80; REGION 46..54;  /note=RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q9UQ80; REGION 301..394;  /note=Necessary for nucleolar localization;  /evidence=ECO:0000250|UniProtKB:Q9UQ80; REGION 358..394;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 361..375;  /note=Interaction with RNA;  /evidence=ECO:0000269|PubMed:17690690	NA							5 out of 5	Alternative sequence (1); Beta strand (13); Chain (1); Cross-link (1); Helix (10); Initiator methionine (1); Modified residue (6); Mutagenesis (1); Region (5); Sequence conflict (2); Turn (1)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Ribonucleoprotein;Transcription;Transcription regulation;Translation regulation;Ubl conjugation;rRNA processing						PS01202;	18813	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006417~regulation of translation,GO:0043066~negative regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,	IPR000994:Peptidase M24, structural domain,IPR004545:Proliferation-associated protein 1,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018349:Peptidase M24A, methionine aminopeptidase, subfamily 2, binding site,	PF00557:Metallopeptidase family M24,	SSF46785:Winged helix DNA-binding domain,SSF55920:Creatinase/aminopeptidase,	3.13488865225758	8.84521131203432e-07	FDR<0.01	6.05329178733829	3661737.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	449	Transcription factor activity
Q91YK2	Q91YK2	Rrp1b	23.83	30.772	5034400	8.5755938598748	8.04052424218059	6.36010939388157	6.41190048730444	11.1658236469813	8.53898044573478	2100735	0	Rrp1b	0	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)		FUNCTION: Positively regulates DNA damage-induced apoptosis by acting as a transcriptional coactivator of proapoptotic target genes of the transcriptional activator E2F1 (By similarity). Likely to play a role in ribosome biogenesis by targeting serine/threonine protein phosphatase PP1 to the nucleolus (By similarity). Involved in regulation of mRNA splicing (PubMed:23604122). Inhibits SIPA1 GTPase activity (PubMed:18081427). Involved in regulating expression of extracellular matrix genes (PubMed:18081427). Associates with chromatin and may play a role in modulating chromatin structure (By similarity). {ECO:0000250|UniProtKB:Q14684, ECO:0000269|PubMed:18081427, ECO:0000269|PubMed:23604122}.		apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]	transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q14684}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q14684}. Chromosome {ECO:0000250|UniProtKB:Q14684}. Note=Predominantly located in the nucleolus with a small amount found in the nucleoplasm. Associates with the perichromatin region during metaphase and with cytoplasmic foci during telophase before reaccumulation in the nucleolus during G2. Associates with heterochromatin and euchromatin. {ECO:0000250|UniProtKB:Q14684}.	72462;		IPR010301;	PF05997;		80582	COMPBIAS 353..374;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 409..444;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 446..463;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 470..498;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 516..534;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..560;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..649;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 691..708;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 331..576;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..649;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 687..724;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Modified residue (12); Region (3); Sequence conflict (2)		Acetylation;Activator;Apoptosis;Chromosome;Citrullination;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;mRNA processing;mRNA splicing							72462	GO:0006364~rRNA processing,GO:0010923~negative regulation of phosphatase activity,	GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0030687~preribosome, large subunit precursor,GO:0030688~preribosome, small subunit precursor,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR010301:Nucleolar, Nop52,	PF05997:Nucleolar protein,Nop52,		3.44383308901933	1.47748428962362e-07	FDR<0.01	6.83047712835943	3567567.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	461	Transcription factor activity
Q8CGF7	Q8CGF7;Q8CGF7-2;Q8CGF7-3;Q3B807-3;Q3B807	Tcerg1	13.637	12.285	4596750	12.3148159550756	9.03832248734635	3.72328542706084	6.55093350802489	12.0614167340096	8.24742268041237	1789273	0	Tcerg1	0	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)		FUNCTION: Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	56070;	cd00201;	IPR002713;IPR036517;IPR001202;IPR036020;	PF01846;PF00397;	SM00441;SM00456;	123788	COMPBIAS 36..90;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 258..329;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..486;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 498..522;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 620..642;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 258..332;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 461..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 616..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 872..897;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1078..1100;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Beta strand (7); Chain (1); Coiled coil (3); Compositional bias (5); Cross-link (3); Domain (9); Erroneous initiation (1); Modified residue (8); Motif (1); Natural variant (1); Region (6); Sequence conflict (3); Turn (3)		3D-structure;Alternative splicing;Coiled coil;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 131..164;  /note=WW 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00224; DOMAIN 431..464;  /note=WW 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00224; DOMAIN 530..563;  /note=WW 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00224; DOMAIN 661..714;  /note=FF 1; DOMAIN 727..781;  /note=FF 2; DOMAIN 793..848;  /note=FF 3; DOMAIN 898..954;  /note=FF 4; DOMAIN 956..1012;  /note=FF 5; DOMAIN 1014..1079;  /note=FF 6	DOMAIN: The FF domains preferentially binds peptides with the consensus sequence [DE](2-5)-[FWY]-[DE](2-5) and mediate interaction with HTATSF1 and probably bind the phosphorylated C-terminus of the largest subunit of RNA polymerase II. {ECO:0000269|PubMed:15485897}.; DOMAIN: The WW domains bind Pro-rich domains. {ECO:0000269|PubMed:15485897}.	MOTIF 628..632;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS51676;PS01159;PS50020;	56070	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0015629~actin cytoskeleton,GO:0016363~nuclear matrix,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0070064~proline-rich region binding,	IPR001202:WW domain,IPR002713:FF domain,	PF00397:WW domain,PF01846:FF domain,	SSF51045:WW domain,SSF81698:FF domain,	3.17890076064211	4.90003136157141e-08	FDR<0.01	7.30980114035642	3193011.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	488	Transcription factor activity
Q91YR7	Q91YR7;Q91YR7-2	Prpf6	8.9809	5.5349	2968050	9.87849451743554	5.51055270843666	9.41708258781429	NA	9.92161920825479	8.55139387720198	2500612.66666667	1	Prpf6	0	Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)		FUNCTION: Involved in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex, one of the building blocks of the spliceosome. Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but does not affect estrogen-induced transactivation. {ECO:0000250|UniProtKB:O94906}.		mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]	catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]	androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:O94906}. Nucleus speckle {ECO:0000250|UniProtKB:O94906}. Note=Localized in splicing speckles. {ECO:0000250|UniProtKB:O94906}.	68879;		IPR003107;IPR010491;IPR027108;IPR013026;IPR011990;IPR019734;	PF06424;	SM00386;SM00028;	106722	COMPBIAS 38..68;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..79;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Modified residue (5); Region (1); Repeat (9); Sequence conflict (2)		3D-structure;Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;mRNA processing;mRNA splicing				REPEAT 384..416;  /note=HAT 1; REPEAT 418..444;  /note=HAT 2; REPEAT 445..476;  /note=HAT 3; REPEAT 554..586;  /note=HAT 4; REPEAT 588..620;  /note=HAT 5; REPEAT 622..654;  /note=HAT 6; REPEAT 689..721;  /note=HAT 7; REPEAT 723..755;  /note=HAT 8; REPEAT 855..887;  /note=HAT 9			68879	GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006403~RNA localization,GO:0008380~RNA splicing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005682~U5 snRNP,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0050681~androgen receptor binding,	IPR003107:RNA-processing protein, HAT helix,IPR010491:PRP1 splicing factor, N-terminal,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	PF06424:PRP1 splicing factor, N-terminal,	SSF48452:TPR-like,	3.00627440983003	7.24420787378472e-08	FDR<0.01	7.14000909602469	2734331.33333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	531	Transcription factor activity
Q8C2Q3	Q8C2Q3;Q8C2Q3-2	Rbm14	8.4683	10.067	2331650	6.36780438104941	6.84369011771147	1.21422587029639	3.25977116406428	8.03600128576021	5.09761941173472	1276653.33333333	0	Rbm14	0	RNA-binding protein 14 (RNA-binding motif protein 14)		FUNCTION: May function as a nuclear receptor coactivator, enhancing transcription through other coactivators such as NCOA6 and CITED1 (By similarity). Regulates centriole biogenesis by suppressing the formation of aberrant centriolar protein complexes in the cytoplasm and thus preserving mitotic spindle integrity (PubMed:25385835). Prevents the formation of the STIL-CENPJ complex (which can induce the formation of aberrant centriolar protein complexes) by interfering with the interaction of STIL with CENPJ (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:Q96PK6, ECO:0000269|PubMed:25385835}.		activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96PK6}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96PK6}. Cytoplasm {ECO:0000250|UniProtKB:Q96PK6}. Note=In punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles. Cytoplasmic localization is crucial for its function in suppressing the formation of aberrant centriolar protein complexes. {ECO:0000250|UniProtKB:Q96PK6}.	56275;	cd12608;cd12609;	IPR012677;IPR035979;IPR034506;IPR034507;IPR000504;	PF00076;	SM00360;	69449		REGION 148..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 193..232;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 307..354;  /note=TRBP-interacting domain; interaction with STIL;  /evidence=ECO:0000250|UniProtKB:Q96PK6; REGION 566..590;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Cross-link (7); Domain (2); Modified residue (21); Region (4); Sequence conflict (3)		Acetylation;Alternative splicing;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 1..73;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 79..149;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	56275	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016575~histone deacetylation,GO:0043153~entrainment of circadian clock by photoperiod,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046600~negative regulation of centriole replication,GO:0046822~regulation of nucleocytoplasmic transport,GO:0060395~SMAD protein signal transduction,GO:0097167~circadian regulation of translation,GO:0098534~centriole assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.4000392143771	1.41879504354137e-05	FDR<0.01	4.84808033737404	1804151.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	653	Transcription factor activity
Q9WU56	Q9WU56-4;Q9WU56-2;Q9WU56-3;Q9WU56	Pus1	5.1869	8.4447	2572600	4.91497100167109	4.7254512805973	NA	NA	NA	NA	135515	4	Pus1	0	tRNA pseudouridine synthase A (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)		FUNCTION: Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA (PubMed:10094309). Involved in regulation of nuclear receptor activity possibly through pseudouridylation of SRA1 RNA (PubMed:15327771). Isoforms 3 and 4 do not form pseudouridine when expressed in vitro (PubMed:11085940). {ECO:0000269|PubMed:10094309, ECO:0000269|PubMed:11085940, ECO:0000269|PubMed:15327771}.		mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA pseudouridine synthesis [GO:0031119]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]	SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000250}.	56361;	cd02568;	IPR020103;IPR001406;IPR020097;IPR020095;IPR041708;	PF01416;		47502	COMPBIAS 49..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 32..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 403..423;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 142;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q9Y606		BINDING 197;  /note=Substrate;  /evidence=ECO:0000250	5.4.99.12			5 out of 5	Active site (1); Alternative sequence (3); Binding site (1); Chain (1); Compositional bias (1); Erroneous initiation (1); Frameshift (1); Modified residue (3); Region (2); Sequence conflict (3); Transit peptide (1)		Alternative splicing;Isomerase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transit peptide;tRNA processing							56361	GO:0001522~pseudouridine synthesis,GO:0008033~tRNA processing,GO:0009451~RNA modification,GO:0031119~tRNA pseudouridine synthesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0009982~pseudouridine synthase activity,GO:0016853~isomerase activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0044822~poly(A) RNA binding,	IPR001406:Pseudouridine synthase I, TruA,IPR020094:Pseudouridine synthase I, TruA, N-terminal,IPR020095:Pseudouridine synthase I, TruA, C-terminal,IPR020097:Pseudouridine synthase I, TruA, alpha/beta domain,IPR020103:Pseudouridine synthase, catalytic domain,	PF01416:tRNA pseudouridine synthase,	SSF55120:Pseudouridine synthase,	2.49763843639793	0.000108141578368339	FDR<0.01	3.96600729601749	1354057.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	727	Transcription factor activity
Q9D1J3	Q9D1J3	Sarnp	9.0408	6.9871	1231700	15.124016938899	20.7947763521803	17.0418718792072	20.9156888582125	12.8513230437074	14.5511691864441	636194.666666667	0	Sarnp	0	SAP domain-containing ribonucleoprotein (Nuclear protein Hcc-1)		FUNCTION: Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway (By similarity). {ECO:0000250}.		mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}.	66118;		IPR003034;IPR036361;	PF02037;	SM00513;	23533	COMPBIAS 46..65;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 66..87;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 165..182;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 194..210;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 45..87;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 162..210;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Domain (1); Initiator methionine (1); Modified residue (4); Region (2)		Acetylation;DNA-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Translation regulation;Transport;mRNA transport	DOMAIN 8..42;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186					PS50800;	66118	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0006417~regulation of translation,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,GO:0050733~RS domain binding,	IPR003034:SAP domain,	PF02037:SAP domain,		3.78781207883178	4.01389787429213e-09	FDR<0.01	8.39643368147375	933947.333333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	848	Transcription factor activity
Q9JMG1	Q9JMG1	Edf1	2.9411	10.733	781205	NA	1.32819763580821	NA	NA	1.55823918971562	9.24043614858621	535850	3	Edf1	0	Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1)	DNA_BIND 92..111;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00257	FUNCTION: Transcriptional coactivator stimulating NR5A1 and ligand-dependent NR1H3/LXRA and PPARG transcriptional activities. Enhances the DNA-binding activity of ATF1, ATF2, CREB1 and NR5A1. Regulates nitric oxid synthase activity probably by sequestering calmodulin in the cytoplasm. Might function in endothelial cells differentiation, hormone-induced cardiomyocytes hypertrophy and lipid metabolism (By similarity). {ECO:0000250}.		cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of DNA binding [GO:0043388]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Also nuclear upon binding to NR5A1 and treatment of cells with TPA or forskolin. {ECO:0000250}.	59022;	cd00093;	IPR001387;IPR010982;IPR013729;	PF01381;PF08523;	SM00530;	16369		REGION 34..67;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 37..113;  /note=Interaction with NR5A2, PPARG and NR1H3;  /evidence=ECO:0000250; REGION 69..108;  /note=Interaction with TBP and NR5A1;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); DNA binding (1); Domain (1); Initiator methionine (1); Modified residue (3); Motif (1); Region (3); Sequence conflict (1)		Acetylation;Activator;Calmodulin-binding;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 81..135;  /note=HTH cro/C1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00257	DOMAIN: The IQ motif, which is involved in calmodulin binding, overlaps with the binding domain for nuclear receptors and transcription factors. Its phosphorylation probably allows a switch between the two activities of the protein (By similarity). {ECO:0000250}.	MOTIF 81..88;  /note=IQ motif;  /evidence=ECO:0000250			PS50943;	59022	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0043388~positive regulation of DNA binding,	GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005516~calmodulin binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR001387:Helix-turn-helix,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013729:Multiprotein bridging factor 1, N-terminal,	PF01381:Helix-turn-helix,PF08523:Multiprotein bridging factor 1,	SSF47413:lambda repressor-like DNA-binding domains,	1.84753696076069	0.00675402388060608	FDR<0.01	2.17043740813692	658527.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	954	Transcription factor activity
Q61066	Q61066	Nr0b1	4.2795	6.0454	682755	NA	NA	NA	NA	NA	3.71222807929319	393383.333333333	5	Nr0b1	0	Nuclear receptor subfamily 0 group B member 1 (Nuclear receptor DAX-1)		FUNCTION: Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity). {ECO:0000250, ECO:0000269|PubMed:16466956}.		adrenal gland development [GO:0030325]; cell differentiation [GO:0030154]; gonad development [GO:0008406]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; response to immobilization stress [GO:0035902]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	AF-2 domain binding [GO:0050682]; DNA hairpin binding [GO:0032448]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; steroid hormone receptor binding [GO:0035258]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Shuttles between the cytoplasm and nucleus. Homodimers exits in the cytoplasm and in the nucleus (By similarity). {ECO:0000250}.	11614;		IPR035500;IPR033544;IPR000536;IPR001723;IPR025900;	PF00104;PF14046;	SM00430;	52576	COMPBIAS 214..231;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..255;  /note=4 X 67 AA tandem repeats; REGION 214..238;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 324..343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Helix (10); Motif (4); Region (3); Repeat (4)		3D-structure;Cytoplasm;Nucleus;Receptor;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 190..471;  /note=NR LBD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01189	DOMAIN: Homodimerization involved an interaction between amino and carboxy termini involving LXXLL motifs and steroid binding domain (AF-2 motif). Heterodimerizes with NR5A1 and NROB2 through its N-terminal LXXLL motifs (By similarity). {ECO:0000250}.	MOTIF 13..17;  /note=LXXLL motif 1; MOTIF 80..84;  /note=LXXLL motif 2; MOTIF 148..152;  /note=LXXLL motif 3; MOTIF 463..468;  /note=AF-2 motif	REPEAT 1..67;  /note=1; REPEAT 68..135;  /note=2; REPEAT 136..202;  /note=3; REPEAT 203..255;  /note=4; truncated		PS51843;	11614	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006694~steroid biosynthetic process,GO:0007283~spermatogenesis,GO:0007530~sex determination,GO:0008104~protein localization,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0030154~cell differentiation,GO:0030238~male sex determination,GO:0030325~adrenal gland development,GO:0033144~negative regulation of intracellular steroid hormone receptor signaling pathway,GO:0033327~Leydig cell differentiation,GO:0035902~response to immobilization stress,GO:0043401~steroid hormone mediated signaling pathway,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060008~Sertoli cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0032448~DNA hairpin binding,GO:0035258~steroid hormone receptor binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001723:Steroid hormone receptor,IPR025900:Nuclear receptor repeat,	PF00104:Ligand-binding domain of nuclear hormone receptor,PF14046:Nuclear receptor repeat,	SSF48508:Nuclear receptor ligand-binding domain,	2.1951884666735	0.00127486681637152	FDR<0.01	2.89453518302305	538069.166666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1014	Transcription factor activity
Q9R0I7	Q9R0I7	Ylpm1	5.9914	8.5837	576180	6.22122682593007	2.04704100223127	3.69494531480934	NA	1.31400864617689	5.59033989266547	482770.166666667	1	Ylpm1	0	YLP motif-containing protein 1 (Nuclear protein ZAP3)		FUNCTION: Plays a role in the reduction of telomerase activity during differentiation of embryonic stem cells by binding to the core promoter of TERT and controlling its down-regulation. {ECO:0000269|PubMed:15511642}.		negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of telomere maintenance [GO:0032204]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000269|PubMed:10716735}. Note=Migrates to nucleolar caps upon blockage of transcription. {ECO:0000250}.			IPR027417;IPR026314;			155129	COMPBIAS 13..31;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 34..74;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..116;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 141..205;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 206..258;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 299..319;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 517..611;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 612..626;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 637..651;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 652..683;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 705..719;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 737..769;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 776..805;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 827..841;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 846..877;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 907..1014;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1048..1068;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 517..1068;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1336..1343;  /note=Involved in interaction with PPP1CA;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); Compositional bias (17); Cross-link (2); Erroneous initiation (1); Modified residue (1); Region (3); Sequence conflict (3)		Isopeptide bond;Methylation;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation							NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032204~regulation of telomere maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0044822~poly(A) RNA binding,	IPR026314:YLP motif-containing protein 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.01681367140671	0.000149346732281754	FDR<0.01	3.82580427535331	529475.083333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1021	Transcription factor activity
P42227	P42227-2;P42227-3;P42227	Stat3	4.1292	5.708	366115	3.14871375043295	3.45375423084893	3.82102327003171	NA	6.90989496959646	5.06098486765525	620686.666666667	1	Stat3	0	Signal transducer and activator of transcription 3 (Acute-phase response factor)		FUNCTION: Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors (By similarity). Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (By similarity). May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Upon activation of IL6ST/gp130 signaling by interleukin-6 (IL6), binds to the IL6-responsive elements identified in the promoters of various acute-phase protein genes (By similarity). Activated by IL31 through IL31RA (By similarity). Acts as a regulator of inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity (By similarity). Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (By similarity). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation (PubMed:12594516). May play an apoptotic role by transctivating BIRC5 expression under LEP activation (PubMed:16825198). Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity (By similarity). Plays a crucial role in basal beta cell functions, such as regulation of insulin secretion (PubMed:20215569). Plays an important role in host defense in methicillin-resistant S.aureus lung infection by regulating the expression of the antimicrobial lectin REG3G (PubMed:23401489). {ECO:0000250|UniProtKB:P40763, ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:12594516, ECO:0000269|PubMed:16825198, ECO:0000269|PubMed:20215569, ECO:0000269|PubMed:23084476, ECO:0000269|PubMed:23401489}.		acute-phase response [GO:0006953]; aging [GO:0007568]; astrocyte differentiation [GO:0048708]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to hormone stimulus [GO:0032870]; cellular response to leptin stimulus [GO:0044320]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; eye photoreceptor cell differentiation [GO:0001754]; glucose homeostasis [GO:0042593]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular receptor signaling pathway [GO:0030522]; leptin-mediated signaling pathway [GO:0033210]; modulation of chemical synaptic transmission [GO:0050804]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron migration [GO:2001223]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of metalloendopeptidase activity [GO:1904685]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]; radial glial cell differentiation [GO:0060019]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of feeding behavior [GO:0060259]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to leptin [GO:0044321]; response to peptide hormone [GO:0043434]; sexual reproduction [GO:0019953]; stem cell population maintenance [GO:0019827]; temperature homeostasis [GO:0001659]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 17 type immune response [GO:0072538]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; RNA polymerase II transcription regulator complex [GO:0090575]; Schaffer collateral - CA1 synapse [GO:0098685]; transcription regulator complex [GO:0005667]	CCR5 chemokine receptor binding [GO:0031730]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; primary miRNA binding [GO:0070878]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P40763}. Nucleus {ECO:0000250|UniProtKB:P40763}. Note=Predominantly present in the cytoplasm without stimuli. Upon leukemia inhibitory factor (LIF) stimulation, accumulates in the nucleus. The complex composed of BART and ARL2 plays an important role in the nuclear translocation and retention of STAT3 (By similarity). Shuttles between the nucleus and the cytoplasm. Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Constitutive nuclear presence is independent of tyrosine phosphorylation. {ECO:0000250}.	20848;	cd10374;	IPR008967;IPR000980;IPR036860;IPR001217;IPR035855;IPR036535;IPR013800;IPR015988;IPR013801;IPR012345;IPR013799;	PF00017;PF01017;PF02864;PF02865;	SM00964;	88054			NA							5 out of 5	Alternative sequence (2); Beta strand (20); Chain (1); Domain (1); Helix (30); Initiator methionine (1); Modified residue (14); Motif (1); Mutagenesis (6); Sequence conflict (4); Turn (6)	MISCELLANEOUS: Involved in the gp130-mediated signaling pathway.	3D-structure;Acetylation;Activator;Acute phase;Alternative splicing;Cytoplasm;DNA-binding;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;SH2 domain;Transcription;Transcription regulation	DOMAIN 580..670;  /note=SH2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00191		MOTIF 150..162;  /note=Essential for nuclear import			PS50001;	20848	GO:0001659~temperature homeostasis,GO:0001754~eye photoreceptor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006953~acute-phase response,GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0007568~aging,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010730~negative regulation of hydrogen peroxide biosynthetic process,GO:0016310~phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019827~stem cell population maintenance,GO:0019953~sexual reproduction,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0032870~cellular response to hormone stimulus,GO:0033210~leptin-mediated signaling pathway,GO:0034097~response to cytokine,GO:0035278~miRNA mediated inhibition of translation,GO:0040014~regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042593~glucose homeostasis,GO:0042755~eating behavior,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043066~negative regulation of apoptotic process,GO:0044320~cellular response to leptin stimulus,GO:0044321~response to leptin,GO:0045471~response to ethanol,GO:0045747~positive regulation of Notch signaling pathway,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048708~astrocyte differentiation,GO:0051726~regulation of cell cycle,GO:0055091~phospholipid homeostasis,GO:0060019~radial glial cell differentiation,GO:0060259~regulation of feeding behavior,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0060548~negative regulation of cell death,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071345~cellular response to cytokine stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0097009~energy homeostasis,GO:1901215~negative regulation of neuron death,GO:1902728~positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904685~positive regulation of metalloendopeptidase activity,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000737~negative regulation of stem cell differentiation,GO:2001171~positive regulation of ATP biosynthetic process,GO:2001223~negative regulation of neuron migration,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031490~chromatin DNA binding,GO:0031730~CCR5 chemokine receptor binding,GO:0035259~glucocorticoid receptor binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015988:STAT transcription factor, coiled coil,	PF00017:SH2 domain,PF01017:STAT protein, all-alpha domain,PF02864:STAT protein, DNA binding domain,PF02865:STAT protein, protein interaction domain,	SSF47655:STAT,SSF48092:Transcription factor STAT-4 N-domain,SSF49417:p53-like transcription factors,SSF55550:SH2 domain,	2.15197380733379	2.04456033565301e-06	FDR<0.01	5.68940006874646	493400.833333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1046	Transcription factor activity
Q9EPQ8	Q9EPQ8-2;Q9EPQ8	Tcf20	1.6895	2.2402	456365	2.70051309748852	4.43616360571378	NA	NA	7.74413381863239	8.02761499558481	435095.333333333	2	Tcf20	0	Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein)	DNA_BIND 1565..1579;  /note=A.T hook	FUNCTION: Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator. {ECO:0000269|PubMed:7760812}.		positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:7760812}.	21411;	cd15699;	IPR034732;IPR041972;IPR001965;IPR013083;		SM00249;	215683	COMPBIAS 1..60;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 114..432;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 502..541;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 548..608;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 615..632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 662..678;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 693..737;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 764..778;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 953..967;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1032..1046;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1145..1166;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1209..1235;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1254..1276;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1301..1318;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1335..1349;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1465..1481;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1482..1504;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1582..1598;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1608..1623;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1692..1710;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1773..1803;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1842..1858;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..79;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 96..432;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 446..481;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 502..816;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 844..891;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 949..1065;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1136..1372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1198..1219;  /note=Leucine-zipper; REGION 1415..1434;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1446..1636;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1685..1710;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1760..1865;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1966..1987;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (22); Cross-link (32); DNA binding (1); Frameshift (1); Modified residue (22); Motif (3); Mutagenesis (7); Region (13); Sequence conflict (11); Zinc finger (2)		Acetylation;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The atypical PHD domain functions as a negative modulator of cofactor binding.	MOTIF 1282..1295;  /note=Nuclear localization signal; MOTIF 1604..1628;  /note=Nuclear localization signal; MOTIF 1812..1819;  /note=Nuclear localization signal		ZN_FING 1856..1892;  /note=C2HC pre-PHD-type; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 1912..1960;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146	PS51805;	21411	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,			1.91014088614118	0.000464745837234994	FDR<0.01	3.33278449154846	445730.166666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1075	Transcription factor activity
Q7TPR4	Q7TPR4	Actn1	4.545	5.2006	580650	4.13633355393779	3.37849251663908	11.6293944574306	NA	1.96390345450618	NA	144751.666666667	2	Actn1	0	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)		FUNCTION: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (By similarity). {ECO:0000250}.		actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; focal adhesion assembly [GO:0048041]; negative regulation of cellular component movement [GO:0051271]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]	actin filament [GO:0005884]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; dense core granule membrane [GO:0032127]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sarcomere [GO:0030017]; secretory granule [GO:0030141]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; ion channel binding [GO:0044325]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; vinculin binding [GO:0017166]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:23100251}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:11114196}. Cell membrane {ECO:0000250|UniProtKB:Q9Z1P2}. Cell junction {ECO:0000250|UniProtKB:Q9Z1P2}. Cell projection, ruffle {ECO:0000269|PubMed:17298598}. Note=Colocalizes with MYOZ2 and PPP3CA at the Z-line of heart and skeletal muscle (PubMed:11114196). Colocalizes with PSD in membrane ruffles and central reticular structures (PubMed:17298598). {ECO:0000269|PubMed:11114196, ECO:0000269|PubMed:17298598}.	109711;	cd00014;cd00051;	IPR001589;IPR001715;IPR036872;IPR011992;IPR014837;IPR018247;IPR002048;IPR018159;IPR002017;	PF00307;PF08726;PF00435;	SM00033;SM00054;SM00150;	103068		REGION 1..247;  /note=Actin-binding; REGION 274..733;  /note=Interaction with DDN;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (3); Calcium binding (2); Chain (1); Domain (4); Helix (4); Modified residue (9); Mutagenesis (2); Region (2); Repeat (4)		3D-structure;Acetylation;Actin-binding;Calcium;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat	DOMAIN 31..135;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 144..250;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 746..781;  /note=EF-hand 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448; DOMAIN 787..822;  /note=EF-hand 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448			REPEAT 274..384;  /note=Spectrin 1; REPEAT 394..499;  /note=Spectrin 2; REPEAT 509..620;  /note=Spectrin 3; REPEAT 630..733;  /note=Spectrin 4		PS00019;PS00020;PS50021;PS00018;PS50222;	109711	GO:0007015~actin filament organization,GO:0030220~platelet formation,GO:0030865~cortical cytoskeleton organization,GO:0036344~platelet morphogenesis,GO:0048041~focal adhesion assembly,GO:0051017~actin filament bundle assembly,GO:0051271~negative regulation of cellular component movement,GO:0051639~actin filament network formation,GO:0051764~actin crosslink formation,	GO:0001725~stress fiber,GO:0001726~ruffle,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005916~fascia adherens,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030141~secretory granule,GO:0030863~cortical cytoskeleton,GO:0030864~cortical actin cytoskeleton,GO:0032127~dense core granule membrane,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,	GO:0003725~double-stranded RNA binding,GO:0003779~actin binding,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017166~vinculin binding,GO:0019904~protein domain specific binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042803~protein homodimerization activity,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR014837:EF-hand, Ca insensitive,IPR018159:Spectrin/alpha-actinin,IPR018247:EF-Hand 1, calcium-binding site,IPR026921:Alpha-actinin,	PF00307:Calponin homology (CH) domain,PF00435:Spectrin repeat,PF08726:Ca2+ insensitive EF hand,PF13405:EF-hand domain,	SSF47473:EF-hand,SSF47576:Calponin-homology domain, CH-domain,	2.14685310712322	0.000116968690753477	FDR<0.01	3.93193037118257	362700.833333333	Present in Nucleus	RBP	Others	Others	Others	Others	1126	Transcription factor activity
Q7TQK0	Q7TQK0;Q7TQK0-2	Ccnt2	NA	5.7424	351110	NA	NA	NA	NA	NA	3.37279503524571	125006.666666667	5	Ccnt2	1	Cyclin-T2 (CycT2)		FUNCTION: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II). The activity of this complex is regulated by binding with 7SK snRNA (By similarity). Plays a role during muscle differentiation; P-TEFB complex interacts with MYOD1; this tripartite complex promotes the transcriptional activity of MYOD1 through its CDK9-mediated phosphorylation and binds the chromatin of promoters and enhancers of muscle-specific genes; this event correlates with hyperphosphorylation of the CTD domain of RNA pol II (PubMed:16245309, PubMed:23060074, PubMed:12037670). In addition, enhances MYOD1-dependent transcription through interaction with PKN1 (By similarity). Involved in early embryo development (PubMed:19364821). {ECO:0000250|UniProtKB:O60583, ECO:0000269|PubMed:12037670, ECO:0000269|PubMed:16245309, ECO:0000269|PubMed:19364821, ECO:0000269|PubMed:23060074}.		cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]	SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:23060074}. Nucleus {ECO:0000269|PubMed:23060074}. Note=Nucleus in differentiating cells. {ECO:0000269|PubMed:23060074}.	72949;	cd00043;	IPR028862;IPR013763;IPR036915;IPR043198;IPR006671;	PF00134;	SM00385;	80252	COMPBIAS 389..413;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 466..483;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 486..505;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 515..560;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 561..579;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 630..645;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..298;  /note=Interaction with MDFIC and MDFI;  /evidence=ECO:0000250|UniProtKB:O60583; REGION 250..298;  /note=Interaction with POLR2A;  /evidence=ECO:0000250|UniProtKB:O60583; REGION 297..325;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 340..364;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 385..428;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..645;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (6); Cross-link (1); Domain (1); Modified residue (2); Region (6); Sequence conflict (2)		Alternative splicing;Cell cycle;Cell division;Cyclin;Cytoplasm;Host-virus interaction;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 12..147;  /note=Cyclin N-terminal;  /evidence=ECO:0000255						72949	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0007519~skeletal muscle tissue development,GO:0016032~viral process,GO:0019085~early viral transcription,GO:0019086~late viral transcription,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051147~regulation of muscle cell differentiation,GO:0051301~cell division,GO:1901409~positive regulation of phosphorylation of RNA polymerase II C-terminal domain,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001223~transcription coactivator binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0070063~RNA polymerase binding,GO:0097322~7SK snRNA binding,	IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,	PF00134:Cyclin, N-terminal domain,	SSF47954:Cyclin-like,	2.13779923835443	0.00934275902390593	FDR<0.01	2.02952485268693	238058.333333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1243	Transcription factor activity
P57780	P57780;Q9JI91;O88990	Actn4	4.5971	7.6707	58845.5	NA	NA	0.961815908435125	NA	1.10134584462213	NA	37401.4166666667	4	Actn4	0	Alpha-actinin-4 (Non-muscle alpha-actinin 4)		FUNCTION: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (By similarity). Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recruits it to the tight junctions (PubMed:18332111). May also function as a transcriptional coactivator, stimulating transcription mediated by the nuclear hormone receptors PPARG and RARA (By similarity). {ECO:0000250|UniProtKB:O43707, ECO:0000269|PubMed:18332111}.		actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]	cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43707}. Cytoplasm {ECO:0000250|UniProtKB:O43707}. Cell junction {ECO:0000269|PubMed:18332111}. Cytoplasm, cytoskeleton, stress fiber {ECO:0000250|UniProtKB:O43707}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250|UniProtKB:O43707}.	60595;	cd00014;cd00051;	IPR001589;IPR001715;IPR036872;IPR011992;IPR014837;IPR018247;IPR002048;IPR018159;IPR002017;	PF00307;PF08726;PF00435;	SM00033;SM00054;SM00150;	104977		REGION 1..267;  /note=Actin-binding; REGION 12..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 12..27;  /note=Interaction with VCL;  /evidence=ECO:0000250|UniProtKB:O43707; REGION 41..62;  /note=Interaction with VCL;  /evidence=ECO:0000250|UniProtKB:O43707; REGION 109..127;  /note=Interaction with VCL;  /evidence=ECO:0000250|UniProtKB:O43707; REGION 178..193;  /note=Polyphosphoinositide (PIP2)-binding;  /evidence=ECO:0000255; REGION 737..912;  /note=Mediates interaction with MICALL2;  /evidence=ECO:0000269|PubMed:18332111	NA							5 out of 5	Calcium binding (2); Chain (1); Domain (4); Modified residue (10); Motif (1); Region (7); Repeat (4)		Acetylation;Actin-binding;Calcium;Cell junction;Cytoplasm;Cytoskeleton;Direct protein sequencing;Metal-binding;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	DOMAIN 51..155;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 164..270;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 766..801;  /note=EF-hand 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448; DOMAIN 807..842;  /note=EF-hand 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448	DOMAIN: Contains one Leu-Xaa-Xaa-Leu-Leu (LXXLL) motif that mediates interaction with nuclear receptors. {ECO:0000250|UniProtKB:O43707}.	MOTIF 85..89;  /note=LXXLL motif;  /evidence=ECO:0000250|UniProtKB:O43707	REPEAT 294..404;  /note=Spectrin 1;  /evidence=ECO:0000255; REPEAT 414..519;  /note=Spectrin 2;  /evidence=ECO:0000255; REPEAT 529..640;  /note=Spectrin 3;  /evidence=ECO:0000255; REPEAT 650..753;  /note=Spectrin 4;  /evidence=ECO:0000255		PS00019;PS00020;PS50021;PS00018;PS50222;	60595	GO:0001666~response to hypoxia,GO:0006810~transport,GO:0015031~protein transport,GO:0030050~vesicle transport along actin filament,GO:0030335~positive regulation of cell migration,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0042981~regulation of apoptotic process,GO:0048384~retinoic acid receptor signaling pathway,GO:0048549~positive regulation of pinocytosis,GO:0051017~actin filament bundle assembly,GO:0051271~negative regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0070830~bicellular tight junction assembly,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902396~protein localization to bicellular tight junction,GO:1903506~regulation of nucleic acid-templated transcription,	GO:0001725~stress fiber,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0030863~cortical cytoskeleton,GO:0031143~pseudopodium,GO:0043005~neuron projection,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001882~nucleoside binding,GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0031490~chromatin DNA binding,GO:0032403~protein complex binding,GO:0035257~nuclear hormone receptor binding,GO:0042803~protein homodimerization activity,GO:0042974~retinoic acid receptor binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,GO:0051015~actin filament binding,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR014837:EF-hand, Ca insensitive,IPR018159:Spectrin/alpha-actinin,IPR018247:EF-Hand 1, calcium-binding site,	PF00307:Calponin homology (CH) domain,PF00435:Spectrin repeat,PF08726:Ca2+ insensitive EF hand,	SSF47473:EF-hand,SSF47576:Calponin-homology domain, CH-domain,	1.30579563921614	0.056074289131363	FDR<0.1	1.25123622337644	48123.4583333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1429	Transcription factor activity
Q6ZWX6	Q6ZWX6	Eif2s1	6.4987	1.651	3660800	8.19470621978202	4.99725151166858	12.2171724576064	7.31689470988512	8.88809883565905	9.29454410261177	1728380	0	Eif2s1	0	Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha)		FUNCTION: Functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA (PubMed:15277680, PubMed:19131336). This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S pre-initiation complex (PubMed:15277680, PubMed:19131336). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex (PubMed:15277680, PubMed:19131336). In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B (PubMed:15277680, PubMed:19131336). EIF2S1/eIF-2-alpha is a key component of the integrated stress response (ISR), required for adaptation to various stress: phosphorylation by metabolic-stress sensing protein kinases (EIF2AK1/HRI, EIF2AK2/PKR, EIF2AK3/PERK and EIF2AK4/GCN2) in response to stress converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, leading to a attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and QRICH1-mediated reprogramming (PubMed:15277680, PubMed:21285359). {ECO:0000269|PubMed:15277680, ECO:0000269|PubMed:19131336, ECO:0000269|PubMed:21285359}.		aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2B complex [GO:0005851]; eukaryotic translation initiation factor 2 complex [GO:0005850]; glial limiting end-foot [GO:0097451]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm, Stress granule {ECO:0000269|PubMed:19861488}. Note=Colocalizes with NANOS3 in the stress granules. {ECO:0000269|PubMed:19861488}.	13665;	cd04452;	IPR012340;IPR022967;IPR003029;IPR044126;IPR024055;IPR024054;IPR011488;	PF07541;PF00575;	SM00316;	36108	COMPBIAS 300..315;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 292..315;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Activity is regulated by phosphorylation at Ser-49 and Ser-52, which stabilizes the eIF-2/GDP/eIF-2B complex and prevents the eIF-2B-mediated exchange of GDP for GTP, thereby preventing the formation of the 43S pre-initiation complex (PIC) (PubMed:11106749, PubMed:12176355, PubMed:15277680, PubMed:19131336, PubMed:21285359). This results in the global attenuation of 5' cap-dependent protein synthesis and concomitant translation of ISR-specific mRNAs that contain a short upstream open reading frame (uORF) in their 5' UTR, such as ATF4, ATF5, DDIT3/CHOP and PPP1R15A/GADD34 (PubMed:15277680, PubMed:19131336, PubMed:21285359). {ECO:0000269|PubMed:11106749, ECO:0000269|PubMed:12176355, ECO:0000269|PubMed:15277680, ECO:0000269|PubMed:19131336, ECO:0000269|PubMed:21285359}.					5 out of 5	Chain (1); Compositional bias (1); Domain (1); Modified residue (6); Region (1)		Acetylation;Cytoplasm;Initiation factor;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Translation regulation	DOMAIN 17..88;  /note=S1 motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00180					PS50126;	13665	GO:0002230~positive regulation of defense response to virus by host,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0007568~aging,GO:0032057~negative regulation of translational initiation in response to stress,GO:0034198~cellular response to amino acid starvation,GO:0034605~cellular response to heat,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0043558~regulation of translational initiation in response to stress,GO:0046777~protein autophosphorylation,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,GO:1901216~positive regulation of neuron death,GO:1905098~negative regulation of guanyl-nucleotide exchange factor activity,GO:1990737~response to manganese-induced endoplasmic reticulum stress,GO:2000676~positive regulation of type B pancreatic cell apoptotic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005850~eukaryotic translation initiation factor 2 complex,GO:0005851~eukaryotic translation initiation factor 2B complex,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0033290~eukaryotic 48S preinitiation complex,GO:0043614~multi-eIF complex,GO:0044207~translation initiation ternary complex,GO:0070062~extracellular exosome,GO:0097451~glial limiting end-foot,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR003029:Ribosomal protein S1, RNA-binding domain,IPR011488:Translation initiation factor 2, alpha subunit,IPR012340:Nucleic acid-binding, OB-fold,IPR022967:RNA-binding domain, S1,IPR024054:Translation initiation factor 2, alpha subunit, middle domain,IPR024055:Translation initiation factor 2, alpha subunit, C-terminal,	PF00575:S1 RNA binding domain,PF07541:Eukaryotic translation initiation factor 2 alpha subunit,	SSF110993:eIF-2-alpha, C-terminal domain,SSF116742:eIF2alpha middle domain-like,SSF50249:Nucleic acid-binding proteins,	2.70370591414204	2.08943732191567e-06	FDR<0.01	5.67997065211281	2694590	Present in Nucleus	RBP	DBD	DBD	Others	RBD	537	Translation
Q9D8E6	Q9D8E6	Rpl4	32.396	33.559	152010000	31.2275551947038	30.757874015748	43.7483594365211	25.5617187699701	56.249296883789	52.1757278514035	67829833.3333333	0	Rpl4	0	60S ribosomal protein L4				positive regulation of axon extension [GO:0045773]; positive regulation of axonogenesis [GO:0050772]; translation [GO:0006412]	A band [GO:0031672]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		67891;		IPR025755;IPR002136;IPR013000;IPR023574;	PF14374;PF00573;		47154	COMPBIAS 369..383;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 394..419;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 364..419;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (3); Initiator methionine (1); Modified residue (13); Region (1); Sequence conflict (1)		3D-structure;Acetylation;Citrullination;Direct protein sequencing;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00939;	67891	GO:0006412~translation,GO:0045773~positive regulation of axon extension,GO:0050772~positive regulation of axonogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0008097~5S rRNA binding,GO:0044822~poly(A) RNA binding,	IPR002136:Ribosomal protein L4/L1e,IPR013000:Ribosomal protein L4/L1e, eukaryotic/archaeal, conserved site,IPR023574:Ribosomal protein L4 domain,IPR025755:60S ribosomal protein L4, C-terminal domain,	PF00573:Ribosomal protein L4/L1 family,PF14374:60S ribosomal protein L4 C-terminal domain,	SSF52166:Ribosomal protein L4,	5.205017904663	3.38112236103372e-11	FDR<0.01	10.4709391120617	109919916.666667	Present in Nucleus	RBP	Others	Others	Others	Others	20	Translation
P47955	P47955	Rplp1	9.0385	2.6169	129600000	8.73438728273212	8.64603147155456	13.3956678410202	6.21040864488883	4.43105281814959	5.02638853983413	21620016.6666667	0	Rplp1	0	60S acidic ribosomal protein P1		FUNCTION: Plays an important role in the elongation step of protein synthesis.		cytoplasmic translation [GO:0002181]; regulation of translation [GO:0006417]; translational elongation [GO:0006414]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]		56040;		IPR038716;IPR027534;			11475	COMPBIAS 90..104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 69..114;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (2); Region (1)		Acetylation;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein							56040	GO:0002181~cytoplasmic translation,GO:0006414~translational elongation,GO:0006417~regulation of translation,GO:0045860~positive regulation of protein kinase activity,	GO:0005622~intracellular,GO:0005840~ribosome,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0030687~preribosome, large subunit precursor,	GO:0003735~structural constituent of ribosome,GO:0030295~protein kinase activator activity,GO:0070180~large ribosomal subunit rRNA binding,	IPR027534:Ribosomal protein L12 family,			2.70728015954639	6.42260175409514e-07	FDR<0.01	6.19228900642449	75610008.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	32	Translation
Q8R1B4	Q8R1B4	Eif3c	9.5579	9.8237	79860500	1.75712955316195	1.63569746139754	2.21650855572303	1.28498368070725	1.43426751957775	1.40984068800226	29236133.3333333	0	Eif3c	0	Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)		FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. {ECO:0000255|HAMAP-Rule:MF_03002, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]	ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03002}.	56347;		IPR027516;IPR008905;IPR000717;IPR036388;IPR036390;	PF05470;PF01399;	SM00088;	105531	COMPBIAS 1..23;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 169..190;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 191..217;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 218..238;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 257..275;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 157..299;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 520..540;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 883..911;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Domain (1); Modified residue (15); Region (4); Sequence conflict (2)		Acetylation;Cytoplasm;Initiation factor;Phosphoprotein;Protein biosynthesis;Reference proteome	DOMAIN 671..847;  /note=PCI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01185					PS50250;	56347	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0031369~translation initiation factor binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR000717:Proteasome component (PCI) domain,IPR008905:Eukaryotic translation initiation factor 3 subunit C, N-terminal domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR027516:Eukaryotic translation initiation factor 3 subunit C,	PF01399:PCI domain,PF05470:Eukaryotic translation initiation factor 3 subunit 8 N-terminus,	SSF46785:Winged helix DNA-binding domain,	1.32524649137243	0.00544023538893187	FDR<0.01	2.26438230877561	54548316.6666667	Unexpected	RBP	DBD	DBD	Others	Others	44	Translation
P47911	P47911	Rpl6	39.644	38.886	30337000	66.8717400026749	72.3693732812274	34.5697790991116	95.8680855143323	46.6113545259625	57.1820677035682	71204500	0	Rpl6	0	60S ribosomal protein L6 (TAX-responsive enhancer element-binding protein 107) (TAXREB107)		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:Q02878}.		cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q02878}. Cytoplasm {ECO:0000250|UniProtKB:Q02878}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:Q2YGT9}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:Q02878, ECO:0000250|UniProtKB:Q2YGT9}.	19988;	cd13156;	IPR000915;IPR041997;IPR014722;IPR005568;IPR008991;	PF01159;PF03868;		33510	COMPBIAS 1..18;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 31..52;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..53;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Erroneous initiation (1); Modified residue (4); Region (1); Sequence conflict (3)		3D-structure;Acetylation;Cytoplasm;Endoplasmic reticulum;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01170;	19988	GO:0000027~ribosomal large subunit assembly,GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0000049~tRNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990932~5.8S rRNA binding,	IPR000915:Ribosomal protein L6E,IPR005568:Ribosomal protein L6, N-terminal,IPR008991:Translation protein SH3-like domain,IPR014722:Ribosomal protein L2 domain 2,	PF01159:Ribosomal protein L6e ,PF03868:Ribosomal protein L6, N-terminal domain,	SSF50104:Translation proteins SH3-like domain,	5.73817003778885	3.15283715974524e-11	FDR<0.01	10.5012984594615	50770750	Present in Nucleus	RBP	Others	Others	Others	Others	53	Translation
P12970	P12970	Rpl7a	25.408	33.301	33559000	25.0037505625844	36.6501740883269	50.1831685652632	17.1667925564787	31.8207853369821	39.7914925788866	47821166.6666667	0	Rpl7a	0	60S ribosomal protein L7a (Surfeit locus protein 3)				maturation of LSU-rRNA [GO:0000470]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		27176;		IPR029064;IPR001921;IPR038524;IPR004038;IPR018492;IPR004037;	PF01248;		29977			NA							4 out of 5	Chain (1); Cross-link (7); Erroneous initiation (1); Modified residue (3)		3D-structure;Acetylation;Isopeptide bond;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01082;	27176	GO:0000470~maturation of LSU-rRNA,GO:0006412~translation,GO:0042254~ribosome biogenesis,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0042788~polysomal ribosome,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001921:Ribosomal protein L7A/L8,IPR004037:Ribosomal protein L7Ae conserved site,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR018492:Ribosomal protein L7Ae/L8/Nhp2 family,	PF01248:Ribosomal protein L7Ae/L30e/S12e/Gadd45 family,	SSF55315:L30e-like,	4.95268639727383	1.09990879001207e-10	FDR<0.01	9.95864332723889	40690083.3333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	59	Translation
P67984	P67984	Rpl22	16.8	18.982	20246000	22.1253623028077	11.3763054310482	1.30688204082699	5.44336182026019	7.39699681929137	10.8323584210754	46251872	0	Rpl22	0	60S ribosomal protein L22 (Heparin-binding protein HBp15)				alpha-beta T cell differentiation [GO:0046632]; cytoplasmic translation [GO:0002181]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	heparin binding [GO:0008201]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]		19934;		IPR002671;IPR038526;	PF01776;		14759			NA							4 out of 5	Chain (1); Modified residue (3)	MISCELLANEOUS: Binds to Epstein-Barr virus small RNAs and to heparin.	3D-structure;Heparin-binding;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein							19934	GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0046632~alpha-beta T cell differentiation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,	IPR002671:Ribosomal protein L22e,	PF01776:Ribosomal L22e protein family,		3.18092259983974	8.4213508252923e-06	FDR<0.01	5.07461823998293	33248936	Present in Nucleus	RBP	Others	Others	Others	Others	72	Translation
P62242	P62242	Rps8	15.878	14.113	32112500	10.8562309337444	13.4511655434943	43.561596096881	29.8284862043251	14.1689218867336	16.5223712907276	20400183.3333333	0	Rps8	0	40S ribosomal protein S8				maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; ribonucleoprotein complex [GO:1990904]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250|UniProtKB:P62241}; Lipid-anchor {ECO:0000250|UniProtKB:P62241}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	20116;		IPR042563;IPR001047;IPR022309;IPR018283;	PF01201;		24205	COMPBIAS 10..26;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..27;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Initiator methionine (1); Lipidation (1); Modified residue (4); Region (1); Sequence conflict (1)		Acetylation;Cytoplasm;Isopeptide bond;Lipoprotein;Membrane;Myristate;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01193;	20116	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001047:Ribosomal protein S8e,IPR018283:Ribosomal protein S8e, conserved site,IPR022309:Ribosomal protein S8e/ribosomal biogenesis NSA2,	PF01201:Ribosomal protein S8e,		4.15157893508977	4.26300539914053e-09	FDR<0.01	8.37028411731406	26256341.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	86	Translation
P62900	P62900	Rpl31	2.7126	8.2204	40651500	4.06586704614759	3.30283713710077	2.3303504847129	2.57420135402991	10.1393141767891	5.85137507314219	9670433.33333333	0	Rpl31	0	60S ribosomal protein L31				cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]		114641;	cd00463;	IPR000054;IPR020052;IPR023621;	PF01198;	SM01380;	14463			NA							3 out of 5	Chain (1); Modified residue (7)		3D-structure;Acetylation;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS01144;	114641	GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000054:Ribosomal protein L31e,IPR020052:Ribosomal protein L31e, conserved site,IPR023621:Ribosomal protein L31e domain,	PF01198:Ribosomal protein L31e,	SSF54575:Ribosomal protein L31e,	2.08768618929488	1.31582759499527e-05	FDR<0.01	4.88080100999803	25160966.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	91	Translation
P35980	P35980	Rpl18	17.003	19.359	32492000	11.0814374840704	19.0777801095065	43.8558021226208	27.189428750102	22.6875694806815	33.685912551371	15215183.3333333	0	Rpl18	0	60S ribosomal protein L18		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:Q07020}.		cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q07020}. Cytoplasm {ECO:0000250|UniProtKB:Q07020}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:Q95342}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:Q07020, ECO:0000250|UniProtKB:Q95342}.	19899;		IPR036227;IPR000039;IPR021131;IPR021132;	PF17135;		21645	COMPBIAS 165..188;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 150..188;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Modified residue (2); Region (1); Sequence conflict (8)		3D-structure;Cytoplasm;Endoplasmic reticulum;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01106;	19899	GO:0006412~translation,GO:0007018~microtubule-based movement,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0003777~microtubule motor activity,	IPR000039:Ribosomal protein L18e,IPR009053:Prefoldin,IPR021131:Ribosomal protein L18e/L15P,IPR021132:Ribosomal protein L18e, conserved site,		SSF46579:Prefoldin,SSF52080:Ribosomal proteins L15p and L18e,	4.48551473311772	1.13229462978015e-09	FDR<0.01	8.94604055244208	23853591.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	100	Translation
P53026	P53026	Rpl10a	9.6049	8.5828	33231150	20.6138813877265	3.39109498457052	23.3972859148339	7.26427429899753	13.0585807934394	17.2556598564329	9885766.66666667	0	Rpl10a	0	60S ribosomal protein L10a (CSA-19) (Neural precursor cell expressed developmentally down-regulated protein 6) (NEDD-6)		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P62906}.		cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; mitochondrion [GO:0005739]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]			cd00403;	IPR002143;IPR023674;IPR028364;IPR016095;IPR023673;	PF00687;		24916			NA							4 out of 5	Chain (1); Cross-link (3); Frameshift (1); Initiator methionine (1); Modified residue (5)		Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01199;	NA	GO:0000470~maturation of LSU-rRNA,GO:0006412~translation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR002143:Ribosomal protein L1,IPR016094:Ribosomal protein L1, 2-layer alpha/beta-sandwich,IPR016095:Ribosomal protein L1, 3-layer alpha/beta-sandwich,IPR023673:Ribosomal protein L1, conserved site,IPR023674:Ribosomal protein L1, superfamily,	PF00687:Ribosomal protein L1p/L10e family,	SSF56808:Ribosomal protein L1,	3.46469079342848	2.25899367977805e-07	FDR<0.01	6.64608498414885	21558458.3333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	109	Translation
Q6ZWV7	Q6ZWV7	Rpl35	26.553	25.265	31622000	295.75298710517	74.9456643933148	NA	NA	80.450522928399	190.748688602766	8632798.33333333	2	Rpl35	0	60S ribosomal protein L35		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P42766}.		maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]		66489;		IPR001854;IPR036049;IPR018254;	PF00831;		14553		REGION 100..123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Cross-link (1); Modified residue (3); Region (1)		3D-structure;Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00579;	66489	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR001854:Ribosomal protein L29,IPR018254:Ribosomal protein L29, conserved site,	PF00831:Ribosomal L29 protein,	SSF46561:Ribosomal protein L29 (L29p),	6.28857541747729	4.33413470525513e-07	FDR<0.01	6.36309759489902	20127399.1666667	Unexpected	RBP	Others	Others	Others	Others	115	Translation
P60843	P60843	Eif4a1	20.328	12.596	24299000	12.9391214336547	14.9111296671836	13.4385120879416	11.329134000997	9.2910898448388	9.53016296578672	15033800	0	Eif4a1	0	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)		FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon.		cytoplasmic translational initiation [GO:0002183]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]		13681;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	46154		REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Cross-link (6); Domain (2); Erroneous initiation (4); Initiator methionine (1); Modified residue (7); Motif (2); Nucleotide binding (1); Region (1); Sequence conflict (1)		3D-structure;ATP-binding;Acetylation;Helicase;Hydrolase;Initiation factor;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 63..234;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 245..406;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 32..60;  /note=Q motif; MOTIF 182..185;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	13681	GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.66386143137958	1.04340896164953e-09	FDR<0.01	8.98154543752142	19666400	Unexpected	RBP	DBD	DBD	Others	RBD	117	Translation
O70194	O70194	Eif3d	16.064	9.4168	17386000	16.9923534409516	13.7125305103804	7.64525993883792	8.79120879120879	17.3961450142648	28.2733467160508	19853133.3333333	0	Eif3d	0	Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)		FUNCTION: mRNA cap-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, a complex required for several steps in the initiation of protein synthesis of a specialized repertoire of mRNAs. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. In the eIF-3 complex, EIF3D specifically recognizes and binds the 7-methylguanosine cap of a subset of mRNAs. {ECO:0000255|HAMAP-Rule:MF_03003}.		cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]	mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03003}.	55944;		IPR007783;	PF05091;		63989	COMPBIAS 527..548;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 285..299;  /note=RNA gate;  /evidence=ECO:0000250|UniProtKB:K7IM66; REGION 523..548;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (2); Sequence conflict (2)		Acetylation;Cytoplasm;Initiation factor;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome		DOMAIN: The RNA gate region regulates mRNA cap recognition to prevent promiscuous mRNA-binding before assembly of eif3d into the full eukaryotic translation initiation factor 3 (eIF-3) complex. {ECO:0000255|HAMAP-Rule:MF_03003}.					55944	GO:0001731~formation of translation preinitiation complex,GO:0001732~formation of cytoplasmic translation initiation complex,GO:0002191~cap-dependent translational initiation,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075522~IRES-dependent viral translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0044822~poly(A) RNA binding,GO:0098808~mRNA cap binding,	IPR007783:Eukaryotic translation initiation factor 3 subunit D,	PF05091:Eukaryotic translation initiation factor 3 subunit 7 (eIF-3),		3.76474080714589	8.19732801932489e-09	FDR<0.01	8.0863276861001	18619566.6666667	Unexpected	RBP	Others	Others	Others	Others	122	Translation
P63323	P63323	Rps12	6.1565	8.0828	22022500	NA	30.6372549019608	33.8512575742189	21.4297959883422	5.16902718908301	10.3497169352418	14245146.6666667	1	Rps12	0	40S ribosomal protein S12				translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm.			IPR029064;IPR004038;IPR000530;	PF01248;		14525			NA							3 out of 5	Chain (1); Initiator methionine (1); Modified residue (2)		Acetylation;Cytoplasm;Direct protein sequencing;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS01189;	NA	GO:0006412~translation,	GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022627~cytosolic small ribosomal subunit,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000530:Ribosomal protein S12e,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,	PF01248:Ribosomal protein L7Ae/L30e/S12e/Gadd45 family,	SSF55315:L30e-like,	3.68832523145263	1.93290076420395e-06	FDR<0.01	5.71379044222853	18133823.3333333	Unexpected	RBP	ChD	Others	ChD	Others	127	Translation
P35979	P35979	Rpl12	11.413	13.15	19113500	10.2334244108106	26.6410912190963	8.04311107536395	NA	18.7948727587114	33.2303193433689	16553016.6666667	1	Rpl12	0	60S ribosomal protein L12		FUNCTION: Binds directly to 26S ribosomal RNA.		translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]		269261;	cd00349;	IPR000911;IPR036796;IPR020783;IPR036769;IPR020785;IPR020784;	PF00298;PF03946;	SM00649;	17805			NA							4 out of 5	Beta strand (4); Chain (1); Cross-link (1); Helix (2); Modified residue (3); Sequence conflict (1); Turn (2)		3D-structure;Acetylation;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00359;	269261	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR000911:Ribosomal protein L11,IPR020783:Ribosomal protein L11, C-terminal,IPR020784:Ribosomal protein L11, N-terminal,IPR020785:Ribosomal protein L11, conserved site,	PF00298:Ribosomal protein L11, RNA binding domain,PF03946:Ribosomal protein L11, N-terminal domain,	SSF46906:Ribosomal protein L11, C-terminal domain,SSF54747:Ribosomal L11/L12e N-terminal domain,	3.94497779362101	8.64998119408069e-08	FDR<0.01	7.06298483673355	17833258.3333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	131	Translation
Q9JJI8	Q9JJI8	Rpl38	14.278	12.992	17122500	26.4984895860936	28.2861426187311	NA	NA	7.45434215430488	16.6251039068994	11579756.6666667	2	Rpl38	0	60S ribosomal protein L38				90S preribosome assembly [GO:0034463]; axial mesoderm development [GO:0048318]; cytoplasmic translation [GO:0002181]; middle ear morphogenesis [GO:0042474]; ossification [GO:0001503]; regulation of translation [GO:0006417]; ribonucleoprotein complex assembly [GO:0022618]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; eukaryotic 80S initiation complex [GO:0033291]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]		67671;		IPR002675;IPR038464;	PF01781;		8204			NA							5 out of 5	Chain (1); Cross-link (2); Modified residue (2)		3D-structure;Acetylation;Isopeptide bond;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation							67671	GO:0001501~skeletal system development,GO:0001503~ossification,GO:0006412~translation,GO:0006417~regulation of translation,GO:0007605~sensory perception of sound,GO:0034463~90S preribosome assembly,GO:0042474~middle ear morphogenesis,GO:0048318~axial mesoderm development,	GO:0005622~intracellular,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0033291~eukaryotic 80S initiation complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,	IPR002675:Ribosomal protein L38e,	PF01781:Ribosomal L38e protein family,		4.00641798252692	3.43412526491488e-07	FDR<0.01	6.46418386733786	14351128.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	159	Translation
P62918	P62918	Rpl8	7.5353	9.0177	12090150	24.7353319481547	21.218808351723	8.95977062987187	15.5802069051477	29.2628683463553	33.889114816321	16145266.6666667	0	Rpl8	0	60S ribosomal protein L8		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P62917}.		cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P62917}.	26961;		IPR012340;IPR022666;IPR014722;IPR002171;IPR023672;IPR022669;IPR022671;IPR014726;IPR008991;	PF00181;PF03947;	SM01383;SM01382;	28025		REGION 207..232;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (4); Modified residue (1); Region (1)		3D-structure;Cytoplasm;Hydroxylation;Isopeptide bond;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding						PS00467;	26961	GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR002171:Ribosomal protein L2,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR014726:Ribosomal protein L2, domain 3,IPR022666:Ribosomal Proteins L2, RNA binding domain,IPR022669:Ribosomal protein L2, C-terminal,IPR022671:Ribosomal protein L2, conserved site,IPR023672:Ribosomal protein L2, archaeal-type,	PF00181:Ribosomal Proteins L2, RNA binding domain,PF03947:Ribosomal Proteins L2, C-terminal domain,	SSF50104:Translation proteins SH3-like domain,SSF50249:Nucleic acid-binding proteins,	4.02513139666733	2.77353566181016e-08	FDR<0.01	7.55696624563955	14117708.3333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	167	Translation
P47963	P47963	Rpl13	23.672	19.889	19355500	28.1238574682904	16.7523830264855	8.50557114910266	NA	29.3927458703192	38.2848392036753	8107850	1	Rpl13	0	60S ribosomal protein L13 (A52)				blastocyst development [GO:0001824]; bone development [GO:0060348]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		270106;		IPR001380;IPR018256;	PF01294;		24305			NA							3 out of 5	Chain (1); Cross-link (5); Modified residue (5); Sequence conflict (3)		3D-structure;Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01104;	270106	GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001380:Ribosomal protein L13e,IPR018256:Ribosomal protein L13e, conserved site,	PF01294:Ribosomal protein L13e,		4.42621759845339	2.0317160479666e-08	FDR<0.01	7.69213698901525	13731675	Present in Nucleus	RBP	Others	Others	Others	Others	170	Translation
O09167	O09167	Rpl21	14.392	13.014	15552000	22.8164643606827	27.3171797743601	21.3871719742498	15.3985925686392	21.5796288303841	18.9548306385882	11730605	0	Rpl21	0	60S ribosomal protein L21		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P46778}.		translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; ribosome [GO:0005840]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P46778}. Cytoplasm {ECO:0000250|UniProtKB:P46778}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P49666}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:P46778, ECO:0000250|UniProtKB:P49666}.			IPR036948;IPR001147;IPR018259;IPR008991;	PF01157;		18562		REGION 111..145;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Region (1)		3D-structure;Cytoplasm;Endoplasmic reticulum;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS01171;	NA	GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001147:Ribosomal protein L21e,IPR008991:Translation protein SH3-like domain,IPR018259:Ribosomal protein L21e, conserved site,	PF01157:Ribosomal protein L21e,	SSF50104:Translation proteins SH3-like domain,	4.23405249312331	2.33737731966059e-10	FDR<0.01	9.63127117437743	13641302.5	Present in Nucleus	RBP	Others	Others	Others	Others	171	Translation
P51410	P51410	Rpl9	12.623	13.064	13547350	6.76773145641581	9.23616883716634	17.9975883231647	10.7836476766631	9.54562810232913	8.48968503268529	13252433.3333333	0	Rpl9	0	60S ribosomal protein L9				cytoplasmic translation [GO:0002181]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]		20005;		IPR000702;IPR020040;IPR036789;IPR002359;	PF00347;		21881			NA							3 out of 5	Chain (1); Modified residue (1); Natural variant (1)		3D-structure;Acetylation;Reference proteome;Ribonucleoprotein;Ribosomal protein;Tumor antigen						PS00700;	20005	GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,	IPR000702:Ribosomal protein L6,IPR002359:Ribosomal protein L6, conserved site-2,IPR020040:Ribosomal protein L6, alpha-beta domain,	PF00347:Ribosomal protein L6,	SSF56053:Ribosomal protein L6,	3.40906634934469	4.10440556907703e-09	FDR<0.01	8.38674973178766	13399891.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	175	Translation
P62267	P62267	Rps23	16.309	10.323	6996000	16.0570345868525	11.8183752097762	19.9776250599329	14.7149710115071	15.5412230942575	14.2269771941556	19017116.6666667	0	Rps23	0	40S ribosomal protein S23		FUNCTION: Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polypeptide chain. The nascent polypeptides leave the ribosome through a tunnel in the LSU and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel. Plays an important role in translational accuracy. {ECO:0000250|UniProtKB:P62266}.		cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P62266}. Cytoplasm {ECO:0000250|UniProtKB:P62266}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:Q6SA96}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:P62266, ECO:0000250|UniProtKB:Q6SA96}.	66475;	cd03367;	IPR012340;IPR006032;IPR005680;	PF00164;		15808	COMPBIAS 1..24;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Modified residue (3); Region (1)		Acetylation;Cytoplasm;Endoplasmic reticulum;Hydroxylation;Isopeptide bond;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00055;	66475	GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR005680:Ribosomal protein S23, eukaryotic/archaeal,IPR006032:Ribosomal protein S12/S23,IPR012340:Nucleic acid-binding, OB-fold,	PF00164:Ribosomal protein S12/S23,	SSF50249:Nucleic acid-binding proteins,	3.86894894611427	3.37198328509326e-10	FDR<0.01	9.47211458683785	13006558.3333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	179	Translation
P62281	P62281	Rps11	15.924	14.217	6877350	20.4876049989756	28.7952084773094	27.1480928464775	13.6403317328677	19.7839591659083	23.5582359592914	18901050	0	Rps11	0	40S ribosomal protein S11				translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]	rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]		27207;		IPR012340;IPR032440;IPR000266;IPR028333;IPR019979;	PF00366;PF16205;		18431			NA							3 out of 5	Chain (1); Initiator methionine (1); Lipidation (1); Modified residue (8)		Acetylation;Citrullination;Lipoprotein;Methylation;Palmitate;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;rRNA-binding						PS00056;	27207	GO:0001649~osteoblast differentiation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR000266:Ribosomal protein S17,IPR012340:Nucleic acid-binding, OB-fold,IPR019979:Ribosomal protein S17, conserved site,	PF00366:Ribosomal protein S17,	SSF50249:Nucleic acid-binding proteins,	4.3030146221886	2.7860418475106e-10	FDR<0.01	9.5550123645788	12889200	Present in Nucleus	RBP	DBD	DBD	Others	Others	184	Translation
P41105	P41105	Rpl28	17.93	7.1696	13094500	14.3754582177307	33.4873752595272	45.9242250287026	14.7084779667	31.9284802043423	17.8558674380401	11380288.3333333	0	Rpl28	0	60S ribosomal protein L28		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:P46779}.		translation [GO:0006412]	cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]	structural constituent of ribosome [GO:0003735]		19943;		IPR029004;IPR002672;	PF01778;		15733			NA							3 out of 5	Chain (1); Cross-link (2); Initiator methionine (1); Modified residue (2)		3D-structure;Acetylation;Direct protein sequencing;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation							19943	GO:0006412~translation,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR002672:Ribosomal protein L28e,	PF01778:Ribosomal L28e protein family,		4.30901693413258	1.41727890331623e-08	FDR<0.01	7.84854467745024	12237394.1666667	Present in Nucleus	RBP	Others	Others	Others	Others	193	Translation
P97461	P97461	Rps5	6.9313	12.68	14623850	8.60733344809778	7.25689404934688	9.53379731146916	7.27802037845706	4.42948263642807	4.13513625273953	9819766.66666667	0	Rps5	0	40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]				regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]		20103;	cd14867;	IPR000235;IPR005716;IPR020606;IPR023798;IPR036823;	PF00177;		22889			NA							3 out of 5	Chain (2); Cross-link (1); Initiator methionine (1); Modified residue (5); Sequence conflict (1)		Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00052;	20103	GO:0000028~ribosomal small subunit assembly,GO:0006412~translation,GO:0006450~regulation of translational fidelity,	GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR000235:Ribosomal protein S5/S7,IPR005716:Ribosomal protein S5/S7, eukaryotic/archaeal,IPR020606:Ribosomal protein S7, conserved site,IPR023798:Ribosomal protein S7 domain,	PF00177:Ribosomal protein S7p/S5e,	SSF47973:Ribosomal protein S7,	2.84177468539126	6.87910321106744e-08	FDR<0.01	7.16246817453633	12221808.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	194	Translation
P62702	P62702	Rps4x	18.903	19.017	12325500	7.02345835089198	12.7622645362193	7.55972180223768	6.28417017532835	14.1376726563273	15.4249575813667	11948383.3333333	0	Rps4x	0	40S ribosomal protein S4, X isoform				multicellular organism development [GO:0007275]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	20102;	cd06087;cd00165;	IPR032277;IPR005824;IPR041982;IPR014722;IPR000876;IPR013845;IPR038237;IPR013843;IPR018199;IPR002942;	PF16121;PF00467;PF00900;PF08071;PF01479;	SM00363;	29598			NA							4 out of 5	Chain (1); Cross-link (1); Domain (1); Modified residue (1); Sequence conflict (1)		Acetylation;Cytoplasm;Isopeptide bond;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding	DOMAIN 42..104;  /note=S4 RNA-binding					PS00528;PS50889;	20102	GO:0006412~translation,GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0045727~positive regulation of translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR000876:Ribosomal protein S4e,IPR002942:RNA-binding S4 domain,IPR005824:KOW,IPR013843:Ribosomal protein S4e, N-terminal,IPR013845:Ribosomal protein S4e, central region,IPR018199:Ribosomal protein S4e, N-terminal, conserved site,	PF00467:KOW motif,PF00900:Ribosomal family S4e,PF01479:S4 domain,PF08071:RS4NT (NUC023) domain,		3.5393097318364	1.89801935326404e-08	FDR<0.01	7.72169936357736	12136941.6666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	196	Translation
P25444	P25444	Rps2	16.331	7.5075	9793150	14.5475705557172	16.9736060426038	8.81600987393106	10.2334244108106	12.6019180119214	13.5398613518198	14277061.6666667	0	Rps2	0	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3)				cellular response to interleukin-4 [GO:0071353]; formation of translation preinitiation complex [GO:0001731]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; structural constituent of ribosome [GO:0003735]		16898;		IPR000851;IPR005324;IPR020568;IPR014721;IPR005711;IPR013810;IPR018192;	PF00333;PF03719;		31231		REGION 1..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Cross-link (4); Domain (1); Frameshift (1); Initiator methionine (1); Modified residue (7); Region (1); Sequence conflict (1)		Acetylation;Citrullination;Isopeptide bond;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Ubl conjugation	DOMAIN 102..165;  /note=S5 DRBM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00268					PS00585;PS50881;	16898	GO:0000028~ribosomal small subunit assembly,GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0051347~positive regulation of transferase activity,GO:0071353~cellular response to interleukin-4,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0017134~fibroblast growth factor binding,GO:0019899~enzyme binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000851:Ribosomal protein S5,IPR005324:Ribosomal protein S5, C-terminal,IPR005711:Ribosomal protein S5, eukaryotic/archaeal,IPR013810:Ribosomal protein S5, N-terminal,IPR014720:Double-stranded RNA-binding-like domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR018192:Ribosomal protein S5, N-terminal, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,	PF00333:Ribosomal protein S5, N-terminal domain,PF03719:Ribosomal protein S5, C-terminal domain,	SSF54211:Ribosomal protein S5 domain 2-like,	3.59948209297998	2.1310864242016e-09	FDR<0.01	8.67139893752523	12035105.8333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	198	Translation
Q9D8M4	Q9D8M4	Rpl7l1	8.7732	30.626	16943100	12.690999543124	20.5862977602108	NA	7.56830394308635	10.2303883455416	22.4497126436782	7096055	1	Rpl7l1	0	60S ribosomal protein L7-like 1				blastocyst formation [GO:0001825]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		66229;	cd01657;	IPR036919;IPR023106;IPR018038;IPR016082;IPR012988;IPR039699;IPR005998;IPR035808;	PF00327;PF08079;		28544			NA							3 out of 5	Chain (1); Modified residue (1)		Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00634;	66229	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001825~blastocyst formation,GO:0002181~cytoplasmic translation,	GO:0005730~nucleolus,GO:0005840~ribosome,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR005998:Ribosomal protein L7, eukaryotic,IPR012988:Ribosomal protein L30, N-terminal,IPR016082:Ribosomal protein L30, ferredoxin-like fold domain,IPR018038:Ribosomal protein L30, conserved site,	PF00327:Ribosomal protein L30p/L7e,PF08079:Ribosomal L30 N-terminal domain,	SSF55129:Ribosomal protein L30p/L7e,	3.83750265729048	1.22521614168298e-07	FDR<0.01	6.91178729018928	12019577.5	Present in Nucleus	RBP	Others	Others	Others	Others	199	Translation
P14115	P14115	Rpl27a	21.347	18.658	10530200	17.9182569119676	16.3521601203519	5.79777365491651	6.48802958541491	21.2512750765046	13.6349381655554	13029453.3333333	0	Rpl27a	0	60S ribosomal protein L27a (L29)				translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]	structural constituent of ribosome [GO:0003735]		26451;		IPR036227;IPR030878;IPR001196;IPR021131;	PF00828;		16605	COMPBIAS 1..35;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..37;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Modified residue (5); Region (1); Sequence conflict (3)		3D-structure;Acetylation;Hydroxylation;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00475;	26451	GO:0006412~translation,	GO:0005622~intracellular,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001196:Ribosomal protein L15, conserved site,IPR021131:Ribosomal protein L18e/L15P,	PF00828:Ribosomal protein L18e/L15,	SSF52080:Ribosomal proteins L15p and L18e,	3.78055559410435	2.26526259462981e-08	FDR<0.01	7.64488144628322	11779826.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	201	Translation
P99027	P99027	Rplp2	8.5945	8.2808	16003000	7.43107676302296	8.35073068893528	9.21998893601328	5.84966364434045	7.11642470822659	NA	4965600	1	Rplp2	0	60S acidic ribosomal protein P2		FUNCTION: Plays an important role in the elongation step of protein synthesis.		cytoplasmic translational elongation [GO:0002182]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]		67186;	cd05833;	IPR038716;IPR027534;IPR044076;			11651		REGION 76..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Modified residue (9); Region (1); Sequence conflict (3)		Acetylation;Direct protein sequencing;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein							67186	GO:0002181~cytoplasmic translation,GO:0006414~translational elongation,	GO:0005622~intracellular,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0030687~preribosome, large subunit precursor,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0070180~large ribosomal subunit rRNA binding,	IPR027534:Ribosomal protein L12 family,			2.95613269696651	3.41366678446918e-08	FDR<0.01	7.46677887359299	10484300	Present in Nucleus	RBP	Others	Others	Others	Others	219	Translation
Q8JZQ9	Q8JZQ9	Eif3b	8.8882	10.977	7338000	10.4199228925706	8.44951415293621	5.2468649981636	6.42921435000643	9.33706816059757	14.3395901745128	12007266.6666667	0	Eif3b	0	Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) (eIF3 p116)		FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. {ECO:0000255|HAMAP-Rule:MF_03001, ECO:0000269|PubMed:12038979, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; synapse [GO:0045202]	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03001}.	27979;	cd12278;	IPR011400;IPR034363;IPR012677;IPR035979;IPR000504;IPR013979;IPR015943;	PF08662;PF00076;	SM00360;	91370	COMPBIAS 68..91;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..147;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 113..402;  /note=Sufficient for interaction with EIF3E;  /evidence=ECO:0000255|HAMAP-Rule:MF_03001; REGION 159..263;  /note=Sufficient for interaction with EIF3J;  /evidence=ECO:0000255|HAMAP-Rule:MF_03001	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Modified residue (22); Region (3); Repeat (5)		Acetylation;Cytoplasm;Initiation factor;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Repeat;WD repeat	DOMAIN 174..257;  /note=RRM;  /evidence=ECO:0000255|HAMAP-Rule:MF_03001	DOMAIN: The RRM domain mediates interaction with EIF3J. {ECO:0000255|HAMAP-Rule:MF_03001}.		REPEAT 321..359;  /note=WD 1; REPEAT 361..406;  /note=WD 2; REPEAT 410..448;  /note=WD 3; REPEAT 549..590;  /note=WD 4; REPEAT 638..683;  /note=WD 5		PS50102;	27979	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075522~IRES-dependent viral translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0070062~extracellular exosome,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0031369~translation initiation factor binding,	IPR000504:RNA recognition motif domain,IPR011042:Six-bladed beta-propeller, TolB-like,IPR011400:Eukaryotic translation initiation factor 3 subunit B,IPR012677:Nucleotide-binding, alpha-beta plait,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08662:Eukaryotic translation initiation factor eIF2A,	SSF54928:RNA-binding domain, RBD,	3.15118048813198	1.09167283658442e-08	FDR<0.01	7.96190749583889	9672633.33333333	Present in Nucleus	RBP	ChD	Others	ChD	RBD	229	Translation
P62889	P62889	Rpl30	8.1088	4.333	10589000	23.6619185083527	16.8489157722701	8.81678716275789	5.13004668342482	13.5481161344515	14.8723211231577	8381200	0	Rpl30	0	60S ribosomal protein L30				antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-negative bacterium [GO:0050829]; killing of cells of other organism [GO:0031640]; liver regeneration [GO:0097421]; positive regulation of selenocysteine incorporation [GO:1904571]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]	RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; structural constituent of ribosome [GO:0003735]		19946;		IPR039109;IPR029064;IPR000231;IPR022991;IPR004038;	PF01248;		12784			NA							3 out of 5	Chain (1); Cross-link (1); Modified residue (3)		3D-structure;Acetylation;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00709;PS00993;	19946	GO:0006412~translation,GO:0097421~liver regeneration,GO:1904571~positive regulation of selenocysteine incorporation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0035368~selenocysteine insertion sequence binding,GO:0044822~poly(A) RNA binding,	IPR000231:Ribosomal protein L30e,IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45,IPR022991:Ribosomal protein L30e, conserved site,	PF01248:Ribosomal protein L7Ae/L30e/S12e/Gadd45 family,	SSF55315:L30e-like,	3.36596711598743	1.84006676184617e-07	FDR<0.01	6.73516641950383	9485100	Present in Nucleus	RBP	ChD	Others	ChD	Others	232	Translation
P62751	P62751	Rpl23a	14.769	27.437	7938650	10.7493362284879	21.4619908142679	6.69433659124381	2.23124637422464	16.6309102097158	41.8585182084554	7938091.66666667	0	Rpl23a	0	60S ribosomal protein L23a		FUNCTION: Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. Binds a specific region on the 26S rRNA (By similarity). May promote p53/TP53 degradation possibly through the stimulation of MDM2-mediated TP53 polyubiquitination (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P62750}.		ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]	large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]		268449;		IPR012677;IPR019985;IPR012678;IPR001014;IPR005633;IPR013025;	PF00276;PF03939;		17695	COMPBIAS 1..23;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 24..64;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..67;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Initiator methionine (1); Modified residue (5); Region (1)		3D-structure;Acetylation;Citrullination;Isopeptide bond;Methylation;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding						PS00050;	268449	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031932~TORC2 complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0019843~rRNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR001014:Ribosomal protein L23/L25, conserved site,IPR005633:Ribosomal protein L23/L25, N-terminal,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012678:Ribosomal protein L23/L15e core domain,IPR013025:Ribosomal protein L25/L23,IPR019985:Ribosomal protein L23,	PF00276:Ribosomal protein L23,PF03939:Ribosomal protein L23, N-terminal domain,	SSF54189:Ribosomal proteins S24e, L23 and L15e,	3.73205927853832	1.77854912502992e-06	FDR<0.01	5.74993413473191	7938370.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	255	Translation
Q99L45	Q99L45	Eif2s2	30.704	48.656	14162000	21.613677134891	9.3976130062964	15.7128940008171	4.14954977384954	16.4571127641367	9.52653138992093	1486633.33333333	0	Eif2s2	0	Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta)		FUNCTION: eIF-2 functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S preinitiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex. In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B (By similarity). {ECO:0000250}.		formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]	cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]	metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]		67204;		IPR002735;IPR016189;IPR016190;	PF01873;	SM00653;	38092	COMPBIAS 35..49;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 56..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 97..120;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (10); Region (2); Zinc finger (1)		Acetylation;Initiation factor;Isopeptide bond;Metal-binding;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 279..303;  /note=C4-type;  /evidence=ECO:0000255		67204	GO:0001701~in utero embryonic development,GO:0002176~male germ cell proliferation,GO:0006412~translation,GO:0006413~translational initiation,GO:0008584~male gonad development,	GO:0005737~cytoplasm,	GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR002735:Translation initiation factor IF2/IF5,IPR016189:Translation initiation factor IF2/IF5, N-terminal,IPR016190:Translation initiation factor IF2/IF5, zinc-binding,	PF01873:Domain found in IF2B/IF5,	SSF100966:Translation initiation factor 2 beta, aIF2beta, N-terminal domain,SSF75689:Zinc-binding domain of translation initiation factor 2 beta,	3.94131121492052	2.51576247384312e-07	FDR<0.01	6.59933036528116	7824316.66666667	Unexpected	RBP	Others	Others	Others	Others	261	Translation
Q9CZM2	Q9CZM2	Rpl15	8.0823	6.8254	11613500	8.2223318533136	13.637169469105	27.4906531779195	11.0834026045996	8.04764204088202	12.1583503550238	3767488.33333333	0	Rpl15	0	60S ribosomal protein L15				cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]	A band [GO:0031672]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleus [GO:0005634]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P61313}; Lipid-anchor {ECO:0000250|UniProtKB:P61313}.	66480;		IPR024794;IPR000439;IPR020925;IPR012678;	PF00827;	SM01384;	24146	COMPBIAS 172..186;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 165..186;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Initiator methionine (1); Lipidation (1); Modified residue (3); Region (1); Sequence conflict (1)		3D-structure;Isopeptide bond;Lipoprotein;Membrane;Myristate;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01194;	66480	GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0098609~cell-cell adhesion,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000439:Ribosomal protein L15e,IPR012678:Ribosomal protein L23/L15e core domain,IPR020925:Ribosomal protein L15e, conserved site,IPR024794:Ribosomal protein L15e core domain,	PF00827:Ribosomal L15,	SSF54189:Ribosomal proteins S24e, L23 and L15e,	3.43229242304885	2.48255296796697e-08	FDR<0.01	7.60510147658873	7690494.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	263	Translation
Q64368	Q64368	Dazl	10.865	8.7414	12148200	2.35233233751264	5.53709856035437	19.0712310479641	NA	4.99251123315027	3.04971027752363	2498773.33333333	1	Dazl	0	Deleted in azoospermia-like (DAZ-like autosomal) (Deleted in azoospermia-like 1)		FUNCTION: RNA-binding protein, which is essential for gametogenesis in both males and females. Plays a central role during spermatogenesis. Acts by binding to the 3'-UTR of mRNA, specifically recognizing GUU triplets, and thereby regulating the translation of key transcripts. {ECO:0000269|PubMed:22021443, ECO:0000269|PubMed:9288969}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; female meiosis II [GO:0007147]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; oocyte maturation [GO:0001556]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9288969}.	13164;	cd12672;	IPR037366;IPR043628;IPR037551;IPR034779;IPR012677;IPR035979;IPR000504;	PF18872;PF00076;	SM00360;	33313		REGION 1..27;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..132;  /note=Homodimerization	NA							5 out of 5	Beta strand (5); Chain (1); Domain (2); Helix (3); Modified residue (1); Mutagenesis (4); Region (2)		3D-structure;Cytoplasm;Developmental protein;Differentiation;Oogenesis;Phosphoprotein;RNA-binding;Reference proteome;Spermatogenesis;Translation regulation	DOMAIN 40..115;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 167..190;  /note=DAZ;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01238	DOMAIN: The DAZ domain mediates the interaction with DAZAP1 and DAZAP2. {ECO:0000250}.				PS51890;PS50102;	13164	GO:0001556~oocyte maturation,GO:0006417~regulation of translation,GO:0007147~female meiosis II,GO:0007275~multicellular organism development,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0045836~positive regulation of meiotic nuclear division,GO:0045948~positive regulation of translational initiation,GO:0048477~oogenesis,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005737~cytoplasm,GO:0005844~polysome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008494~translation activator activity,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.63635238013438	2.57514514365167e-05	FDR<0.01	4.58919828766724	7323486.66666667	Present in Nucleus	RBP	RBD	Others	Others	RBD	272	Translation
P84099	P84099	Rpl19	35.887	35.454	6441400	7.08365800099171	7.38497895280998	2.89008988179532	1.88047688893903	14.6387164773393	15.4354335813293	6997866.66666667	0	Rpl19	0	60S ribosomal protein L19				cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]	5.8S rRNA binding [GO:1990932]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		19921;	cd01417;	IPR035970;IPR000196;IPR023638;IPR015972;IPR033935;IPR039547;	PF01280;	SM01416;	23466		REGION 157..176;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (1); Modified residue (6); Region (1); Sequence conflict (1)		3D-structure;Citrullination;Direct protein sequencing;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00526;	19921	GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,GO:1990932~5.8S rRNA binding,	IPR000196:Ribosomal protein L19/L19e domain,IPR015972:Ribosomal protein L19/L19e, domain 1,IPR015974:Ribosomal protein L19/L19e, domain 3,IPR023638:Ribosomal protein L19/L19e conserved site,IPR027547:Ribosomal protein L19/L19e,	PF01280:Ribosomal protein L19e,	SSF48140:Ribosomal protein L19 (L19e),	3.2855573110762	2.26713909433901e-05	FDR<0.01	4.6445218340637	6719633.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	294	Translation
P48024	P48024;Q9CXU9	Eif1	11.447	5.0491	7944300	2.0715513848321	7.1285999429712	NA	NA	6.67735042735043	6.80920604657497	2822121.66666667	2	Eif1	0	Eukaryotic translation initiation factor 1 (eIF1) (Protein translation factor SUI1 homolog)		FUNCTION: Necessary for scanning and involved in initiation site selection. Promotes the assembly of 48S ribosomal complexes at the authentic initiation codon of a conventional capped mRNA (By similarity). {ECO:0000250}.		dosage compensation by inactivation of X chromosome [GO:0009048]	eukaryotic 43S preinitiation complex [GO:0016282]	ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]		20918;	cd11566;	IPR001950;IPR036877;IPR005874;	PF01253;		12747			NA							3 out of 5	Chain (1); Initiator methionine (1); Modified residue (3)		Acetylation;Initiation factor;Phosphoprotein;Protein biosynthesis;Reference proteome						PS50296;	20918	GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0009048~dosage compensation by inactivation of X chromosome,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003743~translation initiation factor activity,GO:0044822~poly(A) RNA binding,	IPR001950:Translation initiation factor SUI1,IPR005874:Eukaryotic translation initiation factor SUI1,	PF01253:Translation initiation factor SUI1,	SSF55159:eIF1-like,	2.54066943443574	2.89921378207651e-05	FDR<0.01	4.53771975948012	5383210.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	353	Translation
P62911	P62911;P17932	Rpl32	7.7588	8.0574	5637900	1.87691210420616	19.8657078151695	11.2597396748187	NA	23.0271490086812	15.5325328901384	4664905	1	Rpl32	0	60S ribosomal protein L32				cellular response to dexamethasone stimulus [GO:0071549]; liver regeneration [GO:0097421]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735]		19951;	cd00513;	IPR001515;IPR018263;IPR036351;	PF01655;	SM01393;	15860			NA							3 out of 5	Chain (1); Cross-link (1); Modified residue (2)		3D-structure;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00580;	19951	GO:0006412~translation,GO:0071549~cellular response to dexamethasone stimulus,GO:0097421~liver regeneration,	GO:0005622~intracellular,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001515:Ribosomal protein L32e,IPR018263:Ribosomal protein L32e, conserved site,	PF01655:Ribosomal protein L32,	SSF52042:Ribosomal protein L32e,	3.30890056680331	9.45640912562916e-06	FDR<0.01	5.02427374657709	5151402.5	Present in Nucleus	RBP	Others	Others	Others	Others	364	Translation
Q8QZY1	Q8QZY1	Eif3l	7.8984	16.342	3434550	9.63483957992099	11.3951023849949	7.92707094728498	2.63852242744063	9.50931913275009	7.54773945203412	6725495	0	Eif3l	0	Eukaryotic translation initiation factor 3 subunit L (eIF3l) (66 kDa tyrosine-rich heat shock protein) (67 kDa polymerase-associated factor) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein) (HSP-66Y) (PAF67)		FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. {ECO:0000255|HAMAP-Rule:MF_03011, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03011}.	223691;		IPR019382;IPR000717;IPR011990;	PF10255;		66613			NA							5 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (3); Sequence conflict (3)		Acetylation;Cytoplasm;Initiation factor;Protein biosynthesis;Reference proteome	DOMAIN 331..537;  /note=PCI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01185					PS50250;	223691	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0001650~fibrillar center,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,	GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR011990:Tetratricopeptide-like helical,IPR019382:Translation initiation factor 3 complex subunit L,	PF10255:RNA polymerase I-associated factor PAF67,	SSF48452:TPR-like,	3.04282256464771	2.27364562623109e-07	FDR<0.01	6.64327722415377	5080022.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	370	Translation
Q60872	Q60872;Q8BMJ3	Eif1a;Eif1ax	9.4063	5.0355	5373685	0.212621194080626	9.63483957992099	NA	NA	7.30300153363032	6.51168848082308	3518415	2	Eif1a	0	Eukaryotic translation initiation factor 1A (eIF-1A) (Eukaryotic translation initiation factor 4C) (eIF-4C)		FUNCTION: Seems to be required for maximal rate of protein biosynthesis. Enhances ribosome dissociation into subunits and stabilizes the binding of the initiator Met-tRNA(I) to 40 S ribosomal subunits.				ribosomal large subunit binding [GO:0043023]; translation initiation factor activity [GO:0003743]		13664;	cd05793;	IPR012340;IPR006196;IPR001253;IPR018104;	PF01176;	SM00652;	16502	COMPBIAS 122..144;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 114..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Domain (1); Region (2); Sequence conflict (6)		Initiation factor;Protein biosynthesis;Reference proteome	DOMAIN 22..96;  /note=S1-like					PS01262;PS50832;	13664	GO:0006412~translation,GO:0006413~translational initiation,		GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0043023~ribosomal large subunit binding,GO:0044822~poly(A) RNA binding,	IPR001253:Translation initiation factor 1A (eIF-1A),IPR006196:RNA-binding domain, S1, IF1 type,IPR012340:Nucleic acid-binding, OB-fold,IPR018104:Translation initiation factor 1A (eIF-1A), conserved site,	PF01176:Translation initiation factor 1A / IF-1,	SSF50249:Nucleic acid-binding proteins,	2.02865026040157	0.0152985127249789	FDR<0.1	1.81535078792297	4446050	Unexpected	RBP	DBD	DBD	Others	RBD	398	Translation
P62270	P62270	Rps18	5.4342	5.8942	6773900	13.3123885087462	12.6585483176789	NA	NA	7.57403620389305	NA	2043025	3	Rps18	0	40S ribosomal protein S18 (Ke-3) (Ke3)		FUNCTION: Located at the top of the head of the 40S subunit, it contacts several helices of the 18S rRNA. {ECO:0000250}.		translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	protein kinase binding [GO:0019901]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm.	20084;		IPR027437;IPR001892;IPR010979;IPR018269;	PF00416;		17719			NA							4 out of 5	Chain (1); Cross-link (3); Initiator methionine (1); Modified residue (3); Sequence conflict (1)		Acetylation;Cytoplasm;Isopeptide bond;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding						PS00646;PS50159;	20084	GO:0006412~translation,GO:0042254~ribosome biogenesis,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR001892:Ribosomal protein S13,IPR010979:Ribosomal protein S13-like, H2TH,IPR018269:Ribosomal protein S13, conserved site,IPR027437:30s ribosomal protein S13, C-terminal,	PF00416:Ribosomal protein S13/S18,	SSF46946:S13-like H2TH domain,	3.06383271872758	9.78783760241424e-06	FDR<0.01	5.0093132449762	4408462.5	Present in Nucleus	RBP	Others	Others	Others	Others	399	Translation
P19253	P19253	Rpl13a	5.7193	7.6753	2213900	26.2439638883057	11.059377799405	15.3964588144727	68.719076415613	28.6754795973963	10.8456340899971	6081416.66666667	0	Rpl13a	0	60S ribosomal protein L13a (Transplantation antigen P198) (Tum-P198 antigen)		FUNCTION: Associated with ribosomes but is not required for canonical ribosome function and has extra-ribosomal functions (By similarity). Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation and subsequent phosphorylation dissociates from the ribosome and assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation. In the GAIT complex interacts with m7G cap-bound eIF4G at or near the eIF3-binding site and blocks the recruitment of the 43S ribosomal complex. {ECO:0000250, ECO:0000269|PubMed:23071094}.		cellular response to interferon-gamma [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]		22121;	cd00392;	IPR005822;IPR023563;IPR005755;IPR036899;	PF00572;		23464			NA							5 out of 5	Chain (1); Initiator methionine (1); Modified residue (5); Mutagenesis (1); Natural variant (1)		3D-structure;Acetylation;Citrullination;Direct protein sequencing;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Translation regulation;Tumor antigen						PS00783;	22121	GO:0006412~translation,GO:0006417~regulation of translation,GO:0017148~negative regulation of translation,GO:0032496~response to lipopolysaccharide,GO:0032844~regulation of homeostatic process,GO:0048246~macrophage chemotaxis,GO:0060425~lung morphogenesis,GO:0071346~cellular response to interferon-gamma,GO:1901194~negative regulation of formation of translation preinitiation complex,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0097452~GAIT complex,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR005755:Ribosomal protein L13, eukaryotic/archaeal,IPR005822:Ribosomal protein L13,IPR023563:Ribosomal protein L13, conserved site,	PF00572:Ribosomal protein L13,	SSF52161:Ribosomal protein L13,	3.99564092379603	3.41602752428844e-07	FDR<0.01	6.46647863868607	4147658.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	414	Translation
Q60865	Q60865	Caprin1	11.319	11.868	5026500	3.90076454985177	0.841963458785889	NA	6.63658083355455	7.34861845972957	4.45513677269892	991031.666666667	1	Caprin1	0	Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105)		FUNCTION: May regulate the transport and translation of mRNAs of proteins involved in synaptic plasticity in neurons and cell proliferation and migration in multiple cell types (PubMed:20516077). Binds directly and selectively to MYC and CCND2 RNAs. In neuronal cells, directly binds to several mRNAs associated with RNA granules, including BDNF, CAMK2A, CREB1, MAP2, NTRK2 mRNAs, as well as to GRIN1 and KPNB1 mRNAs, but not to rRNAs (By similarity). {ECO:0000250|UniProtKB:Q14444, ECO:0000269|PubMed:20516077}.		negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]	cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; P-body [GO:0000932]; postsynapse [GO:0098794]; synapse [GO:0045202]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:14764709, ECO:0000269|PubMed:17210633}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q5M9G3}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:Q14444}. Note=Associated with RNA granules (PubMed:17210633). At the leading edge of migrating fibroblasts, colocalizes with DDX3X (By similarity). {ECO:0000250|UniProtKB:Q14444, ECO:0000269|PubMed:17210633}.	53872;		IPR028816;IPR022070;IPR041637;	PF12287;PF18293;		78169	COMPBIAS 1..22;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 325..342;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 530..558;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 570..607;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 639..677;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 325..347;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 358..379;  /note=G3BP1-binding;  /evidence=ECO:0000250; REGION 412..496;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 526..558;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 570..707;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (5); Erroneous gene model prediction (1); Erroneous initiation (1); Frameshift (1); Initiator methionine (1); Modified residue (11); Region (6); Sequence conflict (8)		Acetylation;Cell projection;Coiled coil;Cytoplasm;Differentiation;Glycoprotein;Methylation;Phosphoprotein;Protein synthesis inhibitor;RNA-binding;Reference proteome							53872	GO:0017148~negative regulation of translation,GO:0030154~cell differentiation,GO:0050775~positive regulation of dendrite morphogenesis,GO:0061003~positive regulation of dendritic spine morphogenesis,	GO:0000932~cytoplasmic mRNA processing body,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0042995~cell projection,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR022070:Cytoplasmic activation/proliferation-associated protein-1 C term,	PF12287:Cytoplasmic activation/proliferation-associated protein-1 C term,		2.36409270040443	0.000239162544174721	FDR<0.01	3.62130683526876	3008765.83333333	Unexpected	RBP	Others	Others	Others	Others	502	Translation
Q6ZWN5	Q6ZWN5	Rps9	11.275	9.9071	2865200	5.50964187327824	9.60891707504564	3.9177277179236	2.19211714674032	10.1184874884902	4.89332550401253	2956351.66666667	0	Rps9	0	40S ribosomal protein S9				positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	5.8S rRNA binding [GO:1990932]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	76846;	cd00165;	IPR022801;IPR005710;IPR001912;IPR018079;IPR002942;IPR036986;	PF00163;PF01479;	SM01390;SM00363;	22591		REGION 162..194;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (2); Domain (1); Modified residue (5); Region (1); Sequence conflict (2)		Acetylation;Cytoplasm;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;rRNA-binding	DOMAIN 108..182;  /note=S4 RNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00182					PS00632;PS50889;	76846	GO:0006412~translation,GO:0008284~positive regulation of cell proliferation,GO:0045903~positive regulation of translational fidelity,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:1990932~5.8S rRNA binding,	IPR001912:Ribosomal protein S4/S9, N-terminal,IPR002942:RNA-binding S4 domain,IPR005710:Ribosomal protein S4/S9, eukaryotic/archaeal,IPR018079:Ribosomal protein S4, conserved site,IPR022801:Ribosomal protein S4/S9,	PF00163:Ribosomal protein S4/S9 N-terminal domain,PF01479:S4 domain,		2.65774122133534	1.71929389192743e-06	FDR<0.01	5.76464987972198	2910775.83333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	511	Translation
P60867	P60867	Rps20	9.9742	9.8638	3791700	17.7201282937288	5.79575750550597	10.5234356912845	4.46428571428571	NA	8.23045267489712	1935445	1	Rps20	0	40S ribosomal protein S20				translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.	67427;		IPR001848;IPR018268;IPR027486;IPR036838;IPR005729;	PF00338;	SM01403;	13373			NA							3 out of 5	Chain (1); Cross-link (2); Initiator methionine (1); Modified residue (6)		Acetylation;Cytoplasm;Isopeptide bond;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00361;	67427	GO:0006412~translation,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR001848:Ribosomal protein S10,IPR005729:Ribosomal protein S10, eukaryotic/archaeal,IPR018268:Ribosomal protein S10, conserved site,IPR027486:Ribosomal protein S10 domain,	PF00338:Ribosomal protein S10p/S20e,	SSF54999:Ribosomal protein S10,	3.12822772691952	3.3895819884732e-07	FDR<0.01	6.4698538567506	2863572.5	Present in Nucleus	RBP	Others	Others	Others	Others	518	Translation
Q91WK2	Q91WK2	Eif3h	8.5756	93.639	1423870	31.1100049776008	26.5745415891576	NA	NA	11.6310175977296	12.0182196209454	3984243.33333333	2	Eif3h	0	Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)		FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. {ECO:0000255|HAMAP-Rule:MF_03007, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; translational initiation [GO:0006413]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; polysomal ribosome [GO:0042788]	deubiquitinase activity [GO:0101005]; isopeptidase activity [GO:0070122]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03007}.	68135;	cd08065;	IPR027524;IPR000555;IPR037518;	PF01398;	SM00232;	39832	COMPBIAS 1..18;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 268..290;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..34;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 268..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Domain (1); Modified residue (3); Region (2)		Cytoplasm;Initiation factor;Isopeptide bond;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	DOMAIN 39..173;  /note=MPN;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01182					PS50249;	68135	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0070062~extracellular exosome,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003743~translation initiation factor activity,GO:0044822~poly(A) RNA binding,	IPR000555:JAB1/Mov34/MPN/PAD-1,IPR027524:Eukaryotic translation initiation factor 3 subunit H,	PF01398:JAB1/Mov34/MPN/PAD-1 ubiquitin protease,		4.41126859371125	3.74422019810217e-06	FDR<0.01	5.42663861826497	2704056.66666667	Unexpected	RBP	Others	Others	Others	Others	535	Translation
Q8CGC4	Q8CGC4	Lsm14b	NA	5.261	4369995	NA	NA	NA	NA	NA	17.8262652191739	103830	5	Lsm14b	1	Protein LSM14 homolog B (RNA-associated protein 55B) (mRAP55B)		FUNCTION: Required for oocyte meiotic maturation (PubMed:28458300). May be involved in the storage of translationally inactive mRNAs and protect them from degradation (PubMed:28458300). Plays a role in control of mRNA translation (By similarity). {ECO:0000250|UniProtKB:Q68FI1, ECO:0000269|PubMed:28458300}.		multicellular organism development [GO:0007275]; regulation of translation [GO:0006417]		mRNA binding [GO:0003729]		241846;	cd01736;	IPR025762;IPR019050;IPR025761;IPR025609;IPR010920;IPR025768;	PF09532;PF12701;	SM01199;SM01271;	42310	COMPBIAS 180..213;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 180..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 357..385;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Domain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (8); Motif (2); Region (2); Sequence conflict (1)		Acetylation;Developmental protein;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ribonucleoprotein;Translation regulation;Ubl conjugation	DOMAIN 241..277;  /note=DFDF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00845		MOTIF 310..326;  /note=FFD box; MOTIF 330..350;  /note=TFG box			PS51512;PS51513;PS51536;	241846	GO:0006417~regulation of translation,GO:0007275~multicellular organism development,	GO:0030529~intracellular ribonucleoprotein complex,	GO:0044822~poly(A) RNA binding,	IPR010920:Like-Sm (LSM) domain,IPR019050:FDF domain,IPR025609:Lsm14 N-terminal,IPR025761:FFD box,IPR025762:DFDF domain,IPR025768:TFG box,	PF09532:FDF domain,PF12701:Scd6-like Sm domain,	SSF50182:Sm-like ribonucleoproteins,	3.27563481027184	0.00352084613554375	FDR<0.01	2.45335295361326	2236912.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	588	Translation
Q8BGD9	Q8BGD9	Eif4b	12.53	9.1516	2292450	13.6039614735811	8.58369098712446	8.24606250515379	3.69099029269553	29.7353553374963	22.7961793603392	2019148.33333333	0	Eif4b	0	Eukaryotic translation initiation factor 4B (eIF-4B)		FUNCTION: Required for the binding of mRNA to ribosomes. Functions in close association with EIF4-F and EIF4-A. Binds near the 5'-terminal cap of mRNA in presence of EIF-4F and ATP. Promotes the ATPase activity and the ATP-dependent RNA unwinding activity of both EIF4-A and EIF4-F (By similarity). {ECO:0000250}.		eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]	cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]	ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]		75705;		IPR033107;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	68840	COMPBIAS 49..66;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 173..274;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 282..344;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 345..359;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 368..421;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..462;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 463..477;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 488..509;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 550..582;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..93;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 173..611;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (9); Cross-link (1); Domain (1); Modified residue (23); Region (2)		Acetylation;Initiation factor;Isopeptide bond;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 96..173;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	75705	GO:0001731~formation of translation preinitiation complex,GO:0002181~cytoplasmic translation,GO:0006412~translation,GO:0006413~translational initiation,GO:0097010~eukaryotic translation initiation factor 4F complex assembly,	GO:0005844~polysome,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0033592~RNA strand annealing activity,GO:0034057~RNA strand-exchange activity,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.50517905759183	2.31105394718093e-07	FDR<0.01	6.63618991661975	2155799.16666667	Unexpected	RBP	RBD	Others	Others	RBD	601	Translation
P47964	P47964	Rpl36	4.1998	9.8843	2937050	16.091658084449	15.8747797374311	NA	NA	6.3609185166338	6.6795805223432	718008.333333333	2	Rpl36	0	60S ribosomal protein L36		FUNCTION: Component of the large ribosomal subunit. {ECO:0000250|UniProtKB:Q9Y3U8}.		cytoplasmic translation [GO:0002181]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; synapse [GO:0045202]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9Y3U8}. Cytoplasm {ECO:0000250|UniProtKB:Q9Y3U8}. Note=Detected on cytosolic polysomes. {ECO:0000250|UniProtKB:Q2YGT9, ECO:0000250|UniProtKB:Q9Y3U8}.			IPR038097;IPR000509;	PF01158;		12216			NA							3 out of 5	Chain (1); Modified residue (1)		3D-structure;Acetylation;Cytoplasm;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS01190;	NA	GO:0002181~cytoplasmic translation,GO:0006412~translation,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR000509:Ribosomal protein L36e,	PF01158:Ribosomal protein L36e,		3.13022629812153	4.10124137099218e-06	FDR<0.01	5.3870846703601	1827529.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	648	Translation
Q9CQR2	Q9CQR2	Rps21	1.5995	1.9458	2327400	7.21032518566587	4.79869475502663	5.06919450499316	NA	4.04825520200793	3.97109046144071	607013.333333333	1	Rps21	0	40S ribosomal protein S21				cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]	protein N-terminus binding [GO:0047485]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P63220}. Cytoplasm {ECO:0000250|UniProtKB:P63220}. Rough endoplasmic reticulum {ECO:0000250|UniProtKB:P63221}. Note=Detected on cytosolic polysomes (By similarity). Detected in ribosomes that are associated with the rough endoplasmic reticulum (By similarity). {ECO:0000250|UniProtKB:P63220, ECO:0000250|UniProtKB:P63221}.	66481;		IPR001931;IPR018279;IPR038579;	PF01249;		9141			NA							3 out of 5	Chain (1); Modified residue (2)		Acetylation;Cytoplasm;Endoplasmic reticulum;Reference proteome;Ribonucleoprotein;Ribosomal protein						PS00996;	66481	GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000461~endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006412~translation,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0047485~protein N-terminus binding,	IPR001931:Ribosomal protein S21e,IPR018279:Ribosomal protein S21e, conserved site,	PF01249:Ribosomal protein S21e ,		1.87132611173204	8.18677302298393e-05	FDR<0.01	4.08688725019088	1467206.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	707	Translation
P16254	P16254	Srp14	7.0036	17.34	2147450	1.83402109124255	NA	4.11556506708371	NA	1.9017914875813	NA	274935	3	Srp14	0	Signal recognition particle 14 kDa protein (SRP14)		FUNCTION: Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. SRP9 together with SRP14 and the Alu portion of the SRP RNA, constitutes the elongation arrest domain of SRP. The complex of SRP9 and SRP14 is required for SRP RNA binding.		protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]	SUBCELLULAR LOCATION: Cytoplasm.	20813;		IPR003210;IPR009018;	PF02290;		12510		REGION 90..110;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Beta strand (4); Chain (1); Helix (2); Modified residue (1); Region (1)		3D-structure;Cytoplasm;Direct protein sequencing;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Signal recognition particle							20813	GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0042493~response to drug,GO:0045047~protein targeting to ER,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0030529~intracellular ribonucleoprotein complex,GO:0048500~signal recognition particle,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0008312~7S RNA binding,GO:0030942~endoplasmic reticulum signal peptide binding,GO:0044822~poly(A) RNA binding,	IPR003210:Signal recognition particle, SRP14 subunit,IPR009018:Signal recognition particle, SRP9/SRP14 subunit,	PF02290:Signal recognition particle 14kD protein,	SSF54762:Signal recognition particle alu RNA binding heterodimer, SRP9/14,	2.15351770326248	0.0025080831874501	FDR<0.01	2.60065806303614	1211192.5	Present in Nucleus	RBP	RBD	Others	Others	RBD	770	Translation
Q8VHE0	Q8VHE0	Sec63	1.6457	1.7998	150526.5	3.50557386244128	2.12062091780473	3.14396202093879	2.26101112417473	1.93832257564304	1.90157450368905	2188230	0	Sec63	0	Translocation protein SEC63 homolog		FUNCTION: Mediates cotranslational and post-translational transport of certain precursor polypeptides across endoplasmic reticulum (ER) (PubMed:22375059). Proposed to play an auxiliary role in recognition of precursors with short and apolar signal peptides. May cooperate with SEC62 and HSPA5/BiP to facilitate targeting of small presecretory proteins into the SEC61 channel-forming translocon complex, triggering channel opening for polypeptide translocation to the ER lumen (By similarity). Required for efficient PKD1/Polycystin-1 biogenesis and trafficking to the plasma membrane of the primary cilia (PubMed:21685914). {ECO:0000250|UniProtKB:Q9UGP8, ECO:0000269|PubMed:21685914, ECO:0000269|PubMed:22375059}.		liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]	protein transmembrane transporter activity [GO:0008320]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.	140740;	cd06257;	IPR035892;IPR001623;IPR014756;IPR036869;IPR027137;IPR004179;	PF00226;PF02889;	SM00271;SM00973;	87870	COMPBIAS 520..535;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 540..554;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 576..617;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 734..760;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 492..617;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 720..760;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Domain (3); Modified residue (3); Region (2); Sequence conflict (3); Topological domain (4); Transmembrane (3)		Chaperone;Coiled coil;Endoplasmic reticulum;Membrane;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	DOMAIN 104..165;  /note=J;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00286; DOMAIN 367..457;  /note=SEC63 1; DOMAIN 637..714;  /note=SEC63 2					PS50076;	140740	GO:0001889~liver development,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006620~posttranslational protein targeting to membrane,GO:0006807~nitrogen compound metabolic process,GO:0006810~transport,GO:0010259~multicellular organism aging,GO:0015031~protein transport,GO:0072001~renal system development,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0044822~poly(A) RNA binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR001623:DnaJ domain,IPR004179:Sec63 domain,IPR014756:Immunoglobulin E-set,	PF00226:DnaJ domain,PF02889:Sec63 Brl domain,	SSF46565:Chaperone J-domain,SSF81296:E set domains,	1.14652879673505	0.000123003425449688	FDR<0.01	3.91008279398188	1169378.25	Unexpected	RBP	DBD	DBD	Others	Others	778	Translation
P00375	P00375	Dhfr	8.0905	6.1553	690365	6.76956404007582	8.59919167598246	NA	NA	8.01089481695105	1.89789333839438	1169105	2	Dhfr	0	Dihydrofolate reductase (EC 1.5.1.3)		FUNCTION: Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway (PubMed:25980602). Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis (PubMed:25980602). Binds its own mRNA. {ECO:0000250|UniProtKB:P00374, ECO:0000269|PubMed:25980602}.	PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8-tetrahydrofolate from 7,8-dihydrofolate: step 1/1.	axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; response to nicotine [GO:0035094]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]	dihydrofolate reductase activity [GO:0004146]; dihydrofolic acid binding [GO:0051871]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; methotrexate binding [GO:0051870]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; translation repressor activity, mRNA regulatory element binding [GO:0000900]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25980602}. Cytoplasm {ECO:0000269|PubMed:25980602}.	13361;	cd00209;	IPR012259;IPR024072;IPR017925;IPR001796;	PF00186;		21606		REGION 31..36;  /note=Substrate binding;  /evidence=ECO:0000305|PubMed:15681865	NA			BINDING 10;  /note=NADP; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000269|PubMed:15681865, ECO:0000269|PubMed:17019704; BINDING 65;  /note=Substrate;  /evidence=ECO:0000305|PubMed:15681865; BINDING 71;  /note=Substrate;  /evidence=ECO:0000305|PubMed:15681865	1.5.1.3			5 out of 5	Beta strand (14); Binding site (3); Chain (1); Domain (1); Helix (6); Initiator methionine (1); Modified residue (2); Natural variant (2); Nucleotide binding (4); Region (1); Sequence conflict (7); Turn (1)		3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Methotrexate resistance;Mitochondrion;NADP;One-carbon metabolism;Oxidoreductase;RNA-binding;Reference proteome	DOMAIN 4..185;  /note=DHFR;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00660					PS00075;PS51330;	13361	GO:0006545~glycine biosynthetic process,GO:0006729~tetrahydrobiopterin biosynthetic process,GO:0006730~one-carbon metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0031103~axon regeneration,GO:0031427~response to methotrexate,GO:0035094~response to nicotine,GO:0046452~dihydrofolate metabolic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046654~tetrahydrofolate biosynthetic process,GO:0046655~folic acid metabolic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0055114~oxidation-reduction process,GO:2000121~regulation of removal of superoxide radicals,	GO:0005829~cytosol,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004146~dihydrofolate reductase activity,GO:0005542~folic acid binding,GO:0008144~drug binding,GO:0016491~oxidoreductase activity,GO:0050661~NADP binding,GO:0051870~methotrexate binding,GO:0051871~dihydrofolic acid binding,GO:0070402~NADPH binding,	IPR001796:Dihydrofolate reductase domain,IPR012259:Dihydrofolate reductase,IPR017925:Dihydrofolate reductase conserved site,IPR024072:Dihydrofolate reductase-like domain,	PF00186:Dihydrofolate reductase,	SSF53597:Dihydrofolate reductase-like,	2.57128072239285	2.68409956228324e-05	FDR<0.01	4.57120137876077	929735	Unexpected	RBP	Others	Others	Others	Others	851	Translation
O08582	O08582	Gtpbp1	6.9811	10.518	1045150	2.51958981077881	13.5120527510539	NA	NA	5.80315691736305	4.60087416609156	785425	2	Gtpbp1	0	GTP-binding protein 1 (G-protein 1) (GP-1) (GP1)		FUNCTION: Promotes degradation of target mRNA species. Plays a role in the regulation of circadian mRNA stability. Binds GTP and has GTPase activity (By similarity). {ECO:0000250}.		GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]	cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10938096}.	14904;	cd04165;	IPR039263;IPR035531;IPR027417;IPR000795;IPR009000;IPR009001;	PF00009;		72301	COMPBIAS 573..595;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 622..641;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 167..174;  /note=G1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 206..210;  /note=G2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 252..255;  /note=G3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 308..311;  /note=G4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 366..368;  /note=G5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 573..668;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (2); Frameshift (3); Modified residue (9); Nucleotide binding (3); Region (7); Sequence conflict (1)		3D-structure;Cytoplasm;GTP-binding;Nucleotide-binding;Phosphoprotein;Reference proteome	DOMAIN 158..389;  /note=tr-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059					PS51722;	14904	GO:0006414~translational elongation,GO:0061014~positive regulation of mRNA catabolic process,	GO:0000177~cytoplasmic exosome (RNase complex),GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF50447:Translation proteins,SSF50465:EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.67105877597372	2.46995249100433e-05	FDR<0.01	4.60731140021932	915287.5	Unexpected	RBP	Others	Others	Others	Others	857	Translation
Q9QZD9	Q9QZD9	Eif3i	13.038	24.799	897765	3.10896937665164	3.52746128611238	2.65132433650608	5.73756383039761	3.58667192711883	NA	865878.333333333	1	Eif3i	0	Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1) (TRIP-1) (eIF-3-beta) (eIF3 p36)		FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. {ECO:0000255|HAMAP-Rule:MF_03008, ECO:0000269|PubMed:17581632}.		cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]	eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]	enzyme binding [GO:0019899]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03008}.	54709;		IPR027525;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	36461			NA							5 out of 5	Chain (1); Cross-link (1); Modified residue (3); Repeat (5)		Acetylation;Cytoplasm;Direct protein sequencing;Initiation factor;Isopeptide bond;Phosphoprotein;Protein biosynthesis;Reference proteome;Repeat;Ubl conjugation;WD repeat				REPEAT 8..47;  /note=WD 1; REPEAT 50..91;  /note=WD 2; REPEAT 144..183;  /note=WD 3; REPEAT 186..225;  /note=WD 4; REPEAT 283..324;  /note=WD 5		PS00678;PS50082;PS50294;	54709	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,	GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0070062~extracellular exosome,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003743~translation initiation factor activity,GO:0019899~enzyme binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR027525:Eukaryotic translation initiation factor 3 subunit I,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.50881780348746	9.56460692976176e-05	FDR<0.01	4.0193328731791	881821.666666667	Unexpected	RBP	ChD	Others	ChD	Others	868	Translation
Q8CGC7	Q8CGC7	Eprs	8.1726	6.3764	1129405	5.02386335091686	5.16075759921556	5.30672893228614	8.97424391994974	5.39490720759603	3.13538596601242	427141.666666667	0	Eprs	0	Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]		FUNCTION: Multifunctional protein which is primarily part of the aminoacyl-tRNA synthetase multienzyme complex, also know as multisynthetase complex, that catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA (By similarity). The phosphorylation of EPRS1, induced by interferon-gamma, dissociates the protein from the aminoacyl-tRNA synthetase multienzyme complex and recruits it to the GAIT complex that binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin), suppressing their translation. Interferon-gamma can therefore redirect, in specific cells, the EPRS1 function from protein synthesis to translation inhibition (PubMed:23071094). Also functions as an effector of the mTORC1 signaling pathway by promoting, through SLC27A1, the uptake of long-chain fatty acid by adipocytes. Thereby, it also plays a role in fat metabolism and more indirectly influences lifespan (PubMed:28178239). {ECO:0000250|UniProtKB:P07814, ECO:0000269|PubMed:23071094, ECO:0000269|PubMed:28178239}.		cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P07814}. Membrane {ECO:0000269|PubMed:28178239}; Peripheral membrane protein {ECO:0000305|PubMed:28178239}. Note=Translocates from cytosol to membranes upon phosphorylation at Ser-999. {ECO:0000305|PubMed:28178239}.	107508;	cd00778;	IPR002314;IPR001412;IPR006195;IPR004154;IPR036621;IPR004526;IPR000924;IPR020058;IPR020059;IPR036282;IPR004046;IPR004499;IPR016061;IPR017449;IPR033721;IPR020056;IPR011035;IPR014729;IPR009068;IPR000738;	PF00043;PF03129;PF09180;PF00749;PF03950;PF00587;PF00458;	SM00946;SM00991;	170079	COMPBIAS 710..732;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 804..819;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 875..892;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 956..981;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 982..1000;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 164..759;  /note=Glutamate--tRNA ligase; REGION 294..315;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 709..742;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 760..956;  /note=3 X 57 AA approximate repeats; REGION 795..819;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 869..898;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 956..1011;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1007..1512;  /note=Proline--tRNA ligase; REGION 1121..1123;  /note=L-proline binding;  /evidence=ECO:0000250|UniProtKB:P07814	NA			BINDING 211;  /note=ATP;  /evidence=ECO:0000250; BINDING 398;  /note=ATP;  /evidence=ECO:0000250; BINDING 1152;  /note=L-proline;  /evidence=ECO:0000250|UniProtKB:P07814; BINDING 1242;  /note=L-proline;  /evidence=ECO:0000250|UniProtKB:P07814; BINDING 1276;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P07814	6.1.1.17; 6.1.1.15	METAL 1448;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P07814; METAL 1453;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P07814; METAL 1495;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P07814; METAL 1497;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P07814		5 out of 5	Binding site (5); Chain (1); Compositional bias (5); Domain (3); Metal binding (4); Modified residue (18); Motif (2); Mutagenesis (2); Nucleotide binding (4); Region (9); Sequence caution (1); Sequence conflict (5)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Membrane;Metal-binding;Methylation;Multifunctional enzyme;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Repeat;Translation regulation;Zinc	DOMAIN 749..805;  /note=WHEP-TRS 1; DOMAIN 822..878;  /note=WHEP-TRS 2; DOMAIN 900..956;  /note=WHEP-TRS 3	DOMAIN: The WHEP-TRS domains are involved in RNA binding. {ECO:0000250|UniProtKB:Q7SIA2}.	MOTIF 204..214;  /note='HIGH' region; MOTIF 432..436;  /note='KMSKS' region			PS00178;PS50862;PS00762;PS51185;	107508	GO:0006412~translation,GO:0006417~regulation of translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006424~glutamyl-tRNA aminoacylation,GO:0006433~prolyl-tRNA aminoacylation,GO:0008152~metabolic process,GO:0017148~negative regulation of translation,GO:0043039~tRNA aminoacylation,GO:0071346~cellular response to interferon-gamma,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0097452~GAIT complex,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004818~glutamate-tRNA ligase activity,GO:0004827~proline-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0035613~RNA stem-loop binding,GO:0051020~GTPase binding,	IPR000738:WHEP-TRS,IPR000924:Glutamyl/glutaminyl-tRNA synthetase, class Ib,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR004046:Glutathione S-transferase, C-terminal,IPR004154:Anticodon-binding,IPR004499:Proline-tRNA ligase, class IIa, archaeal-type,IPR004526:Glutamyl-tRNA synthetase, class Ib, archaeal/eukaryotic cytosolic,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR009068:S15/NS1, RNA-binding,IPR010987:Glutathione S-transferase, C-terminal-like,IPR011035:Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain,IPR012336:Thioredoxin-like fold,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR016061:Proline-tRNA ligase, class II, C-terminal,IPR017449:Prolyl-tRNA synthetase, class II,IPR020056:Ribosomal protein L25/Gln-tRNA synthetase, beta-barrel domain,IPR020058:Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain,IPR020059:Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain,IPR020061:Glutamyl/glutaminyl-tRNA synthetase, class Ib, alpha-bundle domain,	PF00043:Glutathione S-transferase, C-terminal domain,PF00458:WHEP-TRS domain,PF00587:tRNA synthetase class II core domain (G, H, P, S and T),PF00749:tRNA synthetases class I (E and Q), catalytic domain,PF03129:Anticodon binding domain,PF03950:tRNA synthetases class I (E and Q), anti-codon binding domain,PF09180:Prolyl-tRNA synthetase, C-terminal,	SSF47060:S15/NS1 RNA-binding domain,SSF47616:GST C-terminal domain-like,SSF50715:Ribosomal protein L25-like,SSF52954:Class II aaRS ABD-related,SSF64586:C-terminal domain of ProRS,	2.50672147520077	1.36123624008797e-07	FDR<0.01	6.86606649723365	778273.333333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	904	Translation
Q14C51	Q14C51	Ptcd3	3.5887	NA	31329	8.5954959601169	4.3859649122807	6.36496722041881	1.88341651756286	7.21917412647993	1.48139369518843	1439393.83333333	0	Ptcd3	1	Pentatricopeptide repeat domain-containing protein 3, mitochondrial (28S ribosomal protein S39, mitochondrial) (MRP-S39)		FUNCTION: Mitochondrial RNA-binding protein that has a role in mitochondrial translation. {ECO:0000250}.		mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]	cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ribosome [GO:0005840]	ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}.	69956;		IPR002885;IPR037387;IPR011990;	PF13812;		77796		REGION 663..685;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Erroneous initiation (1); Modified residue (1); Region (1); Repeat (10); Sequence conflict (5); Transit peptide (1)		Acetylation;Mitochondrion;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Transit peptide;Translation regulation;rRNA-binding				REPEAT 150..184;  /note=PPR 1; REPEAT 185..220;  /note=PPR 2; REPEAT 254..288;  /note=PPR 3; REPEAT 289..329;  /note=PPR 4; REPEAT 330..366;  /note=PPR 5; REPEAT 367..407;  /note=PPR 6; REPEAT 412..446;  /note=PPR 7; REPEAT 454..488;  /note=PPR 8; REPEAT 489..523;  /note=PPR 9; REPEAT 572..606;  /note=PPR 10		PS51375;	69956	GO:0006417~regulation of translation,GO:0032543~mitochondrial translation,	GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0019843~rRNA binding,GO:0043024~ribosomal small subunit binding,GO:0044822~poly(A) RNA binding,	IPR002885:Pentatricopeptide repeat,	PF13041:PPR repeat family ,PF13812:Pentatricopeptide repeat domain,		2.01174722244606	0.000148750843411338	FDR<0.01	3.82754056316007	735361.416666667	Present in Nucleus	RBP	Others	Others	Others	Others	917	Translation
Q8BWY3	Q8BWY3	Etf1	5.0426	3.8797	749630	NA	2.65195714437255	0.974184120798831	NA	NA	2.3448308204563	618928.333333333	3	Etf1	0	Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1)		FUNCTION: Directs the termination of nascent peptide synthesis (translation) in response to the termination codons UAA, UAG and UGA (By similarity). Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (By similarity). {ECO:0000250|UniProtKB:P62495}.		cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]; viral process [GO:0016032]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]	sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P62495}.	225363;		IPR042226;IPR005140;IPR005141;IPR005142;IPR029064;IPR004403;IPR024049;	PF03463;PF03464;PF03465;	SM01194;	49031			NA							4 out of 5	Beta strand (9); Chain (1); Cross-link (2); Helix (5); Initiator methionine (1); Modified residue (4); Motif (1); Sequence conflict (2)		3D-structure;Acetylation;Cytoplasm;Host-virus interaction;Hydroxylation;Isopeptide bond;Methylation;Nonsense-mediated mRNA decay;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation			MOTIF 61..64;  /note=NIKS motif; plays an important role in translational termination;  /evidence=ECO:0000250|UniProtKB:P62495				225363	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0006412~translation,GO:0006415~translational termination,GO:0006479~protein methylation,GO:0016032~viral process,	GO:0005737~cytoplasm,	GO:0003747~translation release factor activity,GO:0016149~translation release factor activity, codon specific,GO:0044822~poly(A) RNA binding,	IPR004403:Peptide chain release factor eRF1/aRF1,IPR005140:eRF1 domain 1/Pelota-like,IPR005141:eRF1 domain 2,IPR005142:eRF1 domain 3,IPR024049:Peptide Chain Release Factor eRF1/aRF1, N-terminal,	PF03463:eRF1 domain 1,PF03464:eRF1 domain 2,PF03465:eRF1 domain 3,	SSF55315:L30e-like,SSF55481:N-terminal domain of eukaryotic peptide chain release factor subunit 1, ERF1,	1.37778411181345	0.00649523808190018	FDR<0.01	2.18740492530528	684279.166666667	Unexpected	RBP	Others	Others	Others	Others	939	Translation
P61514	P61514	Rpl37a	6.5389	NA	784395	NA	NA	NA	NA	NA	6.95265243690468	444499.166666667	5	Rpl37a	1	60S ribosomal protein L37a				translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]	large ribosomal subunit rRNA binding [GO:0070180]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]		19981;		IPR002674;IPR011331;IPR011332;	PF01780;		10275			NA							2 out of 5	Chain (1); Zinc finger (1)		3D-structure;Metal-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Zinc;Zinc-finger					ZN_FING 39..60;  /note=C4-type		19981	GO:0006412~translation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR002674:Ribosomal protein L37ae,IPR011331:Ribosomal protein L37ae/L37e,IPR011332:Ribosomal protein, zinc-binding domain,	PF01780:Ribosomal L37ae protein family,	SSF57829:Zn-binding ribosomal proteins,	2.75330571559629	0.00253399292837484	FDR<0.01	2.5961946014384	614447.083333333	Present in Nucleus	RBP	Others	Others	Others	Others	970	Translation
Q3TBW2	Q3TBW2	Mrpl10	5.1021	9.6095	276530	NA	NA	NA	NA	5.58659217877095	2.33644859813084	746950	4	Mrpl10	0	39S ribosomal protein L10, mitochondrial (L10mt) (MRP-L10)				ribosome biogenesis [GO:0042254]; translation [GO:0006412]	large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]	structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q7Z7H8}.	107732;	cd05797;	IPR043141;IPR001790;			29396		REGION 243..262;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Region (1); Sequence conflict (2); Transit peptide (1)		Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide							107732	GO:0006412~translation,GO:0032543~mitochondrial translation,GO:0042254~ribosome biogenesis,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005762~mitochondrial large ribosomal subunit,GO:0005840~ribosome,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,				2.33045958706009	0.000677463768556501	FDR<0.01	3.16911392633804	511740	Present in Nucleus	RBP	Others	Others	Others	Others	1034	Translation
Q9D0I9	Q9D0I9	Rars	5.4035	8.8534	736730	19.6309383588536	NA	4.44148345547413	NA	2.47408397040996	1.83392018779343	286390.666666667	2	Rars	0	Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)		FUNCTION: Forms part of a macromolecular complex that catalyzes the attachment of specific amino acids to cognate tRNAs during protein synthesis (PubMed:12060739). Modulates the secretion of AIMP1 and may be involved in generation of the inflammatory cytokine EMAP2 from AIMP1. {ECO:0000250|UniProtKB:P54136, ECO:0000269|PubMed:12060739}.		arginyl-tRNA aminoacylation [GO:0006420]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P54136}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P54136}.	104458;	cd00671;	IPR001412;IPR001278;IPR005148;IPR036695;IPR035684;IPR008909;IPR014729;IPR009080;	PF03485;PF05746;PF00750;	SM01016;SM00836;	75674		REGION 1..72;  /note=Could be involved in the assembly of the multisynthetase complex; REGION 200..202;  /note=L-arginine binding;  /evidence=ECO:0000250|UniProtKB:P54136; REGION 529..543;  /note=Interaction with tRNA;  /evidence=ECO:0000250|UniProtKB:Q05506	NA			BINDING 211;  /note=L-arginine;  /evidence=ECO:0000250|UniProtKB:P54136; BINDING 384;  /note=L-arginine;  /evidence=ECO:0000250|UniProtKB:P54136; BINDING 388;  /note=L-arginine;  /evidence=ECO:0000250|UniProtKB:P54136; BINDING 412;  /note=L-arginine;  /evidence=ECO:0000250|UniProtKB:P54136	6.1.1.19			5 out of 5	Binding site (4); Chain (1); Modified residue (1); Motif (1); Region (3); Sequence conflict (10)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Protein biosynthesis;Reference proteome		DOMAIN: The alpha-helical N-terminus (residues 1-72) mediates interaction with AIMP1 and thereby contributes to the assembly of the multisynthetase complex. {ECO:0000250|UniProtKB:P54136}.	MOTIF 201..212;  /note='HIGH' region			PS00178;	104458	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006420~arginyl-tRNA aminoacylation,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004814~arginine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0034618~arginine binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001278:Arginine-tRNA ligase, class Ia,IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR005148:Arginyl tRNA synthetase N-terminal domain,IPR008909:DALR anticodon binding,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	PF00750:tRNA synthetases class I (R),PF03485:Arginyl tRNA synthetase N terminal domain,PF05746:DALR anticodon binding domain,	SSF47323:Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases,SSF55190:Arginyl-tRNA synthetase (ArgRS), N-terminal 'additional' domain,	2.36800832612743	0.000404233230716409	FDR<0.01	3.39336798739778	511560.333333333	Present in Nucleus	RBP	DBD	DBD	ChD	RBD	1035	Translation
Q8C0C7	Q8C0C7	Farsa	3.2311	12.447	490560	NA	3.50176839303848	NA	NA	6.1143381228982	10.2264127789254	427094.166666667	3	Farsa	0	Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)				phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q505J8}.	66590;		IPR006195;IPR004529;IPR002319;IPR040724;IPR040586;IPR040725;IPR036390;	PF18552;PF18554;PF18553;PF01409;		57599		REGION 372..374;  /note=L-phenylalanine binding;  /evidence=ECO:0000250|UniProtKB:Q9Y285	NA			BINDING 329;  /note=L-phenylalanine;  /evidence=ECO:0000250|UniProtKB:Q9Y285; BINDING 435;  /note=L-phenylalanine;  /evidence=ECO:0000250|UniProtKB:Q9Y285	6.1.1.20			3 out of 5	Binding site (2); Chain (1); Initiator methionine (1); Modified residue (4); Region (1); Sequence conflict (5)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome						PS50862;	66590	GO:0006412~translation,GO:0006432~phenylalanyl-tRNA aminoacylation,GO:0043039~tRNA aminoacylation,GO:0051290~protein heterotetramerization,	GO:0005737~cytoplasm,GO:0009328~phenylalanine-tRNA ligase complex,GO:0016020~membrane,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004826~phenylalanine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR002319:Phenylalanyl-tRNA synthetase,IPR004529:Phenylalanyl-tRNA synthetase, class IIc, alpha subunit,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013196:Helix-turn-helix, type 11,	PF01409:tRNA synthetases class II core domain (F),PF08279:HTH domain,	SSF46785:Winged helix DNA-binding domain,	2.62085196443729	0.000107637085250134	FDR<0.01	3.96803807119184	458827.083333333	Unexpected	RBP	DBD	DBD	Others	RBD	1068	Translation
P59325	P59325	Eif5	6.2791	8.0003	622115	NA	5.25568928364955	2.67486960010699	3.22258386774516	NA	NA	205174.5	3	Eif5	0	Eukaryotic translation initiation factor 5 (eIF-5)		FUNCTION: Catalyzes the hydrolysis of GTP bound to the 40S ribosomal initiation complex (40S.mRNA.Met-tRNA[F].eIF-2.GTP) with the subsequent joining of a 60S ribosomal subunit resulting in the release of eIF-2 and the guanine nucleotide. The subsequent joining of a 60S ribosomal subunit results in the formation of a functional 80S initiation complex (80S.mRNA.Met-tRNA[F]).		activation of GTPase activity [GO:0090630]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]		217869;		IPR016024;IPR016021;IPR002735;IPR016189;IPR016190;IPR003307;	PF01873;PF02020;	SM00653;SM00515;	48968	COMPBIAS 150..171;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 143..216;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Domain (1); Modified residue (7); Nucleotide binding (1); Region (1)		GTP-binding;Initiation factor;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	DOMAIN 231..390;  /note=W2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00695					PS51363;	217869	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0090630~activation of GTPase activity,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,	GO:0000166~nucleotide binding,GO:0003743~translation initiation factor activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,GO:0071074~eukaryotic initiation factor eIF2 binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR002735:Translation initiation factor IF2/IF5,IPR003307:W2 domain,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,IPR016189:Translation initiation factor IF2/IF5, N-terminal,IPR016190:Translation initiation factor IF2/IF5, zinc-binding,	PF01873:Domain found in IF2B/IF5,PF02020:eIF4-gamma/eIF5/eIF2-epsilon,	SSF100966:Translation initiation factor 2 beta, aIF2beta, N-terminal domain,SSF48371:ARM repeat,SSF75689:Zinc-binding domain of translation initiation factor 2 beta,	2.23043566836009	0.000123867706742876	FDR<0.01	3.90704190275547	413644.75	Unexpected	RBP	Others	Others	Others	Others	1101	Translation
Q91WQ3	Q91WQ3	Yars	3.4086	4.6211	521365	5.86510263929619	NA	0.851933889930141	NA	4.86523304466284	6.1267001592942	167687.5	2	Yars	0	Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]		FUNCTION: Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr). {ECO:0000250}.		tyrosyl-tRNA aminoacylation [GO:0006437]	cytosol [GO:0005829]; nuclear body [GO:0016604]	ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.	107271;	cd00805;	IPR002305;IPR012340;IPR014729;IPR002547;IPR002307;	PF00579;PF01588;		59105		REGION 339..363;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 39;  /note=Tyrosine;  /evidence=ECO:0000250; BINDING 166;  /note=Tyrosine;  /evidence=ECO:0000250; BINDING 170;  /note=Tyrosine;  /evidence=ECO:0000250; BINDING 173;  /note=Tyrosine;  /evidence=ECO:0000250; BINDING 188;  /note=Tyrosine;  /evidence=ECO:0000250	6.1.1.1			4 out of 5	Binding site (5); Chain (2); Domain (1); Initiator methionine (1); Modified residue (9); Motif (2); Region (1); Sequence conflict (6)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;tRNA-binding	DOMAIN 364..468;  /note=tRNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00209		MOTIF 44..52;  /note='HIGH' region; MOTIF 222..226;  /note='KMSKS' region			PS50886;	107271	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006437~tyrosyl-tRNA aminoacylation,GO:0006438~valyl-tRNA aminoacylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004831~tyrosine-tRNA ligase activity,GO:0004832~valine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR002305:Aminoacyl-tRNA synthetase, class Ic,IPR002307:Tyrosine-tRNA ligase,IPR002547:tRNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,	PF00579:tRNA synthetases class I (W and Y),PF01588:Putative tRNA binding domain,	SSF50249:Nucleic acid-binding proteins,	1.8660007533499	0.000977544567317092	FDR<0.01	3.00986343352425	344526.25	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1140	Translation
Q9DBG7	Q9DBG7	Srpr	3.5279	3.5088	337160	7.52388834549695	3.81533765738268	NA	NA	4.13753154867806	9.26097425449157	284355.166666667	2	Srpr	0	Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha)		FUNCTION: Component of the SRP (signal recognition particle) receptor. Ensures, in conjunction with the signal recognition particle, the correct targeting of the nascent secretory proteins to the endoplasmic reticulum membrane system (By similarity). {ECO:0000250}.		protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; signal recognition particle binding [GO:0005047]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Thought to be anchored in the membrane through an interaction with SR-beta, which contains a bona fide transmembrane domain. {ECO:0000250}.	67398;		IPR003593;IPR011012;IPR027417;IPR007222;IPR013822;IPR036225;IPR000897;IPR042101;	PF04086;PF00448;PF02881;	SM00382;SM00962;SM00963;	69623	COMPBIAS 132..176;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 217..245;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 289..312;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 132..205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 217..246;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 280..314;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Erroneous initiation (1); Modified residue (7); Nucleotide binding (3); Region (3); Sequence conflict (1)		Endoplasmic reticulum;GTP-binding;Membrane;Nucleotide-binding;Phosphoprotein;Receptor;Reference proteome						PS00300;	67398	GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006810~transport,GO:0006886~intracellular protein transport,	GO:0005622~intracellular,GO:0005783~endoplasmic reticulum,GO:0005785~signal recognition particle receptor complex,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005047~signal recognition particle binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR000897:Signal recognition particle, SRP54 subunit, GTPase domain,IPR003593:AAA+ ATPase domain,IPR007222:Signal recognition particle receptor, alpha subunit, N-terminal,IPR011012:Longin-like domain,IPR013822:Signal recognition particle, SRP54 subunit, helical bundle,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00448:SRP54-type protein, GTPase domain,PF02881:SRP54-type protein, helical bundle domain,PF04086:Signal recognition particle, alpha subunit, N-terminal,	SSF47364:Domain of the SRP/SRP receptor G-proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF64356:SNARE-like,	2.28883514181151	1.97773586523962e-05	FDR<0.01	4.70383171068056	310757.583333333	Unexpected	RBP	Others	Others	Others	Others	1175	Translation
Q9WUA2	Q9WUA2	Farsb	4.8365	5.5748	343140	NA	4.19621501405732	NA	NA	2.58277803605558	3.37302256552096	241793.333333333	3	Farsb	0	Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)				phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]	phenylalanine-tRNA ligase complex [GO:0009328]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9NSD9}.	23874;	cd00769;	IPR005146;IPR009061;IPR004531;IPR020825;IPR041616;IPR040659;IPR005147;	PF03483;PF03484;PF18262;PF17759;	SM00873;SM00874;	65697			NA				6.1.1.20			3 out of 5	Chain (1); Domain (1); Sequence conflict (2)		ATP-binding;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Protein biosynthesis;Reference proteome	DOMAIN 302..379;  /note=B5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00816					PS51483;	23874	GO:0006412~translation,GO:0006432~phenylalanyl-tRNA aminoacylation,GO:0051290~protein heterotetramerization,	GO:0005737~cytoplasm,GO:0009328~phenylalanine-tRNA ligase complex,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004826~phenylalanine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR004531:Phenylalanyl-tRNA synthetase, class IIc, beta subunit, archae/euk cytosolic,IPR005146:B3/B4 tRNA-binding domain,IPR005147:tRNA synthetase, B5-domain,IPR009061:DNA binding domain, putative,IPR020825:Phenylalanyl-tRNA synthetase, B3/B4,	PF03483:B3/4 domain,PF03484:tRNA synthetase B5 domain,	SSF46955:Putative DNA-binding domain,SSF56037:PheT/TilS domain,	1.98898753684323	0.000107241235258881	FDR<0.01	3.96963819223647	292466.666666667	Unexpected	RBP	DBD	DBD	Others	RBD	1191	Translation
Q922B2	Q922B2	Dars	1.7446	5.2293	277549.5	4.67333395644453	3.70233246945576	NA	NA	4.28210508285873	2.14279592011657	248867.166666667	2	Dars	0	Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)		FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000250|UniProtKB:P15178}.		aspartyl-tRNA aminoacylation [GO:0006422]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202]	aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm.	226414;		IPR004364;IPR006195;IPR004523;IPR002312;IPR012340;IPR004365;	PF00152;PF01336;		57147		REGION 251..254;  /note=Aspartate;  /evidence=ECO:0000250	NA			BINDING 229;  /note=Aspartate;  /evidence=ECO:0000250; BINDING 273;  /note=Aspartate;  /evidence=ECO:0000250; BINDING 424;  /note=ATP;  /evidence=ECO:0000250; BINDING 427;  /note=Aspartate;  /evidence=ECO:0000250; BINDING 431;  /note=Aspartate;  /evidence=ECO:0000250	6.1.1.12			4 out of 5	Binding site (5); Chain (1); Modified residue (4); Nucleotide binding (3); Region (1); Sequence conflict (1)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome						PS50862;	226414	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006422~aspartyl-tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004815~aspartate-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR002312:Aspartyl/Asparaginyl-tRNA synthetase, class IIb,IPR004364:Aminoacyl-tRNA synthetase, class II (D/K/N),IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type,IPR004523:Aspartyl-tRNA synthetases,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR012340:Nucleic acid-binding, OB-fold,IPR018150:Aminoacyl-tRNA synthetase, class II (D/K/N)-like,	PF00152:tRNA synthetases class II (D, K and N) ,PF01336:OB-fold nucleic acid binding domain,	SSF50249:Nucleic acid-binding proteins,	1.75003589641538	0.000189420304751653	FDR<0.01	3.72257346900249	263208.333333333	Unexpected	RBP	DBD	DBD	Others	RBD	1225	Translation
Q8BU30	Q8BU30	Iars	5.0209	9.1567	105165	3.95538327663951	3.70096225018505	NA	7.66753565404079	1.36654959891769	2.98338255914556	331391.666666667	1	Iars	0	Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)		FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000269|PubMed:12060739}.		isoleucyl-tRNA aminoacylation [GO:0006428]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]	aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P41252}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P41252}.	105148;	cd07961;	IPR001412;IPR002300;IPR033709;IPR002301;IPR023586;IPR013155;IPR014729;IPR009080;IPR009008;	PF08264;PF00133;		144271			NA			BINDING 603;  /note=ATP;  /evidence=ECO:0000250	6.1.1.5			5 out of 5	Binding site (1); Chain (1); Modified residue (3); Motif (2); Sequence conflict (1)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome			MOTIF 48..58;  /note='HIGH' region; MOTIF 600..604;  /note='KMSKS' region			PS00178;	105148	GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006428~isoleucyl-tRNA aminoacylation,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0002161~aminoacyl-tRNA editing activity,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004822~isoleucine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0051020~GTPase binding,	IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site,IPR002300:Aminoacyl-tRNA synthetase, class Ia,IPR002301:Isoleucine-tRNA ligase,IPR009008:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class Ia, editing domain,IPR009080:Aminoacyl-tRNA synthetase, class 1a, anticodon-binding,IPR013155:Valyl/Leucyl/Isoleucyl-tRNA synthetase, class I, anticodon-binding,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR023586:Isoleucine-tRNA ligase, type 2,	PF00133:tRNA synthetases class I (I, L, M and V),PF08264:Anticodon-binding domain of tRNA,	SSF47323:Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases,SSF50677:ValRS/IleRS/LeuRS editing domain,	2.05153449237069	8.92669346374156e-05	FDR<0.01	4.04930937833147	218278.333333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1266	Translation
P50431	P50431	Shmt1	NA	8.7365	8714.5	NA	1.25705522243592	NA	NA	NA	3.52708803611738	393718.333333333	4	Shmt1	1	Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)		FUNCTION: Interconversion of serine and glycine. {ECO:0000250|UniProtKB:P34896}.	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion. {ECO:0000250|UniProtKB:P34896}.	cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm.	20425;	cd00378;	IPR015424;IPR015422;IPR015421;IPR001085;IPR019798;IPR039429;	PF00464;		52601			NA				2.1.2.1			5 out of 5	Beta strand (17); Chain (1); Helix (25); Modified residue (1); Sequence conflict (5); Turn (4)	MISCELLANEOUS: In eukaryotes there are two forms of the enzymes: a cytosolic one and a mitochondrial one. {ECO:0000305}.	3D-structure;Cytoplasm;Direct protein sequencing;One-carbon metabolism;Pyridoxal phosphate;Reference proteome;Transferase						PS00096;	20425	GO:0006231~dTMP biosynthetic process,GO:0006544~glycine metabolic process,GO:0006545~glycine biosynthetic process,GO:0006563~L-serine metabolic process,GO:0006565~L-serine catabolic process,GO:0006730~one-carbon metabolic process,GO:0009113~purine nucleobase biosynthetic process,GO:0019264~glycine biosynthetic process from serine,GO:0035999~tetrahydrofolate interconversion,GO:0046653~tetrahydrofolate metabolic process,GO:0046655~folic acid metabolic process,GO:0051262~protein tetramerization,GO:0051289~protein homotetramerization,GO:1904482~cellular response to tetrahydrofolate,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004372~glycine hydroxymethyltransferase activity,GO:0008732~L-allo-threonine aldolase activity,GO:0016597~amino acid binding,GO:0016740~transferase activity,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0070905~serine binding,	IPR001085:Serine hydroxymethyltransferase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR019798:Serine hydroxymethyltransferase, pyridoxal phosphate binding site,	PF00464:Serine hydroxymethyltransferase,	SSF53383:PLP-dependent transferases,	1.75852701345064	0.0253260104330895	FDR<0.1	1.59643321855362	201216.416666667	Present in Nucleus	RBP	Others	Others	Others	Others	1278	Translation
Q9CQS8	Q9CQS8	Sec61b	2.3276	3.0817	282520	NA	4.94731113639737	NA	NA	1.76678445229682	NA	55245	4	Sec61b	0	Protein transport protein Sec61 subunit beta		FUNCTION: Component of SEC61 channel-forming translocon complex that mediates transport of signal peptide-containing precursor polypeptides across the endoplasmic reticulum (ER). Component of a ribosome-associated ER translocon complex involved in multi-pass membrane protein transport into the ER membrane and biogenesis. The SEC61 channel cooperates with the translocating protein TRAM1 to import nascent proteins into the ER (By similarity). Required for PKD1/Polycystin-1 biogenesis (PubMed:28375157). {ECO:0000250|UniProtKB:P60468, ECO:0000269|PubMed:28375157}.		posttranslational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]; ubiquitin-dependent ERAD pathway [GO:0030433]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]	epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P60468}; Single-pass membrane protein {ECO:0000255}.	66212;		IPR030671;IPR016482;	PF03911;		9958	COMPBIAS 1..17;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 31..54;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Initiator methionine (1); Lipidation (1); Modified residue (6); Region (1); Topological domain (1); Transmembrane (1)		Acetylation;Direct protein sequencing;Endoplasmic reticulum;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport							66212	GO:0000060~protein import into nucleus, translocation,GO:0006616~SRP-dependent cotranslational protein targeting to membrane, translocation,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0015031~protein transport,GO:0030433~ER-associated ubiquitin-dependent protein catabolic process,GO:0030970~retrograde protein transport, ER to cytosol,GO:0031204~posttranslational protein targeting to membrane, translocation,	GO:0005783~endoplasmic reticulum,GO:0005784~Sec61 translocon complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031205~endoplasmic reticulum Sec complex,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0015450~P-P-bond-hydrolysis-driven protein transmembrane transporter activity,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0048408~epidermal growth factor binding,	IPR016482:Preprotein translocase Sec, Sec61-beta subunit, eukarya,	PF03911:Sec61beta family,		1.49258506260879	0.0042979290214939	FDR<0.01	2.36674076097768	168882.5	Unexpected	RBP	Others	Others	Others	Others	1311	Translation
Q9Z0N1	Q9Z0N1	Eif2s3x	28.135	9.8621	43074.5	NA	9.80103891012447	4.46488368977988	NA	3.96353547364249	3.51432085749429	246298.833333333	2	Eif2s3x	0	Eukaryotic translation initiation factor 2 subunit 3, X-linked (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma, X-linked) (eIF-2-gamma X)		FUNCTION: As a subunit of eukaryotic initiation factor 2 (eIF-2), involved in the early steps of protein synthesis. In the presence of GTP, eIF-2 forms a ternary complex with initiator tRNA Met-tRNAi and then recruits the 40S ribosomal complex and initiation factors eIF-1, eIF-1A and eIF-3 to form the 43S pre-initiation complex (43S PIC), a step that determines the rate of protein translation. The 43S PIC binds to mRNA and scans downstream to the initiation codon, where it forms a 48S initiation complex by codon-anticodon base pairing. This leads to the displacement of eIF-1 to allow GTPase-activating protein (GAP) eIF-5-mediated hydrolysis of eIF2-bound GTP. Hydrolysis of GTP and release of Pi, which makes GTP hydrolysis irreversible, causes the release of the eIF-2-GDP binary complex from the 40S subunit, an event that is essential for the subsequent joining of the 60S ribosomal subunit to form an elongation-competent 80S ribosome. In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must be exchanged with GTP by way of a reaction catalyzed by GDP-GTP exchange factor (GEF) eIF-2B (By similarity). Along with its paralog on chromosome Y, may contribute to spermatogenesis up to the round spermatid stage (PubMed:26823431). {ECO:0000250|UniProtKB:P32481, ECO:0000269|PubMed:26823431}.		formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]		26905;	cd01888;cd03688;cd15490;	IPR004161;IPR015256;IPR044127;IPR044128;IPR027417;IPR000795;IPR009000;IPR009001;	PF09173;PF00009;PF03144;		51065		REGION 48..55;  /note=G1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 76..80;  /note=G2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 134..137;  /note=G3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 190..193;  /note=G4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059; REGION 225..227;  /note=G5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059	NA				3.6.5.3			4 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (2); Nucleotide binding (3); Region (5)	MISCELLANEOUS: Encoded by an chromosome X-linked gene which escapes inactivation. Has a homolog on chromosome Y (Eif2s3y). {ECO:0000269|PubMed:9736774}.	Acetylation;GTP-binding;Hydrolase;Initiation factor;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome	DOMAIN 39..248;  /note=tr-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059					PS51722;	26905	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0098609~cell-cell adhesion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003743~translation initiation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008135~translation factor activity, RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR015256:Translation initiation factor 2, gamma subunit, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF03144:Elongation factor Tu domain 2,PF09173:Initiation factor eIF2 gamma, C terminal,	SSF50447:Translation proteins,SSF50465:EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.89463000341732	5.74065891728987e-05	FDR<0.01	4.24103825608298	144686.666666667	Unexpected	RBP	Others	Others	Others	Others	1340	Translation
Q9CQN1	Q9CQN1	Trap1	3.0276	NA	21203.5	NA	4.47607537710935	1.34927274199207	NA	3.94742036079422	3.58692922988629	180612.166666667	2	Trap1	1	Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)		FUNCTION: Chaperone that expresses an ATPase activity. Involved in maintaining mitochondrial function and polarization, downstream of PINK1 and mitochondrial complex I. Is a negative regulator of mitochondrial respiration able to modulate the balance between oxidative phosphorylation and aerobic glycolysis. The impact of TRAP1 on mitochondrial respiration is probably mediated by modulation of mitochondrial SRC and inhibition of SDHA. {ECO:0000250}.		negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]	mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}. Mitochondrion inner membrane {ECO:0000250}. Mitochondrion matrix {ECO:0000250}.	68015;		IPR003594;IPR036890;IPR037196;IPR001404;IPR020575;IPR020568;	PF00183;	SM00387;	80209			NA			BINDING 121;  /note=ATP;  /evidence=ECO:0000250; BINDING 160;  /note=ATP;  /evidence=ECO:0000250; BINDING 173;  /note=ATP;  /evidence=ECO:0000250; BINDING 207;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250; BINDING 404;  /note=ATP;  /evidence=ECO:0000250				4 out of 5	Binding site (5); Chain (1); Modified residue (11); Transit peptide (1)		ATP-binding;Acetylation;Chaperone;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Transit peptide							68015	GO:0006457~protein folding,GO:0006950~response to stress,GO:0009386~translational attenuation,GO:1901856~negative regulation of cellular respiration,GO:1903751~negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,	GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005811~lipid particle,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR001404:Heat shock protein Hsp90,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020575:Heat shock protein Hsp90, N-terminal,	PF00183:Hsp90 protein,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,	1.6032500778003	0.00121249064203743	FDR<0.01	2.91632160458317	100907.833333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	1382	Translation
Q9D0R2	Q9D0R2	Tars	2.2123	2.4174	89755	NA	4.76417341591234	NA	3.88078236572493	5.51845924617847	2.52054242072894	88685.8333333333	2	Tars	0	Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)		FUNCTION: Catalyzes the attachment of threonine to tRNA(Thr) in a two-step reaction: threonine is first activated by ATP to form Thr-AMP and then transferred to the acceptor end of tRNA(Thr). Also edits incorrectly charged tRNA(Thr) via its editing domain, at the post-transfer stage. {ECO:0000269|PubMed:29579307}.		threonyl-tRNA aminoacylation [GO:0006435]	cytoplasm [GO:0005737]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:29579307}.	110960;	cd00771;	IPR002314;IPR006195;IPR004154;IPR036621;IPR012675;IPR004095;IPR012676;IPR002320;IPR018163;IPR033728;IPR012947;	PF03129;PF02824;PF00587;PF07973;	SM00863;	83356	COMPBIAS 16..40;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				6.1.1.3			5 out of 5	Chain (1); Compositional bias (1); Domain (1); Modified residue (4); Mutagenesis (2); Region (1); Sequence conflict (6)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;Ligase;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	DOMAIN 78..142;  /note=TGS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01228					PS50862;PS51880;	110960	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006435~threonyl-tRNA aminoacylation,GO:0043039~tRNA aminoacylation,	GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004829~threonine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,	IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR002320:Threonine-tRNA ligase, class IIa,IPR004095:TGS,IPR004154:Anticodon-binding,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR012675:Beta-grasp domain,IPR012676:TGS-like,IPR012947:Threonyl/alanyl tRNA synthetase, SAD,IPR018163:Threonyl/alanyl tRNA synthetase, class II-like, putative editing domain,	PF00587:tRNA synthetase class II core domain (G, H, P, S and T),PF02824:TGS domain,PF03129:Anticodon binding domain,PF07973:Threonyl and Alanyl tRNA synthetase second additional domain,	SSF52954:Class II aaRS ABD-related,SSF55186:ThrRS/AlaRS common domain,SSF81271:TGS-like,	1.73759607711652	0.00012607860557321	FDR<0.01	3.89935860311602	89220.4166666667	Unexpected	RBP	ChD	Others	ChD	RBD	1395	Translation
P51881	P51881	Slc25a5	1.2591	1.3539	4757050	6.29287017808823	4.84613520717228	NA	NA	NA	4.77691793254992	148193.333333333	3	Slc25a5	0	ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]		FUNCTION: ADP:ATP antiporter that mediates import of ADP into the mitochondrial matrix for ATP synthesis, and export of ATP out to fuel the cell (PubMed:31341297). Cycles between the cytoplasmic-open state (c-state) and the matrix-open state (m-state): operates by the alternating access mechanism with a single substrate-binding site intermittently exposed to either the cytosolic (c-state) or matrix (m-state) side of the inner mitochondrial membrane (By similarity). In addition to its ADP:ATP antiporter activity, also involved in mitochondrial uncoupling and mitochondrial permeability transition pore (mPTP) activity (PubMed:31489369, PubMed:31341297). Plays a role in mitochondrial uncoupling by acting as a proton transporter: proton transport uncouples the proton flows via the electron transport chain and ATP synthase to reduce the efficiency of ATP production and cause mitochondrial thermogenesis (PubMed:31341297). Proton transporter activity is inhibited by ADP:ATP antiporter activity, suggesting that SLC25A5/ANT2 acts as a master regulator of mitochondrial energy output by maintaining a delicate balance between ATP production (ADP:ATP antiporter activity) and thermogenesis (proton transporter activity) (PubMed:31341297). Proton transporter activity requires free fatty acids as cofactor, but does not transport it (PubMed:31341297). Probably mediates mitochondrial uncoupling in tissues that do not express UCP1 (PubMed:31341297). Also plays a key role in mPTP opening, a non-specific pore that enables free passage of the mitochondrial membranes to solutes of up to 1.5 kDa, and which contributes to cell death (PubMed:31489369). It is however unclear if SLC25A5/ANT2 constitutes a pore-forming component of mPTP or regulates it (PubMed:31489369). Acts as a regulator of mitophagy independently of ADP:ATP antiporter activity: promotes mitophagy via interaction with TIMM44, leading to inhibit the presequence translocase TIMM23, thereby promoting stabilization of PINK1 (PubMed:31618756). As part of the mitotic spindle-associated MMXD complex it may play a role in chromosome segregation (By similarity). {ECO:0000250|UniProtKB:G2QNH0, ECO:0000250|UniProtKB:P05141, ECO:0000269|PubMed:31341297, ECO:0000269|PubMed:31489369, ECO:0000269|PubMed:31618756}.		adaptive thermogenesis [GO:1990845]; adenine nucleotide transport [GO:0051503]; B cell differentiation [GO:0030183]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; erythrocyte differentiation [GO:0030218]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitophagy [GO:1901526]; regulation of mitochondrial membrane permeability [GO:0046902]	membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; myelin sheath [GO:0043209]	adenine nucleotide transmembrane transporter activity [GO:0000295]; ATP:ADP antiporter activity [GO:0005471]; oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P02722}; Multi-pass membrane protein {ECO:0000255}. Membrane {ECO:0000250|UniProtKB:P05141}; Multi-pass membrane protein {ECO:0000255}. Note=May localize to non-mitochondrial membranes. {ECO:0000250|UniProtKB:P05141}.	11740;		IPR002113;IPR002067;IPR018108;IPR023395;	PF00153;		32931		REGION 235..240;  /note=Important for transport activity;  /evidence=ECO:0000250|UniProtKB:P12235	NA		ACTIVITY REGULATION: The matrix-open state (m-state) is inhibited by the membrane-permeable bongkrekic acid (BKA) (By similarity). The cytoplasmic-open state (c-state) is inhibited by the membrane-impermeable toxic inhibitor carboxyatractyloside (CATR) (By similarity). Proton transporter activity is inhibited by ADP:ATP antiporter activity (PubMed:31341297). {ECO:0000250|UniProtKB:G2QNH0, ECO:0000269|PubMed:31341297}.	BINDING 80;  /note=ADP;  /evidence=ECO:0000250|UniProtKB:P02722; BINDING 92;  /note=ADP;  /evidence=ECO:0000250|UniProtKB:P02722; BINDING 235;  /note=ADP;  /evidence=ECO:0000250|UniProtKB:P02722				5 out of 5	Binding site (3); Chain (2); Initiator methionine (1); Modified residue (22); Motif (1); Region (1); Repeat (3); Topological domain (7); Transmembrane (6)		Acetylation;Antiport;Chromosome partition;Direct protein sequencing;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport		DOMAIN: The transmembrane helices are not perpendicular to the plane of the membrane, but cross the membrane at an angle. Odd-numbered transmembrane helices exhibit a sharp kink, due to the presence of a conserved proline residue. {ECO:0000250|UniProtKB:P02722}.	MOTIF 235..240;  /note=Nucleotide carrier signature motif;  /evidence=ECO:0000250|UniProtKB:P02722	REPEAT 6..98;  /note=Solcar 1; REPEAT 111..201;  /note=Solcar 2; REPEAT 212..297;  /note=Solcar 3		PS50920;	11740	GO:0006412~translation,GO:0006810~transport,GO:0007059~chromosome segregation,GO:0008284~positive regulation of cell proliferation,GO:0055085~transmembrane transport,GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0042645~mitochondrial nucleoid,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0071817~MMXD complex,	GO:0003735~structural constituent of ribosome,GO:0005215~transporter activity,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,	IPR002067:Mitochondrial carrier protein,IPR002113:Adenine nucleotide translocator 1,IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,	PF00153:Mitochondrial carrier protein,	SSF103506:Mitochondrial carrier,	1.59122939638476	0.0060325162014697	FDR<0.01	2.21950150303717	2452621.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	564	Translation
P05064	P05064;P05063	Aldoa	2.3603	2.4358	11319450	5.47675119119338	4.52632055402164	10.9071474537264	10.972853161279	4.17588842026141	2.98739320069308	1536591.66666667	0	Aldoa	0	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Aldolase 1) (Muscle-type aldolase)		FUNCTION: Plays a key role in glycolysis and gluconeogenesis. In addition, may also function as scaffolding protein (By similarity). {ECO:0000250}.	PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4.	ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; methylglyoxal biosynthetic process [GO:0019242]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of cell migration [GO:0030335]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm fibrous sheath [GO:0035686]; sperm head [GO:0061827]; Z disc [GO:0030018]	cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; protease binding [GO:0002020]	SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, I band. Cytoplasm, myofibril, sarcomere, M line. Note=In skeletal muscle, accumulates around the M line and within the I band, colocalizing with FBP2 on both sides of the Z line in the absence of Ca(2+). {ECO:0000250}.	11674;		IPR029768;IPR013785;IPR000741;	PF00274;		39356			NA	ACT_SITE 188;  /note=Proton acceptor;  /evidence=ECO:0000250; ACT_SITE 230;  /note=Schiff-base intermediate with dihydroxyacetone-P		BINDING 56;  /note=Substrate; BINDING 147;  /note=Substrate	4.1.2.13			5 out of 5	Active site (2); Binding site (2); Chain (1); Cross-link (2); Initiator methionine (1); Modified residue (14); Sequence conflict (1); Site (1)	MISCELLANEOUS: In vertebrates, three forms of this ubiquitous glycolytic enzyme are found, aldolase A in muscle, aldolase B in liver and aldolase C in brain.	Acetylation;Cytoplasm;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Lyase;Phosphoprotein;Reference proteome;Schiff base;Ubl conjugation						PS00158;	11674	GO:0001666~response to hypoxia,GO:0006000~fructose metabolic process,GO:0006096~glycolytic process,GO:0006754~ATP biosynthetic process,GO:0006941~striated muscle contraction,GO:0008360~regulation of cell shape,GO:0009408~response to heat,GO:0030388~fructose 1,6-bisphosphate metabolic process,GO:0032496~response to lipopolysaccharide,GO:0035094~response to nicotine,GO:0043627~response to estrogen,GO:0046716~muscle cell cellular homeostasis,GO:0051289~protein homotetramerization,GO:0061615~glycolytic process through fructose-6-phosphate,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0031430~M band,GO:0035686~sperm fibrous sheath,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004332~fructose-bisphosphate aldolase activity,GO:0008092~cytoskeletal protein binding,GO:0044822~poly(A) RNA binding,GO:0070061~fructose binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000741:Fructose-bisphosphate aldolase, class-I,IPR013785:Aldolase-type TIM barrel,	PF00274:Fructose-bisphosphate aldolase class-I,		2.21238300751038	1.30779526535331e-05	FDR<0.01	4.88346023925851	6428020.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	300	metabolic process
P16460	P16460	Ass1	6.4843	6.6929	5872570	4.56537618699781	4.62577481728189	4.87519500780031	NA	3.66488309022942	4.01139235428617	2652326.33333333	1	Ass1	0	Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)		FUNCTION: One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues. {ECO:0000250|UniProtKB:P00966}.	PATHWAY: Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. {ECO:0000250|UniProtKB:P00966}.; PATHWAY: Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. {ECO:0000250|UniProtKB:P00966}.	acute-phase response [GO:0006953]; aging [GO:0007568]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to interferon-gamma [GO:0071346]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]	cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]	amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; toxic substance binding [GO:0015643]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P00966}.	11898;	cd01999;	IPR001518;IPR018223;IPR023434;IPR024074;IPR014729;	PF00764;		46584			NA			BINDING 36;  /note=ATP; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000250; BINDING 87;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 92;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 119;  /note=Aspartate;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 123;  /note=Aspartate;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 123;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 124;  /note=Aspartate;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 127;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 180;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 189;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 270;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966; BINDING 282;  /note=Citrulline;  /evidence=ECO:0000250|UniProtKB:P00966	6.3.4.5			5 out of 5	Binding site (12); Chain (1); Modified residue (8); Nucleotide binding (2)		ATP-binding;Acetylation;Amino-acid biosynthesis;Arginine biosynthesis;Cytoplasm;Direct protein sequencing;Ligase;Nucleotide-binding;Phosphoprotein;Reference proteome;Urea cycle						PS00564;PS00565;	11898	GO:0000050~urea cycle,GO:0000052~citrulline metabolic process,GO:0000053~argininosuccinate metabolic process,GO:0006526~arginine biosynthetic process,GO:0006531~aspartate metabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0010043~response to zinc ion,GO:0010046~response to mycotoxin,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0051384~response to glucocorticoid,GO:0071499~cellular response to laminar fluid shear stress,GO:1903038~negative regulation of leukocyte cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005764~lysosome,GO:0005783~endoplasmic reticulum,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0070852~cell body fiber,	GO:0000166~nucleotide binding,GO:0004055~argininosuccinate synthase activity,GO:0005524~ATP binding,GO:0015643~toxic substance binding,GO:0016597~amino acid binding,GO:0016874~ligase activity,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR001518:Argininosuccinate synthase,IPR014729:Rossmann-like alpha/beta/alpha sandwich fold,IPR018223:Argininosuccinate synthase, conserved site,IPR023434:Argininosuccinate synthase, type 1 subfamily,IPR024074:Argininosuccinate synthetase, catalytic/multimerisation domain body,	PF00764:Arginosuccinate synthase,		2.28619160955249	6.92902858964618e-07	FDR<0.01	6.15932764673414	4262448.16666667	Present in Nucleus	RBP	DBD	DBD	Others	Others	403	metabolic process
P70296	P70296	Pebp1	3.818	18.942	3619900	NA	NA	NA	NA	NA	4.01171420548	3344273.33333333	5	Pebp1	0	Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)]		FUNCTION: Binds ATP, opioids and phosphatidylethanolamine. Has lower affinity for phosphatidylinositol and phosphatidylcholine. Serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase. Inhibits the kinase activity of RAF1 by inhibiting its activation and by dissociating the RAF1/MEK complex and acting as a competitive inhibitor of MEK phosphorylation (By similarity). {ECO:0000250}.; FUNCTION: HCNP may be involved in the function of the presynaptic cholinergic neurons of the central nervous system. HCNP increases the production of choline acetyltransferase but not acetylcholinesterase. Seems to be mediated by a specific receptor (By similarity). {ECO:0000250}.		MAPK cascade [GO:0000165]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of acetylcholine metabolic process [GO:0060409]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of neurotransmitter levels [GO:0001505]; regulation of the force of heart contraction [GO:0002026]; sperm capacitation [GO:0048240]	apical part of cell [GO:0045177]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; lipid binding [GO:0008289]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase binding [GO:0019901]; receptor serine/threonine kinase binding [GO:0033612]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]	SUBCELLULAR LOCATION: Cytoplasm.	23980;	cd00866;	IPR008914;IPR036610;IPR035810;IPR001858;	PF01161;		20830		REGION 93..134;  /note=Interaction with RAF1;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (10); Chain (1); Helix (6); Initiator methionine (1); Modified residue (8); Peptide (1); Region (1); Sequence conflict (1)		3D-structure;ATP-binding;Acetylation;Cytoplasm;Direct protein sequencing;Disulfide bond;Lipid-binding;Nucleotide-binding;Phosphoprotein;Protease inhibitor;Reference proteome;Serine protease inhibitor						PS01220;	23980	GO:0000165~MAPK cascade,GO:0001505~regulation of neurotransmitter levels,GO:0001933~negative regulation of protein phosphorylation,GO:0002026~regulation of the force of heart contraction,GO:0006979~response to oxidative stress,GO:0007286~spermatid development,GO:0007568~aging,GO:0009408~response to heat,GO:0009611~response to wounding,GO:0009636~response to toxic substance,GO:0010466~negative regulation of peptidase activity,GO:0014823~response to activity,GO:0021766~hippocampus development,GO:0042493~response to drug,GO:0042755~eating behavior,GO:0043409~negative regulation of MAPK cascade,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045471~response to ethanol,GO:0045840~positive regulation of mitotic nuclear division,GO:0048240~sperm capacitation,GO:0051412~response to corticosterone,GO:0051591~response to cAMP,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0060409~positive regulation of acetylcholine metabolic process,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0043679~axon terminus,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005524~ATP binding,GO:0008289~lipid binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030414~peptidase inhibitor activity,GO:0044822~poly(A) RNA binding,GO:0051019~mitogen-activated protein kinase binding,	IPR001858:Phosphatidylethanolamine-binding, conserved site,IPR008914:Phosphatidylethanolamine-binding protein PEBP,	PF01161:Phosphatidylethanolamine-binding protein,	SSF49777:PEBP-like,	2.72685089871002	0.00312453220304978	FDR<0.01	2.50521499490928	3482086.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	467	metabolic process
Q920E5	Q920E5	Fdps	5.6649	4.1548	5343050	5.07433906733648	1.40884756269372	2.82007896221094	NA	4.42419147900721	NA	708123.166666667	2	Fdps	0	Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Cholesterol-regulated 39 kDa protein) (CR 39) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)		FUNCTION: Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product farnesyl pyrophosphate (By similarity). {ECO:0000250}.	PATHWAY: Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1.; PATHWAY: Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1.	cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholesterol biosynthetic process [GO:0045542]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]	dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.	110196;	cd00685;	IPR008949;IPR000092;IPR033749;	PF00348;		40582			NA		ACTIVITY REGULATION: Inactivated by interferon-induced RSAD2. This inactivation may result of disruption of lipid rafts at the plasma membrane, and thus have an antiviral effect since many enveloped viruses need lipid rafts to bud efficiently out of the cell (By similarity). {ECO:0000250}.	BINDING 57;  /note=Isopentenyl diphosphate;  /evidence=ECO:0000250|UniProtKB:P14324; BINDING 60;  /note=Isopentenyl diphosphate;  /evidence=ECO:0000250|UniProtKB:P14324; BINDING 96;  /note=Isopentenyl diphosphate;  /evidence=ECO:0000250|UniProtKB:P14324; BINDING 112;  /note=Dimethylallyl diphosphate;  /evidence=ECO:0000250; BINDING 113;  /note=Isopentenyl diphosphate;  /evidence=ECO:0000250|UniProtKB:P14324; BINDING 200;  /note=Dimethylallyl diphosphate;  /evidence=ECO:0000250; BINDING 201;  /note=Dimethylallyl diphosphate;  /evidence=ECO:0000250; BINDING 240;  /note=Dimethylallyl diphosphate;  /evidence=ECO:0000250; BINDING 257;  /note=Dimethylallyl diphosphate;  /evidence=ECO:0000250; BINDING 266;  /note=Dimethylallyl diphosphate;  /evidence=ECO:0000250	2.5.1.10; 2.5.1.1	METAL 103;  /note=Magnesium 1;  /evidence=ECO:0000250|UniProtKB:P14324; METAL 103;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P14324; METAL 107;  /note=Magnesium 1;  /evidence=ECO:0000250|UniProtKB:P14324; METAL 107;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P14324		5 out of 5	Binding site (10); Chain (1); Metal binding (4); Modified residue (1); Site (2)		Acetylation;Cholesterol biosynthesis;Cholesterol metabolism;Cytoplasm;Isoprene biosynthesis;Lipid biosynthesis;Lipid metabolism;Magnesium;Metal-binding;Reference proteome;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transferase						PS00723;PS00444;	110196	GO:0006629~lipid metabolic process,GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0008299~isoprenoid biosynthetic process,GO:0016126~sterol biosynthetic process,GO:0033384~geranyl diphosphate biosynthetic process,GO:0045337~farnesyl diphosphate biosynthetic process,GO:0045542~positive regulation of cholesterol biosynthetic process,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005777~peroxisome,	GO:0004161~dimethylallyltranstransferase activity,GO:0004311~farnesyltranstransferase activity,GO:0004337~geranyltranstransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000092:Polyprenyl synthetase,IPR008949:Terpenoid synthase,	PF00348:Polyprenyl synthetase,	SSF48576:Terpenoid synthases,	1.83928572498934	0.000219146618552792	FDR<0.01	3.65926522615167	3025586.58333333	Present in Nucleus	RBP	Others	Others	Others	Others	501	metabolic process
P84078	P84078;P61205;Q8BSL7;P84084	Arf1;Arf3;Arf2	5.2754	2.4514	1717250	NA	NA	NA	NA	5.80282017060291	4.10340582683627	1614149	4	Arf1	0	ADP-ribosylation factor 1		FUNCTION: GTP-binding protein involved in protein trafficking among different compartments (PubMed:11950392). Modulates vesicle budding and uncoating within the Golgi complex. Deactivation induces the redistribution of the entire Golgi complex to the endoplasmic reticulum, suggesting a crucial role in protein trafficking. In its GTP-bound form, its triggers the association with coat proteins with the Golgi membrane. The hydrolysis of ARF1-bound GTP, which is mediated by ARFGAPs proteins, is required for dissociation of coat proteins from Golgi membranes and vesicles. The GTP-bound form interacts with PICK1 to limit PICK1-mediated inhibition of Arp2/3 complex activity; the function is linked to AMPA receptor (AMPAR) trafficking, regulation of synaptic plasicity of excitatory synapses and spine shrinkage during long-term depression (LTD). {ECO:0000269|PubMed:11950392}.		actin filament organization [GO:0007015]; cellular copper ion homeostasis [GO:0006878]; cellular response to virus [GO:0098586]; dendritic spine organization [GO:0097061]; Golgi to transport vesicle transport [GO:0055108]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; lysosomal membrane organization [GO:0097212]; mitotic cleavage furrow ingression [GO:1990386]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endocytosis [GO:0045807]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of late endosome to lysosome transport [GO:1902824]; positive regulation of protein secretion [GO:0050714]; positive regulation of sodium ion transmembrane transport [GO:1902307]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of phospholipid metabolic process [GO:1903725]; regulation of receptor internalization [GO:0002090]; synaptic vesicle budding [GO:0070142]; very-low-density lipoprotein particle assembly [GO:0034379]; vesicle-mediated transport [GO:0016192]	cell leading edge [GO:0031252]; COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; trans-Golgi network [GO:0005802]	GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phospholipase D activator activity [GO:1990583]; protein domain specific binding [GO:0019904]	SUBCELLULAR LOCATION: Golgi apparatus. Cytoplasm, perinuclear region {ECO:0000250}. Cell junction, synapse, synaptosome {ECO:0000250}. Cell junction, synapse, postsynaptic density {ECO:0000250}. Membrane {ECO:0000250|UniProtKB:P84077}; Lipid-anchor {ECO:0000250|UniProtKB:P84077}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:11950392}; Lipid-anchor {ECO:0000305}.	11840;		IPR027417;IPR005225;IPR006689;	PF00025;		20697			NA			BINDING 160;  /note=GTP; via amide nitrogen;  /evidence=ECO:0007744|PDB:1O3Y, ECO:0007744|PDB:2J59				5 out of 5	Beta strand (6); Binding site (1); Chain (1); Helix (8); Initiator methionine (1); Lipidation (1); Modified residue (1); Nucleotide binding (2); Sequence conflict (3); Turn (1)		3D-structure;Acetylation;Cell junction;Cytoplasm;Direct protein sequencing;ER-Golgi transport;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Myristate;Nucleotide-binding;Protein transport;Reference proteome;Synapse;Synaptosome;Transport						PS51417;	11840	GO:0002090~regulation of receptor internalization,GO:0006810~transport,GO:0006878~cellular copper ion homeostasis,GO:0007015~actin filament organization,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034315~regulation of Arp2/3 complex-mediated actin nucleation,GO:0034379~very-low-density lipoprotein particle assembly,GO:0043085~positive regulation of catalytic activity,GO:0045807~positive regulation of endocytosis,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0050714~positive regulation of protein secretion,GO:0055108~Golgi to transport vesicle transport,GO:0060292~long term synaptic depression,GO:0060999~positive regulation of dendritic spine development,GO:0070142~synaptic vesicle budding,GO:0097061~dendritic spine organization,GO:0097212~lysosomal membrane organization,GO:1902307~positive regulation of sodium ion transmembrane transport,GO:1902824~positive regulation of late endosome to lysosome transport,GO:1902953~positive regulation of ER to Golgi vesicle-mediated transport,GO:1903725~regulation of phospholipid metabolic process,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005770~late endosome,GO:0005778~peroxisomal membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030017~sarcomere,GO:0030054~cell junction,GO:0030137~COPI-coated vesicle,GO:0031252~cell leading edge,GO:0043005~neuron projection,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019003~GDP binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:1990583~phospholipase D activator activity,	IPR005225:Small GTP-binding protein domain,IPR006689:Small GTPase superfamily, ARF/SAR type,IPR024156:Small GTPase superfamily, ARF type,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00025:ADP-ribosylation factor family,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.06661561589521	0.000556895861876074	FDR<0.01	3.25422600920858	1665699.5	Present in Nucleus	RBP	Others	Others	Others	Others	676	metabolic process
Q03265	Q03265	Atp5a1	2.3697	3.0637	275710	7.47831289261143	4.49498808828157	3.47523892267593	NA	3.20143424254066	2.95735494174011	1484640	1	Atp5a1	0	ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)		FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Subunits alpha and beta form the catalytic core in F(1). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits. Subunit alpha does not bear the catalytic high-affinity ATP-binding sites (By similarity). Binds the bacterial siderophore enterobactin and can promote mitochondrial accumulation of enterobactin-derived iron ions (By similarity). {ECO:0000250|UniProtKB:P19483, ECO:0000250|UniProtKB:P25705}.		ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]	cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]	ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]	SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:17438143}; Peripheral membrane protein {ECO:0000269|PubMed:17438143}; Matrix side {ECO:0000250|UniProtKB:P19483}. Cell membrane {ECO:0000250|UniProtKB:P25705}; Peripheral membrane protein {ECO:0000250|UniProtKB:P25705}; Extracellular side {ECO:0000250|UniProtKB:P25705}. Note=Colocalizes with HRG on the cell surface of T-cells. {ECO:0000250|UniProtKB:P25705}.	11946;	cd18113;cd01132;	IPR023366;IPR000793;IPR038376;IPR033732;IPR005294;IPR020003;IPR004100;IPR036121;IPR000194;IPR027417;	PF00006;PF00306;PF02874;		59753			NA							5 out of 5	Chain (1); Glycosylation (1); Modified residue (37); Nucleotide binding (2); Sequence conflict (8); Site (1); Transit peptide (1)	MISCELLANEOUS: The siderophore enterobactin (Ent) produced by enteric bacteria binds Fe(3+) and helps bacteria scavenge iron ions from the environment. As a consequence, the mammalian siderocalin LCN2 plays an important role in defense against bacterial infections by sequestering iron bound to microbial siderophores. LCN2 can also bind iron bound to endogenous or nutrient-derived iron chelators and plays an important role in cellular iron homeostasis. Enterobactin produced by non-pathogenic E.coli strains can facilitate mitochondrial iron assimilation, suggesting that iron bound to siderophores from non-pathogenic bacteria may contribute to iron absorption by the host. {ECO:0000250|UniProtKB:P25705}.	ATP synthesis;ATP-binding;Acetylation;CF(1);Cell membrane;Direct protein sequencing;Glycoprotein;Hydrogen ion transport;Ion transport;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Transit peptide;Transport						PS00152;	11946	GO:0001937~negative regulation of endothelial cell proliferation,GO:0006629~lipid metabolic process,GO:0006754~ATP biosynthetic process,GO:0006810~transport,GO:0006811~ion transport,GO:0009790~embryo development,GO:0015986~ATP synthesis coupled proton transport,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0046034~ATP metabolic process,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005886~plasma membrane,GO:0008180~COP9 signalosome,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0043209~myelin sheath,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0032559~adenyl ribonucleotide binding,GO:0042288~MHC class I protein binding,GO:0043531~ADP binding,GO:0044822~poly(A) RNA binding,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR000194:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain,IPR000793:ATPase, F1/V1/A1 complex, alpha/beta subunit, C-terminal,IPR004100:ATPase, alpha/beta subunit, N-terminal,IPR005294:ATPase, F1 complex, alpha subunit,IPR020003:ATPase, alpha/beta subunit, nucleotide-binding domain, active site,IPR023366:ATPase, F1/A1 complex, alpha subunit, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00006:ATP synthase alpha/beta family, nucleotide-binding domain,PF00306:ATP synthase alpha/beta chain, C terminal domain,PF02874:ATP synthase alpha/beta family, beta-barrel domain,	SSF47917:C-terminal domain of alpha and beta subunits of F1 ATP synthase,SSF50615:N-terminal domain of alpha and beta subunits of F1 ATP synthase,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.8530210770881	1.84179979665757e-05	FDR<0.01	4.73475757931413	880175	Present in Nucleus	RBP	Others	Others	Others	Others	872	metabolic process
P19096	P19096	Fasn	3.4053	1.704	870755	7.20097933318931	6.73128702207862	15.4221029579593	3.59079320621925	6.4989926561383	5.00400320256205	760058.666666667	0	Fasn	0	Fatty acid synthase (EC 2.3.1.85) (Type I Fatty Acid Synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]		FUNCTION: Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain. {ECO:0000269|PubMed:29328619, ECO:0000269|PubMed:31811668}.	PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:29328619}.	acetyl-CoA metabolic process [GO:0006084]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; glandular epithelial cell development [GO:0002068]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; tissue development [GO:0009888]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; identical protein binding [GO:0042802]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Melanosome {ECO:0000250}.	14104;		IPR029058;IPR001227;IPR036736;IPR014043;IPR016035;IPR013149;IPR023102;IPR011032;IPR018201;IPR014031;IPR014030;IPR016036;IPR013217;IPR036291;IPR032821;IPR020841;IPR020807;IPR042104;IPR020843;IPR013968;IPR020806;IPR009081;IPR006162;IPR029063;IPR001031;IPR016039;	PF00698;PF00107;PF16197;PF00109;PF02801;PF08659;PF08242;PF00550;PF14765;PF00975;	SM00827;SM00826;SM00829;SM00825;SM00823;	272428		REGION 1..414;  /note=Beta-ketoacyl synthase; REGION 429..817;  /note=Acyl and malonyl transferases; REGION 647..648;  /note=Acyl-CoA binding;  /evidence=ECO:0000269|PubMed:31811668, ECO:0007744|PDB:6ROP; REGION 1628..1856;  /note=Enoyl reductase; REGION 1857..2111;  /note=Beta-ketoacyl reductase; REGION 2181..2205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2201..2504;  /note=Thioesterase	NA	ACT_SITE 161;  /note=For beta-ketoacyl synthase activity;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10022; ACT_SITE 581;  /note=For malonyltransferase activity;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10022; ACT_SITE 878;  /note=For beta-hydroxyacyl dehydratase activity;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10022; ACT_SITE 2301;  /note=For thioesterase activity;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10022; ACT_SITE 2474;  /note=For thioesterase activity;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10022		BINDING 671;  /note=Acyl-CoA;  /evidence=ECO:0000269|PubMed:31811668, ECO:0007744|PDB:6ROP; BINDING 773;  /note=Acyl-CoA;  /evidence=ECO:0000269|PubMed:31811668, ECO:0007744|PDB:6ROP	2.3.1.85; 2.3.1.38; 2.3.1.39; 2.3.1.41; 1.1.1.100; 4.2.1.59; 1.3.1.39; 3.1.2.14			5 out of 5	Active site (5); Beta strand (27); Binding site (2); Chain (1); Cross-link (1); Domain (1); Frameshift (1); Helix (46); Modified residue (27); Nucleotide binding (2); Region (7); Sequence conflict (6); Turn (9)		3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Fatty acid biosynthesis;Fatty acid metabolism;Hydrolase;Isopeptide bond;Lipid biosynthesis;Lipid metabolism;Lyase;Multifunctional enzyme;NAD;NADP;Oxidoreductase;Phosphopantetheine;Phosphoprotein;Pyridoxal phosphate;Reference proteome;S-nitrosylation;Transferase;Ubl conjugation	DOMAIN 2112..2192;  /note=Carrier;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00258					PS00606;PS50075;PS00012;	14104	GO:0001649~osteoblast differentiation,GO:0006084~acetyl-CoA metabolic process,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008152~metabolic process,GO:0008611~ether lipid biosynthetic process,GO:0009058~biosynthetic process,GO:0030223~neutrophil differentiation,GO:0030224~monocyte differentiation,GO:0030879~mammary gland development,GO:0055114~oxidation-reduction process,GO:0071353~cellular response to interleukin-4,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0042470~melanosome,GO:0042587~glycogen granule,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004312~fatty acid synthase activity,GO:0004313~[acyl-carrier-protein] S-acetyltransferase activity,GO:0004314~[acyl-carrier-protein] S-malonyltransferase activity,GO:0004315~3-oxoacyl-[acyl-carrier-protein] synthase activity,GO:0004316~3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,GO:0004317~3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,GO:0004319~enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,GO:0004320~oleoyl-[acyl-carrier-protein] hydrolase activity,GO:0008144~drug binding,GO:0016295~myristoyl-[acyl-carrier-protein] hydrolase activity,GO:0016296~palmitoyl-[acyl-carrier-protein] hydrolase activity,GO:0016297~acyl-[acyl-carrier-protein] hydrolase activity,GO:0016491~oxidoreductase activity,GO:0016740~transferase activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0016829~lyase activity,GO:0019171~3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,GO:0031177~phosphopantetheine binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0047117~enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,GO:0047451~3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,GO:0070402~NADPH binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:0102132~3-oxo-pimeloyl-[acp] methyl ester reductase activity,	IPR001031:Thioesterase,IPR001227:Acyl transferase domain,IPR006162:Phosphopantetheine attachment site,IPR009081:Acyl carrier protein-like,IPR011032:GroES-like,IPR013149:Alcohol dehydrogenase, C-terminal,IPR013217:Methyltransferase type 12,IPR013968:Polyketide synthase, KR,IPR014030:Beta-ketoacyl synthase, N-terminal,IPR014031:Beta-ketoacyl synthase, C-terminal,IPR014043:Acyl transferase,IPR016035:Acyl transferase/acyl hydrolase/lysophospholipase,IPR016036:Malonyl-CoA ACP transacylase, ACP-binding,IPR016039:Thiolase-like,IPR016040:NAD(P)-binding domain,IPR018201:Beta-ketoacyl synthase, active site,IPR020801:Polyketide synthase, acyl transferase domain,IPR020806:Polyketide synthase, phosphopantetheine-binding domain,IPR020807:Polyketide synthase, dehydratase domain,IPR020841:Polyketide synthase, beta-ketoacyl synthase domain,IPR020843:Polyketide synthase, enoylreductase,IPR023102:Fatty acid synthase, domain 2,	PF00107:Zinc-binding dehydrogenase,PF00109:Beta-ketoacyl synthase, N-terminal domain,PF00550:Phosphopantetheine attachment site,PF00698:Acyl transferase domain,PF00975:Thioesterase domain,PF02801:Beta-ketoacyl synthase, C-terminal domain,PF08242:Methyltransferase domain,PF08659:KR domain,PF14765:Polyketide synthase dehydratase,	SSF47336:ACP-like,SSF50129:GroES-like,SSF51735:NAD(P)-binding Rossmann-fold domains,SSF52151:FabD/lysophospholipase-like,SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,SSF53474:alpha/beta-Hydrolases,SSF53901:Thiolase-like,SSF55048:Probable ACP-binding domain of malonyl-CoA ACP transacylase,	2.36878896742838	1.10045442478448e-05	FDR<0.01	4.95842793900293	815406.833333333	Unexpected	RBP	Others	Others	Others	Others	888	metabolic process
P08249	P08249	Mdh2	1.0728	1.1229	656760	6.57808183133798	1.99234937838699	NA	NA	4.23980327312813	3.76194417274848	384900	2	Mdh2	0	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)				aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]	cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]	L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; malate dehydrogenase activity [GO:0016615]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250|UniProtKB:P04636}.	17448;	cd01337;	IPR001557;IPR022383;IPR001236;IPR015955;IPR001252;IPR010097;IPR036291;	PF02866;PF00056;		35611			NA	ACT_SITE 200;  /note=Proton acceptor;  /evidence=ECO:0000250|UniProtKB:P00346	ACTIVITY REGULATION: Enzyme activity is enhanced by acetylation. {ECO:0000250|UniProtKB:P40926}.	BINDING 57;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:P40926; BINDING 104;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00346; BINDING 110;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00346; BINDING 117;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:P40926; BINDING 142;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00346; BINDING 176;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00346; BINDING 251;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:P40926	1.1.1.37			5 out of 5	Active site (1); Binding site (7); Chain (1); Frameshift (1); Glycosylation (1); Modified residue (34); Nucleotide binding (2); Sequence conflict (3); Transit peptide (1)		Acetylation;Direct protein sequencing;Glycoprotein;Mitochondrion;NAD;Oxidoreductase;Phosphoprotein;Reference proteome;Transit peptide;Tricarboxylic acid cycle						PS00068;	17448	GO:0005975~carbohydrate metabolic process,GO:0006099~tricarboxylic acid cycle,GO:0006107~oxaloacetate metabolic process,GO:0006108~malate metabolic process,GO:0006475~internal protein amino acid acetylation,GO:0006734~NADH metabolic process,GO:0019752~carboxylic acid metabolic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0016491~oxidoreductase activity,GO:0016615~malate dehydrogenase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0030060~L-malate dehydrogenase activity,GO:0043621~protein self-association,GO:0044822~poly(A) RNA binding,GO:0046554~malate dehydrogenase (NADP+) activity,	IPR001236:Lactate/malate dehydrogenase, N-terminal,IPR001252:Malate dehydrogenase, active site,IPR001557:L-lactate/malate dehydrogenase,IPR010097:Malate dehydrogenase, type 1,IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal,IPR016040:NAD(P)-binding domain,IPR022383:Lactate/malate dehydrogenase, C-terminal,	PF00056:lactate/malate dehydrogenase, NAD binding domain,PF02866:lactate/malate dehydrogenase, alpha/beta C-terminal domain,	SSF51735:NAD(P)-binding Rossmann-fold domains,SSF56327:LDH C-terminal domain-like,	1.32937066285805	0.00782970302464563	FDR<0.01	2.10625471012642	520830	Present in Nucleus	RBP	Others	Others	Others	Others	1024	metabolic process
P24527	P24527	Lta4h	0.90404	3.3553	892195	NA	NA	NA	NA	4.94706638963095	NA	27391.3333333333	5	Lta4h	0	Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4)		FUNCTION: Bifunctional zinc metalloenzyme that comprises both epoxide hydrolase (EH) and aminopeptidase activities (By similarity). Acts as an epoxide hydrolase to catalyze the conversion of LTA4 to the proinflammatory mediator leukotriene B4 (LTB4) (PubMed:1881903, PubMed:9287304). Has also aminopeptidase activity, with high affinity for N-terminal arginines of various synthetic tripeptides (By similarity). In addition to its proinflammatory EH activity, may also counteract inflammation by its aminopeptidase activity, which inactivates by cleavage another neutrophil attractant, the tripeptide Pro-Gly-Pro (PGP), a bioactive fragment of collagen generated by the action of matrix metalloproteinase-9 (MMP9) and prolylendopeptidase (PREPL) (PubMed:20813919). Involved also in the biosynthesis of resolvin E1 and 18S-resolvin E1 from eicosapentaenoic acid, two lipid mediators that show potent anti-inflammatory and pro-resolving actions (By similarity). {ECO:0000250|UniProtKB:P09960, ECO:0000269|PubMed:1881903, ECO:0000269|PubMed:20813919, ECO:0000269|PubMed:9287304}.	PATHWAY: Lipid metabolism; leukotriene B4 biosynthesis. {ECO:0000269|PubMed:1881903, ECO:0000269|PubMed:9287304}.	cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; peptide catabolic process [GO:0043171]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P09960}.	16993;	cd09599;	IPR042097;IPR016024;IPR012777;IPR038502;IPR034015;IPR001930;IPR015211;IPR014782;IPR027268;	PF09127;PF01433;	SM01263;	69051		REGION 135..137;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:P09960; REGION 267..272;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:P09960; REGION 564..566;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:P09960	NA	ACT_SITE 297;  /note=Proton acceptor;  /evidence=ECO:0000250|UniProtKB:P09960; ACT_SITE 384;  /note=Proton donor;  /evidence=ECO:0000250|UniProtKB:P09960	ACTIVITY REGULATION: Inhibited by bestatin (By similarity). The epoxide hydrolase activity is restrained by suicide inactivation that involves binding of LTA4 to Tyr-379 (PubMed:9287304). 4-(4-benzylphenyl)thiazol-2-amine (ARM1) selectively inhibits the epoxide hydrolase activity (By similarity). {ECO:0000250|UniProtKB:P09960, ECO:0000269|PubMed:9287304}.		3.3.2.6; 3.4.11.4	METAL 296;  /note=Zinc; catalytic;  /evidence=ECO:0000250|UniProtKB:P09960; METAL 300;  /note=Zinc; catalytic;  /evidence=ECO:0000250|UniProtKB:P09960; METAL 319;  /note=Zinc; catalytic;  /evidence=ECO:0000250|UniProtKB:P09960		5 out of 5	Active site (2); Chain (1); Metal binding (3); Modified residue (5); Mutagenesis (4); Region (3); Sequence conflict (2); Site (2)		Acetylation;Cytoplasm;Hydrolase;Leukotriene biosynthesis;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Reference proteome;Zinc						PS00142;	16993	GO:0006508~proteolysis,GO:0006691~leukotriene metabolic process,GO:0019370~leukotriene biosynthetic process,GO:0043171~peptide catabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004177~aminopeptidase activity,GO:0004301~epoxide hydrolase activity,GO:0004463~leukotriene-A4 hydrolase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042277~peptide binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR001930:Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase,IPR012777:Leukotriene A4 hydrolase,IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal,IPR015211:Peptidase M1, leukotriene A4 hydrolase, aminopeptidase C-terminal,IPR016024:Armadillo-type fold,	PF01433:Peptidase family M1,PF09127:Leukotriene A4 hydrolase, C-terminal,	SSF48371:ARM repeat,	1.30249117922804	0.0604432009145527	FDR<0.1	1.21865254461896	459793.166666667	Present in Nucleus	RBP	Others	Others	Others	Others	1066	metabolic process
P47941	P47941	Crkl	4.8935	2.5464	350210	NA	NA	NA	NA	NA	3.38604273185928	40806.6666666667	5	Crkl	0	Crk-like protein		FUNCTION: May mediate the transduction of intracellular signals.		acetylcholine receptor signaling pathway [GO:0095500]; activation of GTPase activity [GO:0090630]; activation of MAPK activity [GO:0000187]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cellular response to drug [GO:0035690]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharynx development [GO:0060465]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202]	identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]		12929;	cd11759;cd11758;	IPR035458;IPR035457;IPR000980;IPR036860;IPR036028;IPR001452;	PF00017;PF00018;PF07653;	SM00252;SM00326;	33830		REGION 184..203;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Domain (3); Modified residue (2); Region (1); Sequence conflict (1)		Phosphoprotein;Reference proteome;Repeat;SH2 domain;SH3 domain	DOMAIN 14..102;  /note=SH2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00191; DOMAIN 123..183;  /note=SH3 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00192; DOMAIN 235..296;  /note=SH3 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00192					PS50001;PS50002;	12929	GO:0001568~blood vessel development,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0009952~anterior/posterior pattern specification,GO:0048538~thymus development,GO:0060017~parathyroid gland development,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,	PF00017:SH2 domain,PF00018:SH3 domain,PF07653:Variant SH3 domain,	SSF50044:SH3-domain,SSF55550:SH2 domain,	1.79964198062378	0.0040539166267239	FDR<0.01	2.3921251872972	195508.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	1287	metabolic process
P62983	P62983;P62984;P0CG49;P0CG50	Rps27a;Uba52;Ubb;Ubc	7.9815	11.442	401985000	39.332913782253	29.6551110583909	43.3688958279122	26.7587166519494	31.5208825847124	28.7571173865532	132969166.666667	0	Rps27a	0	Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a]		FUNCTION: [Ubiquitin]: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in lysosomal degradation; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling. {ECO:0000269|PubMed:19754430}.; FUNCTION: [40S ribosomal protein S27a]: Component of the 40S subunit of the ribosome. {ECO:0000269|PubMed:19754430}.		modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: [Ubiquitin]: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	78294;		IPR002906;IPR011332;IPR038582;IPR000626;IPR029071;IPR019954;IPR019956;	PF01599;PF00240;	SM01402;SM00213;	17951			NA							5 out of 5	Beta strand (4); Chain (2); Cross-link (7); Domain (1); Helix (3); Modified residue (5); Site (3); Zinc finger (1)	MISCELLANEOUS: Ubiquitin is encoded by 4 different genes. Uba52 and Rps27a genes code for a single copy of ubiquitin fused to the ribosomal proteins L40 and S27a, respectively. UBB and UBC genes code for a polyubiquitin precursor with exact head to tail repeats, the number of repeats differ between species and strains.	3D-structure;ADP-ribosylation;Acetylation;Cytoplasm;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1..76;  /note=Ubiquitin-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00214				ZN_FING 121..144;  /note=C4-type	PS00299;PS50053;	78294	GO:0006412~translation,GO:0007219~Notch signaling pathway,GO:0007623~circadian rhythm,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000626:Ubiquitin,IPR002906:Ribosomal protein S27a,IPR011332:Ribosomal protein, zinc-binding domain,IPR019954:Ubiquitin conserved site,IPR019956:Ubiquitin subgroup,	PF00240:Ubiquitin family,PF01599:Ribosomal protein S27a,	SSF54236:Ubiquitin-like,SSF57829:Zn-binding ribosomal proteins,	4.58817628680623	8.02736965371964e-09	FDR<0.01	8.09542673766179	267477083.333333	Present in Nucleus	RBP	Others	Others	Others	Others	6	miscellaneous
P97351	P97351	Rps3a	34.02	38.179	24941000	62.7785799485216	24.8669617546128	19.5966999157342	21.6501764489381	24.339783375928	53.7663315232002	22662933.3333333	0	Rps3a	0	40S ribosomal protein S3a (Protein TU-11)		FUNCTION: May play a role during erythropoiesis through regulation of transcription factor DDIT3. {ECO:0000255|HAMAP-Rule:MF_03122, ECO:0000269|PubMed:10713066}.		cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of translation [GO:0045727]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03122, ECO:0000269|PubMed:10713066}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03122, ECO:0000269|PubMed:10713066}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000255|HAMAP-Rule:MF_03122}.	20091;		IPR027500;IPR001593;IPR018281;	PF01015;	SM01397;	29885		REGION 233..264;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Cross-link (2); Modified residue (7); Region (1)		ADP-ribosylation;Acetylation;Cytoplasm;Differentiation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS01191;	20091	GO:0006412~translation,GO:0030154~cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0045727~positive regulation of translation,GO:0048146~positive regulation of fibroblast proliferation,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0031369~translation initiation factor binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,	IPR001593:Ribosomal protein S3Ae,IPR018281:Ribosomal protein S3Ae, conserved site,IPR027500:40S ribosomal protein S1/3, eukaryotes,	PF01015:Ribosomal S3Ae family,		5.00426234212161	3.63975035614205e-10	FDR<0.01	9.4389284027982	23801966.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	101	miscellaneous
P27659	P27659	Rpl3	20.504	17.452	38795500	17.4675540184108	44.2321302193914	21.478124530166	13.3566629713232	31.6225532049458	18.8932343327854	49423366.6666667	0	Rpl3	0	60S ribosomal protein L3 (J1 protein)		FUNCTION: The L3 protein is a component of the large subunit of cytoplasmic ribosomes. {ECO:0000250|UniProtKB:P39023}.		cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm.	27367;		IPR000597;IPR019926;IPR009000;	PF00297;		46110		REGION 1..36;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (9); Modified residue (7); Region (1); Sequence conflict (1)		3D-structure;Acetylation;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation						PS00474;	27367	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,GO:0071353~cellular response to interleukin-4,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0008097~5S rRNA binding,GO:0044822~poly(A) RNA binding,	IPR000597:Ribosomal protein L3,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR019926:Ribosomal protein L3, conserved site,	PF00297:Ribosomal protein L3,	SSF50447:Translation proteins,	4.43296825420068	6.78613578819879e-10	FDR<0.01	9.16837745452358	44109433.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	57	miscellaneous
P14206	P14206	Rpsa	7.0416	4.9156	11736800	15.8192805391211	15.2121331974383	9.38967136150235	10.2431729252453	8.84720870565337	8.83782589482987	10616383.3333333	0	Rpsa	0	40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37 kDa oncofetal antigen) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (OFA/iLRP)		FUNCTION: Required for the assembly and/or stability of the 40S ribosomal subunit. Required for the processing of the 20S rRNA-precursor to mature 18S rRNA in a late step of the maturation of 40S ribosomal subunits. Also functions as a cell surface receptor for laminin. Plays a role in cell adhesion to the basement membrane and in the consequent activation of signaling transduction pathways. May play a role in cell fate determination and tissue morphogenesis. Also acts as a receptor for several other ligands, including the pathogenic prion protein, viruses, and bacteria. Acts as a PPP1R16B-dependent substrate of PPP1CA (By similarity). Enables malignant tumor cells to penetrate laminin tissue and vessel barriers. Activates precursor thymic anti-OFA/iLRP specific cytotoxic T-cell. May induce CD8 T-suppressor cells secreting IL-10. {ECO:0000255|HAMAP-Rule:MF_03016, ECO:0000269|PubMed:10697612, ECO:0000269|PubMed:1374897, ECO:0000269|PubMed:16453457, ECO:0000269|PubMed:6301485, ECO:0000269|PubMed:6302102}.		cell-cell adhesion [GO:0098609]; cytoplasmic translation [GO:0002181]; epithelial cell differentiation [GO:0030855]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]	laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Cell membrane. Cytoplasm. Nucleus. Note=67LR is found at the surface of the plasma membrane, with its C-terminal laminin-binding domain accessible to extracellular ligands. 37LRP is found at the cell surface, in the cytoplasm and in the nucleus. Colocalizes with PPP1R16B in the cell membrane (By similarity). 37LRP shuttles to the nucleus upon midkine (MDK) binding. {ECO:0000255|HAMAP-Rule:MF_03016}.	16785;	cd01425;	IPR027504;IPR032281;IPR001865;IPR018130;IPR027498;IPR005707;IPR023591;	PF16122;PF00318;		32838		REGION 54..113;  /note=Interaction with PPP1R16B;  /evidence=ECO:0000255|HAMAP-Rule:MF_03016; REGION 161..180;  /note=Laminin-binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03016; REGION 205..229;  /note=Laminin-binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03016; REGION 242..295;  /note=Laminin-binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03016; REGION 266..295;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (5); Region (5); Repeat (5); Sequence conflict (5); Site (2)	MISCELLANEOUS: This protein appears to have acquired a second function as a laminin receptor specifically in the vertebrate lineage.; MISCELLANEOUS: It is thought that in vertebrates 37/67 kDa laminin receptor acquired a dual function during evolution. It developed from the ribosomal protein SA, playing an essential role in the protein biosynthesis lacking any laminin binding activity, to a cell surface receptor with laminin binding activity.	Acetylation;Cell membrane;Cytoplasm;Direct protein sequencing;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Receptor;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein;Ubl conjugation				REPEAT 230..232;  /note=[DE]-W-[ST] 1; REPEAT 247..249;  /note=[DE]-W-[ST] 2; REPEAT 266..268;  /note=[DE]-W-[ST] 3; REPEAT 275..277;  /note=[DE]-W-[ST] 4; REPEAT 293..295;  /note=[DE]-W-[ST] 5		PS00962;PS00963;	16785	GO:0000028~ribosomal small subunit assembly,GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000461~endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006407~rRNA export from nucleus,GO:0006412~translation,GO:0016337~single organismal cell-cell adhesion,GO:0030855~epithelial cell differentiation,	GO:0005604~basement membrane,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005886~plasma membrane,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0030686~90S preribosome,GO:0031012~extracellular matrix,GO:0043025~neuronal cell body,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0005055~laminin receptor activity,GO:0043022~ribosome binding,GO:0043236~laminin binding,GO:0044822~poly(A) RNA binding,	IPR001865:Ribosomal protein S2,IPR005707:Ribosomal protein S2, eukaryotic/archaeal,IPR018130:Ribosomal protein S2, conserved site,IPR023591:Ribosomal protein S2, flavodoxin-like domain,IPR027498:Ribosomal protein S2, eukaryotic,IPR027504:40S ribosomal protein SA,	PF00318:Ribosomal protein S2,	SSF52313:Ribosomal protein S2,	3.23757659422883	1.98050280327414e-08	FDR<0.01	7.70322453854339	11176591.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	209	miscellaneous
P14869	P14869	Rplp0	5.405	7.4799	5930950	5.54815801154017	7.97321001435178	9.00576368876081	3.97314156303389	5.14562107646393	2.50771121197683	3145921.66666667	0	Rplp0	0	60S acidic ribosomal protein P0 (60S ribosomal protein L10E)		FUNCTION: Ribosomal protein P0 is the functional equivalent of E.coli protein L10.		cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P05388}. Cytoplasm {ECO:0000250|UniProtKB:P05388}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250|UniProtKB:P05388}.	11837;		IPR030670;IPR043141;IPR001790;IPR043164;IPR040637;	PF00466;PF17777;		34216	COMPBIAS 303..317;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 293..317;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Modified residue (4); Region (1); Sequence conflict (3)		Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation							11837	GO:0002181~cytoplasmic translation,GO:0007595~lactation,GO:0010269~response to selenium ion,GO:0042254~ribosome biogenesis,GO:0071320~cellular response to cAMP,GO:0071353~cellular response to interleukin-4,GO:1904401~cellular response to Thyroid stimulating hormone,GO:1904628~cellular response to phorbol 13-acetate 12-myristate,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0030687~preribosome, large subunit precursor,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0003735~structural constituent of ribosome,GO:0042277~peptide binding,GO:0044822~poly(A) RNA binding,GO:0070180~large ribosomal subunit rRNA binding,	IPR001790:Ribosomal protein L10/acidic P0,	PF00466:Ribosomal protein L10,		2.45691605053246	5.0807618319557e-07	FDR<0.01	6.29407116279325	4538435.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	394	miscellaneous
Q8BMA6	Q8BMA6	Srp68	13.732	9.67	726510	8.26719576719577	17.7163610594384	13.6529954672055	6.42095800693463	8.40336134453782	8.27951647623779	584939.833333333	0	Srp68	0	Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein)		FUNCTION: Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. SRP68 binds the 7S RNA, SRP72 binds to this complex subsequently. This ribonucleoprotein complex might interact directly with the docking protein in the ER membrane and possibly participate in the elongation arrest function (By similarity). {ECO:0000250}.		response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]	7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; ribosome binding [GO:0043022]; signal recognition particle binding [GO:0005047]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}.	217337;	cd15481;	IPR026258;IPR034652;IPR038253;	PF16969;		70574	COMPBIAS 34..48;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..52;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (3); Region (1); Sequence conflict (2)		Acetylation;Cytoplasm;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Signal recognition particle		DOMAIN: The RNA-binding domain is located near the N-terminus. {ECO:0000250}.					217337	GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0042493~response to drug,GO:0045047~protein targeting to ER,	GO:0005622~intracellular,GO:0005623~cell,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0005925~focal adhesion,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0005047~signal recognition particle binding,GO:0008312~7S RNA binding,GO:0030942~endoplasmic reticulum signal peptide binding,GO:0044822~poly(A) RNA binding,	IPR026258:Signal recognition particle subunit SRP68,			3.3527301758211	8.24620844433151e-09	FDR<0.01	8.08374569147514	655724.916666667	Present in Nucleus	RBP	Others	Others	Others	Others	957	miscellaneous
Q9CX86	Q9CX86	Hnrnpa0	11.978	14.41	77805000	27.526218723334	11.7424642735524	10.1483691570765	8.99604174163368	10.6074910101514	22.6772796335352	30356050	0	Hnrnpa0	0	Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0)		FUNCTION: mRNA-binding component of ribonucleosomes. Specifically binds AU-rich element (ARE)-containing mRNAs. Involved in post-transcriptional regulation of cytokines mRNAs. {ECO:0000269|PubMed:12456657}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; inflammatory response [GO:0006954]; response to lipopolysaccharide [GO:0032496]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Component of ribonucleosomes. {ECO:0000250}.	77134;	cd12326;	IPR034801;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	30530		REGION 178..211;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 265..305;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (9); Domain (2); Modified residue (9); Region (2)		Acetylation;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 7..86;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 98..175;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	77134	GO:0006954~inflammatory response,GO:0032496~response to lipopolysaccharide,GO:0070935~3'-UTR-mediated mRNA stabilization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017091~AU-rich element binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.7737956228713	4.97210869405548e-09	FDR<0.01	8.30345938592087	54080525	Present in Nucleus	RBP	RBD	Others	Others	RBD	46	miscellaneous
P63325	P63325	Rps10	7.3073	11.752	14027100	43.2488539053715	17.7496938177816	24.8681985476972	15.0226842532224	1.89584241757825	20.123153700648	4043218.33333333	0	Rps10	0	40S ribosomal protein S10		FUNCTION: Component of the 40S ribosomal subunit. {ECO:0000250}.		ribosomal small subunit assembly [GO:0000028]	cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Note=Localized in the granular component (GC) region of the nucleolus. Methylation is required for its localization in the GC region. Colocalizes with NPS1 in the GC region of the nucleolus (By similarity). {ECO:0000250}.	67097;		IPR037447;IPR005326;IPR036388;	PF03501;		18916	COMPBIAS 98..135;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 90..165;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Modified residue (5); Region (1)		Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosomal protein;Ubl conjugation							67097	GO:0000028~ribosomal small subunit assembly,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0003735~structural constituent of ribosome,GO:0044822~poly(A) RNA binding,	IPR005326:Plectin/S10, N-terminal,	PF03501:Plectin/S10 domain,		3.72592618028258	2.3545015540965e-06	FDR<0.01	5.62810101856366	9035159.16666667	Present in Nucleus	RBP	Others	Others	Others	Others	238	miscellaneous
Q922Q8	Q922Q8	Lrrc59	17.32	6.8408	27007500	27.359781121751	19.9151614123832	2.95263965985591	16.5332980622975	9.98402555910543	12.1590895273762	14815633.3333333	0	Lrrc59	0	Leucine-rich repeat-containing protein 59 [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]		FUNCTION: Required for nuclear import of FGF1, but not that of FGF2. Might regulate nuclear import of exogenous FGF1 by facilitating interaction with the nuclear import machinery and by transporting cytosolic FGF1 to, and possibly through, the nuclear pores (By similarity). {ECO:0000250}.			endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]		SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}. Nucleus envelope {ECO:0000250}. Note=Localization in the nuclear envelope depends upon the nuclear import machinery, including KPNB1. {ECO:0000250}.	98238;		IPR001611;IPR003591;IPR032675;	PF13855;	SM00369;	34877	COMPBIAS 150..225;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 150..241;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (2); Coiled coil (1); Compositional bias (1); Erroneous initiation (4); Initiator methionine (1); Modified residue (6); Region (1); Repeat (5); Sequence conflict (1); Topological domain (2); Transmembrane (1)		Acetylation;Coiled coil;Endoplasmic reticulum;Leucine-rich repeat;Membrane;Microsome;Nucleus;Phosphoprotein;Reference proteome;Repeat;Signal-anchor;Transmembrane;Transmembrane helix				REPEAT 10..31;  /note=LRR 1; REPEAT 40..62;  /note=LRR 2; REPEAT 63..84;  /note=LRR 3; REPEAT 86..107;  /note=LRR 4; REPEAT 109..128;  /note=LRR 5		PS51450;	98238	GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0042645~mitochondrial nucleoid,GO:0043231~intracellular membrane-bounded organelle,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,	PF13855:Leucine rich repeat,	SSF52058:L domain-like,	3.56390062396155	3.66954305871513e-07	FDR<0.01	6.43538801188787	20911566.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	112	miscellaneous
P70168	P70168	Kpnb1	10.037	7.1028	4306550	4.25477598604433	7.86225332180203	2.13839705756565	4.1406152954329	5.65802874278601	4.1543766357858	2827485	0	Kpnb1	0	Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG)		FUNCTION: Functions in nuclear protein import, either in association with an adapter protein, like an importin-alpha subunit, which binds to nuclear localization signals (NLS) in cargo substrates, or by acting as autonomous nuclear transport receptor. Acting autonomously, serves itself as NLS receptor. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Mediates autonomously the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In association with IPO7 mediates the nuclear import of H1 histone. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. Imports SNAI1 and PRKCI into the nucleus (By similarity). {ECO:0000250|UniProtKB:Q14974, ECO:0000269|PubMed:11493596}.		astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus envelope {ECO:0000250}.	16211;		IPR011989;IPR016024;IPR000225;IPR021133;IPR001494;IPR040122;	PF03810;	SM00185;SM00913;	97184		REGION 329..342;  /note=IAB-binding; REGION 334..419;  /note=Ran-GTP binding;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (8); Chain (1); Domain (1); Helix (55); Modified residue (5); Region (2); Repeat (19); Sequence conflict (1); Turn (6)		3D-structure;ADP-ribosylation;Acetylation;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	DOMAIN 21..101;  /note=Importin N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00115			REPEAT 3..29;  /note=HEAT 1;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 32..62;  /note=HEAT 2;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 85..120;  /note=HEAT 3;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 129..160;  /note=HEAT 4;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 170..201;  /note=HEAT 5;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 212..247;  /note=HEAT 6;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 260..302;  /note=HEAT 7;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 314..359;  /note=HEAT 8;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 363..392;  /note=HEAT 9;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 399..438;  /note=HEAT 10;  /evidence=ECO:0000269|PubMed:10964573; REPEAT 449..485;  /note=HEAT 11;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 500..537;  /note=HEAT 12;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 544..592;  /note=HEAT 13;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 597..639;  /note=HEAT 14;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 644..680;  /note=HEAT 15;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 686..724;  /note=HEAT 16;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 729..777;  /note=HEAT 17;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 785..828;  /note=HEAT 18;  /evidence=ECO:0000269|PubMed:14645851; REPEAT 834..875;  /note=HEAT 19;  /evidence=ECO:0000269|PubMed:14645851		PS50077;PS50166;	16211	GO:0000059~protein import into nucleus, docking,GO:0000060~protein import into nucleus, translocation,GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing protein import into nucleus,GO:0006610~ribosomal protein import into nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0007079~mitotic chromosome movement towards spindle pole,GO:0007080~mitotic metaphase plate congression,GO:0015031~protein transport,GO:0030953~astral microtubule organization,GO:0031291~Ran protein signal transduction,GO:0040001~establishment of mitotic spindle localization,GO:0045184~establishment of protein localization,GO:0090307~mitotic spindle assembly,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0071782~endoplasmic reticulum tubular network,	GO:0005515~protein binding,GO:0008139~nuclear localization sequence binding,GO:0008536~Ran GTPase binding,GO:0008565~protein transporter activity,GO:0019894~kinesin binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0051879~Hsp90 protein binding,	IPR000225:Armadillo,IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,	PF03810:Importin-beta N-terminal domain,	SSF48371:ARM repeat,	2.36512206881669	1.72616355732445e-06	FDR<0.01	5.76291805643184	3567017.5	Present in Nucleus	RBP	Others	Others	Others	Others	462	miscellaneous
Q9CRT8	Q9CRT8	Xpot	19.924	5.997	331625	NA	5.79710144927536	NA	NA	9.56846234810066	1.07472567627113	257058.333333333	3	Xpot	0	Exportin-T (Exportin(tRNA)) (tRNA exportin)		FUNCTION: Mediates the nuclear export of aminoacylated tRNAs. In the nucleus binds to tRNA and to the GTPase Ran in its active GTP-bound form. Docking of this trimeric complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the tRNA from the export receptor. XPOT then return to the nuclear compartment and mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). {ECO:0000250}.		tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]	small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Nuclear, once bound to tRNA and Ran the complex translocates to the cytoplasm. Shuttles between the nucleus and the cytoplasm (By similarity). {ECO:0000250}.			IPR011989;IPR016024;IPR013598;IPR001494;IPR040017;	PF03810;PF08389;	SM00913;	109734			NA							3 out of 5	Chain (1); Modified residue (2); Sequence conflict (1)		Acetylation;Cytoplasm;Nucleus;RNA-binding;Reference proteome;Transport;tRNA-binding							NA	GO:0006409~tRNA export from nucleus,GO:0006810~transport,GO:0006886~intracellular protein transport,GO:0071528~tRNA re-export from nucleus,	GO:0005622~intracellular,GO:0005623~cell,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008536~Ran GTPase binding,GO:0015932~nucleobase-containing compound transmembrane transporter activity,	IPR001494:Importin-beta, N-terminal,IPR011989:Armadillo-like helical,IPR013598:Exportin-1/Importin-beta-like,IPR016024:Armadillo-type fold,	PF03810:Importin-beta N-terminal domain,PF08389:Exportin 1-like protein,	SSF48371:ARM repeat,	2.55965273559012	0.00162972394967842	FDR<0.01	2.7878859522122	294341.666666667	Present in Nucleus	RBP	Others	Others	Others	Others	1189	miscellaneous
Q62446	Q62446	Fkbp3	12.452	7.8418	10637350	16.0454406880285	NA	NA	NA	3.74854743786783	4.47868147617341	860944.166666667	3	Fkbp3	0	Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase)		FUNCTION: FK506- and rapamycin-binding proteins (FKBPs) constitute a family of receptors for the two immunosuppressants which inhibit T-cell proliferation by arresting two distinct cytoplasmic signal transmission pathways. PPIases accelerate the folding of proteins (By similarity). {ECO:0000250}.			nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	30795;		IPR043368;IPR041200;IPR001179;	PF18410;PF00254;		25148		REGION 88..118;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Inhibited preferentially by rapamycin over FK506. {ECO:0000250}.		5.2.1.8			4 out of 5	Beta strand (8); Chain (1); Domain (1); Helix (3); Initiator methionine (1); Modified residue (5); Region (1); Sequence conflict (1); Turn (1)		3D-structure;Acetylation;Direct protein sequencing;Isomerase;Nucleus;Phosphoprotein;Reference proteome;Rotamase	DOMAIN 128..224;  /note=PPIase FKBP-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00277					PS50059;	30795	GO:0006457~protein folding,GO:0061077~chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005789~endoplasmic reticulum membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005528~FK506 binding,GO:0016853~isomerase activity,GO:0044822~poly(A) RNA binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,	PF00254:FKBP-type peptidyl-prolyl cis-trans isomerase,		2.9365975315484	5.46529807390724e-05	FDR<0.01	4.26238614692143	5749147.08333333	Present in Nucleus	RBP	Others	Others	Others	Others	336	miscellaneous
Q9CXG3	Q9CXG3	Ppil4	2.4803	2.4119	3524450	2.21813100281703	1.79410814883921	3.13892899742608	1.33529176124983	3.28677074774034	3.68419113583613	3714850	0	Ppil4	0	Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)		FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (By similarity). {ECO:0000250}.		regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	67418;	cd01921;	IPR035542;IPR029000;IPR002130;IPR035538;IPR012677;IPR035979;IPR000504;	PF00160;PF00076;	SM00360;	57230	COMPBIAS 423..474;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 475..492;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 167..188;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 368..409;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 423..492;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				5.2.1.8			3 out of 5	Chain (1); Compositional bias (2); Cross-link (7); Domain (2); Modified residue (4); Region (3); Sequence conflict (2)		Isomerase;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Rotamase;Ubl conjugation	DOMAIN 1..161;  /note=PPIase cyclophilin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00156; DOMAIN 240..318;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50072;PS50102;	67418	GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016853~isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00160:Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD,	SSF50891:Cyclophilin-like,SSF54928:RNA-binding domain, RBD,	1.27984278719979	9.39981907182732e-05	FDR<0.01	4.02688050564107	3619650	Present in Nucleus	RBP	RBD	Others	Others	RBD	454	miscellaneous
P38647	P38647	Hspa9	4.2447	3.8159	1613955	8.04246421103426	7.55686541222701	8.39207787848271	5.15756356697096	6.03245460577909	6.0842054027744	5249166.66666667	0	Hspa9	0	Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (Peptide-binding protein 74) (PBP74) (p66 MOT)		FUNCTION: Chaperone protein which plays an important role in mitochondrial iron-sulfur cluster (ISC) biogenesis (PubMed:26702583). Interacts with and stabilizes ISC cluster assembly proteins FXN, NFU1, NFS1 and ISCU (By similarity). Regulates erythropoiesis via stabilization of ISC assembly (PubMed:21123823). May play a role in the control of cell proliferation and cellular aging (PubMed:8454632). {ECO:0000250|UniProtKB:P38646, ECO:0000269|PubMed:21123823, ECO:0000269|PubMed:26702583, ECO:0000269|PubMed:8454632}.		cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cell death [GO:0060548]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]	cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:7865888}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P38646}.	15526;		IPR043129;IPR012725;IPR018181;IPR029048;IPR029047;IPR013126;	PF00012;		73461	COMPBIAS 665..679;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..432;  /note=Interaction with NFS1;  /evidence=ECO:0000250|UniProtKB:P38646; REGION 432..679;  /note=Interaction with FXN and ISCU;  /evidence=ECO:0000250|UniProtKB:P38646; REGION 656..679;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (28); Natural variant (2); Region (3); Sequence conflict (5); Transit peptide (1)		ATP-binding;Acetylation;Chaperone;Direct protein sequencing;Methylation;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transit peptide						PS00297;PS00329;PS01036;	15526	GO:0006457~protein folding,GO:0006611~protein export from nucleus,GO:0030218~erythrocyte differentiation,GO:0045647~negative regulation of erythrocyte differentiation,GO:1902037~negative regulation of hematopoietic stem cell differentiation,GO:1903707~negative regulation of hemopoiesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005925~focal adhesion,GO:0031012~extracellular matrix,GO:0042645~mitochondrial nucleoid,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0017134~fibroblast growth factor binding,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR012725:Chaperone DnaK,IPR013126:Heat shock protein 70 family,IPR018181:Heat shock protein 70, conserved site,	PF00012:Hsp70 protein,	SSF100920:Heat shock protein 70kD (HSP70), peptide-binding domain,	2.5720804092402	7.01241095258504e-08	FDR<0.01	7.15413264060872	3431560.83333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	469	miscellaneous
P30416	P30416	Fkbp4	4.7448	9.3009	1790100	12.7949229745637	8.67754251995835	7.67518612326349	2.42142476633251	4.24881033310673	8.08146112817197	2612340	0	Fkbp4	0	Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]		FUNCTION: Immunophilin protein with PPIase and co-chaperone activities. Component of steroid receptors heterocomplexes through interaction with heat-shock protein 90 (HSP90). May play a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors between cytoplasm and nuclear compartments. The isomerase activity controls neuronal growth cones via regulation of TRPC1 channel opening. Acts also as a regulator of microtubule dynamics by inhibiting MAPT/TAU ability to promote microtubule assembly. May have a protective role against oxidative stress in mitochondria. {ECO:0000269|PubMed:11278753, ECO:0000269|PubMed:11751894, ECO:0000269|PubMed:8341706}.		androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein-containing complex localization [GO:0031503]; protein peptidyl-prolyl isomerization [GO:0000413]; reproductive structure development [GO:0048608]; steroid hormone receptor complex assembly [GO:0006463]	axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; glucocorticoid receptor binding [GO:0035259]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; tau protein binding [GO:0048156]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:11751894}. Mitochondrion {ECO:0000250|UniProtKB:Q02790}. Nucleus {ECO:0000269|PubMed:11751894, ECO:0000269|PubMed:8341706}. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Shuttles from mitochondria to nucleus; co-localizes in mitochondria with the glucocorticoid receptor. Colocalized with MAPT/TAU in the distal part of the primary cortical neurons. {ECO:0000250|UniProtKB:Q02790, ECO:0000250|UniProtKB:Q9QVC8}.	14228;		IPR031212;IPR001179;IPR013026;IPR011990;IPR001440;IPR013105;IPR019734;	PF00254;PF00515;PF07719;	SM00028;	51572		REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 267..400;  /note=Interaction with tubulin;  /evidence=ECO:0000250; REGION 428..458;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Inhibited by FK506. {ECO:0000250}.		5.2.1.8			5 out of 5	Chain (2); Cross-link (1); Domain (2); Erroneous initiation (1); Frameshift (1); Initiator methionine (1); Modified residue (8); Region (3); Repeat (3); Sequence conflict (7)		Acetylation;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isomerase;Isopeptide bond;Methylation;Microtubule;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Repeat;Rotamase;TPR repeat;Ubl conjugation	DOMAIN 50..138;  /note=PPIase FKBP-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00277; DOMAIN 167..253;  /note=PPIase FKBP-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00277	DOMAIN: The PPIase activity is mainly due to the first PPIase FKBP-type domain (1-138 AA). {ECO:0000250}.; DOMAIN: The C-terminal region (AA 375-458) is required to prevent tubulin polymerization. {ECO:0000250}.; DOMAIN: The chaperone activity resides in the C-terminal region, mainly between amino acids 264 and 400. {ECO:0000250}.; DOMAIN: The TPR repeats mediate mitochondrial localization. {ECO:0000250}.		REPEAT 270..303;  /note=TPR 1; REPEAT 319..352;  /note=TPR 2; REPEAT 353..386;  /note=TPR 3		PS50059;PS50005;PS50293;	14228	GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,GO:0006463~steroid hormone receptor complex assembly,GO:0006825~copper ion transport,GO:0007566~embryo implantation,GO:0010977~negative regulation of neuron projection development,GO:0030521~androgen receptor signaling pathway,GO:0030850~prostate gland development,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0031115~negative regulation of microtubule polymerization,GO:0031503~protein complex localization,GO:0046661~male sex differentiation,GO:0048608~reproductive structure development,GO:0061077~chaperone-mediated protein folding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0044295~axonal growth cone,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0005528~FK506 binding,GO:0016853~isomerase activity,GO:0031072~heat shock protein binding,GO:0032767~copper-dependent protein binding,GO:0035259~glucocorticoid receptor binding,GO:0044822~poly(A) RNA binding,GO:0048156~tau protein binding,GO:0051219~phosphoprotein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR001440:Tetratricopeptide TPR-1,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,IPR023114:Elongated TPR repeat-containing domain,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,	PF00254:FKBP-type peptidyl-prolyl cis-trans isomerase,PF00515:Tetratricopeptide repeat,PF07719:Tetratricopeptide repeat,	SSF48452:TPR-like,	2.69702958786588	8.61607950259532e-07	FDR<0.01	6.06469030235409	2201220	Present in Nucleus	RBP	Others	Others	Others	Others	594	miscellaneous
P07901	P07901	Hsp90aa1	27.694	27.094	34162000	1.58272925833307	1.45866153217807	1.39856227797824	0.981836033382425	3.52211890673429	3.31751982218094	69022000	0	Hsp90aa1	0	Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Tumor-specific transplantation 86 kDa antigen) (TSTA)		FUNCTION: Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle. Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70. Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation. Mediates the association of TOMM70 with IRF3 or TBK1 in mitochodria outer membrane which promotes host antiviral response. {ECO:0000250|UniProtKB:P07900}.		activation of innate immune response [GO:0002218]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to virus [GO:0098586]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; neuron migration [GO:0001764]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cell size [GO:0045793]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cellular protein localization [GO:1903827]; regulation of protein ubiquitination [GO:0031396]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]	apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTPase binding [GO:0051020]; GTP binding [GO:0005525]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22431752}. Cytoplasm {ECO:0000269|PubMed:11751894, ECO:0000269|PubMed:22431752, ECO:0000269|PubMed:27496612, ECO:0000269|PubMed:27686098}. Melanosome {ECO:0000250|UniProtKB:P07900}. Cell membrane {ECO:0000250|UniProtKB:P07900}. Mitochondrion {ECO:0000250|UniProtKB:P07900}.	15519;		IPR003594;IPR036890;IPR019805;IPR037196;IPR001404;IPR020575;IPR020568;	PF02518;PF00183;	SM00387;	84788	COMPBIAS 243..257;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 9..236;  /note=Interaction with NR3C1;  /evidence=ECO:0000269|PubMed:27686098; REGION 225..279;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 272..617;  /note=Interaction with NR3C1;  /evidence=ECO:0000269|PubMed:27686098; REGION 285..733;  /note=Interaction with FLCN and FNIP1;  /evidence=ECO:0000250|UniProtKB:P07900; REGION 285..621;  /note=Interaction with FNIP2 and TSC1;  /evidence=ECO:0000250|UniProtKB:P07900; REGION 629..732;  /note=Interaction with NR1D1;  /evidence=ECO:0000269|PubMed:27686098; REGION 683..733;  /note=Required for homodimerization;  /evidence=ECO:0000250|UniProtKB:P07900; REGION 701..733;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 729..733;  /note=Essential for interaction with SMYD3, TSC1 and STIP1/HOP;  /evidence=ECO:0000250|UniProtKB:P07900; REGION 730..733;  /note=Essential for interaction with SGTA and TTC1;  /evidence=ECO:0000250|UniProtKB:P07900	NA		ACTIVITY REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation (By similarity). Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation (By similarity). After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state (By similarity). Co-chaperone TSC1 promotes ATP binding and inhibits HSP90AA1 ATPase activity (PubMed:29127155). Binding to phosphorylated AHSA1 promotes HSP90AA1 ATPase activity (PubMed:29127155). Inhibited by geldanamycin, Ganetespib (STA-9090) and SNX-2112 (By similarity). {ECO:0000250|UniProtKB:P07900, ECO:0000269|PubMed:29127155}.	BINDING 51;  /note=ATP;  /evidence=ECO:0000250; BINDING 93;  /note=ATP;  /evidence=ECO:0000250; BINDING 112;  /note=ATP;  /evidence=ECO:0000250; BINDING 138;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250; BINDING 401;  /note=ATP;  /evidence=ECO:0000250	3.6.4.10			5 out of 5	Beta strand (8); Binding site (5); Chain (1); Compositional bias (1); Helix (9); Initiator methionine (1); Modified residue (17); Motif (1); Region (10); Sequence conflict (3); Turn (2)		3D-structure;ATP-binding;Acetylation;Cell membrane;Chaperone;Cytoplasm;Direct protein sequencing;Hydrolase;Membrane;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;Stress response;Ubl conjugation		DOMAIN: The TPR repeat-binding motif mediates interaction with TPR repeat-containing proteins like the co-chaperone STUB1. {ECO:0000250|UniProtKB:P07900}.	MOTIF 724..733;  /note=TPR repeat-binding;  /evidence=ECO:0000250|UniProtKB:P07900			PS00298;	15519	GO:0001764~neuron migration,GO:0003009~skeletal muscle contraction,GO:0006457~protein folding,GO:0006809~nitric oxide biosynthetic process,GO:0006950~response to stress,GO:0006986~response to unfolded protein,GO:0009408~response to heat,GO:0009409~response to cold,GO:0009651~response to salt stress,GO:0010592~positive regulation of lamellipodium assembly,GO:0010659~cardiac muscle cell apoptotic process,GO:0031396~regulation of protein ubiquitination,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0042026~protein refolding,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0043627~response to estrogen,GO:0045040~protein import into mitochondrial outer membrane,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045585~positive regulation of cytotoxic T cell differentiation,GO:0045793~positive regulation of cell size,GO:0046677~response to antibiotic,GO:0051131~chaperone-mediated protein complex assembly,GO:0060452~positive regulation of cardiac muscle contraction,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031012~extracellular matrix,GO:0031526~brush border membrane,GO:0032587~ruffle membrane,GO:0036126~sperm flagellum,GO:0042470~melanosome,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0097226~sperm mitochondrial sheath,GO:0097524~sperm plasma membrane,	GO:0000166~nucleotide binding,GO:0001948~glycoprotein binding,GO:0002134~UTP binding,GO:0002135~CTP binding,GO:0003729~mRNA binding,GO:0004713~protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0016887~ATPase activity,GO:0017098~sulfonylurea receptor binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0023026~MHC class II protein complex binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0030911~TPR domain binding,GO:0032564~dATP binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0048156~tau protein binding,GO:0051020~GTPase binding,GO:0051022~Rho GDP-dissociation inhibitor binding,GO:0051082~unfolded protein binding,	IPR001404:Heat shock protein Hsp90,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR019805:Heat shock protein Hsp90, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR020575:Heat shock protein Hsp90, N-terminal,	PF00183:Hsp90 protein,PF02518:Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,	1.8453137378708	0.00755614374346466	FDR<0.01	2.12169978891858	51592000	Present in Nucleus	RBP	DBD	DBD	Others	Others	49	miscellaneous
P10126	P10126;P62631	Eef1a1	1.7525	1.7696	166680000	10.5119310417324	10.1509445453899	14.6406453596475	10.0151228354816	7.19476221310886	7.28650539201399	83897000	0	Eef1a1	0	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1)		FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. Plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and PARP1. {ECO:0000250|UniProtKB:P68104}.		cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of cell death [GO:0010942]; positive regulation of neuron projection development [GO:0010976]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414]	cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]	calmodulin binding [GO:0005516]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19856081}. Nucleus {ECO:0000250|UniProtKB:P68104}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P68104}. Cell membrane {ECO:0000250|UniProtKB:P68104}. Note=Colocalizes with DLC1 at actin-rich regions in the cell periphery. Translocates together with ZPR1 from the cytoplasm to the nucleus and nucleolus after treatment with mitogens. Localization at the cell membrane depends on EEF1A1 phosphorylation status and the presence of PPP1R16B. {ECO:0000250|UniProtKB:P68104}.	13627;		IPR004161;IPR031157;IPR027417;IPR000795;IPR009000;IPR009001;IPR004539;IPR004160;	PF00009;PF03144;PF03143;		50114		REGION 14..21;  /note=G1;  /evidence=ECO:0000250; REGION 70..74;  /note=G2;  /evidence=ECO:0000250; REGION 91..94;  /note=G3;  /evidence=ECO:0000250; REGION 153..156;  /note=G4;  /evidence=ECO:0000250; REGION 194..196;  /note=G5;  /evidence=ECO:0000250	NA		ACTIVITY REGULATION: Inhibited by plitidepsin, a chemical compound extracted from the ascidian Aplidium albicans. {ECO:0000250|UniProtKB:P68104}.					5 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (20); Nucleotide binding (3); Region (5); Sequence conflict (13)		Acetylation;Cell membrane;Cytoplasm;Direct protein sequencing;Elongation factor;GTP-binding;Membrane;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	DOMAIN 5..242;  /note=tr-type G					PS00301;PS51722;	13627	GO:0006412~translation,GO:0006414~translational elongation,GO:0010942~positive regulation of cell death,GO:0010976~positive regulation of neuron projection development,GO:0051260~protein homooligomerization,GO:0071364~cellular response to epidermal growth factor stimulus,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030864~cortical actin cytoskeleton,GO:0032587~ruffle membrane,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0000049~tRNA binding,GO:0000166~nucleotide binding,GO:0003729~mRNA binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008144~drug binding,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,	IPR000795:Elongation factor, GTP-binding domain,IPR004160:Translation elongation factor EFTu/EF1A, C-terminal,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR004539:Translation elongation factor EF1A, eukaryotic/archaeal,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009001:Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF03143:Elongation factor Tu C-terminal domain,PF03144:Elongation factor Tu domain 2,	SSF50447:Translation proteins,SSF50465:EF-Tu/eEF-1alpha/eIF2-gamma C-terminal domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.65981564289018	1.92339152573455e-05	FDR<0.01	4.71593230174257	125288500	Present in Nucleus	RBP	Others	Others	Others	Others	15	miscellaneous
Q8BVY0	Q8BVY0	Rsl1d1	28.574	34.372	96495000	15.6267091713156	18.2292141385785	40.9433344251556	25.6792152431822	14.8836101684825	21.190032208849	46422816.6666667	0	Rsl1d1	0	Ribosomal L1 domain-containing protein 1		FUNCTION: Regulates cellular senescence through inhibition of PTEN translation. Acts as a pro-apoptotic regulator in response to DNA damage. {ECO:0000250|UniProtKB:O76021}.		maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]	90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O76021}.	66409;	cd00403;	IPR023674;IPR028364;IPR016095;	PF00687;		50421	COMPBIAS 283..307;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 308..323;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 382..396;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..452;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 283..452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (2); Frameshift (1); Modified residue (9); Region (1)		Acetylation;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							66409	GO:0000470~maturation of LSU-rRNA,GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0032880~regulation of protein localization,GO:0042981~regulation of apoptotic process,GO:2000772~regulation of cellular senescence,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR016094:Ribosomal protein L1, 2-layer alpha/beta-sandwich,IPR023674:Ribosomal protein L1, superfamily,	PF00687:Ribosomal protein L1p/L10e family,	SSF56808:Ribosomal protein L1,	4.55412099178284	4.45942268300526e-10	FDR<0.01	9.3507213614255	71458908.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	35	miscellaneous
P58252	P58252	Eef2	8.7489	9.6758	18321500	6.13948919449902	21.82405447284	9.18273645546373	20.0104054108136	13.11303435615	11.9053288251822	19592116.6666667	0	Eef2	0	Elongation factor 2 (EF-2)		FUNCTION: Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.		aging [GO:0007568]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; glial cell proliferation [GO:0014009]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of translation [GO:0045727]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to hydrogen peroxide [GO:0042542]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle contraction [GO:0003009]; translational elongation [GO:0006414]	aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; actin filament binding [GO:0051015]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P13639}. Nucleus {ECO:0000250|UniProtKB:P13639}. Note=Phosphorylation by CSK promotes cleavage and SUMOylation-dependent nuclear translocation of the C-terminal cleavage product. {ECO:0000250|UniProtKB:P13639}.	13629;		IPR041095;IPR035647;IPR000640;IPR004161;IPR031157;IPR027417;IPR020568;IPR014721;IPR005225;IPR000795;IPR009000;IPR005517;	PF00679;PF14492;PF03764;PF00009;PF03144;	SM00838;SM00889;	95314			NA							5 out of 5	Chain (1); Cross-link (3); Domain (1); Initiator methionine (1); Modified residue (21); Nucleotide binding (3)		Acetylation;Cytoplasm;Direct protein sequencing;Elongation factor;GTP-binding;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	DOMAIN 17..362;  /note=tr-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01059					PS00301;PS51722;	13629	GO:0002244~hematopoietic progenitor cell differentiation,GO:0002931~response to ischemia,GO:0003009~skeletal muscle contraction,GO:0006412~translation,GO:0006414~translational elongation,GO:0007568~aging,GO:0014009~glial cell proliferation,GO:0032355~response to estradiol,GO:0034976~response to endoplasmic reticulum stress,GO:0035914~skeletal muscle cell differentiation,GO:0042542~response to hydrogen peroxide,GO:0045471~response to ethanol,GO:0045727~positive regulation of translation,GO:0051593~response to folic acid,GO:1990416~cellular response to brain-derived neurotrophic factor stimulus,GO:2000767~positive regulation of cytoplasmic translation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005844~polysome,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016235~aggresome,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0042788~polysomal ribosome,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0002039~p53 binding,GO:0003723~RNA binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0008097~5S rRNA binding,GO:0019901~protein kinase binding,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,GO:0051015~actin filament binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000640:Translation elongation factor EFG, V domain,IPR000795:Elongation factor, GTP-binding domain,IPR004161:Translation elongation factor EFTu/EF1A, domain 2,IPR005225:Small GTP-binding protein domain,IPR005517:Translation elongation factor EFG/EF2, domain IV,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR009022:Elongation factor G, III-V domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00679:Elongation factor G C-terminus,PF03144:Elongation factor Tu domain 2,PF03764:Elongation factor G, domain IV,PF14492:Elongation Factor G, domain II,	SSF50447:Translation proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54211:Ribosomal protein S5 domain 2-like,SSF54980:EF-G C-terminal domain-like,	3.53468953938188	1.4390972428247e-08	FDR<0.01	7.84190985888113	18956808.3333333	Present in Nucleus	RBP	Others	Others	Others	Others	121	miscellaneous
P23116	P23116	Eif3a	66.421	203.92	11906000	13.1837418096004	18.0472838837755	26.0328534610679	8.63781636002419	21.9519690916275	19.3229247178853	18905033.3333333	0	Eif3a	0	Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Centrosomin) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185) (p162)		FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. {ECO:0000255|HAMAP-Rule:MF_03000, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; viral translational termination-reinitiation [GO:0075525]	cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03000}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:9372446}. Nucleus {ECO:0000269|PubMed:9372446}. Note=Centrosomin-A is found in the centrosome. Centrosomin-B is found in the nucleus.	13669;		IPR027512;IPR000717;	PF01399;	SM00088;	161936	COMPBIAS 866..1128;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1136..1240;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 664..835;  /note=Interaction with EIF3B;  /evidence=ECO:0000255|HAMAP-Rule:MF_03000; REGION 807..844;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 866..1240;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 924..1133;  /note=21 X 10 AA approximate tandem repeats of [DA]-[DE]-[ED]-R-[PLIGFSV]-[RPS]-[RW]-[RL]-[GNIHT]-[DGLPTAM]; REGION 1252..1344;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Domain (1); Frameshift (2); Modified residue (11); Region (5); Repeat (21); Sequence conflict (12)		Acetylation;Coiled coil;Cytoplasm;Cytoskeleton;Initiation factor;Nucleus;Phosphoprotein;Protein biosynthesis;RNA editing;RNA-binding;Reference proteome;Repeat	DOMAIN 315..498;  /note=PCI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01185			REPEAT 924..931;  /note=1; truncated; REPEAT 932..941;  /note=2; REPEAT 942..951;  /note=3; approximate; REPEAT 953..962;  /note=4; REPEAT 963..972;  /note=5; REPEAT 973..982;  /note=6; REPEAT 983..992;  /note=7; REPEAT 993..1002;  /note=8; REPEAT 1003..1012;  /note=9; REPEAT 1013..1022;  /note=10; REPEAT 1023..1032;  /note=11; REPEAT 1033..1042;  /note=12; REPEAT 1043..1052;  /note=13; REPEAT 1054..1063;  /note=14; REPEAT 1064..1073;  /note=15; REPEAT 1074..1083;  /note=16; REPEAT 1084..1093;  /note=17; REPEAT 1094..1103;  /note=18; REPEAT 1104..1113;  /note=19; REPEAT 1114..1123;  /note=20; REPEAT 1124..1133;  /note=21; approximate		PS50250;	13669	GO:0001731~formation of translation preinitiation complex,GO:0001732~formation of cytoplasmic translation initiation complex,GO:0002188~translation reinitiation,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0075522~IRES-dependent viral translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0043614~multi-eIF complex,GO:0071540~eukaryotic translation initiation factor 3 complex, eIF3e,GO:0071541~eukaryotic translation initiation factor 3 complex, eIF3m,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0030971~receptor tyrosine kinase binding,GO:0044822~poly(A) RNA binding,	IPR000717:Proteasome component (PCI) domain,IPR027512:Eukaryotic translation initiation factor 3 subunit A,	PF01399:PCI domain,		4.77015912934722	3.39514283607789e-07	FDR<0.01	6.46914194992087	15405516.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	150	miscellaneous
P20152	P20152;P15331-3;P31001;P15331;P15331-2	Vim	8.1314	12.858	4157750	7.02296509586347	17.0805862057186	29.4889563858335	11.3110656154916	13.5076723578993	17.8186418631172	23805200	0	Vim	0	Vimentin		FUNCTION: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally.; FUNCTION: Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. {ECO:0000250}.		astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; intermediate filament-based process [GO:0045103]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; negative regulation of neuron projection development [GO:0010977]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of translation [GO:0045727]; regulation of axonogenesis [GO:0050770]; regulation of mRNA stability [GO:0043488]; regulation of Schwann cell migration [GO:1900147]; SMAD protein signal transduction [GO:0060395]	axon [GO:0030424]; cell body [GO:0044297]; cell leading edge [GO:0031252]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; type III intermediate filament [GO:0045098]	double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19029034, ECO:0000269|PubMed:27559293}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P08670}. Nucleus matrix {ECO:0000250|UniProtKB:P31000}. Cell membrane {ECO:0000269|PubMed:19029034}.	22352;		IPR018039;IPR039008;IPR042180;IPR006821;IPR027699;	PF00038;PF04732;	SM01391;	53688		REGION 1..33;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..95;  /note=Head; REGION 96..131;  /note=Coil 1A; REGION 132..153;  /note=Linker 1; REGION 154..245;  /note=Coil 1B; REGION 246..268;  /note=Linker 12; REGION 269..407;  /note=Coil 2; REGION 408..466;  /note=Tail	NA							5 out of 5	Chain (1); Coiled coil (3); Cross-link (12); Domain (1); Glycosylation (3); Initiator methionine (1); Modified residue (57); Motif (1); Region (8); Sequence conflict (6); Site (1)		Acetylation;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;Glycoprotein;Intermediate filament;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;Ubl conjugation	DOMAIN 103..411;  /note=IF rod;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01188	DOMAIN: The central alpha-helical coiled-coil IF rod domain mediates elementary homodimerization. {ECO:0000250}.; DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex. {ECO:0000250|UniProtKB:P08670}.	MOTIF 326..329;  /note=[IL]-x-C-x-x-[DE] motif;  /evidence=ECO:0000250|UniProtKB:P08670			PS00226;PS51842;	22352	GO:0010628~positive regulation of gene expression,GO:0010977~negative regulation of neuron projection development,GO:0014002~astrocyte development,GO:0045103~intermediate filament-based process,GO:0045109~intermediate filament organization,GO:0050770~regulation of axonogenesis,GO:0060020~Bergmann glial cell differentiation,GO:0060252~positive regulation of glial cell proliferation,GO:0060395~SMAD protein signal transduction,GO:0070307~lens fiber cell development,GO:1900147~regulation of Schwann cell migration,	GO:0005737~cytoplasm,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030424~axon,GO:0031012~extracellular matrix,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045098~type III intermediate filament,GO:0045111~intermediate filament cytoskeleton,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0003725~double-stranded RNA binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005212~structural constituent of eye lens,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0051721~protein phosphatase 2A binding,GO:0097110~scaffold protein binding,GO:1990254~keratin filament binding,	IPR001664:Intermediate filament protein,IPR006821:Intermediate filament head, DNA-binding domain,IPR018039:Intermediate filament protein, conserved site,	PF00038:Intermediate filament protein,PF04732:Intermediate filament head (DNA binding) region,		3.73840655410165	1.15174788635783e-08	FDR<0.01	7.93864257607461	13981475	Present in Nucleus	RBP	DBD	DBD	Others	Others	168	miscellaneous
Q6P542	Q6P542	Abcf1	6.1389	3.9838	6485100	2.59161353858913	2.24014336917563	2.38788862887435	1.57922996746786	13.067454198573	11.2869364996953	8759403.33333333	0	Abcf1	0	ATP-binding cassette sub-family F member 1		FUNCTION: Required for efficient Cap- and IRES-mediated mRNA translation initiation. Not involved in the ribosome biogenesis (By similarity). {ECO:0000250}.		positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]	ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8NE71}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q8NE71}. Nucleus envelope {ECO:0000250|UniProtKB:Q8NE71}.	224742;		IPR003593;IPR032781;IPR003439;IPR017871;IPR027417;	PF00005;PF12848;	SM00382;	94945	COMPBIAS 37..73;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 81..119;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 147..193;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 205..256;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..256;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 551..599;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Domain (2); Modified residue (8); Nucleotide binding (2); Region (2)		ATP-binding;Activator;Cytoplasm;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat	DOMAIN 296..540;  /note=ABC transporter 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00434; DOMAIN 617..832;  /note=ABC transporter 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00434					PS00211;PS50893;	224742	GO:0006413~translational initiation,GO:0045727~positive regulation of translation,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0008494~translation activator activity,GO:0016887~ATPase activity,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00005:ABC transporter,PF12848:ABC transporter,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.03362651695089	0.000150021776703136	FDR<0.01	3.82384569550724	7622251.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	265	miscellaneous
P60229	P60229	Eif3e	3.1567	27.671	5536450	13.4377897523415	20.3111670796604	13.8007176373171	6.58718134510243	0.749063670411985	11.6025432774864	8553065	0	Eif3e	0	Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (MMTV integration site 6) (Mammary tumor-associated protein INT-6) (Viral integration site protein INT-6) (eIF-3 p48)		FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. Required for nonsense-mediated mRNA decay (NMD); may act in conjunction with UPF2 to divert mRNAs from translation to the NMD pathway. May interact with MCM7 and EPAS1 and regulate the proteasome-mediated degradation of these proteins. {ECO:0000255|HAMAP-Rule:MF_03004, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]	protein N-terminus binding [GO:0047485]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03004}. Nucleus, PML body {ECO:0000255|HAMAP-Rule:MF_03004}.	16341;		IPR016650;IPR019010;IPR000717;IPR036388;IPR036390;	PF09440;PF01399;	SM01186;SM00088;	52221		REGION 4..128;  /note=Sufficient for interaction with EPAS1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03004; REGION 9..195;  /note=Sufficient for interaction with TRIM27;  /evidence=ECO:0000255|HAMAP-Rule:MF_03004; REGION 351..445;  /note=Sufficient for interaction with MCM7;  /evidence=ECO:0000255|HAMAP-Rule:MF_03004	NA							5 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (5); Region (3)		Acetylation;Cytoplasm;Initiation factor;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome	DOMAIN 221..398;  /note=PCI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01185					PS50250;	16341	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016282~eukaryotic 43S preinitiation complex,GO:0016605~PML body,GO:0033290~eukaryotic 48S preinitiation complex,GO:0070062~extracellular exosome,	GO:0003743~translation initiation factor activity,GO:0044822~poly(A) RNA binding,GO:0047485~protein N-terminus binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000717:Proteasome component (PCI) domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016650:Eukaryotic translation initiation factor 3 subunit E,IPR019010:Eukaryotic translation initiation factor 3 subunit E, N-terminal,	PF01399:PCI domain,PF09440:eIF3 subunit 6 N terminal domain,	SSF46785:Winged helix DNA-binding domain,	3.02087591405877	9.34017664270462e-05	FDR<0.01	4.0296449102553	7044757.5	Present in Nucleus	RBP	DBD	DBD	Others	Others	280	miscellaneous
Q99L28	Q99L28	Rsl24d1	11.355	10.852	4003170	6.35687496026953	NA	15.7890581826794	11.324130589874	3.94632991318074	7.213966238638	1453506.66666667	1	Rsl24d1	0	Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like)		FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. Ensures the docking of GTPBP4/NOG1 to pre-60S particles (By similarity). {ECO:0000250}.		assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]	cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	225215;	cd00472;	IPR038630;IPR023438;IPR000988;IPR023442;IPR011017;	PF01246;	SM00746;	19611			NA							3 out of 5	Chain (1)		Nucleus;Reference proteome;Ribosome biogenesis						PS01073;	225215	GO:0000027~ribosomal large subunit assembly,GO:0006412~translation,GO:0042254~ribosome biogenesis,GO:1902626~assembly of large subunit precursor of preribosome,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0016021~integral component of membrane,GO:0022625~cytosolic large ribosomal subunit,	GO:0003735~structural constituent of ribosome,	IPR000988:Ribosomal protein L24e-related,IPR011017:TRASH domain,IPR023438:Ribosomal protein L24e, archaeal,IPR023442:Ribosomal protein L24e, conserved site,IPR024546:Ribosome biogenesis protein RLP24,	PF01246:Ribosomal protein L24e,		3.13242119993995	4.17248983132734e-07	FDR<0.01	6.37960471305586	2728338.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	533	miscellaneous
Q9Z1D1	Q9Z1D1	Eif3g	6.7408	46.422	2323100	5.05919255286856	9.8599881680142	21.997360316762	NA	11.1995878551669	15.2380952380952	1921023.16666667	1	Eif3g	0	Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)		FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. This subunit can bind 18S rRNA. {ECO:0000255|HAMAP-Rule:MF_03006, ECO:0000269|PubMed:17581632}.		formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03006}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03006}. Cytoplasm, perinuclear region {ECO:0000255|HAMAP-Rule:MF_03006}. Note=Colocalizes with AIFM1 in the nucleus and perinuclear region. {ECO:0000255|HAMAP-Rule:MF_03006}.	53356;	cd12933;cd12408;	IPR017334;IPR024675;IPR034240;IPR012677;IPR035979;IPR000504;	PF12353;PF00076;	SM00360;	35638		REGION 1..60;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 204..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Domain (1); Modified residue (8); Region (2); Sequence conflict (7)		Cytoplasm;Initiation factor;Nucleus;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome	DOMAIN 239..317;  /note=RRM;  /evidence=ECO:0000255|HAMAP-Rule:MF_03006					PS50102;	53356	GO:0001731~formation of translation preinitiation complex,GO:0006412~translation,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0075525~viral translational termination-reinitiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0016282~eukaryotic 43S preinitiation complex,GO:0033290~eukaryotic 48S preinitiation complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017334:Eukaryotic translation initiation factor 3 subunit G,IPR024675:Eukaryotic translation initiation factor 3 subunit G, N-terminal,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF12353:Eukaryotic translation initiation factor 3 subunit G ,	SSF54928:RNA-binding domain, RBD,	3.68634179640185	1.52360488187939e-06	FDR<0.01	5.81712764445827	2122061.58333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	604	miscellaneous
P31230	P31230	Aimp1	6.2611	5.9429	1132715	1.52267259493864	NA	7.85422557335847	NA	NA	NA	23151	4	Aimp1	0	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)]		FUNCTION: Non-catalytic component of the multisynthase complex (PubMed:12060739). Stimulates the catalytic activity of cytoplasmic arginyl-tRNA synthase (By similarity). Binds tRNA. Possesses inflammatory cytokine activity (PubMed:1400342, PubMed:7545917). Negatively regulates TGF-beta signaling through stabilization of SMURF2 by binding to SMURF2 and inhibiting its SMAD7-mediated degradation (PubMed:18448069). Involved in glucose homeostasis through induction of glucagon secretion at low glucose levels (PubMed:17001013). Promotes dermal fibroblast proliferation and wound repair (PubMed:15681823). Regulates KDELR1-mediated retention of HSP90B1/gp96 in the endoplasmic reticulum (PubMed:17525271). Plays a role in angiogenesis by inducing endothelial cell migration at low concentrations and endothelian cell apoptosis at high concentrations (By similarity). Induces maturation of dendritic cells and monocyte cell adhesion (PubMed:18292511). Modulates endothelial cell responses by degrading HIF-1A through interaction with PSMA7 (By similarity). {ECO:0000250|UniProtKB:Q12904, ECO:0000269|PubMed:12060739, ECO:0000269|PubMed:1400342, ECO:0000269|PubMed:15681823, ECO:0000269|PubMed:17001013, ECO:0000269|PubMed:17525271, ECO:0000269|PubMed:18292511, ECO:0000269|PubMed:18448069, ECO:0000269|PubMed:7545917}.		angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q12904}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q12904}. Secreted {ECO:0000269|PubMed:17001013, ECO:0000269|PubMed:9770485}. Endoplasmic reticulum {ECO:0000269|PubMed:17525271}. Golgi apparatus {ECO:0000269|PubMed:17525271}. Note=Enriched in secretory vesicles of pancreatic alpha cells and secreted from the pancreas in response to low glucose levels (PubMed:17001013). Secreted in response to hypoxia (By similarity). Also secreted in response to both apoptotic and necrotic cell death. {ECO:0000250|UniProtKB:Q12904, ECO:0000269|PubMed:17001013}.			IPR012340;IPR002547;	PF01588;		33997	COMPBIAS 92..111;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 113..139;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 6..46;  /note=Required for fibroblast proliferation;  /evidence=ECO:0000250; REGION 54..192;  /note=Interaction with HSP90B1;  /evidence=ECO:0000269|PubMed:17525271; REGION 92..147;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 101..115;  /note=Required for endothelial cell death;  /evidence=ECO:0000250; REGION 115..190;  /note=Required for endothelial cell migration;  /evidence=ECO:0000250	NA							5 out of 5	Chain (2); Compositional bias (2); Domain (1); Initiator methionine (1); Modified residue (3); Region (5)		Acetylation;Angiogenesis;Apoptosis;Cytokine;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Inflammatory response;Nucleus;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Secreted;tRNA-binding	DOMAIN 149..250;  /note=tRNA-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00209					PS50886;	NA	GO:0001525~angiogenesis,GO:0001937~negative regulation of endothelial cell proliferation,GO:0005975~carbohydrate metabolic process,GO:0006006~glucose metabolic process,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0048514~blood vessel morphogenesis,GO:0050900~leukocyte migration,GO:0051607~defense response to virus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0009986~cell surface,GO:0016020~membrane,GO:0017101~aminoacyl-tRNA synthetase multienzyme complex,GO:0017102~methionyl glutamyl tRNA synthetase complex,GO:0030133~transport vesicle,GO:0031410~cytoplasmic vesicle,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0005125~cytokine activity,GO:0042803~protein homodimerization activity,GO:0051020~GTPase binding,	IPR002547:tRNA-binding domain,IPR012340:Nucleic acid-binding, OB-fold,	PF01588:Putative tRNA binding domain,	SSF50249:Nucleic acid-binding proteins,	2.19941451212353	0.00199992514622152	FDR<0.01	2.69898625893167	577933	Present in Nucleus	RBP	DBD	DBD	Others	RBD	989	miscellaneous
Q62095	Q62095	Ddx3y	9.153	6.5635	717425	5.60129950148434	3.47077606552825	1.07545384152112	4.91400491400491	6.27470665746376	8.15394651011089	199925.333333333	0	Ddx3y	0	ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (D1Pas1-related sequence 1) (DEAD box protein 3, Y-chromosomal) (DEAD-box RNA helicase DEAD2) (mDEAD2)		FUNCTION: Probable ATP-dependent RNA helicase. During immune response, may enhance IFNB1 expression via IRF3/IRF7 pathway (PubMed:30475900). {ECO:0000269|PubMed:30475900}.		cell differentiation [GO:0030154]; gamete generation [GO:0007276]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15383328}. Nucleus {ECO:0000269|PubMed:15383328}. Note=Shuttles between the nucleus and the cytoplasm in an XPO1-dependent manner.	26900;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	73428	COMPBIAS 19..34;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 40..54;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 91..141;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 599..627;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 597..627;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Initiator methionine (1); Modified residue (16); Motif (2); Nucleotide binding (2); Region (2); Sequence conflict (1)		ATP-binding;Acetylation;Cytoplasm;Direct protein sequencing;Helicase;Hydrolase;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 210..402;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 413..574;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 179..207;  /note=Q motif; MOTIF 346..349;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	26900	GO:0006413~translational initiation,GO:0007059~chromosome segregation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0036464~cytoplasmic ribonucleoprotein granule,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.28357766137203	2.06378479702551e-05	FDR<0.01	4.68533559112284	458675.166666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1069	miscellaneous
Q9QXB9	Q9QXB9	Drg2	0.54039	2.3487	131258	4.55913194127838	7.78998208304121	NA	NA	NA	NA	242946.666666667	4	Drg2	0	Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-)		FUNCTION: Catalyzes the conversion of GTP to GDP through hydrolysis of the gamma-phosphate bond in GTP. When hydroxylated at C-3 of 'Lys-21' by JMJD7, may bind to RNA and play a role in translation. {ECO:0000250|UniProtKB:P55039}.		cytoplasmic translation [GO:0002181]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P55039}. Cytoplasm {ECO:0000250|UniProtKB:P55039}.	13495;		IPR012675;IPR031167;IPR006073;IPR031662;IPR006074;IPR027417;IPR005225;IPR004095;IPR012676;	PF01926;PF16897;PF02824;		40718			NA				3.6.5.-	METAL 76;  /note=Magnesium;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01047; METAL 96;  /note=Magnesium;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01047		5 out of 5	Chain (1); Domain (2); Metal binding (2); Modified residue (1); Nucleotide binding (5)		Cytoplasm;GTP-binding;Hydrolase;Hydroxylation;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Reference proteome;Ubl conjugation	DOMAIN 63..288;  /note=OBG-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01047; DOMAIN 288..363;  /note=TGS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01228					PS51710;PS00905;PS51880;	13495		GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0005525~GTP binding,	IPR004095:TGS,IPR005225:Small GTP-binding protein domain,IPR006073:GTP binding domain,IPR006074:GTP1/OBG, conserved site,IPR012676:TGS-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF01926:50S ribosome-binding GTPase,PF02824:TGS domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF81271:TGS-like,	1.3735786258916	0.0624086580937768	FDR<0.1	1.20475515548567	187102.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	1297	miscellaneous
Q8VDJ3	Q8VDJ3	Hdlbp	8.9096	4.3409	1357550	4.70322641331954	6.36577757973136	14.3161873129948	6.93818080899188	6.04558370110634	6.46287080721256	1141336.66666667	0	Hdlbp	0	Vigilin (High density lipoprotein-binding protein) (HDL-binding protein)		FUNCTION: Appears to play a role in cell sterol metabolism. It may function to protect cells from over-accumulation of cholesterol (By similarity). {ECO:0000250}.		cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; polysome [GO:0005844]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	110611;		IPR004087;IPR004088;IPR036612;	PF00013;	SM00322;	141743	COMPBIAS 928..947;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1230..1252;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 910..947;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1213..1268;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Domain (14); Initiator methionine (1); Modified residue (12); Region (2)		Acetylation;Cholesterol metabolism;Cytoplasm;HDL;Lipid metabolism;Lipid transport;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Steroid metabolism;Sterol metabolism;Transport	DOMAIN 150..212;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 222..284;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 295..357;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 364..424;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 435..497;  /note=KH 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 507..570;  /note=KH 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 581..643;  /note=KH 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 653..716;  /note=KH 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 727..790;  /note=KH 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 800..863;  /note=KH 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 873..967;  /note=KH 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 972..1034;  /note=KH 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 1052..1117;  /note=KH 13;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 1127..1190;  /note=KH 14;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117					PS50084;	110611	GO:0006629~lipid metabolic process,GO:0006810~transport,GO:0006869~lipid transport,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0034364~high-density lipoprotein particle,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.76244150435781	9.42855140869099e-08	FDR<0.01	7.02555502661981	1249443.33333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	753	miscellaneous
Q9DB96	Q9DB96	Ngdn	15.432	17.935	9709750	15.1998784009728	6.68181210744354	17.0989860301284	24.1225425159812	14.0615332695877	6.71727010143078	7127106.66666667	0	Ngdn	0	Neuroguidin (EIF4E-binding protein)		FUNCTION: Inhibits mRNA translation in a cytoplasmic polyadenylation element (CPE)-dependent manner. {ECO:0000269|PubMed:16705177}.		maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]	axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16705177}. Nucleus, nucleolus {ECO:0000250}. Chromosome, centromere {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:16705177}. Cell projection, axon {ECO:0000269|PubMed:16705177}. Cell projection, dendrite {ECO:0000269|PubMed:16705177}. Cell projection, filopodium {ECO:0000269|PubMed:16705177}. Note=Translocated from nucleolus to nuclear foci in response to UV damage (By similarity). Detected in axons, dendrites and filopodia. Colocalized with EIF4E in neurites. {ECO:0000250}.	68966;		IPR007146;	PF04000;		35659	COMPBIAS 298..315;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 41..174;  /note=Necessary for interaction with EIF4E;  /evidence=ECO:0000269|PubMed:16705177; REGION 123..190;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 212..243;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 284..315;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (6); Region (4); Sequence conflict (1)		Acetylation;Cell projection;Centromere;Chromosome;Coiled coil;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repressor;Translation regulation							68966	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006417~regulation of translation,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0032040~small-subunit processome,GO:0042995~cell projection,	GO:0044822~poly(A) RNA binding,	IPR007146:Sas10/Utp3/C1D,	PF04000:Sas10/Utp3/C1D family,		3.7535615332968	1.17075863882612e-08	FDR<0.01	7.93153262894996	8418428.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	248	miscellaneous
Q8BKS9	Q8BKS9	Kiaa0020	18.595	21.604	28359850	13.2359169843287	18.1106925528832	12.3120867755876	6.05363520794237	17.1315014047831	16.0945069447797	18950116.6666667	0	Kiaa0020	0	Pumilio homolog 3		FUNCTION: Inhibits the poly(ADP-ribosyl)ation activity of PARP1 and the degradation of PARP1 by CASP3 following genotoxic stress. Binds to double-stranded RNA or DNA without sequence specificity. Involved in development of the eye and of primordial germ cells. {ECO:0000250|UniProtKB:Q15397, ECO:0000250|UniProtKB:X1WGX5}.		regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q15397}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q15397}. Chromosome {ECO:0000250|UniProtKB:Q15397}. Note=Localizes predominantly in the nucleolus with minor punctate signals in the nucleoplasm. {ECO:0000250|UniProtKB:Q15397}.	52874;		IPR011989;IPR016024;IPR012959;IPR033133;IPR040059;IPR001313;	PF08144;	SM00025;	72800	COMPBIAS 10..36;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 72..123;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (2); Frameshift (1); Modified residue (1); Motif (1); Region (1); Repeat (11)		Acetylation;Chromosome;DNA-binding;Nucleus;RNA-binding;Reference proteome;Repeat	DOMAIN 142..509;  /note=PUM-HD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00318	DOMAIN: A 90 degree bend between Pumilio repeats 3 and 4 gives rise to a L-shaped protein. {ECO:0000250|UniProtKB:Q15397}.	MOTIF 105..117;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q15397	REPEAT 176..211;  /note=Pumilio 1;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 212..247;  /note=Pumilio 2;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 248..276;  /note=Pumilio 3;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 288..324;  /note=Pumilio 4;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 325..360;  /note=Pumilio 5;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 361..396;  /note=Pumilio 6;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 397..434;  /note=Pumilio 7;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 435..503;  /note=Pumilio 8;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 504..550;  /note=Pumilio 9;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 551..595;  /note=Pumilio 10;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 596..635;  /note=Pumilio 11;  /evidence=ECO:0000250|UniProtKB:Q15397		PS50302;PS50303;	52874	GO:0006417~regulation of translation,GO:0010835~regulation of protein ADP-ribosylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR001313:Pumilio RNA-binding repeat,IPR011989:Armadillo-like helical,IPR012959:CPL,IPR016024:Armadillo-type fold,	PF08144:CPL (NUC119) domain,	SSF48371:ARM repeat,	3.86026334387129	3.81737993390343e-09	FDR<0.01	8.41823461369871	23654983.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	102	miscellaneous
P28656	P28656	Nap1l1	33.044	56.122	41858000	4.05597241938755	12.4939092192556	9.25326177477561	8.58516483516484	2.54712175241977	4.58926112895824	8443983.33333333	0	Nap1l1	0	Nucleosome assembly protein 1-like 1 (Brain protein DN38) (NAP-1-related protein)		FUNCTION: Histone chaperone that plays a role in the nuclear import of H2A-H2B and nucleosome assembly. Participates also in several important DNA repair mechanisms: greatly enhances ERCC6-mediated chromatin remodeling which is essential for transcription-coupled nucleotide excision DNA repair. Stimulates also homologous recombination (HR) by RAD51 and RAD54 which is essential in mitotic DNA double strand break (DSB) repair (By similarity). Plays a key role in the regulation of embryonic neurogenesis (PubMed:29490266). Promotes the proliferation of neural progenitors and inhibits neuronal differentiation during cortical development (PubMed:29490266). Regulates neurogenesis via the modulation of RASSF10; regulates RASSF10 expression by promoting SETD1A-mediated H3K4 methylation at the RASSF10 promoter (PubMed:29490266). {ECO:0000250|UniProtKB:P55209, ECO:0000269|PubMed:29490266}.		nucleosome assembly [GO:0006334]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; kinase binding [GO:0019900]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29490266}. Cytoplasm {ECO:0000269|PubMed:29490266}. Melanosome {ECO:0000250|UniProtKB:P55209}.	53605;		IPR037231;IPR002164;	PF00956;		45345	COMPBIAS 10..27;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 142..163;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 346..375;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..391;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 131..163;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 346..391;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (4); Initiator methionine (1); Lipidation (1); Modified residue (10); Motif (1); Mutagenesis (2); Propeptide (1); Region (3); Sequence conflict (1)		Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Lipoprotein;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Prenylation;Reference proteome		DOMAIN: The acidic domains are probably involved in the interaction with histones.	MOTIF 273..279;  /note=Nuclear localization signal;  /evidence=ECO:0000255				53605	GO:0006334~nucleosome assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042470~melanosome,GO:0043005~neuron projection,	GO:0005515~protein binding,GO:0019900~kinase binding,GO:0044822~poly(A) RNA binding,	IPR002164:Nucleosome assembly protein (NAP),	PF00956:Nucleosome assembly protein (NAP),		3.2973686873092	1.85303983538267e-05	FDR<0.01	4.73211524441509	25150991.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	92	miscellaneous
Q9CXK8	Q9CXK8	Nip7	4.1323	11.449	8856100	2.93160564040925	9.3222709051925	38.2029339853301	16.1681487469685	3.9883540063016	6.80966973101805	11852633.3333333	0	Nip7	0	60S ribosome subunit biogenesis protein NIP7 homolog (Nucleolar pre-rRNA processing protein NIP7) (PEachy) (kDa93)		FUNCTION: Required for proper 34S pre-rRNA processing and 60S ribosome subunit assembly. {ECO:0000250}.		ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	66164;		IPR002478;IPR015947;IPR036974;IPR016686;IPR040598;IPR005155;	PF03657;PF17833;	SM00359;	20452		REGION 1..92;  /note=N-terminal domain;  /evidence=ECO:0000250; REGION 93..180;  /note=C-terminal domain;  /evidence=ECO:0000250	NA							3 out of 5	Chain (1); Domain (1); Region (2); Sequence conflict (1)		Nucleus;RNA-binding;Reference proteome;Ribosome biogenesis	DOMAIN 94..170;  /note=PUA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00161					PS50890;	66164	GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030687~preribosome, large subunit precursor,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002478:Pseudouridine synthase/archaeosine transglycosylase,IPR005155:Ribosome biogenesis factor NIP7-like,IPR015947:PUA-like domain,IPR016686:Ribosome biogenesis factor, NIP7,	PF03657:Uncharacterised protein family (UPF0113),	SSF88697:PUA domain-like,	3.0463174495836	7.03139501742244e-06	FDR<0.01	5.15295850310748	10354366.6666667	Present in Nucleus	RBP	Others	Others	Others	Others	221	miscellaneous
Q6A0A9	Q6A0A9	FAM120A	5.4382	12.331	163678	2.02269463379114	3.26083412136825	NA	NA	NA	NA	75673	4	FAM120A	0	Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A)		FUNCTION: Critical component of the oxidative stress-induced survival signaling. Activates src family kinases and acts as a scaffolding protein enabling src family kinases to phosphorylate and activate PI3-kinase. Binds RNA and promotes the secretion of IGF-II (By similarity). May participate in mRNA transport in the cytoplasm. {ECO:0000250, ECO:0000269|PubMed:18413649}.			cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Translocates to plasma membrane upon ultraviolet exposure. {ECO:0000250}.	218236;		IPR026784;IPR029060;			121646	COMPBIAS 399..421;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 432..469;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..518;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 919..938;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1062..1090;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 339..403;  /note=Interaction with YES1, SRC and FYN;  /evidence=ECO:0000250; REGION 372..525;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 827..1112;  /note=RNA binding;  /evidence=ECO:0000250; REGION 919..943;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1030..1090;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (5); Erroneous initiation (1); Modified residue (10); Region (5)		Acetylation;Cell membrane;Cytoplasm;Membrane;Methylation;Phosphoprotein;RNA-binding;Reference proteome							218236		GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR026783:Constitutive coactivator of PPAR-gamma-like protein 1,IPR026784:Constitutive coactivator of PPAR-gamma,		SSF88723:PIN domain-like,	2.19721667316378	0.00226489773244338	FDR<0.01	2.64495140302785	119675.5	Present in Nucleus	RBP	Others	Others	Others	Others	1364	miscellaneous
Q02053	Q02053	Uba1	7.2242	9.2838	3542900	4.68515742128936	3.64750510650715	6.28219625581103	1.77676699477631	5.96694313503192	7.28013977868375	4148728.33333333	0	Uba1	0	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) (Ubiquitin-activating enzyme E1 X) (Ubiquitin-like modifier-activating enzyme 1 X)		FUNCTION: Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1511901). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP. Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites. {ECO:0000250|UniProtKB:P22314, ECO:0000305|PubMed:1511901}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000305|PubMed:1511901}.	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P22314}. Mitochondrion {ECO:0000250|UniProtKB:P22314}. Nucleus {ECO:0000250|UniProtKB:P22314}.	22201;		IPR032420;IPR032418;IPR042302;IPR000594;IPR018965;IPR042449;IPR038252;IPR019572;IPR042063;IPR035985;IPR018075;IPR018074;IPR033127;IPR000011;	PF16191;PF16190;PF09358;PF00899;PF10585;	SM00985;	117809	COMPBIAS 20..42;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..46;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 63..611;  /note=2 approximate repeats	NA	ACT_SITE 632;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10132		BINDING 478;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P22515; BINDING 504;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22515; BINDING 515;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22515; BINDING 528;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22515	6.2.1.45			5 out of 5	Active site (1); Beta strand (7); Binding site (4); Chain (1); Compositional bias (1); Frameshift (1); Helix (15); Initiator methionine (1); Modified residue (15); Nucleotide binding (1); Region (2); Repeat (2); Sequence conflict (1); Turn (2)	MISCELLANEOUS: There are two active sites within the E1 molecule, allowing it to accommodate two ubiquitin moieties at a time, with a new ubiquitin forming an adenylate intermediate as the previous one is transferred to the thiol site. {ECO:0000250|UniProtKB:P22515}.	3D-structure;ATP-binding;Acetylation;Cytoplasm;Direct protein sequencing;Ligase;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway				REPEAT 63..199;  /note=1-1; REPEAT 459..611;  /note=1-2		PS00536;PS00865;	22201	GO:0006464~cellular protein modification process,GO:0006974~cellular response to DNA damage stimulus,GO:0019941~modification-dependent protein catabolic process,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0030057~desmosome,GO:0030867~rough endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0004839~ubiquitin activating enzyme activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008641~small protein activating enzyme activity,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000011:Ubiquitin/SUMO-activating enzyme E1,IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR016040:NAD(P)-binding domain,IPR018074:Ubiquitin-activating enzyme, E1, active site,IPR018075:Ubiquitin-activating enzyme, E1,IPR018965:Ubiquitin-activating enzyme e1, C-terminal,IPR019572:Ubiquitin-activating enzyme,	PF00899:ThiF family,PF09358:Ubiquitin-activating enzyme e1 C-terminal domain,PF10585:Ubiquitin-activating enzyme active site ,	SSF69572:Activating enzymes of the ubiquitin-like proteins,	2.3855053111346	2.46353859719988e-06	FDR<0.01	5.60844062907829	3845814.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	434	miscellaneous
Q9Z321	Q9Z321	Top3b	5.2664	7.5113	633380	2.17117547440184	4.60893211043001	NA	NA	1.8803000958953	3.50042005040605	364781.666666667	2	Top3b	0	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)		FUNCTION: Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand than undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Possesses negatively supercoiled DNA relaxing activity. {ECO:0000250}.		chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]		21976;	cd00186;cd03362;	IPR000380;IPR003601;IPR023406;IPR013497;IPR013824;IPR013825;IPR013826;IPR023405;IPR003602;IPR006171;IPR034144;	PF01131;PF01751;	SM00437;SM00436;SM00493;	96949	COMPBIAS 826..844;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 820..855;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 336;  /note=O-(5'-phospho-DNA)-tyrosine intermediate;  /evidence=ECO:0000250			5.6.2.1			4 out of 5	Active site (1); Chain (1); Compositional bias (1); Domain (1); Region (1)		DNA-binding;Isomerase;Reference proteome;Topoisomerase	DOMAIN 3..153;  /note=Toprim;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995					PS00396;PS50880;	21976	GO:0006265~DNA topological change,GO:0007059~chromosome segregation,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003916~DNA topoisomerase activity,GO:0003917~DNA topoisomerase type I activity,GO:0016853~isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000380:DNA topoisomerase, type IA,IPR003601:DNA topoisomerase, type IA, domain 2,IPR003602:DNA topoisomerase, type IA, DNA-binding,IPR006171:Toprim domain,IPR011031:Multihaem cytochrome,IPR013497:DNA topoisomerase, type IA, central,IPR013824:DNA topoisomerase, type IA, central region, subdomain 1,IPR013825:DNA topoisomerase, type IA, central region, subdomain 2,IPR013826:DNA topoisomerase, type IA, central region, subdomain 3,IPR023405:DNA topoisomerase, type IA, core domain,IPR023406:DNA topoisomerase, type IA, active site,	PF01131:DNA topoisomerase,PF01751:Toprim domain,	SSF48695:Multiheme cytochromes,SSF56712:Prokaryotic type I DNA topoisomerase,	1.89121325993794	0.000204791781307135	FDR<0.01	3.68868747642951	499080.833333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1044	miscellaneous
Q7TSC1	Q7TSC1	Prrc2a	5.1124	7.556	65364	1.27562409909048	2.6837712353399	NA	NA	4.2244001351808	0.643500643500644	151297.333333333	2	Prrc2a	0	Protein PRRC2A (HLA-B-associated transcript 2) (Proline-rich and coiled-coil-containing protein 2A)		FUNCTION: May play a role in the regulation of pre-mRNA splicing. {ECO:0000250}.		cell differentiation [GO:0030154]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]		SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	53761;		IPR009738;IPR033184;	PF07001;		229203	COMPBIAS 86..121;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 191..209;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 212..231;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 237..277;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 306..345;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 352..375;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 399..419;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..452;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..501;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 509..559;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 570..587;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 593..614;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 643..671;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 672..714;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 824..871;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 938..962;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 965..988;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1044..1063;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1084..1121;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1179..1203;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1230..1265;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1301..1321;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1380..1404;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1441..1456;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1467..1487;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1492..1515;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1551..1566;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1638..1670;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1707..1724;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1802..1824;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1840..1876;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1952..1967;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1996..2037;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2067..2111;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2133..2149;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 41..1811;  /note=4 X 57 AA type A repeats; REGION 49..714;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 337..559;  /note=2 X type B repeats; REGION 737..1769;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1802..1883;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1917..2107;  /note=3 X 50 AA type C repeats; REGION 1945..1975;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1996..2158;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (35); Modified residue (53); Region (9); Repeat (9); Sequence conflict (1)		Acetylation;Cytoplasm;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 41..95;  /note=1-1; REPEAT 98..154;  /note=1-2; REPEAT 281..336;  /note=1-3; REPEAT 337..428;  /note=2-1; REPEAT 486..559;  /note=2-2; REPEAT 1756..1811;  /note=1-4; REPEAT 1917..1966;  /note=3-1; REPEAT 1983..2032;  /note=3-2; REPEAT 2058..2107;  /note=3-3			53761	GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0044822~poly(A) RNA binding,	IPR009738:BAT2, N-terminal,	PF07001:BAT2 N-terminus,		1.41497472830613	0.0130476049514525	FDR<0.1	1.88446920110953	108330.666666667	Present in Nucleus	RBP	Others	Others	Others	Others	1374	miscellaneous
Q91VY9	Q91VY9	Znf622	12.594	NA	564790	NA	9.9147332936744	NA	NA	NA	NA	223024.666666667	5	Znf622	1	Zinc finger protein 622		FUNCTION: May behave as an activator of the bound transcription factor, MYBL2, and be involved in embryonic development.		intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	52521;		IPR003604;IPR041661;IPR040025;IPR036236;IPR013087;	PF12756;	SM00355;SM00451;	53451	COMPBIAS 196..238;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 137..243;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (2); Region (1); Zinc finger (2)		Acetylation;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger					ZN_FING 4..28;  /note=U1-type 1; ZN_FING 69..93;  /note=U1-type 2		52521	GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0033674~positive regulation of kinase activity,GO:0042273~ribosomal large subunit biogenesis,GO:0043065~positive regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0046330~positive regulation of JNK cascade,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0022625~cytosolic large ribosomal subunit,GO:0030687~preribosome, large subunit precursor,	GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,	PF12756:C2H2 type zinc-finger (2 copies),		3.48211931591536	0.00093029229369663	FDR<0.01	3.0313805766125	393907.333333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	1111	miscellaneous
Q91YQ5	Q91YQ5	Rpn1	5.2258	3.9215	819631	9.40556809631302	6.1980909879757	8.58516483516484	NA	5.90388475616956	16.4831542163908	302551.666666667	1	Rpn1	0	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)		FUNCTION: Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. {ECO:0000250|UniProtKB:E2RQ08}.	PATHWAY: Protein modification; protein glycosylation.	protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]		SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000250|UniProtKB:E2RQ08, ECO:0000250|UniProtKB:Q9GMB0}. Endoplasmic reticulum membrane; Single-pass type I membrane protein {ECO:0000305}. Melanosome {ECO:0000250|UniProtKB:P04843}.	103963;		IPR007676;	PF04597;		68528			NA							5 out of 5	Chain (1); Cross-link (1); Glycosylation (1); Modified residue (2); Signal peptide (1); Topological domain (2); Transmembrane (1)		Acetylation;Endoplasmic reticulum;Glycoprotein;Isopeptide bond;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix;Ubl conjugation							103963	GO:0006486~protein glycosylation,GO:0018279~protein N-linked glycosylation via asparagine,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005791~rough endoplasmic reticulum,GO:0008250~oligosaccharyltransferase complex,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0042470~melanosome,	GO:0004579~dolichyl-diphosphooligosaccharide-protein glycotransferase activity,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0044822~poly(A) RNA binding,	IPR007676:Ribophorin I,	PF04597:Ribophorin I,		2.8469753376097	1.05016735242932e-06	FDR<0.01	5.97874148717273	561091.333333333	Unexpected	RBP	Others	Others	Others	Others	998	miscellaneous
O08663	O08663	Metap2	7.4391	6.6242	745080	NA	3.19815786107202	NA	NA	NA	NA	22890	5	Metap2	0	Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)		FUNCTION: Cotranslationally removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). {ECO:0000255|HAMAP-Rule:MF_03175}.; FUNCTION: Protects eukaryotic initiation factor EIF2S1 from translation-inhibiting phosphorylation by inhibitory kinases such as EIF2AK2/PKR and EIF2AK1/HCR. Plays a critical role in the regulation of protein synthesis. {ECO:0000255|HAMAP-Rule:MF_03175}.		N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]	SUBCELLULAR LOCATION: Cytoplasm. Note=About 30% of expressed METAP2 associates with polysomes. {ECO:0000255|HAMAP-Rule:MF_03175}.	56307;	cd01088;	IPR036005;IPR000994;IPR001714;IPR002468;IPR018349;IPR036388;IPR036390;	PF00557;		52922	COMPBIAS 16..35;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 59..77;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 231;  /note=Substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; BINDING 339;  /note=Substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175	3.4.11.18	METAL 251;  /note=Divalent metal cation 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; METAL 262;  /note=Divalent metal cation 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; METAL 262;  /note=Divalent metal cation 2; catalytic;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; METAL 331;  /note=Divalent metal cation 2; catalytic; via tele nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; METAL 364;  /note=Divalent metal cation 2; catalytic;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; METAL 459;  /note=Divalent metal cation 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175; METAL 459;  /note=Divalent metal cation 2; catalytic;  /evidence=ECO:0000255|HAMAP-Rule:MF_03175		5 out of 5	Binding site (2); Chain (1); Compositional bias (2); Glycosylation (1); Initiator methionine (1); Metal binding (7); Modified residue (2); Region (1)		Acetylation;Aminopeptidase;Cytoplasm;Direct protein sequencing;Glycoprotein;Hydrolase;Metal-binding;Phosphoprotein;Protease;Reference proteome						PS01202;	56307	GO:0006508~proteolysis,GO:0016485~protein processing,GO:0018206~peptidyl-methionine modification,GO:0031365~N-terminal protein amino acid modification,GO:0070084~protein initiator methionine removal,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0004177~aminopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000994:Peptidase M24, structural domain,IPR001714:Peptidase M24, methionine aminopeptidase,IPR002468:Peptidase M24A, methionine aminopeptidase, subfamily 2,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018349:Peptidase M24A, methionine aminopeptidase, subfamily 2, binding site,	PF00557:Metallopeptidase family M24,	SSF46785:Winged helix DNA-binding domain,SSF55920:Creatinase/aminopeptidase,	2.43337182501033	0.00127881214896979	FDR<0.01	2.89319324649678	383985	Unexpected	RBP	DBD	DBD	Others	Others	1115	miscellaneous
Q8K363	Q8K363	Ddx18	26.719	35.113	47797000	14.3893173707839	5.97621466563079	7.69408324998076	5.54170130229981	25.7712032574801	16.1451774355	22868266.6666667	0	Ddx18	0	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18)		FUNCTION: Probable RNA-dependent helicase.		cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NVP1}. Chromosome {ECO:0000250|UniProtKB:Q9NVP1}.	66942;		IPR011545;IPR025313;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF13959;PF00271;	SM00487;SM01178;SM00490;	74181	COMPBIAS 27..43;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 47..61;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 118..151;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 15..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (3); Domain (2); Motif (2); Nucleotide binding (1); Region (1); Sequence conflict (3)		ATP-binding;Chromosome;Helicase;Hydrolase;Nucleotide-binding;Nucleus;RNA-binding;Reference proteome	DOMAIN 200..375;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 389..559;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 169..197;  /note=Q motif; MOTIF 323..326;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	66942	GO:0010501~RNA secondary structure unwinding,GO:0071392~cellular response to estradiol stimulus,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF13959:Domain of unknown function (DUF4217),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.80183543249554	2.14915984558211e-07	FDR<0.01	6.6677312822877	35332633.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	68	miscellaneous
Q9CYH6	Q9CYH6	Rrs1	37.567	36.498	24676000	29.8659020995729	10.7403310170019	17.06921566954	36.1663652802893	22.7334727652996	20.9916453251606	12263271.6666667	0	Rrs1	0	Ribosome biogenesis regulatory protein homolog		FUNCTION: Involved in ribosomal large subunit assembly. May regulate the localization of the 5S RNP/5S ribonucleoprotein particle to the nucleolus. {ECO:0000250|UniProtKB:Q15050}.		endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]	5S rRNA binding [GO:0008097]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q15050}.	59014;		IPR007023;	PF04939;		41552	COMPBIAS 281..305;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 200..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 281..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (3); Modified residue (2); Region (2); Sequence conflict (3)		Acetylation;Citrullination;Isopeptide bond;Nucleus;Reference proteome;Ribosome biogenesis;Ubl conjugation							59014	GO:0000055~ribosomal large subunit export from nucleus,GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0002244~hematopoietic progenitor cell differentiation,GO:0007080~mitotic metaphase plate congression,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0030687~preribosome, large subunit precursor,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007023:Ribosomal biogenesis regulatory protein,	PF04939:Ribosome biogenesis regulatory protein (RRS1),		4.61436556949182	1.03599917484251e-09	FDR<0.01	8.98464059049956	18469635.8333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	123	miscellaneous
P97855	P97855	G3bp1	26.842	23.189	19100500	7.07664001132262	20.0831442170586	9.765625	5.91470988348022	14.6511559762065	11.2416390309707	3772718.33333333	0	G3bp1	0	Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (GAP SH3 domain-binding protein 1) (HDH-VIII)		FUNCTION: ATP- and magnesium-dependent helicase that plays an essential role in innate immunity. Participates in the DNA-triggered cGAS/STING pathway by promoting the DNA binding and activation of CGAS. Enhances also DDX58-induced type I interferon production probably by helping DDX58 at sensing pathogenic RNA. In addition, plays an essential role in stress granule formation. Unwinds preferentially partial DNA and RNA duplexes having a 17 bp annealed portion and either a hanging 3' tail or hanging tails at both 5'- and 3'-ends. Unwinds DNA/DNA, RNA/DNA, and RNA/RNA substrates with comparable efficiency. Acts unidirectionally by moving in the 5' to 3' direction along the bound single-stranded DNA. Phosphorylation-dependent sequence-specific endoribonuclease in vitro (PubMed:11604510). Cleaves exclusively between cytosine and adenine and cleaves MYC mRNA preferentially at the 3'-UTR (PubMed:11604510). {ECO:0000250|UniProtKB:Q13283, ECO:0000269|PubMed:11604510}.		defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:15086518, ECO:0000269|PubMed:8649363}. Perikaryon {ECO:0000269|PubMed:15086518}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q13283}. Nucleus {ECO:0000250|UniProtKB:Q13283}. Note=Cytoplasmic in proliferating cells, can be recruited to the plasma membrane in exponentially growing cells. Cytosolic and partially nuclear in resting cells. Recruited to stress granules in response to arsenite treatment. The unphosphorylated form is recruited to stress granules. HRAS signaling contributes to this process by regulating G3BP dephosphorylation. {ECO:0000250|UniProtKB:Q13283}.	27041;	cd00780;cd12463;	IPR034375;IPR034374;IPR002075;IPR032710;IPR018222;IPR012677;IPR039539;IPR035979;IPR000504;	PF02136;PF00076;	SM00360;	51829	COMPBIAS 187..205;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 206..222;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 246..261;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 411..428;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 144..330;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 411..465;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12; 3.6.4.13			5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Modified residue (14); Region (2)		ATP-binding;Acetylation;Cytoplasm;DNA-binding;Direct protein sequencing;Endonuclease;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Methylation;Nuclease;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transport;Ubl conjugation	DOMAIN 11..133;  /note=NTF2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00137; DOMAIN 338..413;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The NTF2 domain mediates multimerization. {ECO:0000250}.				PS50177;PS50102;	27041	GO:0006810~transport,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02136:Nuclear transport factor 2 (NTF2) domain,	SSF54427:NTF2-like,SSF54928:RNA-binding domain, RBD,	3.70606370223302	4.34661479074426e-08	FDR<0.01	7.36184884650504	11436609.1666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	206	miscellaneous
Q5RJG1	Q5RJG1	Nol10	9.4904	6.5613	11510300	8.48176420695505	6.99545295557887	2.93849725250507	2.66680889647448	11.6196651212512	12.0078291045762	8046235	0	Nol10	0	Nucleolar protein 10				maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	217431;		IPR040382;IPR012580;IPR001680;IPR036322;	PF08159;	SM00320;	80077	COMPBIAS 542..560;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 650..666;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 667..687;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 526..560;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 643..687;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Coiled coil (3); Compositional bias (3); Modified residue (5); Region (2); Repeat (5)		Acetylation;Coiled coil;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat				REPEAT 50..90;  /note=WD 1; REPEAT 174..213;  /note=WD 2; REPEAT 228..266;  /note=WD 3; REPEAT 270..308;  /note=WD 4; REPEAT 310..349;  /note=WD 5			217431		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR012580:NUC153,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF08159:NUC153 domain,	SSF50978:WD40 repeat-like,	2.74322818223347	1.22824536247923e-06	FDR<0.01	5.91071486696801	9778267.5	Present in Nucleus	RBP	ChD	Others	ChD	Others	226	miscellaneous
Q8BHB4	Q8BHB4	Wdr3	20.838	25.023	8209200	5.64079422382672	7.11794433767528	4.11319512997697	NA	4.23155044008125	10.3783963301991	9075591.66666667	1	Wdr3	0	WD repeat-containing protein 3				maturation of SSU-rRNA [GO:0030490]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	269470;		IPR020472;IPR011047;IPR007148;IPR015943;IPR001680;IPR019775;IPR017986;	PF04003;PF00400;	SM00320;	105775	COMPBIAS 230..245;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 230..263;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 723..742;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Modified residue (2); Region (2); Repeat (13)		Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat				REPEAT 21..60;  /note=WD 1; REPEAT 63..102;  /note=WD 2; REPEAT 105..144;  /note=WD 3; REPEAT 147..186;  /note=WD 4; REPEAT 189..228;  /note=WD 5; REPEAT 277..316;  /note=WD 6; REPEAT 412..450;  /note=WD 7; REPEAT 452..490;  /note=WD 8; REPEAT 493..532;  /note=WD 9; REPEAT 546..585;  /note=WD 10; REPEAT 588..629;  /note=WD 11; REPEAT 630..669;  /note=WD 12; REPEAT 672..711;  /note=WD 13		PS00678;PS50082;PS50294;	269470	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0031965~nuclear membrane,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR007148:Small-subunit processome, Utp12,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,PF04003:Dip2/Utp12 Family,	SSF50978:WD40 repeat-like,	3.12152060557669	6.03042705123156e-06	FDR<0.01	5.2196519317361	8642395.83333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	244	miscellaneous
Q9CQS7	Q9CQS7;P85965	Dppa5a	8.4606	10.442	11140850	4.61382301374919	8.70625108828139	6.49730361899812	NA	7.42721330956625	5.84351078127739	3286340	1	Dppa5a	0	Developmental pluripotency-associated protein 5A (mDppa5) (ES cell-associated transcript 2 protein) (Embryonal stem cell-specific gene 1 protein) (ESG-1) (Protein pH 34)		FUNCTION: Involved in the maintenance of embryonic stem (ES) cell pluripotency. Dispensable for self-renewal of pluripotent ES cells and establishment of germ cells. Associates with specific target mRNAs. {ECO:0000269|PubMed:16504174}.		multicellular organism development [GO:0007275]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]	mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16166252, ECO:0000269|PubMed:16872451}.	434423;	cd12795;	IPR036612;IPR031952;	PF16005;		13810			NA							4 out of 5	Chain (1); Domain (1)		Cytoplasm;Developmental protein;RNA-binding;Reference proteome	DOMAIN 24..86;  /note=KH; atypical						434423	GO:0007275~multicellular organism development,GO:0010468~regulation of gene expression,	GO:0005737~cytoplasm,	GO:0003723~RNA binding,GO:0003729~mRNA binding,	IPR004088:K Homology domain, type 1,		SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.84751399518935	1.38265345972089e-07	FDR<0.01	6.85928665531346	7213595	Unexpected	RBP	RBD	Others	Others	RBD	274	miscellaneous
P62259	P62259	Ywhae	1.458	4.8473	8469400	10.3942540563576	21.2607632614011	13.6407038603192	6.03245460577909	5.21240552514986	12.0484830959782	5755755	0	Ywhae	0	14-3-3 protein epsilon (14-3-3E)		FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Positively regulates phosphorylated protein HSF1 nuclear export to the cytoplasm. {ECO:0000250|UniProtKB:P62258, ECO:0000250|UniProtKB:P62261}.		cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; hippocampus development [GO:0021766]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; neuron migration [GO:0001764]; positive regulation of protein export from nucleus [GO:0046827]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of potassium ion transmembrane transporter activity [GO:1901016]	axon [GO:0030424]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; synapse [GO:0045202]	calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P62258}. Cytoplasm {ECO:0000250|UniProtKB:P62258}. Melanosome {ECO:0000250|UniProtKB:P62258}.	22627;		IPR000308;IPR023409;IPR036815;IPR023410;	PF00244;	SM00101;	29174	COMPBIAS 238..255;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 234..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Modified residue (10); Region (1); Site (2)		Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation						PS00796;PS00797;	22627	GO:0001764~neuron migration,GO:0006605~protein targeting,GO:0021762~substantia nigra development,GO:0021766~hippocampus development,GO:0021987~cerebral cortex development,GO:0035308~negative regulation of protein dephosphorylation,GO:0060306~regulation of membrane repolarization,GO:1901016~regulation of potassium ion transmembrane transporter activity,GO:1902309~negative regulation of peptidyl-serine dephosphorylation,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030424~axon,GO:0030659~cytoplasmic vesicle membrane,GO:0042470~melanosome,GO:0070062~extracellular exosome,	GO:0004497~monooxygenase activity,GO:0005515~protein binding,GO:0015459~potassium channel regulator activity,GO:0019899~enzyme binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0023026~MHC class II protein complex binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0042826~histone deacetylase binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0050815~phosphoserine binding,GO:0051219~phosphoprotein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000308:14-3-3 protein,IPR023409:14-3-3 protein, conserved site,IPR023410:14-3-3 domain,	PF00244:14-3-3 protein,	SSF48445:14-3-3 protein,	2.86804102332343	1.04928450794012e-05	FDR<0.01	4.97910673918911	7112577.5	Present in Nucleus	RBP	Others	Others	Others	Others	277	miscellaneous
Q9ESV0	Q9ESV0	Ddx24	9.1814	8.4575	8363350	15.4554727829124	9.08595311648192	3.65951840737759	7.57805395574417	19.6282411133138	14.699829481978	5833818.33333333	0	Ddx24	0	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)		FUNCTION: ATP-dependent RNA helicase. {ECO:0000305}.			nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		27225;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	96429	COMPBIAS 66..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 310..330;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 349..363;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 808..832;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 61..179;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 279..363;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 808..857;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			3 out of 5	Chain (1); Compositional bias (4); Cross-link (2); Domain (2); Modified residue (5); Motif (2); Nucleotide binding (1); Region (3); Sequence conflict (4)		ATP-binding;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 225..528;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 576..723;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 193..221;  /note=Q motif; MOTIF 471..474;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	27225	GO:0010501~RNA secondary structure unwinding,	GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.29733711165146	9.93253352286172e-08	FDR<0.01	7.00293996050172	7098584.16666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	279	miscellaneous
O35841	O35841	Api5	8.1836	7.9881	9485050	10.629816635663	5.87440521647183	9.73425484279178	4.35009570210545	5.78268663621118	6.04193100114797	3531573.33333333	0	Api5	0	Apoptosis inhibitor 5 (API-5) (AAC-11)		FUNCTION: Antiapoptotic factor that may have a role in protein assembly. Negatively regulates ACIN1. By binding to ACIN1, it suppresses ACIN1 cleavage from CASP3 and ACIN1-mediated DNA fragmentation. Also known to efficiently suppress E2F1-induced apoptosis (By similarity). {ECO:0000250}.		apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Mainly nuclear.	11800;		IPR008383;IPR016024;	PF05918;		56785	COMPBIAS 483..504;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..360;  /note=ARM-like and Heat-like helical repeats;  /evidence=ECO:0000250; REGION 370..391;  /note=Leucine-zipper; REGION 451..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (5); Motif (1); Region (3); Sequence conflict (1)		Acetylation;Apoptosis;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat			MOTIF 454..475;  /note=Nuclear localization signal;  /evidence=ECO:0000250				11800	GO:0006915~apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:2000270~negative regulation of fibroblast apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0017134~fibroblast growth factor binding,GO:0044822~poly(A) RNA binding,	IPR008383:Apoptosis inhibitory 5,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	PF05918:Apoptosis inhibitory protein 5 (API5),	SSF48371:ARM repeat,	2.81574286677262	3.09833658570681e-08	FDR<0.01	7.50887140472564	6508311.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	299	miscellaneous
Q9Z0H1	Q9Z0H1	Wdr46	13.926	9.0831	9249300	20.2769835959203	8.44665934622857	11.9410114036659	7.55915035150049	10.0670465298891	21.3803130077824	3132078.33333333	0	Wdr46	0	WD repeat-containing protein 46 (WD repeat-containing protein BING4)		FUNCTION: Scaffold component of the nucleolar structure. Required for localization of DDX21 and NCL to the granular compartment of the nucleolus. {ECO:0000250|UniProtKB:O15213}.		maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]	nucleolus [GO:0005730]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O15213}.	57315;		IPR012952;IPR015943;IPR001680;IPR017986;IPR036322;IPR040315;	PF08149;	SM01033;SM00320;	69048	COMPBIAS 108..135;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 566..588;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 607..622;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..135;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 547..622;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Modified residue (1); Region (2); Repeat (5)		Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat				REPEAT 192..233;  /note=WD 1; REPEAT 234..271;  /note=WD 2; REPEAT 314..353;  /note=WD 3; REPEAT 356..395;  /note=WD 4; REPEAT 398..435;  /note=WD 5		PS50082;PS50294;	57315	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030686~90S preribosome,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR012952:BING4, C-terminal domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF00400:WD domain, G-beta repeat,PF08149:BING4CT (NUC141) domain,	SSF50978:WD40 repeat-like,	3.58111283403461	7.84036326174325e-09	FDR<0.01	8.10566381500488	6190689.16666667	Present in Nucleus	RBP	ChD	Others	ChD	Others	313	miscellaneous
Q00PI9	Q00PI9	Hnrnpul2	3.3316	5.603	6899650	8.80902043692741	7.9853070350555	7.13368526180625	3.0829942039709	8.7527352297593	10.5873883030534	4918516.66666667	0	Hnrnpul2	0	Heterogeneous nuclear ribonucleoprotein U-like protein 2 (MLF1-associated nuclear protein)					nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17008314}.	68693;	cd12884;	IPR001870;IPR043136;IPR013320;IPR027417;IPR003034;IPR036361;IPR003877;IPR035778;	PF02037;PF00622;	SM00513;SM00449;	84940	COMPBIAS 72..98;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 144..232;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 625..639;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 44..239;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..664;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Domain (2); Modified residue (11); Region (2); Sequence conflict (1)		Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 3..37;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 224..417;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548					PS50188;PS50800;	68693		GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00622:SPRY domain,PF02037:SAP domain,	SSF49899:Concanavalin A-like lectins/glucanases,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.66896658590971	3.9547593693327e-07	FDR<0.01	6.40287993637623	5909083.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	326	miscellaneous
Q3U9G9	Q3U9G9	Lbr	4.5399	8.107	7817750	9.24727205474385	6.18697024067314	9.56571647216377	NA	10.7676239084321	10.0095090335819	3878366.66666667	1	Lbr	0	Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (Lamin-B receptor) (Sterol C14-reductase)		FUNCTION: Catalyzes the reduction of the C14-unsaturated bond of lanosterol, as part of the metabolic pathway leading to cholesterol biosynthesis (PubMed:18785926). Plays a critical role in myeloid cell cholesterol biosynthesis which is essential to both myeloid cell growth and functional maturation (PubMed:22140257). Mediates the activation of NADPH oxidases, perhaps by maintaining critical levels of cholesterol required for membrane lipid raft formation during neutrophil differentiation (PubMed:22140257). Anchors the lamina and the heterochromatin to the inner nuclear membrane (By similarity). {ECO:0000250|UniProtKB:Q14739, ECO:0000269|PubMed:18785926, ECO:0000269|PubMed:22140257}.	PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.	cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; NADPH binding [GO:0070402]; nuclear localization sequence binding [GO:0008139]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]	SUBCELLULAR LOCATION: Nucleus inner membrane {ECO:0000269|PubMed:18785926}; Multi-pass membrane protein {ECO:0000255}. Nucleus {ECO:0000250|UniProtKB:Q14739}. Cytoplasm {ECO:0000250|UniProtKB:Q14739}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q14739}. Note=Nucleus; nuclear rim. {ECO:0000250|UniProtKB:Q14739}.	98386;	cd04508;	IPR001171;IPR019023;IPR018083;IPR002999;	PF01222;PF09465;	SM00333;	71440	COMPBIAS 76..94;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 100..117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 52..117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.3.1.70			5 out of 5	Chain (1); Compositional bias (2); Domain (1); Glycosylation (1); Modified residue (13); Region (1); Sequence conflict (6); Topological domain (1); Transmembrane (8)		Acetylation;Cholesterol biosynthesis;Cholesterol metabolism;Cytoplasm;DNA-binding;Endoplasmic reticulum;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Membrane;Nucleus;Oxidoreductase;Phosphoprotein;Receptor;Reference proteome;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transmembrane;Transmembrane helix	DOMAIN 1..62;  /note=Tudor	DOMAIN: The Tudor domain may not recognize methylation marks, but rather bind unassembled free histone H3. {ECO:0000250|UniProtKB:P23913}.				PS01017;PS01018;	98386	GO:0016126~sterol biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005639~integral component of nuclear inner membrane,GO:0005643~nuclear pore,GO:0005652~nuclear lamina,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0008139~nuclear localization sequence binding,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0044822~poly(A) RNA binding,GO:0051087~chaperone binding,GO:0070087~chromo shadow domain binding,	IPR001171:Ergosterol biosynthesis ERG4/ERG24,IPR002999:Tudor domain,IPR018083:Sterol reductase, conserved site,IPR019023:Lamin-B receptor of TUDOR domain,	PF01222:Ergosterol biosynthesis ERG4/ERG24 family,PF09465:Lamin-B receptor of TUDOR domain,		3.00712713546147	1.17785215864825e-07	FDR<0.01	6.92890921779394	5848058.33333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	327	miscellaneous
Q9CQM9	Q9CQM9	Glrx3	6.6327	11.658	8808950	10.8569381263096	6.34195839675292	22.0507166482911	6.64849411608271	1.86323830817962	4.48531060775959	2368393.33333333	0	Glrx3	0	Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2)		FUNCTION: Together with BOLA2, acts as a cytosolic iron-sulfur (Fe-S) cluster assembly factor that facilitates [2Fe-2S] cluster insertion into a subset of cytosolic proteins (By similarity). Acts as a critical negative regulator of cardiac hypertrophy and a positive inotropic regulator (PubMed:16809552, PubMed:18258855, PubMed:18929570). Required for hemoglobin maturation. Does not possess any thyoredoxin activity since it lacks the conserved motif that is essential for catalytic activity (By similarity). {ECO:0000250|UniProtKB:O76003, ECO:0000269|PubMed:16809552, ECO:0000269|PubMed:18258855, ECO:0000269|PubMed:18929570}.		[2Fe-2S] cluster assembly [GO:0044571]; cellular iron ion homeostasis [GO:0006879]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026]	cell cortex [GO:0005938]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; Z disc [GO:0030018]	identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; protein kinase C binding [GO:0005080]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:O76003}. Cytoplasm, cell cortex {ECO:0000269|PubMed:18258855}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:18258855}. Note=Under the plasma membrane (PubMed:18258855). After PMA stimulation, GLRX3 and PRKCQ/PKC-theta translocate to a more extended submembrane area (PubMed:18258855). In the Z line, found associated with CSRP3 (PubMed:18258855). {ECO:0000269|PubMed:18258855}.	30926;	cd03028;	IPR002109;IPR033658;IPR004480;IPR036249;IPR013766;	PF00462;PF00085;		37778			NA					METAL 161;  /note=Iron-sulfur (2Fe-2S); shared with dimeric partner;  /evidence=ECO:0000250|UniProtKB:O76003; METAL 263;  /note=Iron-sulfur (2Fe-2S); shared with dimeric partner;  /evidence=ECO:0000250|UniProtKB:O76003		5 out of 5	Beta strand (4); Chain (1); Domain (3); Helix (5); Initiator methionine (1); Metal binding (2); Modified residue (2); Sequence conflict (1); Turn (1)	MISCELLANEOUS: Transgenic mice with cardiac-specific Glrx3 overexpression show that it is a potent inhibitor of cardiac hypertrophy induced by pressure overload (transverse aortic constriction). In addition, overexpression dramatically increases the ventricular function and cardiomyocyte contractility. {ECO:0000269|PubMed:16809552, ECO:0000269|PubMed:18258855, ECO:0000269|PubMed:18929570}.	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Iron;Iron-sulfur;Metal-binding;Phosphoprotein;Reference proteome;Repeat	DOMAIN 2..119;  /note=Thioredoxin;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00691; DOMAIN 144..238;  /note=Glutaredoxin 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00686; DOMAIN 239..337;  /note=Glutaredoxin 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00686	DOMAIN: The thioredoxin domain lacks the two redox-active cysteines. This strongly suggests that it lacks thioredoxin activity. {ECO:0000305}.				PS51354;PS51352;	30926	GO:0002026~regulation of the force of heart contraction,GO:0010614~negative regulation of cardiac muscle hypertrophy,GO:0045454~cell redox homeostasis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005938~cell cortex,GO:0030018~Z disc,GO:0030425~dendrite,GO:0070062~extracellular exosome,	GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,	IPR002109:Glutaredoxin,IPR004480:Monothiol glutaredoxin-related,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,	PF00085:Thioredoxin,PF00462:Glutaredoxin,	SSF52833:Thioredoxin-like,	2.82963997792514	4.59255467200518e-06	FDR<0.01	5.33794566493858	5588671.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	341	miscellaneous
Q60864	Q60864	Stip1	3.2364	6.0912	5234800	5.17089818501474	10.5860433604336	10.9855101121621	8.1913499344692	11.1541164266673	8.37591088030823	5813633.33333333	0	Stip1	0	Stress-induced-phosphoprotein 1 (STI1) (mSTI1) (Hsc70/Hsp90-organizing protein) (Hop)		FUNCTION: Acts as a co-chaperone for HSP90AA1. Mediates the association of the molecular chaperones HSPA8/HSC70 and HSP90. {ECO:0000250|UniProtKB:O35814, ECO:0000250|UniProtKB:P31948}.		cellular response to interleukin-7 [GO:0098761]	chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8999875}. Nucleus {ECO:0000269|PubMed:8999875}. Dynein axonemal particle {ECO:0000250|UniProtKB:Q7ZWU1}.	20867;		IPR041243;IPR006636;IPR013026;IPR011990;IPR001440;IPR019734;	PF17830;PF00515;PF13181;	SM00727;SM00028;	62582	COMPBIAS 208..233;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 191..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (4); Domain (2); Modified residue (12); Motif (1); Region (1); Repeat (9); Sequence conflict (7)		Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Ubl conjugation	DOMAIN 130..169;  /note=STI1 1; DOMAIN 492..531;  /note=STI1 2	DOMAIN: The TPR 1 repeat interacts with the C-terminal of HSC70. The TPR 4, 5 and 6 repeats (also called TPR2A domain) and TPR 7, 8 and 9 repeats (also called TPR2B domain) interact with HSP90 (By similarity). {ECO:0000250}.	MOTIF 222..239;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255	REPEAT 4..37;  /note=TPR 1; REPEAT 39..71;  /note=TPR 2; REPEAT 73..105;  /note=TPR 3; REPEAT 225..258;  /note=TPR 4; REPEAT 260..292;  /note=TPR 5; REPEAT 300..333;  /note=TPR 6; REPEAT 360..393;  /note=TPR 7; REPEAT 395..427;  /note=TPR 8; REPEAT 428..461;  /note=TPR 9		PS50005;PS50293;	20867		GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0043209~myelin sheath,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0030544~Hsp70 protein binding,GO:0044822~poly(A) RNA binding,GO:0051087~chaperone binding,	IPR001440:Tetratricopeptide TPR-1,IPR006636:Heat shock chaperonin-binding,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013105:Tetratricopeptide TPR2,IPR019734:Tetratricopeptide repeat,	PF00515:Tetratricopeptide repeat,PF07719:Tetratricopeptide repeat,PF13181:Tetratricopeptide repeat,PF13414:TPR repeat,	SSF48452:TPR-like,	2.88912555893164	1.27904428862367e-07	FDR<0.01	6.89311441723217	5524216.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	345	miscellaneous
Q9CPT5	Q9CPT5	Nop16	10.188	10.559	9524450	4.93900330913222	22.4441701268096	NA	NA	19.6313237401598	9.87069390978186	1454996.66666667	2	Nop16	0	Nucleolar protein 16				ribosomal large subunit biogenesis [GO:0042273]	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	28126;		IPR019002;	PF09420;		21139	COMPBIAS 1..27;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..30;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Modified residue (3); Natural variant (2); Region (1); Sequence conflict (1)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							28126	GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0044822~poly(A) RNA binding,	IPR019002:Ribosome biogenesis protein Nop16,	PF09420:Ribosome biogenesis protein Nop16,		3.5233210182141	1.62479084935314e-06	FDR<0.01	5.78920253549606	5489723.33333333	Present in Nucleus	RBP	Others	Others	Others	Others	346	miscellaneous
Q3UQA7	Q3UQA7	Selh	7.0684	8.2819	9703700	NA	5.2695368077146	0.932835820895522	NA	1.58142771293924	4.96056352001587	1238070	2	Selh	0	Selenoprotein H (SelH)		FUNCTION: May be involved in a redox-related process. {ECO:0000305}.			Golgi apparatus [GO:0005794]			72657;		IPR011893;IPR036249;	PF10262;		12974			NA							2 out of 5	Chain (1); Cross-link (1); Modified residue (1); Non-standard residue (1)		Acetylation;Redox-active center;Reference proteome;Selenocysteine							72657			GO:0044822~poly(A) RNA binding,	IPR011893:Selenoprotein, Rdx type,IPR012336:Thioredoxin-like fold,	PF10262:Rdx family,	SSF52833:Thioredoxin-like,	1.85674139128521	0.00231328654308363	FDR<0.01	2.63577056853834	5470885	Unexpected	RBP	Others	Others	Others	Others	348	miscellaneous
Q8C5L7	Q8C5L7	Rbm34	10.706	9.6189	8209450	16.2077181153665	9.03913947392208	2.42854020448309	10.5872762114491	6.19003404518725	9.85804416403785	2404008	0	Rbm34	0	RNA-binding protein 34 (RNA-binding motif protein 34)					chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P42696}.	52202;	cd12394;cd12395;	IPR012677;IPR035979;IPR034220;IPR034221;IPR000504;	PF00076;	SM00360;	49116	COMPBIAS 1..18;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 92..154;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 423..442;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 60..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 418..442;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Domain (2); Frameshift (1); Modified residue (2); Region (3)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 189..284;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 291..368;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	52202		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.06207647730742	3.41809472822313e-07	FDR<0.01	6.46621590551976	5306729	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	357	miscellaneous
Q99MJ9	Q99MJ9	Ddx50	1.8626	3.1409	7309200	7.95671546785487	7.73215804531045	0.0724165399377218	NA	14.8117427496519	5.42299349240781	2725120	1	Ddx50	0	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)					nucleolus [GO:0005730]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	94213;		IPR011545;IPR012562;IPR014001;IPR001650;IPR027417;IPR035979;IPR014014;	PF00270;PF08152;PF00271;	SM00487;SM00490;	82175	COMPBIAS 17..131;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 665..684;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 694..708;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..131;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 664..734;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			3 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Domain (2); Modified residue (8); Motif (2); Nucleotide binding (1); Region (2)		ATP-binding;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 165..344;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 377..521;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 134..162;  /note=Q motif; MOTIF 287..290;  /note=DEVD box			PS51192;PS51194;PS51195;	94213	GO:0010501~RNA secondary structure unwinding,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012562:GUCT,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08152:GUCT (NUC152) domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54928:RNA-binding domain, RBD,	1.57596600276185	0.0686462815298511	FDR<0.1	1.16338298289634	5017160	Present in Nucleus	RBP	DBD	DBD	Others	RBD	373	miscellaneous
Q8BHY2	Q8BHY2	Noc4l	8.5446	8.0413	5957500	6.70555890833501	3.48760157639591	3.45936970284014	NA	17.7424505872751	12.9910621492413	3995260	1	Noc4l	0	Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein)				ribosome biogenesis [GO:0042254]	integral component of membrane [GO:0016021]; Noc4p-Nop14p complex [GO:0030692]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:Q9BVI4}; Multi-pass membrane protein {ECO:0000255}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9BVI4}.	100608;		IPR016024;IPR005612;IPR027193;	PF03914;		58676			NA							2 out of 5	Chain (1); Sequence conflict (1); Transmembrane (3)		Membrane;Nucleus;Reference proteome;Transmembrane;Transmembrane helix							100608	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030692~Noc4p-Nop14p complex,GO:0031965~nuclear membrane,GO:0032040~small-subunit processome,	GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR016024:Armadillo-type fold,IPR027193:Nucleolar complex protein 4,	PF03914:CBF/Mak21 family,	SSF48371:ARM repeat,	2.89844637194493	3.87426209865642e-06	FDR<0.01	5.41181100206043	4976380	Present in Nucleus	RBP	Others	Others	Others	Others	375	miscellaneous
Q3U1G5	Q3U1G5	Isg20l2	9.7436	16.19	6018250	6.79948323927381	1.37206207208814	5.93190176770673	6.01033778098329	15.357680375956	7.74113639882335	3088113.33333333	0	Isg20l2	0	Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-)		FUNCTION: 3'-> 5'-exoribonuclease involved in ribosome biogenesis in the processing of the 12S pre-rRNA. Displays a strong specificity for a 3'-end containing a free hydroxyl group. {ECO:0000250}.		ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	229504;	cd06149;	IPR013520;IPR037433;IPR034933;IPR012337;IPR036397;	PF00929;	SM00479;	41020	COMPBIAS 55..96;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 168..183;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 33..107;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 127..187;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.-.-			3 out of 5	Chain (1); Compositional bias (2); Domain (1); Region (2); Sequence caution (1); Sequence conflict (4)		Exonuclease;Hydrolase;Nuclease;Nucleus;Reference proteome;Ribosome biogenesis	DOMAIN 194..368;  /note=Exonuclease						229504	GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR012337:Ribonuclease H-like domain,IPR013520:Exonuclease, RNase T/DNA polymerase III,	PF00929:Exonuclease,	SSF53098:Ribonuclease H-like,	2.82157892709576	6.95149001719588e-06	FDR<0.01	5.15792209657691	4553181.66666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	393	miscellaneous
Q8BMC4	Q8BMC4	Nop9	7.3782	10.296	4854940	3.39754697108688	21.7732102421181	1.35685210312076	NA	12.881286067601	11.0246290212334	3655640	1	Nop9	0	Nucleolar protein 9 (Pumilio domain-containing protein NOP9)				endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]	90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]	RNA binding [GO:0003723]		67842;		IPR011989;IPR016024;IPR040000;IPR001313;		SM00025;	70046	COMPBIAS 224..238;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 222..242;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Erroneous initiation (2); Frameshift (1); Modified residue (1); Region (2); Repeat (6); Sequence conflict (7)		Phosphoprotein;RNA-binding;Reference proteome;Repeat				REPEAT 92..123;  /note=Pumilio 1; REPEAT 189..223;  /note=Pumilio 2; REPEAT 313..348;  /note=Pumilio 3; REPEAT 351..386;  /note=Pumilio 4; REPEAT 509..544;  /note=Pumilio 5; REPEAT 547..581;  /note=Pumilio 6			67842			GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR001313:Pumilio RNA-binding repeat,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,		SSF48371:ARM repeat,	2.86376901287116	6.40234914613907e-05	FDR<0.01	4.19366064570158	4255290	Present in Nucleus	RBP	RBD	Others	Others	RBD	405	miscellaneous
Q8VC52	Q8VC52	Rbpms2	6.7888	3.6021	7479950	NA	7.73156022885418	NA	NA	4.34272810179355	NA	931283.333333333	4	Rbpms2	0	RNA-binding protein with multiple splicing 2		FUNCTION: RNA-binding protein involved in the regulation of smooth muscle cell differentiation and proliferation in the gastrointestinal system (By similarity). Binds NOG mRNA, the major inhibitor of the bone morphogenetic protein (BMP) pathway. Mediates an increase of NOG mRNA levels, thereby contributing to the negative regulation of BMP signaling pathway and promoting reversible dedifferentiation and proliferation of smooth muscle cells (By similarity). {ECO:0000250|UniProtKB:Q6ZRY4, ECO:0000250|UniProtKB:Q9W6I1}.		embryonic digestive tract morphogenesis [GO:0048557]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell proliferation [GO:0048661]	cytoplasm [GO:0005737]	identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q6ZRY4}.	71973;	cd12683;	IPR012677;IPR035979;IPR034787;IPR000504;	PF00076;	SM00360;	22463		REGION 35..45;  /note=Important for homodimerization;  /evidence=ECO:0000250|UniProtKB:Q6ZRY4	NA							3 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (1); Region (1)		Acetylation;Cytoplasm;Developmental protein;RNA-binding;Reference proteome	DOMAIN 25..102;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	71973	GO:0007275~multicellular organism development,GO:0030514~negative regulation of BMP signaling pathway,GO:0048557~embryonic digestive tract morphogenesis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0051151~negative regulation of smooth muscle cell differentiation,	GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0042803~protein homodimerization activity,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.42033900622803	0.000191172207759495	FDR<0.01	3.71857524435075	4205616.66666667	Unexpected	RBP	RBD	Others	Others	RBD	408	miscellaneous
P70279	P70279	Surf6	27.042	10.296	5728200	9.51384264104272	11.3050556208737	12.1728545343883	NA	10.5029881001145	6.23791404154451	1555838	1	Surf6	0	Surfeit locus protein 6		FUNCTION: Binds to both DNA and RNA in vitro, with a stronger binding capacity for RNA. May represent a nucleolar constitutive protein involved in ribosomal biosynthesis or assembly. {ECO:0000269|PubMed:9548374}.		ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]	chromosome [GO:0005694]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:8639267, ECO:0000269|PubMed:9548374}. Note=Granular component of the nucleolus.	20935;		IPR029190;IPR007019;	PF04935;		41235	COMPBIAS 53..71;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..104;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..178;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 301..317;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 318..340;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 18..104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 123..178;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 198..227;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 290..355;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Modified residue (3); Motif (2); Region (4)		Citrullination;DNA-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome			MOTIF 45..49;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 152..156;  /note=Nuclear localization signal;  /evidence=ECO:0000255				20935	GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,GO:0042273~ribosomal large subunit biogenesis,GO:0042274~ribosomal small subunit biogenesis,	GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0022625~cytosolic large ribosomal subunit,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR007019:Surfeit locus 6,	PF04935:Surfeit locus protein 6,		3.50135050967634	1.1112991555888e-07	FDR<0.01	6.95416901564709	3642019	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	453	miscellaneous
P70318	P70318;P52912	Tial1	NA	12.043	5446700	4.58799779776106	NA	NA	3.16786517565812	12.2591085176286	13.0167655940852	746105.833333333	2	Tial1	1	Nucleolysin TIAR (TIA-1-related protein)		FUNCTION: RNA-binding protein. Possesses nucleolytic activity against cytotoxic lymphocyte target cells. May be involved in apoptosis (By similarity). {ECO:0000250|UniProtKB:Q01085}.		apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell population proliferation [GO:0008284]; stem cell division [GO:0017145]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19861488}. Nucleus {ECO:0000269|PubMed:19861488}. Cytoplasm, Stress granule {ECO:0000269|PubMed:19861488}. Cytolytic granule {ECO:0000250|UniProtKB:Q01085}.	21843;	cd12616;cd12617;cd12620;	IPR012677;IPR035979;IPR000504;IPR003954;IPR034492;IPR034494;IPR034496;	PF00076;	SM00360;SM00361;	43389		REGION 363..392;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Domain (3); Modified residue (2); Region (1)		Acetylation;Apoptosis;Cytoplasm;Lysosome;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 9..102;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 114..192;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 222..294;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	21843	GO:0006915~apoptotic process,GO:0007281~germ cell development,GO:0008284~positive regulation of cell proliferation,GO:0017145~stem cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017091~AU-rich element binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.95391596484076	6.47130188791371e-05	FDR<0.01	4.18900833975484	3096402.91666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	494	miscellaneous
Q8VDQ9	Q8VDQ9	Kri1	1.305	1.9194	4042550	2.66261948504939	2.17292105777797	2.55232261357836	1.56445556946183	2.10650488709134	2.19596820238043	1796071.66666667	0	Kri1	0	Protein KRI1 homolog				endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]	90S preribosome [GO:0030686]; nucleolus [GO:0005730]					IPR018034;IPR024626;	PF05178;PF12936;		82057	COMPBIAS 48..63;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 116..178;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 255..270;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..351;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 444..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 599..632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 690..704;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 29..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 83..204;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 250..289;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 302..351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 414..493;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 599..673;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 685..704;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (7); Erroneous initiation (1); Modified residue (13); Region (7); Sequence caution (1)		Phosphoprotein;Reference proteome							NA		GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,	IPR018034:KRR1 interacting protein 1,IPR024626:Kri1-like, C-terminal,	PF05178:KRI1-like family,PF12936:KRI1-like family C-terminal,		1.00804588078801	0.000272482749368114	FDR<0.01	3.56466098730067	2919310.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	510	miscellaneous
Q6NZQ2	Q6NZQ2	Ddx31	9.3538	5.0122	1420705	6.2445360309729	5.42269941977116	3.61141206211629	NA	6.83947746392176	10.5785403729993	4154661.66666667	1	Ddx31	0	Probable ATP-dependent RNA helicase DDX31 (EC 3.6.4.13) (DEAD box protein 31)		FUNCTION: Probable ATP-dependent RNA helicase (By similarity). Plays a role in ribosome biogenesis and TP53/p53 regulation through its interaction with NPM1 (By similarity). {ECO:0000250|UniProtKB:Q9H8H2}.		ribosome biogenesis [GO:0042254]	Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H8H2}. Note=Colocalized with NPM1 in the nucleoli. {ECO:0000250|UniProtKB:Q9H8H2}.	227674;		IPR011545;IPR025313;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF13959;PF00271;	SM00487;SM01178;SM00490;	76913	COMPBIAS 1..19;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 27..45;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..687;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (2); Domain (2); Motif (2); Nucleotide binding (1); Region (2); Sequence conflict (3)		ATP-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;RNA-binding;Reference proteome	DOMAIN 135..316;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 344..523;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 103..132;  /note=Q motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00552; MOTIF 261..264;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541			PS00039;PS51192;PS51194;PS51195;	227674	GO:0010501~RNA secondary structure unwinding,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF13959:Domain of unknown function (DUF4217),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.66601713916452	6.66969188540456e-07	FDR<0.01	6.1758942283862	2787683.33333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	525	miscellaneous
Q3UHX2	Q3UHX2	Pdap1	8.0752	5.5122	3021400	3.78859632506156	8.00640512409928	6.08494584398199	4.27259132663961	8.42815002107037	3.14653409269689	2551883.33333333	0	Pdap1	0	28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1)				platelet-derived growth factor receptor signaling pathway [GO:0048008]	cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	platelet-derived growth factor binding [GO:0048407]		231887;		IPR019380;IPR039876;	PF10252;		20605	COMPBIAS 45..60;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 99..118;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 151..169;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..118;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 151..181;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Modified residue (11); Region (2)		Acetylation;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation							231887	GO:0048008~platelet-derived growth factor receptor signaling pathway,	GO:0005615~extracellular space,	GO:0044822~poly(A) RNA binding,GO:0048407~platelet-derived growth factor binding,	IPR019380:Casein kinase substrate, phosphoprotein PP28,	PF10252:Casein kinase substrate phosphoprotein PP28,		2.47853494936072	2.90898695424735e-07	FDR<0.01	6.53625822640199	2786641.66666667	Unexpected	RBP	Others	Others	Others	Others	526	miscellaneous
Q99LH1	Q99LH1	Gnl2	46.392	14.692	3429200	5.82479030754893	6.37551801083838	3.62226971420292	1.68367175135536	5.32056397978186	13.186871151082	1709665	0	Gnl2	0	Nucleolar GTP-binding protein 2		FUNCTION: GTPase that associates with pre-60S ribosomal subunits in the nucleolus and is required for their nuclear export and maturation (By similarity). May promote cell proliferation possibly by increasing p53/TP53 protein levels, and consequently those of its downstream product CDKN1A/p21, and decreasing RPL23A protein levels (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q13823}.		ribosome biogenesis [GO:0042254]	nucleolus [GO:0005730]	GTP binding [GO:0005525]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q13823}.	230737;		IPR030378;IPR006073;IPR023179;IPR024929;IPR012971;IPR027417;	PF01926;PF08153;		83345	COMPBIAS 11..26;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 470..490;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 499..516;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 550..582;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 636..682;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 695..720;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..33;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 462..521;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 538..595;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 636..728;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (6); Domain (1); Modified residue (2); Nucleotide binding (2); Region (4); Sequence conflict (4)		Acetylation;GTP-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis	DOMAIN 207..368;  /note=CP-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01058					PS51721;	230737	GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR012971:Nucleolar GTP-binding protein 2, N-terminal domain,IPR023179:GTP-binding protein, orthogonal bundle domain,IPR024929:Nucleolar GTP-binding protein 2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF01926:50S ribosome-binding GTPase,PF08153:NGP1NT (NUC091) domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.92107826955177	3.81125497359665e-05	FDR<0.01	4.41893199588227	2569432.5	Present in Nucleus	RBP	Others	Others	Others	Others	546	miscellaneous
P61982	P61982	Ywhag	13.118	3.1492	3482550	2.62660222735869	7.2406053146043	16.1194126086045	NA	4.66222201501235	4.9519659304744	1420968.66666667	1	Ywhag	0	14-3-3 protein gamma [Cleaved into: 14-3-3 protein gamma, N-terminally processed]		FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.		cellular response to insulin stimulus [GO:0032869]; protein targeting [GO:0006605]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic plasticity [GO:0048167]	cytosol [GO:0005829]; myelin sheath [GO:0043209]; presynapse [GO:0098793]; synapse [GO:0045202]; vesicle [GO:0031982]	actin binding [GO:0003779]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; receptor tyrosine kinase binding [GO:0030971]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.	22628;		IPR000308;IPR023409;IPR036815;IPR023410;	PF00244;	SM00101;	28303			NA							5 out of 5	Chain (2); Erroneous initiation (1); Initiator methionine (1); Modified residue (8); Sequence conflict (1); Site (2)		Acetylation;Cytoplasm;Direct protein sequencing;Phosphoprotein;Reference proteome						PS00796;PS00797;	22628	GO:0006605~protein targeting,GO:0032869~cellular response to insulin stimulus,GO:0045664~regulation of neuron differentiation,GO:0048167~regulation of synaptic plasticity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003779~actin binding,GO:0004497~monooxygenase activity,GO:0005080~protein kinase C binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0030971~receptor tyrosine kinase binding,GO:0044822~poly(A) RNA binding,	IPR000308:14-3-3 protein,IPR023409:14-3-3 protein, conserved site,IPR023410:14-3-3 domain,	PF00244:14-3-3 protein,	SSF48445:14-3-3 protein,	2.59393080990181	2.00883310877579e-05	FDR<0.01	4.69705614236994	2451759.33333333	Unexpected	RBP	Others	Others	Others	Others	565	miscellaneous
Q9CPS7	Q9CPS7	Pno1	16.951	10.4	1895050	NA	6.87757909215956	NA	NA	6.23791404154451	3.17107975265578	2934811.66666667	3	Pno1	0	RNA-binding protein PNO1		FUNCTION: Positively regulates dimethylation of two adjacent adenosines in the loop of a conserved hairpin near the 3'-end of 18S rRNA. {ECO:0000250|UniProtKB:Q9NRX1}.			nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NRX1}.	66249;		IPR004087;IPR036612;IPR039912;		SM00322;	27454		REGION 1..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Domain (1); Region (1)		Nucleus;RNA-binding;Reference proteome	DOMAIN 169..221;  /note=KH						66249		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,		SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.90994975271265	5.62285417540244e-05	FDR<0.01	4.2500431794533	2414930.83333333	Present in Nucleus	RBP	RBD	Others	Others	RBD	570	miscellaneous
Q8BU03	Q8BU03	Pwp2	3.2647	10.429	2352950	7.23222680263253	5.16182315593868	39.4042083694539	2.35321802565008	11.6195301062025	7.50976269149895	2122101.66666667	0	Pwp2	0	Periodic tryptophan protein 2 homolog				maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]	Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	110816;		IPR020472;IPR027145;IPR011047;IPR007148;IPR015943;IPR001680;IPR019775;IPR017986;	PF04003;PF00400;	SM00320;	102910	COMPBIAS 900..919;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 238..266;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 885..919;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Modified residue (5); Region (2); Repeat (14); Sequence conflict (1)		Acetylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat				REPEAT 12..50;  /note=WD 1; REPEAT 53..93;  /note=WD 2; REPEAT 94..132;  /note=WD 3; REPEAT 142..181;  /note=WD 4; REPEAT 186..225;  /note=WD 5; REPEAT 286..325;  /note=WD 6; REPEAT 328..368;  /note=WD 7; REPEAT 371..410;  /note=WD 8; REPEAT 413..452;  /note=WD 9; REPEAT 456..498;  /note=WD 10; REPEAT 499..538;  /note=WD 11; REPEAT 541..580;  /note=WD 12; REPEAT 603..642;  /note=WD 13; REPEAT 700..740;  /note=WD 14		PS00678;PS50082;PS50294;	110816	GO:0000028~ribosomal small subunit assembly,GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),	GO:0005634~nucleus,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0030515~snoRNA binding,	IPR001680:WD40 repeat,IPR007148:Small-subunit processome, Utp12,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR027145:Periodic tryptophan protein 2,	PF00400:WD domain, G-beta repeat,PF04003:Dip2/Utp12 Family,	SSF50978:WD40 repeat-like,SSF50998:Quinoprotein alcohol dehydrogenase-like,	2.9117449917013	1.23959336155401e-05	FDR<0.01	4.90672075822186	2237525.83333333	Present in Nucleus	RBP	ChD	Others	ChD	Others	587	miscellaneous
Q6PGG6	Q6PGG6	Gnl3l	20.27	13.004	3755700	3.39201519622808	2.65174617485614	NA	NA	2.94386057876299	2.52289527461715	689861.666666667	2	Gnl3l	0	Guanine nucleotide-binding protein-like 3-like protein		FUNCTION: Stabilizes TERF1 telomeric association by preventing TERF1 recruitment by PML. Stabilizes TERF1 protein by preventing its ubiquitination and hence proteasomal degradation. Does so by interfering with TERF1-binding to FBXO4 E3 ubiquitin-protein ligase. Required for cell proliferation. By stabilizing TRF1 protein during mitosis, promotes metaphase-to-anaphase transition. Stabilizes MDM2 protein by preventing its ubiquitination, and hence proteasomal degradation. By acting on MDM2, may affect TP53 activity. Required for normal processing of ribosomal pre-rRNA. Binds GTP (By similarity). {ECO:0000250, ECO:0000269|PubMed:19487455, ECO:0000269|PubMed:21132010}.		negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]	GTP binding [GO:0005525]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21132010}.	237107;		IPR030378;IPR006073;IPR023179;IPR027417;	PF01926;		65195	COMPBIAS 1..26;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 27..41;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 44..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 9..28;  /note=Required for nucleolar localization;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Domain (1); Mutagenesis (2); Nucleotide binding (3); Region (2)		Coiled coil;GTP-binding;Nucleotide-binding;Nucleus;Reference proteome;Ribosome biogenesis	DOMAIN 118..304;  /note=CP-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01058	DOMAIN: In contrast to other GTP-binding proteins, this family is characterized by a circular permutation of the GTPase motifs described by a G4-G1-G3 pattern.				PS51721;	237107	GO:0031397~negative regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0032091~negative regulation of protein binding,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0033234~negative regulation of protein sumoylation,GO:0042254~ribosome biogenesis,GO:0090073~positive regulation of protein homodimerization activity,GO:1904816~positive regulation of protein localization to chromosome, telomeric region,	GO:0005634~nucleus,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF01926:50S ribosome-binding GTPase,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.35067212141025	0.000583960534310863	FDR<0.01	3.2336165027338	2222780.83333333	Present in Nucleus	RBP	Others	Others	Others	Others	590	miscellaneous
Q8CIL4	Q8CIL4		8.1051	27.791	2804450	3.83832955897593	NA	NA	NA	11.307356566182	3.30786278985148	772940	3	NA	0	Uncharacterized protein C1orf131 homolog					chromosome [GO:0005694]		SUBCELLULAR LOCATION: Chromosome {ECO:0000250|UniProtKB:Q8NDD1}.	66523;		IPR027973;	PF15375;		31344	COMPBIAS 119..141;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 29..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 221..254;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (2); Sequence conflict (4)		Acetylation;Chromosome;Phosphoprotein;Reference proteome							66523		GO:0005694~chromosome,	GO:0044822~poly(A) RNA binding,		PF15375:Domain of unknown function (DUF4602),		2.99618871963199	0.000202833123333673	FDR<0.01	3.6928611217924	1788695	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	657	miscellaneous
F7BJB9	F7BJB9	Morc3	5.6592	7.1574	2219095	3.4473248758963	4.04891084298324	4.5332970669568	6.69478476266988	10.8849461195167	8.14332247557003	631494.166666667	0	Morc3	0	MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3)		FUNCTION: Nuclear factor which forms MORC3-NBs (nuclear bodies) via an ATP-dependent mechanism (By similarity). Sumoylated MORC3-NBs can also associate with PML-NBs (By similarity). Recruits TP53 and SP100 to PML-NBs, thus regulating TP53 activity (PubMed:17332504). Binds RNA in vitro (By similarity). Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) 'Lys-4' on histone H3 (By similarity). The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0 (By similarity). {ECO:0000250|UniProtKB:Q14149, ECO:0000269|PubMed:17332504}.		cell aging [GO:0007569]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]	nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:17332504}. Nucleus matrix {ECO:0000250|UniProtKB:Q14149}. Nucleus, PML body {ECO:0000269|PubMed:17332504}. Note=Also found in PML-independent nuclear bodies. Localization to nuclear bodies is ATP-dependent. {ECO:0000250|UniProtKB:Q14149}.	338467;		IPR036890;IPR041006;IPR011124;	PF17942;PF07496;		106522	COMPBIAS 624..654;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 326..353;  /note=Nuclear matrix binding;  /evidence=ECO:0000250|UniProtKB:Q14149; REGION 503..594;  /note=RNA binding;  /evidence=ECO:0000250|UniProtKB:Q14149; REGION 623..654;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 413;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454; METAL 416;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454; METAL 435;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454; METAL 446;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454		5 out of 5	Beta strand (19); Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (15); Erroneous initiation (1); Helix (12); Metal binding (4); Modified residue (4); Region (3); Sequence conflict (2); Turn (4); Zinc finger (1)		3D-structure;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The CW-TYPE zinc finger mediates its binding to trimethylated histone H3K4me3. {ECO:0000250|UniProtKB:Q14149}.			ZN_FING 404..454;  /note=CW-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454	PS51050;	338467	GO:0006468~protein phosphorylation,GO:0007569~cell aging,GO:0009791~post-embryonic development,GO:0018105~peptidyl-serine phosphorylation,GO:0048147~negative regulation of fibroblast proliferation,GO:0050821~protein stabilization,GO:0051457~maintenance of protein location in nucleus,	GO:0005623~cell,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,	GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,	PF07496:CW-type Zinc Finger,	SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,	2.56706539322307	2.23638880723261e-07	FDR<0.01	6.65045268998217	1425294.58333333	Present in Nucleus	RBP	DBD	DBD	Others	Others	718	miscellaneous
Q61879	Q61879	Myh10	7.4685	12.619	1246820	3.94383972235368	6.21195179525407	9.41353666572531	5.14694528797159	5.41829215431296	13.9817119208076	1534173.33333333	0	Myh10	0	Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)		FUNCTION: Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. During cell spreading, plays an important role in cytoskeleton reorganization, focal contacts formation (in the central part but not the margins of spreading cells), and lamellipodial extension; this function is mechanically antagonized by MYH9 (By similarity). Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. {ECO:0000250}.		actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actomyosin structure organization [GO:0031032]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; modification of postsynaptic actin cytoskeleton [GO:0098885]; myofibril assembly [GO:0030239]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]	actomyosin [GO:0042641]; axon [GO:0030424]; brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; polysome [GO:0005844]; postsynaptic actin cytoskeleton [GO:0098871]; spindle [GO:0005819]; stress fiber [GO:0001725]	actin-dependent ATPase activity [GO:0030898]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]	SUBCELLULAR LOCATION: Cell projection, lamellipodium {ECO:0000250}. Note=Colocalizes with MCC at the leading edge of migrating cells. {ECO:0000250}.	77579;		IPR000048;IPR036961;IPR001609;IPR027401;IPR004009;IPR008989;IPR002928;IPR027417;	PF00612;PF00063;PF02736;PF01576;	SM00015;SM00242;	228996	COMPBIAS 1125..1156;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1697..1717;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1874..1915;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1950..1965;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 661..683;  /note=Actin-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00782; REGION 1125..1175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1697..1718;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1874..1976;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Domain (3); Modified residue (16); Nucleotide binding (1); Region (4)		ATP-binding;Acetylation;Actin-binding;Calmodulin-binding;Cell adhesion;Cell projection;Cell shape;Coiled coil;Methylation;Motor protein;Myosin;Nucleotide-binding;Phosphoprotein;Reference proteome	DOMAIN 31..81;  /note=Myosin N-terminal SH3-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01190; DOMAIN 85..783;  /note=Myosin motor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00782; DOMAIN 786..815;  /note=IQ;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00116	DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles of a 28-residue repeat pattern composed of 4 heptapeptides, characteristic for alpha-helical coiled coils.				PS50096;PS51456;PS51844;	77579	GO:0000281~mitotic cytokinesis,GO:0001701~in utero embryonic development,GO:0001764~neuron migration,GO:0001778~plasma membrane repair,GO:0003279~cardiac septum development,GO:0006887~exocytosis,GO:0006930~substrate-dependent cell migration, cell extension,GO:0007097~nuclear migration,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007420~brain development,GO:0007507~heart development,GO:0007512~adult heart development,GO:0008283~cell proliferation,GO:0008360~regulation of cell shape,GO:0021592~fourth ventricle development,GO:0021670~lateral ventricle development,GO:0021678~third ventricle development,GO:0021680~cerebellar Purkinje cell layer development,GO:0030036~actin cytoskeleton organization,GO:0030048~actin filament-based movement,GO:0030239~myofibril assembly,GO:0031032~actomyosin structure organization,GO:0031175~neuron projection development,GO:0035904~aorta development,GO:0050885~neuromuscular process controlling balance,GO:0055003~cardiac myofibril assembly,GO:0055015~ventricular cardiac muscle cell development,GO:0060041~retina development in camera-type eye,GO:0060976~coronary vasculature development,	GO:0001725~stress fiber,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005819~spindle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030027~lamellipodium,GO:0030424~axon,GO:0030426~growth cone,GO:0030496~midbody,GO:0031594~neuromuscular junction,GO:0032154~cleavage furrow,GO:0042641~actomyosin,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0070062~extracellular exosome,GO:0097513~myosin II filament,	GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0030898~actin-dependent ATPase activity,GO:0043531~ADP binding,GO:0051015~actin filament binding,	IPR000048:IQ motif, EF-hand binding site,IPR001609:Myosin head, motor domain,IPR002928:Myosin tail,IPR004009:Myosin, N-terminal, SH3-like,IPR008989:Myosin S1 fragment, N-terminal,IPR027401:Myosin-like IQ motif-containing domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00063:Myosin head (motor domain),PF00612:IQ calmodulin-binding motif,PF01576:Myosin tail,PF02736:Myosin N-terminal SH3-like domain,	SSF50084:Myosin S1 fragment, N-terminal domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.87684404284288	1.5541170009222e-07	FDR<0.01	6.80851628866115	1390496.66666667	Present in Nucleus	RBP	Others	Others	Others	Others	723	miscellaneous
O88532	O88532	Zfr	4.7984	8.6261	1435350	11.0625587698435	4.50653447498873	21.9992960225273	4.27131385614215	7.22178089116776	6.72178530617732	1030196.66666667	0	Zfr	0	Zinc finger RNA-binding protein		FUNCTION: Involved in postimplantation and gastrulation stages of development. Binds to DNA and RNA. Involved in the nucleocytoplasmic shuttling of STAU2 (By similarity). {ECO:0000250, ECO:0000269|PubMed:16277607}.		multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasmic granule {ECO:0000250}. Chromosome {ECO:0000250}. Note=Associated with chromosome foci in meiotic cells. Localizes in somatodendritic compartment of primary hippocampal neurons (By similarity). Colocalizes with STAU2 in several cytosolic RNA granules (By similarity). Associated with chromosomes. {ECO:0000250}.	22763;		IPR006561;IPR003604;IPR043519;IPR036236;IPR013087;	PF07528;	SM00572;SM00355;SM00451;	116859	COMPBIAS 363..377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 423..452;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1048..1074;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 120..139;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 349..377;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 417..452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 703..723;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 760..781;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1040..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (3); Cross-link (3); Domain (1); Erroneous initiation (5); Modified residue (3); Region (6); Sequence caution (2); Sequence conflict (5)	MISCELLANEOUS: Knockout mice form mesoderm but are delayed in their development and fail to form normal anterior embryonic structures. Show both an increase in programmed cell death and a decrease in mitotic index, especially in the region of the distal tip of the embryonic ectoderm. Also show a reduction in apical vacuoles in the columnar visceral endoderm cells in the extraembryonic region. Knockout mice die by 8 to 9 days of gestation.	Acetylation;Chromosome;Cytoplasm;DNA-binding;Developmental protein;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 703..1073;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040					PS51703;PS00028;	22763	GO:0007275~multicellular organism development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR006561:DZF,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,	PF07528:DZF domain,		2.89576974844429	5.08230527662368e-07	FDR<0.01	6.29393925192413	1232773.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	762	miscellaneous
Q78ZA7	Q78ZA7	Nap1l4	916.11	65.755	757421.5	2.85396272724678	10.7682036482674	5.66187294757106	6.27510040160643	7.23274989150875	6.27549419516787	1589010.5	0	Nap1l4	0	Nucleosome assembly protein 1-like 4		FUNCTION: Acts as histone chaperone in nucleosome assembly (PubMed:28366643). In condensing spermatids, mediates the loading of the heterodimer composed of histones H2AB1 and H2BC1/TH2B onto the nucleosomes, thereby promoting the replacement of histones to protamine in male germ cells (PubMed:28366643). {ECO:0000269|PubMed:28366643}.		nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q99733}. Cytoplasm {ECO:0000250|UniProtKB:Q99733}. Note=Present in the cytoplasm and excluded from the nucleus during G0/G1 phase, then relocates to the nucleus by the time cells are in S phase. Phosphorylated form localizes in the cytoplasm during the G0/G1 transition, whereas dephosphorylation leads to relocalization into the nucleus at the G1/S-boundary. {ECO:0000250|UniProtKB:Q99733}.	17955;		IPR037231;IPR002164;	PF00956;		42679	COMPBIAS 340..368;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..28;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 339..375;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (12); Motif (1); Region (2)		Acetylation;Chaperone;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome			MOTIF 265..271;  /note=Nuclear localization signal;  /evidence=ECO:0000255				17955	GO:0006334~nucleosome assembly,	GO:0005634~nucleus,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0044822~poly(A) RNA binding,	IPR002164:Nucleosome assembly protein (NAP),	PF00956:Nucleosome assembly protein (NAP),		3.93440864605808	0.000406001558190451	FDR<0.01	3.39147229964395	1173216	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	777	miscellaneous
A2A6A1	A2A6A1	Gpatch8	2.5739	2.6074	1729700	2.58792474314847	2.22900831420101	NA	2.32671769934154	2.45537358509097	2.07792207792208	345367.666666667	1	Gpatch8	0	G patch domain-containing protein 8					nucleus [GO:0005634]	metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]		237943;		IPR000467;IPR022755;IPR036236;IPR013087;	PF01585;PF12171;	SM00443;	164987	COMPBIAS 166..204;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 322..343;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 352..366;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 432..455;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 484..498;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 499..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 575..621;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 645..661;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 662..684;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 685..701;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 740..764;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 788..806;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 807..831;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 832..849;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 871..895;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 896..936;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 952..983;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1013..1034;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1048..1062;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1065..1089;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1159..1185;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1290..1304;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 166..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 322..393;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 419..537;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 575..1304;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (1); Compositional bias (22); Cross-link (3); Domain (1); Modified residue (14); Region (4); Sequence conflict (1); Zinc finger (1)		Acetylation;Coiled coil;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 40..86;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092				ZN_FING 136..160;  /note=C2H2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50174;PS00028;PS50157;	237943		GO:0016021~integral component of membrane,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000467:G-patch domain,IPR007087:Zinc finger, C2H2,IPR022755:Zinc finger, double-stranded RNA binding,	PF01585:G-patch domain,PF12171:Zinc-finger double-stranded RNA-binding,		1.26344940994443	5.441876218975e-05	FDR<0.01	4.26425134091486	1037533.83333333	Present in Nucleus	RBP	DBD	DBD	Others	RBD	806	miscellaneous
Q505F5	Q505F5	Lrrc47	3.8908	3.6857	1669800	NA	NA	NA	NA	1.83847186218815	2.34224949641636	197166.666666667	4	Lrrc47	0	Leucine-rich repeat-containing protein 47						phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]		72946;		IPR005146;IPR001611;IPR003591;IPR032675;IPR020825;	PF03483;PF13855;	SM00873;SM00369;	63590	COMPBIAS 265..283;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 262..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Coiled coil (1); Compositional bias (1); Modified residue (3); Region (1); Repeat (7); Sequence conflict (2)		Coiled coil;Leucine-rich repeat;Phosphoprotein;Reference proteome;Repeat				REPEAT 78..97;  /note=LRR 1; REPEAT 102..123;  /note=LRR 2; REPEAT 132..154;  /note=LRR 3; REPEAT 156..177;  /note=LRR 4; REPEAT 182..204;  /note=LRR 5; REPEAT 205..227;  /note=LRR 6; REPEAT 228..248;  /note=LRR 7		PS51450;	72946			GO:0003723~RNA binding,GO:0004826~phenylalanine-tRNA ligase activity,GO:0044822~poly(A) RNA binding,	IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR005146:B3/B4 tRNA-binding domain,IPR025875:Leucine rich repeat 4,	PF03483:B3/4 domain,PF12799:Leucine Rich repeats (2 copies),PF13855:Leucine rich repeat,	SSF52058:L domain-like,	1.4871018314262	0.00324558903882779	FDR<0.01	2.48870647202318	933483.333333333	Unexpected	RBP	RBD	Others	Others	RBD	850	miscellaneous
Q80VD1	Q80VD1	Fam98b	5.9964	9.3084	1547600	0.531490831783152	NA	14.8102071947987	NA	1.81732272016865	5.64334085778781	227550.5	2	Fam98b	0	Protein FAM98B		FUNCTION: Positively stimulates PRMT1-induced protein arginine dimethylated arginine methylation. {ECO:0000250|UniProtKB:Q52LJ0}.		positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein methylation [GO:0006479]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]	identical protein binding [GO:0042802]; protein methyltransferase activity [GO:0008276]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q52LJ0}. Cytoplasm {ECO:0000250|UniProtKB:Q52LJ0}.	68215;		IPR018797;	PF10239;		45349		REGION 304..429;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Region (1)		Cytoplasm;Nucleus;Reference proteome							68215		GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0072669~tRNA-splicing ligase complex,	GO:0044822~poly(A) RNA binding,	IPR018797:Uncharacterised protein family FAM98,	PF10239:Protein of unknown function (DUF2465),		2.0229384313403	0.00657810490177358	FDR<0.01	2.18189920505553	887575.25	Present in Nucleus	RBP	Others	Others	Others	Others	867	miscellaneous
Q9CZT6	Q9CZT6	Cmss1	1.788	7.3747	1010130	1.62451061617688	NA	NA	NA	3.510249929795	5.27120341573981	583204	3	Cmss1	0	Protein CMSS1 (Cms1 ribosomal small subunit homolog)								66497;		IPR032704;IPR027417;	PF14617;		31594	COMPBIAS 15..54;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..91;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (1); Sequence conflict (1)		Methylation;Phosphoprotein;Reference proteome							66497		GO:0005634~nucleus,GO:0030686~90S preribosome,	GO:0044822~poly(A) RNA binding,	IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF14617:U3-containing 90S pre-ribosomal complex subunit,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.72612847826337	0.00219227941679925	FDR<0.01	2.65910409369111	796667	Present in Nucleus	RBP	Others	Others	Others	Others	897	miscellaneous
P24547	P24547;P50096	Impdh2	5.5523	2.9915	459940	NA	4.64943276920216	2.49744012387303	2.63887056339887	4.21780758361804	5.2443885043004	1097471.16666667	1	Impdh2	0	Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II)		FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. {ECO:0000250|UniProtKB:P12268}.	PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway; XMP from IMP: step 1/1. {ECO:0000250|UniProtKB:P12268}.	cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; purine nucleotide biosynthetic process [GO:0006164]; retina development in camera-type eye [GO:0060041]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P12268}. Nucleus {ECO:0000250|UniProtKB:P12268}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P12268}. Note=Can form fiber-like subcellular structures termed 'cytoophidia' in response to intracellular guanine-nucleotide depletion. {ECO:0000250|UniProtKB:P12268}.	23918;	cd00381;	IPR013785;IPR000644;IPR005990;IPR015875;IPR001093;	PF00571;PF00478;	SM00116;	55815		REGION 364..366;  /note=IMP binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; REGION 387..388;  /note=IMP binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; REGION 411..415;  /note=IMP binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156	NA	ACT_SITE 331;  /note=Thioimidate intermediate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; ACT_SITE 429;  /note=Proton acceptor;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156	ACTIVITY REGULATION: Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. {ECO:0000255|HAMAP-Rule:MF_03156}.	BINDING 329;  /note=IMP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; BINDING 441;  /note=IMP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156	1.1.1.205	METAL 326;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 328;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 331;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 500;  /note=Potassium; via carbonyl oxygen; shared with tetrameric partner;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 501;  /note=Potassium; via carbonyl oxygen; shared with tetrameric partner;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 502;  /note=Potassium; via carbonyl oxygen; shared with tetrameric partner;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156		5 out of 5	Active site (2); Binding site (2); Chain (1); Cross-link (3); Domain (2); Metal binding (6); Modified residue (5); Natural variant (2); Nucleotide binding (2); Region (3); Sequence conflict (3)		Acetylation;CBS domain;Cytoplasm;DNA-binding;Direct protein sequencing;GMP biosynthesis;Isopeptide bond;Metal-binding;NAD;Nucleus;Oxidoreductase;Phosphoprotein;Potassium;Purine biosynthesis;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 114..173;  /note=CBS 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; DOMAIN 179..237;  /note=CBS 2;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156					PS51371;PS00487;	23918	GO:0006164~purine nucleotide biosynthetic process,GO:0006177~GMP biosynthetic process,GO:0006183~GTP biosynthetic process,GO:0046651~lymphocyte proliferation,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,GO:0060041~retina development in camera-type eye,GO:0071353~cellular response to interleukin-4,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005778~peroxisomal membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003938~IMP dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001093:IMP dehydrogenase/GMP reductase,IPR005990:Inosine-5'-monophosphate dehydrogenase,IPR013785:Aldolase-type TIM barrel,IPR015875:IMP dehydrogenase / GMP reductase, conserved site,	PF00478:IMP dehydrogenase / GMP reductase domain,PF00571:CBS domain,		1.92266397509525	8.97935583028823e-06	FDR<0.01	5.04675481805272	778705.583333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	903	miscellaneous
Q62426	Q62426	Cstb	7.9071	7.5471	1190950	NA	NA	NA	NA	NA	4.13018338014208	205050	5	Cstb	0	Cystatin-B (Stefin-B)		FUNCTION: This is an intracellular thiol proteinase inhibitor.		adult locomotory behavior [GO:0008344]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]	SUBCELLULAR LOCATION: Cytoplasm.	13014;	cd00042;	IPR000010;IPR018073;IPR001713;	PF00031;	SM00043;	11046			NA							4 out of 5	Chain (1); Modified residue (1); Motif (1); Site (1)		Acetylation;Cytoplasm;Protease inhibitor;Reference proteome;Thiol protease inhibitor			MOTIF 46..50;  /note=Secondary area of contact;  /evidence=ECO:0000250			PS00287;	13014	GO:0008344~adult locomotory behavior,GO:0010466~negative regulation of peptidase activity,GO:0045861~negative regulation of proteolysis,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,GO:0044822~poly(A) RNA binding,	IPR000010:Proteinase inhibitor I25, cystatin,IPR001713:Proteinase inhibitor I25A, stefin A,IPR018073:Proteinase inhibitor I25, cystatin, conserved site,	PF00031:Cystatin domain,		2.64842563309246	0.000622480107573071	FDR<0.01	3.20587452264072	698000	Present in Nucleus	RBP	Others	Others	Others	Others	935	miscellaneous
P46061	P46061	Rangap1	1.5367	2.8593	853470	7.3008688033876	2.2013340084091	3.99696230864543	1.90045420855584	NA	NA	233541.666666667	2	Rangap1	0	Ran GTPase-activating protein 1 (RanGAP1)		FUNCTION: GTPase activator for RAN. Converts cytoplasmic GTP-bound RAN to GDP-bound RAN, which is essential for RAN-mediated nuclear import and export (PubMed:18305100). Mediates dissociation of cargo from nuclear export complexes containing XPO1, RAN and RANBP2 after nuclear export (By similarity). Required for postimplantation embryonic development (PubMed:8314081). {ECO:0000250|UniProtKB:P46060, ECO:0000269|PubMed:18305100, ECO:0000269|PubMed:8314081}.		activation of GTPase activity [GO:0090630]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:26506250, ECO:0000269|PubMed:9442102, ECO:0000269|PubMed:9456312}. Nucleus, nucleoplasm {ECO:0000269|PubMed:26506250}. Nucleus envelope {ECO:0000269|PubMed:16469311, ECO:0000269|PubMed:18305100, ECO:0000269|PubMed:26506250, ECO:0000269|PubMed:9442102, ECO:0000269|PubMed:9456312}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P46060}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P46060}. Note=Cytoplasmic during interphase (PubMed:26506250). Detected at the nuclear envelope during interphase (PubMed:9442102, PubMed:9456312, PubMed:26506250). Shuttles between nucleus and cytoplasm (PubMed:26506250). Targeted to the nuclear pores after sumoylation. During mitosis, associates with mitotic spindles, but is essentially not detected at the spindle poles. Association with kinetochores appears soon after nuclear envelope breakdown and persists until late anaphase. Mitotic location also requires sumoylation (By similarity). {ECO:0000250|UniProtKB:P46060, ECO:0000269|PubMed:26506250, ECO:0000269|PubMed:9442102, ECO:0000269|PubMed:9456312}.	19387;		IPR001611;IPR032675;IPR009109;IPR036720;	PF13516;PF07834;		63531	COMPBIAS 359..402;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 357..436;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 541..566;  /note=Important for accumulation in the nucleus;  /evidence=ECO:0000269|PubMed:26506250	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (9); Helix (10); Initiator methionine (1); Modified residue (11); Motif (1); Mutagenesis (23); Region (2); Repeat (6); Sequence conflict (2); Site (2)		3D-structure;Acetylation;Centromere;Chromosome;Cytoplasm;Cytoskeleton;GTPase activation;Isopeptide bond;Kinetochore;Leucine-rich repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation			MOTIF 525..528;  /note=SUMO conjugation;  /evidence=ECO:0000250	REPEAT 48..71;  /note=LRR 1; REPEAT 111..134;  /note=LRR 2; REPEAT 207..230;  /note=LRR 3; REPEAT 235..258;  /note=LRR 4; REPEAT 292..315;  /note=LRR 5; REPEAT 320..343;  /note=LRR 6			19387	GO:0007165~signal transduction,GO:0046826~negative regulation of protein export from nucleus,GO:0048678~response to axon injury,GO:0071375~cellular response to peptide hormone stimulus,GO:1904117~cellular response to vasopressin,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044614~nuclear pore cytoplasmic filaments,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,GO:1904115~axon cytoplasm,GO:1990723~cytoplasmic periphery of the nuclear pore complex,	GO:0005096~GTPase activator activity,GO:0008536~Ran GTPase binding,GO:0031625~ubiquitin protein ligase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001611:Leucine-rich repeat,IPR009109:Ran-GTPase activating protein 1, C-terminal,IPR027038:Ran GTPase-activating protein,	PF07834:RanGAP1 C-terminal domain,PF13516:Leucine Rich repeat,	SSF69099:Ran-GTPase activating protein 1 (RanGAP1), C-terminal domain,	1.51119866501141	0.00125479153258767	FDR<0.01	2.90142842061093	543505.833333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1009	miscellaneous
P11260	P11260		10.031	3.5257	417380	3.27868852459016	1.78069019551978	0.443458980044346	0.604193100114797	2.29058341159493	5.36768652710682	658484.666666667	0	NA	0	LINE-1 retrotransposable element ORF1 protein (L1-ORF1p) (LINE retrotransposable element 1) (LINE1 retrotransposable element 1) (Transposase element L1Md-A101/L1Md-A102/L1Md-A2)		FUNCTION: Nucleic acid-binding protein which is essential for retrotransposition of LINE-1 elements in the genome. Functions as a nucleic acid chaperone binding its own transcript and therefore preferentially mobilizing the transcript from which they are encoded. {ECO:0000269|PubMed:11134335, ECO:0000269|PubMed:28806172}.		transposition, RNA-mediated [GO:0032197]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]	nucleotide binding [GO:0000166]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9UN81}. Cytoplasm {ECO:0000269|PubMed:28806172}. Cytoplasm, Cytoplasmic ribonucleoprotein granule {ECO:0000250|UniProtKB:Q9UN81}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9UN81}. Note=Colocalizes with its encoding RNA in cytoplasmic ribonucleoprotein particle. Mainly cytoplasmic, rarely detected in the nucleus, possibly within the nucleolus. {ECO:0000250|UniProtKB:Q9UN81}.			IPR042566;IPR035300;IPR043636;IPR004244;IPR042497;	PF17490;PF02994;		41226		REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 179..274;  /note=RNA recognition motif (RRM) domain;  /evidence=ECO:0000250; REGION 278..339;  /note=C-terminal domain (CTD)	NA							5 out of 5	Beta strand (3); Chain (1); Coiled coil (1); Helix (3); Region (3); Turn (3)	MISCELLANEOUS: An active LINE-1 encodes for 2 proteins translated from a single RNA containing two non-overlapping ORFs, ORF1 and ORF2. ORF1p is described in that entry as a representative of all ORF1p potentially expressed by active elements in mouse genome. ORF2p is described in the related entry AC P11369.	3D-structure;Coiled coil;Cytoplasm;Nucleotide-binding;Nucleus;Reference proteome;Ubl conjugation		DOMAIN: The coiled coil domain mediates homotrimerization. {ECO:0000250}.; DOMAIN: The RRM and the CTD domain are both required for proper RNA-binding activity.					NA	NA	NA	NA	NA	NA	NA	1.17622854301674	0.0265865984529921	FDR<0.1	1.57533722369116	537932.333333333	Present in Nucleus	RBP	Others	Others	Others	Others	1015	miscellaneous
Q8BT60	Q8BT60	Cpne3	2.2795	15.35	664760	NA	4.68055230517201	NA	NA	1.69459931199268	5.16448897381604	175483.333333333	3	Cpne3	0	Copine-3 (Copine III)		FUNCTION: Calcium-dependent phospholipid-binding protein that plays a role in ERBB2-mediated tumor cell migration in response to growth factor heregulin stimulation. {ECO:0000250|UniProtKB:O75131}.		cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75131}. Cytoplasm {ECO:0000250|UniProtKB:O75131}. Cell membrane {ECO:0000250|UniProtKB:O75131}. Cell junction {ECO:0000250|UniProtKB:O75131}. Cell junction, focal adhesion {ECO:0000250|UniProtKB:O75131}. Note=Associates to the membrane in a calcium-dependent manner. Translocates to the cell membrane and the nucleus in a calcium- or growth factor heregulin-dependent manner. Colocalizes with the tyrosine phosphorylated ERBB2 form at cell membrane and focal adhesions in a calcium- or growth factor heregulin-dependent manner. {ECO:0000250|UniProtKB:O75131}.	70568;	cd04047;cd01459;	IPR000008;IPR035892;IPR037768;IPR010734;IPR002035;IPR036465;	PF00168;PF07002;	SM00239;SM00327;	59585			NA					METAL 22;  /note=Calcium 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 22;  /note=Calcium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 28;  /note=Calcium 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 81;  /note=Calcium 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 81;  /note=Calcium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 83;  /note=Calcium 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 83;  /note=Calcium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 93;  /note=Calcium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 154;  /note=Calcium 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 154;  /note=Calcium 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 160;  /note=Calcium 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 216;  /note=Calcium 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 216;  /note=Calcium 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 218;  /note=Calcium 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 218;  /note=Calcium 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; METAL 224;  /note=Calcium 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041		5 out of 5	Chain (1); Domain (3); Erroneous initiation (1); Metal binding (16); Modified residue (3); Sequence conflict (2)		Calcium;Cell junction;Cell membrane;Cytoplasm;Membrane;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat	DOMAIN 1..115;  /note=C2 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; DOMAIN 124..247;  /note=C2 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00041; DOMAIN 291..513;  /note=VWFA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00219					PS50004;	70568	GO:0030335~positive regulation of cell migration,GO:0038128~ERBB2 signaling pathway,GO:0071277~cellular response to calcium ion,GO:0071363~cellular response to growth factor stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030054~cell junction,GO:0070062~extracellular exosome,	GO:0004674~protein serine/threonine kinase activity,GO:0005544~calcium-dependent phospholipid binding,GO:0030971~receptor tyrosine kinase binding,GO:0044822~poly(A) RNA binding,GO:0048306~calcium-dependent protein binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR002035:von Willebrand factor, type A,IPR010734:Copine,	PF00168:C2 domain,PF07002:Copine,	SSF49562:C2 domain (Calcium/lipid-binding domain, CaLB),SSF53300:vWA-like,	2.09702654549491	0.00190851894662527	FDR<0.01	2.71930352427974	420121.666666667	Present in Nucleus	RBP	Others	Others	Others	Others	1096	miscellaneous
Q6ZPL9	Q6ZPL9	Ddx55	NA	2.204	121315	15.2084315544538	6.18008775724615	NA	NA	2.35100505466087	7.49232037161909	518630.333333333	2	Ddx55	1	ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55)		FUNCTION: Probable ATP-binding RNA helicase.			cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]		67848;		IPR011545;IPR025313;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF13959;PF00271;	SM00487;SM01178;SM00490;	68465	COMPBIAS 499..517;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 518..535;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 499..551;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (2); Domain (2); Erroneous initiation (2); Modified residue (2); Motif (2); Nucleotide binding (1); Region (1); Sequence conflict (2)		ATP-binding;Helicase;Hydrolase;Nucleotide-binding;Phosphoprotein;RNA-binding;Reference proteome	DOMAIN 40..223;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 254..402;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The Q motif is unique to and characteristic of the DEAD box family of RNA helicases and controls ATP binding and hydrolysis.	MOTIF 9..37;  /note=Q motif; MOTIF 171..174;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	67848	GO:0010501~RNA secondary structure unwinding,	GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF13959:Domain of unknown function (DUF4217),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.3666482500528	0.000745230269448312	FDR<0.01	3.12770951342771	319972.666666667	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1164	miscellaneous
Q8BMK4	Q8BMK4	Ckap4	6.4147	6.063	149245	5.6205035971223	3.77557955146115	NA	NA	2.69432843863667	2.7114967462039	486917.5	2	Ckap4	0	Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63)		FUNCTION: High-affinity epithelial cell surface receptor for APF. {ECO:0000250}.; FUNCTION: Mediates the anchoring of the endoplasmic reticulum to microtubules. {ECO:0000250}.			cell surface [GO:0009986]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]		SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type II membrane protein. Cell membrane; Single-pass type II membrane protein. Cytoplasm, cytoskeleton. Cytoplasm, perinuclear region. Note=Translocates to the perinuclear region upon APF-stimulation. {ECO:0000250}.	216197;		IPR028428;			63692	COMPBIAS 38..53;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..73;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (3); Compositional bias (1); Erroneous initiation (2); Lipidation (1); Modified residue (7); Region (1); Sequence caution (1); Sequence conflict (2); Topological domain (2); Transmembrane (1)		Acetylation;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Endoplasmic reticulum;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix							216197		GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005811~lipid particle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0044822~poly(A) RNA binding,				2.0929710499964	3.28188687520748e-05	FDR<0.01	4.48387639291117	318081.25	Present in Nucleus	RBP	Others	Others	Others	Others	1166	miscellaneous
E9Q8D0	E9Q8D0	Dnajc21	2.3938	4.0777	191505	5.15437348590279	3.13312654698123	2.08999519301106	2.00144103754703	2.55754475703325	3.05707560147962	353335.5	0	Dnajc21	0	DnaJ homolog subfamily C member 21		FUNCTION: May act as a co-chaperone for HSP70. May play a role in ribosomal RNA (rRNA) biogenesis, possibly in the maturation of the 60S subunit. Binds the precursor 45S rRNA. {ECO:0000250|UniProtKB:Q5F1R6}.			cytosol [GO:0005829]; nucleolus [GO:0005730]	nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q5F1R6}. Nucleus {ECO:0000250|UniProtKB:Q5F1R6}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q5F1R6}. Note=Within the nucleus, localizes primarily to the nucleolus. {ECO:0000250|UniProtKB:Q5F1R6}.	78244;	cd06257;	IPR001623;IPR018253;IPR036869;IPR003604;IPR022755;IPR036236;IPR013087;	PF00226;PF12171;	SM00271;SM00355;SM00451;	61735	COMPBIAS 327..353;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 409..429;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 443..458;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 278..309;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 327..480;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 507..531;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Domain (1); Modified residue (4); Region (3); Zinc finger (2)		Chaperone;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger	DOMAIN 3..69;  /note=J;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00286				ZN_FING 314..338;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 483..507;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00636;PS50076;PS00028;PS50157;	78244			GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,	IPR001623:DnaJ domain,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,IPR018253:DnaJ domain, conserved site,IPR022755:Zinc finger, double-stranded RNA binding,	PF00226:DnaJ domain,PF12171:Zinc-finger double-stranded RNA-binding,	SSF46565:Chaperone J-domain,	1.54148860459931	1.64607155552949e-05	FDR<0.01	4.78355128972147	272420.25	Present in Nucleus	RBP	DBD	DBD	Others	RBD	1214	miscellaneous
Q3UFM5	Q3UFM5	Nom1	NA	2.6972	272984.1	2.91621708319967	3.67958199948486	NA	NA	4.31424996764312	3.996003996004	187668.333333333	2	Nom1	1	Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)		FUNCTION: Plays a role in targeting PPP1CA to the nucleolus. {ECO:0000250}.		hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]	nucleolus [GO:0005730]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	433864;		IPR016024;IPR003891;IPR016021;IPR003890;	PF02847;PF02854;	SM00544;SM00543;	95960	COMPBIAS 75..98;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 140..154;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 179..208;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 277..333;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..275;  /note=Necessary for nucleolar localization and for targeting PPP1CA to the nucleolus;  /evidence=ECO:0000250; REGION 66..215;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 231..333;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (4); Domain (2); Modified residue (4); Motif (1); Region (3); Sequence conflict (1)		Nucleus;Phosphoprotein;Reference proteome	DOMAIN 356..553;  /note=MIF4G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00698; DOMAIN 648..764;  /note=MI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00698		MOTIF 301..304;  /note=Required for efficient binding to PPP1CA and for targeting PPP1CA to the nucleolus;  /evidence=ECO:0000250			PS51366;	433864	GO:0022008~neurogenesis,GO:0042274~ribosomal small subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR003890:MIF4G-like, type 3,IPR003891:Initiation factor eIF-4 gamma, MA3,IPR016021:MIF4-like, type 1/2/3,IPR016024:Armadillo-type fold,	PF02847:MA3 domain,PF02854:MIF4G domain,	SSF48371:ARM repeat,	1.79255406011809	0.000133598799911431	FDR<0.01	3.87419744301455	230326.216666667	Present in Nucleus	RBP	Others	Others	Others	Others	1251	miscellaneous
Q60676	Q60676	Ppp5c	0.32324	NA	13587.5	9.56846234810066	7.81921964187974	6.84228532329798	NA	NA	NA	93898.3333333333	3	Ppp5c	1	Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PPT)		FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT (PubMed:17376776, PubMed:21994940, PubMed:22526606). Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses (By similarity). Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 (PubMed:17376776). Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress (By similarity). Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (PubMed:21994940). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (PubMed:21994940). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E. May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels. Dephosphorylates and may play a role in the regulation of TAU/MAPT (By similarity). Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 (By similarity). {ECO:0000250|UniProtKB:P53041, ECO:0000250|UniProtKB:P53042, ECO:0000269|PubMed:17376776, ECO:0000269|PubMed:21994940, ECO:0000269|PubMed:22526606}.		cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278]	cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]	ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine phosphatase activity [GO:0106306]; protein threonine phosphatase activity [GO:0106307]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21994940}. Cytoplasm {ECO:0000269|PubMed:21994940}. Cell membrane {ECO:0000250|UniProtKB:P53041}. Note=Predominantly nuclear. But also present in the cytoplasm. Translocates from the cytoplasm to the plasma membrane in a RAC1-dependent manner. {ECO:0000250|UniProtKB:P53041}.	19060;	cd07417;	IPR004843;IPR029052;IPR041753;IPR013235;IPR006186;IPR011236;IPR013026;IPR011990;IPR001440;IPR019734;	PF00149;PF08321;PF00515;	SM00156;SM00028;	56877	COMPBIAS 9..24;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 184..499;  /note=Catalytic; REGION 303..304;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:P53041; REGION 495..499;  /note=Required for autoinhibition;  /evidence=ECO:0000250|UniProtKB:P53042	NA	ACT_SITE 304;  /note=Proton donor/acceptor;  /evidence=ECO:0000250|UniProtKB:P53041	ACTIVITY REGULATION: Autoinhibited. In the autoinhibited state, the TPR domain interacts with the catalytic region and prevents substrate access to the catalytic pocket. Allosterically activated by various polyunsaturated fatty acids, free long-chain fatty-acids and long-chain fatty acyl-CoA esters, arachidonic acid being the most effective activator. HSP90A and probably RAC1, GNA12 and GNA13 can also release the autoinhibition by the TPR repeat. Activation by RAC1, GNA12 and GNA13 is synergistic with the one produced by fatty acids binding. Inhibited by okadaic acid.	BINDING 244;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P53041; BINDING 275;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P53041; BINDING 400;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P53041; BINDING 427;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P53041	3.1.3.16	METAL 242;  /note=Manganese 1;  /evidence=ECO:0000250|UniProtKB:P53041; METAL 244;  /note=Manganese 1; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:P53041; METAL 271;  /note=Manganese 1;  /evidence=ECO:0000250|UniProtKB:P53041; METAL 271;  /note=Manganese 2;  /evidence=ECO:0000250|UniProtKB:P53041; METAL 303;  /note=Manganese 2;  /evidence=ECO:0000250|UniProtKB:P53041; METAL 352;  /note=Manganese 2; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:P53041; METAL 427;  /note=Manganese 2; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:P53041		5 out of 5	Active site (1); Binding site (4); Chain (1); Compositional bias (1); Initiator methionine (1); Metal binding (7); Modified residue (1); Region (4); Repeat (3); Sequence conflict (3)		Acetylation;Cell membrane;Cytoplasm;Hydrolase;Magnesium;Manganese;Membrane;Metal-binding;Nucleus;Protein phosphatase;Reference proteome;Repeat;TPR repeat				REPEAT 28..61;  /note=TPR 1; REPEAT 62..95;  /note=TPR 2; REPEAT 96..129;  /note=TPR 3		PS00125;PS50005;PS50293;	19060	GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0010288~response to lead ion,GO:0016576~histone dephosphorylation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043278~response to morphine,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0060548~negative regulation of cell death,GO:0070301~cellular response to hydrogen peroxide,GO:0071276~cellular response to cadmium ion,GO:1901215~negative regulation of neuron death,GO:2000324~positive regulation of glucocorticoid receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0071944~cell periphery,GO:1990635~proximal dendrite,	GO:0001965~G-protein alpha-subunit binding,GO:0003723~RNA binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016787~hydrolase activity,GO:0031072~heat shock protein binding,GO:0042802~identical protein binding,GO:0043531~ADP binding,GO:0046872~metal ion binding,	IPR001440:Tetratricopeptide TPR-1,IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,IPR011236:Serine/threonine protein phosphatase 5,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR013235:PPP domain,IPR019734:Tetratricopeptide repeat,	PF00149:Calcineurin-like phosphoesterase,PF00515:Tetratricopeptide repeat,PF08321:PPP5 TPR repeat region,	SSF48452:TPR-like,SSF56300:Metallo-dependent phosphatases,	1.84261691131513	0.0587675299858399	FDR<0.1	1.23086256240901	53742.9166666667	Present in Nucleus	RBP	Others	Others	Others	Others	1425	miscellaneous
